Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,mesonephric tubule development (GO:0072164),-0.7759233342795404,-2.086441957815802,0.0,0.04347157708278379,0.043,8/15,11.67%,FGFR2;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1;PKD1
prerank,retinoid metabolic process (GO:0001523),-0.5329206981790556,-2.0404502507161433,0.0,0.05119985745305647,0.095,12/71,3.93%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;HSPG2;GPC3;RBP1;CYP26B1;APOE;ABCA4;RBP4
prerank,ureteric bud development (GO:0001657),-0.7397661706058478,-2.028010126061383,0.0,0.0425055420364997,0.116,8/17,11.08%,FGFR2;GPC3;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5826798620056794,-2.0110156921874816,0.0,0.04516213841378094,0.152,17/50,9.91%,GLI3;ZIC1;FGFR2;GPC3;SMO;DCDC2;GAS1;TULP3;IFT81;CREBBP;RORA;ARMC9;EVC;MEGF8;INTU;GLI1;PTCH1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.813859552958782,1.993839922503059,0.0,0.16846742917166455,0.127,7/26,5.93%,NOS1;ACER2;NOS3;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,establishment of endothelial barrier (GO:0061028),0.7749168741574255,1.9782905398205985,0.0,0.11823165962951157,0.166,12/29,9.21%,PECAM1;RAPGEF2;F11R;RAPGEF1;F2RL1;SOX18;MSN;RAPGEF6;PPP1R16B;ROBO4;TJP2;TJP1
prerank,skeletal system morphogenesis (GO:0048705),-0.5794459416155647,-1.9651183733780366,0.0,0.07032735136948133,0.273,14/42,8.10%,FGFR2;HOXC4;PDGFRA;TGFBR1;CYP26B1;HOXA3;HOXB3;FBN2;HOXB4;MEGF8;ANKRD11;SFRP4;SIX1;WWOX
prerank,embryonic skeletal system development (GO:0048706),-0.6067784892614525,-1.9600241780583427,0.0,0.06311428969056017,0.293,15/35,7.50%,COL1A1;HOXC4;PDGFRA;SULF1;SULF2;OSR1;WNT5A;HOXA3;HOXB3;RBP4;XYLT1;HOXB4;MEGF8;SIX1;WNT9A
prerank,mesoderm development (GO:0007498),0.8299811439871805,1.9525557979489256,0.0032679738562091504,0.1525678926835757,0.305,4/18,1.44%,BMX;TIE1;TBX1;TBXT
prerank,regulation of glucose import (GO:0046324),-0.6148119163475315,-1.930197651609197,0.0,0.08156095890769911,0.412,13/30,8.12%,PRKAG2;PID1;IGF1;SORBS1;APPL2;RHOQ;GRB10;ENPP1;IRS2;IRS1;PIK3R1;OSBPL8;PRKCI
prerank,respiratory system development (GO:0060541),-0.5908207557136546,-1.9287007239698748,0.0,0.07281489161366285,0.419,11/32,9.63%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,B cell differentiation (GO:0030183),0.7063276865360657,1.9140448116181474,0.0013513513513513514,0.2610737720145223,0.512,8/46,6.32%,PTPRJ;PLCG2;VCAM1;KLF6;HDAC9;HHEX;TPD52;ADAM17
prerank,vasodilation (GO:0042311),0.8993434455232904,1.912555304114173,0.0,0.21677495705462377,0.527,5/13,2.63%,NOS1;NOS3;KLF2;F2RL1;ADRB2
prerank,negative regulation of blood pressure (GO:0045776),0.876970500417847,1.910198211133214,0.0,0.19079443785706585,0.547,3/13,0.97%,NOS1;NOS3;BMPR2
prerank,heterochromatin organization (GO:0070828),0.862367281082786,1.8931915729574416,0.0,0.22616969837159784,0.656,2/14,0.09%,PRDM16;MECOM
prerank,B cell receptor signaling pathway (GO:0050853),0.7348168845127617,1.8909215496955551,0.0029411764705882353,0.20804712638669418,0.674,4/32,5.48%,BMX;PLCG2;MEF2C;PLEKHA1
prerank,lung development (GO:0030324),-0.5851866819611953,-1.8889379878127965,0.0,0.12021769464868604,0.612,13/33,11.67%,ERRFI1;GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6;PKD1
prerank,lymphocyte differentiation (GO:0030098),0.6507965174089209,1.8884291820767611,0.0012345679012345679,0.1923731152388619,0.69,11/68,6.32%,PTPRJ;PLCG2;JAG2;VCAM1;KLF6;DLL4;HDAC9;HHEX;TPD52;GATA3;ADAM17
prerank,activation of protein kinase A activity (GO:0034199),-0.709295652361993,-1.879661804795673,0.0,0.12374908942899118,0.663,10/16,14.78%,ADCY5;ADCY9;ADCY1;ADCY2;PRRC1;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A
prerank,regulation of cell-cell adhesion (GO:0022407),0.7053200085232753,1.8796273008933968,0.001349527665317139,0.20388618385896026,0.759,8/39,1.06%,PODXL;JAG1;PTPRG;PTPRR;EFNA5;CEACAM1;MAGI1;SMAD7
prerank,glutamine family amino acid catabolic process (GO:0009065),0.8449381763172633,1.8782132851403464,0.004830917874396135,0.19042539639119146,0.765,6/13,5.83%,NOS1;NOS3;GLS2;GLS;ARG1;GLUD1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.641082830282638,1.874607011591683,0.0012315270935960591,0.18732698575062096,0.781,20/73,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;IL1A;HSPB1;OAS2;JAK2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.6488162809663579,1.872277021610377,0.00125,0.18033353168977992,0.791,20/69,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;IL1A;HSPB1;OAS2;JAK2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,zinc ion homeostasis (GO:0055069),-0.6152609667015726,-1.869446954095573,0.0,0.12971216030559932,0.705,13/28,6.94%,SLC39A14;SLC30A10;PRKN;SLC39A8;SLC39A13;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,positive regulation of interleukin-10 production (GO:0032733),0.739170894012441,1.8655299791366802,0.0014771048744460858,0.18774984576360204,0.819,5/30,5.43%,PLCG2;NOD2;F2RL1;LGALS9;CD34
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6288346262577347,1.865384925750842,0.0,0.17570679259390073,0.821,22/88,7.72%,VEGFC;PTPRM;CDH13;TEK;TIE1;PDGFB;BMPR2;FLT4;EGFL7;ACVRL1;EGR3;CAV1;PRKD1;CAV2;VEGFD;NRAS;VASH2;ANGPT1;PPP1R16B;AKT3;STAT1;ATP5F1A
prerank,regulation of interleukin-10 production (GO:0032653),0.6792535471196371,1.8642506574004598,0.0,0.16808685515998156,0.826,10/44,10.88%,PLCG2;NOD2;F2RL1;LGALS9;FCGR2B;CD34;CD47;HMGB1;TYROBP;VSIR
prerank,peptide hormone secretion (GO:0030072),0.7523832491113744,1.8638309525934447,0.00303951367781155,0.15951274654382977,0.829,3/26,0.76%,LTBP4;EDN1;EXOC3L1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.6909638249974388,1.8613232067448524,0.002770083102493075,0.1580932635198619,0.841,8/42,4.97%,PTPRJ;CDH13;TEK;UTRN;EMP2;PPM1F;RRAS;MAP4K4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8512911634333591,1.8612259872369399,0.004893964110929853,0.1498793932326223,0.841,3/14,1.04%,NOS3;EDN1;ACE
prerank,nitric oxide metabolic process (GO:0046209),0.8517258009384141,1.8571410148579555,0.0015748031496062992,0.15243257747942177,0.862,3/14,3.43%,NOS1;NOS3;GCH1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.6331487415583585,1.85707702594175,0.0,0.14536719074824067,0.862,17/75,6.91%,VEGFC;CDH13;TEK;GATA2;PDGFB;BMPR2;FLT4;EGFL7;JCAD;EGR3;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B;ADAM17;AKT3
prerank,ceramide biosynthetic process (GO:0046513),0.6973754360030681,1.8530852564492664,0.0,0.14858532019768111,0.875,12/40,9.87%,SGMS1;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5;B4GALT6
prerank,energy reserve metabolic process (GO:0006112),-0.6629149493217955,-1.852662556412176,0.0027247956403269754,0.149252414650891,0.784,5/19,6.77%,PRKAG2;PID1;LEPR;PHKB;PYGM
prerank,collagen fibril organization (GO:0030199),-0.48046652736937595,-1.8510584530478247,0.0,0.1402237024875436,0.789,40/88,13.67%,COL1A2;COL3A1;ADAMTS2;COL4A5;COL1A1;COL4A6;COL5A1;COL12A1;COL22A1;TGFBR1;COL4A3;COL25A1;COL4A4;LOXL1;COL6A2;COL6A3;COL11A1;COL26A1;COL8A2;COL6A1;TLL1;COL13A1;COL27A1;COL23A1;LOXL3;P4HA1;COL15A1;ADAMTS3;SERPINH1;COL20A1;COL16A1;P3H1;COL9A2;PLOD2;P3H2;DPT;LUM;ADAMTS14;COL8A1;COL5A3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7463463020046686,1.8481019850375822,0.004405286343612335,0.1542152082124064,0.884,6/25,10.16%,PLCG2;CDH13;GPR143;LRRK2;CMKLR1;CCL4
prerank,diterpenoid metabolic process (GO:0016101),-0.5121978732643544,-1.8453797876408427,0.0,0.14014408421449823,0.816,13/55,9.63%,GPC6;ALDH1A1;LRP1;SDC2;HSPG2;GPC3;RBP1;APOE;ABCA4;RBP4;NAPEPLD;DHRS3;STRA6
prerank,nitric oxide biosynthetic process (GO:0006809),0.8544186032202866,1.8446657084139801,0.0015748031496062992,0.15645820480300168,0.891,3/13,3.43%,NOS1;NOS3;GCH1
prerank,regulation of vasculogenesis (GO:2001212),0.8470461098887232,1.8413350160648045,0.0,0.16022673323868913,0.907,9/14,5.43%,RAPGEF2;CEACAM1;ASB4;HEY1;EMP2;TMEM100;HEY2;RRAS;CD34
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.8710633351784127,1.8287031940644551,0.003367003367003367,0.18825727777917933,0.95,2/11,0.16%,PLCG2;CDH13
prerank,cardiac ventricle development (GO:0003231),0.7839550558234204,1.8283151529427233,0.004622496147919877,0.18222447492731586,0.951,8/20,6.03%,GJA5;ENG;NOTCH1;DAND5;HEY1;DLL4;HEY2;GATA3
prerank,positive regulation of vasculature development (GO:1904018),0.6118091432268674,1.8246829266512017,0.0,0.18532142111762495,0.959,20/94,7.36%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;VEGFD;RRAS;VASH2;CD34;IL1A;ZC3H12A;ADAM12;HSPB1
prerank,negative regulation of cell adhesion (GO:0007162),0.6273509212357866,1.8246239180804742,0.0012285012285012285,0.17896602259740185,0.959,19/72,10.05%,CDH13;PODXL;ACER2;JAG1;PLXNA4;RND1;ACVRL1;NOTCH1;DUSP1;PDE3B;PLXND1;ANGPT1;GCNT2;ARHGDIA;PTPRO;SNAI2;PTK2;ADAM10;SPINT2
prerank,ceramide metabolic process (GO:0006672),0.6630562376714538,1.8234571804973423,0.0,0.1758421077980547,0.96,12/49,9.27%,SGMS1;ACER2;ST6GALNAC3;SGMS2;DEGS2;PLPP1;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.6365040113039481,1.8214506797824062,0.0,0.17530957699461008,0.962,14/65,7.33%,PTPRJ;CDH13;AFAP1L2;HIP1;CEACAM1;HIP1R;ITGA1;DAB2IP;CBL;SHKBP1;SH3KBP1;BCAR3;DUSP3;PTPN12
prerank,aortic valve development (GO:0003176),0.7061205388055263,1.8205142049264351,0.0013869625520110957,0.1719560242787585,0.963,15/34,9.04%,ELN;JAG1;NOS3;TIE1;SMAD6;BMPR2;NOTCH1;HEY1;DLL4;HEY2;EFNA1;TNFRSF1B;GATA3;SNAI2;ROCK1
prerank,blood vessel diameter maintenance (GO:0097746),0.7115607143530017,1.8198100292055985,0.0013986013986013986,0.1682521549832378,0.964,6/34,2.44%,NOS1;NOS3;EDN1;ACE;KLF2;F2RL1
prerank,negative regulation of catalytic activity (GO:0043086),0.7394386210031759,1.8188721004474602,0.0061068702290076335,0.1657511754412213,0.968,2/24,1.60%,NOS1;NOTCH1
prerank,regulation of lymphocyte migration (GO:2000401),0.8833759351648651,1.817715737030648,0.0,0.1634511012462432,0.969,3/10,4.24%,STK10;JAM2;MSN
prerank,cellular response to sterol (GO:0036315),-0.718194259850484,-1.8134453642311505,0.002564102564102564,0.19340021626607365,0.914,9/13,17.12%,SMO;GRAMD1C;RORA;GPLD1;PTCH1;INSIG2;GRAMD1A;OSBPL7;GRAMD1B
prerank,endothelial cell development (GO:0001885),0.7383225226829706,1.8133121695742294,0.004437869822485207,0.16939772120022295,0.974,8/25,5.54%,PECAM1;RAPGEF2;RAPGEF1;F2RL1;SOX18;MSN;PPP1R16B;ROBO4
prerank,blood vessel morphogenesis (GO:0048514),0.6533158772175222,1.8131156911603208,0.0012953367875647669,0.16539540832060193,0.974,13/54,3.58%,GJA5;SOX17;ENG;FLT1;RASIP1;FLT4;SMAD7;TBX1;EGFL7;CAV1;ID1;SOX18;HEY2
prerank,B cell activation (GO:0042113),0.6302674690695246,1.8051861885349374,0.002484472049689441,0.1804321419600136,0.983,11/68,6.32%,PTPRJ;PLCG2;VCAM1;CASP8;KLF6;HDAC9;HHEX;CTPS1;MEF2C;TPD52;ADAM17
prerank,cellular glucan metabolic process (GO:0006073),-0.7503102960437714,-1.8013872281992453,0.007263922518159807,0.20902583313971873,0.943,3/11,6.77%,PRKAG2;PHKB;PYGM
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.6545492838518522,1.7988125452235766,0.006587615283267457,0.19209554558931535,0.99,16/45,12.46%,IRF6;VCAM1;B2M;IRF2;IFNGR1;IRF9;CAMK2D;FCGR1A;STAT1;MT2A;OAS2;JAK2;TRIM25;GBP2;TRIM8;IRF5
prerank,regulation of plasminogen activation (GO:0010755),-0.7482133405862298,-1.797401962970726,0.007978723404255319,0.20445847626647853,0.948,5/12,11.24%,SERPINE2;THBS1;CLEC3B;RUNX1;SERPINE1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6030108917788298,-1.7929506460848548,0.0,0.2039944006069891,0.953,12/26,6.94%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,macrophage activation (GO:0042116),0.6877086023987277,1.789771624883071,0.0072254335260115606,0.21233492691832237,0.995,9/34,9.10%,PLCG2;CD93;DYSF;IFNGR1;APP;ITGAM;JAK2;NMI;FOXP1
prerank,regulation of angiogenesis (GO:0045765),0.5648919516091836,1.7893292848268372,0.0,0.2082946541991709,0.995,40/192,7.36%,VEGFC;PTPRM;TEK;NOS3;GATA6;CLDN5;GATA2;FLT1;TIE1;CEACAM1;PIK3R6;FOXO4;ATP2B4;ECSCR;DAB2IP;PRKD1;TGFB2;RHOB;EMP2;CEMIP2;BTG1;HHEX;ANXA3;PDE3B;KLF4;VEGFD;PLXND1;RRAS;VASH2;PPP1R16B;CD34;TSPAN12;PGK1;WARS1;IL1A;NPR1;ZC3H12A;ADAM12;STAT1;HSPB1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8507613015203476,1.788338573615275,0.005154639175257732,0.20596907146575855,0.995,2/11,1.06%,CEACAM1;SMAD7
prerank,heart morphogenesis (GO:0003007),0.6446195546261009,1.7869395363199116,0.0026490066225165563,0.20488452684774727,0.996,14/50,4.11%,SOX17;NOS3;ENG;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;INSR;HEY1;TGFB2;FKBP1A;HEY2;ACVR1
prerank,regulation of hydrolase activity (GO:0051336),0.6189313821765043,1.7861580365820129,0.0024271844660194173,0.20230391857402377,0.996,16/71,5.38%,NOS1;FGD5;EFNA5;RASIP1;RABGAP1;PLXNA4;CHN2;DAB2IP;CAV1;PRKG1;CRK;APOA1;GPR137B;PLXND1;RAPGEF6;FGD6
prerank,regulation of cellular respiration (GO:0043457),0.7704808057951954,1.785548864759308,0.0064,0.19936440078681586,0.996,1/17,0.01%,PRDM16
prerank,embryonic limb morphogenesis (GO:0030326),-0.5588721877361543,-1.7837002322325561,0.007194244604316547,0.21501906372291535,0.969,14/34,11.56%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;CREBBP;FBXW4;NIPBL;MEGF8;INTU;PTCH1;SALL1;TBX2;HDAC1
prerank,cellular response to zinc ion (GO:0071294),-0.6787339364208731,-1.7820777645122365,0.0,0.20731112093256446,0.971,9/15,7.34%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;P2RX4
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6609308499403248,-1.781161119069499,0.0027100271002710027,0.19955523956096938,0.972,10/17,17.75%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.796600503141436,1.7789325479656601,0.004594180704441042,0.21404806152743444,0.998,5/14,8.12%,VEGFC;FLT4;VEGFD;NUS1;MYO1C
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.7277684571042377,1.7761082135057842,0.01661631419939577,0.21741842403607922,0.998,6/22,11.23%,PTPRJ;CEACAM1;FCGR2B;DUSP3;PRNP;LAPTM5
prerank,mesenchyme morphogenesis (GO:0072132),0.7686270839166489,1.7714776940676564,0.007739938080495356,0.22627239294617896,0.998,8/17,5.38%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1;SMAD2
prerank,respiratory tube development (GO:0030323),-0.5738043533096882,-1.7709576612267945,0.006230529595015576,0.2135376559127046,0.981,11/28,9.63%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,membrane lipid biosynthetic process (GO:0046467),0.6345314798861676,1.7708575459851692,0.002509410288582183,0.22341506742989248,0.998,17/58,9.75%,SGMS1;ACER2;SGPP2;ST8SIA6;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;CERT1;ELOVL4;CERS6;CERS5;HACD4
prerank,regulation of cell junction assembly (GO:1901888),0.6968537995759777,1.7706730348425737,0.009929078014184398,0.2195962790612336,0.998,11/27,9.21%,RAPGEF2;CLDN5;F11R;OCLN;RAPGEF1;PDLIM5;MEF2C;MYO1C;SNAI2;ROCK1;TJP1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.6686361344334519,1.770079724614526,0.0013550135501355014,0.21688241324615776,0.998,6/41,5.31%,NOS1;KCNN4;KCNQ1;KCNN3;NOS1AP;STAC
prerank,positive regulation of angiogenesis (GO:0045766),0.5817537921030063,1.768489987583295,0.0,0.2171809026670856,0.998,22/108,7.36%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;KLF4;VEGFD;RRAS;VASH2;CD34;IL1A;JMJD8;ZC3H12A;ADAM12;HSPB1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6928178096323989,1.767933480718355,0.0014144271570014145,0.21474905866790384,0.998,11/34,7.60%,VEGFC;FLT1;FLT4;NOTCH1;EGR3;DAB2IP;PRKD1;DLL4;VEGFD;HSPB1;NUS1
prerank,keratan sulfate catabolic process (GO:0042340),-0.7198646377507747,-1.7662493110644808,0.007281553398058253,0.21479579246507852,0.983,7/11,12.72%,OGN;FMOD;GNS;PRELP;HEXA;LUM;OMD
prerank,aortic valve morphogenesis (GO:0003180),0.6956084488772482,1.7661045765931012,0.008522727272727272,0.21505720571300282,0.999,13/30,9.04%,ELN;JAG1;NOS3;TIE1;SMAD6;NOTCH1;HEY1;DLL4;HEY2;EFNA1;GATA3;SNAI2;ROCK1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7241809452450763,1.765198520215999,0.005943536404160475,0.2136012004481039,0.999,6/24,9.75%,PECAM1;VCAM1;F11R;MSN;ROCK1;GFUS
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6955519097853333,1.762696045782778,0.006033182503770739,0.21670971579547813,0.999,9/31,12.46%,PLCG2;PLCB1;LGALS9;TLR3;TIRAP;LTB;HMGB1;LAPTM5;IRF5
prerank,response to prostaglandin E (GO:0034695),-0.747089604782838,-1.7609583435451577,0.007125890736342043,0.21639185036763486,0.985,1/10,0.09%,TGFBR3
prerank,lamellipodium assembly (GO:0030032),0.7019946319512242,1.7587074899587676,0.007331378299120235,0.22410690456391266,1.0,10/26,10.68%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;CCDC88A;CYFIP1;RAC1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.6619180660289631,1.7563647249282957,0.001394700139470014,0.2267346226845066,1.0,15/38,12.63%,EDN1;KLF2;ATP2B4;INSR;CAV1;NOS1AP;KLF4;CD34;ASS1;CD47;ZC3H12A;JAK2;RAC1;CLU;CX3CR1
prerank,response to glucagon (GO:0033762),-0.6349187438030202,-1.7555516105121205,0.002857142857142857,0.22160843961756893,0.99,11/19,17.75%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;CREB1;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5699049588746373,1.7545179770499493,0.0,0.2281379939865006,1.0,28/112,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;CD34;IL1A;NFKBIL1;CD47;ZC3H12A;HSPB1;OAS2;JAK2;CACTIN;FOXP1;HMGB1;DHX9;TYROBP;VSIR;CYBA;CLU;CX3CR1;DDT
prerank,clathrin coat assembly (GO:0048268),0.7939703965492203,1.754294997581551,0.007836990595611285,0.22496152690593757,1.0,5/15,8.71%,HIP1;HIP1R;PIK3C2A;FCHO2;NSG2
prerank,response to lipid (GO:0033993),0.5764780030378109,1.753860147878328,0.002320185614849188,0.2222884970533883,1.0,21/105,10.93%,NOS1;ACER2;NOS3;GATA6;SMAD6;ALPL;FOXO1;LGALS9;GCH1;TIRAP;TRIM6;IFNAR1;PCK2;RXRG;ADAM17;HNRNPA0;PAQR8;JAK2;FOXP1;STRN3;TAB2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.6566054022991317,1.7509519513999356,0.009575923392612859,0.22628194139808497,1.0,12/39,10.05%,PODXL;JAG1;NOTCH4;NOTCH1;APOA1;KLF4;PPM1F;ASS1;FXYD5;PTK2;MAD2L2;SPINT2
prerank,substrate-dependent cell migration (GO:0006929),0.7985517760492862,1.7498146008646627,0.011647254575707155,0.22620191627734876,1.0,4/14,4.50%,VEGFC;CD2AP;NTN1;SHTN1
prerank,amide biosynthetic process (GO:0043604),0.6380249027520694,1.7476895977467573,0.0039164490861618795,0.22856640851660134,1.0,13/47,9.27%,SGMS1;SGMS2;DEGS2;CERS4;PCSK5;SPTLC2;FURIN;SPTLC1;ARG1;ASAH2;ASS1;CERS6;CERS5
prerank,hemidesmosome assembly (GO:0031581),0.8281977327227904,1.7470896377298,0.0033613445378151263,0.22637713211862504,1.0,3/11,6.94%,LAMA3;DST;PLEC
prerank,intestinal lipid absorption (GO:0098856),0.8360117960422551,1.7446362773612325,0.006568144499178982,0.22900560630281122,1.0,1/11,0.46%,LIMA1
prerank,response to molecule of bacterial origin (GO:0002237),0.6042795168165344,1.7429086287419027,0.0038314176245210726,0.23060134343727937,1.0,17/69,12.88%,NOS1;NOS3;SMAD6;LGALS9;GCH1;TIRAP;FCGR2B;TRIM6;IFNAR1;ADAM17;HNRNPA0;JAK2;ACOD1;FOXP1;TAB2;IRF5;RPS6KA3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.7455720282789842,1.7423161667295037,0.006172839506172839,0.22886676349640997,1.0,6/19,6.03%,PDGFB;KLF2;APP;SLCO1C1;KLF4;GATA3
prerank,endocardial cushion development (GO:0003197),0.7422352924118616,1.741852793935951,0.009302325581395349,0.22678534052714297,1.0,8/21,4.11%,NOS3;ENG;BMPR2;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5757282341897421,-1.7417427238740943,0.009202453987730062,0.24581876408521158,0.997,11/25,14.75%,ANK2;DMD;WNK1;ACTN2;WNK4;ATP1B3;SLC6A9;COX17;TRPC6;ATP1B1;ATP1B2
prerank,negative regulation of receptor binding (GO:1900121),0.8301475728148542,1.74043842856946,0.01217391304347826,0.22714106822998864,1.0,3/10,4.08%,ATP2A3;B2M;ADAM15
prerank,positive regulation of lyase activity (GO:0051349),0.7752111369717424,1.7392783885832546,0.009933774834437087,0.22698649034838222,1.0,4/14,5.18%,NOS1;NOS3;ORAI1;AKAP5
prerank,positive regulation of vasculogenesis (GO:2001214),0.8529844315254816,1.738588376955107,0.0033783783783783786,0.22538438691891868,1.0,6/10,5.43%,RAPGEF2;CEACAM1;ASB4;TMEM100;RRAS;CD34
prerank,T cell mediated immunity (GO:0002456),0.8078878471311343,1.7375319490216716,0.0049586776859504135,0.22459080031921444,1.0,4/13,2.80%,JAG1;CRTAM;CADM1;EMP2
prerank,sphingolipid biosynthetic process (GO:0030148),0.6063719101801087,1.735234724221321,0.004807692307692308,0.22793297564580467,1.0,26/71,14.95%,SGMS1;ACER2;SGPP2;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;CERT1;A4GALT;ELOVL4;CERS6;CERS5;HACD4;B4GALT6;ELOVL7;PRKD2;ALOXE3;PPM1L;ELOVL5;VAPA;AGK
prerank,cellular response to drug (GO:0035690),0.7030566975370265,1.7348379679852541,0.012949640287769784,0.22589520181459982,1.0,5/25,5.32%,ACER2;KCNQ1;AIM2;PPM1F;MEF2C
prerank,positive regulation of sodium ion transport (GO:0010765),0.8121535705894418,1.7341380819027274,0.009787928221859706,0.2246722016338979,1.0,2/12,0.99%,NOS1;CNKSR3
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6771843449708869,1.7327163462094537,0.017191977077363897,0.2251548343404432,1.0,3/33,0.80%,PTPRJ;KCNN4;CEACAM1
prerank,regulation of glucose metabolic process (GO:0010906),-0.5425600460998475,-1.7324946374577315,0.003424657534246575,0.26025699728408996,0.999,12/34,15.36%,OGT;PDK1;PRKN;RORA;IRS2;IRS1;GPLD1;ZNF692;FOXK2;PDK3;SLC45A3;PDK2
prerank,positive regulation of cyclase activity (GO:0031281),0.7678156475581661,1.7258498809338603,0.012924071082390954,0.2400543766000317,1.0,4/14,5.18%,NOS1;NOS3;ORAI1;AKAP5
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7363685379650824,-1.7257095884646165,0.005089058524173028,0.2686267453702814,0.999,4/11,9.13%,EGFR;DDX5;BMP4;MAP2K2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.6014333315259722,1.7245964252218569,0.0037974683544303796,0.24065123918505352,1.0,16/64,9.21%,CDH13;ACER2;JAG1;EFNA5;UTRN;LIMCH1;MACF1;EMP2;ADAM15;SLK;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7481902095955025,1.7242790421442105,0.0189873417721519,0.23881019233106815,1.0,5/17,11.23%,PTPRJ;CEACAM1;DUSP3;PRNP;LAPTM5
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6238305132606177,-1.7234753344671832,0.00819672131147541,0.26432717559531754,0.999,11/19,11.27%,TGFBR3;BMPR1A;FGFR2;TGFBR1;ZFPM2;RBPJ;RBP4;FGF2;RUNX1;GLI1;TBX2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8236861864511974,1.7232983343353634,0.009852216748768473,0.2383677554656342,1.0,3/11,4.95%,NOS1;NOS1AP;CAMK2D
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.7804284780762222,1.7228411915116748,0.008012820512820512,0.23654995399338996,1.0,1/15,0.01%,BMX
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.808077272504988,1.7215808714780865,0.008064516129032258,0.23689127397095577,1.0,6/12,7.87%,PODXL;JAG1;MYO1E;IQGAP1;PROM1;PTPRO
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.7169556691706074,1.7215464014665984,0.013782542113323124,0.23413154833029887,1.0,8/24,10.68%,PTPRJ;TEK;PPM1F;IQSEC1;MAP4K4;DUSP3;ROCK1;RAC1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7014120242100886,1.719815724212695,0.004484304932735426,0.2357350050719592,1.0,6/25,6.07%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7262319310267762,1.7171445710491868,0.010574018126888218,0.24018055379174058,1.0,8/19,4.92%,SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;ACVR1;EFNA1
prerank,regulation of epithelial cell migration (GO:0010632),0.6213015225342863,1.7168317856354058,0.003861003861003861,0.23816642441475386,1.0,19/51,10.49%,PLCG2;PTPRG;PTPRR;CEACAM1;BMPR2;RAB11A;MACF1;DAB2IP;TGFB2;EMP2;EVL;PPM1F;ADIPOR1;CLASP1;MCC;PTK2;RTN4;CLASP2;PLCG1
prerank,regulation of cardiac conduction (GO:1903779),0.6212817928901204,1.713202509716051,0.006313131313131313,0.24475521969538855,1.0,11/54,3.81%,NOS1;ATP2A3;GJA5;NPR2;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,regulation of interleukin-12 production (GO:0032655),0.6257065132547748,1.7111868512213229,0.008379888268156424,0.2477066443682191,1.0,12/47,12.46%,PLCG2;PLCB1;LGALS9;TLR3;TIRAP;CD47;CMKLR1;LTB;FOXP1;HMGB1;LAPTM5;IRF5
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6561965600230133,1.7071523760950376,0.015277777777777777,0.2558246697200504,1.0,5/34,3.81%,NOS1;GJA5;KCNQ1;SMAD7;SLC8A1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6979231170252495,1.707151938425703,0.014814814814814815,0.25301340961323665,1.0,4/23,2.70%,PIK3R6;CRTAM;LGALS9;CADM1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.47799186175040836,-1.7060389719812943,0.0,0.3031417975239456,0.999,23/55,18.14%,GPC6;DCN;SDC2;OGN;HSPG2;GPC3;CEMIP;FMOD;GNS;BGN;FGF2;PRELP;HEXA;VCAN;HYAL1;LUM;CSPG4;OMD;HPSE2;GPC1;SDC1;SLC9A1;IDUA
prerank,dephosphorylation (GO:0016311),0.5402779146601816,1.7056619872919072,0.0,0.2541572530195882,1.0,25/147,9.03%,PTPRM;PTPRJ;PTPRB;SGPP2;PTPRG;PTPRR;ALPL;PTPN14;DUSP12;DUSP1;PLPP1;INPP5K;PPM1F;ACP6;PTPRE;CTTNBP2NL;DUSP16;THTPA;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C
prerank,cardiac atrium morphogenesis (GO:0003209),0.7557404966356422,1.7037181264168977,0.010687022900763359,0.25647687445405054,1.0,6/16,3.58%,ENG;BMPR2;NOTCH1;TGFB2;DLL4;HEY2
prerank,cellular response to interferon-gamma (GO:0071346),0.572101223162189,1.7016903380531476,0.004705882352941176,0.259524484903132,1.0,25/88,12.46%,IRF6;VCAM1;GBP5;B2M;IRF2;IFNGR1;LGALS9;GBP4;IRF9;CAMK2D;GBP3;FCGR1A;CD47;STAT1;MT2A;OAS2;JAK2;ACOD1;GAPDH;TRIM25;CCL4;CASP1;GBP2;TRIM8;IRF5
prerank,Rap protein signal transduction (GO:0032486),0.8148990907122606,1.7012300295900271,0.0068143100511073255,0.25798911949877606,1.0,2/10,1.83%,RAPGEF2;RAPGEF1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.6876567402047559,-1.7009174591980512,0.019704433497536946,0.30785355555614413,0.999,8/12,26.83%,STX4;ANO1;GPLD1;PPP3CB;C2CD2L;PLA2G6;CFTR;BAIAP3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6845903674387664,1.7000443653091608,0.007331378299120235,0.2587797564440999,1.0,6/26,6.07%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6376543557470813,-1.6987800055996878,0.002512562814070352,0.3048142456978249,0.999,6/16,7.26%,IGF1;IGFBP5;IGFBP2;BMP5;IGFBP6;IGFBP3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5681707593423737,1.6983634005595891,0.0024154589371980675,0.2607782059435933,1.0,18/86,11.83%,SYNPO;EDN1;FCHSD2;TRPV4;STMN2;OCLN;F2RL1;APP;FES;EVL;CDC42EP1;CLIP1;CLASP1;WDR1;NCKAP1;RAC1;NUMA1;CLU
prerank,regulation of Notch signaling pathway (GO:0008593),0.5724309121333059,1.6982926919066665,0.0036540803897685747,0.2583450304613668,1.0,21/76,11.31%,JAG1;JAG2;NOTCH4;NOS3;GATA2;EGFL7;MFNG;NOTCH1;NOD2;HEY1;TGFB2;DLL4;TSPAN14;ARRDC1;POGLUT1;ARRB1;TM2D3;FBXW7;EPN2;MAML2;HIF1AN
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5742526676382218,1.6979402533178611,0.0023781212841854932,0.2566683395156466,1.0,11/86,4.92%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;FYN;ARHGEF2;APP;ACVR1;ANGPT1;EFNA1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.8057553166618873,1.6975395536368765,0.008389261744966443,0.25495414190666005,1.0,4/12,11.20%,LAMA3;LAMA5;ACTG1;ACTB
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6208601008884765,-1.6972261501550068,0.008522727272727272,0.3001441615015368,0.999,5/17,6.67%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1G
prerank,artery morphogenesis (GO:0048844),0.6664021450133214,1.6965803703763198,0.017366136034732273,0.2550524128989837,1.0,9/30,3.58%,GJA5;JAG1;ENG;BMPR2;SMAD7;TBX1;NOTCH1;TGFB2;HEY2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7510130340050061,1.6959315116904867,0.007874015748031496,0.25423338945159296,1.0,3/15,3.48%,SMAD7;TGFB2;APOA1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5259522748259057,-1.6946445411327868,0.0,0.29802181177864,1.0,10/31,7.10%,FGFR2;HOXC4;PDGFRA;TGFBR1;OSR1;HOXA3;HOXB3;HOXB4;MEGF8;SIX1
prerank,muscle cell differentiation (GO:0042692),0.6571093417175293,1.6941559700222244,0.01032448377581121,0.2565832450028843,1.0,8/32,5.52%,MRTFB;NEBL;GATA6;SYNE1;TBX1;HEY2;MEF2C;TMEM204
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7639812554321315,1.693804147409938,0.01910828025477707,0.2527494706161232,1.0,3/15,2.60%,NANOS1;NANOS3;TNRC6C
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7639812554321315,1.693804147409938,0.01910828025477707,0.2527494706161232,1.0,3/15,2.60%,NANOS1;NANOS3;TNRC6C
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7778929215721775,1.6933227153593138,0.012924071082390954,0.25175329904915433,1.0,3/13,2.96%,NOTCH4;ENG;DLL4
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.7385012105506488,1.6927292344316314,0.012944983818770227,0.25082317106433216,1.0,6/19,10.68%,PTPRJ;TEK;PPM1F;MAP4K4;ROCK1;RAC1
prerank,second-messenger-mediated signaling (GO:0019932),0.5728215206553057,1.6902390358306218,0.0012091898428053204,0.25483423760075696,1.0,6/82,1.49%,NOS1;PLCG2;NOS3;EDN1;CCR1;MCTP1
prerank,sprouting angiogenesis (GO:0002040),0.6116385309844309,1.6886130768595935,0.002574002574002574,0.25682577463640954,1.0,10/51,4.45%,VEGFC;CDH13;TEK;ENG;FLT4;RECK;ACVRL1;EGR3;VEGFD;ANGPT1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5767533813963349,1.6854342829855018,0.0037593984962406013,0.26263758522616504,1.0,8/67,3.24%,BMX;TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES
prerank,negative regulation of cell growth (GO:0030308),0.5494199387687636,1.685102839199582,0.0011235955056179776,0.26125891612831403,1.0,19/121,7.45%,SEMA3G;PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;TGFB2;HNF4A;PPT1;BTG1;ADAM15;WFDC1;SERTAD2;HYAL2;SH3BP4;NPR1;HSPA1B
prerank,response to laminar fluid shear stress (GO:0034616),0.8144797941943602,1.6846606921347,0.017123287671232876,0.2600951531273375,1.0,6/10,8.27%,SMAD6;SMAD7;KLF2;KLF4;ASS1;NFE2L2
prerank,lipoprotein localization (GO:0044872),-0.7048397204438238,-1.683266141800759,0.017456359102244388,0.321275655392764,1.0,5/11,13.81%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,endothelial cell migration (GO:0043542),0.6328861572674979,1.682673543814707,0.012622720897615708,0.26337966882867225,1.0,10/37,7.31%,CDH13;NOS3;EGR3;EMP2;ID1;SOX18;PLXND1;PLEKHG5;MYH9;STAT1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7612032310171908,1.681178112614577,0.01652892561983471,0.2650130468722935,1.0,4/15,3.84%,VEGFC;CDH13;F2RL1;VEGFD
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7026299773513179,1.6771460075700582,0.01854714064914992,0.2727778017651205,1.0,7/20,12.77%,NOS1;RPS6KA5;ARRB1;PRKAA1;BRCA1;DIP2B;GLYR1
prerank,sphingolipid metabolic process (GO:0006665),0.557969257054213,1.677102144674054,0.002290950744558992,0.270557501409105,1.0,29/108,15.26%,SGMS1;ACER2;SGPP2;ST6GALNAC3;SGMS2;DEGS2;ESYT2;PRKD1;PPT1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;GLTP;CERT1;ELOVL4;CERS6;CERS5;HACD4;ELOVL7;PRKD2;ALOXE3;PPM1L;ELOVL5;VAPA;AGK;TECR
prerank,nitric oxide mediated signal transduction (GO:0007263),0.75610693324896,1.6746933603281087,0.024671052631578948,0.2747939530510932,1.0,2/16,0.41%,NOS1;NOS3
prerank,regulation of heart contraction (GO:0008016),0.5659047902885673,1.67457049590508,0.0011947431302270011,0.27280061189994015,1.0,15/90,4.95%,NOS1;ATP2A3;GJA5;KCNQ1;NPR2;SMAD7;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;TGFB2;SLC8A1;CAMK2D
prerank,artery development (GO:0060840),0.70030609792412,1.674365044082455,0.0187207488299532,0.2709175267032635,1.0,6/23,1.57%,GJA5;ENG;BMPR2;SMAD7;TBX1;ACVRL1
prerank,eye development (GO:0001654),-0.47074597206809315,-1.6743032474921222,0.0,0.3401516735193625,1.0,13/54,6.70%,CACNA1C;SMOC1;EFEMP1;COL5A1;LAMA1;PBX3;FBN2;RBP4;SH3PXD2B;FBN1;NIPBL;MEIS1;SHROOM2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7362959478526703,1.6738690076804852,0.01834862385321101,0.2699622894873847,1.0,2/17,1.54%,JAG1;BACH2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.6294656187490972,1.673445221281649,0.019230769230769232,0.2687292856049055,1.0,8/39,4.97%,ACER2;JAG1;EFNA5;NOTCH1;ACTN4;ADAM15;GCNT2;MAP4K4
prerank,plasma membrane tubulation (GO:0097320),0.7632102950498361,1.6704111993303816,0.018581081081081082,0.2743210750441429,1.0,6/13,8.41%,CAVIN2;PACSIN2;FNBP1L;PACSIN1;WHAMM;BIN3
prerank,endocardial cushion morphogenesis (GO:0003203),0.7226551596961507,1.6702498280439464,0.01564945226917058,0.2725528743181308,1.0,7/18,4.11%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,skeletal system development (GO:0001501),-0.4023611397906304,-1.670049252507509,0.0,0.34367349497938915,1.0,38/148,10.82%,COL1A2;BMP6;IGF1;SOX5;COL1A1;GLI2;FGFR2;SULF1;TGFBR1;CDH11;BMP5;BMP7;NPR3;SULF2;MMP14;TLL1;WNT5A;COL13A1;TRIP11;GJA1;RBP4;SH3PXD2B;FBN1;ITGB8;TNFRSF11B;XYLT1;PRELP;EVC;ANKRD11;VCAN;IGF2;WWOX;P3H1;PKDCC;PTH1R;COL9A2;MMP16;HYAL1
prerank,regulation of interleukin-6 production (GO:0032675),0.5503469969370791,1.669325083588997,0.0035169988276670576,0.27297387121854483,1.0,20/96,11.05%,PLCG2;AFAP1L2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TLR3;TIRAP;HYAL2;IL1A;CD47;ZC3H12A;ARRB1;CD200;HMGB1;DHX9;TYROBP;CYBA
prerank,positive regulation of interleukin-1 production (GO:0032732),0.6111122827350794,1.6692896714828163,0.005319148936170213,0.2709118639325351,1.0,15/51,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;TMED10;P2RX7;HSPB1;JAK2;EGR1;HMGB1;TYROBP;CASP1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7475064797219482,1.6679435564043228,0.021705426356589147,0.27221714016612863,1.0,5/13,10.63%,MMRN2;DAB2IP;HHEX;EPN2;PTPN1
prerank,embryonic digestive tract development (GO:0048566),-0.6126175145895072,-1.6669600043896777,0.005780346820809248,0.34411185227635166,1.0,10/18,11.08%,GLI3;GLI2;FGFR2;PDGFRA;RARB;NIPBL;RBPMS2;PKDCC;STRA6;SALL1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7164862311064919,1.6649478364219104,0.0124804992199688,0.27832046725262805,1.0,5/20,7.75%,PLCB1;GNAQ;AGRN;CHRM3;LYPD1
prerank,lipoprotein transport (GO:0042953),-0.7129179930393419,-1.6649255591126753,0.023696682464454975,0.34133238302037644,1.0,5/10,13.81%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,oogenesis (GO:0048477),0.735803307432264,1.664602857777434,0.012903225806451613,0.276931022501313,1.0,2/15,0.40%,NANOS1;NANOS3
prerank,sphingosine metabolic process (GO:0006670),0.735930145408897,1.6644867240141301,0.009819967266775777,0.27521696435567106,1.0,6/17,5.93%,ACER2;SGPP2;PLPP1;SPTLC2;SPTLC1;ASAH2
prerank,vasculogenesis (GO:0001570),0.6460199806205514,1.664123190716319,0.011461318051575931,0.274052321643711,1.0,8/32,3.58%,SOX17;ENG;RASIP1;EGFL7;NOTCH1;CAV1;SOX18;HEY2
prerank,defense response to fungus (GO:0050832),0.736140104744655,1.6608544547143678,0.017684887459807074,0.28034263126253217,1.0,4/17,14.37%,PLCG2;GAPDH;CX3CR1;FAM3A
prerank,camera-type eye development (GO:0043010),-0.5575174132250511,-1.6604377016538254,0.012539184952978056,0.34477790801878966,1.0,8/25,9.63%,CACNA1C;EFEMP1;LAMA1;FBN2;FBN1;SHROOM2;VEGFA;STRA6
prerank,lamellipodium organization (GO:0097581),0.6553291280864457,1.6591837231836668,0.016224188790560472,0.28251661885459955,1.0,10/29,10.68%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;CCDC88A;CYFIP1;RAC1
prerank,pulmonary valve morphogenesis (GO:0003184),0.7254391059563763,1.6571661532214024,0.015503875968992248,0.28600089286996827,1.0,8/17,3.58%,GJA5;JAG1;NOS3;SMAD6;NOTCH1;HEY1;TGFB2;HEY2
prerank,cellular response to fluid shear stress (GO:0071498),0.7826415565396834,1.6564192769079602,0.01877133105802048,0.28572966644305825,1.0,5/12,8.27%,KLF2;KLF4;MEF2C;ASS1;NFE2L2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6515272766688014,-1.6559763167367174,0.02481389578163772,0.3500581142107961,1.0,9/13,28.02%,IDH2;ADHFE1;L2HGDH;IDH1;GOT1;DLST;D2HGDH;PHYH;GOT2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7190830365129366,1.6552922797582792,0.015822784810126583,0.28668781253416326,1.0,4/18,6.12%,PLCB1;GNAQ;AGRN;CHRM3
prerank,negative regulation of vascular permeability (GO:0043116),0.782632221902795,1.655098168284759,0.023923444976076555,0.285057396986073,1.0,4/12,4.45%,PTPRJ;CLDN5;CEACAM1;ANGPT1
prerank,negative regulation of potassium ion transport (GO:0043267),0.7551769895836464,1.6549557731400526,0.019261637239165328,0.2834433753581655,1.0,4/13,10.96%,NOS1;CAV1;STK39;NEDD4L
prerank,regulation of biomineral tissue development (GO:0070167),0.6661770098211641,1.6535782218698056,0.017341040462427744,0.2850370650979809,1.0,8/26,9.04%,NOS3;SGMS2;S1PR1;NOTCH1;HEY1;HEY2;NBR1;ROCK1
prerank,membrane repolarization during action potential (GO:0086011),0.7661988656233628,1.6529320637559468,0.018867924528301886,0.2846657101488268,1.0,3/13,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,epithelial cell migration (GO:0010631),0.6197244507813936,1.6527400752163923,0.023154848046309694,0.28319055886489874,1.0,9/37,9.04%,NANOS1;CDH13;NOS3;PKN3;PLXND1;PKN1;PLEKHG5;STAT1;ROCK1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.764748903096613,1.6524727043501213,0.020618556701030927,0.28188028405750226,1.0,3/12,11.05%,PLCG2;ADGRB1;CYBA
prerank,response to lipopolysaccharide (GO:0032496),0.5278370735579417,1.65241471349923,0.0044742729306487695,0.2800738848794837,1.0,31/138,10.93%,NOS1;NOS3;SMAD6;NOD2;DAB2IP;LGALS9;VIM;GCH1;TIRAP;DEFA6;TRIM6;MEF2C;TNFRSF1B;IFNAR1;IL1A;PDCD4;ADAM17;NFKBIL1;IRGM;HNRNPA0;ZC3H12A;JAK2;NR1D1;ACOD1;CACTIN;FOXP1;STAP1;HMGB1;NFKBIB;CASP1;TAB2
prerank,bicellular tight junction assembly (GO:0070830),0.6020368868742361,1.6523410698103593,0.00801068090787717,0.27838501039210184,1.0,5/46,3.22%,PECAM1;CLDN5;F11R;OCLN;ESAM
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6377431320417097,-1.6515220557610462,0.021739130434782608,0.3542818528074702,1.0,7/13,16.37%,BMP5;DKK3;APOE;ERLIN1;REST;NFKB1;SCAP
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7592791332944251,1.6511571221961419,0.023923444976076555,0.27965846958504104,1.0,2/13,0.41%,NOS1;NOS3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6078065603707105,-1.6506304155722786,0.018867924528301886,0.34907564067818836,1.0,6/17,1.61%,DOCK5;IGF1;PDGFRB;IGFBP5;DOCK7;VTN
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5718018332455775,1.6499980772881901,0.012706480304955527,0.280907364761311,1.0,15/68,11.05%,PLCG2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TLR3;TIRAP;HYAL2;IL1A;HMGB1;DHX9;TYROBP;CYBA
prerank,positive regulation of histone methylation (GO:0031062),-0.5435733431035953,-1.6498675092646156,0.02147239263803681,0.34344741429595294,1.0,9/24,11.92%,AUTS2;OGT;SNW1;JARID2;MTF2;PAF1;WDR5;CTR9;TET1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7534827864500122,1.64974329503784,0.014778325123152709,0.2797132096826119,1.0,3/14,2.63%,RAPGEF2;ATP2B4;ADRB2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7691642988862164,1.648801875740924,0.01485148514851485,0.28007485725088466,1.0,4/13,8.51%,EDN1;NOD2;JAK2;NAMPT
prerank,axon extension (GO:0048675),-0.5745898566637004,-1.6481107949632785,0.01488095238095238,0.3410747736747006,1.0,10/23,11.04%,ALCAM;AUTS2;NRP2;SLIT2;SEMA5A;SEMA3A;USP9X;SPG11;PPP3CB;ULK2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.7601529154527615,1.647535009405224,0.019261637239165328,0.28160419707720397,1.0,6/12,7.07%,INSR;ADRB2;SMCR8;SETX;IRGM;FYCO1
prerank,diol metabolic process (GO:0034311),0.7083011721355298,1.6468879304227497,0.021406727828746176,0.2813897833495988,1.0,6/19,5.93%,SGPP2;NOS3;DEGS2;PLPP1;GCH1;ASAH2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5656527997805977,1.6464947808113366,0.010126582278481013,0.2804001660478098,1.0,27/70,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.6092508212419097,1.646100351050751,0.010767160161507403,0.27959168010616947,1.0,13/45,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;P2RX7;HSPB1;JAK2;EGR1;TYROBP;CASP1
prerank,sphingosine biosynthetic process (GO:0046512),0.7954697518418538,1.6453849475850866,0.01867572156196944,0.2777676220171913,1.0,4/11,5.93%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,sphingoid biosynthetic process (GO:0046520),0.7954697518418538,1.6453849475850866,0.01867572156196944,0.2777676220171913,1.0,4/11,5.93%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.643770325211039,1.6453800623807975,0.021613832853025938,0.2759902962646421,1.0,6/29,2.67%,ENG;S1PR1;SMAD7;MYBPC3;NOTCH1;FKBP1A
prerank,regulation of membrane depolarization (GO:0003254),0.6992636181826813,1.6446720987170766,0.02735562310030395,0.2759578988456333,1.0,6/18,10.96%,GJA5;SMAD7;CAMK2D;LRRK2;SCN1B;NEDD4L
prerank,response to growth factor (GO:0070848),0.6151442925853615,1.6438212975228734,0.01646090534979424,0.27632926017514764,1.0,7/41,4.11%,NOS1;GATA6;PDGFB;BMPR2;ACVRL1;KLF4;ACVR1
prerank,intestinal absorption (GO:0050892),0.76371089454304,1.6437715022762887,0.010050251256281407,0.2746532345205608,1.0,3/13,7.70%,KCNQ1;F11R;TJP2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6918492100079976,-1.6434620847124533,0.022613065326633167,0.3464915701878501,1.0,5/10,13.93%,IRS2;IRS1;GPLD1;PTH1R;SLC45A3
prerank,eye morphogenesis (GO:0048592),-0.600980014019501,-1.6434026707085776,0.016713091922005572,0.33928384061726335,1.0,9/19,8.98%,EFEMP1;COL5A1;NKD1;MFAP5;FBN2;FBN1;NIPBL;SHROOM2;VEGFA
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5435141947348586,1.6431938564147661,0.0023121387283236996,0.2743986798159795,1.0,23/109,11.65%,BMX;PLCG2;PIP5K1B;PLCB1;PITPNM3;PIK3R6;IP6K3;INPP5D;PIK3C2A;INPP5K;PLEKHA1;PIP5K1C;PGAP1;FIG4;LCLAT1;MTMR10;INPP5B;PIK3C3;ARF3;PLCG1;MTMR11;OCRL;INPP5F
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.725416083930862,1.6427801773559394,0.02576489533011272,0.27363032085281724,1.0,4/16,2.53%,PTPRJ;PDGFD;PDGFB;PIK3C2A
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6642915034894654,1.6427240478477807,0.021148036253776436,0.2720660180519656,1.0,8/26,11.08%,TRPV4;STMN2;OCLN;FES;CLIP1;CLASP1;RAC1;NUMA1
prerank,diol biosynthetic process (GO:0034312),0.7492989082169184,1.63960311587736,0.013422818791946308,0.2780601375297637,1.0,5/15,5.93%,ACER2;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,positive regulation of cell migration (GO:0030335),0.5051523823879426,1.6395131518612605,0.0,0.27656924226798474,1.0,49/253,9.54%,SEMA3G;PECAM1;PLCG2;CDH13;PODXL;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;BMPR2;CCR1;NOTCH1;RAB11A;MYLK;INSR;FAM107A;ARHGEF2;DAB2IP;CAV1;F2RL1;TGFB2;NEDD9;SEMA3F;ACTN4;TNFRSF18;MGAT5;PPM1F;ACVR1;SHTN1;LEF1;GCNT2;SEMA7A;MAP4K4;SPAG9;ADAM17;CLASP1;PPP3CA;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;TJP1;PTK2;ADAM10;RTN4;RIPOR1
prerank,polyol metabolic process (GO:0019751),0.604482946253188,1.6388647402380607,0.010680907877169559,0.27639790757697186,1.0,9/46,4.18%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5278239071069176,1.637685136316234,0.001141552511415525,0.2777571465754541,1.0,14/121,6.05%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;ACE;ARHGEF2;NEDD9;TNFRSF18;ACVR1;ANGPT1;EFNA1;FGFR3;FCGR1A
prerank,regulation of macrophage cytokine production (GO:0010935),0.740201635065153,1.6370459032298768,0.02247191011235955,0.2776667989239001,1.0,3/13,4.67%,PLCG2;TGFB2;SEMA7A
prerank,hemopoiesis (GO:0030097),0.5469987548526126,1.6359566319587304,0.008293838862559242,0.2787513584367123,1.0,17/87,7.98%,MECOM;JAG1;TEK;NOTCH4;FLT1;PDGFB;FLT4;KITLG;TAL1;SNRK;TGFB2;TIRAP;RRAS;CD34;ZBTB16;CEBPA;TPO
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.647330118410944,1.6354819919970738,0.022253129346314324,0.2783158257414289,1.0,8/27,13.00%,NOS1;UTRN;ATP2B4;CAMK2D;FXYD5;SCN1B;NEDD4L;YWHAH
prerank,tight junction assembly (GO:0120192),0.5879164158910599,1.6337917731055296,0.013175230566534914,0.2808454980500522,1.0,6/49,3.70%,PECAM1;CLDN5;F11R;OCLN;ESAM;LSR
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5598579650272789,1.6323754934823589,0.011320754716981131,0.28283479883639506,1.0,27/71,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,endoderm development (GO:0007492),0.7442474392075497,1.6311818101442335,0.026446280991735537,0.28426938491482356,1.0,2/13,2.05%,SOX17;DUSP1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5949641326301235,1.6283971129600099,0.011658031088082901,0.2900137178152103,1.0,18/48,11.99%,NOS3;GATA2;PDGFB;JCAD;PRKD1;PIK3C2A;HDAC9;HDAC7;ANGPT1;ADAM17;AKT3;HSPB1;NUS1;ATP5F1A;HMGB1;PLCG1;MAP3K3;PRKD2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.724774076951515,1.6275261675745596,0.03204047217537943,0.2904930281734576,1.0,3/14,7.72%,NOS1;ALDH9A1;SLC6A4
prerank,cellular response to calcium ion (GO:0071277),0.5641747556140535,1.6273359421341274,0.007434944237918215,0.28923038261298656,1.0,13/67,8.29%,PLCG2;SYT15;ITPKB;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;MCOLN1;PRKAA1
prerank,endothelial cell differentiation (GO:0045446),0.7703387027367656,1.6272168729851686,0.030100334448160536,0.287941422356555,1.0,5/12,3.25%,JAG1;TIE1;BMPR2;ACVRL1;SOX18
prerank,epithelial tube morphogenesis (GO:0060562),0.630927623822991,1.6264458992433954,0.02282453637660485,0.2882677786321894,1.0,8/32,6.03%,PODXL;SOX17;RASIP1;ACVRL1;RHOB;ACVR1;MEF2C;GATA3
prerank,retinoic acid metabolic process (GO:0042573),-0.6207315383501928,-1.626165579761738,0.01837270341207349,0.3838580507870071,1.0,2/14,2.57%,ALDH1A2;CYP26B1
prerank,inositol phosphate metabolic process (GO:0043647),0.5988790000160568,1.6258968917975267,0.011984021304926764,0.2880772280253008,1.0,9/46,4.18%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,smooth muscle cell differentiation (GO:0051145),0.7609293438573254,1.6237543193182558,0.03389830508474576,0.2918106779750424,1.0,7/12,8.56%,MRTFB;GATA6;HEY1;HEY2;MEF2C;TMEM204;MRTFA
prerank,neutrophil migration (GO:1990266),0.5808953034687173,1.623335263666647,0.014416775884665793,0.2912488724914086,1.0,5/58,6.86%,PECAM1;EDN1;TGFB2;PIP5K1C;BSG
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5580524643615253,1.6232057939232845,0.011306532663316583,0.2898995957597614,1.0,27/73,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,regulation of acrosome reaction (GO:0060046),0.7761474177790603,1.6229224737507417,0.025041736227045076,0.2890332760728317,1.0,1/10,0.84%,PLCB1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6257922371405804,1.6211951805671723,0.027932960893854747,0.29181546133393066,1.0,10/32,4.05%,MMRN2;GATA2;NOTCH1;JCAD;PIK3C2A;DLL4;HDAC9;HDAC7;KLF4;CARD10
prerank,leukocyte tethering or rolling (GO:0050901),0.6919836149610451,1.6210403168962093,0.027552674230145867,0.29051876935799426,1.0,3/17,1.64%,GCNT1;VCAM1;JAM2
prerank,cellular response to copper ion (GO:0071280),-0.6038428638052326,-1.6181949021231519,0.02247191011235955,0.4025211742853499,1.0,8/16,6.94%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,lipid oxidation (GO:0034440),0.7756549282714739,1.6180352959350985,0.013422818791946308,0.2963402970971448,1.0,3/12,8.17%,ADIPOR2;ADIPOR1;ACOX1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.718342484242952,1.6172331798628872,0.028169014084507043,0.297040773901257,1.0,7/15,12.56%,ATL2;ATL1;REEP2;RTN4;REEP1;REEP3;RTN3
prerank,cytoplasmic microtubule organization (GO:0031122),0.5773217630556697,1.616481762431868,0.009102730819245773,0.297388075637418,1.0,17/54,11.08%,CCDC88C;TRPV4;PLK3;RAB11A;CLIP2;SLK;DST;CAMSAP2;CLIP1;CLASP1;KPNB1;HOOK1;PCM1;KATNAL2;CCDC88A;LIMK2;NUMA1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5836693486738195,1.615819072884812,0.021052631578947368,0.29751884887525987,1.0,10/49,9.50%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TLR3;TIRAP;HYAL2;HSPA1B;HMGB1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6976585615060376,-1.6146208396146402,0.014634146341463415,0.4066041509809711,1.0,5/10,4.91%,PID1;APPL2;PRKCB;GRB10;ENPP1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5547735956928895,-1.6145152890233403,0.025,0.39897247411532677,1.0,11/23,22.68%,SMO;BMP4;GJA1;FGF2;SIX1;VEGFA;MDK;PAX2;AGT;WNT5B;SIX4
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6202671450194756,-1.613932797784456,0.029177718832891247,0.3931019534494466,1.0,6/16,11.08%,FOXD1;BMP4;FGF1;FGF2;SIX1;SALL1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6273298797931698,1.6136149031639215,0.01808066759388039,0.3013603464491128,1.0,9/33,10.33%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;ADAM17;FBXW7;CCDC88A
prerank,neurotransmitter uptake (GO:0001504),-0.653257223509391,-1.6126427709197437,0.0390625,0.3898042547138005,1.0,4/12,10.51%,ATP1A2;SLC1A3;SNAP25;SLC29A1
prerank,negative regulation of developmental growth (GO:0048640),0.631860564852765,1.6122680336184068,0.02109704641350211,0.303395761398842,1.0,8/30,11.97%,SEMA3G;FGFR3;SLC6A4;WWC2;RTN4;DCC;TRIM46;DIP2B
prerank,establishment of epithelial cell polarity (GO:0090162),0.6739860645877435,1.6122674968355175,0.028662420382165606,0.30179049282001214,1.0,6/19,6.73%,CYTH3;SIPA1L3;CYTH1;MSN;SYNE4;CLASP1
prerank,early endosome to Golgi transport (GO:0034498),-0.679238231576724,-1.6122107691292773,0.017543859649122806,0.3840704890495001,1.0,8/11,16.07%,SURF4;TRAPPC10;LMAN1;EHD3;STX5;SNX1;SNX8;SNX2
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4804407320729599,-1.6115209174682068,0.007547169811320755,0.3789316379733242,1.0,10/40,5.55%,ARHGAP6;EGFR;NTRK3;LPAR1;PDGFRB;PDGFRA;KIT;EDNRA;NTRK2;FGF2
prerank,cGMP-mediated signaling (GO:0019934),-0.6427744798939343,-1.6110000850653066,0.028423772609819122,0.3738038110344611,1.0,3/13,2.91%,IRAG1;PDE3A;APOE
prerank,regulation of microtubule depolymerization (GO:0031114),0.65110521936426,1.6102819800466401,0.03671071953010279,0.3055595356117388,1.0,8/25,9.92%,TRPV4;STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,pulmonary valve development (GO:0003177),0.6941971330481544,1.6083428505280262,0.015174506828528073,0.30903938104719464,1.0,9/18,5.71%,JAG1;NOS3;SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;TNFRSF1B
prerank,response to muramyl dipeptide (GO:0032495),0.7436732501834145,1.6077840413596618,0.03414634146341464,0.30875652422830197,1.0,4/12,2.69%,NOD1;NOD2;ARHGEF2;VIM
prerank,lymphocyte migration (GO:0072676),0.6241651994144515,1.6067229664167353,0.01991465149359886,0.30980696437065236,1.0,5/32,10.16%,S1PR1;CRTAM;MSN;GATA3;CCL4
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.614201864423101,-1.6058801159177865,0.011799410029498525,0.38312610975961414,1.0,4/16,0.76%,ATP1A2;ANK2;CACNA1C;DMD
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7665081618934556,1.605474612400207,0.03547297297297297,0.3114429386329353,1.0,3/10,4.30%,CEACAM1;LGALS9;FCGR2B
prerank,metal ion transport (GO:0030001),0.5407257161112198,1.6045291506535315,0.016149068322981366,0.3119587943150678,1.0,17/86,11.28%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B2;CAV1;CACNA1A;SLC8A1;ATP2C1;NIPAL2;SLC30A1;NIPAL3;NDFIP2;NIPA2;GRIN3A;TRPM2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.6189135507461992,-1.6026884793697576,0.024509803921568627,0.3862807723003531,1.0,7/15,16.48%,GGACT;ALDH4A1;PRODH;GGT5;SARDH;ABHD12;GGT7
prerank,regulation of axon extension (GO:0030516),0.6107194241803026,1.6020192985733952,0.01510989010989011,0.31685504858405583,1.0,10/37,11.97%,SEMA3G;MACF1;NTN1;SHTN1;SEMA7A;ISLR2;NRCAM;RTN4;TRIM46;DIP2B
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.628579316435893,-1.6019328949361407,0.034031413612565446,0.3822551557720039,1.0,6/13,4.80%,FSTL1;NBL1;LTBP1;GREM2;FBN2;FBN1
prerank,vesicle transport along actin filament (GO:0030050),0.6834277765588622,1.6018543248277273,0.02384737678855326,0.3156742296297501,1.0,5/19,8.12%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,negative regulation of cartilage development (GO:0061037),-0.6361197556347545,-1.6004094256983845,0.035897435897435895,0.3800059860399493,1.0,4/13,7.50%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5661899383412387,-1.6003215858674442,0.02147239263803681,0.3739980926728677,1.0,7/20,10.07%,ATP1A2;ANK2;CACNA1C;DMD;CALM2;PRKACA;ATP2A2
prerank,regulation of feeding behavior (GO:0060259),-0.6814629317385724,-1.6000808641332749,0.014388489208633094,0.36876050710331326,1.0,3/11,15.27%,LEPR;CFAP20;EIF2AK4
prerank,ameboidal-type cell migration (GO:0001667),0.5793001025771461,1.5983531055795257,0.016304347826086956,0.32308555222120916,1.0,7/51,4.99%,SEMA3G;NANOS1;TBX1;SEMA3F;PKN3;SEMA7A;PKN1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5742916057742057,1.5961331755637254,0.022280471821756225,0.32741859561903514,1.0,11/51,9.50%,VEGFC;CCR1;F2RL1;LGALS9;VEGFD;ANO6;ADAM17;MAPK1;CMKLR1;PTK2;HMGB1
prerank,filopodium assembly (GO:0046847),0.7021130485832421,1.5960245639820827,0.04060913705583756,0.3260961104905979,1.0,4/16,5.38%,SPATA13;FGD5;DNM3;FGD6
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.65529489032387,1.5960144377044647,0.03211009174311927,0.3244989871555988,1.0,5/25,5.08%,PLCG2;NOD2;B2M;F2RL1;TRIM6
prerank,positive regulation of ruffle assembly (GO:1900029),0.7238573394944662,1.5959225427821502,0.04318936877076412,0.323138736414861,1.0,2/13,7.52%,EPS8L2;PLEKHM1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5493068826891608,1.5958501729510615,0.014796547472256474,0.32171189787601,1.0,14/72,7.74%,EPS8L2;HEG1;ARHGEF3;RASIP1;ARHGEF28;F11R;ARHGEF2;F2RL1;APOA1;BCR;LPAR6;CUL3;ARHGDIA;ARRB1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.7443174818080321,1.5958488019800898,0.04492512479201331,0.3201448284161389,1.0,5/11,9.21%,RAPGEF2;F11R;RAPGEF6;TJP2;TJP1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5546626574746857,1.5956948684352907,0.012706480304955527,0.31901879527626315,1.0,28/67,16.98%,VEGFC;FLT1;FYN;FLT4;ELMO1;DAB2IP;PRKD1;CRK;VEGFD;SHB;CLEC14A;HSPB1;NCKAP1;ROCK1;PTK2;CYFIP1;RAC1;CYBA;PRKD2;WASF2;PIK3CB;DOCK1;PGF;NCF2;PAK2;NCK1;ELMO2;MAPK14
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6558985715646332,1.5941731642845773,0.030973451327433628,0.32149513080139447,1.0,8/25,10.33%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;RTN4;CCDC88A
prerank,cholesterol homeostasis (GO:0042632),0.5560829656855741,1.5928997455200633,0.01338199513381995,0.32338862975356975,1.0,10/64,5.21%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5509400813330998,1.5912692811367721,0.01486988847583643,0.32583478300257557,1.0,17/73,11.78%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;CASP8;CASP2;TNFSF10;DAP;BBC3;CRADD;JAK2;HSPE1;CASP1;LAPTM5;CASP8AP2
prerank,negative regulation of cell motility (GO:2000146),0.5253825495898999,1.5910577085237954,0.005841121495327103,0.32487788518851146,1.0,21/108,7.86%,PTPRJ;JAG1;ENG;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;RHOB;CRK;CLIC4;ADAM15;STK24;SPOCK3;GATA3;SRGAP1;DUSP3;PTPRU
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5847963076160291,1.590984247025698,0.022315202231520222,0.32356281656140146,1.0,9/41,11.28%,PLCG2;TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;HTR2A;TRPM2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6775026452264774,1.5909291265430685,0.036418816388467376,0.32217363696127466,1.0,6/19,11.89%,PTPRJ;VCAM1;GPR143;PRNP;TRPM2;GRM5
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5098499676646626,1.5900907030535822,0.003246753246753247,0.322779419946517,1.0,40/151,14.92%,SGMS1;ACER2;SGPP2;GCNT1;SGMS2;DEGS2;GSTA2;PRKD1;PLPP1;GCH1;APOA1;GPHN;CERS4;SLC44A1;PCSK5;SPTLC2;LCAT;SPNS2;FURIN;SPTLC1;ARG1;ASS1;ALAS1;CERT1;PCYT1A;ELOVL4;CERS6;CERS5;HACD4;CEPT1;LPCAT3;ELOVL7;ACHE;PRKD2;PPM1L;TYW1;ELOVL5;VAPA;STARD10;CSNK2B
prerank,negative regulation of axonogenesis (GO:0050771),0.645720398910226,1.5896078137197729,0.02406015037593985,0.3225600002119045,1.0,9/27,18.15%,SEMA3G;ARHGDIA;RTN4;DCC;TRIM46;DIP2B;MAP2;GDI1;CDKL3
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5928654373549672,1.5896009326609584,0.024161073825503355,0.3210669375571454,1.0,10/39,6.29%,JAG1;JAG2;NOTCH4;NOS3;NOTCH1;NOD2;TGFB2;DLL4;TSPAN14;POGLUT1
prerank,cardiac cell development (GO:0055006),0.7532106772929938,1.5893164079856839,0.02689075630252101,0.3202297243607423,1.0,4/11,4.18%,JAG1;NOTCH1;SLC8A1;ALPK3
prerank,sterol homeostasis (GO:0055092),0.5542255984318428,1.5890675268927563,0.013414634146341463,0.3192921989128405,1.0,10/65,5.21%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5539792097980031,1.5887398934351038,0.010126582278481013,0.3185878003054511,1.0,13/65,9.82%,PRDM16;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;WFIKKN1;SMAD2;ADAM17;UBA52;RPS27A;PMEPA1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6241656934665015,1.587974141910426,0.03468208092485549,0.3190443882895348,1.0,8/29,9.21%,KANK4;LIMA1;HIP1R;FKBP4;KANK3;SHANK3;CLASP1;TJP1
prerank,regulation of cell migration (GO:0030334),0.4795772168235426,1.5877110709162428,0.0,0.3183243836898273,1.0,70/382,9.54%,SEMA3G;PTPRJ;PECAM1;CDH13;PODXL;JAG1;SPATA13;EDN1;PDGFD;ENG;CLDN5;FLT1;CEACAM1;PDGFB;LDB2;DACH1;RECK;ACE;SMAD7;PLXNA4;CCR1;LIMCH1;MCTP1;ACVRL1;NOTCH1;MYLK;INSR;FAM107A;ADARB1;MACF1;CAV1;F2RL1;RHOB;NEDD9;SEMA3F;ACTN4;CLIC4;MGAT5;PPM1F;PLXND1;ADAM15;ACVR1;SLK;STK24;LEF1;GCNT2;SEMA7A;MAP4K4;TTBK2;ROBO4;SPAG9;SRGAP1;ADAM17;KIF2A;DUSP3;PPP3CA;PRR5L;PTPRU;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;ROCK1;TJP1;PTK2;SGK1;ADAM10;RIPOR1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5878579888812283,1.5845174233934887,0.017711171662125342,0.32544382969966484,1.0,12/41,6.03%,JAG1;ENG;SMAD7;MYBPC3;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4;HEY2;MEF2C;GATA3
prerank,somite development (GO:0061053),-0.666229746776109,-1.5844506179605924,0.03117505995203837,0.41015087965089975,1.0,5/11,9.91%,SMO;MEOX2;LOXL3;MTHFD1;PTCH1
prerank,positive chemotaxis (GO:0050918),0.6917733654345705,1.5844019671389549,0.03605015673981191,0.3242605383162399,1.0,2/17,4.45%,PTPRJ;ANGPT1
prerank,apical junction assembly (GO:0043297),0.5651213530051358,1.5837238846502324,0.01703800786369594,0.3244639165550869,1.0,8/53,8.44%,PECAM1;CLDN5;F11R;OCLN;ESAM;WDR1;CTNNA1;APC
prerank,negative regulation of developmental process (GO:0051093),0.5470626370419617,1.583688502894707,0.0136986301369863,0.3230953896494225,1.0,10/69,5.43%,NOTCH4;NOS3;TBX1;NOTCH1;ARHGEF15;HEY1;KLF7;HEY2;OMA1;FGFR3
prerank,atrioventricular valve development (GO:0003171),0.7265770740815501,1.581328038768469,0.02875399361022364,0.3278509191358961,1.0,5/14,4.11%,GJA5;BMPR2;NOTCH1;TGFB2;ACVR1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5417557336097067,-1.5812197258681773,0.03067484662576687,0.4134931884047844,1.0,7/23,9.81%,PLCE1;AGMO;LPGAT1;MOGAT3;PLA2G4A;GK;DGAT1
prerank,positive regulation of cell motility (GO:2000147),0.4919239717942797,1.5811213842231981,0.0,0.32694859627676776,1.0,40/205,9.54%,SEMA3G;PECAM1;CDH13;PODXL;EDN1;PDGFD;FLT1;PDGFB;CCR1;NOTCH1;MYLK;INSR;FAM107A;CAV1;F2RL1;NEDD9;SEMA3F;ACTN4;MGAT5;PPM1F;SPOCK2;NTN1;ACVR1;LEF1;GCNT2;SEMA7A;MAP4K4;SPAG9;ADAM17;PPP3CA;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;TJP1;PTK2;ADAM10;RIPOR1
prerank,vasoconstriction (GO:0042310),0.7472207020698577,1.5795145668224078,0.035058430717863104,0.3299475643943177,1.0,3/11,3.81%,EDN1;PIK3C2A;SLC8A1
prerank,regulation of cell adhesion (GO:0030155),0.5126150966438011,1.5788594804916944,0.007927519818799546,0.3300945853580139,1.0,22/129,9.42%,PTPRJ;CDH13;PODXL;NUAK1;EFNA5;PLXNA4;RND1;ACVRL1;DUSP1;FES;CYTH1;TNFRSF18;PDE3B;PLXND1;ANGPT1;EFNA1;ARHGDIA;PPP3CA;RSU1;ROCK1;PTK2;ADAM10
prerank,positive regulation of phagocytosis (GO:0050766),0.5739895643799188,1.578244681040467,0.02461139896373057,0.33017800045169443,1.0,11/47,12.10%,PTPRJ;GATA2;MERTK;F2RL1;APOA1;ANO6;FCGR2B;CD47;STAP1;CYBA;DOCK2
prerank,regulation of cellular component organization (GO:0051128),0.5115129751982612,1.577853549340202,0.0045351473922902496,0.3296624047401644,1.0,28/135,11.63%,CDH13;LTBP4;RAPGEF2;HIP1;CEACAM1;HIP1R;RAPGEF1;FAM107A;DAB2IP;RASGRP2;PACSIN2;CISH;WFDC1;CAMK2D;STK38L;CAMSAP2;PACSIN1;IRGM;ROCK1;TJP1;SGK1;STON1;TAOK2;MAD2L2;ERMN;PTPN1;SPOCK1;SNCAIP
prerank,cation transmembrane transport (GO:0098655),-0.46321537743050184,-1.5763401287599814,0.008130081300813009,0.42325710897114516,1.0,8/44,7.04%,ATP1A2;TRPM3;SLC7A2;TRPM6;SFXN2;ABCC9;SLC25A20;SLC6A9
prerank,sphingolipid catabolic process (GO:0030149),0.7299658445080857,1.5761501857288849,0.03048780487804878,0.3323238456800397,1.0,4/15,5.93%,ACER2;PPT1;SMPDL3A;ASAH2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4795577308050278,1.5759628648101092,0.0010193679918450561,0.33137287625050776,1.0,48/348,8.22%,VEGFC;NOS1;PTPRJ;PECAM1;PLCG2;TEK;PDGFD;ENG;RAPGEF2;EFNA5;PDGFB;BMPR2;FLT4;RPS6KA5;FAS;TBX1;LIMCH1;CCND2;ACVRL1;ATP2B4;INSR;CCND3;ARHGEF2;RBPMS;CAV1;PRKD1;TGFB2;APP;IQGAP1;VEGFD;KRAS;ACVR1;ANGPT1;EFNA1;TRIM6;CSNK1D;BRAT1;BCAR3;ADAM17;MAPK1;IRGM;LRRK2;PDE8A;MAPRE3;ARRB1;THPO;TOM1L1;JAK2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.615143167531965,1.5758723284984757,0.023776223776223775,0.33020700972300243,1.0,7/33,3.54%,PTPRM;PTPRG;PTPRR;ACVRL1;DAB2IP;DLL4;EVL
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.5141809020934923,1.5743625679084485,0.0022675736961451248,0.332365792383324,1.0,16/119,7.29%,BMX;PLCG2;EFR3B;PIP5K1B;PITPNM3;PIK3R6;ITPKB;IP6K3;INPP5D;PIK3C2A;INPP5K;CISH;PLEKHA1;PIP5K1C;FIG4;SOCS6
prerank,alcohol catabolic process (GO:0046164),-0.6945719146396422,-1.573875790698509,0.03816793893129771,0.42407474842407233,1.0,2/10,2.91%,CYP27A1;APOE
prerank,cellular response to cAMP (GO:0071320),0.6335892278212251,1.572632662688666,0.03188405797101449,0.3356077284564346,1.0,4/30,3.52%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K
prerank,positive regulation of histone acetylation (GO:0035066),0.6447308094810036,1.5717472562164156,0.03941605839416058,0.3364598156053418,1.0,2/23,1.03%,NOS1;RPS6KA5
prerank,positive regulation of cell junction assembly (GO:1901890),0.558266633641106,1.5707824710248772,0.024675324675324677,0.33763150229691824,1.0,9/56,10.68%,PTPRJ;TEK;CLDN5;CAV1;PPM1F;MAP4K4;IL1RAP;ROCK1;RAC1
prerank,embryonic eye morphogenesis (GO:0048048),-0.6570759736163742,-1.569574922849841,0.04275534441805225,0.43200510532483183,1.0,7/11,19.36%,EFEMP1;MFAP5;FBN2;FBN1;TBX2;RARG;MFAP2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6790171678301365,1.5689680960201629,0.043010752688172046,0.34089154342681793,1.0,6/18,12.10%,PLCG2;DYSF;KARS1;NMI;TYROBP;DOCK2
prerank,determination of heart left/right asymmetry (GO:0061371),0.5788236525690931,1.5689082828075351,0.0326975476839237,0.33961273486251015,1.0,7/42,5.57%,SOX17;ENG;NOTCH1;DAND5;SOX18;MEF2C;BBS7
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6405138118033835,1.5682603119560563,0.04732824427480916,0.33986055423230616,1.0,5/21,3.58%,NOS3;CCR1;NOTCH1;HEY1;HEY2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7458969187337585,1.5669277540134992,0.04145077720207254,0.34190769209598665,1.0,5/10,12.58%,GATA6;FURIN;CDH3;TYROBP;TSKU
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5510331148986731,1.5654792174701022,0.02617801047120419,0.3443042029678957,1.0,13/59,11.00%,PTPRM;PECAM1;CDH13;CEACAM1;CADM1;AMIGO2;ROBO4;BSG;TENM3;NECTIN4;NECTIN1;KIRREL3;CDH2
prerank,cell differentiation in spinal cord (GO:0021515),0.7483507738698464,1.5629362619004887,0.05132450331125828,0.34956614124348473,1.0,3/10,12.21%,SOX13;ZC4H2;SOX6
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6567789818739851,1.5629242531088983,0.04823151125401929,0.3481526558234989,1.0,3/18,1.64%,GCNT1;VCAM1;JAM2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.48851390523283744,1.5621741532597704,0.0031914893617021275,0.3485933168651585,1.0,38/199,10.04%,LAMA4;NOS3;PTPRG;PTPRR;SMAD6;BMPR2;RPS6KA5;SMAD7;NOVA2;NOTCH1;ATP2B4;PAEP;HEY1;KLF7;DAB2IP;IFNGR1;ID1;HDAC9;APOA1;EVL;HEY2;IL17RD;FCGR2B;EFNA1;MEF2C;GATA3;ADAM17;ADIPOR1;SLC6A4;PTPRO;WWC2;ABHD6;PROC;NR1D1;MCC;ROCK1;MAD2L2;ACOT13
prerank,lung epithelium development (GO:0060428),-0.6575176066536496,-1.5614209675543311,0.03146067415730337,0.45280051515018555,1.0,5/10,16.11%,ERRFI1;BMP4;STRA6;PKD1;RCN3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5497773498971203,-1.5603539110157256,0.0438871473354232,0.4500883285208803,1.0,4/21,0.76%,ATP1A2;ANK2;CACNA1C;DMD
prerank,cellular response to cadmium ion (GO:0071276),-0.5154390898370581,-1.5603236838627246,0.032640949554896145,0.4438655027662143,1.0,9/24,6.94%,EGFR;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,negative regulation of platelet activation (GO:0010544),0.6984017659960157,1.5598148067159374,0.04081632653061224,0.3531519713309629,1.0,5/16,3.41%,NOS3;CEACAM1;PDGFB;PRKG1;ADAMTS18
prerank,T cell proliferation (GO:0042098),0.7004435549156137,1.5588591680527355,0.05357142857142857,0.3543195617062783,1.0,4/13,4.64%,CRTAM;CADM1;MSN;CTPS1
prerank,regulation of DNA repair (GO:0006282),-0.44789057148398315,-1.5588482203388638,0.0038910505836575876,0.4430019024220211,1.0,8/44,8.59%,EYA2;EGFR;EYA1;TRIP12;EYA4;UBE2V2;UBE2N;USP1
prerank,protein hydroxylation (GO:0018126),-0.6038121832765785,-1.5575817932168436,0.024128686327077747,0.4411023358560493,1.0,10/15,18.59%,P3H3;EGLN3;VIPAS39;P3H1;PLOD2;P3H2;JMJD4;VPS33B;P3H4;PLOD3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6961748165510557,1.5575701758131146,0.0380952380952381,0.3564391480432923,1.0,3/17,2.55%,PODXL;PIEZO1;TGFB2
prerank,positive regulation of immune effector process (GO:0002699),0.6274696303294832,1.5573209502646712,0.04610951008645533,0.3557057507260153,1.0,2/27,2.67%,PTPRJ;LGALS9
prerank,icosanoid secretion (GO:0032309),0.7371923646959347,1.557260518209935,0.049019607843137254,0.35448507729172957,1.0,2/12,1.04%,ABCC4;ACE
prerank,positive regulation of immune response (GO:0050778),0.5459067493115572,1.5557292907719473,0.021170610211706103,0.3568952041080779,1.0,14/64,11.05%,GBP5;NOD2;F2RL1;TGFB2;LGALS9;FCGR2B;KARS1;ITGAM;PLSCR1;NMI;POLR3B;SLC15A4;DHX9;CYBA
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6097267980058051,-1.555708121785179,0.03535353535353535,0.44077664824151064,1.0,6/14,14.75%,ANK2;ACTN2;ATP1B3;LRRC38;ATP1B1;ATP1B2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.5068897308492656,1.5555209422913678,0.007865168539325843,0.3560757600305239,1.0,22/124,10.68%,PTPRM;LIMA1;STMN2;RAPGEF2;FRYL;RAB11A;FRY;BTG2;APP;MAP4;BLOC1S6;TTC29;EHD1;FAM161A;PLEKHA1;UHMK1;FLRT3;RAB35;ROCK1;HMGB1;CYFIP1;RAC1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.5327423734288308,1.5545252813820407,0.0175,0.3573207382072363,1.0,20/76,16.66%,TEK;SYNPO;EDN1;FCHSD2;F2RL1;FES;EVL;CDC42EP1;P2RX7;WDR1;NCKAP1;STAP1;PFDN2;NUMA1;SORBS3;NES;VIL1;TENM1;NCK1;PYCARD
prerank,female gamete generation (GO:0007292),0.6112282505969568,1.5541059511126822,0.027616279069767442,0.3570195389915153,1.0,2/29,0.40%,NANOS1;NANOS3
prerank,ketone body metabolic process (GO:1902224),-0.6595771989714941,-1.5540111899523483,0.0395778364116095,0.4402769996077976,1.0,6/10,11.91%,OXCT1;ACSS3;HMGCS2;BDH2;BDH1;HMGCL
prerank,protein autophosphorylation (GO:0046777),0.49275445437556153,1.5535833661884553,0.0054525627044711015,0.3570083894162454,1.0,34/157,12.18%,BMX;TEK;FLT1;STK10;FLT4;INSR;PRKD1;OXSR1;FES;SLK;STK24;CAMK2D;FGFR3;MEX3B;UHMK1;EEF2K;ALK;SIK2;LRRK2;LMTK2;JAK2;STK39;PASK;PIM3;CAD;PTK2;TAOK2;MAP3K11;MARK3;MINK1;MAP3K3;PRKD2;MARK2;VRK1
prerank,regulation of hemopoiesis (GO:1903706),-0.6734558351316186,-1.55350152213561,0.03225806451612903,0.4360295784907843,1.0,5/10,9.67%,PTN;PRKCB;CREBBP;RUNX1;IL17D
prerank,regulation of ruffle assembly (GO:1900027),0.639276776552527,1.5514450430464894,0.03442879499217527,0.36122393748896264,1.0,5/23,9.11%,EPS8L2;CAV1;EVL;PLEKHM1;STAP1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5909712698865123,1.5513420791160553,0.034532374100719423,0.360066622490935,1.0,7/34,7.87%,PTPRJ;PTPRB;DUSP1;DUSP16;DUSP3;PTPN12;PTPRO
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7437552024623841,1.5507909782757774,0.03284072249589491,0.3599766156265475,1.0,2/11,2.15%,KCNQ1;ATP1A1
prerank,regulation of histone acetylation (GO:0035065),0.5962905472630369,1.5506227625535045,0.041666666666666664,0.35908485586050576,1.0,2/33,1.03%,NOS1;RPS6KA5
prerank,lymphocyte mediated immunity (GO:0002449),0.7216612766170468,1.549619840234138,0.05627009646302251,0.36028848624171306,1.0,1/12,0.26%,JAG1
prerank,epidermis development (GO:0008544),0.5499370212491673,1.5493186680160715,0.03018867924528302,0.3597536857515207,1.0,4/56,3.89%,LAMA3;GATA6;EMP1;ATP2C1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5962842638379562,-1.5488465613490465,0.026385224274406333,0.4451769135000984,1.0,4/15,2.70%,PIEZO2;ADGRV1;COL11A1;KIT
prerank,regulation of interleukin-1 production (GO:0032652),0.6911858856607125,1.5486116221539001,0.054858934169279,0.3603078380033687,1.0,4/15,9.50%,CEACAM1;TMED10;FOXP1;HMGB1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5453643417827305,1.5482233300987058,0.02072538860103627,0.35992811364460287,1.0,10/56,10.93%,PLCG2;NOD1;NOD2;TLR3;IRAK2;HSP90B1;UBA52;RPS27A;HMGB1;TAB2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.696448591802352,1.548117944302696,0.05071315372424723,0.3588103875928175,1.0,2/15,2.15%,KCNQ1;ATP1A1
prerank,response to cadmium ion (GO:0046686),-0.5074383197061454,-1.547847894737331,0.027522935779816515,0.4426447857531826,1.0,9/26,6.94%,EGFR;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,positive regulation of JNK cascade (GO:0046330),0.5331378048011279,1.546928475006381,0.024906600249066,0.3606726817993127,1.0,17/70,10.64%,MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;TRAF1;MFHAS1;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;MINK1
prerank,positive regulation of protein depolymerization (GO:1901881),0.7341149397541916,1.5458229083563546,0.05612244897959184,0.3623983713363365,1.0,4/11,7.47%,TRPV4;STMN2;F2RL1;WDR1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.5271123916706358,1.5457412747004275,0.016129032258064516,0.3612839645344144,1.0,12/75,8.44%,PTPRJ;HEG1;RASIP1;DUSP1;DAB2IP;HHEX;INPP5K;SLC8A1;STK38;HYAL2;CEBPA;APC
prerank,positive regulation of heart rate (GO:0010460),0.675624618182284,1.5445249499264277,0.04654895666131621,0.36316168162035817,1.0,2/17,0.47%,KCNQ1;EDN1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7380733138388665,1.543995243907375,0.049342105263157895,0.3632872418985712,1.0,3/11,5.32%,RAPGEF2;LGALS9;MEF2C
prerank,digestive tract development (GO:0048565),-0.47772450120529936,-1.5433058809237838,0.03767123287671233,0.45058103870334953,1.0,15/32,11.67%,GLI3;CLMP;GLI2;FGFR2;RARB;SMO;COBL;KIT;NIPBL;MEGF8;GLI1;PKDCC;STRA6;SALL1;PKD1
prerank,negative regulation of protein polymerization (GO:0032272),0.6037299903827202,1.5429510236003374,0.05539358600583091,0.3646040509250684,1.0,4/27,2.97%,KANK4;STMN2;HIP1R;KANK3
prerank,aorta morphogenesis (GO:0035909),0.6808310070561983,1.5428758395169,0.04220779220779221,0.36345287960183176,1.0,8/17,3.58%,JAG1;ENG;TBX1;ACVRL1;MYLK;HEY1;DLL4;HEY2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6547738838905087,1.5428565535742031,0.04675716440422323,0.3621604085789653,1.0,6/20,11.77%,ENTPD1;APP;ANO6;P2RX7;CASP1;SUGT1
prerank,bile acid and bile salt transport (GO:0015721),0.6258472619478102,1.5414691395482936,0.043731778425655975,0.36436603612659624,1.0,3/24,2.99%,ABCC4;CEACAM1;SLCO1C1
prerank,response to cAMP (GO:0051591),0.5915275804402825,1.5397155201524555,0.03765690376569038,0.36764843572574435,1.0,6/37,8.30%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K;STAT1;NDUFS4
prerank,negative regulation of hydrolase activity (GO:0051346),0.5628725169227893,1.5396354822136487,0.02455661664392906,0.3665214783464787,1.0,8/49,7.14%,NOS1;F11R;DAB2IP;ZCCHC9;LRCH1;SH3BP4;GPATCH2;LRRK2
prerank,regulation of integrin activation (GO:0033623),0.6921251210921444,1.5391260937643516,0.057003257328990226,0.3665024605891862,1.0,3/15,2.02%,RASIP1;PIEZO1;FBLIM1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.4707399683985244,1.5386307497554619,0.005192107995846314,0.36648725768532026,1.0,49/259,10.78%,CDH13;SPATA13;EXOC6;EHD4;FGD5;CD2AP;ABCC4;RAPGEF2;S1PR1;ABLIM1;EMP1;NOTCH1;RAB11A;MYLK;PARVB;EMP2;DNM3;INPP5K;ANO6;NTN1;TEKT5;EHD1;SHTN1;RAPGEF6;MAP4K4;FAM161A;TTBK2;FGD6;TTC36;FNBP1L;BBS7;SNX10;RAB23;P2RX7;FXYD5;WHAMM;TMEM216;PTPRO;IFT140;CFAP43;PCM1;CFAP52;CCDC88A;CDC14A;DYNLL1;CYFIP1;MINK1;RAC1;EXOC8
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5449351056669192,1.5381871868294998,0.02295918367346939,0.3664172080137302,1.0,7/54,4.87%,KCNN4;KCNQ1;CAV1;KCNN3;NOS1AP;DPP6;DPP10
prerank,positive regulation of histone modification (GO:0031058),0.5924307253237907,1.5360345498064822,0.03133903133903134,0.37092915279696825,1.0,7/33,12.77%,NOS1;RPS6KA5;ING2;ARRB1;BRCA1;CHTOP;GLYR1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4911918259186836,1.5359958224536763,0.007717750826901874,0.36972697031773333,1.0,42/163,18.86%,BMX;PTPRJ;PLCG2;FYN;INPP5D;PSMD13;MEF2C;PLEKHA1;GATA3;CD247;PSMD4;ZC3H12A;EIF2B2;PSMA5;PSMB10;PLCG1;TAB2;PSMB8;PSMD14;CD38;PRKD2;PIK3CB;BTK;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PDE4D;PAK2;CD79A;PSMC6;NCK1;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6
prerank,regulation of receptor binding (GO:1900120),0.7577816286961543,1.5354970971598036,0.05945945945945946,0.36982370198153225,1.0,3/10,4.08%,ATP2A3;B2M;ADAM15
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6146265132033684,1.5351061660493817,0.036418816388467376,0.36958747651296886,1.0,2/26,1.09%,PLCG2;ITPR3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6710935392640833,1.5347001668742262,0.03840245775729647,0.3694536930437298,1.0,2/16,3.80%,CEACAM1;STX7
prerank,regulation of ossification (GO:0030278),0.5824617505298477,1.534560391549109,0.036986301369863014,0.36849605388464246,1.0,10/36,8.57%,SGMS2;SMAD6;S1PR1;BMPR2;NOTCH1;TGFB2;ACVR1;MEF2C;ZBTB16;NBR1
prerank,macrophage activation involved in immune response (GO:0002281),0.7208098214482048,1.5343288654706302,0.043973941368078175,0.36775599309230256,1.0,5/13,12.63%,PLCG2;DYSF;NMI;TYROBP;CX3CR1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6615004893416597,-1.5342268130183965,0.05472636815920398,0.4754359822724708,1.0,8/11,20.24%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6189486477907382,1.5341402984790922,0.043478260869565216,0.366960589959805,1.0,2/24,1.09%,PLCG2;ITPR3
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5216784472067068,1.5338961598867533,0.015366430260047281,0.3663020426854113,1.0,29/84,13.57%,TEK;NOS3;EDN1;GATA2;PDGFB;BMPR2;FLT4;PRKD1;RHOB;ANXA3;RRAS;ANGPT1;GPI;GATA3;ADAM17;AKT3;ZC3H12A;HSPB1;NUS1;ATP5F1A;FOXP1;HMGB1;GFUS;PLCG1;RAC1;PRKD2;PIK3CB;ITGB1BP1;HIF1A
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5504823112397537,1.531101847435561,0.02621231979030144,0.3724126660944585,1.0,21/54,17.40%,NOS3;GATA2;PDGFB;ACVRL1;ATP2B4;PRKD1;ANGPT1;MEF2C;ADAM17;AKT3;HSPB1;NUS1;ATP5F1A;HMGB1;PLCG1;PRKD2;HIF1A;CSNK2B;TMSB4X;MAPK14;ETS1
prerank,regulation of striated muscle contraction (GO:0006942),0.6067131873242602,1.530668965074696,0.0463768115942029,0.3722330979269252,1.0,4/27,1.45%,NOS1;GJA5;SMAD7;MYBPC3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7055622936142744,1.530496398454052,0.07084019769357495,0.3713840491586463,1.0,2/12,2.62%,PTPRJ;CBL
prerank,regulation of cellular component biogenesis (GO:0044087),0.5735906624214582,1.5300606291576657,0.0449438202247191,0.37118826916036796,1.0,9/39,9.21%,RAPGEF2;TIE1;NOTCH1;RAPGEF1;DAB2IP;MSN;IRGM;ROCK1;TJP1
prerank,positive regulation of neuron migration (GO:2001224),0.7258348488901132,1.5297937197360854,0.04628099173553719,0.37064857170817983,1.0,4/11,4.50%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.46947564748630777,-1.5293794068025586,0.03424657534246575,0.48602430722360124,1.0,9/35,5.64%,IRAG1;PDE7B;PDE3A;ADCY1;ADGRG6;APOE;NUDT4;KSR1;ADCY2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5675080128369507,1.5291228173443123,0.04495912806539509,0.37108225254228117,1.0,13/44,13.27%,NANOS1;NANOS3;TNRC6C;BTG2;ZC3H12A;PRR5L;POLR2G;ROCK1;ZFP36L2;CNOT1;GTPBP1;TOB1;METTL14
prerank,modified amino acid transport (GO:0072337),-0.5768618599520876,-1.5289836894839879,0.05333333333333334,0.4816340655448946,1.0,4/15,6.15%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,positive regulation of integrin activation (GO:0033625),0.7221481657804323,1.52816070535001,0.05695142378559464,0.37253822822810106,1.0,2/11,1.14%,RASIP1;PIEZO1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5159930924125997,1.5271269612261795,0.020905923344947737,0.3740947607085649,1.0,30/92,13.57%,PLCG2;TEK;EDN1;BMPR2;FLT4;RAB11A;PRKD1;TGFB2;RHOB;ANXA3;PPM1F;RRAS;ANGPT1;IQSEC1;MAP4K4;GPI;GATA3;CLASP1;ZC3H12A;FOXP1;RTN4;GFUS;CLASP2;PLCG1;RAC1;PRKD2;PIK3CB;DOCK1;ITGB1BP1;HIF1A
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5682801778166087,-1.5265099855820015,0.0391644908616188,0.4841602719163049,1.0,8/16,22.50%,AUTS2;OGT;ARHGAP24;CADM4;GABARAP;ARF6;KBTBD7;RASGRF1
prerank,regulation of MAPK cascade (GO:0043408),0.4832949977668892,1.5264064077683697,0.006578947368421052,0.37476348507748514,1.0,30/157,9.50%,PTPRJ;PLCG2;TEK;FLT1;CEACAM1;PDGFB;FLT4;FAS;TBX1;JCAD;INSR;DUSP1;DAB2IP;CAV1;CAV2;ADRB2;IQGAP1;RRAS;MAP4K4;FGFR3;IAPP;BCAR3;MAPK1;P2RX7;DUSP3;THPO;NBR1;ROCK1;TAOK2;HMGB1
prerank,actin filament-based transport (GO:0099515),0.6372838875368201,1.5260277277892245,0.032507739938080496,0.3744916846854492,1.0,5/21,8.12%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.739904654154764,1.5247559203539025,0.05922165820642978,0.37638812468579064,1.0,5/11,11.05%,F2RL1;TIRAP;MFHAS1;ACOD1;CYBA
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5916457989883257,-1.5231981691593528,0.04607046070460705,0.4891861806665067,1.0,7/15,12.28%,UST;DSE;DCN;BGN;VCAN;B3GAT3;CSPG4
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5702657270491782,-1.5216900587194073,0.05699481865284974,0.48858372507539327,1.0,7/15,22.68%,SMO;BMP4;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,positive regulation of MAPK cascade (GO:0043410),0.4690463514853778,1.5212245806094624,0.0,0.38424863681591614,1.0,44/245,9.67%,PTPRJ;PLCG2;TEK;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;FLT4;PIK3R6;TBX1;CCR1;NOTCH1;JCAD;NOD2;INSR;DAB2IP;ARL6IP5;CAV2;F2RL1;TGFB2;ADRB2;LGALS9;APP;IQGAP1;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;IAPP;BCAR3;MFHAS1;LRRK2;PDE8A;ARRB1;THPO;TPD52L1;ROCK1;HTR2A;TAOK2;HMGB1;FBXW7
prerank,regulation of GTPase activity (GO:0043087),0.48081199425404636,1.520809119414772,0.0021953896816684962,0.38411076191863963,1.0,30/177,7.14%,FGD5;RAPGEF2;EFNA5;DOCK9;RASIP1;RABGAP1;F11R;PLXNA4;CHN2;RAPGEF1;DAB2IP;RASGRP2;CAV2;F2RL1;PRKG1;AGRN;CRK;GPR137B;PLXND1;TBC1D30;RAPGEF6;MAP4K4;FGD6;RAP1GDS1;BCAR3;LRCH1;SH3BP4;RGS7;RAB3GAP2;LRRK2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6852166114889889,1.5205560640649596,0.05921052631578947,0.38345960841156,1.0,5/14,4.05%,MMRN2;NOTCH1;DLL4;KLF4;CARD10
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6093919419923634,1.5204915436913264,0.04940119760479042,0.3823609815717211,1.0,4/26,2.89%,PLCG2;LMCD1;ATP2B4;HOMER2
prerank,Rac protein signal transduction (GO:0016601),0.6550937799788967,1.5201737589116637,0.0544,0.3820122958066002,1.0,6/18,13.75%,CDH13;ELMO1;NCKAP1;CYFIP1;RAC1;RHOH
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.4808035794562518,1.5200804364202847,0.006557377049180328,0.3809859861906736,1.0,31/172,11.86%,BMX;PLCG2;PIP5K1B;PITPNM3;PIK3R6;INPP5D;PIK3C2A;APOA1;INPP5K;ACP6;SLC44A1;LPCAT4;LCAT;FAR1;PLEKHA1;PIP5K1C;CRLS1;FIG4;LCLAT1;PLD1;PLSCR1;PCYT1A;DGKH;PIK3C3;ARF3;CEPT1;LPCAT3;PTDSS1;OCRL;INPP5F;ACHE
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5277184447593362,1.5198790460394362,0.02252816020025031,0.3802935887270002,1.0,16/66,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;APOA1;P2RX7;ZC3H12A;HSPB1;JAK2;FOXP1;EGR1;TYROBP;CASP1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6091466022995827,-1.5194399235004994,0.06937799043062201,0.49056396162124954,1.0,8/13,20.24%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,platelet degranulation (GO:0002576),0.501025264789354,1.518866876377742,0.006888633754305396,0.38191496317332235,1.0,14/118,4.78%,VEGFC;PECAM1;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;VEGFD;TIMP3;SELENOP;TAGLN2
prerank,myoblast fusion (GO:0007520),0.7119555194948304,1.5186582893376692,0.06988352745424292,0.38121078911428985,1.0,2/12,1.64%,NOS1;JAM2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5900521509901194,-1.5185877884145773,0.04736842105263158,0.4879487950643527,1.0,4/14,7.50%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,ganglioside metabolic process (GO:0001573),0.6346866881556195,1.5184602709221064,0.0487062404870624,0.38056078869885784,1.0,2/20,0.49%,ST6GALNAC3;ST8SIA6
prerank,negative regulation of cell migration (GO:0030336),0.4895290486561127,1.5181611311778322,0.010146561443066516,0.38012918491607495,1.0,24/137,6.93%,PTPRJ;JAG1;PTPRG;ENG;PTPRR;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;DAB2IP;RHOB;CLIC4;EVL;ADAM15;STK24;HYAL2;SRGAP1;ADIPOR1;CLASP1;DUSP3
prerank,neuron projection regeneration (GO:0031102),-0.6745521105074903,-1.5176283606825682,0.03359173126614987,0.4857157589609735,1.0,3/10,12.78%,PTN;GAP43;NREP
prerank,cellular response to peptide (GO:1901653),0.5412204217086322,1.5172619175622473,0.028871391076115485,0.38130642164720846,1.0,12/56,4.30%,FYN;VCAM1;NOD1;NOD2;ARHGEF2;ATP1A3;CAV1;CACNA1A;ADRB2;VIM;APP;FCGR2B
prerank,positive regulation of protein modification process (GO:0031401),0.47418848396186336,1.5163892463262636,0.00211864406779661,0.38244659950820437,1.0,30/203,7.97%,VEGFC;PECAM1;TEK;ENG;EFNA5;FLT4;ACE;FAS;TBX1;LIMCH1;CCND2;INSR;CCND3;APP;NOS1AP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;PPP1R16B;FAM161A;BRAT1;ADAM17;IRGM;RAB3GAP2;LRRK2;PDE8A;ARRB1;THPO
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6276271076653116,1.5163069587231417,0.05112781954887218,0.3814485568931039,1.0,5/24,8.27%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,regulation of cell aging (GO:0090342),0.7211775395435168,1.5161930937502217,0.07308970099667775,0.3805122090656953,1.0,2/11,4.15%,NUAK1;ING2
prerank,endodermal cell fate commitment (GO:0001711),0.7292593682323989,1.5145479845408625,0.06473594548551959,0.3836186037764409,1.0,2/10,6.27%,SOX17;RTF1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5570081277375677,1.5144926972815864,0.04065040650406504,0.38251001026470205,1.0,7/43,5.57%,SOX17;ENG;NOTCH1;SOX18;ACVR1;MEF2C;BBS7
prerank,circulatory system development (GO:0072359),0.49376750686583143,1.5139400727458374,0.015011547344110854,0.38286792657244406,1.0,20/118,5.32%,HEG1;SOX17;TEK;NOTCH4;PDGFB;FLT4;TBX1;ACVRL1;NOTCH1;HEY1;CASP8;TGFB2;HDAC9;SOX18;HEY2;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6604412514390037,1.5131740196876104,0.05429864253393665,0.38358969942112325,1.0,6/17,7.56%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5389785904748442,-1.512834840047986,0.05325443786982249,0.49656396913198025,1.0,7/20,1.90%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2
prerank,adenine nucleotide transport (GO:0051503),0.6662977305805564,1.5127287131538987,0.06259541984732825,0.3835033510788966,1.0,3/17,4.75%,LRRC8C;ABCC4;SLC17A9
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4935386552500718,-1.5125249283849755,0.041935483870967745,0.49196148806494194,1.0,10/26,8.12%,IGF1;SORBS1;RHOQ;IRS2;C2CD5;IRS1;PIK3R1;CLIP3;OSBPL8;PRKCI
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6555446144819421,-1.512506618607841,0.05853658536585366,0.48653818419961076,1.0,4/10,8.91%,MECP2;PCGF3;IGF2;DNMT3A
prerank,heart looping (GO:0001947),0.566760595484227,1.5123092751767573,0.046348314606741575,0.3833473350888682,1.0,6/39,5.57%,SOX17;ENG;NOTCH1;SOX18;MEF2C;BBS7
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5509759698536628,1.5122062137571095,0.06147540983606557,0.3823746795250884,1.0,14/42,12.50%,PDGFB;NOTCH1;EMP2;FBLN2;PPM1F;GCNT2;PTPRO;JAK2;RSU1;PTK2;MINK1;RAC1;SPOCK1;PIK3CB
prerank,toll-like receptor signaling pathway (GO:0002224),0.5084319035415392,1.5114726185602059,0.02033492822966507,0.38309531451037687,1.0,17/84,12.88%,PLCG2;CASP8;LGALS9;TLR3;TIRAP;IRAK2;UBE2D1;ITGAM;HSP90B1;UBA52;NMI;RPS27A;HMGB1;PIK3C3;TAB2;BTK;RPS6KA3
prerank,negative regulation of protein depolymerization (GO:1901880),0.6187783642168878,1.5114592660995656,0.06351550960118169,0.3819334868648976,1.0,8/24,9.92%,LIMA1;STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6042287029212048,1.5113088166143744,0.041728763040238454,0.3811381752282463,1.0,9/27,13.96%,PDGFB;DACH1;BMPR2;ACVRL1;HMBOX1;TOM1L1;TNKS;PRKD2;ATM
prerank,bone development (GO:0060348),-0.4577788636691019,-1.5106269464229651,0.02973977695167286,0.4872956783470145,1.0,9/39,8.50%,RANBP3L;FGFR2;SULF1;SULF2;CYP26B1;GJA1;SH3PXD2B;SFRP4;P3H1
prerank,phospholipid biosynthetic process (GO:0008654),0.5735463292416848,1.51043653262084,0.04657534246575343,0.3822863983609315,1.0,5/36,7.60%,SGMS1;SGMS2;FAR1;CRLS1;NUS1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6674209096117059,1.510286991129419,0.06307692307692307,0.38154815586102986,1.0,4/17,3.68%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,negative regulation of angiogenesis (GO:0016525),0.5091858550402777,1.5090397935996627,0.021352313167259787,0.38353429199539113,1.0,20/84,11.18%,PTPRM;TEK;CLDN5;KLF2;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;NPR1;STAT1;ISM1;ROCK1;EPN2;ADGRB1;ADAMTS1
prerank,embryonic heart tube development (GO:0035050),0.6799288175720898,1.5087350046062311,0.05958132045088567,0.38318588567726763,1.0,3/14,4.11%,SOX17;SOX18;ACVR1
prerank,response to cholesterol (GO:0070723),-0.5606316642741391,-1.508563747131583,0.04395604395604396,0.48869822922942996,1.0,9/17,17.12%,TGFBR1;SMO;GRAMD1C;GPLD1;PTCH1;GRAMD1A;OSBPL7;TGFBR2;GRAMD1B
prerank,fat cell differentiation (GO:0045444),0.5367235375367173,1.5063133234343882,0.03372243839169909,0.388363946601014,1.0,12/57,13.92%,PRDM16;SMAD6;NR4A2;FOXO1;KLF4;BBS7;CEBPA;PSMB8;NR4A1;ALOXE3;CTBP2;SDF4
prerank,purine ribonucleotide transport (GO:0015868),0.6733125724618191,1.5058226676988071,0.0671875,0.3884732429986409,1.0,3/16,4.75%,LRRC8C;ABCC4;SLC17A9
prerank,negative regulation of growth (GO:0045926),0.49066300371114574,1.505659388775736,0.012304250559284116,0.3877366690700318,1.0,21/121,7.69%,PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;NOTCH1;TGFB2;HNF4A;PPT1;BTG1;ADAM15;WFDC1;SERTAD2;HYAL2;FGFR3;SH3BP4;NPR1;HSPA1B;MT2A
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4568220455373459,-1.505150321927234,0.027586206896551724,0.4951604797990969,1.0,18/37,22.14%,IFT80;TRIP11;IFT81;KIF3C;WDR35;DYNC2LI1;IFT43;DYNLRB1;DYNC2I2;KIF3A;TTC21B;WDR19;IFT27;IFT74;IFT20;IFT88;DYNC2H1;DYNC2I1
prerank,negative regulation of ossification (GO:0030279),0.6028724848138567,1.5050723881284043,0.059001512859304085,0.38810553293236383,1.0,4/23,5.32%,SMAD6;CCR1;NOTCH1;MEF2C
prerank,limb development (GO:0060173),-0.498414945384208,-1.5049975876056134,0.038348082595870206,0.4902627859891727,1.0,8/28,11.08%,GLI3;SMOC1;KAT2B;MEGF8;RSPO2;INTU;PTCH1;SALL1
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6277921734288324,-1.5040806837753247,0.05289672544080604,0.48807141175260205,1.0,5/12,7.61%,UST;DSE;DCN;BGN;VCAN
prerank,cellular response to superoxide (GO:0071451),0.7388780587530281,1.5036535134551283,0.060064935064935064,0.3908146336287668,1.0,2/10,4.38%,NOS3;ATP7A
prerank,melanocyte differentiation (GO:0030318),-0.6275022933036594,-1.5034209155859415,0.06636155606407322,0.48540242216255597,1.0,5/11,6.86%,LRMDA;MITF;KIT;ENPP1;USP13
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5952497150326514,-1.503360929261546,0.0399002493765586,0.48055761946748365,1.0,5/13,2.18%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4
prerank,inositol phosphate dephosphorylation (GO:0046855),0.708152873505262,1.502961830465943,0.06655574043261231,0.39020760087961287,1.0,6/11,17.34%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.708152873505262,1.502961830465943,0.06655574043261231,0.39020760087961287,1.0,6/11,17.34%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,regulation of T cell cytokine production (GO:0002724),0.6563157657212204,1.5023603884677441,0.07198748043818466,0.3907256905095865,1.0,3/15,5.71%,SMAD7;B2M;TNFRSF1B
prerank,negative regulation of MAPK cascade (GO:0043409),0.49828568513244,1.501828790066432,0.014302741358760428,0.3910740675993408,1.0,13/87,6.93%,PTPRJ;PTPRR;CNKSR3;FOXO1;DUSP1;DAB2IP;CAV1;INPP5K;TIMP3;STK38;HYAL2;P2RX7;DUSP3
prerank,modulation by symbiont of host process (GO:0044003),0.7340426997064883,1.5015113831789162,0.06206896551724138,0.3907739992818138,1.0,4/10,8.54%,B2M;PGK1;UBA52;RPS27A
prerank,regulation of protein metabolic process (GO:0051246),0.5481686727960687,1.5012643677031305,0.03867403314917127,0.390228771575801,1.0,7/44,5.65%,LTBP4;ACE;KLF2;FKBP1A;APP;KLF4;FURIN
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6369203458321392,1.5012610536084094,0.06855439642324888,0.3890772511392784,1.0,4/21,3.68%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,microvillus organization (GO:0032528),0.6968761616085538,1.5010620268334856,0.04746317512274959,0.38856120116710835,1.0,5/13,10.64%,RAPGEF2;RAPGEF6;MAP4K4;FXYD5;MINK1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5673014697642966,1.500848861160367,0.051560379918588875,0.387985504004615,1.0,9/39,10.49%,TEK;GATA2;ECSCR;ANO6;ANGPT1;GATA3;PDCD4;NFE2L2;PLCG1
prerank,regulation of focal adhesion assembly (GO:0051893),0.5466883563055505,1.500546063702864,0.04342105263157895,0.387648298492521,1.0,17/54,10.68%,PTPRJ;TEK;EFNA5;LIMCH1;ACVRL1;FAM107A;MACF1;PPM1F;SLK;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2;CLASP2;RAC1
prerank,adherens junction organization (GO:0034332),0.5364487492938393,1.5005394525008786,0.03795811518324607,0.3865237262515882,1.0,21/48,20.22%,CDH13;SMAD7;CADM1;PIP5K1C;CTNNA1;CDH15;CDH3;NECTIN4;TJP1;NECTIN1;CDH12;CDH2;ACTB;CTNNB1;CDH22;PAK2;VCL;ANG;CDH18;CDH24;JUP
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5580941579879758,-1.5003916850262564,0.04,0.4852256032478343,1.0,7/17,9.48%,FSTL1;SULF1;CASK;SLIT2;TWSG1;SFRP4;ZDHHC17
prerank,positive regulation of developmental growth (GO:0048639),0.5484478054982521,1.500127442212714,0.041504539559014265,0.3864205753143517,1.0,12/49,13.94%,PLCB1;INSR;MACF1;ITSN2;AGRN;NTN1;SHTN1;SEMA7A;ISLR2;NEDD4L;SMURF1;RASAL1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5866248674759673,-1.5000751935963224,0.05511811023622047,0.4812903695744433,1.0,7/14,11.24%,LRP1;BMPR1A;IGFBP5;SLIT2;TPM1;IGFBP3;SERPINE1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5148331144986794,1.4999241270495363,0.029832935560859187,0.3857869905871928,1.0,16/75,9.04%,PTPRM;TEK;CLDN5;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;NPR1;STAT1;ISM1;ROCK1
prerank,maintenance of blood-brain barrier (GO:0035633),0.5958551065155611,1.498433643264079,0.053019145802650956,0.3884075853495415,1.0,12/30,11.60%,PECAM1;CLDN5;F11R;OCLN;JAM2;ESAM;LSR;TJP2;ACTG1;TJP1;ACTB;SLC1A1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.49533195731221247,1.4982524623048576,0.02494061757719715,0.38775725449308585,1.0,13/95,6.32%,PRDM16;LTBP4;ENG;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;ING2;WFIKKN1;SMAD2;ADAM17
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.627905518098953,1.498062830558368,0.055800293685756244,0.3871603915047644,1.0,6/20,7.56%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,dermatan sulfate metabolic process (GO:0030205),-0.6055975982370471,-1.494084524891833,0.05808080808080808,0.496252203276134,1.0,5/13,7.61%,UST;DSE;DCN;BGN;VCAN
prerank,sphingoid metabolic process (GO:0046519),0.6941578079478461,1.491906987382323,0.07487520798668885,0.40207571427407746,1.0,4/12,5.93%,SGPP2;DEGS2;PLPP1;ASAH2
prerank,Rho protein signal transduction (GO:0007266),0.5302658838872867,1.4899204170201477,0.04920212765957447,0.4062218648485462,1.0,14/53,10.19%,EPS8L2;CDH13;ARHGEF3;RHOB;CDC42EP1;NTN1;SHTN1;PLEKHG5;ARHGDIA;ARHGAP5;ROCK1;RIPOR1;TAX1BP3;ARHGEF1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5504711214055031,1.4897871617426404,0.048,0.4054294816117122,1.0,10/44,12.50%,PTPRJ;DUSP1;DAB2IP;INPP5K;STK38;HYAL2;PDCD4;AIDA;PTPN1;PIK3CB
prerank,response to zinc ion (GO:0010043),-0.4873864783368855,-1.4891298394005015,0.05,0.5083831166345707,1.0,9/25,7.34%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;P2RX4
prerank,alanine transport (GO:0032328),0.710666752956375,1.4890151278996269,0.06365159128978225,0.40637353233822654,1.0,1/10,0.19%,SLC6A6
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.5429326990662561,-1.4885074433679237,0.03571428571428571,0.5055299280931917,1.0,14/19,32.68%,ADK;AMPD3;GMPR;PNP;TERT;APRT;TYMS;CDA;POLD2;DCK;AMPD2;ADA;POLL;POLD3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5982384619617059,1.4880889900443321,0.0620384047267356,0.4076091821947292,1.0,8/26,10.93%,NOD1;NOD2;CASP8;IFIH1;IRAK2;UBA52;RPS27A;TAB2
prerank,actin filament organization (GO:0007015),0.4712424331472013,1.4877863341708377,0.012074643249176729,0.4072450984167485,1.0,32/151,13.75%,MYO1D;CD2AP;TRPV4;NEBL;HIP1;MYO1E;SHROOM4;HIP1R;ELMO1;RND1;ARHGEF2;PLS3;RHOB;EMP2;NEDD9;FLII;EVL;WHAMM;ARHGAP25;ENAH;MYO1C;BIN3;MAD2L2;GAS2L3;ERMN;RAC1;SHROOM1;TPM4;TMOD3;RND2;CAPG;RHOH
prerank,calcium-mediated signaling (GO:0019722),0.492427897160626,1.4876532367468942,0.023696682464454975,0.40647024556269334,1.0,22/93,13.33%,PTPRJ;PLCG2;EDN1;VCAM1;CCR1;MCTP1;SLC8A1;GPR143;CHRM3;P2RX7;IRGM;LRRK2;PPP3CA;PRKAA1;PRNP;PLCG1;TPCN2;TRPM2;GRM5;BTK;CX3CR1;KSR2
prerank,angiogenesis involved in wound healing (GO:0060055),0.697649110349639,1.4864514898058225,0.07317073170731707,0.4084527554345819,1.0,4/11,6.22%,GATA2;ADIPOR2;CD34;MCAM
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.58794088675918,1.4863999672706545,0.04782608695652174,0.4074451025752898,1.0,6/29,10.12%,CRTAM;CADM1;STX7;ITGAM;STAP1;TYROBP
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6273401724307732,1.4863090355632231,0.07786259541984733,0.4065454340600877,1.0,7/21,9.92%,STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.59352095104632,-1.485960834746839,0.058673469387755105,0.5094943865950515,1.0,5/13,7.81%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,actin filament depolymerization (GO:0030042),-0.621835798038761,-1.4859094072779349,0.06716417910447761,0.5047997556760437,1.0,3/11,1.41%,MICAL3;GSN;MICAL2
prerank,amino sugar biosynthetic process (GO:0046349),-0.6205835847405493,-1.4858444059269948,0.07231920199501247,0.5001945462983505,1.0,8/12,20.24%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,ruffle organization (GO:0031529),0.6456102347901111,1.4848462642031677,0.0713128038897893,0.40919431128782874,1.0,5/16,10.68%,LIMA1;INPP5K;PLEKHA1;CYFIP1;RAC1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5436086528818342,1.4847505043253133,0.05662805662805663,0.40833435927611983,1.0,5/45,4.59%,NANOS1;NANOS3;APP;PUM2;GCNT2
prerank,T-helper cell differentiation (GO:0042093),0.674345697996776,1.484704197039559,0.06260032102728733,0.40731285983714777,1.0,5/14,11.95%,ATP7A;LEF1;FOXP1;HMGB1;TMEM98
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.7268816390440794,1.4843131802932832,0.056105610561056105,0.4072556585519199,1.0,2/10,1.14%,PODXL;PIEZO1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5537286507986152,1.4839865220153485,0.04223433242506812,0.40702776029616733,1.0,8/41,9.21%,PODXL;MAGI1;SMAD7;PIEZO1;GCNT2;CD47;PTPRU;TJP1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5658106863717176,-1.4839747100046987,0.051771117166212535,0.5018005253155468,1.0,8/16,19.35%,PPARGC1B;DDX5;DDX17;PADI2;SAFB;TADA3;AR;TRIP4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.62846965385057,-1.4811335699971016,0.054455445544554455,0.5060398536843264,1.0,5/10,13.86%,CPEB1;NUDT21;NCBP1;PAF1;CPEB3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6002748081169773,-1.4809405753832745,0.04896907216494845,0.5019625437719466,1.0,6/12,13.27%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29
prerank,striated muscle contraction (GO:0006941),0.5343571547782152,1.4803908495447575,0.04731457800511509,0.41509336758563803,1.0,5/53,5.31%,NOS1;KCNQ1;MYBPC3;SLC8A1;STAC
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5141979732928799,1.4799160924412174,0.0403530895334174,0.41527734299006874,1.0,10/67,4.06%,CDH13;UTRN;PDGFB;EMP2;FBLN2;NEDD9;CRK;APOA1;PPM1F;LIMS2
prerank,cellular response to dsRNA (GO:0071359),0.6614730828613816,1.4787534770847748,0.07894736842105263,0.41720365208415733,1.0,7/15,21.89%,CAV1;IFIH1;DHX9;NPM1;RIOK3;RALB;PQBP1
prerank,protein localization to cell-cell junction (GO:0150105),0.6624542101344945,1.4779067779339923,0.06003159557661927,0.41829867054597825,1.0,8/15,15.69%,F11R;LSR;TJP2;ACTG1;TJP1;DSP;ACTB;PAK2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.4690502874033186,-1.4775390394715016,0.06134969325153374,0.5088080000657731,1.0,10/30,12.28%,DSE;DCN;NDNF;CHST15;BGN;HEXA;VCAN;HYAL1;CHPF2;CSPG4
prerank,cholesterol transport (GO:0030301),0.5436230697806138,1.4772667527818384,0.04249667994687915,0.4189093252085801,1.0,14/45,19.69%,LIMA1;CAV1;APOA1;LCAT;STX12;ABCG4;CLU;TSKU;VPS4A;LDLRAP1;ABCA7;SCARB1;SOAT1;RELCH
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6936901149121125,1.4772107933852758,0.076158940397351,0.4179281782644694,1.0,5/12,9.50%,F2RL1;TIRAP;KLF4;FOXP1;HMGB1
prerank,cell-substrate junction assembly (GO:0007044),0.569459936113909,1.4765887447793593,0.060689655172413794,0.41841276328358706,1.0,6/33,9.44%,LAMA3;BCR;DST;PLEC;WHAMM;TAOK2
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6688827681748967,1.4763014967077677,0.07606973058637084,0.4180115229295425,1.0,2/13,3.43%,NOS3;GCH1
prerank,myotube differentiation (GO:0014902),0.661755030046041,1.4761628984945592,0.07062600321027288,0.41722947803734833,1.0,5/17,7.18%,NOS1;JAM2;MEF2C;MYEF2;ADAM12
prerank,regulation of cell growth (GO:0001558),0.46070723648268463,1.4745597383901683,0.010718113612004287,0.42041288116402736,1.0,37/204,10.41%,PTPRJ;SOX17;LTBP4;CEACAM1;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;FAM107A;RASGRP2;TGFB2;HNF4A;PPT1;BTG1;CISH;ADAM15;KIF26A;WFDC1;SERTAD2;CAMK2D;HYAL2;BRAT1;TAF9B;ADAM17;SH3BP4;SLC25A33;NPR1;HSPA1B;SGK1;SERTAD3;ADAM10;TAOK2;RTN4;MAD2L2;RPS6KA1;GNG4
prerank,regulated exocytosis (GO:0045055),0.471254352243128,1.4729541075066412,0.005422993492407809,0.42346222005587264,1.0,20/173,6.37%,VEGFC;PECAM1;SYT15;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;SYT7;VEGFD;TIMP3;SELENOP;TAGLN2;TMED10;MYH9;PIP5K1C;CYB5R1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5892940518806246,-1.471996659463255,0.05459057071960298,0.5222473281579604,1.0,8/13,11.27%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1;TBX2
prerank,clathrin-dependent endocytosis (GO:0072583),0.6025750291059734,1.4717944962393865,0.07520891364902507,0.4253664196034827,1.0,8/26,11.65%,FCHSD2;ITSN2;AP2B1;FCHO2;FNBP1L;PIP5K1C;AP2M1;INPP5F
prerank,inositol phosphate catabolic process (GO:0071545),0.6818060351455136,1.4714335316422886,0.08183306055646482,0.4251576651476197,1.0,6/12,17.34%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,ganglioside biosynthetic process (GO:0001574),0.6592155174323975,1.4711549370168804,0.07894736842105263,0.4247421898899291,1.0,2/15,0.49%,ST6GALNAC3;ST8SIA6
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6085391244060393,1.4699189250338636,0.07079646017699115,0.42682166169686603,1.0,4/23,7.14%,KCNQ1;ATP2B4;MAPK1;LRRK2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.41976792074355784,-1.4698500184614178,0.0411522633744856,0.5249051508696573,1.0,20/50,14.39%,IGF1;PLCE1;OGT;PDGFRB;PDGFRA;PLCL1;ADAP2;PITPNM2;NGF;IRS2;IRS1;PIK3R1;PLCB3;PI4KB;TNFAIP8L3;PI4KA;PLCD3;PIK3R2;PLCD1;GAB2
prerank,regulation of JNK cascade (GO:0046328),0.4838392156848122,1.4695674075569418,0.024793388429752067,0.4266187686520287,1.0,21/101,10.64%,MECOM;MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;MAP4K4;TRAF1;DUSP3;MFHAS1;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;AIDA;MINK1
prerank,response to exogenous dsRNA (GO:0043330),0.6267838472861609,1.468268233032866,0.08860759493670886,0.4288885016938545,1.0,4/18,9.64%,CAV1;IFIH1;TLR3;DHX9
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5589164968504035,-1.4666478175126418,0.06565656565656566,0.5308017566814512,1.0,6/15,6.77%,GPC3;RSPO3;NPHP3;DACT1;SFRP4;DAAM2
prerank,protein dephosphorylation (GO:0006470),0.46762552964448273,1.466055085794127,0.009009009009009009,0.4337608989999349,1.0,31/135,14.97%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP12;DUSP1;PPM1F;PTPRE;CTTNBP2NL;DUSP16;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C;DUSP11;PPP2R2C;RPRD1B;PTPN1;PDP1;EYA3;DUSP22;PPM1D;PPM1L;PPP1R15B;PPP4R1;PPP2CB
prerank,positive regulation of hormone secretion (GO:0046887),0.626729694144894,1.4659103460347767,0.08240887480190175,0.43309655490162935,1.0,3/17,8.94%,EDN1;VAMP8;VAMP7
prerank,Notch signaling pathway (GO:0007219),0.5176971289002559,1.465642411472785,0.03836317135549872,0.4327066736812672,1.0,14/59,9.42%,JAG1;JAG2;NOTCH4;SORBS2;NOTCH1;HEY1;DLL4;HEY2;PLXND1;ADAM17;STAT1;SNAI2;APH1A;ADAM10
prerank,phasic smooth muscle contraction (GO:0014821),0.7121302353528041,1.465092236298217,0.09712230215827339,0.43311906060672606,1.0,1/10,0.47%,EDN1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.48262548719037307,1.464908371932118,0.02358490566037736,0.43242986364986385,1.0,16/104,8.54%,PRDM16;SMAD6;BMPR2;SMAD7;NOTCH1;DAND5;CAV1;FKBP1A;IL17RD;ACVR1;WFIKKN1;SMAD2;ADAM17;UBE2D1;UBA52;RPS27A
prerank,sulfur compound catabolic process (GO:0044273),-0.44800253373791105,-1.4646724775446713,0.06040268456375839,0.5327127596380543,1.0,13/38,12.72%,DCN;OGN;FMOD;GNS;BGN;PRELP;HEXA;VCAN;GGT5;HYAL1;LUM;CSPG4;OMD
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5011698719107219,1.4642664069166778,0.030418250950570342,0.43297526382667173,1.0,17/72,11.83%,KANK4;LIMA1;STMN2;HIP1R;ARHGEF2;KANK3;TTBK2;IAPP;SHANK3;CAMSAP2;CLASP1;PFDN6;VBP1;APC;CLASP2;PFDN2;CLU
prerank,microglial cell activation (GO:0001774),0.6188016569697756,1.463619084172894,0.07523510971786834,0.43354150072867836,1.0,7/21,12.63%,IFNGR1;APP;ITGAM;JAK2;TYROBP;CLU;CX3CR1
prerank,glycogen metabolic process (GO:0005977),-0.48042682336465947,-1.4630872833732287,0.049019607843137254,0.5335903052141773,1.0,9/27,12.76%,PRKAG2;PHKB;PYGB;PYGM;PGM1;AGL;PHKA2;GYS1;GYG1
prerank,negative regulation of cellular process (GO:0048523),0.4371609053676251,1.4628444700058028,0.0,0.4345191485948153,1.0,93/521,12.26%,NOS1;PTPRJ;CDH13;PODXL;SOX17;NOTCH4;NOS3;IRF6;RAPGEF2;SMAD6;MSX1;BMPR2;SMARCA2;PLXNA4;TBX1;PTPN14;APBB2;FOXO4;RND1;ITGA1;ACVRL1;NOTCH1;JAM2;DYSF;DUSP1;ADARB1;DAB2IP;AQP11;PRKD1;TGFB2;RHOB;HNF4A;BTG2;DLL4;APP;PPT1;BTG1;PLPP1;PPP1R13B;APOA1;PDE3B;KLF4;DDX4;PLXND1;ADAM15;TMEM109;FCGR2B;WFDC1;ANGPT1;SERTAD2;HYAL2;CTTNBP2NL;CD34;TNFRSF1B;GMNC;GATA3;MYH9;WARS1;IL1A;PDCD4;SH3BP4;ARHGDIA;NPR1;IGFBP7;VAMP8;HSPA1B;PDE8A;CEBPA;PTPRU;PLSCR1;CD200;JAK2;APC;NMI;KLF11;PPP2R5C;SERTAD3;ADAM10;RTN4;LPCAT3;CHD5;GNG4;ADGRB1;ADAMTS1;NPM1;VPS35;E2F7;TMBIM6;NR4A1;CLU;TMEM98;COPS8;TOB1
prerank,microvillus assembly (GO:0030033),0.6709388658645629,1.4618931326862374,0.06209150326797386,0.43598349528086155,1.0,5/14,10.64%,RAPGEF2;RAPGEF6;MAP4K4;FXYD5;MINK1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5517939003187602,1.4618522903858548,0.06925207756232687,0.4349983781454867,1.0,5/39,2.96%,NOTCH4;ENG;TIE1;RASIP1;DLL4
prerank,positive regulation of cell projection organization (GO:0031346),-0.35321309456443273,-1.461822453239669,0.0,0.5333101476820665,1.0,24/115,5.85%,ROBO1;PTN;DPYSL3;NTRK3;ROR1;CAMK1D;EPHA3;PLXNA2;CUX1;PTK7;SLIT2;WNT5A;GRIP1;NDNF;APOE;MAGI2;DLG4;OBSL1;CBFA2T2;ROR2;NTRK2;PLXNB2;CAMK1;NGF
prerank,Ras protein signal transduction (GO:0007265),0.46447760668898525,1.4616306669418564,0.015927189988623434,0.4344997227537897,1.0,31/137,10.68%,EPS8L2;CDH13;ARHGEF3;RAPGEF2;ELMO1;RAPGEF1;RASGRP2;PRKD1;RHOB;KRAS;NRAS;CDC42EP1;NTN1;RRAS;SHTN1;RAPGEF6;PLEKHG5;ARHGDIA;SHOC2;ARHGAP5;PLD1;KPNB1;NCKAP1;ROCK1;JUN;RIPOR1;TAX1BP3;RRAS2;ARHGEF1;CYFIP1;RAC1
prerank,regulation of interleukin-8 production (GO:0032677),0.5053200096934283,1.4615836965445852,0.049937578027465665,0.4334896971130256,1.0,13/69,9.50%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TLR3;TIRAP;KLF4;HYAL2;HSPA1B;ARRB1;CACTIN;HMGB1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6716201648806555,1.4612827985168626,0.1016949152542373,0.4333029293424819,1.0,3/12,9.64%,CAV1;IFIH1;DHX9
prerank,regulation of membrane repolarization (GO:0060306),0.668281193988186,1.460797850049971,0.09276729559748427,0.43337276481525977,1.0,2/13,2.28%,KCNQ1;CAV1
prerank,regulation of protein neddylation (GO:2000434),0.7226863828501896,1.460375191591617,0.08333333333333333,0.4333314865208163,1.0,1/10,0.18%,EPAS1
prerank,negative regulation of ion transport (GO:0043271),0.5966406157623461,1.4596038344241906,0.06184012066365008,0.43429757343346526,1.0,4/24,9.06%,NOS1;INPP5K;PXK;HTR1B
prerank,modulation by symbiont of entry into host (GO:0052372),0.6499846704445698,1.4591772208382014,0.07655502392344497,0.43432336351480927,1.0,5/16,11.57%,TRIM14;CAV1;TRIM6;TRIM25;HS3ST5
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6532235179887687,1.4586912363618265,0.08852459016393442,0.43455353027708454,1.0,2/14,4.67%,PLCG2;SEMA7A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5476995839605787,1.4582523259337137,0.05825242718446602,0.43452499955023627,1.0,13/41,11.89%,PDGFB;FYN;ACE;NEDD9;EFNA1;FCGR1A;ADAM17;DOCK3;STAP1;FBXW7;PRNP;PTPN1;GRM5
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5965310499837109,-1.4582316231849963,0.07712082262210797,0.5406964777158659,1.0,5/12,7.81%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,regulation of histone modification (GO:0031056),-0.5854305074422363,-1.4579149866309986,0.06419753086419754,0.5372558498005049,1.0,7/13,21.31%,UBE2N;IGF2;FLCN;AKAP8L;NNMT;PARG;MTHFR
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.4369356892729322,-1.4577664515369715,0.049342105263157895,0.5331367312212892,1.0,13/40,8.72%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;WNT6;FBN2;KL;CEBPB;PKDCC
prerank,aminoglycan catabolic process (GO:0006026),-0.47087334095259636,-1.457663105723776,0.05454545454545454,0.528989426226973,1.0,5/28,4.59%,GPC6;SDC2;HSPG2;GPC3;GNS
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.46608265686000583,-1.4576451175780276,0.041401273885350316,0.5247341365574097,1.0,12/29,15.80%,ZBTB20;SORBS1;LPGAT1;APOE;PPARA;GPLD1;SLC27A1;SREBF1;CREB1;SLC45A3;MFSD2A;NR1H3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5501023753967047,-1.4571832526644963,0.06128133704735376,0.5216988437969708,1.0,6/16,11.03%,DPYSL3;DPYD;TET2;NT5M;NT5E;UPB1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5941563993227322,1.4570167645024732,0.08064516129032258,0.43663316768961247,1.0,3/24,1.57%,DACH1;BMPR2;ACVRL1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.6096418390045404,-1.456956288734471,0.08235294117647059,0.5182223740910507,1.0,3/10,15.36%,OGT;ZNF692;PDK2
prerank,cellular copper ion homeostasis (GO:0006878),0.662878954315685,1.456819245673688,0.06984126984126984,0.43607438838674467,1.0,6/14,9.97%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,heart trabecula morphogenesis (GO:0061384),0.6290145566401719,1.4568110644056267,0.0779816513761468,0.43500716774799775,1.0,8/18,2.96%,TEK;ENG;S1PR1;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5759062863213109,1.456301271735302,0.07418397626112759,0.43522519712186986,1.0,7/28,9.92%,STMN2;FKBP4;CAMSAP2;PRUNE1;CLASP1;MAPRE3;CLASP2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5617934995645951,1.4559644758457957,0.06647398843930635,0.4351223237892797,1.0,11/36,12.63%,SGMS1;FAS;NR4A2;DAB2IP;TRAF1;ASAH2;MADD;CRADD;TPD52L1;TMBIM6;CX3CR1
prerank,regulation of calcium ion transport (GO:0051924),0.5168337888690948,1.4550652404650921,0.05613577023498695,0.43645182234882623,1.0,10/54,8.24%,NOS1;CCR1;MYLK;HOMER2;INPP5K;ORAI1;EPB41;STIM2;CASQ1;CRACR2A
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6398853170637567,1.4550350238958214,0.09539473684210527,0.4354618678272005,1.0,2/15,7.42%,ENTPD1;CMPK1
prerank,JNK cascade (GO:0007254),0.5487015522637102,1.453989617171252,0.06887052341597796,0.437023948667126,1.0,10/40,10.93%,MAP4K2;NOD1;NOD2;MAP4K3;IRAK2;UBA52;RPS27A;MAP3K11;MINK1;TAB2
prerank,cell-cell junction assembly (GO:0007043),0.5045525233394722,1.4537126038261496,0.054637865311308764,0.4367082108705754,1.0,19/63,15.69%,GJA5;TRPV4;CLDN5;SMAD7;GJB1;GJA4;PIP5K1C;WDR1;CTNNA1;ACTG1;TJP1;CDH12;CDH2;ACTB;CTNNB1;CD9;CDH22;PKN2;PAK2
prerank,endochondral bone morphogenesis (GO:0060350),0.7048584497567405,1.453026274242245,0.09298245614035087,0.43748848201839013,1.0,4/11,5.43%,TRPV4;BMPR2;MEF2C;FGFR3
prerank,cellular response to growth factor stimulus (GO:0071363),0.4642075082109016,1.4520714374310064,0.020833333333333332,0.43894234079018934,1.0,41/151,13.05%,NOS1;STMN2;RAPGEF2;FLT1;PDGFB;BMPR2;FLT4;SMAD7;TBX1;ACVRL1;NOTCH1;RAPGEF1;EGR3;DAB2IP;PRKD1;DLL4;IQGAP1;TMEM100;INPP5K;KLF4;ACVR1;EHD1;MEF2C;HYAL2;SETX;DUSP3;PTPN12;HSPB1;PDE8A;SYAP1;RAB35;SNAI2;ZFP36L2;PLCG1;NR4A1;VSTM2A;PRKD2;SOX6;RPS6KB1;DUSP22;ITGB1BP1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5379196154239796,1.4515381644047474,0.07627118644067797,0.4394584029930671,1.0,11/38,11.89%,PDGFB;ACE;CAV1;APP;NEDD9;EFNA1;HYAL2;FCGR1A;PRNP;PTPN1;GRM5
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.715069387733078,1.451224307462371,0.07772020725388601,0.4392953779235797,1.0,2/10,2.28%,KCNE3;CAV1
prerank,cAMP biosynthetic process (GO:0006171),-0.6245952255414887,-1.4505477844787202,0.0741687979539642,0.5346022238249191,1.0,5/10,6.64%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5635805021845067,1.4504781680825787,0.06524822695035461,0.4401578613179256,1.0,8/33,5.32%,MMRN2;ACVRL1;NOTCH1;ATP2B4;DLL4;KLF4;CARD10;MEF2C
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6102266494821547,-1.4500707755845836,0.06582278481012659,0.5318100835846004,1.0,7/11,21.05%,FBH1;TIPIN;LIG3;DONSON;SMARCAL1;TIMELESS;ZRANB3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6618009435058545,1.4499510829349154,0.08196721311475409,0.44051487926640154,1.0,1/14,0.10%,ENTPD1
prerank,cellular response to interferon-beta (GO:0035458),0.6522941996832892,1.4481827323872465,0.08634222919937205,0.44412558174984457,1.0,5/14,8.74%,AIM2;TRIM6;IRGM;STAT1;ACOD1
prerank,protein O-linked mannosylation (GO:0035269),-0.5059910997802746,-1.4479819017028164,0.06896551724137931,0.5344337724454662,1.0,4/18,3.45%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7136921425160141,1.4476127240099788,0.08688524590163935,0.4445764729441298,1.0,3/10,8.76%,ACER2;PDE3B;SNAI2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.36445531895084604,-1.4470625710186185,0.013605442176870748,0.5331516752662614,1.0,28/95,12.72%,GPC6;UST;DSE;DCN;SDC2;OGN;HSPG2;GPC3;CEMIP;HS3ST3A1;FMOD;B3GNT2;CHST15;BGN;PXYLP1;XYLT1;PRELP;HEXA;ST3GAL4;B4GALT1;VCAN;B3GAT3;HS2ST1;HYAL1;CHPF2;LUM;CSPG4;OMD
prerank,cardiocyte differentiation (GO:0035051),0.7004424901749718,1.446357960443724,0.0932475884244373,0.4467914501388171,1.0,2/10,2.55%,GATA6;TGFB2
prerank,regulation of sodium ion transport (GO:0002028),0.5595596368138553,1.4460996674917532,0.06329113924050633,0.44639901755980826,1.0,7/34,8.96%,NOS1;CNKSR3;ATP2B4;ATP1A1;P2RX7;NKAIN3;SCN1B
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6172360791438702,-1.4459285540582085,0.08045977011494253,0.5325059011823905,1.0,2/10,2.18%,GLI3;BMP4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.681629653720503,1.4455344147474232,0.09477124183006536,0.4469577732615159,1.0,2/11,3.43%,NOS3;GCH1
prerank,mitochondrion morphogenesis (GO:0070584),-0.5971625246393708,-1.44476504998631,0.07766990291262135,0.5324287063297132,1.0,2/11,3.16%,PID1;WASF1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5767179986023505,1.4441088945042744,0.07380607814761216,0.4496816501958726,1.0,6/27,5.43%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5524831260998703,-1.4441014189079855,0.06970509383378017,0.5303906836288104,1.0,6/16,22.29%,PID1;PPARA;FLCN;SPHK2;ANTKMT;PARP1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.4107245863528958,-1.4439290132736091,0.022727272727272728,0.5268903763209747,1.0,14/53,13.29%,EYA2;EGFR;EYA1;DDX5;PLA2R1;FXR2;EYA4;FBH1;UBE2N;SPRED1;BCLAF1;ATR;SPRED2;HMGA2
prerank,response to calcium ion (GO:0051592),0.4799136593795264,1.4438486227924692,0.03058823529411765,0.44932138442197633,1.0,16/102,8.29%,PLCG2;SYT15;ITPR3;ITPKB;CPNE8;RASGRP2;CAV1;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;PPP3CA;MCOLN1;PRKAA1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5969721666877785,1.4434387079160593,0.07390648567119155,0.44926897675616667,1.0,9/26,11.05%,CAV1;F2RL1;TLR3;TIRAP;MFHAS1;SLC15A4;RTN4;HMGB1;CYBA
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4523892866296097,1.4431036149766787,0.019867549668874173,0.44916631475546914,1.0,29/159,11.00%,PTPRM;PECAM1;CDH13;CLDN5;CEACAM1;VCAM1;CRTAM;MPZ;TGFB2;CADM1;ATP2C1;ACVR1;AMIGO2;ROBO4;MILR1;BSG;ITGAM;FLRT3;TENM3;LRRC4C;CDH15;CDH3;NECTIN4;NECTIN1;CDH12;FAT4;TENM4;KIRREL3;CDH2
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.599991755827867,1.4420513192684083,0.07956318252730109,0.4507915662924378,1.0,6/22,7.18%,GATA2;RASSF10;DLL4;TAFA1;LRRK2;SLC16A2
prerank,metal ion export (GO:0070839),0.5730495922204062,1.4415050776344758,0.06509695290858726,0.45123152630487323,1.0,7/31,4.38%,KCNQ1;KCNE3;ATP2B4;ATP1A4;ATP1A1;ATP1A3;ATP7A
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.482862887090336,1.4405579184321367,0.029797377830750895,0.45283949444728727,1.0,13/90,8.44%,PRDM16;EPAS1;ADIPOR2;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;KDM3A;CMKLR1;GADD45G;JAK2;APC
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.539721171739744,1.4405478694487275,0.07366984993178717,0.45179078479878887,1.0,8/39,9.62%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;PTPN12;RNF115
prerank,ceramide catabolic process (GO:0046514),0.6582579580583587,1.4394886526535533,0.0959349593495935,0.4536965100026554,1.0,2/14,5.93%,ACER2;ASAH2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5578326044873524,1.4389536604414719,0.06896551724137931,0.4539714444408268,1.0,6/30,7.97%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;BCL2L1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.4281735658816659,-1.4388732100494241,0.036101083032490974,0.5393204054197442,1.0,19/39,26.58%,STEAP3;ABCA1;TANGO2;COPG1;MTTP;PPY;TVP23B;SVBP;RCN3;RAB3D;AFM;MON1A;PDIA4;PREB;TMEM167A;LTBP2;RAB3C;RAB15;NECAB3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6118389460150593,1.4386586517783915,0.0995260663507109,0.45367260973117607,1.0,4/16,5.23%,GATA2;JCAD;DLL4;PPP1R16B
prerank,regulation of MAP kinase activity (GO:0043405),0.48424477782059905,1.4382293657674121,0.03182374541003672,0.4539274397952682,1.0,12/92,5.33%,PTPRJ;EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DUSP1;DAB2IP;INPP5K;STK38;HYAL2
prerank,phosphorylation (GO:0016310),0.43497738615316395,1.4380633598642425,0.004069175991861648,0.4533263410810835,1.0,76/385,12.62%,BMX;NUAK1;CDK19;ERG;MAP4K2;STK10;PDGFB;FYN;BMPR2;RPS6KA5;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;CDK14;SNRK;PRKD1;PRKG1;TGFB2;OXSR1;CDC42BPA;APP;MAP3K6;PKN3;CDC42BPG;BCR;ACVR1;STK24;CCNE1;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;MEX3B;PGK1;MAPK1;PXK;MAST1;ALK;AKT3;SIK2;LRRK2;LMTK2;TLK1;STK19;GNPTAB;JAK2;PRKAA1;STK39;PASK;PIM3;DGKH;NEK7;ROCK1;SGK1;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;MINK1;LIMK2;NEK11;PRKD2;MARK2;MATK;VRK1;COPS8;PIK3CB;TTBK1;BTK
prerank,positive regulation of metabolic process (GO:0009893),0.4751318254930187,1.4380621185156066,0.03596287703016241,0.4522793237730976,1.0,15/103,8.44%,PRDM16;EPAS1;ADIPOR2;FASN;INSR;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;KDM3A;CMKLR1;GADD45G;JAK2;APC
prerank,cardiac conduction system development (GO:0003161),0.5805035502489524,1.4377858511392494,0.0962962962962963,0.4520105955295388,1.0,5/24,3.58%,GJA5;GATA6;MSX1;HEY1;HEY2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.5655339544199242,1.4377155651632498,0.09269662921348315,0.4511561681723103,1.0,6/29,5.43%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.608050544734284,1.437660537659676,0.0888208269525268,0.4502660078637826,1.0,7/19,9.21%,CLDN5;F11R;OCLN;MYO1C;SNAI2;ROCK1;TJP1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5442376839868786,1.4359150005912125,0.06353591160220995,0.4539235423016558,1.0,7/39,9.56%,MYO1D;MYO1E;TANC2;ACTN4;FNBP1L;MYO1C;PPFIA2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.49540839333776276,1.4344418109991852,0.05686032138442522,0.45679796415564633,1.0,24/76,19.95%,AIM2;DAB2IP;KLF4;DAP;IRAK2;COMMD7;NFKBIL1;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CACTIN;NFKBIB;NFKBIA;NWD1;HAVCR2;PTGIS;TMSB4X;PYCARD;PYDC1;ERBIN;FOXJ1
prerank,chordate embryonic development (GO:0043009),-0.3929241285885132,-1.434244727804374,0.048582995951417005,0.5500032714650589,1.0,18/55,9.91%,ALDH1A2;COL1A1;FGFR2;SULF1;TGFBR1;ARNT2;BMP5;BMP7;SULF2;WNT5A;RBP4;ZNF568;XYLT1;DACT1;IGF2;FLCN;VEGFA;PTCH1
prerank,atrial septum development (GO:0003283),0.6686149408872332,1.4341207009987929,0.07961783439490445,0.45663783911389816,1.0,5/13,3.58%,GJA5;BMPR2;DAND5;TGFB2;HEY2
prerank,protein phosphorylation (GO:0006468),0.4294697298717234,1.4338701143185548,0.002012072434607646,0.4562819437018431,1.0,97/479,12.94%,BMX;NUAK1;CDK19;TEK;ERG;FLT1;MAP4K2;STK10;PDGFB;FYN;BMPR2;FLT4;RPS6KA5;SMAD7;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;SBK1;DAB2IP;CDK14;SNRK;PRKD1;PRKG1;TGFB2;MAST4;OXSR1;CDC42BPA;APP;MAP3K6;FES;PKN3;TLR3;CDC42BPG;BCR;ACVR1;SLK;STK24;CCNE1;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;SMAD2;FGFR3;MEX3B;MAPK1;PXK;UHMK1;MAST1;EEF2K;ALK;AKT3;SIK2;LRRK2;LMTK2;TLK1;STK19;JAK2;PRKAA1;STK39;PASK;PIM3;CAD;NEK7;ROCK1;CSNK1G3;PTK2;SGK1;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;TNKS;MAP3K3;NEK11;GTF2H3;PRKD2;MARK2;MATK;VRK1;COPS8;TTBK1;BTK;STK33;RPS6KA3;RPS6KB1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.46827805470854283,-1.4338187300972265,0.046822742474916385,0.5474077538586466,1.0,7/27,9.13%,EGFR;DDX5;BMP4;LIMD1;EIF4E2;PUM1;MAP2K2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5412099220097255,-1.4332390438458433,0.07042253521126761,0.5451681808585725,1.0,3/16,3.93%,PRKAG2;APPL2;PPARA
prerank,Notch signaling involved in heart development (GO:0061314),0.693068677601678,1.431982867868591,0.10252100840336134,0.46033540500424397,1.0,5/11,3.58%,JAG1;NOTCH1;HEY1;DLL4;HEY2
prerank,regulation of B cell activation (GO:0050864),0.5857414228256742,1.4316298364595876,0.0960960960960961,0.46028111051080234,1.0,8/25,21.03%,NOD2;SH3KBP1;FCGR2B;ZFP36L2;LAPTM5;BANK1;FOXJ1;ZFP36L1
prerank,cell-cell junction organization (GO:0045216),0.48666714779205245,1.4310968718904586,0.053987730061349694,0.46065872331791263,1.0,18/79,9.28%,CDH13;TRPV4;CLDN5;OCLN;F2RL1;TGFB2;CADM1;LIMS2;GJA4;CTNNA1;TJP2;CDH15;CDH3;NECTIN4;TJP1;DSP;NECTIN1;CDH12
prerank,regulation of hormone secretion (GO:0046883),0.6428640105573286,1.4310756520315622,0.1126984126984127,0.45966467942921097,1.0,2/15,4.32%,EDN1;SCG5
prerank,regulation of phospholipase activity (GO:0010517),-0.6079055240141016,-1.430316608592651,0.10779816513761468,0.5510049229549686,1.0,2/10,1.04%,LRP1;FGFR2
prerank,vasculature development (GO:0001944),0.6323497561803789,1.4291236633088977,0.09713375796178345,0.46394600613424797,1.0,5/16,3.25%,NOTCH4;BMPR2;FLT4;ACVRL1;SOX18
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5948062974779962,1.4289747701264992,0.08649468892261002,0.46330025407871234,1.0,7/22,12.62%,NOD2;F2RL1;APOA1;TRIM6;TNFRSF1B;LAPTM5;BTK
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6566812919383851,1.4289567301747914,0.10714285714285714,0.462318351268623,1.0,2/13,5.80%,ENTPD1;SMPDL3A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.47331058621876687,1.4289519048231982,0.03592120509849363,0.4612999747517314,1.0,22/108,11.78%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;ARL6IP5;CASP8;LGALS9;PPM1F;CASP2;TNFSF10;DAP;BBC3;CRADD;JAK2;GRAMD4;HMGB1;HSPE1;CASP1;LAPTM5;CASP8AP2
prerank,cellular response to increased oxygen levels (GO:0036295),0.6822635020905667,1.4285816166334748,0.09294320137693632,0.46120133444381356,1.0,3/11,2.28%,FAS;FOXO1;CAV1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6692601147299275,1.4279156092652896,0.105,0.46096026396403217,1.0,2/11,2.60%,NOTCH4;TNRC6C
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6692601147299275,1.4279156092652896,0.105,0.46096026396403217,1.0,2/11,2.60%,NOTCH4;TNRC6C
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.49290873107606864,1.4275307190863498,0.049576783555018135,0.46098454669246425,1.0,27/73,18.86%,GATA2;LMO2;KITLG;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;METTL14;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of endothelial cell migration (GO:0010594),0.48723152614648174,1.4269614591246684,0.04918032786885246,0.46138368280086517,1.0,23/85,10.68%,PTPRM;TEK;EDN1;CEACAM1;BMPR2;FLT4;ACVRL1;DAB2IP;PRKD1;RHOB;EMP2;DLL4;ANXA3;RRAS;ANGPT1;GPI;GATA3;ZC3H12A;FOXP1;PTK2;GFUS;ADGRB1;RAC1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5342669478467975,-1.4257603935145395,0.08719346049046321,0.5617280698175857,1.0,5/17,11.43%,PID1;NUPR1;PPARA;FLCN;HDAC4
prerank,ceramide transport (GO:0035627),0.6563563305462246,1.425469516669706,0.1069078947368421,0.46432381759170255,1.0,4/12,8.07%,PLTP;ABCB4;GLTP;CERT1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.666385066511812,1.4250345700600335,0.11398963730569948,0.4644970079861431,1.0,2/12,1.60%,JAG1;NOTCH1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5885439118483251,1.4247468728826445,0.09012875536480687,0.4642411867876813,1.0,3/24,4.95%,NOS1;FKBP1A;CAMK2D
prerank,sterol transport (GO:0015918),0.6119994991179625,1.424499476015365,0.10244648318042814,0.46386408076615687,1.0,3/19,5.21%,CAV1;APOA1;LCAT
prerank,neural crest cell migration (GO:0001755),0.5423460728379498,1.4241176200675556,0.09272467902995721,0.46375511018397947,1.0,4/36,4.67%,SEMA3G;TBX1;SEMA3F;SEMA7A
prerank,regulation of chromatin binding (GO:0035561),0.6806224978397097,1.423569327265346,0.10217755443886097,0.4642404660243212,1.0,4/10,16.04%,HMBOX1;BTAF1;DTX3L;KDM4D
prerank,copper ion homeostasis (GO:0055070),0.6250838744375539,1.4235010793519192,0.10179640718562874,0.46341256460506525,1.0,6/17,9.97%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6142721371001774,1.4222165570778669,0.10062893081761007,0.465954963869245,1.0,7/19,12.73%,LIFR;IFIH1;APOA1;KLF4;IRAK2;DHX9;CBFB
prerank,activation of adenylate cyclase activity (GO:0007190),-0.43818053391178685,-1.4219181884652627,0.05128205128205128,0.5702920907906415,1.0,8/35,9.89%,LGR4;ADCY5;ADCY9;ADCY1;EDNRA;ADCY2;ADCY7;RAF1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5433080265772237,1.4215650469776315,0.07520891364902507,0.46665473477670244,1.0,4/36,2.44%,MECOM;FOXO1;DUSP1;F2RL1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.587721706151557,-1.4195623356668785,0.09111617312072894,0.5739088205402489,1.0,5/11,11.20%,OGT;SETD1A;SETD1B;TET2;CTR9
prerank,mesenchymal cell development (GO:0014031),0.6115805763530044,1.4195229078449216,0.1066066066066066,0.47116270817818234,1.0,9/18,21.33%,NOTCH1;HEY2;SNAI2;CDH2;CYP26C1;TBX20;TCOF1;SOX11;NOLC1
prerank,dicarboxylic acid transport (GO:0006835),-0.4581034272442389,-1.4191544941225498,0.06506849315068493,0.5712603071900207,1.0,8/28,6.15%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;GJA1;SLC22A6;SLC19A1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.5051337786121938,-1.4191342777921658,0.08823529411764706,0.5672488789276836,1.0,10/19,20.24%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;PMM1;NANS;GNPNAT1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.47067697099943484,-1.4185591294151556,0.050314465408805034,0.5651236507638043,1.0,11/24,22.83%,PID1;LEPR;SLC25A13;COQ10A;COX10;GFPT1;GFPT2;ACADVL;LYRM7;CYCS;MTLN
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4719208442407789,1.4184665881628065,0.04883720930232558,0.4730055480323477,1.0,20/93,10.64%,MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;ARL6IP5;F2RL1;TGFB2;APP;TIRAP;FCGR2B;TRAF1;MFHAS1;ZC3H12A;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;MINK1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6772302657124005,1.4181783986050236,0.10884353741496598,0.47272978989131365,1.0,3/10,9.97%,CRTAM;LGALS9;PRNP
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4727168740056456,1.4179820675625208,0.02965599051008304,0.4722828000466686,1.0,19/101,8.72%,EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;PIK3R6;CCNY;CCND2;NOD2;ATP2B4;CCND3;DAB2IP;ADRB2;ADAM17;IRGM;LRRK2;MAPRE3;SYAP1;TPD52L1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5930541445719182,1.4178893746450139,0.0887218045112782,0.47155678985796845,1.0,4/20,5.27%,FASN;FAR2;PPT1;FAR1
prerank,endothelial cell proliferation (GO:0001935),0.6142878565787437,1.4178293447049637,0.10906298003072197,0.4706882874429087,1.0,4/17,5.43%,TEK;BMPR2;ACVRL1;CD34
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.5302193612573687,-1.4178201827691623,0.09641873278236915,0.5638379199720063,1.0,4/16,5.50%,PTN;SOX5;NUDT21;HOXB4
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.4057141991847198,-1.4178075000764077,0.04119850187265917,0.5599220194140563,1.0,14/45,17.82%,EGFR;DDX5;BMP4;PIK3R1;LIN28B;MAP2K2;BUD23;NFKB1;RBM20;HNRNPLL;SUPV3L1;NMD3;ZPR1;U2AF2
prerank,positive regulation of potassium ion transport (GO:0043268),0.5331350555530179,1.4175011297544886,0.0793010752688172,0.4705391058293684,1.0,4/38,3.68%,KCNN4;KCNQ1;KCNN3;NOS1AP
prerank,retina homeostasis (GO:0001895),0.5838488526965087,1.4169735875580802,0.10105580693815988,0.47105920214515407,1.0,6/23,11.20%,B2M;HSPB1;CDH3;ACTG1;POTEF;ACTB
prerank,potassium ion export across plasma membrane (GO:0097623),0.6597879839701372,1.4169401805243054,0.088,0.4701497977859934,1.0,2/13,1.44%,KCNQ1;KCNE3
prerank,regulation of intracellular pH (GO:0051453),-0.4320950429086383,-1.416823020320563,0.03237410071942446,0.5590860744602033,1.0,17/34,22.64%,SLC4A10;SLC9A2;CA2;SLC9A9;SLC4A2;ATP5F1B;VPS33A;SLC4A3;SLC9A1;SLC26A6;SLC9B1;SLC9A6;CLN3;TM9SF4;TMEM165;SLC4A8;CFTR
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6889458654795317,1.416109636477115,0.11222780569514237,0.471334314698464,1.0,3/10,8.51%,NOD2;JAK2;NAMPT
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.48426398781643415,-1.415994859754322,0.06140350877192982,0.5578952326950546,1.0,9/21,14.03%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4;CCN3;SLC2A10;SH2B1;NUP93
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.4890917977224888,-1.4158783517390472,0.06497175141242938,0.5545570499942579,1.0,6/23,9.91%,GLI3;GPC3;TULP3;ENPP1;MEGF8;PTCH1
prerank,embryonic axis specification (GO:0000578),0.6150177338080478,1.4156877994781234,0.11908646003262642,0.4715269002038902,1.0,4/15,10.07%,SMAD6;TBXT;SMAD2;TASOR
prerank,regulation of small molecule metabolic process (GO:0062012),-0.45814737857477617,-1.4155642674452689,0.05362776025236593,0.5517374447678426,1.0,12/28,21.90%,PDK1;APOE;PPARA;PRKN;RORA;EPHX2;FOXK2;PDK3;PDK2;PANK2;ACADVL;NR1H4
prerank,negative regulation of axon extension (GO:0030517),0.5604979331922232,1.415112199773424,0.09393063583815028,0.4720684025508965,1.0,8/30,11.97%,SEMA3G;SEMA3F;SEMA7A;SEMA6D;RTN4;SEMA4G;TRIM46;DIP2B
prerank,epithelial cell differentiation (GO:0030855),0.4718076606635759,1.4146096121288416,0.06096131301289566,0.47256693987409265,1.0,12/88,6.23%,JAG1;IRF6;GATA6;TBX1;RHCG;GSTA2;DEUP1;TST;TAGLN2;GATA3;PGK1;PCK2
prerank,response to peptide hormone (GO:0043434),-0.4173904623936418,-1.4137811722454938,0.040740740740740744,0.5534923906739965,1.0,9/43,8.37%,TGFBR3;OGT;ROCK2;IGFBP5;GNAI1;ANXA1;IRS1;SRC;SLC27A1
prerank,regulation of synapse maturation (GO:0090128),0.6861947276537619,1.413559569149277,0.10965630114566285,0.4743666771643582,1.0,2/10,2.21%,ARHGEF15;DAB2IP
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4602688835672519,1.4130331611805198,0.05005688282138794,0.4748049898025992,1.0,15/113,5.23%,VEGFC;CDH13;TEK;PDGFB;BMPR2;FLT4;TBX1;EGFL7;NOD2;EGR3;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B
prerank,regulation of transferase activity (GO:0051338),0.6114070744883651,1.4127851319848082,0.09508716323296355,0.4744670191439497,1.0,5/17,8.03%,LDB2;EMP2;HMBOX1;JMJD8;NLRC5
prerank,endoderm formation (GO:0001706),0.5440949244033948,1.4118633768772488,0.08976157082748948,0.4760773879369446,1.0,3/35,2.05%,LAMA3;SOX17;DUSP1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5336007008896775,-1.410802359128113,0.09203980099502487,0.5593991263653495,1.0,9/14,21.12%,SEC24D;SEC31A;SEC24C;SAR1A;SCAP;SEC23B;TBC1D20;SEC23A;SEC13
prerank,protein import into peroxisome membrane (GO:0045046),-0.4914106935477777,-1.410623727859126,0.07098765432098765,0.5562880612858689,1.0,15/22,35.37%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX11B;PEX13;PEX3;PEX16;PEX12;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,blood circulation (GO:0008015),0.5096794613020579,1.409850545802104,0.0799475753604194,0.4805179909682069,1.0,12/49,13.10%,ELN;NOS3;ACE;ACVRL1;DLL4;TBC1D8;NPR1;STAT1;ROCK1;MYOF;ITGB1BP1;SGCZ
prerank,regulation of phagocytosis (GO:0050764),0.5002604499899136,1.4085687582755284,0.0851063829787234,0.48295899232602246,1.0,16/53,17.97%,GATA2;MERTK;DYSF;APOA1;SYT7;FCGR2B;CD47;PLSCR1;CYBA;DOCK2;TUB;ABCA7;RACK1;PYCARD;SCARB1;RAB27A
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6294802810944247,1.4084054403594983,0.0890625,0.4823832301763309,1.0,2/15,6.09%,PLCG2;CUL3
prerank,ventricular septum development (GO:0003281),0.5402374373015437,1.4078583265501012,0.09052333804809053,0.48287525376121126,1.0,10/37,6.03%,GJA5;BMPR2;SMAD7;NOTCH1;DAND5;HEY1;TGFB2;HEY2;ACVR1;GATA3
prerank,mesonephros development (GO:0001823),-0.5800522912413856,-1.407791484259717,0.0975609756097561,0.5617781685380907,1.0,4/11,2.43%,BMP7;BMP4;OSR1;FGF1
prerank,"phagocytosis, engulfment (GO:0006911)",0.5363010421212195,1.4076664963637167,0.08454810495626822,0.48246594017734623,1.0,13/36,13.75%,ELMO1;GULP1;FCGR2B;FCGR1A;MYH9;ITGAM;ARHGAP25;XKR6;VAMP7;ADGRB1;RAC1;DOCK1;RHOH
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5290192213612583,-1.4072224977690195,0.09234828496042216,0.5599062862337845,1.0,7/15,23.75%,PPARA;OSBPL8;PPARG;OSBPL11;LPL;PLIN3;FITM2
prerank,cellular response to osmotic stress (GO:0071470),0.5875670476988235,1.4071544867026644,0.10518292682926829,0.4829243073208254,1.0,4/21,2.77%,TRPV4;MYLK;ARHGEF2;OXSR1
prerank,cellular response to lectin (GO:1990858),0.46614739559962565,1.4067275947500657,0.03699421965317919,0.48213350171426156,1.0,29/104,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.46614739559962565,1.4067275947500657,0.03699421965317919,0.48213350171426156,1.0,29/104,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.46519405287779014,1.4066674567669706,0.03690888119953864,0.4813352142176537,1.0,29/105,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5382797694025885,1.4064145084254094,0.10215053763440861,0.4810476304066912,1.0,5/35,6.09%,HEG1;RASIP1;DAB2IP;TGFB2;CUL3
prerank,cGMP biosynthetic process (GO:0006182),0.6713244134164457,1.4061461972148266,0.11056910569105691,0.48080688131210353,1.0,3/10,11.52%,NPR2;NPR1;NPPC
prerank,regulation of platelet aggregation (GO:0090330),0.6195662429321613,1.4058430272755567,0.1062215477996965,0.48066860126999705,1.0,4/17,3.41%,CEACAM1;F11R;PRKG1;ADAMTS18
prerank,regulation of secretion (GO:0051046),0.6487600287375797,1.4053055416579003,0.11889250814332247,0.4811943699327477,1.0,3/13,9.30%,KCNQ1;OAS2;SGK1
prerank,spinal cord development (GO:0021510),-0.557377147161348,-1.4045625309160956,0.09925558312655088,0.564890571803256,1.0,6/12,19.93%,GLI2;VIT;LOXL3;PKD1;ZPR1;NF1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.571028163916412,1.4042847839764043,0.10207100591715976,0.48299483229053736,1.0,7/24,10.93%,NOD1;NOD2;CASP8;IRAK2;UBA52;RPS27A;TAB2
prerank,calcium ion homeostasis (GO:0055074),0.4693815544468267,1.4042232245334723,0.048406139315230225,0.4821777520190782,1.0,12/95,7.19%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2;SLC30A1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.6028630855098213,1.4036148418904226,0.09161490683229814,0.4829088739985731,1.0,9/18,21.60%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,regulation of vesicle-mediated transport (GO:0060627),0.47313982558508255,1.4030957658290435,0.046511627906976744,0.4833397585468023,1.0,29/91,19.49%,CDH13;HIP1;HIP1R;RAB11A;FES;PACSIN2;SYT7;PACSIN1;MAPK1;LRRK2;PLD1;STON1;PTPN1;INPP5F;CHMP3;NSF;ZFYVE16;RNF139;CPLX1;STXBP5L;RIT2;OPHN1;STXBP5;RUFY1;SCARB1;SYT1;HAP1;RAB5C;MAP2K1
prerank,embryonic organ morphogenesis (GO:0048562),-0.41185803839821183,-1.4027431615084962,0.03409090909090909,0.5671629394462935,1.0,15/42,7.10%,EFEMP1;FGFR2;HOXC4;PDGFRA;MFAP5;HOXA3;HOXB3;FBN2;RBP4;FBN1;NIPBL;HOXB4;RBPMS2;MEGF8;SIX1
prerank,histone modification (GO:0016570),-0.3481237101512326,-1.4027203632246128,0.0070921985815602835,0.5635536835812868,1.0,26/109,14.56%,EYA2;EYA1;PRDM5;TBL1XR1;CREBBP;BAZ1B;EYA4;NSD3;NSD1;UBE2N;EHMT1;USP3;PHF20;RBM14;HDAC4;HDAC1;USP22;TAF6L;HDAC6;PADI2;ATXN7L3;MSL3;KDM4A;SIRT2;SIN3B;MTA2
prerank,morphogenesis of an epithelium (GO:0002009),0.5604353563686643,1.402344627802672,0.10471976401179942,0.4843909190957866,1.0,5/25,12.09%,LAMA3;LAMA5;ACTG1;ACTB;SOX10
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6094942701830535,-1.4021994943343012,0.11138613861386139,0.5616255287672355,1.0,7/10,35.76%,PLA2G4A;PLA2G15;PLA2G6;ENPP2;PLA2G7;LIPC;PLA2G5
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.613841174701665,1.4020778588032885,0.12238325281803543,0.48419019987790296,1.0,1/16,0.65%,CLDN5
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5898004478116685,1.402029771020297,0.11332312404287902,0.48335650621171944,1.0,9/21,9.21%,EFNA5;LIMCH1;MACF1;SLK;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.38489469578959595,-1.4005106315869156,0.02834008097165992,0.563309187594023,1.0,13/52,9.12%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;EPB41L2;GNAI1;STX4;GPSM2;PIK3R1;CLIP3;PRKCI;STX3
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5573371315052938,1.4004249762792467,0.0938375350140056,0.4866283198364602,1.0,7/29,9.89%,SMAD7;DAB2IP;IL17RD;EFNA1;GATA3;ADIPOR1;MAD2L2
prerank,small GTPase mediated signal transduction (GO:0007264),0.46248692928373336,1.4004080656092168,0.04302325581395349,0.4857017469422204,1.0,29/103,14.49%,CCDC88C;RAPGEF2;ARHGAP31;RASGRP2;RAPGEF5;ABR;PRKD1;NUCB2;KRAS;NRAS;NTN1;BCR;RRAS;SHTN1;RAPGEF6;SHOC2;TIAM2;PLD1;JUN;SIAH2;RHEBL1;RRAS2;CCDC88A;RAC1;RGS19;KSR2;RRAD;SOS1;RHEB
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.45018383550878655,1.4002759849205768,0.04377104377104377,0.48508880147823036,1.0,25/138,9.21%,TEK;PTPRG;FLT1;TIE1;NPR2;FYN;BMPR2;FLT4;MPZL1;MERTK;LIFR;RAPGEF1;INSR;TRIO;NEDD9;FES;FGFR3;NPR1;ALK;LMTK2;PTPRU;JAK2;YES1;STAP1;PTK2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6160154827171146,1.4000522125413508,0.12305295950155763,0.4847229166490963,1.0,7/17,10.59%,CEACAM1;KLF7;CAV1;MAFF;GATA3;DSPP;APOLD1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5349753406100062,1.3998314410704527,0.09849521203830369,0.48436453949740105,1.0,7/34,5.43%,TEK;FLT1;PDGFB;NOD2;DAB2IP;PRKD1;FGFR3
prerank,neural crest cell development (GO:0014032),0.5188638381756996,1.3994481519471254,0.08590604026845637,0.48438010401250536,1.0,10/44,13.01%,SEMA3G;TBX1;SEMA3F;SEMA7A;SEMA6D;SNAI2;CDH2;SEMA4G;SOX10;CYP26C1
prerank,activation of phospholipase C activity (GO:0007202),-0.4470679349944884,-1.3993651989344558,0.04918032786885246,0.5632534592963842,1.0,5/29,5.53%,ARHGAP6;EGFR;LPAR1;EDNRA;NTRK2
prerank,phospholipid translocation (GO:0045332),0.5555113988241159,1.3990398801731871,0.10294117647058823,0.4845764737430032,1.0,10/28,15.39%,ATP10A;PLSCR4;ANO6;ABCB4;P2RX7;PLSCR1;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,regulation of interleukin-2 production (GO:0032663),0.53032432361417,1.3989541224576256,0.08289473684210526,0.48387152590541915,1.0,13/43,18.77%,PLCG2;HOMER2;HDAC7;CD34;IL1A;PRNP;LAPTM5;PRKD2;NAV3;HAVCR2;PDE4D;SPTBN1;MALT1
prerank,regulation of coagulation (GO:0050818),0.675596481248567,1.3985277264175533,0.11206896551724138,0.4840380985514569,1.0,4/11,11.57%,CAV1;F2RL1;PROC;HS3ST5
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3881822496048577,-1.3978844575785816,0.040983606557377046,0.564249526719515,1.0,17/52,19.93%,SHC1;LMNA;DNAJC3;SSR1;ARFGAP1;SEC31A;TSPYL2;SRPRB;EXTL2;VAPB;GFPT1;FKBP14;WFS1;TLN1;PDIA6;ADD1;ACADVL
prerank,regulation of oxidoreductase activity (GO:0051341),0.6386925023948976,1.397593688280469,0.10873146622734761,0.48570233828031734,1.0,3/13,6.37%,NOD2;ATP7A;SIRT4
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5571346617439236,-1.3974261110105504,0.09313725490196079,0.5620210767709624,1.0,5/12,22.83%,PPARA;IRS2;IRS1;TWIST1;MTLN
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6312637289133648,1.397129075216397,0.13964686998394862,0.4860700249490308,1.0,2/14,2.28%,NOTCH4;CAV1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5136249369138738,1.3963812932328716,0.07427055702917772,0.48716458389630346,1.0,4/46,0.88%,ELN;CDH13;EDN1;PDGFB
prerank,phagosome-lysosome fusion (GO:0090385),0.6749288293033973,1.3962793081840477,0.12780656303972365,0.4865210500508315,1.0,3/10,4.75%,SYT7;RAB34;RAB39A
prerank,phagolysosome assembly (GO:0001845),0.6441118289106799,1.395725554613515,0.13043478260869565,0.4871010382969263,1.0,3/12,4.75%,SYT7;RAB34;RAB39A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6781625007747876,1.395449269130933,0.1260229132569558,0.48692701424607965,1.0,3/10,3.41%,CEACAM1;PRKG1;ADAMTS18
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5922603546987729,1.3952842295769812,0.109717868338558,0.48638247192722645,1.0,3/20,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.677276516289101,1.3950366957677693,0.11764705882352941,0.48612184153282534,1.0,2/10,2.67%,RAPGEF2;LGALS9
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.37359675109924595,-1.3949388187286305,0.033816425120772944,0.5663245453942671,1.0,10/61,6.61%,EYA2;EGFR;EYA1;PDGFRB;EYA4;FGF2;UBE2N;USP9X;MECP2;RAD50
prerank,regulation of cellular senescence (GO:2000772),0.5536818384719827,1.3945886753429346,0.10432190760059612,0.48651912944694053,1.0,6/28,11.13%,NUAK1;B2M;ING2;AKT3;RBL1;MAP3K3
prerank,epidermal cell differentiation (GO:0009913),0.5240504356984272,1.394495184523648,0.08795669824086604,0.4858136450258412,1.0,4/41,4.02%,JAG1;GATA6;CLIC4;BCR
prerank,regulation of ion transport (GO:0043269),0.47953753745531075,1.3939293746178392,0.07268170426065163,0.4863177498171616,1.0,8/76,7.62%,NOS1;SYT15;B2M;ATP1A1;SYT7;PXK;P2RX7;NKAIN3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5574265454328097,-1.3936572094775501,0.11528822055137844,0.5668657872519218,1.0,6/13,19.56%,GLI3;RUNX1;NCKAP1L;PNP;TGFBR2;ZBTB7B
prerank,nerve growth factor signaling pathway (GO:0038180),0.6794465084911536,1.3931411588627611,0.11390284757118928,0.4874710675425702,1.0,2/10,1.83%,RAPGEF2;RAPGEF1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6398082349072857,1.3926342968519372,0.11831442463533225,0.48786660805360105,1.0,1/14,0.26%,KCNN4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.561734521487993,-1.3926038014287032,0.08266666666666667,0.5664936190126636,1.0,5/12,15.80%,ABCA1;ITGAV;PPARA;PPARG;NR1H3
prerank,muscle organ development (GO:0007517),-0.3931437705518648,-1.392506412803257,0.046511627906976744,0.5633339125084048,1.0,16/54,9.80%,LAMA2;IGF1;DMD;CHD2;COL6A3;LARGE1;VAMP5;MRAS;ITGA11;FHL1;SGCD;SPEG;EVC;POU6F1;SMTN;SGCE
prerank,glycolipid metabolic process (GO:0006664),0.5083230896417447,1.3923078104242772,0.08758169934640522,0.4878379324882737,1.0,6/47,7.84%,ST6GALNAC3;ST8SIA6;ST3GAL6;ESYT2;PGAP1;GLTP
prerank,innate immune response (GO:0045087),0.4344525640696641,1.3917377790739005,0.012903225806451613,0.48842372892481506,1.0,53/217,20.93%,PLCG2;FYN;TRIM14;NOD2;B2M;IFIH1;APP;FES;GCH1;TLR3;DEFA6;ADAM15;TRIM11;TRIM6;MFHAS1;IRGM;SERINC3;NLRC5;YES1;ADAR;PTK2;HMGB1;TRIM25;TYROBP;TRIM17;CYBA;SERINC5;CFB;CHGA;TRIM8;IRF5;BTK;CX3CR1;AKAP1;CR2;RNASE6;NCF2;SLPI;SRPK1;SLA;PYDC1;CXCL10;IFITM3;RELA;MALT1;ANG;AGER;CAPZA2;SETD2;DHX58;ANKRD17;MID2;RPL39
prerank,negative regulation of endothelial cell migration (GO:0010596),0.533191111278043,1.3917021824693177,0.10148849797023005,0.4875926850715195,1.0,7/36,5.32%,PTPRM;ACVRL1;NOTCH1;ATP2B4;DAB2IP;DLL4;MEF2C
prerank,chondrocyte differentiation (GO:0002062),-0.43933866595586013,-1.3914815703701386,0.0625,0.5631925772257649,1.0,10/32,7.53%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;RUNX2;RUNX1;CCN3;GPLD1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5713966095072038,1.39135518361478,0.12084592145015106,0.4875317714549487,1.0,6/23,8.22%,IFNGR1;ARG1;IRGM;STAT1;NLRC5;JAK2
prerank,secretion (GO:0046903),0.6432811075329914,1.391346517645891,0.11036789297658862,0.48661667102973555,1.0,3/14,6.82%,FBLN5;TPD52;NPR1
prerank,renal water homeostasis (GO:0003091),-0.47620895681572684,-1.3908689044614284,0.09615384615384616,0.5616329896495824,1.0,10/23,15.56%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;WFS1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5351955329755853,1.3904359280024854,0.09782608695652174,0.48813802258957273,1.0,8/35,7.72%,PTPRM;FLT1;CAV1;CAV2;DLL4;MEF2C;STAT1;ATP5F1A
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5727298460933656,1.3902483860043642,0.10610465116279069,0.4877240108432682,1.0,7/23,9.97%,NOS1;FYN;DIAPH1;NOS1AP;CAMK2D;CASQ1;PRNP
prerank,positive regulation of cell death (GO:0010942),0.4942121464110919,1.3895048281012443,0.07529722589167767,0.48875697973128357,1.0,17/59,14.96%,SLC6A6;ACER2;FYN;FCGR2B;ZC3H12A;ITGAM;LRRK2;CIDEB;GRIN2B;APC;EGR1;PRNP;TYROBP;CLU;BNIP3;SARM1;EIF2S1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6001108225245126,1.3891036142171929,0.11926605504587157,0.4888402436946577,1.0,6/18,6.91%,GATA2;JCAD;PIK3C2A;HDAC9;HDAC7;AKT3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5654469942613438,1.3887014532136956,0.11315417256011315,0.4890151056685387,1.0,9/24,14.00%,MMRN2;DAB2IP;HHEX;TMEM204;EPN2;PTPN1;PRKD2;HIF1A;ITGA5
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.550607449955843,1.3885920890440508,0.1017191977077364,0.4883502783135597,1.0,8/28,10.93%,NOD1;NOD2;CASP8;IRAK2;IRGM;UBA52;RPS27A;TAB2
prerank,cellular response to mechanical stimulus (GO:0071260),0.5047052004713313,1.3879731336329364,0.08632138114209828,0.4891492019032695,1.0,12/46,14.04%,F11R;PIEZO1;FAS;CASP8;TLR3;CASP2;CRADD;CASP1;TMEM150C;CASP8AP2;HABP4;BNIP3
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4635965830010071,-1.3871786541522901,0.07947019867549669,0.5707068959960566,1.0,13/23,25.46%,CAMK1D;SLIT2;DPP4;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,neural tube development (GO:0021915),-0.5307709576972992,-1.3870878791312997,0.12169312169312169,0.567597341569379,1.0,4/15,11.67%,ALDH1A2;DACT1;PTCH1;PKD1
prerank,cAMP metabolic process (GO:0046058),-0.5533216809818087,-1.3860726161053376,0.10666666666666667,0.567205476761403,1.0,5/13,6.64%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,protein localization to microtubule organizing center (GO:1905508),0.6109125145885855,1.385245297820477,0.13584288052373159,0.49566111606398616,1.0,6/15,14.33%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.5208242235558013,-1.385228001159412,0.09859154929577464,0.5665511418501364,1.0,7/15,17.71%,PPARA;IRS2;IRS1;GPLD1;PPARG;SLC45A3;ADM
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.502703076040468,1.3845858185835995,0.09176788124156546,0.4965250779840513,1.0,12/47,9.44%,FAS;NOD2;FOXO1;DAB2IP;ARL6IP5;F2RL1;TGFB2;LGALS9;MAP4K4;MAPK1;NBR1;TAOK2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5898984206816046,1.3843372550221442,0.11343283582089553,0.49618883966580124,1.0,3/18,6.09%,HEG1;RASIP1;CUL3
prerank,positive regulation of telomerase activity (GO:0051973),0.539053545323693,1.3843305466544562,0.10595065312046444,0.49528772845822516,1.0,18/33,26.87%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;CTNNB1;MAPKAPK5;PARM1;TCP1;GREM1;WRAP53;MAP3K4;HSP90AA1
prerank,regulation of transport (GO:0051049),0.5263667899864196,1.3841118843126003,0.1051912568306011,0.49488134140430884,1.0,8/36,11.20%,RAB11A;ARL6IP5;ICA1;FES;EPB41;LRRK2;ACTG1;ACTB
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4738679957229206,-1.382748844394628,0.09686609686609686,0.5709323616816497,1.0,7/24,8.25%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;PIK3R1;BCAS3
prerank,positive regulation of heart contraction (GO:0045823),0.5891001590323828,1.3823160705248871,0.1278538812785388,0.49873210310205185,1.0,3/19,2.55%,KCNQ1;EDN1;TGFB2
prerank,calcium ion transport (GO:0006816),0.4517135367679698,1.3822604722556937,0.05319148936170213,0.49792543210179335,1.0,20/113,8.36%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B4;ATP2B2;CAV1;CACNA1A;FKBP1A;SLC8A1;ATP2C1;ANO6;ORAI1;STIM2;P2RX7;CRACR2B;MCOLN1;CRACR2A;MCUR1
prerank,response to estrogen (GO:0043627),0.5409850525586906,1.382056435288842,0.08664772727272728,0.4975427294070518,1.0,13/31,19.36%,CAV1;PELP1;GATA3;TRIM24;NCOA4;ARID5A;TRIM25;SFR1;BRCA1;ESR1;RARA;CD24;WBP2
prerank,regulation of metal ion transport (GO:0010959),-0.5153809234241179,-1.382027958921029,0.08290155440414508,0.5696854696490752,1.0,4/16,6.07%,ANK2;BCL2;SLC30A10;CACNA2D1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5970580817005537,1.3809090211336663,0.1179245283018868,0.49960386843865556,1.0,7/18,14.84%,HOMER2;HDAC7;CD34;PRNP;LAPTM5;NAV3;HAVCR2
prerank,endocrine system development (GO:0035270),-0.49530664515700973,-1.3803091154692517,0.08253968253968254,0.5718704113297436,1.0,11/21,20.44%,GLI2;WNT4;TGFBR1;DKK3;SIX1;STRA6;SALL1;MDK;FOXE1;NF1;SOX2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5922642902474629,-1.3798732895991783,0.09420289855072464,0.5700828196697836,1.0,4/11,4.29%,NKD1;DAB2;RSPO3;PLEKHA4
prerank,positive regulation of cell adhesion (GO:0045785),0.47116061019168193,1.3795177544943853,0.06618531889290012,0.5023165016785678,1.0,12/74,8.73%,PTPRJ;PDGFB;MAGI1;SMAD7;TGFB2;FBLN2;TNFRSF18;PPM1F;CD47;PPP3CA;JAK2;RSU1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5645478996041746,1.3785248529390148,0.10687022900763359,0.5042061310141852,1.0,2/23,2.21%,EDN1;DAB2IP
prerank,heart process (GO:0003015),0.6151688827103164,1.3783802222274693,0.12836767036450078,0.5036859733446586,1.0,2/14,1.04%,FYN;ACE
prerank,protein localization to cell junction (GO:1902414),0.5801823184116012,1.3779247512361255,0.11684370257966616,0.5039516836979855,1.0,5/22,9.23%,HEG1;TJP2;TJP1;DSP;NECTIN1
prerank,phospholipid dephosphorylation (GO:0046839),0.5264750933250258,1.3777995872636442,0.09490084985835694,0.5033428198473758,1.0,13/37,17.34%,SGPP2;PLPP1;INPP5K;MTMR10;INPP5B;MTMR11;OCRL;INPP5F;PLPP6;PLPP4;INPP5J;PLPPR1;SYNJ1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4806766806521115,-1.3767476812420465,0.12195121951219512,0.5733527776405845,1.0,4/21,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4806766806521115,-1.3767476812420465,0.12195121951219512,0.5733527776405845,1.0,4/21,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.545468455045682,1.3766243168017145,0.11856474258970359,0.5055247391165589,1.0,4/26,11.05%,PLCG2;SLC25A33;ADGRB1;CYBA
prerank,atrial septum morphogenesis (GO:0060413),0.6761168032912699,1.3766073627305497,0.12521150592216582,0.5046578069665919,1.0,4/10,4.11%,BMPR2;TGFB2;HEY2;ACVR1
prerank,glutamate receptor signaling pathway (GO:0007215),0.5209427898744291,1.3761508338698614,0.09269662921348315,0.5048994769203232,1.0,13/37,19.60%,PLCB1;GNAQ;HOMER2;APP;GRIN2B;GRIN2C;GRIK2;GRIN3A;GRM5;GRIK1;GRIN2A;GRM7;GRID2
prerank,defense response to tumor cell (GO:0002357),-0.5990774264955895,-1.3752989595020235,0.11278195488721804,0.5745125034578974,1.0,2/10,0.65%,RBMS3;DAPK1
prerank,establishment of spindle localization (GO:0051293),0.6133879305619634,1.3750196387741176,0.12372881355932204,0.5070666645260872,1.0,6/14,18.50%,MAP4;CLASP1;KPNB1;CLASP2;CFL1;ZBED3
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5533321809971393,1.3747733091844376,0.11705202312138728,0.5067892069622884,1.0,8/27,18.29%,SYT15;DOC2B;SYT7;VAMP7;RIMS3;SDF4;SYT1;SYT2
prerank,negative regulation of protein kinase activity (GO:0006469),0.45718838461119055,1.3746595393923624,0.07151664611590629,0.5061634355383596,1.0,27/88,17.56%,PTPRB;CEACAM1;GNAQ;ADARB1;DAB2IP;CAV1;INPP5K;SLC8A1;PPM1F;WWTR1;HYAL2;WARS1;SMCR8;DUSP3;HSPB1;PTPRO;ADAR;PTPN1;NPM1;ITGB1BP1;LRP5;SH3BP5L;DUSP26;PAK2;PYCARD;TRIB3;PYDC1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.612557696568514,1.374520935228724,0.11146496815286625,0.50562434637172,1.0,4/16,9.87%,ST6GALNAC3;ST8SIA6;A4GALT;B4GALT6
prerank,regulation of protein phosphorylation (GO:0001932),0.42184927780872433,1.3742597804964782,0.017671517671517672,0.5054096150531247,1.0,43/256,10.83%,VEGFC;PECAM1;TEK;CCDC88C;ENG;EFNA5;FYN;FLT4;FAS;TBX1;LIMCH1;CCND2;OCLN;INSR;CCND3;DAB2IP;APP;INPP5K;VEGFD;KRAS;ANGPT1;WWTR1;EFNA1;CSNK1D;BRAT1;WARS1;ADAM17;IRGM;ZC3H12A;LRRK2;HSPB1;PDE8A;PRR5L;ARRB1;THPO;NDUFS4;PPP2R5C;CACTIN;PTK2;PRNP;CCDC88A;RAC1;LIMK2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.655483054369936,1.3741253138317173,0.12413793103448276,0.5048427408599786,1.0,3/11,1.88%,NOTCH1;ATP2B4;FOXO1
prerank,calcium ion import into cytosol (GO:1902656),0.6106517323664816,1.374048275969035,0.11544715447154472,0.5041446592461707,1.0,3/15,3.81%,TRPV4;ATP2B4;SLC8A1
prerank,outflow tract septum morphogenesis (GO:0003148),0.5536038992744643,1.3739999802223724,0.11353711790393013,0.5033689154166658,1.0,7/24,4.11%,ENG;GATA6;SMAD6;BMPR2;TBX1;TGFB2;ACVR1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.44470527838672735,-1.373852021230068,0.08417508417508418,0.5758600036857603,1.0,10/27,20.60%,ABCA1;ITGAV;PPARA;PPARG;NFKB1;AGTR1;NR1H3;MAPK9;LPL;AGT
prerank,organic hydroxy compound transport (GO:0015850),0.5294657015516598,1.3732953964954744,0.11126373626373626,0.5044237985387191,1.0,3/36,2.99%,ABCC4;CEACAM1;SLCO1C1
prerank,calcium ion import across plasma membrane (GO:0098703),0.6191530640698738,1.3720218811187805,0.11532125205930807,0.5069218603129836,1.0,3/14,3.81%,TRPV4;ATP2B4;SLC8A1
prerank,negative regulation of JNK cascade (GO:0046329),0.5297998573867719,1.3713369141454284,0.11401098901098901,0.5078270876465737,1.0,5/31,10.36%,MECOM;F2RL1;PDCD4;DUSP3;AIDA
prerank,neuron development (GO:0048666),0.44275844650001683,1.368946696643199,0.050716648291069456,0.5133330609777063,1.0,23/141,9.87%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;TGFB2;FRY;BTG2;APP;MAP4;PPT1;BLOC1S6;EHD1;ATP7A;MEF2C;UHMK1;ALK;FLRT3;TENM3;RAB35;ROCK1;HMGB1;B4GALT6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5304391638982691,-1.3686765824663003,0.10594315245478036,0.5891032823867697,1.0,3/15,13.04%,GLI3;CD55;PNP
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5631278786924214,1.3684012574459963,0.13808801213960548,0.5140412724350001,1.0,3/22,2.97%,KANK4;HIP1R;KANK3
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5838284009040442,1.3682798838972239,0.13858267716535433,0.5134238593420594,1.0,5/18,11.93%,EDN1;NOD2;ATP7A;RFK;PDP1
prerank,mesoderm formation (GO:0001707),0.6119726347608989,1.3681001660921612,0.1309148264984227,0.5129633844279575,1.0,6/17,17.39%,BMPR2;TBXT;SMAD2;TBX20;ITGA3;ITGA8
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5785155802711478,1.36658961897943,0.12788906009244994,0.5162298988066749,1.0,5/21,3.85%,CNKSR3;SMAD7;CAV1;INPP5K;PPM1F
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4809582979949276,-1.3664512718925943,0.07669616519174041,0.592539063083816,1.0,5/22,3.90%,NOTCH2;FGFR2;CASK;PTPRK;STXBP4
prerank,negative regulation of cell activation (GO:0050866),0.6273774543941476,1.3664383465766896,0.1477832512315271,0.5157176811037435,1.0,4/14,8.68%,NOS3;PDGFB;CD200;NR1D1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5369700371045999,1.3661872720746884,0.1210762331838565,0.5155294492227057,1.0,8/28,11.31%,GATA2;EGFL7;HEY1;DLL4;ARRDC1;ARRB1;FBXW7;HIF1AN
prerank,stress-activated MAPK cascade (GO:0051403),0.48345674303167646,1.3659100658468881,0.09727626459143969,0.515338306665083,1.0,13/61,10.93%,MAP4K2;NOD1;NOD2;MAP4K3;LGALS9;IRAK2;MAPK1;UBA52;RPS27A;TAOK2;MAP3K11;MINK1;TAB2
prerank,autophagy of nucleus (GO:0044804),-0.5157820459263951,-1.3652763870220386,0.11141304347826086,0.5930280997940175,1.0,7/16,21.51%,ATG3;ATG5;ATG2A;ULK2;ATG7;WIPI2;WDR45
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5235720870199412,1.3652409741591642,0.11279229711141678,0.5162714991245826,1.0,4/33,1.96%,PLCG2;PLCB1;CCND2;CCND3
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4343522144228003,1.364677224351921,0.05349344978165939,0.5169272258898423,1.0,32/149,12.80%,TRIM14;RPS6KA5;NOD1;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;TIRAP;TRIM6;TRAF1;IRAK2;ALK;IL1RAP;HSPA1B;UBA52;RPS27A;DHX9;TRIM25;NFKBIB;RHEBL1;NFKBIA;TAB2;NPM1;CLU;PRKD2;TRIM8;BTK;CX3CR1;RTKN2
prerank,cellular response to fatty acid (GO:0071398),-0.5408334160796896,-1.3641297174208282,0.13439635535307518,0.5932782155401701,1.0,7/12,25.29%,PID1;IRS1;PDK3;LPL;NR1H4;DGAT2;PDK4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5569065789156792,1.3640955268448756,0.1466275659824047,0.5175913199592288,1.0,12/23,25.15%,CCDC88C;TUBB;HOOK1;MYO10;CCDC88A;TUBA1A;KIF1A;HOOK2;DYNC1I2;TUBA1B;KIF5A;MAP6
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4638735811891377,-1.364082508308274,0.09345794392523364,0.5870027955697734,1.0,9/23,13.87%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4638735811891377,-1.364082508308274,0.09345794392523364,0.5870027955697734,1.0,9/23,13.87%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,I-kappaB phosphorylation (GO:0007252),0.6500855979194613,1.364063610344299,0.16363636363636364,0.5167716034444318,1.0,2/10,3.64%,DAB2IP;TLR3
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6551238651599315,1.363505183329104,0.13494809688581316,0.5174814719695737,1.0,3/10,8.57%,FAS;MAPK1;NBR1
prerank,carnitine shuttle (GO:0006853),-0.5685242795487464,-1.3629676133589053,0.14039408866995073,0.5874119698734551,1.0,6/11,20.15%,PRKAG2;PRKAA2;SLC25A20;PRKAB2;CPT2;ACACA
prerank,regulation of actin filament polymerization (GO:0030833),0.4685431220895378,1.362142371837381,0.1011378002528445,0.5202292034823499,1.0,7/69,3.93%,KANK4;FCHSD2;HIP1R;KANK3;ESAM;EVL;CDC42EP1
prerank,cellular response to alcohol (GO:0097306),-0.4033465785055609,-1.361665552826828,0.07971014492753623,0.5880452688729924,1.0,14/42,17.12%,ADCY5;SMO;ADCY1;GNAI1;CDH1;GRAMD1C;ADCY2;ADCY7;GPLD1;PTCH1;GRAMD1A;OSBPL7;LARP1;GRAMD1B
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4352884080943433,1.3613945087802584,0.06297502714440825,0.5213912497032189,1.0,39/136,20.17%,FZD6;SMAD7;TBXT;AIM2;DAB2IP;ID1;KLF4;NFKBIE;DAP;IRAK2;COMMD7;NFKBIL1;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CTNNBIP1;CACTIN;MAD2L2;PRNP;NFKBIA;NWD1;KEAP1;HAVCR2;PTGIS;TMSB4X;ESR1;PYCARD;MEN1;PYDC1;TBX6;ID3;TAF3;ERBIN;FOXJ1;EGLN1;SIGIRR
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6542958910688617,1.3613207955344238,0.1407035175879397,0.5206992484845844,1.0,1/10,0.07%,PTPRJ
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4100302459419809,1.3613138910110445,0.0121580547112462,0.5198196886646891,1.0,60/390,9.21%,VEGFC;PTPRJ;TEK;PTPRG;PDGFD;RAPGEF2;KALRN;FLT1;EFNA5;TIE1;PLCB1;PDGFB;ARHGEF28;FYN;FLT4;MPZL1;ELMO1;MERTK;FOXO4;ESRP2;IRS4;RAPGEF1;FOXO1;INSR;PRKD1;CAV2;PIK3C2A;CBL;ADRB2;NEDD9;FES;CRK;AP2B1;VEGFD;SHB;ANGPT1;EFNA1;FGFR3;BCAR3;MAPK1;SETX;SHOC2;ALK;LMTK2;FRS3;NUS1;FLRT3;JAK2;GRIN2B;ARPC5;POLR2G;NCKAP1;APC;NAMPT;ACTG1;APH1A;YES1;ROCK1;STAP1;PTK2
prerank,vascular process in circulatory system (GO:0003018),0.6157338067994268,1.3604149615529249,0.13064516129032258,0.5204657443090225,1.0,5/13,13.05%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,regulation of tube diameter (GO:0035296),0.6157338067994268,1.3604149615529249,0.13064516129032258,0.5204657443090225,1.0,5/13,13.05%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,renal absorption (GO:0070293),0.6756554997047677,1.360288243320094,0.12998266897746968,0.5198973455047949,1.0,5/10,9.30%,KCNQ1;HNF1A;KLHL3;HYAL2;SGK1
prerank,protein import (GO:0017038),-0.3523660140796385,-1.3594471732356757,0.023668639053254437,0.5917403765329236,1.0,33/84,24.75%,APPL2;APOE;ABCD3;HSPA4;NUP107;HEATR3;CSE1L;PPP1R10;ATAD1;NUP155;PEX2;TNPO3;PXMP4;RANBP6;IPO5;FAM53C;PXMP2;NUP93;TNPO2;GDAP1;RANBP17;TSC2;PHB2;TOMM22;PEX11B;SEC13;SYK;PEX13;IPO7;POM121;PEX3;IPO8;PEX16
prerank,positive regulation of neuron projection development (GO:0010976),-0.34791050364541126,-1.359159113141357,0.03208556149732621,0.5894920560891299,1.0,19/85,5.83%,PTN;DPYSL3;NTRK3;ROR1;CAMK1D;EPHA3;BMP5;BMP7;PTK7;COBL;WNT5A;NDNF;APOE;MAGI2;CBFA2T2;ROR2;NTRK2;PLXNB2;CAMK1
prerank,dendrite morphogenesis (GO:0048813),-0.4286101618028534,-1.3591358991791012,0.07744107744107744,0.5864548312460157,1.0,8/35,6.56%,PTN;SDC2;FARP1;DCDC2;PHACTR1;DOCK10;DLG4;CTNND2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5803766320586214,1.3590997429288012,0.14240506329113925,0.5222968914897395,1.0,2/17,2.70%,CRTAM;CADM1
prerank,cellular component maintenance (GO:0043954),0.6305684675568035,1.3589930102596726,0.13810316139767054,0.5216819620766077,1.0,4/12,14.23%,FYN;INSR;PRNP;ITGA3
prerank,extracellular matrix assembly (GO:0085029),0.5566828306209385,1.3585084550511162,0.13469985358711567,0.5221257845086511,1.0,3/23,4.38%,FBLN5;NTN4;ATP7A
prerank,positive regulation of bone mineralization (GO:0030501),-0.423744171750682,-1.35847707694747,0.08695652173913043,0.5853613097033702,1.0,10/35,5.87%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;FBN2;KL
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.532825566189519,1.3581912931391134,0.10822510822510822,0.5220623927661566,1.0,10/35,14.09%,HIP1;HIP1R;B2M;CBL;PPT1;HNRNPK;RAC1;CLU;PIK3CB;LDLRAP1
prerank,male gonad development (GO:0008584),0.5289620717650051,1.3578159713635407,0.11341632088520055,0.5222091297950378,1.0,7/34,8.81%,GATA6;KITLG;TGFB2;ING2;GATA3;COL9A3;NCOA4
prerank,regulation of programmed cell death (GO:0043067),0.4351585431643789,1.357030553976528,0.054764512595837894,0.5233840848451613,1.0,36/161,15.09%,MECOM;ACER2;HIP1;FAS;ACTN4;PPP1R13B;GLS2;SLK;CASP2;OMA1;AMIGO2;TNFRSF25;APEX1;TOX3;TRIM24;MADD;ALK;FANK1;CRADD;LRRK2;STAT1;CIDEB;DCPS;JAK2;SGK1;RTN4;CASP1;CLU;NF2;BNIP3L;ATM;BNIP3;ANP32B;PSMC5;TM7SF3;DFFA
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.43833457993050157,-1.355576001549248,0.10357142857142858,0.5912994305027539,1.0,6/32,3.93%,PID1;IGF1;ZBTB20;NUPR1;PRKAA2;PPARA
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4884995459886588,-1.3548422365296555,0.11049723756906077,0.5904838906086137,1.0,7/17,12.59%,ROBO1;SLIT2;EFNB2;FGF2;GPLD1;VEGFA;EPHB4
prerank,regulation of tissue remodeling (GO:0034103),0.5899681056533681,1.354677051180242,0.14242424242424243,0.5286992088434576,1.0,3/18,3.73%,CEACAM1;FLT4;SYT7
prerank,positive regulation of glucose import (GO:0046326),-0.4685488488684941,-1.3546426177946953,0.12429378531073447,0.5880500589514992,1.0,8/21,8.12%,IGF1;SORBS1;RHOQ;IRS2;IRS1;PIK3R1;OSBPL8;PRKCI
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4517302748175796,1.3540588598231105,0.07342657342657342,0.5295519091543053,1.0,21/87,9.21%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;NLK;SMAD2;FURIN;UBA52;RPS27A;JUN;PTK2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6394657550090868,1.3540387872777235,0.14309210526315788,0.5287079766243268,1.0,4/11,10.96%,KCNE3;CAV1;STK39;NEDD4L
prerank,calcium import into the mitochondrion (GO:0036444),0.6643321235675217,1.3539682848061692,0.16262975778546712,0.5279821521539199,1.0,3/10,8.36%,MCUB;SMDT1;MCUR1
prerank,long-chain fatty acid transport (GO:0015909),-0.4337352282173259,-1.3532648742089002,0.10658307210031348,0.5892863577953856,1.0,9/30,11.57%,PRKAG2;ACSL1;APOE;PRKAA2;ABCD3;SLC25A20;SLC27A1;PPARG;PRKAB2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.33043368539616264,-1.3532384741084376,0.03937007874015748,0.5863436408874121,1.0,24/108,8.83%,TRABD2B;WLS;LRP1;FGFR2;SULF1;GPC3;PTK7;RNF43;NKD1;SULF2;RSPO3;DCDC2;APCDD1;PRKN;GRB10;DACT1;RUNX1;CTNND2;SFRP4;DAAM2;RSPO2;FZD7;WWOX;TLE1
prerank,regulation of calcium ion import (GO:0090279),0.56177947508612,1.3531701252302537,0.13556851311953352,0.5291751769351364,1.0,7/21,16.05%,PDGFB;FYN;SLC30A1;PRNP;PLPP4;CTNNB1;PSEN2
prerank,positive regulation of phosphorylation (GO:0042327),0.41495162478963116,1.3525172210529353,0.028008298755186723,0.530050454812191,1.0,33/240,8.29%,VEGFC;PECAM1;TEK;ENG;FLT1;EFNA5;TIE1;FLT4;FAS;TBX1;MERTK;LIMCH1;CCND2;INSR;CCND3;APP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;BRAT1;FGFR3;ADAM17;P2RX7;ALK;IRGM;LRRK2;LMTK2;PDE8A;ARRB1;THPO;PRKAA1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5287588068650544,1.352016842739467,0.12215909090909091,0.5305650967056617,1.0,16/33,21.52%,ABR;CACNA1A;BCR;GRID1;BTBD9;PXK;LRRC4C;GRIK5;GRIK2;CX3CR1;PSMC5;GRIK1;LRP8;GRID2;BDNF;NLGN1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.42192650907743323,1.3510214894798862,0.029723991507430998,0.532408947010719,1.0,27/198,7.30%,PLCG2;PTPRB;PLCB1;ALPL;ITPKB;IP6K3;PLCB4;DUSP12;INPP5D;INPP1;PLPP1;INPP5K;IPPK;MINPP1;ACP6;PGM2L1;LPCAT4;GPI;LCAT;GPD2;PGK1;DUSP16;THTPA;ALK;DUSP3;LRRK2;PPP3CA
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5461636191331138,-1.350793617999745,0.13994910941475827,0.5909916545652331,1.0,6/13,12.28%,DCN;BGN;HEXA;VCAN;HYAL1;CSPG4
prerank,cardiac muscle tissue development (GO:0048738),0.4934249485378452,1.350757109998842,0.11749680715197956,0.5322475732063252,1.0,7/50,3.58%,GJA5;GATA6;MSX1;BMPR2;NOTCH1;HEY1;HEY2
prerank,protein localization to cell periphery (GO:1990778),0.4374235762101518,1.3506195202908051,0.05518018018018018,0.5317887523250134,1.0,27/133,10.72%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;RAB40B;CLASP2;NKD2;PDZD11
prerank,myoblast differentiation (GO:0045445),0.6097282197038649,1.3504382222429603,0.1424,0.5313994661221082,1.0,3/14,4.60%,EPAS1;JAG1;MBNL1
prerank,regulation of histone methylation (GO:0031060),-0.5394293440182111,-1.3503857842672604,0.14285714285714285,0.5893108006204879,1.0,8/13,21.31%,JARID2;NSD1;PAF1;CTR9;TET1;PIH1D1;NNMT;MTHFR
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6296308319716117,1.3500991612600033,0.1461794019933555,0.5314323619461798,1.0,1/12,0.47%,EDN1
prerank,negative regulation of dephosphorylation (GO:0035305),0.5873650342896057,1.3499985969936528,0.12599681020733652,0.5308043850427082,1.0,6/18,12.11%,INPP5K;ZCCHC9;PPP1R16B;GPATCH2;MFHAS1;ARPP19
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5877988431045313,1.3495196482499667,0.1449511400651466,0.5312102798272552,1.0,2/16,2.70%,CRTAM;CADM1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5024650015352584,1.3494930238426284,0.10962566844919786,0.5303888816397768,1.0,7/38,7.97%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;MADD;BCL2L1
prerank,type I interferon signaling pathway (GO:0060337),0.4992072632949333,1.3490598102465268,0.11141304347826086,0.5298482245838504,1.0,11/41,12.46%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,cellular response to type I interferon (GO:0071357),0.4992072632949333,1.3490598102465268,0.11141304347826086,0.5298482245838504,1.0,11/41,12.46%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,T cell receptor signaling pathway (GO:0050852),0.4353467256236608,1.348828751316148,0.052805280528052806,0.5296128435164947,1.0,36/138,18.86%,PTPRJ;PLCG2;FYN;INPP5D;PSMD13;GATA3;CD247;PSMD4;ZC3H12A;EIF2B2;PSMA5;PSMB10;PLCG1;TAB2;PSMB8;PSMD14;PRKD2;PIK3CB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PDE4D;PAK2;PSMC6;NCK1;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6
prerank,regulation of cell population proliferation (GO:0042127),0.40114387489517034,1.3488073217191436,0.002002002002002002,0.5287877742229711,1.0,86/691,9.42%,VEGFC;PTPRJ;ELN;CDH13;ACER2;NUAK1;JAG1;JAG2;NOS3;EDN1;PDGFD;ENG;IRF6;RAPGEF2;CLDN5;FLT1;SMAD6;PDGFB;BMPR2;FLT4;SMARCA2;KITLG;TBX1;PTPN14;FOXO4;CCND2;ITGA1;LIFR;ACVRL1;NOTCH1;INSR;ARHGEF2;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;EMP2;BTG2;DLL4;APP;FES;BTG1;HHEX;PLPP1;KLF4;VEGFD;KRAS;IER5;WWTR1;LEF1;GCNT2;SERTAD1;TBC1D8;FGFR3;GATA3;CUL3;BCL6B;WARS1;IL1A;ADAM17;SH3BP4;SLC25A33;CD47;ALK;GNAI2;IGFBP7;STAT1;HSPA1B;CNOT6L;CEBPA;PTPRU;THPO;CD200;JAK2;APC;NMI;NAMPT;TSPO;KLF11;PPP2R5C;JUN;TJP1;PTK2;SGK1;ADAM10
prerank,cellular response to interleukin-1 (GO:0071347),0.43282244783201734,1.348494463911473,0.04945054945054945,0.5287006182104109,1.0,46/143,18.86%,PLCB1;RPS6KA5;NOD1;NOD2;DAB2IP;PSMD13;HYAL2;IRAK2;GBP3;IL1A;PSMD4;CD47;ZC3H12A;IL1RAP;UBA52;RPS27A;NR1D1;ACOD1;CACTIN;EGR1;PSMA5;RBX1;PSMB10;CCL4;NFKBIA;TAB2;PSMB8;MAP3K3;GBP2;PSMD14;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PTGIS;PYCARD;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.48683446253178936,-1.3483925069657134,0.08746355685131195,0.5923697630024723,1.0,9/21,20.35%,SMO;DCDC2;ARMC9;EVC;GLI1;KIF7;GAS8;ULK3;STK36
prerank,cGMP metabolic process (GO:0046068),0.623871143989079,1.3478066905416217,0.14467408585055644,0.5297255855796348,1.0,3/12,11.52%,NPR2;NPR1;NPPC
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5358375205879966,1.3457759849801,0.12063953488372094,0.5344527704067943,1.0,4/29,3.92%,CCR1;JAM2;LGALS9;ANO6
prerank,nuclear migration (GO:0007097),-0.5443397790804629,-1.344350233047959,0.12886597938144329,0.6018835238622033,1.0,4/13,8.55%,DOCK7;SYNE2;CLMN;SYNE3
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.45112832248801704,1.3437477411787986,0.07394366197183098,0.5391394341664304,1.0,33/94,18.86%,PLCB1;RPS6KA5;NOD1;NOD2;PSMD13;IRAK2;IL1A;PSMD4;IL1RAP;UBA52;RPS27A;EGR1;PSMA5;RBX1;PSMB10;NFKBIA;TAB2;PSMB8;MAP3K3;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.509683024303534,1.3434945138629117,0.12907801418439716,0.5389260747736252,1.0,10/35,21.52%,CDH13;ATP2C1;CDH12;PCDHB16;PCDHB14;CDH22;PCDHB9;CDH18;CDH24;NLGN1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6017575435616003,1.34338236681297,0.14144736842105263,0.5383679281472775,1.0,1/13,0.16%,CDH13
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5481856367166847,1.3433004331534046,0.14871016691957512,0.5377071342321879,1.0,3/24,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,positive regulation of DNA repair (GO:0045739),-0.3927656088514846,-1.343203210592621,0.09745762711864407,0.6028638309840456,1.0,8/46,8.57%,EYA2;EGFR;EYA1;EYA4;UBE2N;SLF1;FMN2;XRCC1
prerank,regulation of multicellular organismal development (GO:2000026),0.5453893940642001,1.3424902589459498,0.13704819277108435,0.5390798798832594,1.0,6/25,11.00%,SOX17;SPAAR;INSR;GATA3;OAS2;BAG6
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.49785550231861647,-1.3420600824383357,0.13385826771653545,0.6033249324882272,1.0,7/16,18.34%,AUTS2;SNW1;WDR5;CTR9;PIH1D1;BCOR;DNMT3B
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5888917170136571,1.3420456731683152,0.16559485530546625,0.5394233727808817,1.0,6/17,4.11%,JAG1;NOTCH1;HEY1;DLL4;HEY2;ACVR1
prerank,neuron projection development (GO:0031175),0.42483190410193394,1.3420021322779478,0.059203444564047365,0.5387030292201967,1.0,31/168,10.64%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;DAB2IP;FRY;BTG2;TRIO;APP;MAP4;BLOC1S6;EHD1;ATP7A;VASH2;SHTN1;MAP4K4;SHANK3;CAMSAP2;PACSIN1;UHMK1;LRRK2;FLRT3;NCKAP1;RAB35;ROCK1;SGK1;TAOK2;HMGB1;NEFH;MINK1
prerank,cellular metal ion homeostasis (GO:0006875),0.4479017084404614,1.341403687372357,0.07783018867924528,0.5394760178597006,1.0,14/102,5.71%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2
prerank,regulation of trophoblast cell migration (GO:1901163),-0.5292681941560032,-1.3409335298008442,0.13227513227513227,0.6036427804312671,1.0,4/14,9.47%,GJA1;SYDE1;VEGFA;ACVR1B
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6497630140828822,1.3408822948417938,0.16319444444444445,0.5401066897732287,1.0,3/10,8.23%,RAPGEF2;ATP7A;CDH3
prerank,negative regulation of phagocytosis (GO:0050765),0.5783107511037853,1.3404592905151782,0.14130434782608695,0.5403789687440582,1.0,5/17,9.50%,DYSF;FCGR2B;CD47;PLSCR1;HMGB1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.49798982675492753,1.3403796069313372,0.10201342281879194,0.5397404333445608,1.0,5/44,3.92%,KCNN4;KCNQ1;KCNN3;NOS1AP;ANO6
prerank,regulation of pseudopodium assembly (GO:0031272),0.6462318085858523,1.3401108453810961,0.15619694397283532,0.5386345903709178,1.0,3/10,8.44%,F2RL1;CDC42EP1;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6462318085858523,1.3401108453810961,0.15619694397283532,0.5386345903709178,1.0,3/10,8.44%,F2RL1;CDC42EP1;APC
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5455744367693041,1.3398100244330362,0.1567732115677321,0.5385468983331201,1.0,4/23,5.38%,LTBP4;ENG;SMAD7;SMAD2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6365645765979919,1.3390157686172548,0.14705882352941177,0.5398995195980771,1.0,2/10,7.01%,SMAD7;ZC3H12A
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.515423216785923,1.3388659516030317,0.13093525179856116,0.5394311338673138,1.0,7/31,2.96%,ENG;SMAD7;MYBPC3;NOTCH1;TGFB2;FKBP1A;DLL4
prerank,negative regulation of calcium ion transport (GO:0051926),0.6010230890321792,1.3387657612597323,0.14910858995137763,0.5388392157222507,1.0,3/15,7.19%,NOS1;INPP5K;SLC30A1
prerank,negative regulation of heart contraction (GO:0045822),-0.564052765030848,-1.3386433336115342,0.145679012345679,0.6077978430859582,1.0,1/11,0.03%,ATP1A2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4552940115054204,1.3385539461930638,0.08736717827626919,0.5385231695541127,1.0,32/86,20.43%,EPAS1;KLF2;PSMD13;ELOC;PSMD4;UBA52;NFE2L2;RPS27A;PSMA5;RBX1;PSMB10;CUL2;PSMB8;HIF1AN;PSMD14;GCN1;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;PSMB2
prerank,synaptic membrane adhesion (GO:0099560),-0.5234934974550606,-1.33827760176424,0.13399503722084366,0.6058886571907339,1.0,8/14,19.26%,GPC6;PTPRF;LRRC4;SLITRK1;PTPRS;NTNG1;PTPRD;GPC4
prerank,negative regulation of protein binding (GO:0032091),0.46661705231833,1.3364321802473942,0.08662420382165605,0.5433989910737725,1.0,19/71,15.64%,ATP2A3;PDGFB;B2M;CAV1;ADRB2;ADAM15;TTBK2;LRRK2;CTNNBIP1;ROCK1;ACTB;TMBIM6;TTBK1;ITGB1BP1;PIN1;NES;MAP2;RACK1;SLPI
prerank,regulation of cellular pH (GO:0030641),-0.42945336891907876,-1.3363510226999584,0.08833922261484099,0.6090921652312342,1.0,16/29,22.43%,SLC4A10;SLC9A2;CA2;LACC1;SLC9A9;ATP6AP1;SLC4A2;ATP5F1B;SLC4A3;SLC9A1;SLC26A6;SLC9B1;SLC9A6;CLN3;TM9SF4;SLC4A8
prerank,female gonad development (GO:0008585),-0.48522877447884405,-1.3358619598458863,0.1327683615819209,0.6077673498471353,1.0,5/19,8.98%,NR2F2;KIT;NUP107;CEBPB;VEGFA
prerank,plasma membrane invagination (GO:0099024),0.5278560372226003,1.3357152731803326,0.1206896551724138,0.5445828264247761,1.0,8/29,8.94%,ELMO1;GULP1;FCGR2B;FCGR1A;MYH9;ITGAM;ARHGAP25;VAMP7
prerank,gene silencing by miRNA (GO:0035195),0.5140573717849651,1.335411342128879,0.1546242774566474,0.5445447380647721,1.0,9/32,14.77%,NOTCH4;TNRC6C;PUM2;ZC3H7A;ADAR;CNOT1;AGO4;RAN;EIF6
prerank,T cell differentiation (GO:0030217),0.5006428852954464,1.3353274595590763,0.12250332889480692,0.5439236265261048,1.0,5/40,6.32%,SOX13;JAG2;DLL4;GATA3;ADAM17
prerank,negative regulation of cell projection organization (GO:0031345),0.49267290091055355,1.335242238728433,0.10457516339869281,0.543281966852162,1.0,12/48,13.00%,TRPV4;STMN2;RAPGEF2;FYN;FKBP4;PTPRO;GRIN2B;PRNP;SPOCK1;DCC;TSKU;YWHAH
prerank,negative regulation of locomotion (GO:0040013),0.6179016828535722,1.3351007130523131,0.13810316139767054,0.5428157638787138,1.0,8/12,17.43%,CRK;SPOCK3;GATA3;DUSP3;SPINT2;PIN1;FRMD5;PTPN2
prerank,purine-containing compound salvage (GO:0043101),-0.5486670201788897,-1.335093523312248,0.14250614250614252,0.6071040248118369,1.0,8/12,30.33%,ADK;AMPD3;GMPR;PNP;APRT;DCK;AMPD2;ADA
prerank,cytosolic calcium ion transport (GO:0060401),0.5367626576201762,1.3348084908715365,0.1357142857142857,0.5427326099500708,1.0,5/28,4.82%,ATP2A3;ITPR3;MCUB;SLC8A1;SMDT1
prerank,cellular calcium ion homeostasis (GO:0006874),0.43456133118879575,1.3347799935787732,0.05417607223476298,0.5419614036152145,1.0,17/133,7.19%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;CAV2;MCUB;SLC8A1;ATP2C1;SMDT1;CAMK2D;ATP13A3;STIM2;HCRTR1;SLC30A1
prerank,membrane depolarization during action potential (GO:0086010),-0.44212574716355146,-1.3341879224571596,0.13166144200626959,0.6068464962383221,1.0,5/26,6.67%,ATP1A2;CACNA1C;SCN7A;SCN2A;CACNA1G
prerank,heart development (GO:0007507),0.4242003986419735,1.333637839874465,0.07547169811320754,0.544173289927245,1.0,22/150,5.32%,HEG1;SOX17;TEK;PDGFB;BMPR2;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;DAND5;INSR;CASP8;TGFB2;FKBP1A;HDAC9;SOX18;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,positive regulation of protein polymerization (GO:0032273),0.46177770664369955,1.3327248779613847,0.12005108556832694,0.545775046716633,1.0,15/65,16.66%,FCHSD2;OCLN;FES;EVL;CDC42EP1;CLIP1;CLASP1;NCKAP1;RAC1;NUMA1;TTBK1;NAV3;TENM1;NCK1;PYCARD
prerank,primary alcohol metabolic process (GO:0034308),-0.43869219988526453,-1.3327157016207598,0.10903426791277258,0.6085050134366191,1.0,5/25,9.47%,IGF1;RBP4;NAPEPLD;NAAA;DHRS3
prerank,aminoglycan biosynthetic process (GO:0006023),-0.3801022929680223,-1.3319961676141987,0.0970464135021097,0.6077694489524139,1.0,12/49,10.39%,GPC6;B3GALT1;SDC2;HSPG2;GPC3;HS3ST3A1;B3GNT2;PXYLP1;XYLT1;HEXA;B3GAT3;HS2ST1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4973877570119181,1.331526593714608,0.14227086183310533,0.5480632202657423,1.0,8/43,9.62%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;GPRC5A;RNF115
prerank,neuron projection extension (GO:1990138),-0.4293299224485125,-1.3315071210562812,0.07457627118644068,0.6063128965848401,1.0,11/32,12.07%,ALCAM;AUTS2;NRP2;SEMA5A;SEMA3A;USP9X;SPG11;FLRT1;PPP3CB;ULK2;LLPH
prerank,glucose import (GO:0046323),0.6182002535642606,1.3311467544728754,0.168,0.5483001765309456,1.0,2/13,2.68%,SLC2A1;HNF1A
prerank,neuron remodeling (GO:0016322),0.6353884408820549,1.3309929307331398,0.1791044776119403,0.5478280509957963,1.0,2/10,2.98%,RND1;APP
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6483005982672152,1.3309799754075256,0.15924657534246575,0.5470037841670891,1.0,3/10,3.85%,NOTCH4;NOTCH1;PPM1F
prerank,regulation of autophagosome maturation (GO:1901096),0.6106292249329568,1.330588104227196,0.1808,0.5471858704263839,1.0,6/13,17.71%,ADRB2;SMCR8;IRGM;FYCO1;RUBCN;UBQLN4
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5849140438585607,1.3292990915668843,0.1637239165329053,0.5498587067488893,1.0,2/15,0.80%,CDH13;CEACAM1
prerank,histone H3-K4 methylation (GO:0051568),-0.4466023180632857,-1.3290683212880436,0.11206896551724138,0.610825782473061,1.0,10/26,16.37%,OGT;KMT2C;ASH2L;SETD1A;SETD1B;TET2;WDR5;CTR9;DPY30;SETD4
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6210665596768502,1.3286503446129123,0.16583747927031509,0.5507081537891663,1.0,1/12,0.06%,NOS1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.47805380866223146,-1.3267418324066833,0.13165266106442577,0.6152373339604454,1.0,3/18,2.18%,EGFR;DDX5;BMP4
prerank,homeostasis of number of cells (GO:0048872),0.6160242567306428,1.3264466977067608,0.1864406779661017,0.5558019481429232,1.0,4/12,12.63%,NOS3;NOTCH1;LPCAT3;CX3CR1
prerank,sulfate transport (GO:0008272),-0.5186335897077983,-1.32525783341932,0.1450381679389313,0.6171970825614258,1.0,3/14,2.86%,SLC13A4;SLC26A7;SLC26A2
prerank,regulation of dendrite development (GO:0050773),-0.4055116250603336,-1.3247760584762824,0.06349206349206349,0.6157058066388574,1.0,7/37,2.62%,PTN;CAMK1D;SDC2;BMP5;BMP7;MARK1;COBL
prerank,cellular protein modification process (GO:0006464),0.39328198095289985,1.3243508004063633,0.0,0.5607226045248614,1.0,200/983,15.76%,BMX;PTPRM;PTPRJ;LMO7;PTPRB;EPAS1;NUAK1;CDK19;PTPRG;ST8SIA6;ERG;PTPRR;MAP4K2;STK10;PDGFB;ASB4;FYN;BMPR2;RPS6KA5;CDK17;PTPN14;MERTK;ACVRL1;IP6K3;ST3GAL6;FBXL2;RAB11A;MAP4K3;INSR;DUSP12;DUSP1;ST6GALNAC2;CDK14;SNRK;PRKD1;PRKG1;TGFB2;OXSR1;GOLM1;CDC42BPA;APP;TULP4;KLHL2;MAP3K6;PKN3;FBXO7;UBA7;APOA1;SERP2;COPS4;CDC42BPG;PPM1F;CISH;PSMD13;BCR;ACVR1;STK24;FBXL14;FBXL5;KLHL3;MANBA;GCNT2;CCNE1;PTPRE;CAMK2D;MAP4K4;PKN1;STK38;STK38L;TMEM132A;CSNK1D;NLK;ELOC;CTTNBP2NL;RHBDD1;MEX3B;GAN;CUL3;CHRM3;DUSP16;PGAP1;SIRT4;MAPK1;PGGT1B;CD247;PXK;PSMD4;MAST1;KLHL20;ZBTB16;AKT3;SIK2;LRRK2;PRKCSH;FBXL18;IGFBP7;LMTK2;SOCS6;PPP3CA;PTPN12;HSP90B1;NUS1;PTPRU;PTPRO;ASB5;TLK1;B3GNT3;STK19;UBA52;JAK2;FEM1C;PRKAA1;PROC;STK39;PASK;PIM3;PP2D1;NEK7;YES1;PPP2R5C;ROCK1;FBXL16;CSNK1G3;IGFBP4;DSP;SGK1;ADAM10;TAOK2;PSMA5;PIK3C3;MAP3K11;FBXW7;RBX1;PSMB10;CUL2;MARK3;DUSP11;PRKCG;APLP2;PTPN1;MINK1;LIMK2;FBXW2;LIPT1;TNKS;CDH2;MGAT1;PSMB8;PSMD14;NEK11;HS3ST5;PDP1;PRKD2;MARK2;MATK;VRK1;FBXO4;CP;COPS8;SETD3;METAP2;TTBK1;BTK;B3GALNT2;DCAF17;PSMA7;PSMC3;PPM1D;KEAP1;NAGPA;DCAF10;PPM1L;HIF1A;PSMA8;ST3GAL1;PSMC1;LTK;ATM;FBXO2;PSMB5;UBE2E1;ACVR2A;MAP3K20;PSMC5;PRKG2;MSRA;UBE2D3;PPP4R1;PPP2CB;EVPL;ACVR2B;ABCA7;PSMB9;MPI;DUSP26;ST3GAL2;PKN2;PAK2;KLHL25;ENGASE
prerank,positive regulation of MAP kinase activity (GO:0043406),0.45616969637000254,1.3241603610767902,0.11704834605597965,0.5603808968559946,1.0,7/66,2.21%,EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DAB2IP
prerank,axon guidance (GO:0007411),0.41315948656823603,1.323938961100393,0.05698924731182796,0.560131222462467,1.0,35/201,11.35%,SEMA3G;LAMA3;PTPRM;EFNA5;FYN;RPS6KA5;PLXNA4;NTN4;NOTCH1;KLF7;SEMA3F;SH3KBP1;EVL;PLXND1;LAMA5;NTN1;TMEFF1;SEMA7A;DAB1;EFNA1;ROBO4;SHANK3;MAPK1;BSG;PTPRO;ENAH;SEMA6D;SCN1B;PTK2;PLCG1;CYFIP1;RAC1;RANBP9;DCC;SEMA4G
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.44677644805975475,1.32388248275447,0.09859154929577464,0.55937175435695,1.0,12/93,6.98%,NOS1;CNKSR3;SMAD7;ATP2B4;CAV1;PRKD1;APP;INPP5K;PPM1F;TRIM6;BCAR3;IRGM
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6395608282891119,1.323453279482242,0.18057921635434412,0.5588824992982839,1.0,3/10,13.89%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6395608282891119,1.323453279482242,0.18057921635434412,0.5588824992982839,1.0,3/10,13.89%,AP2B1;AP2M1;VLDLR
prerank,pyroptosis (GO:0070269),0.6129815227325709,1.3232768800242853,0.14918032786885246,0.5584729729414087,1.0,4/15,10.37%,AIM2;CASP8;DHX9;CASP1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.46204684775131577,1.3231053978206413,0.10947109471094711,0.5580958335988538,1.0,25/70,18.86%,GATA2;LMO2;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5103285767193261,-1.3230271516433592,0.14511873350923482,0.6181416752410284,1.0,5/14,9.67%,SULF1;SULF2;THBS1;FGF2;CREB3L1
prerank,monocyte chemotaxis (GO:0002548),0.5207159690324379,1.3229044967837036,0.14964028776978416,0.55778201560382,1.0,4/32,10.16%,FLT1;PDGFB;PTPRO;CCL4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5888374404366944,1.3227573306199114,0.1620795107033639,0.5573450149077124,1.0,2/17,3.68%,KCNE3;NOS1AP
prerank,negative regulation of DNA binding (GO:0043392),0.5342510933148042,1.322643505813614,0.13333333333333333,0.5568070874563927,1.0,10/28,13.35%,HEY1;HEY2;SUMO3;LEF1;JAK2;JUN;MAD2L2;NFKBIA;TNKS;HABP4
prerank,anion transport (GO:0006820),-0.40196549626132894,-1.3223377052914864,0.11148648648648649,0.6173498158684119,1.0,9/33,8.43%,SLC13A4;SLC13A3;SLC26A7;SLCO2B1;SLC17A5;SLC22A6;SLC19A1;LRRC8D;SLC4A2
prerank,regulation of vasoconstriction (GO:0019229),0.5311907614453548,1.322164712344297,0.15450643776824036,0.5573073227425366,1.0,4/27,6.12%,BMPR2;ACE;CAV1;CHRM3
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6342746827463385,1.3220710939457903,0.19618055555555555,0.5567324728350356,1.0,2/10,3.83%,APOA1;KLF4
prerank,actin filament polymerization (GO:0030041),-0.42155845028683225,-1.3219997261057574,0.1111111111111111,0.6156257743349375,1.0,7/29,7.16%,ARHGAP6;GAS7;GSN;COBL;WASF1;WASHC3;PREX1
prerank,negative regulation of transport (GO:0051051),0.4788754133329963,1.3215242245584953,0.11473272490221642,0.5573963321263203,1.0,10/51,9.11%,MCTP1;DYSF;PRKD1;ARL6IP5;PPM1F;FCGR2B;CTTNBP2NL;PXK;PLSCR1;NDFIP2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5774232037463265,1.321338304417692,0.15714285714285714,0.5570802727857904,1.0,2/16,1.04%,BMPR2;ACE
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4951649947224238,1.3212191759063177,0.1286472148541114,0.5565821881406753,1.0,10/47,11.66%,RAPGEF2;CEACAM1;FYN;ATP2B4;CAV1;CD34;ZC3H12A;SNAI2;FBXW7;BRCA1
prerank,peptide cross-linking (GO:0018149),-0.44651367760209315,-1.3206868145257566,0.08517350157728706,0.6169038049905102,1.0,4/25,6.16%,COL3A1;NDNF;THBS1;ANXA1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5580301104964821,1.3202921540329433,0.14678899082568808,0.5582043887183794,1.0,8/20,8.76%,ENG;ACVRL1;NOTCH1;HEY1;TGFB2;HEY2;PDCD4;SNAI2
prerank,ethanol metabolic process (GO:0006067),-0.524279792837601,-1.319810100807026,0.1475826972010178,0.6169231537621928,1.0,1/12,0.24%,ALDH1A1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6316139591029256,1.3196448134796992,0.17006802721088435,0.5591195619132675,1.0,2/11,5.43%,MECOM;CD34
prerank,T cell activation (GO:0042110),0.4595504402842375,1.3192411030298201,0.10297766749379653,0.5594120348381596,1.0,10/69,7.30%,JAG2;CRTAM;CASP8;F2RL1;FKBP1A;DLL4;MSN;CTPS1;GATA3;PPP3CA
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.45982665014745194,-1.3187419694031304,0.11174785100286533,0.6174406441525767,1.0,6/22,12.51%,ZBTB20;SORBS1;APOE;PPARA;PPARG;CREB1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4603671250325332,1.318018900374191,0.12628865979381443,0.5619289913225567,1.0,19/60,15.37%,PDGFB;HMBOX1;KLF4;MAPK1;NVL;CCT8;NEK7;DKC1;PTGES3;TNKS;POLG2;CCT2;PRKD2;FBXO4;CCT4;ATM;CTNNB1;CCT6A;RFC2
prerank,protein targeting to ER (GO:0045047),0.43618935961132416,1.3173684536480386,0.09590643274853801,0.5628481700123193,1.0,51/99,28.17%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SGTB;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;RPL37A;RPL18A;SEC62;SRP19;ZFAND2A;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;SGTA;RPL3;SPCS2;RPL28;RPS16;RPLP1;RPL26;RPL9;RPS17;CHMP4A;CHMP4B;RPS13;RPL11;RPL14
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5652658007886656,1.3168007181460077,0.1890971039182283,0.5635802062018581,1.0,4/17,9.04%,CLDN5;F11R;PROC;ROCK1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4968158591024968,-1.316784713183093,0.10997442455242967,0.6206296506361316,1.0,6/15,8.15%,FGFR2;PDGFRA;TGFBR1;NIPBL;SIX1;MTHFD1
prerank,positive regulation of cell cycle (GO:0045787),0.4603447048636087,1.3164095522029668,0.10572139303482588,0.5638277206968612,1.0,11/62,7.56%,PDGFB;CCNY;CCND2;CCND3;TAL1;TGFB2;APP;TTL;ADAM17;DUSP3;MAPRE3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.51842812165251,-1.3163414512575256,0.1597051597051597,0.6191894767065887,1.0,7/14,19.85%,NMNAT2;ME1;AK5;PNP;CMPK2;AK1;NME2
prerank,response to copper ion (GO:0046688),-0.47159963678258027,-1.3158728016036056,0.115625,0.617926042418197,1.0,8/20,6.94%,MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4518397359588925,1.3151805400809728,0.0991636798088411,0.5664582091976902,1.0,27/80,21.60%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;LRRK2;UBE3A;NDFIP2;NSMCE3;FBXW7;RBX1;LAPTM5;BRCA1;FBXO4;PIN1;SPRTN;BMI1;TRIB3;GSK3A;XIAP;CRY1;MALT1;ARRDC4;DCUN1D2;UBB
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4357701714351483,-1.3149397469957935,0.125,0.6181722663508274,1.0,7/24,8.49%,IGF1;SORBS1;ENPP1;IRS2;IRS1;IGF2;PPP1R3B
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3883566400487573,-1.3148210850300226,0.1,0.6157874991271303,1.0,11/43,9.76%,PID1;OGT;SORBS1;PRKCB;NUCKS1;GRB10;ENPP1;IRS1;PIP4K2A;IGF2;PRKCZ
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.5002434515712446,-1.3139714250850616,0.13972602739726028,0.6156494537697503,1.0,4/15,5.79%,LRP1;PDPN;DPP4;FAP
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.5321797082267362,-1.313645973367595,0.15364583333333334,0.613970352859157,1.0,6/12,22.68%,SMO;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3923184361178412,1.3132475297243413,0.009009009009009009,0.5708830138300737,1.0,75/509,11.23%,PTPRJ;PLCG2;CDH13;TEK;PDGFD;ENG;RAPGEF2;HIP1;FLT1;PDGFB;FYN;TRIM14;FLT4;VWF;KITLG;TBX1;NOD1;JCAD;NOD2;INSR;DAB2IP;CAV1;PRKD1;CASP8;CAV2;F2RL1;TGFB2;CBL;ADRB2;LGALS9;FKBP1A;APP;IQGAP1;ACTN4;TLR3;NOS1AP;TIRAP;ATP2C1;PUM2;ANGPT1;GCNT2;TRIM6;TNFSF10;PLEKHG5;FGFR3;IAPP;BCAR3;GATA3;SMCR8;PDCD4;JMJD8;BBC3;MFHAS1;WDR59;BCL2L1;THPO;JAK2;NMI;GAPDH;ROCK1;NDFIP2;PTK2;RTN4;HMGB1;TRIM25;RRAGD;CCL4;RPL37;LURAP1;CHD5;CASP1;RAC1;TAB2;MAP3K3;LAPTM5
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6047506973373546,1.3132170777657923,0.1886178861788618,0.5701097151969243,1.0,6/13,18.99%,HEY1;HEY2;MAD2L2;TMSB4X;SIN3A;SOX11
prerank,pancreas development (GO:0031016),-0.538640968167311,-1.3126705756355725,0.15424164524421594,0.6142464236652093,1.0,7/12,31.47%,TCF7L2;NPHP3;MET;NKX6-1;PROX1;FOXF1;CCDC39
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4552550776002553,1.311964235170632,0.10216346153846154,0.5726419450903145,1.0,16/76,12.21%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;ZC3H12A;LRRK2;UBE3A;NDFIP2;NSMCE3;FBXW7;LAPTM5;BRCA1;FBXO4
prerank,outer dynein arm assembly (GO:0036158),-0.5104686482415557,-1.3109616480349677,0.16531165311653118,0.6167503747667605,1.0,11/14,41.48%,DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63;DNAH8
prerank,positive regulation of GTPase activity (GO:0043547),0.40873525874770295,1.3107872507111487,0.05308775731310943,0.5749023510770992,1.0,42/188,13.86%,RAPGEF2;DOCK9;RABGAP1;SIPA1L2;F11R;ARHGEF15;RAPGEF1;RASGRP2;ABR;CAV2;F2RL1;AGRN;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;RAPGEF6;MAP4K4;TBC1D8;RAP1GDS1;BCAR3;TIAM2;RGS7;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;RSU1;TBC1D1;RAP1GAP2;TAX1BP3;CCL4;RALGAPB;ARHGAP27;USP6NL;PIN1;TBC1D10A;TBC1D4;TBC1D9;RALGAPA2;ARHGEF10
prerank,catecholamine biosynthetic process (GO:0042423),0.6226971549753562,1.3106235367241725,0.20491803278688525,0.5745185995565094,1.0,3/11,6.03%,TGFB2;GCH1;GATA3
prerank,urogenital system development (GO:0001655),-0.5362201106085168,-1.3106024664904183,0.16539440203562342,0.6151510440181975,1.0,5/11,20.48%,OSR1;ANXA1;EPHB2;EPHB3;PAX2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5480483090767573,1.3100192215130715,0.17384615384615384,0.5752803438322384,1.0,6/22,12.45%,PDGFD;PDGFB;ACE;TOM1L1;TAOK2;CALM3
prerank,nucleus organization (GO:0006997),0.4762998859432246,1.3098635434828787,0.14599483204134367,0.5748625888117517,1.0,25/47,27.34%,SYNE1;IRAG2;SUN3;CHMP1B;NUP54;NUP35;NUMA1;REEP3;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;NUP205;RPS19;SUN1;CHMP1A;LEMD3;ATXN7;SEH1L;CTDNEP1;TPR;VPS4B;CHMP4A;CHMP4B
prerank,protein mannosylation (GO:0035268),-0.43994106070770866,-1.309352040189839,0.11349693251533742,0.6162845561434305,1.0,4/22,3.45%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4563112067110644,1.3092182372807242,0.12224938875305623,0.575785209864979,1.0,31/74,20.43%,EPAS1;NOTCH1;PSMD13;ELOC;PSMD4;UBA52;NFE2L2;RPS27A;PSMA5;RBX1;PSMB10;CUL2;PSMB8;HIF1AN;PSMD14;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;PSMB2
prerank,protein localization to plasma membrane (GO:0072659),0.4263089516943599,1.3084145464258468,0.07077625570776255,0.5771248422721459,1.0,26/129,10.33%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;RAB40B;CLASP2;NKD2;CCDC88A
prerank,peptidyl-tyrosine modification (GO:0018212),0.4620248925270936,1.3080465601502451,0.12899106002554278,0.5773184267138477,1.0,9/56,5.43%,TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES;TTL;FGFR3
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.42700726233305736,1.3075547349818912,0.10285714285714286,0.5777715092005236,1.0,17/116,11.03%,PLCG2;FYN;ADRB2;GPR39;FCGR2B;HRH2;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,negative regulation of chemotaxis (GO:0050922),0.5073425425286034,1.307480053957748,0.16905444126074498,0.5771143708929036,1.0,6/31,8.34%,SEMA3G;NOTCH1;SEMA3F;SEMA7A;DUSP3;SEMA6D
prerank,anion transmembrane transport (GO:0098656),-0.3473872526864763,-1.3071520438468416,0.06806282722513089,0.6203271740555026,1.0,14/67,8.37%,SLC1A3;SLC6A13;SLC16A12;SLC7A2;SLC13A4;SLC13A3;SLC25A13;SLC25A4;SFXN2;SLC39A8;SLC19A1;SLC6A9;LRRC8D;SLC27A1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4359371757386036,1.3065863173635557,0.10070257611241218,0.5788107857685102,1.0,18/100,9.21%,TEK;PDGFD;PIP5K1B;FLT1;CEACAM1;PDGFB;FBXL2;INSR;DAB2IP;F2RL1;TGFB2;CBL;PPP1R16B;PIP5K1C;MAPK1;JAK2;PPP2R5C;PTK2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.47999953294139397,1.306220256266303,0.12026143790849673,0.5789962985483984,1.0,11/48,15.93%,PRDM16;JMJD8;NUP54;NUP35;RANBP2;NUP153;NUP160;HIF1A;NUP42;EIF6;NUP205
prerank,oligodendrocyte differentiation (GO:0048709),0.5599518480775555,1.305812626009357,0.15919629057187018,0.5792243589583657,1.0,4/19,12.21%,SOX13;EIF2B2;SOX10;SOX6
prerank,basement membrane organization (GO:0071711),-0.5024703256951343,-1.3054376475380631,0.15206185567010308,0.6230348078846532,1.0,3/14,2.97%,FLRT2;NID1;NID2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5632574472588648,1.3049647771698283,0.17903225806451614,0.5807233000026597,1.0,8/18,19.35%,AOAH;MANBA;BPGM;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,embryonic hemopoiesis (GO:0035162),0.6000243293496628,1.3036689433808186,0.1774193548387097,0.5834238489874956,1.0,3/12,7.98%,KITLG;TAL1;TPO
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4363228656029908,1.3035560073168775,0.125,0.5828411471517105,1.0,39/87,25.82%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SRP9;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;SRP19;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,regulation of leukocyte activation (GO:0002694),0.601614086960319,1.302840058541026,0.20673076923076922,0.5839176052091236,1.0,4/14,8.02%,GPR137B;MFHAS1;PLSCR1;CD200
prerank,regulation of amyloid fibril formation (GO:1905906),0.5752871497437926,1.3018497567897829,0.16828478964401294,0.5859453192433421,1.0,6/15,11.83%,APP;IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5328778878488615,-1.3017377674744257,0.15365239294710328,0.6314827219998973,1.0,2/12,3.22%,B3GALT1;B3GNT2
prerank,regulation of macrophage migration (GO:1905521),0.6376404901790852,1.3009801730914172,0.18196994991652754,0.5874030066418559,1.0,7/10,24.93%,MTUS1;CD200;CX3CR1;CD200R1;P2RY12;EMILIN1;CSF1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4537101557588689,-1.300687268024022,0.1394658753709199,0.6320120555560014,1.0,6/22,5.55%,NTRK3;PDGFRB;FGFR2;PDGFRA;KIT;FGF2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5733578258732716,1.299798508627476,0.1755485893416928,0.5898213250978194,1.0,11/15,26.25%,CCT8;DKC1;CCT2;NHP2;CCT4;CCT6A;SHQ1;TCP1;CCT3;RUVBL1;RUVBL2
prerank,regulation of superoxide anion generation (GO:0032928),0.5939598713517295,1.2997356345091005,0.17004680187207488,0.5891160862295832,1.0,4/14,10.12%,F2RL1;ITGAM;AATF;TYROBP
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5200102517802099,-1.2996859570557364,0.15421686746987953,0.6321945299939615,1.0,6/13,16.04%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;PGM3
prerank,positive regulation of immune system process (GO:0002684),0.5753883954814264,1.2991563931268009,0.18818040435458788,0.5898897181086145,1.0,3/16,3.46%,TGFB2;LGALS9;TNFRSF18
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4309216987481304,-1.2987628682970715,0.15309446254071662,0.6324444735365894,1.0,4/26,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.46242701185453455,1.2985974217160299,0.1251646903820817,0.5905952170220471,1.0,8/56,4.11%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,regulation of microtubule polymerization (GO:0031113),0.4810242136505136,1.2982988972445844,0.15819209039548024,0.5906099206091098,1.0,12/40,15.30%,STMN2;OCLN;FES;CAMSAP2;PRUNE1;CLIP1;CLASP1;MAPRE3;RAC1;NUMA1;NAV3;MAP2
prerank,negative regulation of chemokine production (GO:0032682),0.6013765953205921,1.2981719316243538,0.1859706362153344,0.5900959764458815,1.0,3/14,3.83%,F2RL1;LGALS9;KLF4
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5745079139383709,1.2980365675232095,0.184,0.5896053812033342,1.0,4/17,5.65%,HDAC9;APOA1;PCSK5;FURIN
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5298739754591812,1.2978801885681088,0.17655571635311143,0.5892312213251287,1.0,12/26,15.85%,DAB2IP;IQGAP1;INPP5K;DUSP3;PTPN12;PDE8A;SYAP1;SNAI2;ZFP36L2;PLCG1;DUSP22;VIL1
prerank,positive regulation of ossification (GO:0045778),-0.3927828974455274,-1.2977188635734698,0.10580204778156997,0.632979306623991,1.0,10/39,3.64%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;WNT5A;FBN2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5177141658124379,-1.2974745682769242,0.15025906735751296,0.6311589974897064,1.0,7/13,21.11%,SEC16B;BCAP31;SAR1A;CD81;SEC16A;SAR1B;TM9SF4
prerank,SNARE complex assembly (GO:0035493),0.6227168758666077,1.2972071724801861,0.2131979695431472,0.5902088623132541,1.0,2/10,7.40%,STXBP6;VAMP8
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4862270133015095,1.296470864154719,0.15159944367176634,0.5914377850230904,1.0,4/38,5.48%,PTPRJ;INPP5K;HYAL2;PLEKHA1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.49605522381497436,1.2958064265146192,0.15289256198347106,0.5924022314886016,1.0,9/34,9.05%,DAB2IP;F2RL1;TLR3;NFKBIL1;MFHAS1;GRAMD4;NR1D1;ACOD1;CACTIN
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4644134937138237,1.2957867815675133,0.13654096228868662,0.5916107161357687,1.0,13/46,18.13%,PTPRR;CNKSR3;DAB2IP;TIMP3;DUSP3;PTPN1;RANBP9;ITGB1BP1;PIN1;DUSP26;PTPN2;SEMA6A;SMAD4
prerank,regulation of intracellular signal transduction (GO:1902531),0.3913999764714841,1.2952314081151473,0.02620967741935484,0.5922888161993568,1.0,63/420,10.68%,PLCG2;RASGRF2;SGMS1;NUAK1;ARHGEF3;TEK;PIP5K1B;ARHGAP31;KALRN;CEACAM1;VWF;PLK3;CHN2;FBXL2;CASTOR1;ARHGEF2;DAB2IP;ABR;F2RL1;RHOB;TRIO;BOP1;CRK;PPP1R13B;RBBP8;ARAP3;BCR;ING2;RRAS;ARHGAP8;MAP4K4;TRIM6;AKAP5;PPP1R16B;PLEKHG5;TRAF1;TAF9B;GPR143;SRGAP1;PIP5K1C;MAPK1;PAK1IP1;ARHGDIA;TIAM2;MCF2L;ARHGAP5;LRRK2;ARHGAP25;CMKLR1;HSPB1;PRKAA1;WWC2;INPP5B;SLC15A4;PPP2R5C;SGK1;TAOK2;ARHGEF1;DIPK2A;BRIP1;MINK1;NFKBIA;RAC1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5480431757760296,-1.2950964783056198,0.170316301703163,0.6358194151102964,1.0,2/11,4.31%,PID1;PRKN
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4577232894417643,1.294488981216187,0.1355081555834379,0.5935626452939134,1.0,18/59,12.61%,SBK1;PRKD1;OXSR1;CDC42BPA;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;PRKD2;MARK2;TTBK1
prerank,defense response to bacterium (GO:0042742),0.42697576852407576,1.2944368571096794,0.1047180667433832,0.592866556495453,1.0,29/105,21.23%,NOD1;NOD2;GBP4;ANXA3;TLR3;TIRAP;DEFA6;ADAM17;IRGM;GALP;OAS2;ADGRB1;GBP2;CHGA;RPL30;RNASE6;LYST;HMGB2;SLPI;DROSHA;STAB2;PYCARD;GBP7;EPX;ANG;ANKRD17;RPL39;STAB1;RPS19
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5609572894473157,1.294403948211869,0.1853582554517134,0.5921206195728441,1.0,11/18,25.81%,CCT8;CEP135;DKC1;CCT2;CCT4;CCT6A;CEP120;TCP1;CCT3;WRAP53;PTP4A3
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.49881098318838785,1.2938698910340354,0.14868804664723032,0.5928214676717021,1.0,9/35,11.35%,SEMA3G;PLXNA4;SEMA3F;PLXND1;SEMA7A;ARHGDIA;SEMA6D;RAC1;SEMA4G
prerank,cellular amino acid catabolic process (GO:0009063),0.4356693525554512,1.2937013464842642,0.1063321385902031,0.5924236484211968,1.0,8/87,7.36%,NOS1;NOS3;BCAT2;GLS2;GLS;ARG1;GLUD1;HGD
prerank,vesicle organization (GO:0016050),0.4728803299951797,1.2935193662772657,0.15918367346938775,0.5921057912613901,1.0,16/46,20.36%,ALS2CL;CAV1;CAV2;CD34;FNBP1L;SNX10;HOOK1;EXOC8;SNX11;CHMP2B;ZFYVE16;SRGN;PHETA1;HOOK2;SORT1;EPS15
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.40928005562985176,1.29328289597634,0.10624315443592552,0.5919448535567531,1.0,25/151,10.16%,TEK;PDGFD;RAPGEF2;PDGFB;FLT4;CCR1;NOTCH1;NOD2;F2RL1;LGALS9;APP;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;MFHAS1;PDE8A;ARRB1;THPO;HTR2A;HMGB1;FBXW7;CCL4
prerank,actin polymerization or depolymerization (GO:0008154),-0.37105452068737543,-1.2927535437310567,0.08571428571428572,0.6402736579078074,1.0,11/50,8.28%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;WASF1;SVIL;WASHC3;PREX1;VILL
prerank,regulation of Ras protein signal transduction (GO:0046578),0.43187100047416194,1.2925019491092036,0.10710128055878929,0.5932623542797544,1.0,14/86,8.22%,EPS8L2;ARHGEF28;DENND3;NOTCH1;RAPGEF1;ARHGEF2;DAB2IP;TGFB2;BCR;ARHGDIA;MADD;SHOC2;STK19;JAK2
prerank,Golgi ribbon formation (GO:0090161),-0.5124293881785187,-1.2910832604403508,0.14470284237726097,0.643085157313163,1.0,6/13,17.88%,TRIP11;GOLGA2;GCC2;OPTN;STX16;FHDC1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.535921812754687,1.2909703108936168,0.1878698224852071,0.5967700252059043,1.0,4/22,8.29%,CEACAM1;PDE3B;ALK;PRKAA1
prerank,glycoprotein biosynthetic process (GO:0009101),0.4385686217270921,1.2908869352534011,0.12014563106796117,0.5961513721660052,1.0,11/79,8.01%,GCNT1;ST8SIA6;BMPR2;ST3GAL6;ST6GALNAC2;SERP2;ATP7A;GCNT2;CHST11;NUS1;B3GNT3
prerank,calcium ion transport into cytosol (GO:0060402),0.5386065765844537,1.2904396454990577,0.18330849478390462,0.596489536897473,1.0,7/21,11.28%,TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;TRPM2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6114719634819272,1.2902194996187637,0.1910828025477707,0.5962738382709828,1.0,4/12,11.17%,AMD1;ATP7A;MAOA;SMS
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3378321417100292,-1.2896238201525172,0.05851063829787234,0.6452243093972015,1.0,22/82,11.10%,RANBP3L;BMP6;IGF1;BMPR1A;SMOC1;FGFR2;WNT4;BMP7;DDX5;BMP4;TMEM64;LIMD1;FBN2;RUNX2;NOCT;IL6R;ATP6AP1;PRKACA;PTCH1;PPARG;REST;IFITM1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.42242421483640646,1.2894965857977239,0.10730593607305935,0.5974085831282422,1.0,17/117,11.03%,PLCG2;FYN;ADRB2;GPR39;HRH2;KARS1;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4719172662650901,-1.288743815271105,0.14985590778097982,0.6452719809158791,1.0,10/17,27.89%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29;TOR1A;STX2;STX1A;SYNGR1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5713371820179074,1.2887266087144507,0.19903691813804172,0.5987130820666277,1.0,2/15,1.73%,GBP5;NOD2
prerank,regulation of JUN kinase activity (GO:0043506),0.49102028583897644,1.2885868736366342,0.1773049645390071,0.5982757929601951,1.0,5/33,10.36%,EDN1;DAB2IP;PDCD4;MAP3K11;AIDA
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6023167036339846,1.2884707897510093,0.18433931484502447,0.5977068567218465,1.0,7/13,19.12%,CAV1;SLC8A1;CAMK2D;CALM3;PDE4D;ANK3;IRX3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4951717521006867,1.2881013846615599,0.18059299191374664,0.5978523074212028,1.0,9/33,13.57%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4988209414031459,1.2880692809293384,0.16355810616929697,0.5971107575969549,1.0,8/32,9.92%,STMN2;ARHGEF2;FKBP4;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5231387438373735,1.287983160767471,0.1648,0.5965429893419849,1.0,5/24,13.37%,TRPV4;STMN2;KIF2A;PIN1;KIF24
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6168439892609605,1.2878063559542383,0.19738988580750408,0.5962326183033307,1.0,4/11,8.02%,GATA6;LGALS9;CD34;CD200
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.39803428822662096,1.2872941704120389,0.060542797494780795,0.5968425193013069,1.0,42/234,12.80%,PLCG2;EDN1;TRIM14;RPS6KA5;NOD1;NEUROG2;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;ANXA3;TIRAP;TRIM6;TRAF1;IRAK2;ALK;FANK1;IL1RAP;MBTPS2;HSPA1B;CD200;UBA52;RPS27A;TCF3;DHX9;TRIM25;NFKBIB;RHEBL1;NFKBIA;TAB2;CRTC1;NPM1;CLU;PRKD2;ARID5B;TRIM8;BTK;CX3CR1;RTKN2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5128823678376365,-1.287086195542711,0.16995073891625614,0.6479424819787858,1.0,2/13,3.22%,B3GALT1;B3GNT2
prerank,odontogenesis (GO:0042476),-0.4080744893372447,-1.286893254106426,0.11538461538461539,0.6459098050962357,1.0,7/35,2.71%,COL1A2;GLI2;FGFR2;EDA;BMP4;OSR1;WNT6
prerank,regulation of interleukin-13 production (GO:0032656),0.5947398205392327,1.2866531319667913,0.19425675675675674,0.597795564981145,1.0,3/13,6.03%,LGALS9;LEF1;GATA3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5110473285978812,-1.2864429680084117,0.16957605985037408,0.6448361839998381,1.0,7/13,19.56%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;SNX5;ZBTB7B
prerank,response to alcohol (GO:0097305),-0.42293517003441994,-1.2863681776016198,0.14759036144578314,0.6424482227082998,1.0,3/27,1.90%,TGFBR3;TGFBR1;SLIT2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5763939996041777,1.285505348960573,0.1935483870967742,0.6000100122179111,1.0,2/13,1.77%,SPAAR;CASTOR1
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4217933797759801,-1.2851901137787554,0.13636363636363635,0.6433909332457555,1.0,11/29,14.08%,TCF7L2;CREBBP;PYGO1;BCL9;ASH2L;TLE1;PYGO2;TLE2;HDAC1;AXIN2;TERT
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5292825356107538,1.2848750017117296,0.18621700879765396,0.6009295096871868,1.0,4/22,4.34%,STMN2;RAPGEF2;RAPGEF1;EHD1
prerank,negative regulation of inflammatory response (GO:0050728),0.4050158973823419,1.2847144385673774,0.07857911733046287,0.6005747566374524,1.0,29/182,11.41%,PLCG2;TEK;FYN;AOAH;ADRB2;APOA1;GPR39;KLF4;HRH2;IAPP;FURIN;TNFRSF1B;GATA3;FCGR1A;MYH9;ADAM17;CD247;MFHAS1;MC4R;CD200;PROC;NR1D1;ACOD1;YES1;LPCAT3;ADCY4;PLCG1;GLP1R;VPS35
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.521897700889118,1.2844977761267553,0.16467065868263472,0.6003352897919132,1.0,2/26,0.49%,GCNT1;ST8SIA6
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4310582759557037,-1.2843990215020336,0.1437308868501529,0.6431638110937582,1.0,8/25,12.33%,ERRFI1;CBLB;PPARA;SNX6;SLC6A9;TSG101;PPARG;CNRIP1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5937296432372319,1.284102774702568,0.1812191103789127,0.6005892945522997,1.0,4/12,17.28%,CEACAM1;BRCA1;ERLIN2;TRIB3
prerank,oligosaccharide metabolic process (GO:0009311),0.47074298877938636,1.2835418746849794,0.18319559228650137,0.6013430843013093,1.0,5/46,5.90%,ST6GALNAC3;ST8SIA6;ST3GAL6;MANBA;ST6GAL2
prerank,positive regulation of ion transport (GO:0043270),0.4651936895175518,1.2835081674736994,0.15240641711229946,0.6005981996247612,1.0,12/48,10.16%,CNKSR3;CCR1;MYLK;ANO6;ORAI1;STIM2;P2RX7;VAMP8;CRACR2A;VAMP7;SCN1B;CCL4
prerank,keratinocyte differentiation (GO:0030216),0.5138582012567307,1.2821074373909982,0.16855524079320114,0.6036111789232828,1.0,3/29,4.02%,JAG1;CLIC4;BCR
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5141730186983582,-1.2817202129329268,0.16666666666666666,0.6487883703899098,1.0,5/14,13.86%,CPEB1;UNK;YBX3;CPEB2;CPEB3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4564164614557533,-1.2814545450616064,0.16056338028169015,0.6470525649932842,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,regulation of response to interferon-gamma (GO:0060330),0.581731392526753,1.2813345972966577,0.20952380952380953,0.6048741924512865,1.0,3/14,8.22%,IFNGR1;STAT1;JAK2
prerank,regulation of viral entry into host cell (GO:0046596),0.5105034475496867,1.2812013926742927,0.17837078651685392,0.6044566118418969,1.0,7/30,11.57%,TRIM14;LY6E;LGALS9;TRIM11;TRIM6;TRIM25;HS3ST5
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.43986804356839,1.281070634290152,0.13583441138421734,0.6040070290889308,1.0,16/67,13.12%,PODXL;RABGAP1;CAV1;PPP1R16B;TBC1D8;PLD1;IFT140;TBC1D5;TBC1D1;MYO10;RAC1;TRPM2;ATP8B1;FXR1;USP6NL;TBC1D10A
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5522586417242658,1.2808726621940645,0.18558282208588958,0.6037393027946429,1.0,6/19,9.89%,NOTCH4;NOTCH1;PPM1F;PTPRU;TJP1;MAD2L2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5072968560179278,1.279891892373365,0.18435754189944134,0.6055874063571284,1.0,6/32,4.97%,ACER2;JAG1;ACVRL1;FAM107A;ADAM15;MAP4K4
prerank,regulation of potassium ion transport (GO:0043266),0.49518543925197467,1.2795211694841033,0.1685878962536023,0.6058009434100703,1.0,3/31,4.87%,NOS1;DPP6;DPP10
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4515846961088025,-1.2786036530747116,0.15141955835962145,0.653298314843739,1.0,7/19,20.45%,CUX1;OBSL1;DBN1;PTPRD;FBXW8;SS18L2;CUX2
prerank,regulation of cytokine production (GO:0001817),0.4182383473629526,1.2785152657165657,0.10822998872604284,0.607736012832379,1.0,19/126,10.87%,AFAP1L2;RPS6KA5;CRTAM;CASP8;IFIH1;LGALS9;CADM1;HDAC9;FCGR2B;TNFRSF1B;GATA3;BCL6B;IL1A;CD47;SNAI2;GAPDH;FOXP1;LURAP1;POLA1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.6043144364690833,1.2784122214897033,0.20033670033670034,0.6072013784670801,1.0,3/11,3.53%,ITPKB;IP6K3;IPPK
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4889786100208974,1.2775085922053628,0.17847025495750707,0.6088965052993781,1.0,11/32,14.60%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.505232374910877,1.2773829341980947,0.18328445747800587,0.6083713221800116,1.0,3/30,1.04%,FLT1;FLT4;ACE
prerank,protein catabolic process (GO:0030163),0.4545883178303859,1.2767320604239591,0.16429495472186287,0.6093240911251361,1.0,18/59,19.79%,CEACAM1;DENND3;DAB2IP;PPT1;MANBA;TRIM24;SOCS6;NR1D1;SIAH2;BAG6;PSMA8;FBXO2;OGA;FBXO6;LAMP2;NGLY1;NEU4;RNF5
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4922859666985406,1.276079299161631,0.1763085399449036,0.6102906676381149,1.0,3/31,3.73%,SYT15;DOC2B;SYT7
prerank,sulfation (GO:0051923),-0.5270221551086542,-1.2756399063918429,0.21052631578947367,0.65958978773912,1.0,1/11,0.05%,UST
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.4152981013825568,-1.275625794361676,0.12460063897763578,0.65704722730036,1.0,9/27,12.28%,DCN;CHST15;BGN;PXYLP1;XYLT1;VCAN;B3GAT3;CHPF2;CSPG4
prerank,ear morphogenesis (GO:0042471),-0.45332364517765167,-1.2754951963658219,0.14492753623188406,0.6548251646226126,1.0,5/20,7.10%,ZIC1;FGFR2;OSR1;NIPBL;SIX1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4867995174529858,-1.2754805829683147,0.16752577319587628,0.6523357587736943,1.0,6/16,15.36%,PDK1;PRKN;RORA;FOXK2;PDK3;PDK2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5149629561500272,-1.2754078787789918,0.17525773195876287,0.6500408797930123,1.0,7/13,21.11%,GCC2;SEC16B;SAR1A;CD81;SEC16A;SAR1B;TM9SF4
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6103828600767586,1.274924421003765,0.19185059422750425,0.6126686477904394,1.0,4/11,6.03%,JAG1;TGFB2;HEY2;GATA3
prerank,dendritic cell chemotaxis (GO:0002407),0.5767797928477264,1.2748907725269925,0.1910828025477707,0.6119398838579032,1.0,4/14,14.74%,CCR1;HMGB1;TRPM2;CXCR4
prerank,O-glycan processing (GO:0016266),0.45648599671895956,1.273842236855485,0.15274151436031333,0.6139628499480204,1.0,11/54,13.79%,GCNT1;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;B3GNT3;C1GALT1C1;XXYLT1;GALNT4;ST3GAL1
prerank,regulation of monooxygenase activity (GO:0032768),0.5299230248433331,1.2737688889383454,0.18385650224215247,0.613345559513161,1.0,4/23,6.22%,NOS3;CAV1;NOS1AP;IL1A
prerank,actomyosin structure organization (GO:0031032),0.43784604080083284,1.2737656914133548,0.15403128760529483,0.6125429330897441,1.0,16/75,9.21%,EPB41L4A;FRMD3;F11R;ZYX;CDC42BPA;FLII;CDC42BPG;EPB41;CSRP2;MYH9;CUL3;WDR1;ARRB1;CASQ1;ROCK1;TJP1
prerank,negative regulation of cell population proliferation (GO:0008285),0.3855050527007292,1.272909891555278,0.047764227642276426,0.6141145225322749,1.0,44/351,9.03%,PTPRJ;CDH13;NOS3;IRF6;GATA6;RAPGEF2;GATA2;SMAD6;BMPR2;SMARCA2;PTPN14;FOXO4;ITGA1;ACVRL1;NOTCH1;B2M;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;BTG2;DLL4;APP;BTG1;PLPP1;KLF4;GATA3;WARS1;IL1A;SH3BP4;SLC16A2;IGFBP7;HSPA1B;CEBPA;PTPRU;CD200;JAK2;APC;NMI;MCC;KLF11;CTNNBIP1;PPP2R5C
prerank,calcium ion import (GO:0070509),0.5057695996254552,1.2725440303273572,0.18573551263001487,0.6143359818098059,1.0,6/28,8.36%,TRPV4;CACNA1A;MCUB;SLC8A1;SMDT1;MCUR1
prerank,regulation of steroid metabolic process (GO:0019218),-0.43604867709142686,-1.2722992248988279,0.1484848484848485,0.6567923658909137,1.0,10/23,28.73%,APOE;RORA;EPHX2;STUB1;PANK2;ACADVL;NR1H4;STAR;ABCG1;ARV1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.48904555691443236,1.272149383383406,0.1859504132231405,0.61460948467598,1.0,6/36,9.67%,EDN1;ADRB2;SHANK3;ADAM17;JAK2;FBXW7
prerank,positive regulation of calcium ion transport (GO:0051928),0.48410256472602337,1.271992522384685,0.18246110325318246,0.6142622910480463,1.0,9/36,10.16%,PDGFB;CCR1;MYLK;CAV1;ORAI1;STIM2;P2RX7;CRACR2A;CCL4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5344597062425558,1.2716850504734947,0.1897810218978102,0.614290198995599,1.0,4/21,7.25%,CD2AP;DAB2IP;TGFB2;ARHGAP25
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6078603069737175,1.271376509410809,0.2,0.614363735500985,1.0,2/11,1.73%,MERTK;NOD2
prerank,negative regulation of phosphorylation (GO:0042326),-0.3220392926403626,-1.27100279625736,0.09497206703910614,0.6585546040043753,1.0,15/85,7.26%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;NUPR1;SLIT2;BMP4;PPARA;PRKN;NIBAN1;IRS2;XDH;IGFBP3
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.5323190365265786,-1.269846337300287,0.18779342723004694,0.6596618246587516,1.0,2/11,1.60%,WNT4;BMP5
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.5264259059602187,-1.269701605389647,0.19651741293532338,0.6575319379101149,1.0,9/12,41.86%,GOLGA2;CDC14B;FZR1;BTRC;GORASP1;PLK1;CDC20;UBE2C;RAB1A
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6008470464955118,1.2696626384665455,0.22241992882562278,0.6183153078701208,1.0,2/10,2.28%,ENG;CAV1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6158223190589831,1.2695616548882085,0.1891891891891892,0.6177398259913067,1.0,8/10,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,iron ion transmembrane transport (GO:0034755),-0.5448333889149697,-1.2694916933073606,0.1945080091533181,0.6557475167965645,1.0,3/10,4.83%,SLC39A14;SCARA5;SLC39A8
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5177946579069455,1.269387528366219,0.1783625730994152,0.6174015037869527,1.0,6/26,8.27%,FYN;FBXO7;LRRK2;HSPB1;PDE8A;NFE2L2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5039633120139383,1.2691916624584003,0.18867924528301888,0.6171202315611459,1.0,6/33,9.21%,ACER2;TGFB2;PDE3B;EFNA1;SNAI2;PTK2
prerank,response to interleukin-4 (GO:0070670),0.6266009748708519,1.267684513511152,0.20132013201320131,0.6204090831507705,1.0,2/10,6.03%,LEF1;GATA3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3909858773366624,1.2675284645269869,0.08253968253968254,0.6199645668794304,1.0,34/214,10.95%,TEK;PDGFD;RAPGEF2;PTPRR;CEACAM1;PDGFB;CNKSR3;FLT4;CCR1;NOTCH1;NOD2;DAB2IP;F2RL1;LGALS9;APP;TIRAP;TIMP3;RRAS;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;DUSP3;MFHAS1;PDE8A;ARRB1;THPO;HTR2A;HMGB1;FBXW7;CCL4;PTPN1;RANBP9
prerank,muscle cell development (GO:0055001),0.48684648245773143,1.2674191059525575,0.1797432239657632,0.6194453022915114,1.0,6/30,4.18%,ENG;NEBL;DYSF;HEY2;SLC8A1;ALPK3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.41926704301529505,-1.2672146708920233,0.13114754098360656,0.6604107209619519,1.0,4/26,4.62%,ANK2;ACTN2;ATP1B3;FHL1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4671218455530989,1.2671396296168391,0.1723684210526316,0.6194674182092603,1.0,9/47,11.05%,PLCG2;PDGFB;F2RL1;ZC3H12A;ITGAM;ACOD1;TYROBP;ADGRB1;CYBA
prerank,presynapse organization (GO:0099172),-0.5553124294096399,-1.2668577633220084,0.1776765375854214,0.6590973847361682,1.0,2/10,4.01%,WNT5A;NLGN2
prerank,regulation of gluconeogenesis (GO:0006111),-0.40687133360588634,-1.2667813863799062,0.12460063897763578,0.6568640322765138,1.0,7/27,16.52%,OGT;C1QTNF3;ZNF692;PDK2;SIK1;CLK2;NNMT
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.4762704845143622,-1.2662967841719557,0.2009685230024213,0.65584407660897,1.0,6/15,17.33%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;AMDHD2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.465145170329263,-1.2662414379475295,0.1752021563342318,0.6535891461656671,1.0,5/17,12.36%,BMP6;SASH1;CD55;PRKCA;CD180
prerank,rRNA metabolic process (GO:0016072),0.4041118881824336,1.265497666457267,0.111358574610245,0.6232885745684578,1.0,68/160,26.73%,BOP1;PELP1;RPL27;DHX37;RPL7;TRIR;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;WDR46;RPL21;DKC1;RPL37;RPS28;RPL34;RPS9;XRN2;EXOSC8;RPLP2;RPS25;RPL30;XRN1;RPL27A;NOL8;RPL23A;RPS15;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.486368851211055,1.2654379819318282,0.1568627450980392,0.6226409723375519,1.0,7/36,7.60%,NOS3;ATP2B4;CAV1;GCH1;NOS1AP;IL1A;NUS1
prerank,integrin-mediated signaling pathway (GO:0007229),0.4316126858739973,1.2651645488969634,0.16136919315403422,0.6225780115925075,1.0,13/73,6.80%,LAMA3;CEACAM1;ZYX;PRKD1;NEDD9;APOA1;LAMA5;ADAM15;DST;SEMA7A;MYH9;CUL3;CD47
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.37601105803294027,-1.2647089802198943,0.12062256809338522,0.65585550455258,1.0,19/40,27.19%,NUCKS1;BOD1L1;FBH1;TIPIN;ATR;THOC1;RTEL1;DONSON;SMARCAL1;RFWD3;ATRX;TIMELESS;ZRANB3;MMS22L;EME2;SETMAR;RAD51;POLE;CENPX
prerank,T cell homeostasis (GO:0043029),0.597754888380763,1.2641197551512435,0.21774193548387097,0.6246322716705889,1.0,1/10,1.17%,FAS
prerank,regulation of platelet activation (GO:0010543),0.5398446565929996,1.26405576719414,0.19411764705882353,0.6240039496558636,1.0,2/21,0.88%,NOS3;PDGFB
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5951562146768162,1.263880086936103,0.2197092084006462,0.6237005929618957,1.0,3/12,3.73%,UNC13B;DOC2B;SYT7
prerank,peptidyl-threonine modification (GO:0018210),0.43931920647888106,1.2638285329310897,0.15298507462686567,0.6230237107205772,1.0,19/66,12.61%,SBK1;PRKD1;OXSR1;CDC42BPA;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;PRKD2;GALNT4;MARK2;TTBK1
prerank,bicarbonate transport (GO:0015701),-0.4225410460638841,-1.2633155647780019,0.14626865671641792,0.6576310312866162,1.0,10/25,22.64%,SLC4A10;SLC26A7;CA2;SLC39A8;SLC4A2;SLC4A3;SLC26A6;CYB5RL;SLC4A8;CFTR
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3721881074323555,-1.2629991427648404,0.12403100775193798,0.6561402375946808,1.0,15/41,23.06%,ACSL1;PTGS1;PLA2G4A;SCP2;DEGS1;FADS3;SCD;GSTM2;FADS2;ELOVL1;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5354403418282967,-1.262827337257722,0.1875,0.6542994292971146,1.0,5/10,21.92%,PFKP;HK2;GFPT1;GFPT2;PFKL
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4712134706952287,-1.2628171733253248,0.14882506527415143,0.6519361549030521,1.0,7/16,5.55%,TGFBR3;IGF1;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2
prerank,regulation of neuron death (GO:1901214),0.42936267274179174,1.262368035204395,0.14441747572815533,0.6261645257435904,1.0,30/82,21.60%,FYN;SNCG;FCGR2B;LANCL1;MEF2C;CD34;TNFRSF1B;ITGAM;LRRK2;CD200;GRIN2B;EGR1;PRNP;RRAS2;TYROBP;DCC;VPS35;CLU;CHGA;TRIM2;SARM1;EIF2S1;DAXX;GRID2;NENF;GSK3B;CD200R1;SORL1;AKT1S1;UBB
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4954967695624365,1.2620993866480623,0.1935933147632312,0.6260961755516977,1.0,12/33,18.10%,TAL1;FES;STAT1;HSPA1B;THPO;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5387017996091479,-1.2615606284304708,0.18925831202046037,0.6532926168274317,1.0,2/10,2.27%,ATP1A2;OSR1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5760767114247438,1.2614499192540845,0.22464898595943839,0.6270612466960306,1.0,7/14,22.66%,BOP1;RPL7;RPL35;RPL7L1;FTSJ3;URB1;RPF2
prerank,plasma membrane repair (GO:0001778),0.5837556081311577,1.2614036343695876,0.22632423756019263,0.6263861430119386,1.0,4/13,10.34%,DYSF;SYT7;MYH9;MYOF
prerank,cellular response to cytokine stimulus (GO:0071345),0.38021591714763964,1.261321004995354,0.048830111902339775,0.6258031371672247,1.0,65/416,9.64%,PTPRJ;S1PR1;NPR2;FYN;VCAM1;PTPN14;CCR1;LIFR;GBP5;ST3GAL6;RAPGEF1;FOXO1;ARHGEF2;DUSP1;AIM2;MMP1;INPP5D;DAB2IP;IFNGR1;CBL;LGALS9;VIM;OXSR1;CSF2RB;GBP4;CRK;INPP5K;LAMA5;MAOA;LEF1;TRIM6;HYAL2;LRCH1;TNFRSF1B;IFNAR1;IRAK2;ASAH2;GBP3;GATA3;IL1A;CD47;IRGM;ZC3H12A;ITGAM;IL1RAP;SOCS6;STAT1;PTPN12;IL20RB;HSP90B1;MT2A;CEBPA;BCL2L1;UBA52;JAK2;NFE2L2;STK39;RPS27A;NR1D1;ACOD1;GAPDH;CACTIN;ZFP36L2;EGR1;DHX9
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.40580505597287714,1.2612414403220638,0.1291759465478842,0.6252059401412163,1.0,20/140,7.25%,RASGRF2;ARHGEF3;CD2AP;ARHGAP31;KALRN;CHN2;ARHGEF2;ABR;RHOB;TRIO;ARAP3;BCR;ARHGAP8;PLEKHG5;SRGAP1;ARHGDIA;TIAM2;MCF2L;ARHGAP5;ARHGAP25
prerank,regulation of chemokine production (GO:0032642),0.49424219303703515,1.2607010331869521,0.1804949053857351,0.6258497989190918,1.0,13/36,20.88%,F2RL1;LGALS9;APP;TLR3;ADAM17;SNAI2;FOXP1;EGR1;HIF1A;PYCARD;AGER;SIGIRR;EIF2AK2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.602463411146121,1.2605574024760415,0.205685618729097,0.6254784429543414,1.0,8/11,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.40172377306117824,1.2601809124586563,0.11234705228031146,0.6257021071566463,1.0,17/150,9.49%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;ANGPT1;GCNT2;FGFR3;IAPP;GATA3;MFHAS1;THPO;PTK2;RTN4
prerank,lipid modification (GO:0030258),0.4804082802200491,1.2598330223674632,0.19456366237482117,0.6258627446898485,1.0,9/37,15.81%,SGPP2;PLPP1;MBOAT2;DGKH;LPCAT3;PLPP6;PLPP4;DGKI;PLPPR1
prerank,regulation of cell differentiation (GO:0045595),0.40083139658475525,1.2595483685499742,0.11594202898550725,0.625863139520236,1.0,28/148,13.00%,SLC6A6;LTBP4;NOTCH4;SMAD7;CASZ1;TBX1;HEY1;EMP2;FES;HEY2;KLF4;SPOCK2;MBOAT2;GATA3;BCL6B;CLASP1;ALK;APC;NR1D1;SNAI2;ROCK1;PTK2;CLASP2;RPS6KA1;MCRIP1;CBFB;RPS6KA3;YWHAH
prerank,histone H4-K5 acetylation (GO:0043981),-0.48549722187881106,-1.2592121552680817,0.17746478873239438,0.655536734945584,1.0,5/15,11.08%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),-0.48549722187881106,-1.2592121552680817,0.17746478873239438,0.655536734945584,1.0,5/15,11.08%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.489509220324896,1.2592012151834142,0.16738197424892703,0.6260413292132927,1.0,2/33,1.78%,PLCG2;ATP2B4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5234138939438278,1.259012897259581,0.1906906906906907,0.6257809743062006,1.0,7/24,13.57%,KLF2;NOTCH1;MBTPS2;NFE2L2;CHD6;GCN1;HIF1A
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.502729366783062,1.2588855125550422,0.20694645441389292,0.6253258186862387,1.0,8/28,19.18%,ATP2A3;DAB2IP;BBC3;BAG6;TRIB3;SELENOK;DNAJC10;ERN1
prerank,cellular response to estrogen stimulus (GO:0071391),0.5756620893098275,1.258798483383415,0.24149108589951376,0.6247645186034156,1.0,7/14,19.36%,PELP1;TRIM24;NCOA4;ARID5A;SFR1;RARA;WBP2
prerank,melanosome transport (GO:0032402),0.5496094625879329,1.25877756147155,0.22518518518518518,0.6232322569974852,1.0,4/18,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,pigment granule transport (GO:0051904),0.5496094625879329,1.25877756147155,0.22518518518518518,0.6232322569974852,1.0,4/18,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5065778708264406,1.2585390810373374,0.1828410689170183,0.6230865902749104,1.0,3/27,4.95%,NOS1;FKBP1A;CAMK2D
prerank,positive regulation of cytokine production (GO:0001819),0.3874712738354905,1.2581247607527113,0.07395833333333333,0.6234609443407152,1.0,41/292,11.99%,PLCG2;AFAP1L2;PLCB1;FLT4;NOD1;CRTAM;GBP5;NOD2;PAEP;ARHGEF2;F2RL1;IFIH1;LRRFIP1;LGALS9;CADM1;APP;TLR3;TIRAP;TRIM6;HYAL2;DDX41;CD34;TMED10;GATA3;IL1A;ADAM17;HSPA1B;CD200;POLR3B;GAPDH;LTB;FOXP1;EGR1;HMGB1;DHX9;TYROBP;LURAP1;CYBA;LAPTM5;BRCA1;PRKD2
prerank,cartilage development (GO:0051216),-0.37779620793441837,-1.258031939580427,0.13302752293577982,0.6567474588937429,1.0,17/49,13.29%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;TRIP11;RUNX2;ITGB8;FGF2;RUNX1;CCN3;GPLD1;HYAL1;PKD1;NFIB;HMGA2
prerank,protein destabilization (GO:0031648),0.49766186211656627,1.2579052694475998,0.19498607242339833,0.6232960873467918,1.0,6/32,9.97%,SOX17;CCDC88C;CUL3;IRGM;NR1D1;PRNP
prerank,cellular response to estradiol stimulus (GO:0071392),-0.44798467869682024,-1.2576479131809992,0.17663817663817663,0.6555950097975666,1.0,3/18,9.66%,EGFR;LCOR;CCDC62
prerank,regulation of neurotransmitter transport (GO:0051588),0.561072308831458,1.2574011104205025,0.22488038277511962,0.6238527010222699,1.0,4/16,16.46%,MCTP1;MEF2C;SNCAIP;CPLX1
prerank,regulation of fibrinolysis (GO:0051917),-0.4930142085549428,-1.2571699057672765,0.19109947643979058,0.6545991478627566,1.0,4/13,17.39%,THBS1;FAP;SERPINE1;THBD
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5389800296689431,1.2570488075865138,0.1935483870967742,0.6240388676417841,1.0,12/18,26.25%,CCT8;DKC1;CCT2;NHP2;CCT4;CCT6A;SHQ1;EXOSC10;TCP1;CCT3;RUVBL1;RUVBL2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4175460177037422,1.2567399354144118,0.15133876600698487,0.6241093847076501,1.0,20/95,10.37%,NOD2;DAB2IP;VIM;TIRAP;DEFA6;FCGR2B;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.504128117063978,-1.2566227249943673,0.1942257217847769,0.6539438450858086,1.0,2/13,2.18%,GLI2;BMP4
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5234264564423272,-1.2552374693730353,0.22113022113022113,0.6556980004934184,1.0,5/11,18.19%,PDPN;RREB1;SRC;ARPIN;ENPP2
prerank,positive regulation of programmed cell death (GO:0043068),0.3873293575403304,1.254777729151418,0.08446298227320125,0.6287555594528635,1.0,40/272,9.55%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;RHOB;TRIO;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;TNFSF10;PLEKHG5;IAPP;STPG1;RYBP;TIAM2;MCF2L;FANK1;CRADD;LRRK2;GADD45G;UBA52;APC;RPS27A;KLF11;APH1A;JUN;HMGB1;MAP3K11
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5560945118365854,1.2542530709057016,0.22508038585209003,0.6294888828412228,1.0,3/15,11.98%,SMAD7;MAD2L2;DTX3L
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3776743035194928,1.2538511895188107,0.030181086519114688,0.6298442520386686,1.0,80/476,14.62%,PRDM16;NOS1;MECOM;SOX17;NOTCH4;AFAP1L2;IRF6;GATA6;PLCB1;PDGFB;KLF2;SMARCA2;CASZ1;TBX1;ACVRL1;NOTCH1;FOXO1;HEY1;TAL1;HNF1A;HNF4A;KLF6;SOX18;HHEX;FLI1;INPP5K;HEY2;KLF4;ACVR1;ING2;LEF1;KARS1;FOXF2;MEF2C;SMAD2;ZBTB48;GATA3;RYBP;ZBTB16;FANK1;KDM3A;STAT1;MAPRE3;EBF3;DNAJC2;KMT2E;NR1D1;KMT2B;JUN;SERTAD3;TCF3;EGR1;SEC14L2;MAD2L2;RPS6KA1;SFR1;DEAF1;RAI1;NPM1;BRCA1;CD38;ILF2;DTX3L;SOX10;HINFP;MED30;SETD3;ELF2;YWHAH;PHIP;HIF1A;NFATC1;LRP5;SMARCC1;CTNNB1;MED17;MLLT3;MED4;HMGB2;PSMC5
prerank,protein O-linked glycosylation (GO:0006493),0.4158272248009804,1.2536489730353408,0.1497076023391813,0.6295862456559634,1.0,17/96,12.68%,EOGT;GCNT1;ST8SIA6;GALNT18;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;POGLUT1;B3GNT3;DPM1;TET3;C1GALT1C1;XXYLT1;GALNT4;B3GALNT2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4093582752969271,1.253247970583477,0.13097949886104784,0.6298668401478744,1.0,24/112,9.31%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;NLK;MEF2C;HYAL2;SMAD2;FURIN;UBA52;RPS27A;JUN;PTK2;ZFP36L2
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.4773482894399617,-1.2529135373197886,0.17553191489361702,0.6602286305370666,1.0,7/16,25.40%,CREBBP;KAT2B;NAA60;NAA40;NAA50;NAA10;NAA15
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4360601432455468,1.2527321525537016,0.17726161369193155,0.6305074599162113,1.0,8/73,6.98%,NOS1;ATP2B4;CAV1;PRKD1;APP;TRIM6;BCAR3;IRGM
prerank,protein localization to centrosome (GO:0071539),0.5331325006461671,1.2524888248486363,0.22012578616352202,0.6303663014111771,1.0,8/17,20.15%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83;NUDCD3;CEP192
prerank,negative regulation of hormone secretion (GO:0046888),-0.5393842227227482,-1.2522519923013626,0.2230769230769231,0.659788330484617,1.0,2/10,8.74%,GJA1;RAB11FIP1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5466494240128675,1.2519304378753582,0.23113207547169812,0.6311149267599263,1.0,4/17,9.44%,NOD2;ARL6IP5;TGFB2;TAOK2
prerank,histone H4-K16 acetylation (GO:0043984),-0.45910791823323993,-1.251277480153869,0.1566265060240964,0.6603205449000346,1.0,6/19,13.65%,OGT;KANSL2;PHF20;WDR5;MEAF6;MSL3
prerank,regulation of ion transmembrane transport (GO:0034765),0.47942838243590835,1.250468514173958,0.19647696476964768,0.634439338618357,1.0,4/33,6.78%,KCNQ1;ANO6;CHRM3;P2RX7
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.48225905684055137,1.2501132210052839,0.22507122507122507,0.6346072434714042,1.0,5/30,5.38%,LTBP4;ENG;SMAD7;FKBP1A;SMAD2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.564802066664436,1.2500352095214036,0.2146341463414634,0.6340186317021033,1.0,7/14,16.50%,DUSP1;PPM1F;PPP3CA;PPP2R2C;PPP1R15B;PPP2CB;NCK1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2925242504538883,-1.2494696362090827,0.04081632653061224,0.6635951441539073,1.0,43/152,17.21%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;SULF1;GPC3;PTK7;SULF2;RSPO3;ZEB2;WNK1;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;SFRP4;DAAM2;PSMF1;LYPD6;RSPO2;PPM1A;PSMB3;SALL1;NFKB1;CSNK1G2;AXIN2;DDX3X;TERT;PPM1B;PSMA3;PSMB4;PSMC4;USP8;ZRANB1;PSMB7;GID8;AMER1;PSMD12;USP34
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5300628428181502,-1.249395670220646,0.21377672209026127,0.6614983884006259,1.0,3/10,4.72%,VTN;PRKCB;GRB10
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3757226748944638,1.2491140684247295,0.022155085599194362,0.6356301442730166,1.0,91/532,13.97%,PTPRJ;IRF6;ADIPOR2;S1PR1;CEACAM1;PLCB1;PDGFB;FYN;VCAM1;RPS6KA5;NOD1;CCR1;LIFR;NOD2;B2M;RAPGEF1;FOXO1;GSTA2;AIM2;MMP1;INPP5D;IRF2;IFNGR1;CBL;VIM;CSF2RB;CRK;ACTN4;TNFRSF18;CISH;PSMD13;LAMA5;MSN;MAOA;IRF9;CAMK2D;TNFRSF25;TRAF1;TNFRSF1B;IFNAR1;IRAK2;COMMD7;GATA3;FCGR1A;IL1A;PDCD4;ADAM17;ADIPOR1;PSMD4;ITGAM;IL1RAP;SOCS6;STAT1;IL20RB;HSP90B1;MT2A;CEBPA;BCL2L1;UBA52;OAS2;JAK2;RPS27A;PITPNA;LTB;ADAR;EGR1;PSMA5;RBX1;BOLA2;PSMB10;TRIM25;CCL4;CASP1;NFKBIA;TAB2;PSMB8;MAP3K3;GBP2;PSMD14;TRIM8;TALDO1;IRF5;PIK3CB;PSMA7;PSMC3;HIF1A;NDN;PSMA8;PSMC1;SOS1;CFL1
prerank,negative regulation of wound healing (GO:0061045),-0.4023883156991815,-1.2488724418987327,0.14006514657980457,0.6608820174623887,1.0,8/28,5.55%,PHLDB2;TFPI;CASK;VTN;SLC12A2;APOE;SERPINE2;FGF2
prerank,barbed-end actin filament capping (GO:0051016),-0.4467884399299057,-1.2486418935046666,0.18994413407821228,0.6569904415118096,1.0,5/18,9.42%,ADD3;GSN;SVIL;VILL;CAPZB
prerank,actin filament capping (GO:0051693),-0.4467884399299057,-1.2486418935046666,0.18994413407821228,0.6569904415118096,1.0,5/18,9.42%,ADD3;GSN;SVIL;VILL;CAPZB
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.42945232916419046,-1.2485217135483064,0.18487394957983194,0.6550879511628082,1.0,11/19,25.46%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4825031639992696,1.2482978286809885,0.2112482853223594,0.6370387144840486,1.0,5/33,8.27%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,development of primary male sexual characteristics (GO:0046546),0.48476598669088194,1.2480508220629183,0.19257221458046767,0.6368856568449904,1.0,6/34,8.81%,GATA6;KITLG;TGFB2;GATA3;COL9A3;NCOA4
prerank,regulation of lymphocyte activation (GO:0051249),0.5864250495858424,1.2479595671364085,0.2268370607028754,0.6363385878315458,1.0,1/12,1.39%,CRTAM
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.5028221134238634,1.2477460338503654,0.20588235294117646,0.6361955552730177,1.0,10/25,19.44%,HRK;TNFSF10;BBC3;CIDEB;BNIP3;PYCARD;PLAUR;BMF;BID;PPIF
prerank,positive regulation of protein kinase activity (GO:0045860),0.3970238345025068,1.2475115777858445,0.11538461538461539,0.6360541287998577,1.0,31/148,12.61%,RAPGEF2;PDGFB;ACE;INSR;DAB2IP;TGFB2;ADRB2;EMP2;IQGAP1;NEDD9;EFNA1;MAP4K4;FCGR1A;IRGM;MAPRE3;TOM1L1;SYAP1;PTK2;TAOK2;EGR1;PRNP;CCDC88A;PTPN1;MINK1;TAB2;MMD;CLU;GRM5;MARK2;CALM3;TTBK1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5827527900110452,1.247509759622884,0.24013157894736842,0.6352735991615022,1.0,7/12,25.94%,CAV1;CAMK2D;CALM3;PDE4D;IRX3;SRI;CALM1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4663804583963994,-1.2474451776494677,0.1726027397260274,0.6537122890677062,1.0,6/16,8.25%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4663804583963994,-1.2474451776494677,0.1726027397260274,0.6537122890677062,1.0,6/16,8.25%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.42610146771618385,-1.2472619247812307,0.15877437325905291,0.6520539412408123,1.0,6/21,6.74%,ERRFI1;ROCK2;BMP4;MAFG;RUNX1;SFRP4
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4372851165720728,1.2467964621941479,0.1646039603960396,0.6364797261004251,1.0,14/66,9.67%,PTPRM;CEACAM1;B2M;DAB2IP;AQP11;CAV1;CAV2;TGFB2;GATA3;STAT1;ATP5F1A;SNAI2;MCC;FBXW7
prerank,phosphate ion transmembrane transport (GO:0035435),0.5765849555733102,1.2465723602458836,0.2375,0.63630227140056,1.0,5/12,16.56%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,intraciliary retrograde transport (GO:0035721),-0.5152150494446801,-1.2463697631710875,0.2183288409703504,0.6525452123321464,1.0,8/12,22.14%,WDR35;DYNC2LI1;IFT43;DYNC2I2;TTC21B;WDR19;DYNC2H1;DYNC2I1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4398464899716651,-1.2460752783349858,0.19672131147540983,0.6511924756252139,1.0,11/17,25.46%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,positive regulation of protein binding (GO:0032092),0.4441210164735025,1.245707979736495,0.18053777208706787,0.6378507709126329,1.0,15/56,14.97%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;EPB41;LRRK2;NVL;MARK3;DTX3L;PIN1;RAN;PPP2CB
prerank,protein targeting to peroxisome (GO:0006625),-0.398874242365174,-1.245521951797103,0.16887417218543047,0.6506945355022805,1.0,18/29,35.37%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;HACL1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;ZFAND6;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5137508533223877,1.2448943193163378,0.23485967503692762,0.6391663477489309,1.0,6/22,8.74%,DAB2IP;F2RL1;TIRAP;MFHAS1;NR1D1;ACOD1
prerank,negative chemotaxis (GO:0050919),0.4855050378053445,1.244005357316528,0.18020679468242246,0.640890366791895,1.0,5/33,4.67%,SEMA3G;SEMA3F;APOA1;NTN1;SEMA7A
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5186362403197119,1.2438156633041724,0.2061711079943899,0.6406512418749857,1.0,1/25,0.08%,PLCG2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.45477454714716264,1.243277805932259,0.19391634980988592,0.6413159057900009,1.0,11/47,15.72%,NANOS3;EDN1;APP;KLF4;CYFIP1;NFKBIA;VPS35;GRM5;METTL18;EIF2A;TCOF1
prerank,neuron projection organization (GO:0106027),0.5508539911737154,1.2430299601375936,0.22741935483870968,0.6412478479636103,1.0,4/15,9.97%,INSR;ATP1A3;APP;PRNP
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4975307600879294,1.2430108160645752,0.21198830409356725,0.6405103933991688,1.0,7/27,15.09%,CCDC88C;MAPK1;UBA52;RPS27A;TAOK2;MAP3K20;KAT7
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.31762685591619655,-1.2426793040493063,0.0670391061452514,0.6569621825833555,1.0,10/78,3.14%,PID1;EGFR;LRP1;EPHA3;SORBS1;PTPN9;DAB2;MMP14;RHOQ;STX4
prerank,negative regulation of response to stimulus (GO:0048585),0.4289857473805759,1.2418365863151055,0.19160104986876642,0.6429429405655168,1.0,16/60,11.83%,MCTP1;KLF7;AQP11;APOA1;KLF4;ACVR1;FCGR2B;KIF26A;CD34;AKT3;RBL1;PIM3;LPCAT3;PTPN1;MAP3K3;CLU
prerank,negative regulation of GTPase activity (GO:0034260),0.5241076943330191,1.2412922270803464,0.21374045801526717,0.6436756598181459,1.0,5/22,7.14%,F11R;DAB2IP;LRCH1;SH3BP4;LRRK2
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.36916911931269325,-1.2409725937681895,0.14334470989761092,0.6596888555865448,1.0,7/40,10.92%,SLC7A11;SLC13A3;SLC38A11;SLC19A1;SLC38A10;SLC27A1;SLC38A5
prerank,regulation of mitotic cell cycle (GO:0007346),0.39740708926936186,1.2407471325136092,0.12065217391304348,0.6444546904422329,1.0,41/171,16.08%,AFAP1L2;TAL1;TTC28;CAV2;BTG2;APP;IQGAP1;BTG1;RPRM;TTL;PSMD13;ASAH2;CDC25C;UBE2D1;PSMD4;DUSP3;PIM3;NEK7;PSMA5;PSMB10;PSMB8;ANGEL2;PSMD14;NEK11;RPS6KB1;PSMA7;PSMC3;PIN1;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;BTG3;PSMB9;PKN2;ANAPC7;PSMC6;MEIS2
prerank,cellular response to organonitrogen compound (GO:0071417),0.4116184958745385,1.2404989585154325,0.14668218859138532,0.6443376660325014,1.0,30/99,21.41%,KCNQ1;RAPGEF2;SPAAR;RAPGEF1;DIAPH1;INPP5K;MEF2C;SH3BP4;P2RX7;HSP90B1;CTNNA1;HTR1B;EGR1;RRAGD;ACTB;TRPM2;BRCA1;CTNNB1;GLRA2;P2RY1;CIB2;GABRB1;GOLPH3;RELA;RRAGA;RRAGC;JUP;LAMTOR3;ZFP36L1;GABRB3
prerank,sodium ion transport (GO:0006814),-0.32286355846318665,-1.240016916122737,0.06077348066298342,0.6601851305137222,1.0,14/85,7.04%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC12A2;SCN7A;SLC6A12;SLC8A3;ATP1B3;SLC9B2;SCN2A;SLC6A1;SLC5A5;SLC6A9
prerank,muscle tissue morphogenesis (GO:0060415),0.5444112992708704,1.239793254121481,0.23696682464454977,0.645503959481332,1.0,4/16,3.58%,TBX1;NOTCH1;MYLK;HEY2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.43754534420958924,-1.23975394784922,0.17679558011049723,0.6587524566780265,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,protein polyglutamylation (GO:0018095),0.584188864027364,1.2396091873996709,0.25,0.6452114799715478,1.0,4/11,12.76%,TTLL7;TTLL1;TTLL5;TTLL11
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.4449530390259928,-1.239460561541871,0.19710144927536233,0.6552523260145133,1.0,13/21,24.65%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.4449530390259928,-1.239460561541871,0.19710144927536233,0.6552523260145133,1.0,13/21,24.65%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,triglyceride biosynthetic process (GO:0019432),-0.4667587756554326,-1.2393324252453934,0.19476744186046513,0.6533765324554952,1.0,5/18,9.81%,AGMO;LPGAT1;MOGAT3;GK;DGAT1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.492602743464261,1.2390722370320917,0.20029239766081872,0.6458413074102722,1.0,13/31,22.43%,LSM1;EXOSC3;DCPS;DCP1B;POLR2G;EXOSC8;EDC3;NT5C3B;DDX6;EXOSC9;LSM2;DIS3L2;EXOSC1
prerank,plasma membrane organization (GO:0007009),0.4390831116552817,1.238087259375163,0.2,0.6478337966989937,1.0,14/61,8.41%,CAVIN2;DYSF;PLSCR4;PACSIN2;SYT7;ANO6;FNBP1L;MYH9;PACSIN1;P2RX7;WHAMM;PLSCR1;A4GALT;BIN3
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.45335991763166666,-1.2378541453969314,0.2086720867208672,0.6555703863765032,1.0,5/17,13.86%,CPEB1;NUDT21;NCBP1;CTR9;CPEB3
prerank,dendritic spine morphogenesis (GO:0060997),-0.46751684848452235,-1.2378060892136105,0.20759493670886076,0.653551121606662,1.0,6/15,19.33%,DOCK10;DLG4;CTNND2;EPHB2;EPHB3;PAK3
prerank,response to estradiol (GO:0032355),-0.38939322863681225,-1.2376075822833044,0.16607773851590105,0.6519603752591306,1.0,8/31,17.03%,EGFR;LCOR;ANXA1;CCDC62;GGT5;GGT7;SOCS2;GPER1
prerank,phosphate ion transport (GO:0006817),0.5348819266494437,1.2374382028775177,0.23366013071895425,0.6487784583241192,1.0,5/16,16.56%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,regulation of immune response (GO:0050776),0.3974316689785122,1.237436572817304,0.13662456946039037,0.647998020258706,1.0,19/135,10.12%,VCAM1;CLEC2D;CRTAM;B2M;ICAM2;CASP8;TGFB2;FKBP1A;SPPL2A;TIRAP;FCGR2B;CD34;FCGR1A;OSCAR;CD247;PLSCR1;CD200;FOXP1;TYROBP
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5829431307622234,1.2362321237905127,0.24253075571177504,0.6505205164319711,1.0,2/11,4.89%,FYN;LANCL1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.47156282391380155,1.23592527160189,0.19828815977175462,0.6505668772020696,1.0,13/34,20.37%,MEF2C;LRRK2;GRIN2B;GRIN2C;GABRA4;GABRA2;GABRE;GRIN2A;GABRG3;GSK3A;GRID2;GSK3B;INSYN2A
prerank,regulation of stem cell differentiation (GO:2000736),0.415198593357198,1.2357994982006302,0.1497005988023952,0.6501221420224739,1.0,29/89,18.86%,JAG1;GATA2;LMO2;NOTCH1;TAL1;PSMD13;LMO1;GATA3;PSMD4;ZFP36L2;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;NELFB;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.42094291775084264,1.2353740443818497,0.17005988023952096,0.65056191614381,1.0,33/88,19.04%,FBXL2;PSMD13;FBXL14;FBXL5;PSMD4;FBXL18;FBXL16;PSMA5;FBXW7;RBX1;PSMB10;CUL2;PSMB8;PSMD14;FBXO4;PSMA7;PSMC3;PSMA8;PSMC1;FBXO2;PSMB5;PSMC5;PSMB9;FBXL13;PSMC6;AMN1;PSMA4;FBXO6;PSMD5;PSMD9;FBXL6;PSMB6;FBXL15
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5042121170002009,1.234889994681844,0.2375533428165007,0.6510735612754776,1.0,10/25,18.10%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,tRNA metabolic process (GO:0006399),0.5433964859222838,1.2345960823883995,0.23285486443381181,0.6511627409656691,1.0,4/17,10.20%,DTD2;KARS1;TRPT1;FARS2
prerank,cyclooxygenase pathway (GO:0019371),-0.5282655515483051,-1.2343193734830362,0.23218390804597702,0.6600371724187545,1.0,3/10,6.50%,PTGDS;PTGES;PTGS1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4957745141192238,1.2339794447716779,0.22997032640949555,0.6520264962311619,1.0,11/26,21.58%,FYN;AIM2;EFNA1;GRIN2B;APH1A;VSIR;TTBK1;PYCARD;AGER;APH1B;EPHA4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5152392989338851,1.2337067181042298,0.2391304347826087,0.6519677882816092,1.0,4/22,4.95%,EDN1;LMCD1;NOTCH1;CAMK2D
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4404301565720245,1.2337030087951566,0.19743589743589743,0.6512015975640869,1.0,14/57,13.12%,FYN;NOD1;AIM2;ARL6IP5;CASP8;PPM1F;TNFSF10;CIDEB;GRIN2B;GRAMD4;HMGB1;CASP1;TTBK1;TBC1D10A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5230009675086046,1.2330319134691012,0.20673813169984687,0.6522796925953096,1.0,4/21,11.99%,KCNN4;FOXP1;STAP1;PRKD2
prerank,supramolecular fiber organization (GO:0097435),0.37541346585260305,1.232939313814847,0.07828810020876827,0.6517526798697715,1.0,54/333,10.33%,LAMA3;MYO1D;FBLN5;CD2AP;CCDC88C;TRPV4;STMN2;HIP1;MYO1E;SHROOM4;HIP1R;ELMO1;PLK3;RND1;B2M;ARHGEF2;TGFB2;RHOB;FKBP1A;VIM;EMP2;APP;FLII;APOA1;EVL;CLIP2;SLK;DST;TSPAN14;ATP7A;IAPP;FURIN;CAMSAP2;COL5A2;CLIP1;KIF2A;PLEC;WHAMM;ARHGAP25;HOOK1;UBA52;MYO1C;BIN3;RPS27A;COL9A3;APH1A;PCM1;DSP;ADAM10;SIAH2;KATNAL2;MAD2L2;ERMN;CCDC88A
prerank,regulation of cellular component movement (GO:0051270),-0.35866941439377237,-1.2329231295777583,0.12307692307692308,0.662109165945873,1.0,14/49,12.82%,TGFBR3;EGFR;ROCK2;TGFBR1;PDPN;ARHGAP18;ARAP1;YTHDF1;MEMO1;VEGFA;RAF1;ERBB2;HDAC6;HBEGF
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.44839071260219476,1.2327805524381314,0.1911170928667564,0.6514233831329858,1.0,10/50,12.80%,NOD1;NOD2;LGALS9;APP;ACTN4;TLR3;PDCD4;NMI;LAPTM5;RTKN2
prerank,cardiac muscle cell action potential (GO:0086001),-0.39773171884065295,-1.232532594433657,0.18439716312056736,0.6611045258034706,1.0,7/30,6.67%,ATP1A2;ANK2;CACNA1C;DMD;CACNA2D1;KCND3;CACNA1G
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5135221686560419,-1.2324687304970379,0.2558139534883721,0.6591962233193434,1.0,1/12,1.29%,IL1R1
prerank,regulation of cell motility (GO:2000145),0.3997858159590897,1.2322530629022008,0.1451990632318501,0.6520964890858726,1.0,26/121,11.65%,SPATA13;CEACAM1;LDB2;PLXNA4;MACF1;RHOB;FES;CRK;DIAPH1;SPOCK2;PLXND1;NTN1;SLK;PKN1;TTBK2;ROBO4;SPOCK3;GATA3;KIF2A;ROCK1;SGK1;SPINT2;MINK1;RAC1;CAVIN1;INPP5F
prerank,protein localization to nucleus (GO:0034504),-0.3073105307877273,-1.2319722663781536,0.09803921568627451,0.6585943928041743,1.0,42/102,24.39%,COL1A1;APPL2;BMP7;BMP4;LMNA;TOR1AIP1;NUP107;SIX1;TOR1B;INTS13;HEATR3;BANP;CSE1L;PPP1R10;NUP155;PAF1;TNPO3;RANBP6;IPO5;FAM53C;BCL3;MDM2;NUP93;TNPO2;HNRNPU;RANBP17;TOPORS;TSC2;PHB2;MORC3;SUPT7L;PML;RRS1;CHCHD10;SEC13;SYK;IPO7;SIX4;POM121;TOR1A;TBRG1;IPO8
prerank,regulation of endocytosis (GO:0030100),0.43830862289197664,1.2317495040217898,0.19125,0.6527018654965566,1.0,17/61,17.14%,CDH13;HIP1;HIP1R;MCTP1;PRKD1;PACSIN2;PACSIN1;ROCK1;STON1;PTPN1;NEDD4L;RUBCN;ABCA7;ZFYVE16;RIT2;OPHN1;RUFY1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4287729272104928,1.2313855853419573,0.1683046683046683,0.6529503063971305,1.0,8/72,2.62%,TEK;PDGFD;FLT1;PDGFB;INSR;F2RL1;TGFB2;CBL
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.47787255505075926,1.2313668002233233,0.1967930029154519,0.6522108868019107,1.0,7/32,12.11%,CDK17;CDK14;CCNE1;KLF11;POLA1;E2F7;HINFP
prerank,regulation of telomerase activity (GO:0051972),0.45501414679153046,1.2310647138512003,0.20334261838440112,0.6522592235746103,1.0,21/45,26.87%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;ERCC4;ATM;CTNNB1;MEN1;MAPKAPK5;PARM1;TCP1;GREM1;WRAP53;MAP3K4;HSP90AA1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.4652717563202655,-1.2310254164582979,0.21693121693121692,0.6592895985363645,1.0,8/15,27.40%,SIRT3;SPHK1;PLA2G6;PRKCD;ORMDL2;SPHK2;SMPD3;TNFRSF1A
prerank,regulation of embryonic development (GO:0045995),0.47089386351287127,1.2308824032408,0.2185792349726776,0.6520250077707795,1.0,7/34,11.00%,SOX17;PLCB1;INSR;POGLUT1;CLASP1;CLASP2;BAG6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5259649347986253,-1.2308656985474797,0.22842639593908629,0.6576022071276565,1.0,4/10,10.38%,DSE;PXYLP1;XYLT1;B3GAT3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5320380102315326,1.2303357479266528,0.22611464968152867,0.6527655653674184,1.0,4/19,8.46%,LGALS9;TIRAP;ITGAM;NMI
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4314596408463247,-1.2301678161078606,0.209366391184573,0.6574803857230229,1.0,6/21,7.62%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2
prerank,midbody abscission (GO:0061952),0.5291444743623737,1.2294248893456285,0.24375,0.654457158707196,1.0,11/17,27.34%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;VPS4B;MITD1;CHMP4A;CHMP4B
prerank,cellular response to amyloid-beta (GO:1904646),0.47213841849134036,1.2293126457718448,0.21542940320232898,0.6539886376462605,1.0,7/35,4.30%,FYN;VCAM1;ATP1A3;CACNA1A;ADRB2;APP;FCGR2B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4275060777565128,1.2291023229978713,0.19503105590062111,0.6537856528025058,1.0,28/70,20.52%,B2M;MFSD6;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMC3;TAPBP;PSMA8;PSMC1;PSMB5;PSMC5;NCF2;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;LNPEP
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5500161271703939,1.2289594656270117,0.24584717607973422,0.653421336729502,1.0,2/14,10.12%,CCR1;TYROBP
prerank,autophagy of peroxisome (GO:0030242),0.5776058030314297,1.2281409976835906,0.2417391304347826,0.6549259842268975,1.0,4/12,13.96%,TRAPPC8;NBR1;PIK3C3;ATM
prerank,positive regulation of response to stimulus (GO:0048584),0.46362590701271433,1.228120991595921,0.20970042796005706,0.6542240855993601,1.0,12/40,18.44%,B2M;IFIH1;TGFB2;IER5;FCGR2B;GATA3;DHX9;FXR1;NSMCE4A;RSAD2;EEF1E1;CDKN2AIP
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.47216037488375595,1.2279445640350226,0.1918194640338505,0.6540028048057496,1.0,10/36,14.82%,FZD6;PLCB1;TNRC6C;LEF1;NLK;PPP3CA;AGO4;NFATC1;CTNNB1;FZD3
prerank,negative regulation of intracellular protein transport (GO:0090317),0.512483796849434,1.2277170437582827,0.2175226586102719,0.6538957241388347,1.0,10/22,20.67%,INPP5K;UFM1;RAB23;LRRK2;RANGAP1;ITGB1BP1;CABP1;GDI1;BARD1;BAG4
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4699035994870591,1.2273458414315506,0.21132596685082872,0.6541472891161781,1.0,10/36,14.74%,EDN1;TRIM6;ADAM17;IRGM;HSPA1B;NLRC5;CASP1;LAPTM5;HIF1A;CXCR4
prerank,mRNA metabolic process (GO:0016071),-0.30908414469552137,-1.2272567412730215,0.055944055944055944,0.6638861860482179,1.0,34/90,24.13%,SON;DDX5;SRSF5;SCAF11;NUDT21;HNRNPA2B1;NCBP1;PRPF8;SRSF1;PRKACA;SSB;CNOT10;PRPF3;AKAP8L;SNRPF;YTHDF2;PCF11;U2AF2;SNRPD3;AGO3;ZFP36;LSM11;SLBP;LSM6;SRSF11;SF3A2;NCBP2;DHX15;TCERG1;CELF1;SRSF2;DCP2;LSM10;U2AF1
prerank,mesenchyme development (GO:0060485),-0.4840676829440605,-1.2271302752167512,0.23513513513513515,0.6622155005131557,1.0,4/15,2.18%,FGFR2;TGFBR1;BMP7;BMP4
prerank,negative regulation of translational initiation (GO:0045947),-0.48737389194902664,-1.2271002939095237,0.21464646464646464,0.6602059701376766,1.0,5/13,17.14%,PAIP2;EIF2AK4;EIF3E;LARP1;EIF4EBP1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5049822510753513,-1.226487279406843,0.2375,0.6600351174852706,1.0,7/11,27.19%,P4HA1;EGLN3;P4HTM;P3H2;P4HB;P4HA3;OGFOD1
prerank,positive regulation of vascular permeability (GO:0043117),0.5721203378284916,1.2261805212487733,0.2549019607843137,0.6565839476065382,1.0,5/12,9.21%,TRPV4;OCLN;ANGPT1;TJP2;TJP1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5724621905547267,1.2260844871923757,0.25709779179810727,0.6553004159354274,1.0,4/12,14.51%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5724621905547267,1.2260844871923757,0.25709779179810727,0.6553004159354274,1.0,4/12,14.51%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,external encapsulating structure organization (GO:0045229),0.37988640043301725,1.2260606668860818,0.12098501070663811,0.6545943641134989,1.0,27/205,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;FURIN;COL5A2;CD47;BSG;ITGAM;ADAM12
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.40307306868213494,1.2257795948880537,0.16216216216216217,0.65458142023359,1.0,14/107,7.78%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2;SLC30A1;MT2A;SLC39A6
prerank,membrane repolarization (GO:0086009),0.5537439275500255,1.2252764029007672,0.2503937007874016,0.6552051455581319,1.0,3/15,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4871733591863818,1.2248014123325361,0.2248939179632249,0.6558098299449671,1.0,3/30,1.57%,DACH1;BMPR2;ACVRL1
prerank,positive regulation of lipid transport (GO:0032370),-0.5053404260499162,-1.2244427527032513,0.2422680412371134,0.664031358799042,1.0,3/12,10.58%,LRP1;APOE;SPP1
prerank,glycoprotein metabolic process (GO:0009100),0.43574391933197987,1.223980517158196,0.19035202086049544,0.6572896978497351,1.0,14/53,19.35%,GCNT1;ST6GALNAC3;ST8SIA6;MANBA;PRKCSH;HIF1A;FBXO2;ST3GAL2;ENGASE;OGA;FBXO6;GOLPH3;NGLY1;NEU4
prerank,positive regulation of apoptotic process (GO:0043065),0.37554901867028706,1.2239634362805578,0.09723643807574207,0.6565702062870804,1.0,45/293,10.19%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;TGFB2;RHOB;TRIO;BTG1;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;TNFSF10;PLEKHG5;IAPP;STPG1;RYBP;TIAM2;MCF2L;FANK1;CRADD;ZC3H12A;GADD45G;UBA52;APC;RPS27A;TPD52L1;KLF11;APH1A;JUN;HMGB1;MAP3K11;PRNP;ARHGEF1
prerank,protein targeting to lysosome (GO:0006622),0.5198234515302533,1.223872174969583,0.23343373493975902,0.6560838737812158,1.0,10/20,20.71%,GNPTAB;NCOA4;LAPTM5;CLU;VPS4A;NAGPA;AP3M1;ZFYVE16;LAMP2;SORL1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4483417280292883,1.2237493009812381,0.21106821106821108,0.6556582210574005,1.0,23/53,22.44%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PPM1K;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,hepaticobiliary system development (GO:0061008),-0.4251479059368849,-1.222577352907758,0.18207282913165265,0.6674038198734425,1.0,4/20,5.01%,TGFBR3;WNT4;COBL;NIPBL
prerank,wound healing (GO:0042060),-0.331295337762853,-1.2225328124677788,0.1388888888888889,0.6654661421008008,1.0,17/62,11.81%,COL3A1;IGF1;PDGFRA;TGFBR1;FGF1;WNT5A;TPM1;AHNAK2;FGF2;SMAD3;FZD7;CFLAR;PRCP;RAF1;ERBB2;SYTL4;DCBLD2
prerank,regulation of urine volume (GO:0035809),0.5825025056573201,1.221595926769968,0.2554858934169279,0.6607569734979123,1.0,3/10,6.82%,INPP5K;HYAL2;NPR1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3838817374229584,1.2215626536096398,0.14952279957582185,0.6600892380454807,1.0,55/175,21.03%,ARHGEF2;AIM2;DAB2IP;ACTN4;TNFRSF18;INPP5K;PSMD13;TNFRSF25;HYAL2;TRAF1;TNFRSF1B;COMMD7;GBP3;GATA3;ADAM17;PSMD4;ZC3H12A;STAT1;JAK2;NFE2L2;NR1D1;ACOD1;LTB;CACTIN;ZFP36L2;PSMA5;DHX9;PSMB10;CCL4;NFKBIA;PSMB8;GBP2;PSMD14;BRCA1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6;ERBIN;TNFRSF11A;PSMB2;BAG4;ZFP36L1
prerank,neural crest cell differentiation (GO:0014033),0.5327517479019792,1.2213217028826078,0.228125,0.6600247367387049,1.0,7/18,21.33%,MEF2C;SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4770313966624263,1.22079485525992,0.23219373219373218,0.6606811342886639,1.0,6/30,7.74%,ARHGEF3;F11R;F2RL1;APOA1;LPAR6;ARRB1
prerank,positive regulation of innate immune response (GO:0045089),0.4817710056359859,1.2204610907689835,0.21060171919770773,0.6608216307391932,1.0,8/30,9.64%,GBP5;TRIM6;PLSCR1;NLRC5;NMI;POLR3B;SLC15A4;DHX9
prerank,Golgi to plasma membrane transport (GO:0006893),0.44155938887191065,1.220460087702514,0.21524064171122995,0.6600687257075625,1.0,18/47,22.78%,EXOC6;MACF1;STXBP6;RAB34;GOPC;EXOC8;NSF;ANK3;SPTBN1;GOLPH3L;EXOC4;GOLPH3;EXOC2;STEAP2;RAB31;EXOC5;EXOC6B;OSBPL5
prerank,cellular response to inorganic substance (GO:0071241),0.5152843020813247,1.2201529424108626,0.2559171597633136,0.6601192358809801,1.0,4/21,9.77%,FOXO1;ADCY10;NSMCE3;SPIDR
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.45745897364149624,1.219798763892277,0.20352781546811397,0.6603605687964655,1.0,7/40,5.38%,JAG1;NOTCH1;TGFB2;WWTR1;LEF1;GCNT2;SMAD2
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.43980717722999113,-1.2197211155042815,0.1787878787878788,0.6713943571674384,1.0,3/19,3.41%,CAMK1D;IL34;THBS1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.5316383013178279,-1.2193443988369843,0.2710997442455243,0.6704462116590486,1.0,4/10,22.91%,PIAS3;HDAC4;GNL3;PIAS4
prerank,cotranslational protein targeting to membrane (GO:0006613),0.41047964769561396,1.2193204123968413,0.18235294117647058,0.660892634137942,1.0,41/91,25.82%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;RPL37A;RPL18A;SEC62;SRP19;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4508374305463295,-1.2181936527783475,0.21195652173913043,0.6717421297841007,1.0,3/18,7.81%,IGF1;IGFBP2;IGF2
prerank,neutrophil mediated immunity (GO:0002446),0.3689788359235447,1.217434635705404,0.08012170385395538,0.6651504298114823,1.0,62/432,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;ACE;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;ADAM17;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;KMT2E;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,ephrin receptor signaling pathway (GO:0048013),0.41326679416048057,1.217284282999933,0.19730392156862744,0.664798216153633,1.0,18/82,11.20%,KALRN;EFNA5;ARHGEF28;FYN;CRK;AP2B1;EFNA1;GRIN2B;ARPC5;ACTG1;APH1A;YES1;ROCK1;PTK2;AP2M1;ANKS1B;RAC1;ACTB
prerank,positive regulation of nuclear division (GO:0051785),0.49768226367296686,1.216796268773849,0.24163027656477437,0.6654374752473259,1.0,4/25,6.22%,EDN1;PDGFB;INSR;IL1A
prerank,intracellular lipid transport (GO:0032365),-0.4273833577473595,-1.216625966217977,0.21787709497206703,0.6741857835895231,1.0,4/21,6.25%,PRKAG2;PRKAA2;ABCD3;SLC25A20
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.49648231639429247,1.2165552606518057,0.22986822840409957,0.6653503818945168,1.0,3/23,5.32%,EDN1;PIEZO1;MEF2C
prerank,regulation of phospholipase C activity (GO:1900274),-0.46556363333447415,-1.2163235480772348,0.20161290322580644,0.6730103240491432,1.0,5/15,5.55%,NTRK3;PDGFRB;PDGFRA;KIT;FGF2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4362146111406727,1.2159869438216693,0.21941992433795712,0.6661772082376006,1.0,16/54,17.56%,CASP8;F2RL1;SPATA2;SPPL2A;APOA1;TRAF1;ADAM17;MADD;HSPA1B;CASP1;LAPTM5;RACK1;TRAIP;PYCARD;PTPN2;PYDC1
prerank,regulation of cell communication (GO:0010646),0.4658105888892656,1.2157247522985744,0.2190082644628099,0.6661089917425347,1.0,7/35,7.22%,GJA5;KAZALD1;CRK;SLC8A1;SCG5;CAMK2D;IGFBP7
prerank,negative regulation of protein metabolic process (GO:0051248),0.4343994336427002,1.2157093860071717,0.2156084656084656,0.6654067827319452,1.0,13/48,13.11%,EDN1;AZIN1;IAPP;PFDN6;VBP1;ROCK1;MAD2L2;PRNP;PRKCG;ADGRB1;PFDN2;CLU;PIN1
prerank,Golgi to endosome transport (GO:0006895),0.5282220412897062,1.2154870650844027,0.25199362041467305,0.6652502450902266,1.0,6/16,20.36%,DOP1B;KLHL20;KIF16B;MON2;SORT1;EPS15
prerank,glucose transmembrane transport (GO:1904659),0.530880153051528,1.2154310703508233,0.24382716049382716,0.6646627145911664,1.0,3/18,8.42%,SLC2A1;HNF1A;SLC2A9
prerank,negative regulation of cell death (GO:0060548),0.41196048438194666,1.2152848882110534,0.18321513002364065,0.664305080338986,1.0,20/88,14.80%,MECOM;FYN;PRKD1;TMEM109;AMIGO2;CD34;TNFRSF1B;LRRK2;HSPA1B;PDE8A;DCPS;CD200;VPS35;CLU;CHGA;BNIP3L;BNIP3;RAD18;PSMC5;TM7SF3
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4419893431988944,-1.2143127414930712,0.20708446866485014,0.6768577565907828,1.0,6/17,20.46%,FGFR2;NPR3;PLXNB1;ATRAID;CCN1;MN1
prerank,pinocytosis (GO:0006907),0.6009038176276434,1.214302055441237,0.28183361629881154,0.666216568807175,1.0,6/10,21.45%,PPT1;RAB34;DOCK2;PYCARD;MAPKAPK2;CARMIL1
prerank,regulation of AMPA receptor activity (GO:2000311),0.4970846388390445,1.214216886480503,0.23617339312406577,0.6656892284175535,1.0,6/25,10.64%,ADRB2;SHISA8;MEF2C;SHANK3;SHISA6;MINK1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.43164039921029596,-1.214014316234626,0.22625698324022347,0.6756754486491474,1.0,11/18,25.46%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4631236140979582,-1.2136073474328515,0.22443181818181818,0.6747813345872891,1.0,9/17,17.12%,ATP1A2;TFPI;BMP7;BMP4;SRC;URI1;UBE2L3;GPER1;AR
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5347679852509318,1.2135197332590466,0.24835526315789475,0.6667998389746754,1.0,5/16,16.27%,TUBB;TUBB4B;VAMP7;LYST;PLEKHM2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4700703015423074,1.2132821652383758,0.21618037135278514,0.6667121946911495,1.0,7/37,13.99%,ENTPD1;DFFB;ADPRM;RNASEH2B;XRN2;RNASE6;NUDT9
prerank,extracellular structure organization (GO:0043062),0.3761826800914968,1.213282147798031,0.13141025641025642,0.6659667329546882,1.0,27/204,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;FURIN;COL5A2;CD47;BSG;ITGAM;ADAM12
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.46380185805936675,1.2132397099614787,0.22714681440443213,0.665312619296453,1.0,5/34,6.22%,EDN1;PDGFB;INSR;CUL3;IL1A
prerank,positive regulation of hydrolase activity (GO:0051345),0.390165703198124,1.213102204868168,0.15593220338983052,0.6649468506965401,1.0,22/137,13.11%,RAPGEF2;DOCK9;F11R;RAPGEF1;RASGRP2;CAV2;F2RL1;AGRN;APOA1;TBC1D30;RAPGEF6;MAP4K4;RAP1GDS1;BCAR3;RGS7;CD200;RSU1;CCL4;ARHGAP27;CALM3;USP6NL;PIN1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.45712886926553203,1.212940495149081,0.2243502051983584,0.6646645827790761,1.0,10/40,11.83%,HIP1;B2M;INSR;CBL;PPT1;ANGPT1;ARRB1;TBC1D5;HNRNPK;CLU
prerank,muscle contraction (GO:0006936),0.3923697392311008,1.2123954527600447,0.17633674630261661,0.6654034652428121,1.0,18/126,12.98%,NOS1;UTRN;MYBPC3;ITGA1;DYSF;MYLK;VIM;SLC8A1;MYL6;MYL12B;ROCK1;CLCN1;MYOF;TPCN2;TPM4;SORBS3;GAMT;TMOD3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5643949506859783,1.2122327351215962,0.2465753424657534,0.6651145366762409,1.0,2/11,7.01%,SMAD7;ZC3H12A
prerank,negative regulation of lipid storage (GO:0010888),-0.4279376385531557,-1.211679780419415,0.18950437317784258,0.6782616697472162,1.0,6/19,15.80%,ABCA1;ITGAV;PPARA;OSBPL8;PPARG;NR1H3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5482830184148806,1.2116196655878122,0.2569558101472995,0.6660883398604638,1.0,7/13,27.40%,STAT1;OAS2;JAK2;IL27RA;OASL;CANX;JAK1
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.40277865454411393,-1.2114224925999193,0.1907356948228883,0.6768995930336117,1.0,11/26,22.21%,OGT;KMT5C;SETD1A;SETD1B;TET2;CTR9;KMT5B;SUV39H1;SETD4;ANTKMT;KMT2D
prerank,negative regulation of protein modification process (GO:0031400),-0.31476721666848706,-1.2113597095773005,0.1411764705882353,0.6750467239039901,1.0,15/79,8.57%,PID1;PTPN13;NTRK3;DMD;PLPP3;FBLN1;SNTA1;SLIT2;PRKAA2;PRKN;NIBAN1;XDH;IGFBP3;P3H1;XRCC1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4471006687882646,1.2111113038566255,0.2136181575433912,0.6667487540680567,1.0,6/46,4.92%,TEK;NTN4;PARVB;ATRNL1;LAMA5;EFNA1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4013949543028337,-1.2110721370918185,0.20930232558139536,0.6738325833471316,1.0,2/25,1.58%,ANK2;CEMIP
prerank,smoothened signaling pathway (GO:0007224),-0.38264892041746584,-1.210381495236305,0.17375886524822695,0.6737878171328587,1.0,9/32,15.05%,GLI3;GLI2;CC2D2A;SMO;GLI1;PTCH1;TMEM231;TCTN2;IFT27
prerank,peroxisomal membrane transport (GO:0015919),-0.3944483317183759,-1.2092831005381417,0.19281045751633988,0.6749652367135243,1.0,16/27,35.37%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3886405136051047,1.209008492386827,0.1768018018018018,0.671656389471099,1.0,24/128,9.21%,ENG;CLDN5;SMAD6;BMPR2;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;TMEM100;ACVR1;GCNT2;NLK;SMAD2;FURIN;PDCD4;UBA52;RPS27A;JUN;PTK2
prerank,regulation of actin filament depolymerization (GO:0030834),0.5675432754637759,1.2086339949946039,0.25463743676222594,0.6719164972209327,1.0,3/12,7.47%,LIMA1;F2RL1;WDR1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.523667500457614,1.2086008415436982,0.2544,0.6712578185599657,1.0,7/18,13.22%,FLT1;MEF2C;ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4771485785389157,1.2085102843859323,0.2303448275862069,0.6707499079006198,1.0,9/32,15.72%,NANOS3;APP;TMED10;ROCK1;CYFIP1;GRM5;METTL18;EIF2A;TCOF1
prerank,positive regulation of defense response (GO:0031349),0.40582958418738335,1.2077909175881476,0.1975609756097561,0.6719543710897388,1.0,18/89,13.70%,GBP5;APP;TLR3;MEF2C;HYAL2;PDCD4;CD47;CEBPA;PLSCR1;NMI;POLR3B;SLC15A4;DHX9;NFKBIA;CYBA;DDT;ABCC1;RIOK3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5141027367993103,-1.2073774603441638,0.24257425742574257,0.6784432597751909,1.0,3/10,9.21%,EMC2;EMC7;EMC1
prerank,rRNA processing (GO:0006364),0.3822879321144201,1.2073391733709633,0.1524122807017544,0.67250984369127,1.0,73/172,26.85%,BOP1;PELP1;RPL27;DHX37;RPL7;EXOSC3;NVL;UBA52;RPS14;MRPL1;MRM2;RPL35;WDR46;RPL21;DKC1;RRP15;RPL37;RPS28;RPL34;RPS9;XRN2;EXOSC8;RPLP2;RPS25;NHP2;RPL30;RPL27A;NOL8;RIOK3;SART1;RPL23A;RPS15;EIF6;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1;ERI1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5595778271008147,1.2071393487816984,0.2696245733788396,0.6722909149799777,1.0,5/13,11.83%,AQP11;FCGR2B;MBTPS2;LPCAT3;CLU
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.41615932580014425,1.2060938924571387,0.1878048780487805,0.6743346764189933,1.0,12/78,8.44%,PDGFB;CCNY;CCND2;CCND3;HHEX;CCNE1;SERTAD1;CDC25C;ADAM17;MAPRE3;CEBPA;APC
prerank,regulation of protein binding (GO:0043393),0.39328019191522573,1.2059605080731937,0.16457142857142856,0.6739657324255793,1.0,27/114,15.64%,RAPGEF2;CLDN5;PDGFB;HIP1R;B2M;CAV1;FKBP1A;APP;CRK;EPB41;LRRK2;NVL;CTNNBIP1;ROCK1;MARK3;ACTB;TMBIM6;DTX3L;MARK2;TTBK1;ITGB1BP1;PIN1;LDLRAP1;RAN;NES;RACK1;SLPI
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4034627829857184,1.205821269109266,0.20405727923627684,0.6735730641237052,1.0,5/88,2.84%,NANOS1;NANOS3;EDN1;DAB2IP;BTG2
prerank,rRNA catabolic process (GO:0016075),0.5311782841539502,1.2058185934191823,0.24420401854714066,0.6728392565013475,1.0,7/16,21.35%,TRIR;EXOSC3;EXOSC8;PELO;XRN1;EXOSC9;EXOSC10
prerank,translation (GO:0006412),0.3775889281500738,1.2053656565188444,0.14285714285714285,0.6733199986697828,1.0,90/208,28.17%,RPS21;GARS1;RPL27;VARS1;KARS1;RPL7;FARSB;WARS1;MRPL18;EEF2K;MRPL41;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;FARS2;RPS28;RPL34;TUFM;GTPBP1;MRPL36;MRPL47;MRPL52;RPS9;RPLP2;EEF2;GTPBP2;MRPL23;RPS25;RPL30;RPS5;RPL27A;MRPL24;MRPL32;MRPS34;MRPS12;RPL23A;RPS15;RPL19;RPS18;RPL32;GATB;EEFSEC;RPL37A;RPL18A;RPL22L1;EEF1D;MRPS18B;COPS5;RARS1;EEF1E1;ZC3H15;EEF1G;DARS1;MRPL11;RSL24D1;RPL18;MRPS28;RPL39;RPS19;RPL31;RPS8;TSFM;EIF4G1;MRPL34;WARS2;EIF4EBP2;RPL3;PPA2;RPL28;MRPS24;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;MRPS18C;MRPL27;RPS17;EEF1A1;DARS2;APEH;RPS13;MRPL13;RPL11;RPL14
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5146335784141348,-1.2051774798287351,0.2571428571428571,0.6828524474057607,1.0,6/11,35.76%,AGTR1;AGT;PLA2G7;ABCG1;LIPC;PLA2G5
prerank,cellular response to interleukin-15 (GO:0071350),0.5616547704884647,1.2051124283514,0.2576489533011272,0.6725539465806206,1.0,1/13,0.84%,PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5616547704884647,1.2051124283514,0.2576489533011272,0.6725539465806206,1.0,1/13,0.84%,PLCB1
prerank,cellular response to interleukin-12 (GO:0071349),0.43459745087673174,1.205049674129638,0.21352785145888595,0.6719974866488561,1.0,12/48,15.69%,PLCB1;GSTA2;MSN;PDCD4;CD47;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,positive regulation of actin nucleation (GO:0051127),0.5570833642524515,1.205041567942854,0.2782462057335582,0.6712804838910158,1.0,5/11,12.12%,FCHSD2;WHAMM;NCKAP1;CYFIP1;WASF2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.4501879888152097,-1.205032458224769,0.23380281690140844,0.6812712818589447,1.0,10/16,26.51%,PIGA;PIGB;PIGN;PIGH;DPM2;PIGG;PIGP;PIGZ;PIGL;PIGW
prerank,cytoplasmic translation (GO:0002181),0.40610836866011085,1.2047590847340626,0.21708185053380782,0.6713408570234212,1.0,44/91,28.17%,RPS21;RPL27;RPL7;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPS25;EIF3I;RPL30;RPS5;RPL27A;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;RPL22L1;EIF3M;ZC3H15;RPL18;RPL39;RPS19;RPL31;RPS8;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9;RPS17;EIF4A1;RPS13;RPL11;RPL14
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.43863328353569014,-1.2035377258375923,0.23387096774193547,0.683404445816388,1.0,4/16,6.64%,APPL2;APOD;PPARA;ADCY7
prerank,RNA transport (GO:0050658),-0.31549002150751193,-1.2032462677858804,0.12222222222222222,0.6822558773065973,1.0,32/71,26.04%,SIDT1;SRSF5;HNRNPA2B1;NCBP1;CKAP5;SRRM1;ATXN2;SRSF1;NUP155;SRSF6;THOC1;SIDT2;RTRAF;TGFBR2;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;UPF3B;SRSF3;KIF5C;SLBP;SRSF11;NCBP2;SRSF2;POM121;EIF4A3;U2AF1;ZC3H11A;THOC7;NUP188
prerank,determination of bilateral symmetry (GO:0009855),0.49830004519370086,1.2030406619832161,0.24437781109445278,0.6753986458316329,1.0,3/24,5.57%,TBX1;NOTCH1;BBS7
prerank,negative regulation of interferon-gamma production (GO:0032689),0.490630682115185,1.2028137521228852,0.23467862481315396,0.6752545257128473,1.0,8/23,16.90%,LGALS9;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;RARA
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.35810801123365593,-1.2023843845373303,0.16666666666666666,0.682695837343411,1.0,9/43,5.47%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;FBN2;RUNX2;IL6R
prerank,protein modification process (GO:0036211),0.40958630245620853,1.2021737036561406,0.20828258221680876,0.676233688011402,1.0,17/76,14.78%,ST3GAL6;FBXL2;DUSP12;UBA7;MANBA;STK38;CHRM3;UBA52;YES1;CSNK1G3;FBXW2;LIPT1;NAGPA;ST3GAL1;FBXO2;MSRA;UBE2D3
prerank,positive regulation of locomotion (GO:0040017),0.48568961858159576,1.2019420894615271,0.24962406015037594,0.6761594967699799,1.0,5/27,4.01%,PDGFB;F2RL1;PPM1F;SPOCK2;NTN1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4858428110927836,-1.2015808619788213,0.23484848484848486,0.6829726955793157,1.0,6/12,19.56%,SORBS1;IRS1;IGF2;PRKCZ;SNX5;ZBTB7B
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5176345391719243,1.2013805643521587,0.2451708766716196,0.6769429275055124,1.0,7/18,20.34%,HIP1R;TMEM14A;FZD9;GSK3A;BID;GSK3B;ACAA2
prerank,positive regulation of protein secretion (GO:0050714),0.4180184301049046,1.2013481407878135,0.21894218942189422,0.6763073695112191,1.0,9/69,6.22%,MYRIP;CD2AP;UNC13B;DOC2B;F2RL1;TGFB2;TMED10;GLUD1;IL1A
prerank,regulation of establishment of cell polarity (GO:2000114),-0.43906154490145244,-1.2009025101242181,0.23096446700507614,0.682924996411748,1.0,4/16,8.25%,ROCK2;GSN;RIPOR2;BCAS3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.528524085149501,1.2008024011653562,0.272,0.6770395192774723,1.0,4/17,3.81%,GJA5;ATP1A1;ATP1A3;SLC8A1
prerank,metanephric mesenchyme development (GO:0072075),-0.5278329022880865,-1.2006874078835081,0.27163461538461536,0.6815587259152972,1.0,6/10,22.68%,WNT4;OSR1;SIX1;BASP1;PAX2;SIX4
prerank,regulation of multicellular organism growth (GO:0040014),-0.46186289834366123,-1.200318079861237,0.23684210526315788,0.680655450371266,1.0,5/15,15.02%,IGF1;MBD5;GHR;PTCH1;MFSD2A
prerank,regulation of cellular amine metabolic process (GO:0033238),0.44573848942115607,1.2001486902619298,0.24115334207077327,0.678165060126626,1.0,22/50,22.44%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4125755202045984,1.2000390257010864,0.21782178217821782,0.677742858680287,1.0,8/70,5.32%,TEK;NTN4;PARVB;ATRNL1;SIPA1L3;LAMA5;EFNA1;MEF2C
prerank,positive regulation of T cell differentiation (GO:0045582),-0.37089902088316096,-1.1999973835156394,0.16296296296296298,0.6795513677887998,1.0,8/36,13.04%,GLI3;GLI2;ZMIZ1;BCL6;DUSP10;NCKAP1L;MDK;PNP
prerank,regulation of sprouting angiogenesis (GO:1903670),0.45643397863552604,1.1999552791293855,0.2412831241283124,0.6772328906928146,1.0,10/33,14.00%,CEACAM1;KLF2;CEMIP2;KLF4;PPP1R16B;JMJD8;TJP1;EPN2;PIK3CB;ITGA5
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5120557938243359,-1.199730505520538,0.2701298701298701,0.678389783364668,1.0,1/10,0.03%,ATP1A2
prerank,dopamine metabolic process (GO:0042417),0.5156606521350277,1.1994401099588023,0.25903614457831325,0.6778679310162932,1.0,4/18,4.43%,TGFB2;GCH1;ATP7A;MAOA
prerank,dendritic cell migration (GO:0036336),0.5291849056215714,1.1988380605203248,0.24960753532182103,0.6787801728976807,1.0,4/16,14.74%,CCR1;HMGB1;TRPM2;CXCR4
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5640683120996872,1.198053982983354,0.2750865051903114,0.680219710017076,1.0,2/12,2.98%,JAM2;APP
prerank,negative regulation of blood coagulation (GO:0030195),0.460326463531772,1.1976770942701884,0.2361111111111111,0.6805137513481914,1.0,3/38,0.88%,NOS3;EDN1;PDGFB
prerank,response to amyloid-beta (GO:1904645),0.44205218290972337,1.1970153252290088,0.2302357836338419,0.6815247533165045,1.0,7/44,4.30%,FYN;VCAM1;ATP1A3;CACNA1A;ADRB2;APP;FCGR2B
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.39446565602549843,-1.1968411107090067,0.21710526315789475,0.6848939357368582,1.0,8/28,9.76%,PID1;APPL2;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,cellular protein-containing complex assembly (GO:0034622),0.38076546879988094,1.1965258618566992,0.1838955386289445,0.6821278600141242,1.0,41/159,20.36%,HIP1;HIP1R;STXBP6;PIK3C2A;ADRB2;FKBP1A;PSMD13;FCHO2;ANGPT1;DNAAF3;OMA1;SMAD2;PSMD4;PFDN6;VBP1;VAMP8;IMMP2L;TTC12;CASQ1;NSG2;RTN4;DHX9;AP2M1;PTGES3;CYBA;CCT2;CLU;NUP153;CHMP3;CSNK2B;SAMM50;NUP205;NCK1;SMAD4;SRP19;SHQ1;PSMG2;NSG1;HOPX;DNAJC28;EPS15
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5080333942044781,-1.1961314652886499,0.24257425742574257,0.684877446313432,1.0,4/11,7.09%,ITGB5;KIT;CCN3;PLEKHA7
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5385195832439243,1.1960887053031664,0.2725806451612903,0.682579727472242,1.0,3/15,5.63%,APOA1;LCAT;PLTP
prerank,positive regulation of dendrite development (GO:1900006),-0.5080548150545376,-1.1960282987507065,0.2447058823529412,0.6832564969095594,1.0,4/10,2.62%,PTN;BMP5;BMP7;COBL
prerank,positive regulation of transmembrane transport (GO:0034764),0.5554139540440234,1.1960078821705789,0.268370607028754,0.6820656934772982,1.0,4/13,6.78%,AZIN1;ACSL5;ANO6;P2RX7
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.39155271191582197,1.1956567675133716,0.18764044943820224,0.6822716198676593,1.0,37/114,20.67%,AIM2;ACTN4;TNFRSF18;PSMD13;TNFRSF25;TRAF1;TNFRSF1B;COMMD7;ADAM17;PSMD4;STAT1;JAK2;LTB;PSMA5;PSMB10;NFKBIA;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6;TNFRSF11A;PSMB2;BAG4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.48261872408390943,1.1956229309061996,0.23726346433770015,0.6816387878664575,1.0,11/28,16.16%,ECSCR;DAB2IP;PTK2;FBXW7;LAPTM5;CLU;SMURF1;PSMC3;PSMC5;PSMC6;RNF139
prerank,response to leucine (GO:0043201),-0.5091098868276016,-1.1955169289068275,0.24759615384615385,0.6808932456820335,1.0,3/10,10.41%,KLHL22;SESN1;SESN2
prerank,cellular response to leucine (GO:0071233),-0.5091098868276016,-1.1955169289068275,0.24759615384615385,0.6808932456820335,1.0,3/10,10.41%,KLHL22;SESN1;SESN2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4602572799840295,1.1952941718985426,0.24714285714285714,0.681817681689709,1.0,5/33,9.01%,CCR1;CASP8;FES;LEF1;CTNNBIP1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.51803523157507,1.1951612681153219,0.2532258064516129,0.6814503943379024,1.0,3/17,9.11%,TEK;FES;STAP1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3570013165808928,1.1950802541030523,0.036,0.6809219420605964,1.0,128/834,13.29%,NOS1;LMO7;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;NR1I3;HEY1;ARHGEF2;TAL1;KLF7;DAB2IP;IRF2;PRKD1;ZNF296;F2RL1;TGFB2;HNF1A;HNF4A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;PELP1;HEY2;TLR3;KLF4;PLXND1;IER5;ACVR1;WWTR1;LEF1;BCLAF3;MAFF;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;FOSL2;BRD8;APEX1;GATA3;TOX3;RXRG;CHCHD2;SETX;ZC3H12A;PPP3CA;STAT1;GAL;AATF;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;UBA52;NFE2L2;NAMPT;RPS27A;MRTFA;NR1D1;JUN;TCF3;EGR1;HMGB1;DHX9;SS18;PLAG1;RPS6KA1;RPRD1B;NFKBIA;TET3;TNKS;CRTC1;MAML2;NPM1;PHOX2A;PCBP1;EAF2;E2F7;BRCA1;NR4A1;HELZ2;PRKD2;HINFP;MED30;GCN1;IRF5;SETD3;CTBP2;GLYR1;RPS6KA3;PSMC3;ITGB1BP1;PIN1;POU3F2;APLN;PHIP
prerank,regulation of filopodium assembly (GO:0051489),-0.36695526750409924,-1.1947298551843297,0.20666666666666667,0.6811665930452445,1.0,11/38,13.25%,DPYSL3;DOCK11;RHOQ;FXR2;ARAP1;RIPOR2;PIK3R1;BCAS3;CAPZB;GAP43;PALM
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5553415256514371,1.1943902959779142,0.281198003327787,0.682099713946744,1.0,2/12,5.92%,LMO2;BRD8
prerank,activation of GTPase activity (GO:0090630),0.3960358891537972,1.194237568750028,0.2133492252681764,0.6817968605733201,1.0,25/89,13.86%,RABGAP1;SIPA1L2;ARHGEF15;ABR;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;TBC1D8;TIAM2;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;TBC1D1;RAP1GAP2;TAX1BP3;RALGAPB;USP6NL;TBC1D10A;TBC1D4;TBC1D9;RALGAPA2;ARHGEF10
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5247321672203087,1.1941891146501078,0.25588697017268447,0.6812019209753712,1.0,2/17,1.44%,KCNQ1;KCNE3
prerank,negative regulation of viral process (GO:0048525),0.426928820151,1.193971684576595,0.2222222222222222,0.6810619204667686,1.0,18/57,21.70%,TRIM14;IFIH1;TRIM11;TRIM6;STAT1;PLSCR1;OAS2;TRIM8;CHMP3;SLPI;RSAD2;SRPK1;IFITM3;ZC3HAV1;MID2;EIF2AK2;BANF1;HEXIM1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.391843846841831,1.1936613328054446,0.18213457076566125,0.6811692201996294,1.0,35/124,18.86%,CCDC88C;FZD6;PLCB1;TNRC6C;AP2B1;PSMD13;LEF1;NLK;PSMD4;PPP3CA;PSMA5;AP2M1;PSMB10;AGO4;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;PSMB5;CTNNB1;PSMC5;FZD9;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4476019756996221,-1.193113588311859,0.2418478260869565,0.6839963523768514,1.0,5/16,15.19%,ANK2;BCAP29;SEC16B;BCAP31;SEC16A
prerank,central nervous system neuron development (GO:0021954),0.5284641565662787,1.193108557699418,0.27936507936507937,0.6819478627274554,1.0,3/15,9.87%,RAPGEF2;ATP7A;B4GALT6
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3337047410942582,-1.1927821654913857,0.16666666666666666,0.6830437629362519,1.0,11/52,9.70%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;STX4;PIK3R1;CLIP3;PRKCI;STX3;CNST
prerank,manganese ion transport (GO:0006828),-0.471284371629513,-1.1921890767740786,0.24691358024691357,0.6828595966383226,1.0,6/14,9.43%,SLC39A14;SLC30A10;TRPC3;SLC39A8;TRPC6;TRPC4
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.413430933759468,1.191591928574733,0.2190237797246558,0.6854222343802661,1.0,9/72,11.55%,ACER2;PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7
prerank,response to interferon-beta (GO:0035456),0.48876307904011596,1.1913721831881403,0.2514792899408284,0.6852762317203631,1.0,6/22,8.74%,AIM2;TRIM6;IRGM;STAT1;PLSCR1;ACOD1
prerank,base conversion or substitution editing (GO:0016553),0.5583183557450617,1.1912182130000128,0.2838709677419355,0.6849658486015793,1.0,2/11,9.00%,ADARB1;ADAR
prerank,regulation of cell cycle (GO:0051726),0.36489859611950454,1.1893734275339778,0.15233160621761657,0.6893640197475701,1.0,32/271,9.52%,MECOM;NANOS3;AFAP1L2;IRF6;GATA6;APBB2;FOXO4;NOTCH1;DUSP1;ADARB1;DAB2IP;TTC28;TGFB2;RHOB;IQGAP1;BOP1;RPRM;PPP1R13B;GMNC;ASAH2;GATA3;PDCD4;MADD;UHMK1;WHAMM;GADD45G;APC;PIM3;NEK7;JUN;ADAM10;MLF1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5632251400123492,1.188756041252815,0.24126455906821964,0.6896427505154014,1.0,7/11,23.97%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5632251400123492,1.188756041252815,0.24126455906821964,0.6896427505154014,1.0,7/11,23.97%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.46884380034815143,1.1875018151808,0.24447717231222385,0.6922842275226765,1.0,4/28,10.12%,NOD2;SH3KBP1;CD47;TYROBP
prerank,protein stabilization (GO:0050821),0.37486648188641786,1.187070331092302,0.18995633187772926,0.6926925722078842,1.0,30/168,13.44%,SOX17;HIP1;MSX1;SMAD7;HIP1R;GNAQ;TMEM88;SAXO1;APOA1;EFNA1;NLK;TAF9B;IRGM;HSPA1B;DNLZ;CCT8;STX12;GAPDH;RTN4;FBXW7;TYROBP;PTGES3;GET1;BAG6;CCT2;SUGT1;CLU;CCT4;PIN1;HYPK
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3829608286098519,-1.1869072904398654,0.22569444444444445,0.696327775680469,1.0,8/27,14.19%,SLC1A3;SLC7A2;SLC47A1;SLC25A13;SLC6A9;SLC38A5;SLC1A4;SLC25A12
prerank,regulation of ERAD pathway (GO:1904292),0.557663583778296,1.1868894538125163,0.29642248722316866,0.6924125046234296,1.0,3/11,11.00%,AQP11;RNF185;BAG6
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.523743405717801,1.186857931011187,0.27813504823151125,0.6917943810862873,1.0,6/15,15.16%,SMAD7;FKBP1A;ACVR1;ACVR2A;CSNK2B;ACVR2B
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.38633676228259817,-1.1856521084837903,0.24104234527687296,0.6980908298531889,1.0,5/27,3.24%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.41368398903230014,-1.18517452291649,0.2289156626506024,0.6974719365557405,1.0,6/20,12.62%,B3GALT1;ST6GALNAC6;ST3GAL4;B4GALT1;MPDU1;ST6GALNAC5
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4482441064937627,1.1851690907789518,0.25176803394625175,0.6957364840036989,1.0,9/37,12.15%,STMN2;EFNA5;FAM107A;CLASP1;MAPRE3;PRKAA1;ROCK1;CLASP2;MARK2
prerank,negative regulation of T cell proliferation (GO:0042130),0.4747424435396414,1.1851399597621504,0.2672672672672673,0.6950716882101741,1.0,4/28,9.97%,CRTAM;LGALS9;ARG1;PRNP
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.40220353486308025,-1.1850799363262456,0.196875,0.6958048050682789,1.0,9/24,21.25%,ERRFI1;ROCK2;RUNX1;SRSF6;HOXA7;CTSL;ZFP36;NME2;ETV4
prerank,regulation of stress fiber assembly (GO:0051492),-0.32322740516403864,-1.1839156461799,0.1657754010695187,0.6971517335948805,1.0,15/74,7.14%,ARHGAP6;PHLDB2;LPAR1;ROCK2;ARHGAP28;ASAP3;TGFBR1;CCN2;ARHGEF10L;PPM1E;TPM1;ARAP1;ALMS1;PIK3R1;TMEFF2
prerank,cellular response to chemokine (GO:1990869),0.43698346169509406,1.1838085216537686,0.23265306122448978,0.6980327932490701,1.0,7/46,10.16%,CCR1;DUSP1;OXSR1;LRCH1;ZC3H12A;STK39;CCL4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2851588862021284,-1.1834248594019345,0.09259259259259259,0.696625702274379,1.0,21/129,7.93%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;GPC3;PTK7;ZEB2;WNK1;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;SFRP4;DAAM2;PSMF1;LYPD6;PPM1A
prerank,apoptotic process (GO:0006915),0.3703856685540114,1.1834102850799095,0.17690677966101695,0.6983522542882307,1.0,37/203,11.32%,HIP1;EFNA5;ELMO1;FAS;TBX1;PLK3;PAEP;FOXO1;CASP8;RHOB;APP;ADAM15;CASP2;TNFRSF25;BRAT1;DDX41;IAPP;DAP;IL1A;PDCD4;BBC3;ZBTB16;CIDEB;PLSCR1;BCL2L1;JAK2;RFK;NCKAP1;MAL;GAPDH;TAOK2;RTN4;PRUNE2;CASP1;NFKBIA;BAG6;DCC
prerank,BMP signaling pathway (GO:0030509),0.4166440330789988,1.1833405276910405,0.22431077694235588,0.6978145939420166,1.0,10/62,6.31%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.42549744656999855,1.183182573446855,0.25063291139240507,0.6975164705934466,1.0,10/53,16.45%,CCR1;HRH2;CHRM3;HTR5A;MTNR1B;HTR1B;HTR2A;HTR1F;HRH3;HTR4
prerank,response to peptide (GO:1901652),0.46188959644821215,1.182844185359742,0.2387005649717514,0.69774062548176,1.0,11/33,20.02%,FYN;NOD2;CACNA1A;STAT1;EIF2B2;PRNP;IRF5;KAT7;ERBIN;AGER;STAT5A
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3985230906952588,1.1823761238629962,0.21863799283154123,0.6983085689887568,1.0,11/85,4.45%,SGPP2;TIE1;TBX1;ACVRL1;NOD2;B2M;DAB2IP;AQP11;PRKD1;TGFB2;ANGPT1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3981649084056985,1.182348887408758,0.22168087697929353,0.697655395228237,1.0,9/79,3.31%,MMRN2;SMAD6;BMPR2;SMAD7;NOTCH1;ATP2B4;DAND5;DAB2IP;HHEX
prerank,positive regulation of microtubule polymerization (GO:0031116),0.4697210282994369,1.1819915568630441,0.2565217391304348,0.6978619008269042,1.0,8/28,14.42%,OCLN;FES;CLIP1;CLASP1;HSPA1B;RAC1;NUMA1;NAV3
prerank,cAMP-mediated signaling (GO:0019933),-0.3945519981065093,-1.1817997151756146,0.23121387283236994,0.6994306050491558,1.0,6/24,5.64%,PDE7B;PDE3A;ADCY1;ADGRG6;KSR1;ADCY2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.35225208937521024,-1.1817270655860659,0.19591836734693877,0.6976996238113221,1.0,10/41,13.72%,UBE2E2;PRKN;UBE2V2;TRAF3IP2;UBE2N;RNF135;RNF4;RNF152;BFAR;ARIH2
prerank,regulation of protein kinase B signaling (GO:0051896),0.3678125301441433,1.1812265505351045,0.17513513513513512,0.6992171790242445,1.0,22/193,9.49%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;INPP5K;RRAS;ANGPT1;GCNT2;HYAL2;FGFR3;PLEKHA1;IAPP;GATA3;MFHAS1;THPO;PPP2R5C;PTK2;RTN4
prerank,connective tissue development (GO:0061448),-0.36358744629015105,-1.1808786418246267,0.23272727272727273,0.698134523981384,1.0,7/35,5.81%,SOX5;SULF1;SULF2;TRIP11;SH3PXD2B;ITGB8;SLC39A13
prerank,actin cytoskeleton reorganization (GO:0031532),0.41142010169425797,1.180732706421112,0.23282442748091603,0.6997896375980582,1.0,11/63,7.08%,TRPV4;S1PR1;PLEK2;THSD7A;PARVB;CDC42BPA;NEDD9;CDC42BPG;ATP2C1;MYH9;WHAMM
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5259303841443002,1.1807117752885108,0.2630718954248366,0.6991261110223581,1.0,4/14,12.25%,TLR3;TIRAP;CARD10;COPS8
prerank,cochlea morphogenesis (GO:0090103),0.5595837646983144,1.180481046292852,0.29094076655052264,0.6990278821435073,1.0,1/10,1.26%,TBX1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.41267134985760273,1.1797566450210981,0.24812030075187969,0.7002802205005053,1.0,25/67,18.86%,B2M;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMC3;TAPBP;PSMA8;PSMC1;PSMB5;PSMC5;NCF2;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5174545685493657,1.179708887884622,0.26749611197511663,0.6996923681460365,1.0,2/17,2.63%,RAPGEF2;ADRB2
prerank,protein secretion (GO:0009306),-0.3292059394836196,-1.1795697659718631,0.19140625,0.7000332163052337,1.0,22/56,26.68%,WLS;STEAP3;ABCA1;TANGO2;ANXA1;COPG1;MTTP;PPY;TVP23B;SVBP;RCN3;RAB3D;MON1A;PDIA4;PREB;PORCN;TMEM167A;LTBP2;RAB3C;RAB15;NECAB3;ADCYAP1
prerank,liver development (GO:0001889),-0.3621785159009899,-1.178904580948707,0.19463087248322147,0.7000131454136045,1.0,7/32,10.95%,TGFBR3;WNT4;COBL;NPHP3;ANXA1;CEBPB;MET
prerank,N-terminal protein amino acid modification (GO:0031365),-0.45471211628358865,-1.1788739383555258,0.23772609819121446,0.6982312819898182,1.0,7/14,25.40%,METAP1D;METAP1;NAA60;NAA40;NAA50;NAA10;NAA15
prerank,positive regulation of secretion by cell (GO:1903532),0.4061319730456836,1.178503622272864,0.2408575031525851,0.7022879956104385,1.0,20/70,19.57%,EDN1;CD2AP;CADPS2;UNC13B;TGFB2;TMED10;IL1A;CLASP1;CLASP2;CADPS;ACHE;RAB27B;STXBP5;GOLPH3L;RAB27A;GOLPH3;PPID;SOX11;MYO18A;ANG
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4517156323964909,1.1779783683934528,0.251088534107402,0.7029642221711859,1.0,8/35,11.28%,TEK;F11R;ESAM;FES;ARHGDIA;STAP1;TJP1;TRPM2
prerank,T cell migration (GO:0072678),0.5458045126165905,1.177747879958096,0.28084415584415584,0.7028583969611769,1.0,2/13,4.24%,S1PR1;MSN
prerank,central nervous system myelination (GO:0022010),0.5638813488498629,1.177359889760084,0.3152542372881356,0.7032092694561852,1.0,4/11,12.09%,B4GALT6;TENM4;CLU;SOX10
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3954223518878601,-1.1772966192827237,0.23123123123123124,0.7008793133233471,1.0,4/24,1.40%,SOX5;ADAMTS12;EFEMP1;TGFBR1
prerank,establishment of melanosome localization (GO:0032401),0.5091475331545191,1.1772106703361933,0.28763040238450077,0.7028624188090288,1.0,4/19,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,neutrophil degranulation (GO:0043312),0.356853316847014,1.1768839157184767,0.11393692777212615,0.703026822563327,1.0,59/425,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,nucleosome disassembly (GO:0006337),-0.4584641948968624,-1.176646370045059,0.2692307692307692,0.699147089800874,1.0,3/14,10.19%,SET;SMARCB1;SMARCD1
prerank,chromatin disassembly (GO:0031498),-0.4584641948968624,-1.176646370045059,0.2692307692307692,0.699147089800874,1.0,3/14,10.19%,SET;SMARCB1;SMARCD1
prerank,cellular response to metal ion (GO:0071248),0.3786289678188397,1.1765998752955504,0.22869955156950672,0.7030882637572646,1.0,19/123,9.97%,PLCG2;SYT15;ITPKB;B2M;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;MAPK1;CPNE2;LRRK2;MCOLN1;MT2A;PRKAA1;JUN;PRNP
prerank,ether lipid biosynthetic process (GO:0008611),-0.49185742438344915,-1.1762542211477862,0.2727272727272727,0.6984252091193607,1.0,7/10,21.08%,GNPAT;LPCAT2;PLA2G4A;PEDS1;CHPT1;PEX7;PLA2G4C
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.41143014421511076,-1.1762465546216565,0.24702380952380953,0.6965706769431897,1.0,9/20,20.52%,LDB1;MEIS1;PAF1;HOXA5;CTR9;MAFB;HOXB8;ZFP36;CIB1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.37393315327968324,1.176148145217497,0.19803063457330417,0.7036041972239461,1.0,38/161,16.05%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;CUL3;PSMD4;SHISA6;PTPRU;PTPRO;APC;SNAI2;MCC;IGFBP4;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;NKD2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;MLLT3;PSMC5;PSMB9;PSMC6;LZTS2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.48918476437883246,1.1761188359569175,0.25796661608497723,0.7029780033783982,1.0,9/22,21.60%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5653183927319985,1.1760970625944476,0.2992,0.7023210474174996,1.0,4/11,10.12%,F2RL1;ITGAM;STAP1;TYROBP
prerank,regulation of DNA metabolic process (GO:0051052),-0.3391372177915334,-1.1757823926276123,0.18613138686131386,0.6960243867074976,1.0,13/44,14.43%,NUCKS1;UBE2V2;UBE2N;USP1;KPNA1;YLPM1;HELB;THOC1;WDR70;SUB1;MPHOSPH8;MPV17;XRCC5
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5489959613636576,1.1755713860732593,0.3041958041958042,0.7030457670634934,1.0,1/12,1.73%,NOD2
prerank,protein-containing complex subunit organization (GO:0043933),0.38497191940753706,1.1754479717061612,0.21649484536082475,0.7026778285954086,1.0,21/109,15.93%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;CARD10;TRAF1;CD247;IL1RAP;APC;NUP54;NUP35;RANBP9;TAPBP;CAPG;PPIH;KPNA3;CLDN14;VIL1;NUP205
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5404536503530906,1.174672602723558,0.2916666666666667,0.704030239309997,1.0,5/12,11.83%,IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.48061485667660653,-1.1745242919552483,0.2658536585365854,0.6978292895908877,1.0,5/11,15.80%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.44482482258089695,1.174383581937886,0.24317295188556567,0.7040644947981709,1.0,13/40,20.93%,GBP4;TIRAP;DEFA6;ADAM17;GBP2;CHGA;RNASE6;HMGB2;DROSHA;STAB2;GBP7;ANG;RPL39
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.42972569952789313,-1.1743259185180719,0.2347560975609756,0.6965830163318218,1.0,4/18,5.47%,PTN;CAMK1D;SLIT2;IL6R
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5639596335337925,1.1741467467675961,0.287215411558669,0.7033038551610865,1.0,2/10,3.83%,APOA1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5639596335337925,1.1741467467675961,0.287215411558669,0.7033038551610865,1.0,2/10,3.83%,APOA1;KLF4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4749465270317018,1.173939399582073,0.27976190476190477,0.7031458246834639,1.0,6/24,13.20%,ACE;B2M;MFSD6;TAP1;SEC24B;TAPBP
prerank,myelination in peripheral nervous system (GO:0022011),-0.4676387941006028,-1.173812700718782,0.26785714285714285,0.6963119278057185,1.0,6/13,19.93%,ADGRG6;DICER1;PARD3;LGI4;SIRT2;NF1
prerank,positive regulation of organelle organization (GO:0010638),0.4602340791219086,1.173480944394178,0.2661179698216735,0.7036390616005266,1.0,10/32,12.53%,DOC2B;ADRB2;SMCR8;P2RX7;IRGM;FYCO1;RAB3GAP2;PFDN2;TMED9;SORBS3
prerank,negative regulation of cytokine production (GO:0001818),0.37483065022438106,1.1732804418187426,0.2059145673603505,0.7034830599650616,1.0,30/163,11.23%,CEACAM1;RPS6KA5;F2RL1;IFIH1;LGALS9;HOMER2;HDAC9;HDAC7;UBA7;APOA1;KLF4;FCGR2B;LEF1;CD34;RNF125;PDCD4;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CACTIN;HMGB1;PRNP;TRIM25;TYROBP;RAC1;VSIR;LAPTM5
prerank,peptide metabolic process (GO:0006518),-0.30962757520287076,-1.1732326472886687,0.15083798882681565,0.6960473676361975,1.0,20/75,14.82%,AEBP1;CPQ;DMD;BACE2;ANPEP;GSTT1;MGAT3;CPE;BACE1;HM13;CARNMT1;CPXM2;GSTZ1;CPXM1;ENPEP;ETHE1;SPCS3;CLN5;GSTA3;GSTM1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.467675847587799,-1.1731357202542123,0.29745042492917845,0.6945054745510402,1.0,3/14,3.67%,DMD;WNK1;WNK4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.40459158106960785,1.1730927151040014,0.23869346733668342,0.7032537133628906,1.0,23/70,20.25%,FAS;DAB2IP;CASP8;TGFB2;TLR3;CASP2;FGFR3;TNFRSF1B;P2RX7;CRADD;BCL2L1;JAK2;DELE1;DCC;CASP8AP2;DAXX;SIVA1;GSK3A;DDX47;BID;MCL1;SORT1;GSK3B
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5434754820020125,1.172878274671891,0.29448818897637796,0.7031484928845606,1.0,3/13,10.12%,F2RL1;ITGAM;TYROBP
prerank,positive regulation of chemokine production (GO:0032722),0.4369292647603109,1.1727684124132811,0.26220362622036264,0.7027290192063927,1.0,8/44,9.50%,F2RL1;LGALS9;APP;TLR3;TIRAP;ADAM17;EGR1;HMGB1
prerank,negative regulation of protein processing (GO:0010955),-0.47305300868965333,-1.172667724055904,0.2782152230971129,0.6940087051406872,1.0,5/12,13.59%,GAS1;SERPINE2;THBS1;SERPINE1;SNX12
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.38814665716118874,-1.1720772793935172,0.23839009287925697,0.6939166297386585,1.0,7/25,12.11%,EGFR;THBS1;SRC;FZD7;SDCBP;PTH1R;NCKAP1L
prerank,neutrophil activation involved in immune response (GO:0002283),0.35587783848263016,1.1719471746921972,0.12155260469867211,0.7041748826099402,1.0,59/428,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,regulation of mitotic nuclear division (GO:0007088),0.4250913078194883,1.171881017407291,0.2591623036649215,0.7036329479617847,1.0,8/55,7.99%,EDN1;PDGFB;INSR;DUSP1;CAV2;CDC25C;IL1A;TOM1L1
prerank,response to thyroid hormone (GO:0097066),0.5388230724866876,1.171875175323265,0.2945091514143095,0.7029394127766414,1.0,2/13,5.92%,LMO2;BRD8
prerank,B cell homeostasis (GO:0001782),-0.4989794609705873,-1.1718055805562229,0.28,0.6928514332476963,1.0,3/10,12.11%,DOCK11;DOCK10;NCKAP1L
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5316934016341403,1.1717050189249072,0.2739059967585089,0.7027506318658384,1.0,6/15,12.26%,TNRC6C;BTG2;TENT4A;POLR2G;CNOT1;TOB1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.29522297064553676,-1.1708016572130397,0.13934426229508196,0.6938295148308798,1.0,33/117,19.82%,IGF1;ALDH1A2;PCCA;ABAT;CYP26B1;PPARA;CPT1C;ME1;GNPAT;ACOT11;ALDH4A1;AASDH;MCCC2;NAAA;SCP2;GGT5;PPARG;CKB;LDHB;ECHDC3;THEM4;GBA2;AMACR;PDHA1;PDHX;HLCS;ACOT6;DLAT;HACL1;ACSF2;LPL;PANK2;ALOX12
prerank,negative regulation of neurogenesis (GO:0050768),0.445391189398219,1.169930128111095,0.2699300699300699,0.706707018931945,1.0,6/34,9.49%,RAPGEF2;NOTCH1;B2M;ARHGDIA;PCM1;RTN4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.49933541434631246,1.1688064541114584,0.30368098159509205,0.7090814391115984,1.0,5/17,12.41%,FCHSD2;NCKAP1;CYFIP1;WASF2;CTNNA2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4588105890774494,1.1686989182093899,0.2774725274725275,0.7086620133471302,1.0,9/32,14.92%,APOA1;SLC44A1;LCAT;PCYT1A;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B
prerank,glycerophospholipid metabolic process (GO:0006650),0.3989181253629382,1.1686778590212386,0.25280199252801994,0.7080094590999598,1.0,20/75,17.34%,PLCB1;IP6K3;GPCPD1;APOA1;ACP6;LCAT;FAR1;PNPLA6;CRLS1;ABHD6;GDPD1;DGKH;ENPP6;PLCG1;SERINC5;PIGF;AGK;PIGQ;PIGC;SYNJ1
prerank,regulation of innate immune response (GO:0045088),0.4152713185121612,1.1685401857426587,0.24872448979591838,0.7076678255925977,1.0,12/57,10.63%,GBP5;CASP8;TIRAP;FCGR2B;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;CACTIN;DHX9;PTPN1
prerank,protein localization to membrane (GO:0072657),0.36624853519981165,1.1685330384998478,0.20238095238095238,0.7069831935756957,1.0,31/187,10.72%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;AGRN;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;SHANK3;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;NUP54;RAB40B;CLASP2;NKD2;TM9SF1;PDZD11
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4293278370625452,1.1678276801136702,0.25984251968503935,0.7082175626127205,1.0,4/48,4.95%,NOS1;FKBP1A;DIAPH1;CAMK2D
prerank,cardiac muscle cell development (GO:0055013),0.49159627165376324,1.1665014520345551,0.28149300155520995,0.7111281394129335,1.0,5/20,4.46%,SORBS2;HEY2;SLC8A1;ALPK3;PDLIM5
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.46542350883778993,1.16649494786441,0.2772133526850508,0.710437071707923,1.0,10/29,18.99%,LSM1;EXOSC3;DCPS;DCP1B;EXOSC8;EDC3;NT5C3B;DDX6;EXOSC9;LSM2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3474741747856724,1.166030705680945,0.03,0.7110008530646162,1.0,156/1082,13.15%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;AFAP1L2;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;PLCB1;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;NR1I3;HEY1;ARHGEF2;TAL1;KLF7;DAB2IP;IRF2;PRKD1;ZNF296;F2RL1;HNF1A;HNF4A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;FLI1;PELP1;INPP5K;HEY2;TLR3;KLF4;IER5;ACVR1;ING2;WWTR1;SERTAD2;LEF1;BCLAF3;SERTAD1;MAFF;KARS1;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;ZBTB48;FOSL2;BRD8;APEX1;GATA3;TOX3;RXRG;CHCHD2;SETX;RYBP;ZBTB16;FANK1;ZC3H12A;KDM3A;PPP3CA;STAT1;GAL;AATF;MAPRE3;EBF3;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;DNAJC2;UBA52;NFE2L2;NAMPT;RPS27A;MRTFA;KMT2E;NR1D1;KMT2B;JUN;SERTAD3;TCF3;EGR1;HMGB1;DHX9;SS18;PLAG1;SEC14L2;MAD2L2;ASF1A;RPS6KA1;SFR1;RPRD1B;NFKBIA;TET3;TNKS;DEAF1;RAI1;CRTC1;MAML2;NPM1;PHOX2A;PCBP1;EAF2;E2F7;BRCA1;NR4A1;CD38;ILF2;HELZ2;DTX3L;PRKD2;SOX10;HINFP;MED30;IRF5;SETD3;ELF2;CTBP2;GLYR1;RPS6KA3;YWHAH;PSMC3;ITGB1BP1;PIN1;POU3F2
prerank,positive regulation of dendrite extension (GO:1903861),0.5099652323282347,1.1658810703006166,0.2992248062015504,0.7106924839617524,1.0,6/17,18.29%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT1;SYT2
prerank,excitatory postsynaptic potential (GO:0060079),0.49854256342767483,1.1657504457471883,0.2859399684044234,0.7103636243574545,1.0,8/19,20.25%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GRID2;GSK3B
prerank,regulation of response to biotic stimulus (GO:0002831),0.46240086226374033,1.1656911850064748,0.27153284671532846,0.7098296318083708,1.0,4/28,4.30%,GATA6;CASP8;TIRAP;FCGR2B
prerank,positive regulation of developmental process (GO:0051094),-0.27818599413922596,-1.1649795836479504,0.12643678160919541,0.708582942676468,1.0,29/164,9.47%,PHLDB2;PTN;BMPR1A;SOX5;DCN;FOXD1;CCN2;BMP5;BMP7;BMP4;COBL;WNT5A;GRIP1;APOE;GJA1;ADGRL1;DLG4;LMNA;RREB1;PRKN;DDHD1;CAMK1;DAG1;SRC;KMT5C;SYDE1;CEBPB;VEGFA;ACVR1B
prerank,protein N-linked glycosylation (GO:0006487),-0.3176947495967738,-1.1643130075958665,0.1702127659574468,0.7085791984049746,1.0,23/66,19.04%,MGAT4C;MGAT4A;ST6GAL1;TUSC3;MGAT3;MAN1C1;STT3A;SLC39A8;B4GALT1;LMAN1;UGGT2;MPDU1;GFPT1;GFPT2;DPM2;PGM3;ALG8;OST4;MAGT1;PMM1;ALG9;STT3B;ALG13
prerank,signal transduction in response to DNA damage (GO:0042770),0.4243662744287936,1.1641369604962981,0.26666666666666666,0.7132638903386803,1.0,15/49,19.45%,ACER2;MAD2L2;BRIP1;E2F7;HINFP;STK33;RAD1;ATM;MAP3K20;FBXO6;MAPK14;TIPRL;ATRIP;BID;HUS1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4667647776941882,-1.1641192356566452,0.2860635696821516,0.707235006248955,1.0,7/12,28.08%,GMDS;EXTL2;GFPT1;GFPT2;PARG;CSGALNACT1;GALT
prerank,cell part morphogenesis (GO:0032990),-0.4634059019881123,-1.164008911693969,0.2849740932642487,0.7056960706536649,1.0,2/13,3.16%,PID1;WASF1
prerank,negative regulation of protein secretion (GO:0050709),-0.3518331399281625,-1.1639098041472196,0.1962962962962963,0.704192364510045,1.0,15/38,22.91%,APOE;PRKN;CCN3;IRS1;RAB11FIP1;REST;ADRA2A;DRD2;SERGEF;KCNB1;NR1H3;RHBDF1;CYP51A1;ERP29;INHBB
prerank,replicative senescence (GO:0090399),-0.4731460428773312,-1.163879959736762,0.2809278350515464,0.7024833465672117,1.0,6/12,20.95%,PLA2R1;SERPINE1;ATR;TERT;WNT16;ROMO1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3869796093516948,1.1634301400311753,0.23006833712984054,0.7145053533773413,1.0,25/107,20.25%,RASGRF2;ATP2A3;DAB2IP;RHBDD1;RNF185;UFM1;BBC3;MBTPS2;HSP90B1;JUN;BAG6;TMX1;PPP1R15B;EIF2S1;RNF139;UBXN6;NCK1;SEL1L;TRIB3;CCDC47;SELENOK;DNAJC10;ERN1;RNF5;GSK3B
prerank,regulation of actomyosin structure organization (GO:0110020),-0.4674641323265241,-1.1632830771149087,0.2593516209476309,0.7023593628837517,1.0,3/13,4.84%,ROCK2;ASAP3;ALMS1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.44590369931749513,-1.1629382039358558,0.2802056555269923,0.7015287361112186,1.0,6/14,22.83%,PPARA;IRS2;IRS1;MFSD2A;TWIST1;MTLN
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.43962448754383676,-1.1628811025094827,0.2706552706552707,0.6999403240694666,1.0,5/16,12.36%,SNW1;RBMX;NCBP1;DAZAP1;TRA2A
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.45666772061215316,1.162528927943063,0.2698191933240612,0.7163198577294505,1.0,10/32,21.23%,DEFA6;GALP;GAPDH;RPL30;RNASE6;FAM3A;CXCL10;ANG;RPL39;RPS19
prerank,regulation of establishment of protein localization (GO:0070201),0.5364506652797633,1.1624140715971556,0.3092105263157895,0.7159390803426483,1.0,8/13,32.00%,CEP135;SPIDR;CEP120;DNAJA1;PTP4A3;SCFD1;GAPVD1;CEP295
prerank,positive regulation of axon extension (GO:0045773),0.48668153792899116,1.1622666775370591,0.28593272171253825,0.7155960111486871,1.0,5/22,7.01%,MACF1;NTN1;SHTN1;SEMA7A;ISLR2
prerank,regulation of cellular catabolic process (GO:0031329),0.4168751200185259,1.162104589885574,0.25987261146496815,0.7152995200115803,1.0,18/62,17.76%,ACER2;FBXL2;DRAM1;GPR137B;SMCR8;DEPP1;LRRK2;HSPB1;ROCK1;RRAGD;TPCN2;DRAM2;KEAP1;ATM;RMC1;LONP2;TRIB3;TYSND1
prerank,negative regulation of viral transcription (GO:0032897),0.5392310923933823,1.162084046949462,0.2845659163987138,0.7146536926341384,1.0,2/13,4.67%,TRIM14;TRIM11
prerank,myeloid cell differentiation (GO:0030099),0.4238622876778094,1.1620449878419208,0.2609853528628495,0.7140579339439208,1.0,9/47,8.61%,TAL1;SNRK;TIRAP;ZBTB16;MFHAS1;CEBPA;JAK2;RPS14;KMT2E
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.42171678334589063,1.1617575360897252,0.2647058823529412,0.7141498690761316,1.0,11/46,15.69%,PLCB1;GSTA2;MSN;PDCD4;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4693361985181178,1.1610762698449326,0.2808641975308642,0.7152465482487275,1.0,3/26,3.64%,CEACAM1;GPR137B;TLR3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5271857712918413,1.1608621724895112,0.2972536348949919,0.7151514461418043,1.0,5/14,17.56%,F2RL1;APOA1;TRAIP;PTPN2;PYDC1
prerank,positive regulation of protein transport (GO:0051222),0.40234724521426457,1.1608186521412125,0.26322263222632225,0.7145694349096776,1.0,21/67,19.57%,CD2AP;UNC13B;PLK3;TGFB2;ATP2C1;TMED10;IL1A;PRR5L;PCM1;VPS28;RIPOR1;ACHE;ICE1;PDCD10;RACK1;TENM1;GOLPH3L;GOLPH3;PPID;MYO18A;ANG
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.5508610283779443,1.1606063312220556,0.28642384105960267,0.7144652690109978,1.0,7/10,30.69%,GABRA4;GABRA2;GABRE;GABRG3;GABRA3;GABRB2;GABRA5
prerank,regulation of dendrite extension (GO:1903859),0.5036781155102368,1.1605332279469842,0.2929447852760736,0.7139533805278905,1.0,6/18,18.29%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT1;SYT2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3806922801191925,-1.160297527531329,0.24367088607594936,0.7056125934769327,1.0,7/27,7.14%,ARHGAP6;PHLDB2;ARHGAP28;ARAP1;PRKN;PIK3R1;TMEFF2
prerank,spliceosomal complex assembly (GO:0000245),-0.32582314854028466,-1.1599518254510197,0.20866141732283464,0.704726234751757,1.0,9/46,10.83%,CELF2;SRSF5;SCAF11;NCBP1;SRSF1;SMN1;PUF60;SRSF6;DDX1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3478394680019778,1.1599152336670648,0.12474849094567404,0.7148460883773118,1.0,65/497,12.28%,PRDM16;NANOS1;MECOM;SOX13;NANOS3;GATA6;PLCB1;PDGFB;DACH1;BMPR2;RPS6KA5;SMARCA2;ACVRL1;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;BTG2;ID1;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;SMAD2;BTAF1;DAP;GMNC;COMMD7;GATA3;EID2B;PDCD4;ZBTB16;PHC3;TMPRSS6;CEBPA;WWP1;ZHX3;PASK;GATAD2A;NR1D1;GAPDH;FOXP1;MBD1;JUN;ARID5A;ZBTB14;CNOT1;ENC1;CDAN1;DEAF1;SAMD1;DMAP1;BRCA1;CD38;ARID5B;HINFP;TOB1;SUV39H2
prerank,maturation of LSU-rRNA (GO:0000470),0.4720376409594811,1.1596974963577353,0.26788218793828894,0.7147607328591776,1.0,12/26,22.66%,BOP1;RPL7;MRPL1;RPL35;RRP15;NHP2;EIF6;RPL7L1;LAS1L;FTSJ3;URB1;RPF2
prerank,RNA destabilization (GO:0050779),-0.4323446928763254,-1.159052496498144,0.25761772853185594,0.7054763663382339,1.0,7/18,16.77%,ROCK2;YTHDF1;FTO;PUM1;LIN28B;YTHDF2;GIGYF2
prerank,carbohydrate biosynthetic process (GO:0016051),0.4806954803818349,1.1589741242819362,0.2986627043090639,0.7159688039868108,1.0,2/21,1.70%,ST8SIA6;ST3GAL6
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4801269305313415,1.1588912583939608,0.30229007633587784,0.7154860458009435,1.0,12/22,20.43%,NFE2L2;PSMA5;PSMB10;ENC1;PSMB8;PSMA7;PSMA8;PSMB5;PSMB9;PSMA4;PSMB6;PSMB2
prerank,regulation of nervous system process (GO:0031644),0.49386372705805337,1.158750782401962,0.2949526813880126,0.7151756680595353,1.0,2/18,2.98%,NOS3;APP
prerank,regulation of intracellular protein transport (GO:0033157),0.45275761445351875,1.1581082055692786,0.2829403606102635,0.7161366872334551,1.0,11/32,16.40%,PTPN14;PLK3;UHMK1;PRR5L;PCM1;RIPOR1;PTPN1;ICE1;LCP1;PDCD10;TENM1
prerank,heart contraction (GO:0060047),0.43148191149072657,1.1580463566139376,0.27055702917771884,0.7156030497817542,1.0,4/41,3.81%,KCNQ1;ACE;MYBPC3;SLC8A1
prerank,response to X-ray (GO:0010165),-0.4463856212609981,-1.157977246542277,0.27635327635327633,0.7066850530774085,1.0,5/14,17.74%,NUCKS1;NIPBL;ANXA1;XRCC5;IKBIP
prerank,activation of protein kinase B activity (GO:0032148),-0.37162804057590326,-1.1576391730341666,0.23052959501557632,0.7058924881042116,1.0,9/29,11.93%,IGF1;NTRK3;FGF1;WNT5A;OSBPL8;MAPKAP1;PPIA;TXN;ADRA2A
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.547818200835938,1.15763322974245,0.31118314424635335,0.715963486559698,1.0,4/11,10.11%,ATL2;ATL1;RTN4;LPCAT3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.4735271733408395,-1.1575246160544648,0.2923076923076923,0.7044743993663845,1.0,3/12,2.65%,NOTCH2;DOCK11;DOCK10
prerank,negative regulation of leukocyte migration (GO:0002686),-0.49482066531505364,-1.1574836969644562,0.2795969773299748,0.7028387979239854,1.0,4/10,15.59%,BMP5;SLIT2;HOXA7;CD300A
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4118034999546782,-1.1570255220920809,0.2789317507418398,0.7023484327527357,1.0,3/20,2.40%,FMNL2;ROCK2;RHOQ
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.42293778528873427,1.1569987605089187,0.26,0.7170073269702908,1.0,8/46,10.04%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3596044032556328,1.156322009499161,0.19597457627118645,0.7181020997256767,1.0,71/224,22.11%,UNC13B;APBA1;MPZ;PTCHD1;CACNA1A;NRGN;SNCG;HRH2;AKAP5;GABRQ;CHRM3;HCRTR1;MAPK1;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;HTR2A;ASIC2;SLC6A2;RPS6KA1;GABRA4;GRIK2;MINK1;NPY5R;HTR1F;SLC1A1;GABRA2;SLC1A2;GRM5;KCNC4;KCNA1;GABRE;RPS6KA3;PCDHB16;SYPL1;NPTX2;PCDHB14;GRIK1;CACNA1E;HRH3;GLRA2;PCDHB9;HTR4;CPLX1;SST;RIT2;GRIN2A;GABRG3;NPTX1;KCNQ3;GRM7;GABRB1;EXOC4;SYT1;PENK;HAP1;SLC1A6;HTR6;APBA2;GIPC1;UTS2;HCRTR2;KCNK3;NRXN1;MYCBPAP;GABRB3;NLGN1;KCNIP2;PDYN
prerank,defense response to protozoan (GO:0042832),0.5301864790705246,1.1560317884628026,0.29780033840947545,0.7182034053526466,1.0,4/12,16.69%,GBP4;GBP2;LYST;GBP7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3818554564597879,1.155523357502439,0.2540983606557377,0.7188545190550792,1.0,36/109,20.61%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;PLCG1;RAC1;TAB2;PSMB8;PSMD14;PIK3CB;BTK;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;SOS1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6;NFATC3;PSMB2;TAB1
prerank,negative regulation of secretion by cell (GO:1903531),0.43411160701072116,1.155487468475025,0.25546448087431695,0.7182489972628996,1.0,11/38,20.15%,NOTCH1;STXBP6;TNFRSF1B;SLC30A1;VAMP8;HTR1B;CHGA;HRH3;RSAD2;GRM7;DPH3
prerank,regulation of viral transcription (GO:0046782),0.4339412246326299,1.155409019110843,0.27140974967061926,0.7177833423966185,1.0,14/39,23.64%,TRIM14;TRIM11;POLR2G;DHX9;POLR2D;NELFB;POLR2I;NELFA;IFITM3;MID2;HEXIM1;POLR2C;POLR2B;POLR2J
prerank,proteasome assembly (GO:0043248),0.5416375952442584,1.155401395907264,0.31932773109243695,0.7171136585526354,1.0,6/11,21.80%,PSMD13;PSMD4;PSMD5;PSMD9;PSMG2;POMP
prerank,acyl-CoA biosynthetic process (GO:0071616),0.49947819649557884,1.1549419470097495,0.289922480620155,0.7176833759452078,1.0,2/16,3.24%,FASN;PPT1
prerank,regulation of developmental growth (GO:0048638),0.45609677584104075,1.1546574904265159,0.2894736842105263,0.7177513855193556,1.0,6/29,7.89%,PLCB1;SPAAR;INSR;APP;FGFR3;NRCAM
prerank,proteoglycan metabolic process (GO:0006029),-0.38879602628932053,-1.1545611156991016,0.2253968253968254,0.7078177233279556,1.0,5/26,5.21%,IGF1;ADAMTS12;SULF1;SULF2;XYLT1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3721227758859555,1.1545223334795756,0.24355971896955503,0.7174232439143775,1.0,25/108,13.75%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;CRK;DIAPH1;CLIC4;MAPK1;CLASP1;P2RX7;PRKAA1;ROCK1;TJP1;PTK2;TAOK2;CCDC88A;RAC1;PFDN2;MARK2;SORBS3;RND2;RHOH
prerank,arachidonic acid secretion (GO:0050482),0.5644052732668612,1.1544436401775753,0.30405405405405406,0.7162657829833609,1.0,1/10,1.04%,ACE
prerank,arachidonate transport (GO:1903963),0.5644052732668612,1.1544436401775753,0.30405405405405406,0.7162657829833609,1.0,1/10,1.04%,ACE
prerank,protein homooligomerization (GO:0051260),0.37636929932442537,1.1541151433094865,0.2523041474654378,0.7165027380948461,1.0,18/114,11.88%,EHD4;GBP5;B2M;AQP11;ATL2;GLS;EHD1;SSBP1;ATL1;ELAVL1;ALDH9A1;MCOLN1;MLKL;ACOT13;ACACB;TRPM2;TRMT61B;SLC1A2
prerank,interstrand cross-link repair (GO:0036297),-0.3222024610936752,-1.1539991239548464,0.1971153846153846,0.7077393283132432,1.0,36/53,39.67%,NUCKS1;FAN1;USP1;ATR;FAAP100;MSH6;POLN;DCLRE1B;RFWD3;RPA3;FANCB;RNF168;RPA1;FANCI;FANCD2;FANCG;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX;XRCC3;FANCM;SLX4;DCLRE1C;FANCC;RAD51AP1;DCLRE1A;ERCC6L2;UBC;FAAP24;XPA;ERCC1;MCM9;FANCF
prerank,ncRNA processing (GO:0034470),0.36091907126195616,1.1533616698577043,0.21767241379310345,0.7178219560645708,1.0,79/200,26.73%,BOP1;PELP1;RPL27;DHX37;KARS1;SMAD2;RPL7;INTS11;TRPT1;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;ADAR;WDR46;RPL21;DKC1;RPL37;FARS2;RPS28;RPL34;AGO4;RPS9;XRN2;EXOSC8;RPLP2;INTS12;RPS25;RPL30;RPL27A;NOL8;INTS5;RPL23A;RPS15;RPL19;RPL32;UTP18;DROSHA;RPL37A;RPL18A;NOB1;EXOSC9;TUT7;POP1;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;INTS6;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1
prerank,acute-phase response (GO:0006953),-0.45967950235701494,-1.1532959241066514,0.309462915601023,0.7079913036609482,1.0,3/12,8.52%,LBP;IL6R;CEBPB
prerank,negative regulation of peptidase activity (GO:0010466),-0.3308518577895821,-1.1525029473972357,0.17012448132780084,0.7084280858800477,1.0,11/47,13.45%,LRP1;SERPING1;VTN;SERPINE2;TIMP2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1;ECM1
prerank,epithelial cell morphogenesis (GO:0003382),0.511306840051867,1.1524365300227208,0.3142857142857143,0.7196170370070539,1.0,2/17,3.32%,CCDC88C;SIPA1L3
prerank,microtubule anchoring (GO:0034453),0.5249758542930633,1.152028329017236,0.32338308457711445,0.720042643999227,1.0,4/12,9.92%,SAXO1;CLASP1;PCM1;CLASP2
prerank,xenobiotic transport (GO:0042908),-0.43768047039427505,-1.1516523003832233,0.26756756756756755,0.7091648998391467,1.0,3/17,7.11%,SLC47A1;GJA1;SLC22A4
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.48947708474362817,1.1511537769431972,0.2994011976047904,0.7217877300890885,1.0,7/21,16.66%,FYN;AIM2;GRIN2B;DELE1;TTBK1;PSMB9;PYCARD
prerank,axonogenesis (GO:0007409),0.3529725458820323,1.150696659190734,0.2,0.72236109814862,1.0,39/237,11.35%,SEMA3G;LAMA3;EFNA5;FYN;RPS6KA5;NTN4;NOTCH1;KLF7;APP;SEMA3F;SH3KBP1;EVL;LAMA5;SHTN1;SEMA7A;DAB1;EFNA1;ROBO4;SHANK3;ATL1;MAPK1;BSG;LMTK2;PTPRO;ENAH;NRCAM;SEMA6D;SCN1B;PTK2;TAOK2;B4GALT6;PLCG1;NEFH;ADGRB1;CYFIP1;RANBP9;ACTB;DCC;SEMA4G
prerank,apoptotic cell clearance (GO:0043277),-0.3581923300234102,-1.1504709312938675,0.2572347266881029,0.7107881745216816,1.0,6/30,8.63%,LRP1;THBS1;ITGAV;ANXA1;RHOBTB2;TXNDC5
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3013534374783424,-1.1502098519217592,0.17777777777777778,0.7097942502572309,1.0,20/77,14.57%,IGF1;TGFBR1;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV;PRKN;NDUFS3;SRC;CFLAR;NDUFA13;BIRC6;URI1;DDX3X;QARS1;MPV17L;FXN;PIH1D1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5264204435183456,1.1500278893623581,0.30092592592592593,0.7234408081703838,1.0,5/14,10.16%,OXSR1;ADAM17;STK39;ADAM10;CCL4
prerank,epithelial to mesenchymal transition (GO:0001837),0.42261496560141115,1.1500064309344633,0.2839506172839506,0.7228193171408948,1.0,11/47,10.07%,NOTCH4;ENG;NOTCH1;HEY1;TGFB2;HEY2;LEF1;FOXF2;SNAI2;ROCK1;TASOR
prerank,positive regulation of mRNA processing (GO:0050685),-0.4010415527418601,-1.1497904006002426,0.26126126126126126,0.7092893847532131,1.0,6/21,12.36%,SNW1;RBMX;NCBP1;DAZAP1;PAF1;TRA2A
prerank,arachidonic acid metabolic process (GO:0019369),-0.3557597514898423,-1.1497480157964697,0.24295774647887325,0.7076701512469257,1.0,11/35,23.06%,PTGDS;PTGES;PTGS1;PLA2G4A;EPHX2;CYP2A6;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,positive regulation of RNA splicing (GO:0033120),-0.36581991281057413,-1.1494447979915534,0.21710526315789475,0.7068861557048829,1.0,11/29,19.19%,SNW1;RBMX;NCBP1;PIK3R1;DAZAP1;TRA2A;RBM20;HNRNPLL;ZPR1;U2AF2;NCL
prerank,inner ear morphogenesis (GO:0042472),-0.394735422922674,-1.1493105638173835,0.24376731301939059,0.7055596403213351,1.0,4/22,7.10%,ZIC1;FGFR2;TBX18;SIX1
prerank,chromatin organization (GO:0006325),0.3716904553819906,1.1492875697456826,0.2311212814645309,0.7240390482609272,1.0,15/132,14.54%,PRDM16;MECOM;SMARCA2;NPM3;HDAC11;CHRAC1;TCF7L1;HP1BP3;CDAN1;NPM1;SMARCAD1;SUV39H2;GATAD1;SMARCC1;HMGB2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3705931797076867,1.1489510959310243,0.23076923076923078,0.7242916247975584,1.0,25/113,16.29%,UNC13B;RASIP1;PIEZO1;GBP5;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;RBX1;SPIDR;GTF2H3;CLU;TTBK1;PSMC3;CAPG;ERCC4;ATM;ICE1;PSMC5;LCP1;RACK1;PSMC6;ESR1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3639894288510245,1.1486234749947077,0.2419889502762431,0.7244706835127492,1.0,42/153,16.98%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;MAPK1;UHMK1;MAST1;AKT3;LRRK2;LMTK2;TLK1;STK39;ROCK1;CSNK1G3;SGK1;MARK3;PRKCG;RPS6KA1;TNKS;PRKD2;MARK2;VRK1;TTBK1;RPS6KA3;RPS6KB1;ATM;PRKX;PKN2;PAK2;RICTOR;CSNK1G1;STK32B;MAPK14
prerank,regulation of T cell mediated immunity (GO:0002709),0.5638280079595224,1.1485927902599067,0.3018242122719735,0.7238630518221257,1.0,3/10,19.95%,TNFRSF1B;HMGB1;AGER
prerank,regulation of insulin secretion (GO:0050796),0.38513799596701503,1.1483661915910817,0.2564102564102564,0.7237985330246812,1.0,13/101,8.68%,MYRIP;EFNA5;ITPR3;SLC2A1;DOC2B;CACNA1A;HNF4A;SYT7;RAPGEF4;GLUD1;SIRT4;MTNR1B;NR1D1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.45176491788808604,-1.148355279428094,0.28116710875331563,0.7066066854646796,1.0,5/14,16.52%,IRS2;IRS1;GPLD1;SLC45A3;NNMT
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.47832807929631316,1.1476588034796684,0.30618401206636503,0.7249128733357495,1.0,8/23,17.34%,INPP5K;MTMR10;INPP5B;MTMR11;OCRL;INPP5F;INPP5J;SYNJ1
prerank,chemical synaptic transmission (GO:0007268),0.3523195368788809,1.1466918623806137,0.1950207468879668,0.7267575365743756,1.0,80/284,20.82%,FCHSD2;UNC13B;APBA1;MPZ;PTCHD1;CACNA1A;NRGN;SYN3;SNCG;HRH2;AKAP5;GABRQ;GRID1;CHRM3;HCRTR1;MAPK1;SHISA6;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;GRIN2C;HTR2A;ASIC2;SLC6A2;RPS6KA1;GABRA4;GRIK5;GRIK2;MINK1;PDZD11;NPY5R;HTR1F;SLC1A1;GABRA2;SLC1A2;GRM5;KCNC4;KCNA1;GABRE;RPS6KA3;PCDHB16;SYPL1;STXBP3;NPTX2;PCDHB14;ERC2;GRIK1;SLC32A1;CACNA1E;HRH3;GLRA2;PCDHB9;HTR4;CPLX1;SNPH;SST;RIT2;GRIN2A;GABRG3;NPTX1;KCNQ3;GRM7;GABRB1;EXOC4;SYT1;PENK;HAP1;SLC1A6;HTR6;NSG1;APBA2;GRID2;GIPC1;UTS2;HCRTR2;KCNK3;NRXN1;MYCBPAP
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5568839348454988,1.1466685373864223,0.30236486486486486,0.7261490837807073,1.0,3/10,5.65%,DAB2IP;EFNA1;FURIN
prerank,response to tumor necrosis factor (GO:0034612),0.3886253518464882,1.1466584854630875,0.25886524822695034,0.7254939960567467,1.0,21/91,11.66%,MAP4K3;ARHGEF2;DAB2IP;CASP8;GCH1;INPP5K;HYAL2;GBP3;GATA3;ZC3H12A;JAK2;NFE2L2;NR1D1;ACOD1;CACTIN;ZFP36L2;ADAM10;DHX9;CCL4;GBP2;BRCA1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4464104448662247,1.1464875640528764,0.28688524590163933,0.7252038879859545,1.0,11/31,21.58%,TANC2;PDLIM5;EFNA1;SHANK3;LRRK2;PPFIA2;CFL1;KIF1A;LRP8;NLGN1;EPHA4
prerank,response to axon injury (GO:0048678),-0.4265561948093517,-1.1464212146572872,0.2786377708978328,0.7103017686692279,1.0,5/18,12.78%,DPYSL3;APOD;P2RX4;GAP43;NREP
prerank,carbohydrate transport (GO:0008643),0.5541317900600807,1.1462203725615225,0.3074380165289256,0.7252567464596416,1.0,1/11,2.23%,AQP11
prerank,tRNA wobble base modification (GO:0002097),0.5187171166714049,1.1459329258635258,0.3170731707317073,0.7253390463117496,1.0,6/14,20.60%,ADAT2;ELP4;ALKBH8;ELP3;DPH3;KTI12
prerank,smooth muscle tissue development (GO:0048745),0.5472154992981061,1.145701611868884,0.33676975945017185,0.725327892810427,1.0,2/10,1.89%,ENG;MYLK
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5328145366821496,1.145614992753873,0.30392156862745096,0.7248754322768146,1.0,5/13,12.26%,TNRC6C;BTG2;POLR2G;CNOT1;TOB1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.4940630503671756,-1.1454658354239728,0.30454545454545456,0.7111787065072971,1.0,4/10,29.26%,PRKN;HDAC6;AOC3;ETFBKMT
prerank,protein modification by small protein conjugation (GO:0032446),0.35026892454100744,1.14431035647872,0.17911975435005117,0.7276850675072375,1.0,73/361,16.42%,LMO7;EPAS1;TRIM14;RNF103;FBXL2;TRIM69;IFIH1;CBL;HERC2;KLHL2;FBXO7;UBA7;FBXL5;KLHL3;SUMO2;SUMO3;TRIM11;TRIM6;RNF38;ELOC;ARIH1;GAN;CUL3;ARRDC1;RTF1;UBE2D1;TRIM24;UFM1;KLHL20;RANGAP1;ARRB1;WWP1;ASB5;UBA52;NFE2L2;RPS27A;NUP54;FBXW7;RBX1;ZNRF3;CUL2;TRIM47;ENC1;TRIM17;NUP35;RANBP2;NEDD4L;BRCA1;DTX3L;FBXO4;SMURF1;KCTD10;UBE2T;NUP153;UBE2J2;RNF103-CHMP3;KEAP1;NUP160;HIF1A;FBXO2;UBE2E1;NUP42;RAD18;CDC27;UBE2D3;RACK1;TRAIP;KLHL25;KLHL24;NUP205;ANAPC7;RNF139;KLHL9
prerank,negative regulation of metabolic process (GO:0009892),0.40707458918369627,1.1443061646406187,0.27471116816431324,0.7270166934800136,1.0,8/54,10.04%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,mononuclear cell differentiation (GO:1903131),-0.39412829548491934,-1.144160643615604,0.27514792899408286,0.7132450389081398,1.0,8/24,16.50%,AXL;BMP4;IL31RA;MT1G;VEGFA;PPARG;RELB;FLT3
prerank,peptidyl-glutamic acid modification (GO:0018200),0.478025691496671,1.1440633841148076,0.3018575851393189,0.7269698688214158,1.0,7/24,16.38%,TTLL8;TTLL7;TTLL1;TTLL10;TTLL5;TTLL11;VKORC1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3868818137138353,-1.1435792369368476,0.2645161290322581,0.7131840602847493,1.0,7/25,8.25%,ARHGAP6;PHLDB2;ROCK2;APOD;THBS1;SRC;BCAS3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4003022587611853,-1.1434979434782595,0.26865671641791045,0.7116974317419555,1.0,10/20,40.21%,LBP;PTPN22;TICAM1;HCK;IL18;CCL2;MTDH;CD14;CCL5;BCL10
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5153660762166936,1.1434048502053906,0.3285939968404423,0.7279815845662881,1.0,6/13,15.84%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,protein-DNA complex disassembly (GO:0032986),-0.42933198070150536,-1.1428493901418642,0.2803234501347709,0.7118018278623666,1.0,3/16,10.19%,SET;SMARCB1;SMARCD1
prerank,cellular response to amino acid stimulus (GO:0071230),0.4413442925642107,1.1426145767058553,0.30392156862745096,0.7293776670025984,1.0,5/33,10.04%,FYN;SPAAR;CASTOR1;SH3BP4;RRAGD
prerank,response to fatty acid (GO:0070542),-0.4153004264705735,-1.1425832183796976,0.27319587628865977,0.7109281913948928,1.0,7/17,21.90%,PID1;IRS1;FOXO3;PDK3;SCD;LPL;NR1H4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.42835364959069144,1.1420646234457854,0.27419354838709675,0.7302244637214064,1.0,6/38,9.23%,KCNQ1;KCNE3;CAV1;CAMK2D;SCN1B;DSP
prerank,monocyte differentiation (GO:0030224),-0.4883723085910363,-1.1419637048982876,0.30679156908665106,0.711070632666959,1.0,5/10,10.78%,BMP4;IL31RA;MT1G;VEGFA;PPARG
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3160657859792821,-1.1418743371330358,0.22026431718061673,0.709623706155458,1.0,9/57,8.24%,LPAR1;ADCY5;ADCY9;ADCY1;GNAI1;AKAP12;ADCY2;ADCY7;FLNA
prerank,MAPK cascade (GO:0000165),0.3492188637487757,1.1417949185579632,0.20081967213114754,0.730239082528834,1.0,58/295,15.02%,RASGRF2;TEK;RAPGEF2;PDGFB;FYN;KITLG;DAB2IP;LGALS9;CSF2RB;APOA1;KRAS;NRAS;PSMD13;IL17RD;ANGPT1;MAP4K4;KARS1;MEF2C;FGFR3;SHANK3;CUL3;MAPK1;PSMD4;SETX;SHOC2;LRRK2;FRS3;BCL2L1;UBA52;JAK2;GRIN2B;RPS27A;PTK2;ZFP36L2;TAOK2;PSMA5;RBX1;PSMB10;MARK3;MINK1;RANBP9;PSMB8;MAP3K3;PSMD14;PIK3CB;PSMA7;PSMC3;SPTAN1;PSMA8;PSMC1;RASAL1;SOS1;PSMB5;MAP3K20;GFRA3;PSMC5;PRKG2;FGF20
prerank,regulation of neurotransmitter secretion (GO:0046928),0.44412276320465577,1.14129028112672,0.31843575418994413,0.7308588163189176,1.0,7/32,16.46%,MCTP1;MEF2C;LRRK2;SLC30A1;SNCAIP;RIMS3;CPLX1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.5205409459657401,1.141245230652796,0.3161993769470405,0.7303097386423195,1.0,5/15,16.03%,STOX2;TGFB2;CELF4;BRCA1;RICTOR
prerank,protein polymerization (GO:0051258),-0.31552164202653765,-1.1411739686949183,0.2127659574468085,0.709987799832107,1.0,11/55,7.16%,ARHGAP6;GAS7;GSN;COBL;WASF1;PRKN;WASHC3;RNF135;HDGFL3;CKAP5;PREX1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.38794111615643767,1.1408315949734336,0.27036599763872493,0.730697390899138,1.0,27/84,19.11%,PSMD13;CUL3;UBE2D1;PSMD4;PTTG1;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;PSMB9;ANAPC7;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,regulation of protein ubiquitination (GO:0031396),0.3765622986563117,1.1407327793549942,0.26220204313280365,0.7302558635159475,1.0,22/108,12.21%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;FOXF2;CUL3;UBE2D1;LRRK2;HSPA1B;ARRB1;UBE3A;NDFIP2;VPS28;NSMCE3;FBXW7;PRKCG;ADGRB1;LAPTM5;NXN;BRCA1;FBXO4
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.38629201078036374,1.1403034564158205,0.26555023923444976,0.7307359625843481,1.0,26/85,17.93%,SMAD7;ECSCR;DAB2IP;SUMO2;CSNK1D;BBS7;RNF185;ARIH1;LRRK2;HSPA1B;CEBPA;FBXW7;RBX1;NKD2;RNF144B;BAG6;CLU;PSMC3;KEAP1;PSMC5;RACK1;CBFA2T3;PSMC6;TRIB3;SOCS5;GSK3A
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.38631032031626467,-1.1401257724133183,0.27936507936507937,0.7112524163648294,1.0,6/24,7.14%,ARHGAP6;PHLDB2;ARHGAP28;ARAP1;PIK3R1;TMEFF2
prerank,central nervous system neuron differentiation (GO:0021953),0.4367387055317285,1.1400801416262552,0.296398891966759,0.7306128319841311,1.0,10/33,19.60%,NR4A2;ATP7A;CHD5;ZC4H2;SPOCK1;CTNNB1;MAP2;OPHN1;SIN3A;GRID2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.48133494025042567,1.1399191119101164,0.33781763826606875,0.7303575556233292,1.0,4/21,8.36%,MCUB;SMDT1;RAP1GDS1;MCUR1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.43624427505375657,-1.1397503413497918,0.30563002680965146,0.7106085609756573,1.0,9/15,35.76%,NFKB1;AGTR1;MAPK9;LPL;AGT;MSR1;IL18;CD36;PLA2G5
prerank,protein K48-linked deubiquitination (GO:0071108),-0.39029635085465725,-1.1396263801977176,0.29354838709677417,0.7092692805079005,1.0,9/23,24.72%,USP33;USP20;USP50;OTUD7B;USP8;USP34;VCPIP1;TNFAIP3;BAP1
prerank,regulation of viral life cycle (GO:1903900),0.4813151453203822,1.1394894773329824,0.312406576980568,0.7307977735322198,1.0,5/21,12.82%,TRIM14;TRIM6;TRIM25;HS3ST5;VPS4A
prerank,regulation of microtubule nucleation (GO:0010968),-0.4818883806640957,-1.1394750518539336,0.31009615384615385,0.7080290304800337,1.0,3/10,6.83%,EML2;MECP2;CKAP5
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.46766746233043666,-1.1386250215944367,0.29,0.7086386195476573,1.0,6/12,26.77%,INSIG2;RER1;KDELR1;ANKRD13C;KDELR3;GPAA1
prerank,cell-matrix adhesion (GO:0007160),-0.29220335912257694,-1.1384472089662714,0.1891891891891892,0.7075272204603859,1.0,22/95,10.18%,ITGBL1;COL3A1;ADAMTS12;SORBS1;VTN;ITGB5;PTPRK;ITGA10;COL13A1;NID2;ITGAV;ACTN2;ITGA11;CD63;ITGB8;ADAM9;SRC;ADAMTS9;MSLN;THBS3;SGCE;ECM2
prerank,respiratory electron transport chain (GO:0022904),0.5132439988701064,1.1384218653282856,0.3180379746835443,0.7329754728279745,1.0,5/14,11.70%,GPD2;ETFDH;ETFA;ETFB;UQCRFS1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.38999288141261207,1.1381752546119175,0.26123936816524906,0.73296214096564,1.0,22/78,17.93%,SMAD7;PLK3;CAV1;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;NFE2L2;RBX1;NKD2;RNF144B;CLU;KEAP1;RACK1;UBQLN2;CBFA2T3;TRIB3;SOCS5;GSK3A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4199431580061038,1.137863642284941,0.2945945945945946,0.7331134567836816,1.0,6/45,4.11%,ENG;BMPR2;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.400677312687061,-1.137468913492951,0.2885714285714286,0.708705775885313,1.0,6/19,6.40%,ROBO1;DCN;CCBE1;CD63;ADAMTS3;XDH
prerank,negative regulation of defense response to virus (GO:0050687),-0.48387752208155965,-1.1368017504895576,0.32418952618453867,0.7089419652773017,1.0,6/10,39.32%,PPM1B;C1QBP;TRAF3IP1;TSPAN6;RNF26;PCBP2
prerank,positive regulation of cellular process (GO:0048522),0.33783699796400174,1.136750124677232,0.15995975855130784,0.7354306585985741,1.0,83/565,14.01%,VEGFC;PTPRJ;SLC6A6;ACER2;EDN1;PDGFD;CLDN5;GATA2;FLT1;PDGFB;FLT4;FASN;KITLG;TBX1;MERTK;CCND2;LIFR;NOTCH1;INSR;TAL1;AQP11;CAV1;TGFB2;EMP2;ACTN4;TNFRSF18;APOA1;VEGFD;KRAS;IER5;FCGR2B;WWTR1;LEF1;GCNT2;SERTAD1;BRAT1;TBC1D8;FGFR3;TNFRSF1B;TAF9B;CUL3;ADAM17;SLC25A33;P2RX7;CD47;GNAI2;ZC3H12A;PPP3CA;CIDEB;CNOT6L;THPO;CDH3;PRKAA1;APC;NAMPT;TJP1;PTK2;ADAM10;ACACB;RPS6KA1;RPRD1B;RAC1;TENM4;RPS9;CYBA;NUMA1;NPM1;PRKD2;DOCK2;MATK;CHTOP;RTKN2;PRC1;RPS6KA3;ITGB1BP1;MCTS1;FXR1;POU3F2;PHIP;PGF;LRP5;ATM;NSMCE4A
prerank,amide transport (GO:0042886),0.46614673483883573,1.1365263310093143,0.2987987987987988,0.7353506838582883,1.0,6/26,9.87%,AQP11;SLC25A32;PLTP;GLTP;CERT1;TAP1
prerank,regulation of actin filament-based process (GO:0032970),0.3837147370975365,1.136286055242479,0.28376703841387857,0.7353212262201742,1.0,8/70,3.27%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;CRK
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3848183002212998,1.1361618430832834,0.25770653514180025,0.7349768327443612,1.0,14/80,10.68%,EPS8L2;OCLN;SAXO1;F2RL1;AGRN;CDC42EP1;FNBP1L;P2RX7;PLEKHM1;NCKAP1;APC;CCDC88A;CYFIP1;RAC1
prerank,response to organic cyclic compound (GO:0014070),0.4134391621171236,1.136130859099821,0.30378096479791394,0.7343937867281308,1.0,12/52,16.29%,ALPL;ARL6IP5;TLR3;ABCB4;LRRK2;PAQR8;STRN3;TRPM2;SLC1A1;CTNNB1;CDKN2D;ESR1
prerank,regulation of translation (GO:0006417),0.3578491562840247,1.1359663698042066,0.25026624068157616,0.7341792442722473,1.0,41/173,16.16%,NANOS1;NANOS3;VIM;BTG2;APP;MTG2;YBX2;PLD1;ELAVL1;HSPB1;PASK;GAPDH;ETF1;EIF3B;EIF2B2;DHX9;EIF1;CNOT1;ENC1;RPS6KA1;CYFIP1;METTL5;NPM1;EEF2;GRM5;TOB1;RPS6KA3;RPS6KB1;FXR1;METTL14;METTL18;EIF6;EIF2A;YBX1;DDX6;RACK1;MTIF2;EIF3H;TCOF1;KLHL25;RNF139
prerank,regulation of postsynapse organization (GO:0099175),0.45831903549068764,1.135918613113935,0.3072289156626506,0.733634241642207,1.0,9/28,15.66%,TANC2;FCGR2B;PDLIM5;SHANK3;LRRK2;PPFIA2;VPS35;CFL1;KIF1A
prerank,polyamine metabolic process (GO:0006595),0.5300830807178092,1.1351832448321733,0.339171974522293,0.7349472610319006,1.0,3/13,11.17%,AMD1;PAOX;SMS
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.42938832897229906,1.1351043782593446,0.2874493927125506,0.7344943914252466,1.0,7/39,9.53%,EFR3B;ITPKB;IP6K3;PIK3C2A;CISH;SOCS6;PIK3C3
prerank,negative regulation of nervous system development (GO:0051961),0.4986891908903475,1.134419043030117,0.326984126984127,0.7356123760724642,1.0,3/17,9.16%,NOTCH1;B2M;PCM1
prerank,negative regulation of cell differentiation (GO:0045596),0.3541844741332071,1.1341881118914898,0.25160599571734477,0.7355440039084213,1.0,22/181,6.87%,JAG1;NOTCH4;GATA2;SMAD6;SMAD7;TBX1;NOTCH1;FOXO1;HEY1;DAB2IP;CAV1;TRIO;HDAC7;IL17RD;WWTR1;EFNA1;COL5A2;GATA3;EID2B;PDCD4;ADIPOR1;ZBTB16
prerank,cellular response to chemical stress (GO:0062197),0.38318215540251793,1.1339803633468286,0.2765957446808511,0.7354304251872242,1.0,22/96,14.96%,TRPV4;FAS;FOXO1;CAV1;PRKD1;CHCHD2;SETX;ZC3H12A;LRRK2;HSPA1B;PRR5L;NFE2L2;PRKAA1;BRF2;CYBA;RBM11;KEAP1;ATM;PYROXD1;MSRA;NCF2;EIF2S1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.357545862779844,-1.1339666396821333,0.26158940397350994,0.7152259612003421,1.0,12/33,20.80%,IGFBP5;OGN;APOD;TPM1;IGFBP3;EFEMP2;PPARG;CDKN1A;GPER1;NDRG4;TGFB3;TNFAIP3
prerank,regulation of blood coagulation (GO:0030193),0.45440031409700204,1.1339473047476893,0.3064971751412429,0.7348410469955331,1.0,6/27,8.44%,EDN1;CAV1;F2RL1;ENPP4;CD34;PROC
prerank,regulation of wound healing (GO:0061041),0.42116719135121966,1.1337059647437306,0.2975871313672922,0.7348234292475517,1.0,7/42,9.21%,OCLN;MYLK;CAV1;F2RL1;CRK;ACTG1;PTK2
prerank,cellular response to organic substance (GO:0071310),0.3646018496426434,1.1336587993932603,0.2632768361581921,0.734272578613651,1.0,14/116,7.95%,NOS1;PDGFB;BMPR2;PTPN14;ACVRL1;ARL6IP5;INPP5K;KLF4;ACVR1;LEF1;ASAH2;LRRK2;PTPN12;DCPS
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.47973638553338094,1.1334032024736196,0.33072100313479624,0.7343015974736946,1.0,7/21,15.15%,RASSF10;DLL4;CX3CR1;CTNNB1;FZD9;FZD3;NES
prerank,neuromuscular synaptic transmission (GO:0007274),0.49401951373472375,1.1332898918495162,0.32689210950080516,0.733946536171568,1.0,1/18,0.53%,FCHSD2
prerank,neutral amino acid transport (GO:0015804),0.45067454830170434,1.133253681881503,0.32571428571428573,0.733372216137944,1.0,1/28,0.19%,SLC6A6
prerank,myofibril assembly (GO:0030239),-0.3283513461965126,-1.1329959107983913,0.24390243902439024,0.716347336723046,1.0,8/42,10.21%,PDGFRB;PDGFRA;TPM1;ACTN2;OBSL1;TMOD2;CFLAR;PGM5
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.46347476051726855,1.1329781109023533,0.2904624277456647,0.7334267917323508,1.0,8/26,16.08%,TAL1;APP;TTL;CUL3;DUSP3;RPS6KB1;PKN2;MEIS2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4131623586155131,1.132866901530669,0.2936400541271989,0.7330799150798765,1.0,4/48,3.64%,CRTAM;F2RL1;LGALS9;TLR3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4547678055656559,-1.1325684007039178,0.3065326633165829,0.715898745912609,1.0,6/12,17.97%,APOBEC1;TET1;RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.494225313637388,1.1321391465124548,0.32334384858044163,0.7343449687999271,1.0,4/17,7.31%,NOTCH4;NOTCH1;PLXND1;STAT1
prerank,detection of visible light (GO:0009584),0.5001039723526356,1.1319244836768276,0.3082942097026604,0.7342481675374644,1.0,1/16,1.71%,GNAQ
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4825256635061554,1.1318184479532918,0.30149253731343284,0.7339225554399258,1.0,10/20,20.99%,SPPL2A;RHBDD1;ADAM17;MBTPS2;APH1A;ADAM10;PSEN2;RELA;APH1B;SPPL2B
prerank,regulation of regulated secretory pathway (GO:1903305),0.43264698451982786,1.131720899135191,0.3282967032967033,0.7335270666009953,1.0,8/34,20.25%,SYT15;SYT7;LRRK2;RIMS3;RAB27A;SYT1;SYT2;GSK3B
prerank,histone deacetylation (GO:0016575),-0.33297832180862424,-1.1311680731824412,0.233201581027668,0.7180682849093986,1.0,11/43,14.56%,PRDM5;TBL1XR1;RBM14;REST;HDAC4;HDAC1;HDAC6;MSL3;SIRT2;SIN3B;MTA2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3986275782988254,-1.1308092289653682,0.2972222222222222,0.717473785739847,1.0,6/22,12.75%,SCAF8;CCNK;CDK12;ELL;THOC1;HMGN1
prerank,regulation of muscle contraction (GO:0006937),-0.3785712538505374,-1.1305173861235582,0.2930513595166163,0.71666094673897,1.0,3/26,3.47%,ATP1A2;PLCE1;TPM1
prerank,action potential (GO:0001508),0.4210712049740442,1.1304488020507022,0.3020689655172414,0.7361284249762734,1.0,4/44,4.17%,KCNQ1;KCNE3;GNAQ;SCN11A
prerank,carbohydrate homeostasis (GO:0033500),0.3906335735606889,1.1303602648632884,0.29213483146067415,0.7357252683244926,1.0,10/67,8.29%,ADIPOR2;INSR;KLF7;HNF1A;HNF4A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1
prerank,calcium ion transmembrane transport (GO:0070588),0.38501986627749457,1.1303131129387758,0.29253365973072215,0.7351731625829585,1.0,18/86,11.28%,ATP2A3;TRPV4;ATP2B4;CACNA1A;FKBP1A;MCUB;SLC8A1;ATP2C1;ANO6;ORAI1;SMDT1;P2RX7;MCOLN1;MCUR1;GRIN2B;GRIN2C;TRPM2;TRPC7
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4707275966780747,1.130139842331417,0.31259720062208396,0.7349712788858227,1.0,6/21,12.70%,MTUS1;MAPK1;CMKLR1;STAP1;PTK2;DDT
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.462320804095069,1.1299425092807762,0.30346820809248554,0.7348289732222769,1.0,12/25,19.04%,ENG;BMPR2;ACVRL1;NOTCH1;SMAD2;NUMA1;TBX20;ACVR2A;ACVR2B;SMAD4;SOX11;FBXL15
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3977305435285363,-1.129591639612048,0.2804878048780488,0.717651555856288,1.0,5/19,12.66%,AXL;MMP14;ZMIZ1;NCKAP1L;MDK
prerank,defense response to symbiont (GO:0140546),0.3805910614946851,1.1295483430412416,0.27909738717339666,0.7352539724042346,1.0,29/92,21.89%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;SERINC3;STAT1;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;BNIP3L;RNASE6;BNIP3;LYST;PYCARD;RSAD2;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,Wnt signaling pathway (GO:0016055),0.3792343621533209,1.1295039001904423,0.28859857482185275,0.7347288210065424,1.0,18/92,14.82%,PLCG2;CCDC88C;FZD6;NR4A2;LEF1;LRRK2;UBA52;APC;RPS27A;CSNK1G3;TCF7L1;RBX1;NXN;VPS35;LRP5;CTNNB1;FZD9;FZD3
prerank,AMP metabolic process (GO:0046033),-0.4586671743753571,-1.1290564767001092,0.3139240506329114,0.7175153788874115,1.0,8/13,33.10%,AMPD3;XDH;NT5E;NUDT2;NT5C1A;AMPD2;AK3;AK9
prerank,cellular response to organic cyclic compound (GO:0071407),0.3659898014975309,1.1290039269978052,0.27192008879023305,0.7353975521296213,1.0,25/141,11.66%,KCNQ1;RAPGEF2;PDGFB;RAPGEF1;ATP1A1;ATP1A3;ARL6IP5;FES;DIAPH1;INPP5K;MSN;MEF2C;ABCB4;P2RX7;ZC3H12A;LRRK2;HSP90B1;CTNNA1;NCOA4;EGR1;SPIDR;ACTB;TRPM2;SLC1A1;BRCA1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.35207372826153416,1.1289919535031694,0.24597207303974222,0.7347697283021603,1.0,53/190,20.24%,PTPRJ;CD2AP;ATP2B4;DUSP1;DAB2IP;CAV1;CASP8;HDAC7;INPP5K;PDE3B;HYAL2;PLEKHA1;SH3BP4;ADIPOR1;P2RX7;DUSP3;ZC3H12A;ARHGAP25;STAT1;BCL2L1;PRKAA1;WWC2;NMI;NR1D1;PPP2R5C;CACTIN;MARK3;PIK3IP1;PIK3CB;RTKN2;RIOK3;RHOH;CARD19;EPM2A;PHLDA3;ABCA7;RACK1;PDE4D;TMSB4X;ESR1;PYCARD;MAPK14;TRIB3;PLAUR;GSK3A;RELA;BANK1;MAPKAPK5;PPIF;MCL1;SHANK2;NPRL3;RNF34
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5366835897504262,1.1288813190552665,0.3333333333333333,0.7343924346411178,1.0,3/11,12.68%,CAV1;ADIPOR1;NF2
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3786996151388671,-1.1287015924898645,0.2959770114942529,0.7168023954111826,1.0,7/23,18.12%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1;FBXW11;ZW10
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.45753829599394313,-1.1284197622054215,0.3489583333333333,0.7160269287502916,1.0,4/12,17.94%,WNK1;PPARA;MDK;SKAP1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.42860958997295195,1.1283697772281596,0.29461756373937675,0.7350687361510786,1.0,11/35,14.60%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,cellular response to interleukin-4 (GO:0071353),0.5620346244254553,1.1277811828186048,0.34290540540540543,0.7359439068384394,1.0,2/10,6.03%,LEF1;GATA3
prerank,regulation of DNA recombination at telomere (GO:0072695),0.48614120095684005,1.1277612457067057,0.3118440779610195,0.7346829359640284,1.0,10/19,25.76%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.48614120095684005,1.1277612457067057,0.3118440779610195,0.7346829359640284,1.0,10/19,25.76%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,regulation of exocytosis (GO:0017157),0.4186748267087503,1.1271489063604776,0.3074866310160428,0.7356292492444928,1.0,14/46,18.42%,CADPS2;STXBP6;CLASP1;CLASP2;CADPS;CHMP3;NSF;CPLX1;RAB27B;STXBP5L;STXBP5;RAB27A;SYT1;HAP1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4033713958817563,-1.1268204716623538,0.2692307692307692,0.7188852520106668,1.0,10/18,21.46%,SLC25A13;MTHFD1;NAALAD2;ASPG;SLC25A12;GOT1;ADI1;ASNS;MTHFR;ASPA
prerank,ATP transport (GO:0015867),0.5439702157093302,1.126132741103992,0.34789915966386553,0.7376654228370783,1.0,3/10,11.16%,SLC17A9;CD47;ABCC6
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.39016097450493226,-1.1260584449732343,0.26975476839237056,0.7192992282662393,1.0,6/21,12.28%,DCN;CHST15;BGN;VCAN;CHPF2;CSPG4
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3933258898132046,1.1257048440928283,0.2947103274559194,0.7381621642304871,1.0,12/62,8.22%,ARHGEF3;F11R;NOTCH1;RAPGEF1;F2RL1;APOA1;MAP4K4;LPAR6;SHOC2;ARRB1;STK19;JAK2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3655129885988239,1.1256272328423034,0.27444444444444444,0.7377007920942562,1.0,31/118,15.69%,EFNA5;CEACAM1;FLT4;TBX1;TANC2;EMP2;PLXND1;VASH2;PDLIM5;MEF2C;SHANK3;TSPAN12;WARS1;POGLUT1;CLASP1;LRRK2;LZTS1;LRRC4C;PPFIA2;CLASP2;NEDD4L;CDH2;INF2;MARK2;PHIP;ADGRA2;CFL1;CTNNB1;SARM1;KIF1A;PAK2
prerank,regulation of cell development (GO:0060284),0.42685962957095697,1.1251312958149056,0.3096862210095498,0.7382883910046278,1.0,11/36,14.54%,FOXO1;HEY1;HDAC9;HEY2;PRUNE1;CX3CR1;ADGRA2;HES3;CTNNB1;RHEB;HMGB2
prerank,receptor-mediated endocytosis (GO:0006898),0.3677089683124536,1.1250411554276551,0.2719298245614035,0.7378699729223938,1.0,17/132,7.44%,FCHSD2;HIP1R;INSR;CAV1;CAV2;ADRB2;PPT1;DNM3;APOA1;AP2B1;FCHO2;FCGR2B;FNBP1L;FCGR1A;PIP5K1C;ITGAM;HSP90B1
prerank,membrane organization (GO:0061024),0.34643854078679526,1.1247003483341926,0.25416666666666665,0.7380836665658821,1.0,49/227,15.38%,HIP1;HIP1R;DYSF;PIK3C2A;CBL;ADRB2;TTPA;PPT1;DNM3;PACSIN2;SH3KBP1;VTI1B;AP2B1;ATP2C1;FCHO2;FNBP1L;PIP5K1C;TMEM43;VAMP8;SUN3;ARRB1;GLTP;CERT1;UBA52;A4GALT;ARPC5;ACTG1;RPS27A;VAMP7;CHMP1B;AP2M1;LPCAT3;EPN2;CCDC88A;MYOF;REEP1;ACTB;OCRL;REEP3;VPS4A;CHMP3;SGCZ;ARPC3;CEP55;LDLRAP1;VAPA;CHMP2B;ARPC2;CHMP7
prerank,ventricular septum morphogenesis (GO:0060412),0.44749305223868674,1.1246428453641637,0.34615384615384615,0.7375827190457224,1.0,7/27,4.11%,BMPR2;SMAD7;NOTCH1;HEY1;TGFB2;HEY2;ACVR1
prerank,actin filament bundle organization (GO:0061572),0.4324065198961535,1.1242921711113116,0.3159379407616361,0.7377953923734496,1.0,4/33,3.05%,LIMA1;FAM107A;PLS3;NEDD9
prerank,ribosome biogenesis (GO:0042254),0.35245287735281666,1.1238644942143396,0.2635574837310195,0.7382790969940141,1.0,77/187,26.73%,BOP1;PELP1;RPL27;DHX37;RPL7;PAK1IP1;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;WDR46;XPO1;RPL21;DKC1;RPL37;RPS28;RPL34;MRPL36;RPS9;XRN2;EXOSC8;RPLP2;NPM1;RPS25;RPL30;RPL27A;NOL8;RAN;RPL23A;RPS15;EIF6;EIF2A;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;LSG1;EXOSC1;FBL;RPF2;WDR43;HELQ;RPL3;UTP20;GLUL;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;NIP7;UTP15;RPS17;ESF1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.47716396122686133,-1.1237470728854277,0.3106796116504854,0.7225204052012283,1.0,4/10,18.49%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,negative regulation of glycolytic process (GO:0045820),-0.47716396122686133,-1.1237470728854277,0.3106796116504854,0.7225204052012283,1.0,4/10,18.49%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,regulation of apoptotic process (GO:0042981),0.33634261978919316,1.1236858383785602,0.16381909547738693,0.7380996915684626,1.0,117/676,14.25%,RASGRF2;ACER2;ARHGEF3;TEK;GATA6;HIP1;KALRN;UNC13B;SMAD6;FLT4;HIP1R;FAS;TNFAIP8;PLK3;CCND2;EGR3;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;RHOB;CBL;TRIO;PPT1;ACTN4;PPP1R13B;PNMA1;ANO6;GLS2;SLK;ING3;HRK;ANGPT1;CASP2;LEF1;OMA1;LANCL1;MAP4K4;TNFSF10;TNFRSF25;PLEKHG5;MEF2C;IAPP;RHBDD1;SPTLC1;TAF9B;STPG1;APEX1;TOX3;TRIM24;UFM1;ARHGDIA;MADD;SETX;RYBP;TIAM2;MCF2L;KLHL20;ALK;FANK1;CRADD;STAT1;HSPB1;HSP90B1;HSPA1B;AATF;CIDEB;GADD45G;BCL2L1;UBA52;JAK2;PRKAA1;PROC;APC;PIM3;RPS27A;KLF11;APH1A;JUN;TJP1;PTK2;SGK1;ADAM10;RTN4;HMGB1;MAP3K11;BABAM2;SIAH2;ARHGEF1;CASP1;RPS6KA1;RNF144B;HNRNPK;NFKBIA;NPM1;TMBIM6;CD38;CLU;TMEM14A;IRF5;NF2;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;ITGB3BP;NOL3;LTK;SOS1;ATM;CFL1;BNIP3;ANP32B;CTNNB1
prerank,regulation of cell size (GO:0008361),0.4579550083866034,1.1235248464174992,0.3207831325301205,0.7378472817026434,1.0,4/23,10.68%,EDN1;MSN;RAP1GAP2;RAC1
prerank,negative regulation of viral release from host cell (GO:1902187),0.5270996359199114,1.1234281253162317,0.3474025974025974,0.7374461240608814,1.0,4/13,20.83%,TRIM11;TRIM8;CHMP3;MID2
prerank,endothelial tube morphogenesis (GO:0061154),0.5410735602086622,1.123299156467113,0.3333333333333333,0.7371036897940608,1.0,5/10,14.92%,ACVRL1;RHOB;PRKD2;CTNNB1;CSNK2B
prerank,sulfur amino acid catabolic process (GO:0000098),0.5406744569777575,1.1231411085296645,0.3505338078291815,0.7368394436109347,1.0,1/10,2.88%,TST
prerank,negative regulation of histone methylation (GO:0031061),-0.4837934081846003,-1.1228987160139587,0.3471882640586797,0.7233024959212458,1.0,5/10,18.34%,JARID2;MTF2;WDR5;BCOR;DNMT3B
prerank,cellular response to BMP stimulus (GO:0071773),0.39312874778673784,1.1228870699194309,0.2878598247809762,0.7368928621226789,1.0,10/66,6.31%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,glucan catabolic process (GO:0009251),-0.4301300053061414,-1.1228087460280736,0.3163538873994638,0.7219674804741362,1.0,5/15,11.23%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,negative regulation of defense response (GO:0031348),0.3872212689389605,1.1224920320273364,0.3024390243902439,0.7372782433068766,1.0,13/77,11.41%,TEK;AOAH;APOA1;KLF4;GATA3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35
prerank,neutrophil activation (GO:0042119),0.5226468829816611,1.1223877921936734,0.32362459546925565,0.7369006891386924,1.0,3/12,10.12%,F2RL1;KMT2E;TYROBP
prerank,mammary gland epithelium development (GO:0061180),0.5083833782555781,1.1221272477057032,0.33553719008264465,0.7368757105087513,1.0,2/14,8.22%,IRF6;JAK2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.47772576663093397,1.1219610136196567,0.3140625,0.7366971697439635,1.0,3/18,9.04%,TEK;SHTN1;ROCK1
prerank,Fc receptor signaling pathway (GO:0038093),0.370054977500753,1.1219391014084024,0.2810304449648712,0.736124173199163,1.0,34/110,19.26%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;PLCG1;RAC1;TAB2;PSMB8;PSMD14;PIK3CB;BTK;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;SOS1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6;NFATC3
prerank,regulation of protein autophosphorylation (GO:0031952),0.43023395116100044,1.1218681491289026,0.31285714285714283,0.7356576524733993,1.0,6/36,9.44%,PDGFD;ENG;PDGFB;TOM1L1;PPP2R5C;TAOK2
prerank,limb morphogenesis (GO:0035108),-0.40511805545835555,-1.1218397808889136,0.29971988795518206,0.7231052644106051,1.0,6/20,9.91%,GLI3;CYP26B1;FBXW4;NIPBL;MEGF8;PTCH1
prerank,protein complex oligomerization (GO:0051259),0.37866341454332153,1.121787417635098,0.2912280701754386,0.7352229408947054,1.0,9/85,9.09%,LRRC8C;EHD4;AQP11;ATL2;EHD1;ATL1;ZC3H12A;ELAVL1;KCNC1
prerank,positive regulation of lipid localization (GO:1905954),-0.46823099830369325,-1.1214744419609248,0.33078880407124683,0.7224952444375794,1.0,3/11,11.39%,LRP1;IKBKE;NFKB1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.47663374890034527,1.1213353836226267,0.31393568147013784,0.735764035406238,1.0,2/20,2.63%,RAPGEF2;ADRB2
prerank,response to interferon-gamma (GO:0034341),0.3921004900505476,1.1208067848499308,0.2990074441687345,0.7364907171316648,1.0,12/67,11.38%,GBP5;LGALS9;GBP4;GCH1;GBP3;CD47;STAT1;ACOD1;GAPDH;CCL4;CASP1;GBP2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4709188853376153,1.1205485783697726,0.3373493975903614,0.7365289588399557,1.0,2/22,3.80%,B2M;STX7
prerank,sensory perception of sound (GO:0007605),0.3748126263543403,1.1203000989615532,0.2799043062200957,0.7365247744987579,1.0,6/88,2.89%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,translational elongation (GO:0006414),0.3739341778163769,1.120278481447405,0.2786697247706422,0.735950122164967,1.0,48/101,28.54%,MRPL4;MRPL18;EEF2K;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;GTPBP1;MRPL36;MRPL47;MRPL52;EEF2;GTPBP2;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;RACK1;EEFSEC;MRPL54;EEF1D;MRPS18B;EEF1G;MRPS30;GFM1;MRPL11;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;EEF1A1;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3963180302596333,-1.1201061444014553,0.26869806094182824,0.7246658231086375,1.0,9/22,19.93%,CACNA1C;ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB;CAP2;NF1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4058254815937194,1.120049348006183,0.32561307901907355,0.735913852091308,1.0,13/51,13.86%,SYNPO;LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;CCDC88A;RAC1;SORBS3;NF2;ITGB1BP1;ARHGEF10
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.48760151022069576,1.1199013741404071,0.3370967741935484,0.7356690388821447,1.0,8/16,25.05%,CAV1;ADIPOR1;INPP5F;NF2;PTPN2;LEPROT;PARP14;PPP2R1A
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.29116212107061573,-1.119675250715573,0.2,0.7242456847328785,1.0,22/80,16.07%,DENND2A;SGSM2;VPS54;SNX6;VPS26B;GCC2;SNX32;SURF4;TMEM87A;TRAPPC10;LMAN1;EHD3;RHOBTB3;STX5;SNX1;STX16;TBC1D17;SNX12;CLN5;SNX8;GGA1;SNX2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.4306553389790594,1.119622089951088,0.31095890410958904,0.7357702665661029,1.0,7/36,11.66%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2983513240733454,-1.1194947983806107,0.21379310344827587,0.7231584474793865,1.0,31/84,23.61%,CELF2;SON;DDX5;NOVA1;SNW1;FXR2;RBMX;DDX17;NCBP1;JMJD6;DAZAP1;PUF60;SRSF6;REST;TRA2A;RBM39;HNRNPL;PCBP4;HNRNPU;MAGOH;U2AF2;NCL;SRSF3;SF1;RBFOX3;SRPK2;ZC3H10;KHDRBS1;CELF1;C1QBP;CELF5
prerank,negative regulation of immune response (GO:0050777),0.35578051524482074,1.1189706904674552,0.29411764705882354,0.736817646722949,1.0,20/154,11.03%,PLCG2;FYN;ADRB2;GPR39;FCGR2B;HRH2;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;NMI;ACOD1;YES1;CACTIN;ADCY4;PLCG1;GLP1R
prerank,regulation of neuron migration (GO:2001222),0.44801227668288685,1.1189558591358129,0.3260553129548763,0.7362109880675575,1.0,4/26,4.50%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,synaptonemal complex assembly (GO:0007130),0.5010281806394694,1.118887982770464,0.34488188976377954,0.7351042285353657,1.0,3/15,11.00%,SYCP2;RAD21;BAG6
prerank,synaptonemal complex organization (GO:0070193),0.5010281806394694,1.118887982770464,0.34488188976377954,0.7351042285353657,1.0,3/15,11.00%,SYCP2;RAD21;BAG6
prerank,determination of left/right symmetry (GO:0007368),0.43144645763273665,1.1186270309189361,0.32956152758132956,0.7351722326116821,1.0,4/36,5.57%,TBX1;NOTCH1;DAND5;BBS7
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3670046510418988,1.1184588959049584,0.2901734104046243,0.7349864034318023,1.0,9/110,5.49%,ADGRL4;RAPGEF2;S1PR1;ADGRE5;GNAQ;ADRB2;GNAL;LGR5;IAPP
prerank,regulation of myotube differentiation (GO:0010830),0.45791237454847605,1.1182817089515222,0.325,0.734803516758773,1.0,3/24,3.11%,PIEZO1;NOTCH1;HDAC9
prerank,protein homotetramerization (GO:0051289),0.39972185948511113,1.1175765725834352,0.3045212765957447,0.7359973869587604,1.0,9/49,11.28%,GBP5;B2M;GLS;SSBP1;ALDH9A1;MCOLN1;ACOT13;ACACB;TRPM2
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.42461885849667586,1.1173490072139256,0.3236111111111111,0.7359238963800944,1.0,3/39,5.83%,MYRIP;DOC2B;GLUD1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.367431596138892,-1.1167728559845174,0.2689873417721519,0.72925196608738,1.0,8/26,23.50%,ATP1A2;CALM2;ADRA2A;DRD2;GSTM2;GSTO1;CBARP;CASQ2
prerank,glycogen catabolic process (GO:0005980),-0.4269695469704574,-1.1167052559888615,0.2962962962962963,0.7278052715111332,1.0,5/15,11.23%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,kidney development (GO:0001822),-0.30428727342114464,-1.1166339207307896,0.2358490566037736,0.7264328769582568,1.0,19/65,11.67%,GLI2;SULF1;WNT4;TGFBR1;BMP7;SULF2;BMP4;OSR1;GREB1L;PYGO1;NPHP3;NIPBL;KANK2;SIX1;VEGFA;PYGO2;STRA6;SALL1;PKD1
prerank,neutrophil chemotaxis (GO:0030593),0.40597162065642894,1.116044421966305,0.3172043010752688,0.7385516048990866,1.0,5/53,10.16%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.35515530656293826,-1.1158685350348694,0.2751677852348993,0.7271087336635462,1.0,7/30,6.78%,IGF1;NOTCH2;ITGAV;SHC1;NGF;IRS2;SRC
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5347560450384532,1.1157948413365057,0.346483704974271,0.7385858101411437,1.0,5/10,29.41%,EGR1;CLU;SORL1;HSP90AA1;HSP90AB1
prerank,mammary gland development (GO:0030879),0.45913875950211147,1.1155369854534514,0.346969696969697,0.7386173455696693,1.0,2/21,2.28%,NOTCH4;CAV1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4037573306218736,-1.115164855999188,0.3062330623306233,0.7275787017958513,1.0,4/17,6.64%,SLC12A2;SLC9A2;SLC6A1;SLC9A9
prerank,import into nucleus (GO:0051170),-0.2892370197981752,-1.1145566661849462,0.275,0.7277407768758076,1.0,29/73,26.04%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;GEMIN5;NUP155;TNPO3;SMN1;RANBP6;IPO5;FAM53C;SNRPF;NUP93;TNPO2;RANBP17;HTATIP2;SNUPN;TSC2;PHB2;SNRPD3;SEC13;SYK;IPO7;GEMIN7;POM121;IPO8;SNRPD1;NUP188
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4904348584663767,1.1143325844454404,0.35365853658536583,0.7410455409802046,1.0,5/16,17.28%,CEACAM1;SIRT4;BRCA1;ERLIN2;TRIB3
prerank,organophosphate catabolic process (GO:0046434),-0.4660841059392962,-1.1137483840704157,0.3260340632603406,0.7283672737315129,1.0,8/11,47.54%,ABHD12;ENPP2;ANGPTL3;PLBD2;PLBD1;NUDT15;PDXP;PON1
prerank,cell junction organization (GO:0034330),0.38480543151313507,1.1137298875374004,0.3091364205256571,0.7419620536125939,1.0,16/71,13.11%,APBB2;OCLN;FBLIM1;TGFB2;AGRN;APP;PPFIBP1;SNCG;LIMS2;TJP2;ACTG1;TJP1;PPFIA2;ACTB;GRM5;PIN1
prerank,regulation of dopamine secretion (GO:0014059),0.4478543960684612,1.1135951424412642,0.32547864506627394,0.7416832958702165,1.0,2/25,3.73%,SYT15;SYT7
prerank,lipid translocation (GO:0034204),0.46461341697512165,1.1134022278469824,0.35377358490566035,0.7415810978832316,1.0,6/21,15.39%,ATP10A;ABCB4;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,glycerolipid catabolic process (GO:0046503),0.4761858257308846,1.1123201456433711,0.3424242424242424,0.7437072686580506,1.0,5/19,9.85%,GPCPD1;PNPLA6;ABHD6;GDPD1;ENPP6
prerank,positive regulation of autophagy (GO:0010508),0.37782946936248385,1.1122980166323817,0.29156626506024097,0.7431315890381361,1.0,19/81,14.75%,TRIM14;PLK3;FOXO1;PRKD1;PIK3C2A;FBXO7;TRIM6;SH3BP4;IRGM;ZC3H12A;LRRK2;PRKAA1;ROCK1;HMGB1;TRIM8;PIK3CB;BNIP3L;BNIP3;EPM2A
prerank,regulation of interferon-gamma production (GO:0032649),0.3806836888948249,1.1122271545848115,0.30711610486891383,0.7426979164057053,1.0,14/71,16.90%,CRTAM;F2RL1;LGALS9;TLR3;CD47;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;PDE4D;PYCARD;RARA
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5083930028608497,1.1118338224637707,0.3520900321543408,0.7431060921954026,1.0,1/13,0.24%,SOX13
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.35132809522599073,-1.110930282559783,0.2946708463949843,0.7349027611558667,1.0,10/29,21.22%,TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;DHX34;E2F1
prerank,positive regulation of transport (GO:0051050),0.3764950279578865,1.1108173690162926,0.2911694510739857,0.7450846691094322,1.0,15/85,12.10%,GATA2;HIP1R;DOC2B;MERTK;APOA1;INPP5K;FCGR2B;CD47;CDH3;SGK1;NEDD4L;CYBA;NUMA1;ACTB;DOCK2
prerank,ion transport (GO:0006811),-0.2731229458650636,-1.1108150935783643,0.2,0.7335873162534805,1.0,15/111,6.82%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC12A2;SLC26A7;WNK1;SLC26A2;SLC8A3;WNK4;ANO1;SLC9A2;SLC17A5;SLC9A9;SLC5A5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3759090380999979,1.1106905132172964,0.3104693140794224,0.7447902447005329,1.0,20/84,16.16%,NANOS1;NANOS3;BTG2;RTN1;GAPDH;ROCK1;RTN4;PRNP;CNOT1;ENC1;CLU;TOB1;RTN3;FXR1;PIN1;YBX1;ABCA7;DDX6;RACK1;RNF139
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.38303489960417675,1.1104182901769473,0.32160194174757284,0.744854152850467,1.0,20/69,19.79%,RNF103;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;YOD1;UBE2J2;RNF103-CHMP3;FOXRED2;SGTB;FBXO2;UBQLN2;PSMC6;SEL1L;ERLIN2;FBXO6;DNAJC10;RNF5
prerank,regulation of keratinocyte migration (GO:0051547),0.5169101074886409,1.1104114690029852,0.36619718309859156,0.7442399406194005,1.0,2/12,4.97%,IQSEC1;MAP4K4
prerank,regulation of sister chromatid cohesion (GO:0007063),0.518240192565056,1.1101116744274029,0.34210526315789475,0.7443911462713938,1.0,4/12,14.25%,RAD21;FEN1;BUB1;CTNNB1
prerank,"phototransduction, visible light (GO:0007603)",0.49600953217438715,1.1097527984399231,0.34937888198757766,0.7446040195496069,1.0,1/14,1.71%,GNAQ
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3815727314820955,-1.1092224662920542,0.2996742671009772,0.7364574448301562,1.0,7/23,18.49%,NUPR1;PPARA;C1QTNF3;HDAC4;SIK1;CLK2;PFKFB1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.36535152182020236,-1.1091739588332252,0.2656716417910448,0.7350253956264573,1.0,3/24,2.40%,PID1;DAB2;RHOQ
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3895961320325956,-1.1091082739945477,0.3,0.7335870272161416,1.0,4/20,16.15%,WNT4;C1QTNF3;SIK1;CLK2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.37033253386230436,1.10898546820538,0.30778301886792453,0.7459740444818492,1.0,18/101,10.37%,NOD2;DAB2IP;VIM;DEFA6;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35068698087766537,1.108612730974754,0.2798708288482239,0.7463002706664985,1.0,46/186,16.05%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;NLK;CUL3;PSMD4;SHISA6;PTPRU;PTPRO;APC;SNAI2;MCC;CTNNBIP1;IGFBP4;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;TAX1BP3;NKD2;PSMB8;NXN;PSMD14;HMGXB4;TSKU;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;PSMB5;MLLT3;PSMC5;PSMB9;RACK1;PSMC6;LZTS2
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.375570686193488,-1.1084734515148231,0.3029411764705882,0.7337025789054004,1.0,13/25,30.82%,ADK;AMPD3;PRPSAP2;MTHFD1;GMPR;PNP;APRT;PPAT;DCK;PRPSAP1;AMPD2;ADA;SHMT2
prerank,negative regulation of nuclear division (GO:0051784),-0.47225927887260555,-1.1082709051311184,0.35194174757281554,0.7327127061675178,1.0,2/11,2.18%,BMP7;BMP4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.41540075518318614,-1.1079649708204433,0.3056379821958457,0.7319794416119101,1.0,4/17,4.43%,PTN;IL34;SERPINE2;DICER1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38282397736418683,1.1079121088618191,0.2982885085574572,0.7474743819521138,1.0,23/76,17.93%,SMAD7;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;PTK2;FBXW7;RBX1;NKD2;RNF144B;LAPTM5;CLU;SMURF1;KEAP1;RACK1;CBFA2T3;RNF139;TRIB3;SOCS5;GSK3A
prerank,response to iron ion (GO:0010039),-0.4436728146645274,-1.1078276528592232,0.3325301204819277,0.730776614029619,1.0,3/12,5.52%,BMP6;BCL2;ACO1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4443487730653855,1.1076367794094995,0.3342776203966006,0.7475647883138368,1.0,7/26,11.18%,PLCB1;CCND2;CCND3;ADAM17;MTBP;KMT2E;ADAMTS1
prerank,negative regulation of anoikis (GO:2000811),0.49709554677760953,1.1074926227025983,0.3478964401294498,0.7473064769764852,1.0,5/14,14.00%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,electron transport chain (GO:0022900),0.48575949935915724,1.1073274637276724,0.36436597110754415,0.7470537354594218,1.0,5/15,14.33%,ETFDH;ETFA;ETFB;UQCRFS1;CYB561
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.39520906958870305,-1.1072403630058525,0.3155080213903743,0.7308477379263805,1.0,3/18,5.48%,DCN;PRKN;DDHD1
prerank,regulation of glycolytic process (GO:0006110),-0.2958712963063924,-1.1070973726547908,0.24742268041237114,0.7296647690018082,1.0,9/68,7.46%,PRKAG2;IGF1;ZBTB20;OGT;NUPR1;PRKAA2;PPARA;NUP107;PFKFB4
prerank,response to chemokine (GO:1990868),0.5113131135691728,1.1068374336955866,0.3309608540925267,0.747690601419557,1.0,5/13,8.47%,DUSP1;OXSR1;LRCH1;ZC3H12A;STK39
prerank,positive regulation of binding (GO:0051099),0.37362535036526506,1.106585199931817,0.3025516403402187,0.7477010749531557,1.0,23/84,17.31%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;HMBOX1;EPB41;LRRK2;NVL;HMGB1;DHX9;MARK3;DTX3L;PIN1;RAN;HMGB2;KDM4D;RARA;MEN1;TRIB3;PLAUR
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2961993787349624,-1.106509688673975,0.24267782426778242,0.7298097375352027,1.0,19/62,15.78%,PRKCB;THBS1;CREBBP;TNRC6A;KAT2B;KMT2C;MEIS1;RUNX1;ASH2L;SETD1A;PAF1;MYL9;HOXA5;WDR5;CTR9;HDAC1;DPY30;TNRC6B;MAFB
prerank,negative regulation of histone modification (GO:0031057),-0.4341326186281368,-1.106271101622104,0.3235294117647059,0.7289327962695242,1.0,6/14,21.82%,SET;JARID2;TAF7;TWIST1;NOC2L;SPHK2
prerank,presynapse assembly (GO:0099054),-0.4202378033953891,-1.1062181465382592,0.2950391644908616,0.7275408042232435,1.0,7/16,31.53%,WNT5A;NLGN2;PTPRD;PCLO;NLGN3;LRP4;BSN
prerank,regulation of protein localization (GO:0032880),0.3964731519243372,1.1058463730178554,0.3302387267904509,0.7489312455039561,1.0,14/58,16.27%,TRIM14;FKBP1A;PPM1F;TRIM6;FBXW7;TRIM25;TRIM17;MMD;TRIM46;VPS4A;MAP2;RACK1;DNAJB6;PLEKHM2
prerank,cardiac muscle cell contraction (GO:0086003),-0.38850341530547927,-1.1058055595247185,0.3115727002967359,0.7271349869477544,1.0,4/19,6.67%,CACNA1C;GSN;CACNA2D1;CACNA1G
prerank,granulocyte differentiation (GO:0030851),0.4831104557269956,1.1056300392247365,0.3470948012232416,0.7488579346659803,1.0,5/18,16.90%,TAL1;LEF1;CEBPA;CBFA2T3;RARA
prerank,regulation of kinase activity (GO:0043549),0.3681222766256197,1.1056139946282837,0.31316725978647686,0.7482785930867535,1.0,13/89,8.03%,TEK;FLT1;TIE1;LDB2;FLT4;MERTK;INSR;EMP2;FGFR3;ALK;LMTK2;RBL1;NLRC5
prerank,neuron projection morphogenesis (GO:0048812),-0.26094327113814547,-1.1054263626261616,0.16216216216216217,0.7266413930249273,1.0,28/137,12.11%,ALCAM;GAS7;SDC2;FGFR2;DOCK7;NBL1;DCLK1;BMP7;FARP1;DCDC2;DOCK10;S100A6;DLG4;DICER1;PARD3;EPB41L3;NGF;MAP1A;CTNND2;BRSK1;FLRT1;NRK;ZDHHC17;DTNBP1;PLXNB1;DBN1;SLITRK1;NCKAP1L
prerank,reticulophagy (GO:0061709),-0.45005773161912865,-1.1053354331021092,0.33658536585365856,0.7253522852673439,1.0,4/12,11.04%,TEX264;UBA5;ATG2A;ULK2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.46972556418724126,1.105034318608358,0.34493192133131617,0.7490582001760252,1.0,3/20,9.48%,EPAS1;HSPA1B;EGR1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.38945643441044003,-1.1047340968157136,0.3314447592067989,0.7254376385303123,1.0,6/21,14.40%,SLC30A10;PPARA;PRKN;TRAP1;HDAC6;SIRT2
prerank,positive regulation of cilium assembly (GO:0045724),0.48181248533917925,1.1046002607617034,0.34498480243161095,0.7495600285357882,1.0,8/18,25.79%,SAXO1;CEP135;CCDC88A;CEP120;HAP1;MARK4;WRAP73;KCTD17
prerank,cellular response to heat (GO:0034605),0.4287952839936558,1.1044701312474388,0.3398876404494382,0.7492662944785923,1.0,6/35,10.09%,TRPV4;HSBP1L1;IER5;IL1A;HSPA1B;POLR2D
prerank,peptide biosynthetic process (GO:0043043),0.3567814968085467,1.1042473331196272,0.3080357142857143,0.7492456640382289,1.0,64/153,28.17%,RPS21;RPL27;PCSK5;RPL7;FURIN;FARSB;WARS1;MRPL18;MRPL41;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;MRPL36;MRPL52;RPS9;RPLP2;MRPL23;RPS25;RPL30;RPS5;RPL27A;MRPL24;MRPL32;MRPS12;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;MRPS18B;COPS5;DARS1;MRPL11;RSL24D1;RPL18;RPL39;RPS19;RPL31;RPS8;EIF4G1;MRPL34;EIF4EBP2;RPL3;RPL28;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;MRPS18C;MRPL27;RPS17;EEF1A1;RPS13;MRPL13;RPL11;RPL14
prerank,positive regulation of axonogenesis (GO:0050772),0.40980949354841884,1.104144689355322,0.3351206434316354,0.7488797088488695,1.0,9/43,7.01%,PLXNA4;MACF1;PLXND1;NTN1;SHTN1;SEMA7A;ARHGDIA;TIAM2;ISLR2
prerank,cellular response to retinoic acid (GO:0071300),-0.3274123349332194,-1.1040561807181972,0.27205882352941174,0.7257388810054699,1.0,8/42,9.45%,EPHA3;PTK7;WNT6;WNT5A;SNW1;WNT9A;FZD7;NDUFA13
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5340853439034835,1.103877543290462,0.36151079136690645,0.7489832204260994,1.0,2/10,4.97%,IQSEC1;MAP4K4
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5313368474813879,1.1029950135303686,0.3747870528109029,0.7506537532341152,1.0,2/11,3.64%,CASP8;TLR3
prerank,phospholipid catabolic process (GO:0009395),0.45526551251623926,1.1029248348559602,0.33825701624815363,0.7502172860028762,1.0,5/24,9.85%,GPCPD1;SMPDL3A;PNPLA6;GDPD1;ENPP6
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3326482201544729,1.1027262119411925,0.23100303951367782,0.7500995369467844,1.0,43/417,9.19%,PRDM16;MECOM;SOX13;GATA6;PLCB1;PDGFB;DACH1;RPS6KA5;SMARCA2;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;ID1;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;SMAD2;BTAF1;DAP;COMMD7;GATA3;EID2B;PDCD4;ZBTB16;PHC3;TMPRSS6;CEBPA;WWP1;ZHX3;GATAD2A;NR1D1;FOXP1;MBD1;JUN
prerank,sensory perception of light stimulus (GO:0050953),-0.28005052111497303,-1.1025459025680457,0.22598870056497175,0.7285094146011865,1.0,14/87,10.39%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;WHRN;OAT
prerank,glucose homeostasis (GO:0042593),0.37229192243527276,1.102540387080768,0.32735961768219835,0.7499431132467952,1.0,12/83,8.68%,ADIPOR2;FOXO1;INSR;KLF7;HNF1A;HNF4A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1;NR1D1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.37064601371883105,1.1023778573213543,0.32611311672683513,0.7497337581103976,1.0,6/85,2.89%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,positive regulation of signal transduction (GO:0009967),0.33921504720814766,1.1021695731273649,0.2979381443298969,0.7496183918499193,1.0,33/238,9.66%,JAG1;TEK;JAG2;NOTCH4;NOS3;KLF2;FAS;VWF;NOTCH1;JCAD;NOD2;MACF1;DAB2IP;CAV2;TGFB2;EMP2;DLL4;HHEX;MGAT5;LIMS2;TSPAN14;RAB34;SHANK3;GATA3;POGLUT1;CRADD;LRRK2;MYO1C;JAK2;CDH3;TPD52L1;GKAP1;TM2D3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4431802010164898,1.1019630031458045,0.35119047619047616,0.7495411481923671,1.0,9/25,20.37%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GRID2;GSK3B;INSYN2A
prerank,actin filament bundle assembly (GO:0051017),0.42483464452572883,1.1014832475480314,0.34517045454545453,0.7500914797966616,1.0,4/33,3.05%,LIMA1;FAM107A;PLS3;NEDD9
prerank,inner dynein arm assembly (GO:0036159),-0.4694466652867202,-1.1014493932301859,0.3375,0.7300346970498955,1.0,8/10,47.06%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5040159813471131,1.1012582545547327,0.3729641693811075,0.7500156549844084,1.0,6/14,16.98%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;ANGEL2;MAPK14
prerank,natural killer cell mediated immunity (GO:0002228),0.49212961600396044,1.101218187350358,0.34710743801652894,0.749506935949769,1.0,4/15,16.27%,TUBB;TUBB4B;LYST;PLEKHM2
prerank,defense response to virus (GO:0051607),0.36557346933674373,1.1010457547807535,0.3278879813302217,0.7492771386306772,1.0,31/100,21.89%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;SERINC3;STAT1;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;AKAP1;BNIP3L;RNASE6;BNIP3;LYST;PYCARD;RSAD2;CXCL10;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5194420548303496,1.1005307772712147,0.3614864864864865,0.7499626939903254,1.0,3/11,13.96%,FCGR2B;TYROBP;ATM
prerank,regulation of BMP signaling pathway (GO:0030510),0.3787773610005962,1.1004358644644021,0.3312807881773399,0.7495760572189789,1.0,7/73,1.86%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;NOTCH1;DAND5
prerank,hexose transmembrane transport (GO:0008645),0.4689428818378826,1.1004236849141649,0.3564954682779456,0.7489973102464573,1.0,3/21,8.42%,SLC2A1;SLC5A10;SLC2A9
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4042686833822446,1.1000043445841818,0.34025974025974026,0.7494703882351934,1.0,14/50,24.60%,CCND2;CCND3;CCNE1;SERTAD1;CDC25C;ACTB;TTBK1;CDKN2D;BLM;MNAT1;CAMK2N1;CDKN1B;CCND1;CCNH
prerank,positive regulation of chemotaxis (GO:0050921),0.4065724523592542,1.099846405167048,0.33156498673740054,0.749290094335819,1.0,7/43,7.36%,CDH13;PDGFB;PRKD1;F2RL1;PPM1F;ADAM17;HSPB1
prerank,embryonic organ development (GO:0048568),0.3866917824687015,1.0997028521031809,0.3324905183312263,0.7490047656093218,1.0,10/61,6.03%,SOX17;KITLG;HEY1;TAL1;TGFB2;SOX18;TEAD4;HEY2;PCSK5;GATA3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4847674788158307,-1.099678962342473,0.34192037470725994,0.7333993467390155,1.0,1/10,0.80%,ROCK2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3818857382831654,-1.0994116215929106,0.31420765027322406,0.7325892701719862,1.0,5/20,9.67%,SULF1;SULF2;THBS1;FGF2;CREB3L1
prerank,pre-replicative complex assembly (GO:0036388),0.38937935690189796,1.0986960341971552,0.3236040609137056,0.750940078242711,1.0,22/64,18.86%,PSMD13;ORC3;PSMD4;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;ORC5;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5099145032301575,1.0984160313413232,0.34804753820033957,0.7509977138701465,1.0,6/14,24.23%,TLR3;PUM2;ZDHHC5;DHX58;ANKRD17;OASL
prerank,protein polyubiquitination (GO:0000209),0.33561746488984767,1.0979625445569106,0.2804503582395087,0.7515130693676302,1.0,85/297,21.24%,LMO7;TRIM14;ZNRF1;TRIM69;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM6;TRAF1;RNF125;ARIH1;CUL3;UBE2Q1;UBE2D1;PSMD4;KLHL20;FBXL18;WWP1;UBE4A;UBA52;RPS27A;UBE3A;HERC6;FBXL16;PSMA5;RNF115;FBXW7;RBX1;PSMB10;SIAH2;RNF144B;FBXW2;TNKS;NEDD4L;PSMB8;PSMD14;BRCA1;DTX3L;FBXO4;SMURF1;UBE2T;CBFB;UBE2J2;PSMA7;PSMC3;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;PSMB9;FBXL13;ANAPC7;PSMC6;PSMA4;FBXO6;UNKL;ANAPC13;RUSC1;FBXO10;MKRN1;PSMD5;PSMD9;PSMB6;FBXL15;ANAPC4;RNF166;BARD1;RNF5;RNF34;PSMB2;LNPEP;WWP2;WSB1;TMEM129
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.33416660777334817,1.0974019244909263,0.2889576883384933,0.752336703883639,1.0,99/306,24.07%,GCNT1;NR4A2;EXT1;RBBP8;RPS21;RPL27;RPL7;FARSB;WARS1;MRPL18;ORC3;ALAS1;EEF2K;MRPL41;POLR2G;RPS14;RPS27A;RPL35;FEN1;MLF1;RPL21;NFKBIB;POLR2D;RPL37;RPS28;RPL34;TUFM;GTPBP1;MRPL36;BRIP1;MRPL52;RPS9;POLA1;RPLP2;EEF2;GTPBP2;BRCA1;MRPL23;RPS25;ORC5;RPL30;RPS5;RPL27A;RAD1;MRPL24;ATM;MRPL32;MRPS12;TAF1B;RPL23A;RPS15;RPL19;KAT7;RPS18;RFC2;RPL32;RAD9B;ST3GAL2;POLR2I;EEFSEC;PWP1;RPL37A;RPL18A;EEF1D;MMS19;MRPS18B;COPS5;HOXD3;ATRIP;GOLPH3;MEF2A;PTMA;BARD1;EEF1G;HUS1;DARS1;RRAGC;MRPL11;RSL24D1;BLM;RPL18;RPL39;RPS19;RPL31;RPS8;RMI1;POLR2C;PAX8;ORC4;KIN;TSFM;EIF4G1;POLR2B;POLR2J;MRPL34;RNASEH2A;EIF4EBP2;WRN;RPL3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.406126264191634,-1.0967768422696786,0.33875338753387535,0.7384047882040885,1.0,7/16,20.56%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,leukotriene biosynthetic process (GO:0019370),-0.4346911811361909,-1.0961966600402833,0.32989690721649484,0.738487886260082,1.0,9/14,36.57%,PLA2G4A;GGT5;GGT7;GGTA1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,muscle tissue development (GO:0060537),0.502494034636698,1.0959919517319237,0.38752052545155996,0.755295280019755,1.0,3/13,6.29%,ENG;CSRP2;POGLUT1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3557319121218946,1.0959330190486425,0.3246899661781285,0.7548184328634497,1.0,31/132,14.04%,TRIM14;FOXO1;INSR;PRKD1;PIK3C2A;APP;APOA1;MSN;TRIM6;FURIN;TNFRSF1B;SH3BP4;P2RX7;IRGM;ZC3H12A;LRRK2;PRR5L;PRKAA1;ROCK1;PFKFB3;HMGB1;CNOT1;GTPBP1;PTPN1;LAPTM5;VPS35;DTX3L;TRIM8;PIK3CB;HIF1A;BNIP3
prerank,negative regulation of endocytosis (GO:0045806),0.4532022214741704,1.0957344753442506,0.34307692307692306,0.7547188888196963,1.0,6/24,15.39%,MCTP1;CAV1;PRKD1;RAC1;RUBCN;ABCA7
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.4455841738571686,1.0956980438774817,0.3600605143721634,0.7541843286840956,1.0,10/24,18.66%,MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5370777468829063,1.0955795950115583,0.3771626297577855,0.7538821611772463,1.0,1/10,1.04%,ACE
prerank,regulation of viral release from host cell (GO:1902186),0.468137902574784,1.0953323069374166,0.3545878693623639,0.7539071674966135,1.0,6/21,15.24%,TRIM11;TRIM25;TRIM8;VPS4A;CHMP3;CHMP2B
prerank,negative regulation of macrophage activation (GO:0043031),0.4744469906714856,1.0950812490303719,0.37712519319938176,0.7539462168167077,1.0,4/16,8.68%,FCGR2B;ZC3H12A;CD200;NR1D1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5052249341757782,1.0945218343104082,0.41225165562913907,0.7547749090300168,1.0,5/13,15.56%,CAV1;RNF185;NFE2L2;BAG6;UBQLN2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5187674761192472,1.094170966979485,0.3520900321543408,0.7550596662890764,1.0,4/11,12.73%,LGALS9;HMGB1;VSIR;CBFB
prerank,renal filtration (GO:0097205),0.5141621887303489,1.0940841192050486,0.37745098039215685,0.7546299186316575,1.0,6/10,18.30%,MYO1E;CD34;MCAM;ITGA3;XPNPEP3;TBC1D8B
prerank,tyrosine metabolic process (GO:0006570),0.5173300445266861,1.09370711781779,0.38209982788296043,0.7549473610307712,1.0,2/11,9.85%,HGD;TYR
prerank,negative regulation of response to external stimulus (GO:0032102),0.361417770405291,1.093546856908702,0.3210161662817552,0.7547486043207224,1.0,18/105,12.41%,TEK;AOAH;CRK;APOA1;KLF4;GATA3;NFKBIL1;DUSP3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35;INPP5F;CTNNA2
prerank,melanosome localization (GO:0032400),0.46374775793812734,1.0933928835846127,0.37390029325513197,0.7545501705297801,1.0,4/21,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,positive regulation of cellular senescence (GO:2000774),0.5333959924535117,1.0932859439322455,0.37209302325581395,0.754205430789192,1.0,1/10,1.74%,B2M
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2692467328310345,-1.093111393533986,0.2565789473684211,0.7453926417127994,1.0,29/104,17.80%,UST;DSE;DCN;OGN;FMOD;SLC26A2;B3GNT2;GSTT1;CHST15;BGN;PRELP;GCLC;ST3GAL4;B4GALT1;VCAN;GSTZ1;GGT5;CHPF2;LUM;CSPG4;OMD;GSTA3;GSTM1;B4GALT2;GSTM2;GGT7;GGTA1;PAPSS2;AKR1A1
prerank,protein import into nucleus (GO:0006606),-0.285965420509801,-1.0928721062338271,0.25980392156862747,0.7445645548809435,1.0,22/66,24.39%,APPL2;CBLB;NUP107;HEATR3;CSE1L;KPNA1;PPP1R10;NUP155;TNPO3;RANBP6;IPO5;FAM53C;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,response to cytokine (GO:0034097),-0.2593420632227396,-1.0928132732200642,0.2,0.7432201538633326,1.0,19/141,7.03%,PID1;PTPN13;AFF3;COL3A1;DPYSL3;ALDH1A2;IL1R1;PTPN9;BCL2;IKBKE;PTPN4;TIMP2;IL6R;ANXA1;SMAD3;ADAM9;SRC;TBK1;CXCL16
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3406828376406389,1.0927763830395114,0.30760986066452306,0.7548703526720238,1.0,30/182,10.53%,ENG;CLDN5;GATA2;PDGFB;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;TNRC6C;LGALS9;DLL4;APP;HEY2;KLF4;TRIM6;MEF2C;CD34;SMCR8;ANKRD13A;ZC3H12A;RBL1;PRKAA1;FOXP1;NDFIP2;ADAM10;FBXW7;TCEAL1;AGO4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4404328883630153,1.092672306834304,0.3458083832335329,0.7545160431818126,1.0,6/27,12.62%,TIRAP;IRAK2;UBA52;RPS27A;TAB2;BTK
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33186224277934206,1.0926586319732576,0.2861507128309572,0.7539437213731344,1.0,36/308,10.24%,PRDM16;EPAS1;ADIPOR2;PLCB1;PDGFB;BMPR2;CRTAM;CAV1;F2RL1;TGFB2;ADRB2;CADM1;INPP5K;ACVR1;WWTR1;LEF1;GCNT2;YBX2;OMA1;SMAD2;IL1A;ADIPOR1;NPR1;ZBTB16;KDM3A;CMKLR1;VAMP8;GADD45G;JAK2;APC;GAPDH;VAMP7;ROCK1;RTN4;MAD2L2;LURAP1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.388359757465795,-1.092527499064214,0.3101449275362319,0.7424632592097437,1.0,8/19,20.61%,HK2;BCL3;HNRNPU;TOPORS;MORC3;SUPT7L;PML;CHCHD10
prerank,linoleic acid metabolic process (GO:0043651),-0.40996221469542504,-1.092470698335659,0.33053221288515405,0.7411088985750439,1.0,5/17,19.82%,ACSL1;GSTM2;FADS2;ELOVL1;ALOX12
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.33979775836155096,1.092207937819623,0.29039070749736007,0.7544249597032568,1.0,36/208,14.85%,PLCG2;TRIM14;NOD1;NOD2;DAB2IP;PRKD1;CASP8;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;TRAF1;JMJD8;ZC3H12A;STAT1;HSPB1;NR1D1;GAPDH;CACTIN;NDFIP2;TRIM25;LURAP1;CASP1;TAB2;MAP3K3;TRIM8;DDX21;RIOK3;RHOH;TMED4;CARD19;VAPA
prerank,inorganic cation transmembrane transport (GO:0098662),0.33335070443372716,1.0917426956521243,0.3068062827225131,0.7549587474960833,1.0,33/268,9.99%,ATP2A3;SLC6A6;KCNN4;KCNQ1;TRPV4;RHCG;ATP2B4;KCNH8;ATP1A4;ATP1A1;ATP1A3;CACNA1A;FKBP1A;KCNN3;KCNG3;SLC8A1;ATP2C1;ANO6;SCN11A;ORAI1;KCNK12;P2RX7;SLC30A1;MCOLN1;SLC6A4;SLC39A6;SCN1B;KCNC1;KCNH7;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,positive regulation of cartilage development (GO:0061036),0.4643122594859457,1.091605666143111,0.3650075414781297,0.75471126054477,1.0,3/17,6.87%,BMPR2;ACVRL1;ZBTB16
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.32841141229420645,1.0913041655979763,0.23269809428284854,0.7548991148157699,1.0,66/572,9.89%,PRDM16;SOX13;NOTCH4;KLF8;EDN1;GATA6;PDGFB;LDB2;DACH1;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;NR1I3;KLF12;HEY1;KLF7;DAB2IP;IRF2;CAV1;LRRFIP1;SAP30;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;HEY2;HMBOX1;KLF4;MAFK;EFNA1;MEF2C;SMAD2;TAF9B;PHF6;GATA3;BCL6B;RTF1;UBE2D1;ZBTB16;GTF2IRD1;STAT1;PURA;TMPRSS6;UBA52;WWC2;RPS14;GATAD2A;RPS27A;NR1D1;SNAI2;ERF;KLF11;FOXP1;UXT;JUN;TCF3;HMGB1;ARID5A;MAD2L2
prerank,iron ion transport (GO:0006826),-0.31486528216917586,-1.0912677079085236,0.26865671641791045,0.7431628751059681,1.0,8/47,8.33%,STEAP3;SLC39A14;SCARA5;ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6AP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5072212093942045,1.0908367702804915,0.3904448105436573,0.7554868826373281,1.0,6/13,17.37%,YAE1;BOLA2;ISCA2;GLRX5;GLRX3;MMS19
prerank,fatty acid transmembrane transport (GO:1902001),-0.3980427373560713,-1.0907449794473878,0.3436619718309859,0.7431563984671649,1.0,6/19,11.57%,PRKAG2;PRKAA2;ABCD3;SLC25A20;SLC27A1;PRKAB2
prerank,protein glycosylation (GO:0006486),0.3525443426452814,1.0907308170586518,0.3116438356164384,0.7551512482326289,1.0,26/125,16.63%,EOGT;ST8SIA6;GALNT18;ST3GAL6;POMGNT1;ST6GALNAC2;AQP11;SERP2;MGAT5;GCNT2;GALNT7;POGLUT1;NUS1;B3GNT3;DPM1;TET3;C1GALT1C1;MGAT1;B3GALNT2;KRTCAP2;ST3GAL1;ALG11;MPI;ST3GAL2;OGA;DDOST
prerank,endoplasmic reticulum organization (GO:0007029),0.3776063163672574,1.0905938934418118,0.3385354141656663,0.7549093060729869,1.0,16/72,12.92%,ATL2;CAV2;APP;DOP1B;SHTN1;ATL1;LRRK2;REEP2;RTN4;PRNP;LPCAT3;GET1;REEP1;REEP3;RTN3;UBE2J2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2929514245524483,-1.0905844480023004,0.2807017543859649,0.7421093006469534,1.0,11/74,3.48%,EYA2;IGF1;EYA1;TGFBR1;BMP5;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV
prerank,negative regulation of myoblast differentiation (GO:0045662),0.49865503016893475,1.089779653329988,0.3884430176565008,0.7563676300414087,1.0,2/13,6.06%,NOTCH1;EID2B
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.49620237933989175,1.0895765596103175,0.3642495784148398,0.7563135504972869,1.0,6/13,19.41%,UFM1;RAB23;RANGAP1;NUP153;CABP1;BARD1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4080666449524133,1.0892290885812634,0.34054054054054056,0.7565799124980102,1.0,7/43,9.19%,CDH13;EDN1;PDGFB;STAT1;HTR1B;FOXP1;JUN
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.32925555323072875,1.089088273663363,0.2711518858307849,0.7563172379977537,1.0,59/348,12.61%,PLCG2;NOS3;CLDN5;GATA2;PDGFB;KLF2;OCLN;NOTCH1;INSR;HEY1;IFNGR1;TNRC6C;LGALS9;DLL4;APP;HEY2;TLR3;NOS1AP;MED26;KLF4;PPM1F;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;WARS1;IL1A;MAPK1;P2RX7;ZC3H12A;HSPA1B;ARRB1;PLSCR1;TBC1D5;CDH3;NFE2L2;PRKAA1;ACTG1;ROCK1;STAP1;EGR1;TASOR;TYROBP;AGO4;PTPN1;VSIR;LAPTM5;NWD1;VPS35;INPP5F;BRCA1;VSTM2A;CLU;DTX3L;HINFP;PIK3CB;TTBK1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4978126831743017,1.08888540686803,0.3710691823899371,0.7562177536781157,1.0,3/13,5.58%,APP;AKAP5;SHANK3
prerank,inorganic anion transport (GO:0015698),-0.30776268169841453,-1.0888034679530132,0.3076923076923077,0.745410669141655,1.0,8/53,6.82%,SLC13A4;SLC4A10;SLC26A7;ANO1;CLCN2;ENPP1;ENPP3;SLC5A5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4438767723144856,1.088170905187594,0.3629737609329446,0.7574593829450269,1.0,4/25,4.95%,GJA5;CAV1;NOS1AP;CAMK2D
prerank,positive regulation of protein processing (GO:0010954),-0.39424746339771416,-1.0880919718597286,0.3342541436464088,0.7459863426035925,1.0,3/19,3.88%,GSN;CCBE1;CLEC3B
prerank,mitochondrion transport along microtubule (GO:0047497),0.5074586595889187,1.0879473310932302,0.3691275167785235,0.757423334239603,1.0,6/13,21.60%,UXT;RHOT2;HIF1A;SYBU;LRPPRC;UBB
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.3549367602420413,-1.0878513328890318,0.32550335570469796,0.7450550173430879,1.0,10/28,18.45%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5272918021277181,1.0869704006080119,0.38045375218150085,0.7593025946117027,1.0,2/10,6.03%,LGALS9;GATA3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.4957170209371574,1.0865484443909579,0.3565640194489465,0.7597672890885561,1.0,4/14,10.49%,ECSCR;ANO6;PDCD4;PLCG1
prerank,regulation of inflammatory response (GO:0050727),0.3418579171854133,1.0865026898688928,0.31216361679224974,0.7592706870271732,1.0,29/190,11.41%,TEK;NOD2;AOAH;SPATA2;APP;APOA1;TLR3;KLF4;SEMA7A;HYAL2;TNFRSF1B;GATA3;BCL6B;PDCD4;CD47;MFHAS1;CEBPA;CD200;JAK2;PROC;NMI;NR1D1;ACOD1;FOXP1;DHX9;LPCAT3;CASP1;NFKBIA;VPS35
prerank,visual perception (GO:0007601),-0.28181160693144186,-1.086381029214358,0.275,0.7476838587056392,1.0,13/84,10.39%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;OAT
prerank,protein tetramerization (GO:0051262),0.37450233654256904,1.0862108787972744,0.33249370277078083,0.7594131161395112,1.0,12/67,11.28%,GBP5;B2M;GLS;SSBP1;FARSB;ALDH9A1;MCOLN1;GRIN2B;KCNC1;ACOT13;ACACB;TRPM2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.4522752720946489,-1.0860353733168961,0.33642691415313225,0.7471357810075832,1.0,3/11,23.06%,CAT;PRDX3;GPX1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.38525216506189564,-1.0856024960383295,0.3287292817679558,0.7468071653187238,1.0,3/20,1.27%,BMPR1A;GLI2;NBL1
prerank,methylguanosine-cap decapping (GO:0110156),0.5272643615136486,1.0853520404963393,0.3838209982788296,0.76094084219213,1.0,4/10,15.18%,LSM1;DCPS;DCP1B;EDC3
prerank,regulation of peptide hormone secretion (GO:0090276),0.37704113973052433,1.0853064856615238,0.3446601941747573,0.7604412574988394,1.0,8/67,8.47%,ITPR3;SLC2A1;CACNA1A;HNF4A;SYT7;RAPGEF4;MTNR1B;PASK
prerank,cellular response to hypoxia (GO:0071456),0.35207476983733266,1.0852668210629641,0.33934611048478014,0.7599368122332307,1.0,38/126,20.43%,EPAS1;GATA6;PLK3;PSMD13;ELOC;PGK1;PSMD4;UBA52;RPS27A;PSMA5;RBX1;PSMB10;HP1BP3;CUL2;PSMB8;HIF1AN;PSMD14;SUV39H2;PSMA7;PSMC3;BNIP3L;HIF1A;PSMA8;PSMC1;BNIP3;PSMB5;PSMC5;PSMB9;PSMC6;PTGIS;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;ACAA2;PSMB2
prerank,coenzyme A metabolic process (GO:0015936),0.4834383776788843,1.0851968527501732,0.38752052545155996,0.7594985665515955,1.0,6/14,22.61%,SLC25A16;PANK3;PPCS;CROT;ACAT1;ACLY
prerank,positive regulation of cell population proliferation (GO:0008284),0.3248979505908702,1.085034106763405,0.30010172939979657,0.759272380383097,1.0,45/423,9.64%,VEGFC;CDH13;ACER2;EDN1;PDGFD;CLDN5;FLT1;PDGFB;FLT4;KITLG;TBX1;CCND2;LIFR;NOTCH1;NOD2;INSR;AQP11;TGFB2;EMP2;RASSF10;DLL4;VEGFD;KRAS;WWTR1;LEF1;GCNT2;SERTAD1;MEF2C;TBC1D8;FGFR3;CUL3;ADAM17;SLC25A33;CD47;GNAI2;STAT1;CNOT6L;THPO;NDUFS4;NAMPT;FOXP1;TJP1;PTK2;ADAM10;DHX9
prerank,stabilization of membrane potential (GO:0030322),0.4857043512299172,1.0849091516809988,0.3704918032786885,0.7590102795926246,1.0,2/16,5.81%,KCNN4;KCNK12
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3422914483445774,1.0847270645957017,0.33152173913043476,0.7588669956387877,1.0,70/168,25.82%,RPS21;RPL27;RPL7;LSM1;ZC3H12A;CNOT6L;MTPAP;DCPS;UBA52;DCP1B;POLR2G;RPS14;RPS27A;RPL35;ETF1;RPL21;POLR2D;RPL37;CNOT1;RPS28;RPL34;RPS9;XRN2;EXOSC8;PELO;RPLP2;RPS25;HELZ2;RPL30;RPS5;XRN1;RPL27A;ATM;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CNOT2;TENT2;EXOSC9;TUT7;DXO;NBDY;CTIF;SMG7;RPL18;RPL39;ZFP36L1;RPS19;EXOSC10;CSDE1;SMG9;RPL31;RPS8;DIS3L2;SMG8;EIF4G1;PATL2;RPL3;MRTO4;PPP2R2A;PPP2R1A;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,embryonic digit morphogenesis (GO:0042733),-0.4037907571143868,-1.0844386317014167,0.33242506811989103,0.7486268263787758,1.0,7/18,11.56%,GLI3;OSR1;CREBBP;INTU;SALL1;TBX2;HDAC1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.514022042289568,1.0844212913707323,0.39967637540453077,0.7590281567061119,1.0,2/11,2.67%,FAS;LGALS9
prerank,signal transduction by p53 class mediator (GO:0072331),0.4239190272797023,1.0841711354502086,0.3541963015647226,0.758982390373958,1.0,2/30,3.46%,ACER2;PPP1R13B
prerank,regulation of protein localization to membrane (GO:1905475),-0.35001287617943866,-1.0840143602301455,0.3487544483985765,0.748261765800263,1.0,5/28,4.31%,GPC6;GSN;GPC3;MMP14;PRKN
prerank,positive regulation of interferon-alpha production (GO:0032727),0.45723599257508374,1.083858900643217,0.36334913112164297,0.7591954346124263,1.0,5/19,12.46%,IFIH1;TLR3;STAT1;DHX9;IRF5
prerank,polyol biosynthetic process (GO:0046173),0.47831566206498555,1.0835139025029812,0.37738853503184716,0.7594996722140869,1.0,3/16,3.53%,ITPKB;IP6K3;IPPK
prerank,regulation of G0 to G1 transition (GO:0070316),0.4106000977979754,1.0833431981901052,0.35570469798657717,0.7593164545255385,1.0,7/38,11.66%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.47022149654200557,1.082957663160171,0.3730886850152905,0.7597098985066403,1.0,3/18,3.52%,SLC2A1;OCLN;INPP5K
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.38692810608343886,1.0827447728834205,0.34375,0.759617316843826,1.0,5/51,1.86%,SMAD6;BMPR2;SMAD7;NOTCH1;DAND5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4418844821324599,-1.082525892541439,0.3734015345268542,0.7508907501578582,1.0,3/12,11.56%,DAB2;HEYL;HDAC1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.47301909723666147,1.0823517428064438,0.3939393939393939,0.759964282118259,1.0,3/17,9.50%,CCR1;ANO6;HMGB1
prerank,multivesicular body organization (GO:0036257),0.4284095431484499,1.0816201822576437,0.3551673944687045,0.7612207992736256,1.0,12/31,21.85%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;RAB27A;MVB12A;STAM2;CHMP1A
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5295013508919506,1.0815034863940938,0.3857374392220421,0.760888314066643,1.0,4/10,9.42%,OXSR1;ADAM17;STK39;ADAM10
prerank,regulation of protein targeting to membrane (GO:0090313),0.43321456304822903,1.0812005116749845,0.3539568345323741,0.7610937269425723,1.0,8/28,17.88%,FYN;INPP5K;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3;GDI1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4212235878708659,1.0808837392543633,0.36554621848739494,0.761279668464335,1.0,5/31,7.71%,HIP1R;CASP8;PPP1R13B;BBC3;NMT1
prerank,post-translational protein modification (GO:0043687),0.33007406306776327,1.080098414771323,0.3096707818930041,0.7626141152381407,1.0,80/332,19.04%,LMO7;EPAS1;ASB4;RAB11A;GOLM1;APP;TULP4;KLHL2;FBXO7;APOA1;COPS4;CISH;PSMD13;FBXL14;FBXL5;KLHL3;TMEM132A;ELOC;RHBDD1;GAN;CUL3;PSMD4;KLHL20;ZBTB16;PRKCSH;FBXL18;IGFBP7;SOCS6;HSP90B1;ASB5;FEM1C;PROC;FBXL16;IGFBP4;ADAM10;PSMA5;FBXW7;RBX1;PSMB10;CUL2;APLP2;FBXW2;CDH2;PSMB8;PSMD14;FBXO4;CP;COPS8;DCAF17;PSMA7;PSMC3;KEAP1;DCAF10;HIF1A;PSMA8;PSMC1;FBXO2;PSMB5;PSMC5;PSMB9;KLHL25;FBXL13;PSMC6;CST3;KLHL9;PSMA4;FBXO6;MEN1;CALU;SOCS5;COPS5;FBXO10;PENK;PSMD5;PSMD9;FEM1A;TIMP1;DCAF13;PSMB6;FBXL15
prerank,retinol metabolic process (GO:0042572),-0.4217714546695973,-1.079505277848786,0.3484042553191489,0.7578390988290469,1.0,2/14,9.47%,RBP4;DHRS3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.4369535072438265,-1.07949321396783,0.3492822966507177,0.7563708713978273,1.0,4/12,18.39%,GLI2;NFIB;EPHB2;SZT2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3700786470924,1.079369646532856,0.3580097087378641,0.7638739768311121,1.0,24/72,18.86%,TLR3;TIRAP;PSMD13;CARD10;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;COPS8;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,RNA processing (GO:0006396),-0.24487371254316084,-1.0791161841888863,0.2463768115942029,0.7559856760119931,1.0,56/176,23.42%,CELF2;RBMS1;SON;NOVA1;SNRNP40;SRSF5;HNRNPH1;SCAF11;DDX17;DICER1;APOBEC1;NUDT21;HNRNPA2B1;NCBP1;LIN28B;PRPF8;SRRM1;FUS;SRSF1;PRKACA;CDK12;PRPF3;PABPN1;THOC1;TARDBP;AKAP8L;SNRPF;TENT4B;RBM39;WBP4;SNRPA1;TUT1;HNRNPL;SCNM1;RNASEL;HNRNPU;MAGOH;PPP2CA;BCAS2;U2AF2;SNRPD3;TUT4;MAGOHB;RNGTT;MPHOSPH10;LSM6;DHX8;SF3B1;SRPK2;SRSF11;SF3A2;NCBP2;DHX15;TCERG1;CELF1;SRSF2
prerank,peptidyl-serine modification (GO:0018209),0.3402818871202654,1.0785642527200132,0.33916849015317285,0.7652783209798061,1.0,43/166,16.98%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;PKN1;STK38;STK38L;CSNK1D;TTBK2;POGLUT1;MAPK1;UHMK1;MAST1;AKT3;LRRK2;LMTK2;TLK1;STK39;ROCK1;CSNK1G3;SGK1;MARK3;PRKCG;RPS6KA1;TNKS;PRKD2;GALNT4;MARK2;VRK1;TTBK1;RPS6KA3;RPS6KB1;ATM;PRKX;PKN2;PAK2;RICTOR;CSNK1G1;STK32B;MAPK14
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4040390995651367,1.078503285742105,0.3673469387755102,0.7648201450210019,1.0,5/42,10.16%,CCR1;OXSR1;THPO;STK39;CCL4
prerank,negative regulation of viral genome replication (GO:0045071),0.40024036459101564,1.078368531557865,0.38670284938941657,0.7645621626594862,1.0,16/40,24.96%,IFIH1;INPP5K;TRIM6;PLSCR1;OAS2;TASOR;SLPI;RSAD2;SRPK1;IFITM3;ZC3HAV1;EIF2AK2;BANF1;SETDB1;OASL;BST2
prerank,axonal fasciculation (GO:0007413),-0.43546062653843054,-1.0782423499670633,0.38480392156862747,0.7568588081829514,1.0,6/12,18.43%,EPHA3;SEMA5A;MEGF8;ARHGAP35;EPHB2;EPHB3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4654302867984931,-1.077884157828518,0.3711340206185567,0.7563710763573684,1.0,4/10,11.03%,DPYD;NT5M;NT5E;UPB1
prerank,negative regulation of gene expression (GO:0010629),0.328662066648595,1.0772978329180596,0.3146997929606625,0.7665963661810965,1.0,49/302,13.22%,NANOS1;NANOS3;ENG;CLDN5;GATA2;PDGFB;RPS6KA5;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;TNRC6C;LGALS9;BTG2;DLL4;APP;HDAC9;HEY2;KLF4;FCGR2B;TRIM6;MEF2C;CD34;SMCR8;ZC3H12A;HSPA1B;RBL1;PRKAA1;GAPDH;FOXP1;NDFIP2;ZFP36L2;ADAM10;FBXW7;TCEAL1;TASOR;CNOT1;ENC1;AGO4;PTBP3;TMBIM6;HINFP;TOB1;TTBK1;PPM1D;FXR1;APLN
prerank,mesenchymal to epithelial transition (GO:0060231),-0.46087081755555515,-1.077137134062169,0.36803874092009686,0.7569903973730006,1.0,5/10,20.48%,BMP4;FZD7;SALL1;BASP1;PAX2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.4085972312367922,-1.0770825455461008,0.3575418994413408,0.7556638001615977,1.0,2/15,5.69%,MOXD1;SMOX
prerank,regulation of protein localization to cell periphery (GO:1904375),0.46919455542319116,1.0769666239198181,0.36818181818181817,0.7668515750906918,1.0,7/18,17.72%,VTI1B;STX7;VAMP8;ACTB;VPS4A;LDLRAP1;SPTBN1
prerank,zinc ion transport (GO:0006829),-0.38188468213215915,-1.0766500105573407,0.356353591160221,0.7553596940685272,1.0,5/21,8.22%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,regulation of actin filament-based movement (GO:1903115),-0.45589822357374626,-1.0765858689777326,0.3869346733668342,0.7540414966565898,1.0,2/10,1.63%,ANK2;PDPN
prerank,cellular senescence (GO:0090398),-0.3503020061541861,-1.0764879183542801,0.35294117647058826,0.7528399968230371,1.0,11/27,27.53%,SMC6;TBX2;HMGA2;ECRG4;CDKN1A;PRKCD;PML;ULK3;SRF;OPA1;NSMCE2
prerank,endodermal cell differentiation (GO:0035987),0.4166739657573947,1.0763256569092339,0.3686502177068215,0.7678136186080767,1.0,1/31,0.04%,LAMA3
prerank,hexose biosynthetic process (GO:0019319),-0.3242955275908195,-1.0762587286086147,0.3360995850622407,0.7520469628089609,1.0,15/42,21.23%,SLC39A14;SLC25A13;CHST15;RBP4;ENO2;PGM1;MDH2;SLC25A12;GOT1;AKR1B1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,regulation of axonogenesis (GO:0050770),-0.3085184892122912,-1.075936442311751,0.31020408163265306,0.7514302665966123,1.0,13/51,11.76%,ROBO1;PLXNA2;SLIT2;SIPA1L1;NTRK2;PLXNB2;NGF;BRSK1;KIF13B;CHN1;PLXNB1;ARHGAP35;SLITRK1
prerank,cell junction assembly (GO:0034329),0.3539008830728341,1.0756599238766842,0.3508158508158508,0.7688652681180831,1.0,29/100,20.66%,TRPV4;CLDN5;FBLIM1;DNM3;SPOCK2;PLXND1;LIMS2;SHANK3;GJA4;NRCAM;FLRT3;ACTG1;TJP1;CDH12;KIRREL3;CDH2;ACTB;ACHE;PCDHB16;PCDHB14;CDH22;PCDHB9;OPHN1;DSCAM;SHANK2;CDH18;CDH24;BDNF;NRXN1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3623439837892052,1.0756184842583056,0.35833333333333334,0.7683716070510445,1.0,21/87,15.83%,TBX1;ESRP2;EGR3;CBL;DLL4;HYAL2;FGFR3;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;ZFP36L2;POLR2D;TIAL1;NR4A1;ITGB1BP1;FGF20;KIF16B;POLR2I
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.46029420778384667,-1.0754379222835255,0.39603960396039606,0.7498138933712296,1.0,6/10,27.40%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.46029420778384667,-1.0754379222835255,0.39603960396039606,0.7498138933712296,1.0,6/10,27.40%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,regulation of microtubule-based process (GO:0032886),0.41002674117908366,1.075300614990823,0.35919540229885055,0.76851547744715,1.0,10/36,12.15%,EFNA5;FAM107A;MACF1;DIAPH1;CLASP1;PRKAA1;APC;ROCK1;CLASP2;MARK2
prerank,protein ubiquitination (GO:0016567),0.3258820274211359,1.075217207086195,0.2990936555891239,0.7681271895615112,1.0,99/471,16.16%,LMO7;EPAS1;ASB4;TRIM14;RNF103;FBXL2;ZNRF1;TRIM69;CBL;HERC2;KLHL2;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM11;TRIM6;RNF38;ELOC;RNF125;RNF185;ARIH1;GAN;CUL3;UBE2Q1;ARRDC1;RTF1;UBE2D1;TRIM24;PSMD4;KLHL20;FBXL18;ARRB1;WWP1;ASB5;UBE4A;UBA52;NFE2L2;RPS27A;UBE3A;HERC6;FBXL16;PSMA5;RNF141;RNF115;FBXW7;RBX1;PSMB10;ZNRF3;SIAH2;CUL2;TRIM25;TRIM47;ENC1;RNF144B;TRIM17;FBXW2;TNKS;NEDD4L;PSMB8;PSMD14;OBI1;BRCA1;DTX3L;FBXO4;SMURF1;KCTD10;UBE2T;CBFB;UBE2J2;PSMA7;RNF103-CHMP3;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;RAD18;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;PSMB9;RACK1;TRAIP;KLHL25;FBXL13;KLHL24;ANAPC7;PSMC6;RNF139
prerank,amino acid import across plasma membrane (GO:0089718),-0.360824082744907,-1.074917466333401,0.3355263157894737,0.7497592698948788,1.0,7/24,7.11%,SLC1A3;SLC6A13;SLC7A2;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,regulation of cellular response to heat (GO:1900034),0.36196532937106873,1.0747256434874233,0.3537331701346389,0.7687425233843065,1.0,23/77,21.45%,FKBP4;IER5;CAMK2D;CD34;MAPK1;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NUP153;NUP160;ATM;NUP42;DNAJB6;NUP205;DNAJC7;GSK3B;BAG4;NUP50;MAPKAPK2;AKT1S1
prerank,regulation of gastrulation (GO:0010470),-0.41368389206351874,-1.0746742424681492,0.36768802228412256,0.7489499676724041,1.0,3/14,6.11%,PHLDB2;OSR1;DAG1
prerank,cardiac muscle cell differentiation (GO:0055007),0.4465174042921882,1.074410973010935,0.35843373493975905,0.7688826130777321,1.0,4/21,5.32%,SLC8A1;ACVR1;ALPK3;MEF2C
prerank,skeletal muscle tissue development (GO:0007519),0.41796289111330776,1.0742086004497937,0.3609625668449198,0.7687740917772178,1.0,4/32,7.82%,CAV1;CAV2;MEF2C;MYL6
prerank,response to acidic pH (GO:0010447),-0.43014078306209,-1.0737827044048363,0.3776595744680851,0.749982613635414,1.0,4/13,29.94%,GPR4;SLC9A1;LGMN;IMPACT
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5186373129606021,1.0735450372358186,0.40418679549114334,0.7698043092714392,1.0,3/10,6.58%,ETFDH;ETFA;ETFB
prerank,V(D)J recombination (GO:0033151),0.513935344023668,1.072860777054968,0.3956228956228956,0.7709100863002335,1.0,5/11,22.13%,TCF3;HMGB1;LIG1;HMGB2;XRCC4
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4719230055672081,-1.0723937355614834,0.4097560975609756,0.7523551671350156,1.0,3/10,6.78%,DCN;BCL2;SRC
prerank,cellular response to acid chemical (GO:0071229),0.42553237979312064,1.071878466186667,0.37300435413642963,0.7726930851157169,1.0,8/27,20.76%,SPAAR;KLF2;SH3BP4;RRAGD;GLRA2;RRAGA;RRAGC;LAMTOR3
prerank,synaptic vesicle exocytosis (GO:0016079),0.4087095943093341,1.071857127065295,0.381201044386423,0.7721566646458063,1.0,11/40,18.29%,UNC13B;DOC2B;BLOC1S6;SYT7;PIP5K1C;STX19;RIMS3;CPLX1;SNPH;SYT1;SYT2
prerank,positive regulation of interferon-beta production (GO:0032728),0.40794210447404883,1.0717618138595109,0.37806637806637805,0.7718033101946015,1.0,7/33,13.70%,IFIH1;TLR3;OAS2;POLR3B;DHX9;IRF5;RIOK3
prerank,lipoprotein biosynthetic process (GO:0042158),-0.45437044575750307,-1.0713203225457557,0.38141809290953543,0.7539420518724135,1.0,5/11,23.45%,APOE;ATG7;WIPI2;WDR45;PORCN
prerank,monoacylglycerol metabolic process (GO:0046462),-0.42111804748300835,-1.0711046090459078,0.3805970149253731,0.7531179553727572,1.0,6/13,22.39%,MOGAT3;PLA2G4A;DGAT1;ABHD12;DGAT2;FAAH
prerank,glutamate metabolic process (GO:0006536),0.46621272540364755,1.0709991405552797,0.39076923076923076,0.773149791270351,1.0,4/19,5.83%,DGLUCY;GLS2;GLS;GLUD1
prerank,receptor clustering (GO:0043113),-0.3594728882471001,-1.070835385275466,0.330188679245283,0.7524154574094255,1.0,5/27,8.24%,PTN;MAGI2;DLG4;DNAJA3;FLNA
prerank,regulation of osteoclast differentiation (GO:0045670),0.4077627909475656,1.0706034948312997,0.37572254335260113,0.7735067771549297,1.0,3/33,3.64%,CCR1;GPR137B;TLR3
prerank,positive regulation of cell differentiation (GO:0045597),0.3294346464736427,1.0704371227033407,0.3512658227848101,0.7733303101337522,1.0,40/237,11.44%,SLC6A6;RAPGEF2;CEACAM1;PLCB1;ASB4;BMPR2;KITLG;ACVRL1;ARHGEF2;PRKD1;TGFB2;FES;BTG1;TMEM100;BLOC1S6;ACVR1;RRAS;WWTR1;LEF1;GCNT2;MEF2C;SMAD2;CD34;SPAG9;ZBTB16;ZC3H12A;CMKLR1;CTNNA1;NRCAM;ZHX3;CDH15;SYAP1;CTNNBIP1;TCF3;RPS6KA1;ZC4H2;CDH2;MMD;HIF1AN;PCP4
prerank,amyloid fibril formation (GO:1990000),0.3924228406365424,1.0703754891621864,0.3708165997322624,0.7728870871707679,1.0,13/51,11.63%,B2M;FKBP1A;APP;APOA1;TSPAN14;IAPP;FURIN;UBA52;RPS27A;APH1A;ADAM10;SIAH2;SNCAIP
prerank,regulation of vasculature development (GO:1901342),0.43377067243751244,1.069662328627928,0.38338192419825073,0.7740830405587197,1.0,10/26,22.01%,EMP2;PLXND1;VASH2;TSPAN12;WARS1;ADGRA2;CTNNB1;ETS1;EGLN1;EPHA2
prerank,protein deacetylation (GO:0006476),-0.3212938701512513,-1.0696294977187077,0.33070866141732286,0.7541131859967697,1.0,12/41,14.56%,PRDM5;TBL1XR1;SIRT3;FLNA;RBM14;HDAC4;HDAC1;HDAC6;MSL3;SIRT2;SIN3B;MTA2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.433406002575085,1.0687849977783628,0.39826839826839827,0.7757149969903313,1.0,3/27,4.95%,GJA5;CAV1;CAMK2D
prerank,extracellular matrix organization (GO:0030198),0.3257126792560552,1.0687111811092977,0.3385093167701863,0.7752881496937966,1.0,30/276,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;TGFB2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;DST;ATP7A;FURIN;COL5A2;CD47;BSG;PLEC;ITGAM;ADAM12
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5156320835543553,1.068652062975178,0.41361256544502617,0.774811996548492,1.0,3/10,8.27%,LRRK2;PDE8A;NFE2L2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.36071532615211394,1.0677872979145349,0.3651354534746761,0.776376444285401,1.0,31/88,24.46%,EXOC6;STXBP6;APP;AP1S2;DOP1B;BLOC1S6;GOPC;KLHL20;VAMP8;ARRB1;VAMP7;EXOC8;AP1B1;CLVS1;KIF16B;MON2;EXOC4;SORCS1;SORT1;EXOC2;STEAP2;EPS15;SORL1;SCAMP1;EXOC5;EXOC6B;OSBPL5;SCAMP3;FTH1;FTL;MYO5A
prerank,cellular response to unfolded protein (GO:0034620),0.4367014072719972,1.0673880054954126,0.3896296296296296,0.7768012487681407,1.0,8/26,19.18%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,regulation of neurogenesis (GO:0050767),0.3804723264023266,1.0655769657652159,0.3783783783783784,0.7808074117085279,1.0,13/55,16.11%,NOTCH1;B2M;HEY1;RASSF10;HEY2;PRUNE1;NUMB;PCM1;CX3CR1;HES3;CTNNB1;HMGB2;SPEN
prerank,regulation of protein import into nucleus (GO:0042306),-0.33008898475221693,-1.0652373629280314,0.35094339622641507,0.7646278006038483,1.0,10/36,13.71%,ZIC1;BMP4;APOD;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2
prerank,dopaminergic neuron differentiation (GO:0071542),0.45165447645349144,1.0652327897384128,0.39069767441860465,0.7811137609850036,1.0,3/19,14.25%,NR4A2;PHOX2A;CTNNB1
prerank,negative regulation of autophagy (GO:0010507),-0.2999915853852278,-1.064932211977754,0.29554655870445345,0.7640122772048921,1.0,15/54,14.48%,LEPR;NUPR1;BCL2;SNRNP70;KLHL22;GOLGA2;PTPN22;TAB3;DAPL1;MET;FOXK2;ATG7;KDM4A;SIRT2;TSC1
prerank,prostanoid metabolic process (GO:0006692),-0.4307275463575573,-1.0641877900983605,0.3622448979591837,0.7646369413876722,1.0,4/13,14.82%,PTGES;PTGS1;HPGD;GSTM1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5002066658624242,1.0640763513440876,0.3944636678200692,0.7833778228529691,1.0,2/10,4.47%,MSN;SYNE4
prerank,neurotrophin signaling pathway (GO:0038179),0.45054859429189914,1.0640221518154478,0.3875739644970414,0.7829155358014082,1.0,2/21,1.83%,RAPGEF2;RAPGEF1
prerank,response to retinoic acid (GO:0032526),0.37862054167154424,1.063923871492511,0.3669724770642202,0.7825378163775961,1.0,5/59,6.67%,ACER2;GATA6;TBX1;RXRG;SETX
prerank,regulation of mast cell degranulation (GO:0043304),0.4817664041185089,1.0634043918389668,0.3996815286624204,0.783232178502616,1.0,2/14,3.24%,LGALS9;FES
prerank,GTP metabolic process (GO:0046039),0.46992021571969644,1.0633542056428986,0.37750385208012327,0.7827671857102981,1.0,6/15,15.84%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,response to organonitrogen compound (GO:0010243),0.398066983081966,1.0632146734285488,0.3806818181818182,0.7825020021100348,1.0,18/38,28.25%,RHBDD1;RNF185;TRPM2;IRF5;KAT7;GLRA2;RNF139;UBXN6;SEL1L;CCDC47;RNF5;RRAGC;KYNU;BRSK2;MEAK7;GLRB;DNAJB12;IRAK3
prerank,replication fork processing (GO:0031297),-0.3256258669576154,-1.0630090990681615,0.34328358208955223,0.7664085783326053,1.0,15/38,27.19%,NUCKS1;BOD1L1;FBH1;ATR;THOC1;RTEL1;SMARCAL1;RFWD3;ATRX;ZRANB3;MMS22L;EME2;SETMAR;RAD51;CENPX
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5215391246994547,1.0628861061835426,0.41724137931034483,0.7827388492186873,1.0,4/10,20.91%,PPM1F;NDFIP2;DNAJA1;WWP2
prerank,dendrite self-avoidance (GO:0070593),0.4714237233334113,1.0628310300951023,0.3879310344827586,0.7822722015876015,1.0,9/16,27.54%,ROBO4;BSG;MYPN;NPTN;DSCAM;CNTN4;CNTN6;IGSF9;CNTN2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.36209440355230527,1.0624550363166954,0.38100961538461536,0.7826248032362223,1.0,25/85,18.86%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;AP2M1;PSMB10;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,epithelium development (GO:0060429),0.34752066951927835,1.062342510499658,0.3605051664753157,0.7823118773855117,1.0,13/107,8.76%,SOX17;GATA6;TBX1;RHCG;GSTA2;TST;SOX18;TAGLN2;CD34;PGK1;STAT1;JAK2;SNAI2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4020445624265009,1.0622857459538542,0.37464788732394366,0.7818574236792643,1.0,9/37,10.75%,VCAM1;CRTAM;CADM1;AMIGO2;TENM3;NECTIN4;NECTIN1;FAT4;TENM4
prerank,response to ethanol (GO:0045471),0.48005396246266,1.0621508995579707,0.3968253968253968,0.7816103350701004,1.0,6/14,22.31%,GRIN2B;GRIN3A;SDF4;GLRA2;GRIN2A;SOD1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.348885036917265,1.0621164192001842,0.36134453781512604,0.7810946865750938,1.0,15/87,11.28%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;ESAM;CRK;ARHGDIA;ROCK1;TAOK2;CCDC88A;RAC1;TRPM2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4327694727870899,-1.0616453527049081,0.38944723618090454,0.7686748181729778,1.0,3/12,8.98%,SDK2;NKD1;VEGFA
prerank,regulation of blood circulation (GO:1903522),0.40387005787434016,1.0614628543092395,0.37552155771905427,0.7821059666132729,1.0,3/34,4.95%,KCNQ1;ACE;CAMK2D
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3152237567309355,1.0613860599399452,0.209,0.7816999817709358,1.0,227/1668,13.15%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;SOX13;JAG1;NOTCH4;KLF8;EDN1;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;SMAD6;TAL2;MSX1;LDB2;DACH1;BMPR2;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;PLK3;BACH2;ACVRL1;NOTCH1;FOXQ1;NOD2;ATP2B4;ZFP69;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;ARHGEF2;TAL1;OLIG2;KLF7;DAB2IP;IRF2;CAV1;PRKD1;ZNF296;F2RL1;ZNF235;LRRFIP1;TNRC6C;SAP30;HNF1A;HNF4A;KLF3;AGRN;ID1;KLF6;ARID3B;DLL4;APP;HDAC9;ZGLP1;SOX18;CRK;HHEX;TEAD4;FLI1;PELP1;RBBP8;HEY2;TLR3;HMBOX1;MED26;KLF4;IER5;ACVR1;SIM2;WWTR1;LEF1;BCLAF3;MAFK;IRF9;ZBTB46;EFNA1;CAMK2D;PKN1;SP4;MAFF;ELOC;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;BBS7;ZBTB48;TAF9B;FOSL2;BRD8;APEX1;PHF6;GATA3;BCL6B;RTF1;TOX3;RXRG;RAD21;UBE2D1;CHCHD2;SRCAP;SETX;ZBTB16;GTF2IRD1;MRGBP;ZC3H12A;KDM3A;PPP3CA;LCORL;STAT1;GAL;ELP4;TOX4;AATF;PURA;EBF3;ELP2;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;UBA52;ZHX3;NFE2L2;WWC2;RPS14;GATAD2A;NAMPT;RPS27A;MRTFA;NR1D1;SNAI2;ERF;KLF11;ZBTB40;FOXP1;UXT;JUN;TCF7L1;TCF3;ELOA;EGR1;HMGB1;ZNF182;DHX9;SS18;ARID5A;PLAG1;MAD2L2;ZBTB14;CNOT1;CHD5;ZXDB;RPS6KA1;HNRNPK;AGO4;RPRD1B;BRIP1;NFKBIA;TET3;ZBTB34;TNKS;NEDD4L;DEAF1;RAI1;CRTC1;MAML2;NPM1;PHOX2A;HDX;PCBP1;EAF2;DMAP1;E2F7;GTF2H3;BRCA1;TIAL1;NR4A1;HELZ2;PRKD2;ARID5B;KLF13;SOX10;HINFP;SOX6;TLX3;MED30;SUV39H2;IRF5;SETD3;ELF2;CBFB;CTBP2;GLYR1;RPS6KA3;TGIF1;ASCL4;PSMC3;DUSP22;PPM1D;ITGB1BP1;PIN1;POU3F2
prerank,positive regulation of endocytosis (GO:0045807),0.3903627719764393,1.0605485981053893,0.3729946524064171,0.7832528383354437,1.0,11/45,11.83%,HIP1;B2M;F2RL1;CBL;PPT1;ANO6;STAP1;VPS28;HNRNPK;NEDD4L;CLU
prerank,regulation of catecholamine secretion (GO:0050433),0.41206963597280466,1.0601681464001929,0.3751783166904422,0.7836186956197324,1.0,7/29,18.29%,SYT15;SYT7;CHGA;FGF20;HRH3;SYT1;SYT2
prerank,RNA modification (GO:0009451),0.3777107890858419,1.0595214588899224,0.39367088607594936,0.784652642810653,1.0,13/54,21.08%,ADAT2;ADARB1;TRDMT1;TRMT61A;MRM2;ADAR;TRUB1;RBM15;NSUN5;FTSJ3;NSUN4;TRMT1;NSUN6
prerank,amino acid import (GO:0043090),0.4494630475637387,1.0594772511719157,0.3940740740740741,0.7841631144670362,1.0,5/21,7.82%,SLC6A6;SFXN1;SH3BP4;SLC16A2;SLC7A1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4130109072842947,1.0594082619201182,0.4101508916323731,0.783739479249806,1.0,9/35,17.21%,NUAK1;ITGA1;FKBP1A;HSP90B1;CALM3;PPP1R15B;CSNK2B;BOD1;TIPRL
prerank,positive regulation of T cell activation (GO:0050870),0.37587010000267895,1.0593943179605367,0.38571428571428573,0.7831855085768074,1.0,6/62,7.82%,VCAM1;NOD2;LGALS9;GATA3;CD47;SLC7A1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3476637456839271,1.0587715326892795,0.36627906976744184,0.784174568796812,1.0,33/107,20.14%,MCTP1;ABR;CACNA1A;SYN3;APP;BCR;MEF2C;GRID1;BTBD9;PXK;LRRK2;LRRC4C;GRIK5;GRIK2;CDH2;SNCAIP;GRM5;CX3CR1;RIMS3;NPTX2;PSMC5;DGKI;GRIK1;NMU;CPLX1;OPHN1;LRP8;NPTX1;GRM7;SYT1;GRID2;AGER;BDNF
prerank,nucleoside catabolic process (GO:0009164),-0.44660772809314364,-1.058668721955012,0.3958333333333333,0.7754796114832304,1.0,4/11,11.03%,DPYD;NT5M;NT5E;UPB1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4021537122184167,1.0581872351671129,0.39398084815321477,0.7850305960599225,1.0,11/38,16.66%,DAB2IP;CASP8;ZC3H12A;STAT1;NR1D1;CACTIN;RIOK3;RHOH;CARD19;ESR1;PYCARD
prerank,aorta development (GO:0035904),0.476605799083218,1.0580075446134138,0.4117647058823529,0.7848804047571487,1.0,2/14,1.26%,JAG1;TBX1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.4972098102581737,1.0579331472315,0.41414141414141414,0.7844753871159248,1.0,1/12,1.84%,PAEP
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.42245599301375314,1.0577689420362206,0.3889763779527559,0.7842770035526664,1.0,13/25,27.34%,CHMP1B;CHMP3;LYST;CHMP2B;CHMP7;UBXN6;MVB12A;SORT1;LEPROT;CHMP1A;VPS4B;CHMP4A;CHMP4B
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.48882879725624717,1.0576921838797517,0.4032,0.7838875350121779,1.0,3/14,4.06%,PRKD1;EMP2;LIMS2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4447499033287327,1.0575021863586305,0.38235294117647056,0.7837706531054758,1.0,6/23,18.49%,CEACAM1;APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4677324084589083,1.0570822525321444,0.4149443561208267,0.784237131747669,1.0,2/15,1.26%,MSX1;TBX1
prerank,adipose tissue development (GO:0060612),0.500611983479552,1.0570515105273628,0.41518578352180935,0.7837177169283707,1.0,4/11,13.91%,SPTLC2;NAMPT;ARID5B;LRP5
prerank,relaxation of muscle (GO:0090075),-0.41674328079790307,-1.0568673003666391,0.36033519553072624,0.7792129818709147,1.0,2/13,0.82%,ATP1A2;GSN
prerank,positive regulation of cellular metabolic process (GO:0031325),0.35390113317209604,1.0566189815868228,0.38558352402745993,0.7841949393453655,1.0,18/98,11.65%,PDGFB;FASN;INSR;SLCO1C1;APOA1;KLF4;ANGPT1;LIPT2;IFNAR1;GATA3;CHCHD2;ZC3H12A;ARRB1;TBC1D5;ACOD1;ACACB;NFKBIA;INPP5F
prerank,response to hydrogen peroxide (GO:0042542),0.39621656620445794,1.0564949471759157,0.3949468085106383,0.7838928278725644,1.0,8/45,11.28%,FYN;RHOB;STK24;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4916015016565389,1.0564485035866682,0.4075907590759076,0.7822638649701121,1.0,5/12,23.28%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4916015016565389,1.0564485035866682,0.4075907590759076,0.7822638649701121,1.0,5/12,23.28%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.4916015016565389,1.0564485035866682,0.4075907590759076,0.7822638649701121,1.0,5/12,23.28%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.43235172626674667,1.0564243265062854,0.3849493487698987,0.7817414322250026,1.0,7/23,15.26%,FAR2;ACSL5;FAR1;ACSBG1;ELOVL7;ELOVL5;TECR
prerank,macrophage differentiation (GO:0030225),-0.41966171683112713,-1.0563351122790225,0.3620689655172414,0.7792246080681993,1.0,3/13,8.98%,BMP4;IL31RA;VEGFA
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4620773811609108,-1.0562768658461437,0.3990498812351544,0.777936038127262,1.0,4/10,10.78%,HNMT;SMOX;ALDH7A1;SARDH
prerank,nucleic acid-templated transcription (GO:0097659),0.39008652372356617,1.0561075475727764,0.3953488372093023,0.7819629527566151,1.0,17/42,23.64%,NR4A2;POLR2G;MLF1;NFKBIB;POLR2D;TAF1B;POLR2I;PWP1;MMS19;HOXD3;MEF2A;PTMA;RRAGC;POLR2C;PAX8;POLR2B;POLR2J
prerank,rRNA modification (GO:0000154),0.44249704542555246,1.0558316620233685,0.37712519319938176,0.7820510462311886,1.0,10/21,25.26%,MRM2;DKC1;METTL5;NHP2;FBLL1;TFB2M;FTSJ3;NSUN4;FBL;ZCCHC4
prerank,brain morphogenesis (GO:0048854),0.4839255607526951,1.0557460086000703,0.4158415841584158,0.781687873872889,1.0,3/12,12.41%,SHANK3;SLC6A4;CTNNA2
prerank,ERAD pathway (GO:0036503),0.35643530422257497,1.05570242284017,0.3708530805687204,0.7812157514105709,1.0,27/83,21.24%,RNF103;RHBDD1;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;YOD1;UBE2J2;RNF103-CHMP3;FOXRED2;SGTB;FBXO2;UBQLN2;UGGT1;PSMC6;RNF139;UBXN6;SEL1L;ERLIN2;FBXO6;CCDC47;DNAJC10;RNF5;POMT2;TMEM129
prerank,granulocyte chemotaxis (GO:0071621),0.3813079873963502,1.055490417465454,0.39920948616600793,0.781129149320605,1.0,5/55,10.16%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.4326360154947073,1.0554029408299452,0.40588235294117647,0.7807418358307497,1.0,6/22,14.97%,DUSP1;PPM1F;DUSP16;PDP1;PPM1D;PPP2CB
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.45507318866736546,-1.054935739278013,0.39414414414414417,0.7801068301715017,1.0,4/10,17.33%,ST6GAL1;RENBP;NAGK;AMDHD2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4554114497694763,1.0545978730350052,0.4083204930662558,0.78215427730257,1.0,4/18,10.51%,UNC13B;GRID1;GRIK5;GRIK2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.342178479385943,-1.0544965163797835,0.35987261146496813,0.7799267664685009,1.0,2/26,1.32%,LGR4;APPL2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5081797813148842,1.0544068887300515,0.4069767441860465,0.7820363041852305,1.0,3/10,6.30%,TBX1;ACTN4;RXRG
prerank,exit from mitosis (GO:0010458),0.4923864933206319,1.0543168540942582,0.4184168012924071,0.7816725011257466,1.0,3/12,15.38%,CLASP1;CLASP2;CHMP7
prerank,regulation of exosomal secretion (GO:1903541),-0.3743738536296709,-1.0540774078188175,0.3881401617250674,0.7796372298488323,1.0,9/19,26.72%,PRKN;SDCBP;TSG101;ATP9A;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,miRNA metabolic process (GO:0010586),-0.36766181097065076,-1.0537892530835002,0.3958333333333333,0.7790279634437174,1.0,6/20,18.39%,DDX17;DICER1;LIN28B;TENT4B;TUT4;DGCR8
prerank,cognition (GO:0050890),0.3893544137106684,1.053564050717219,0.3920220082530949,0.7829796280539253,1.0,5/42,3.48%,SHROOM4;PTCHD1;FAM107A;APP;DOP1B
prerank,synaptic vesicle recycling (GO:0036465),0.41625792248278076,1.0535090767725304,0.4101123595505618,0.7825277755426318,1.0,10/31,18.29%,SNCG;SYT7;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3592478492773529,1.0530936569096343,0.38976857490864797,0.7829435795853367,1.0,14/76,11.23%,NOD1;NOD2;LGALS9;APP;HDAC7;ACTN4;TLR3;TRIM6;PDCD4;ADIPOR1;ZC3H12A;NMI;NFKBIA;LAPTM5
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3367192015741035,1.0528927741734084,0.39,0.7828727143743288,1.0,13/140,7.28%,EDN1;TRPV4;ITPR3;CCR1;CAV1;CACNA1A;F2RL1;SLC8A1;GPR157;IAPP;LPAR6;P2RX7;CMKLR1
prerank,TOR signaling (GO:0031929),0.41708901937240667,1.0525916154175987,0.3858615611192931,0.7830133213843015,1.0,13/26,26.00%,GATA3;PRR5L;SYAP1;RHEBL1;CCDC88A;RPS6KB1;RICTOR;TIPRL;NPRL3;EIF4EBP2;MEAK7;MLST8;RPTOR
prerank,cellular component assembly (GO:0022607),0.32516711243980395,1.0524174518733798,0.38160676532769555,0.7828900809012952,1.0,44/253,16.23%,LIMA1;CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;FAM107A;FBLIM1;PLS3;PARVB;NEDD9;CFAP206;STX7;CARD10;LIMS2;SYCP2;TRAF1;RAD21;CD247;IL1RAP;NCKAP1;APC;ACTG1;RTN4;CDAN1;NEFH;CYFIP1;RAC1;RANBP9;BAG6;ACTB;SHROOM1;RTN3;TAPBP;CAPG;RHOH;PPIH;LCP1;KPNA3;CLDN14;PDCD10;VIL1;ANK3
prerank,positive regulation of neurogenesis (GO:0050769),-0.2781078530236328,-1.052342612477395,0.3368421052631579,0.7818119830629148,1.0,24/68,21.79%,ROBO1;PLXNA2;CUX1;SLIT2;SNW1;OBSL1;NTRK2;PLXNB2;NGF;NUMBL;VEGFA;PLXNB1;NAP1L1;SLITRK1;SERPINF1;DRD2;GPER1;PTPRD;FBXW8;PLXNC1;SS18L2;CUX2;DISC1;FAIM
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3746594394895708,-1.0522513405349116,0.38108882521489973,0.7806227547520243,1.0,4/18,8.48%,PDPN;RUNX1;SMAD3;EFEMP2
prerank,regulation of cation channel activity (GO:2001257),0.35595047169317534,1.0521953893318248,0.37514654161781946,0.7828837764579838,1.0,10/89,8.37%,NOS1;FKBP1A;APP;SHISA8;CAMK2D;STAC;MEF2C;SHISA6;GRIA1;GRIN2B
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.42038738718200697,1.0515937080241287,0.39821693907875183,0.7838325154757416,1.0,3/23,2.67%,SMAD7;MYBPC3;FKBP1A
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.38059517053715397,-1.0514439443643842,0.37746478873239436,0.7814291542575407,1.0,6/19,22.36%,DDO;ALDH7A1;GOT1;DLST;ASPA;HYKK
prerank,organophosphate biosynthetic process (GO:0090407),0.39436412543878807,1.0512358232014942,0.39183673469387753,0.7841603268352795,1.0,4/37,3.81%,ITPKB;IP6K3;IPPK;GPHN
prerank,positive regulation of leukocyte activation (GO:0002696),-0.37687960275228277,-1.0511083823194445,0.38873239436619716,0.7809677767691054,1.0,3/18,3.41%,LBP;WNT5A;THBS1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4006523082283148,1.0508981375647624,0.4110787172011662,0.7843883350021297,1.0,6/33,11.55%,PLK3;FAM107A;KLF4;RBL1;APC;E2F7
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3057222513755347,-1.050708528958605,0.3482142857142857,0.7806384571611797,1.0,15/45,16.22%,EGFR;PLCE1;EFEMP1;REPS2;SLC30A10;SHC1;PIK3R1;SRC;TGFA;GAREM1;DGKD;HBEGF;SHC3;GAB1;AAMP
prerank,multivesicular body assembly (GO:0036258),0.41645690765154286,1.0506302376437258,0.39854014598540144,0.7844869111883008,1.0,11/30,21.85%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;MVB12A;STAM2;CHMP1A
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4168163973284718,1.0501984332210696,0.41109530583214793,0.7849455036674003,1.0,9/28,14.77%,ADIPOR2;NOS1AP;TNFRSF1B;ADIPOR1;CD47;JAK2;RAC1;CX3CR1;EIF6
prerank,positive regulation of cell development (GO:0010720),-0.331690634779804,-1.0498923681445596,0.3633217993079585,0.7814670995168227,1.0,10/31,17.53%,PDE3A;BMP4;SNW1;ATP6AP1;NUMBL;NAP1L1;SERPINF1;GPER1;RFX3;NKX6-1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.378816896325599,-1.04964774288649,0.38005390835579517,0.7807466778946899,1.0,6/18,15.29%,PRKN;CCN3;IRS1;REST;ADRA2A;KCNB1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4966130277828603,1.0492502720952548,0.3841166936790924,0.7866008430724228,1.0,3/11,4.11%,SMAD7;TGFB2;ACVR1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4977299217505875,1.048425146486214,0.42517006802721086,0.7881145168482188,1.0,3/11,15.20%,STAT1;JAK2;IL27RA
prerank,positive regulation of cell cycle process (GO:0090068),0.3539492634088608,1.0480850512885749,0.4045346062052506,0.7883752479671797,1.0,18/91,16.70%,EDN1;PDGFB;INSR;CUL3;IL1A;RAD21;PLSCR1;FEN1;CDC14A;RANBP1;NUMA1;E2F7;PHIP;LRP5;MAP3K20;PKN2;NDC80;CEP120
prerank,regulation of neuroinflammatory response (GO:0150077),-0.37232040630173074,-1.0479250847409485,0.3721590909090909,0.7841132442315604,1.0,2/19,1.83%,IGF1;NUPR1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4279741558945547,1.0476393899345284,0.4127906976744186,0.7888720269247265,1.0,9/26,17.28%,ADIPOR2;CEACAM1;APOA1;ADIPOR1;BRCA1;ELOVL5;EIF6;ERLIN2;TRIB3
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.42199177411528993,-1.0474603720481983,0.41509433962264153,0.7839117382096791,1.0,4/13,9.12%,STX4;MAP1A;RIC3;STX3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.31421967937551165,-1.0474188197197825,0.3931297709923664,0.7825786215328929,1.0,6/37,10.20%,OGT;FHIT;MAP1A;TAF1;TRIM39;SDCBP
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.34927575761459323,-1.0474156039846523,0.36807817589576547,0.7811603100590193,1.0,7/27,9.76%,PID1;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,membrane lipid metabolic process (GO:0006643),0.44282671320854017,1.0473278299265956,0.4134328358208955,0.7890723860855567,1.0,7/22,17.29%,ST3GAL6;B4GALT4;SPTLC1;ALOXE3;AGK;TECR;CERKL
prerank,positive regulation of biosynthetic process (GO:0009891),0.3954933021161725,1.0472459835017431,0.39166666666666666,0.7887126807271388,1.0,6/40,11.05%,PLCG2;VIM;APOA1;SIRT4;ADGRB1;CYBA
prerank,presynaptic endocytosis (GO:0140238),0.4403270755308937,1.0470902431647953,0.38945827232796487,0.788489261573705,1.0,9/24,18.29%,SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.31736057075191776,1.0470210370016115,0.37938144329896906,0.7880667543369448,1.0,39/291,10.37%,KCNQ1;RAPGEF2;PDGFB;SPAAR;TBX1;NOD2;ATP2B4;RAPGEF1;FOXO1;DAB2IP;PRKD1;VIM;FES;INPP5K;TIRAP;DEFA6;MEF2C;TNFRSF1B;ABCB4;IL1A;PDCD4;SH3BP4;MAPK1;NFKBIL1;SETX;P2RX7;IRGM;ZC3H12A;HSP90B1;NR1D1;ACOD1;CACTIN;STAP1;JUN;EGR1;HMGB1;RRAGD;NFKBIB;CASP1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.35655435269114727,-1.046132328143661,0.41935483870967744,0.7832869529572006,1.0,3/23,1.76%,PRKAG2;CEMIP;BMP7
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3749391794746045,1.0461147407198628,0.39746835443037976,0.7897382987545762,1.0,8/56,8.61%,PLCB1;CCND2;RAB11A;CCND3;CDC25C;CUL3;ADAM17;KMT2E
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.3625740068907799,-1.0452904912814716,0.4166666666666667,0.784242735288187,1.0,7/21,6.35%,BACE2;RBMX;BACE1;HM13;ADAM19;DAG1;ADAM9
prerank,regulation of DNA binding (GO:0051101),-0.30600542759901517,-1.0450297311358219,0.3699186991869919,0.7835299489127381,1.0,12/44,14.40%,IGF1;SMO;PRKN;RSF1;NGF;DOT1L;PPARG;TXN;MDFI;BCL3;HMGA2;SIRT2
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.2953265921216898,-1.045019956173217,0.3605769230769231,0.7821202071639383,1.0,9/54,7.08%,GPC6;SDC2;HSPG2;GPC3;HS3ST3A1;GNS;PXYLP1;XYLT1;HEXA
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.38778955005906823,-1.0449659304479697,0.40318302387267907,0.7808608284447384,1.0,7/15,22.97%,LPGAT1;PPARA;PPARG;SLC45A3;NR1H3;PPARD;MLXIPL
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.42866825960255656,1.0442721983443515,0.41414141414141414,0.7936821510342811,1.0,6/24,15.59%,ING2;TAF9B;BCL2L1;SNAI2;CLU;CDKN2D
prerank,neuron maturation (GO:0042551),0.44400504615892245,1.0439887200096367,0.41321044546851,0.7937716117260437,1.0,3/18,9.87%,RND1;APP;B4GALT6
prerank,nitrogen compound transport (GO:0071705),0.3349122639748472,1.0438986432356525,0.40707964601769914,0.7934011857836026,1.0,17/141,10.45%,SLC6A6;EDN1;RHCG;ARL6IP5;SLC7A7;PPT1;SLC44A1;MYH9;ARRDC1;HSP90B1;SLC6A4;SLC7A1;CERT1;SLC15A4;CHMP1B;SLC6A2;SLC22A5
prerank,regulation of defense response to virus by host (GO:0050691),0.4117196037717663,1.0438653446482384,0.39586410635155095,0.7928961315545412,1.0,6/30,11.98%,AIM2;TRIM6;ZC3H12A;STAT1;DHX9;DTX3L
prerank,regulation of protein polymerization (GO:0032271),0.39296089945534063,1.043824019955549,0.39335180055401664,0.7924169067694924,1.0,5/35,7.56%,FCHSD2;ESAM;CAMSAP2;PRUNE1;MAPRE3
prerank,regulation of lipid catabolic process (GO:0050994),0.444527986790643,1.043613563793685,0.42022116903633494,0.792332228381396,1.0,5/19,17.76%,PDE3B;ALK;PRKAA1;LONP2;TYSND1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.403236405980683,1.0432180621590932,0.42105263157894735,0.7927223080127911,1.0,3/30,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,regulation of cellular localization (GO:0060341),0.3833064117061257,1.0431096513328046,0.3852140077821012,0.7923959667461129,1.0,12/46,16.31%,EFNA5;FES;TTL;PPM1F;CAMK2D;LRRK2;NR1D1;NUMA1;TRIM46;LRP5;MAP2;GOSR1
prerank,regulation of response to external stimulus (GO:0032101),0.3403998995978761,1.042965594901195,0.3950892857142857,0.7921495805177945,1.0,15/121,9.10%,GATA6;SPAAR;NOD2;CAV1;CASP8;F2RL1;SPATA2;TIRAP;STK24;FCGR2B;SEMA7A;BCL6B;NMT1;JAK2;FOXP1
prerank,striated muscle tissue development (GO:0014706),-0.328329719198154,-1.042902489767812,0.38652482269503546,0.7851366860980045,1.0,10/29,12.50%,BMP5;BMP7;SVIL;RBP4;SGCD;SIX1;CFLAR;PGM5;TBX2;NDUFV2
prerank,regulation of organelle assembly (GO:1902115),-0.2790494233042164,-1.0423610156458507,0.3487179487179487,0.7852452492377168,1.0,27/72,20.07%,GSN;DCDC2;TBC1D24;TBC1D2B;STX18;ALMS1;TBC1D9B;ATG3;ATXN2;ATG5;RNF4;ADPRH;TBC1D16;DYNC2LI1;TSG101;TBC1D17;KIF9;CYLD;TBC1D20;CDKL1;IFT20;TRAPPC12;SDCCAG8;EZR;TBC1D19;IFT88;PDCD6IP
prerank,cellular response to oxidative stress (GO:0034599),-0.25376454856084163,-1.042327226317278,0.3515625,0.7839313479466297,1.0,41/118,23.06%,EGFR;DAPK1;PDGFRA;PTPRK;PRKAA2;PLA2R1;STX4;TPM1;MGAT3;CAT;FOXO3;ERMP1;SOD3;GPX8;PPIA;SESN2;NOX4;PRDX3;CPEB2;CHUK;FER;MPV17;SIRT2;WNT16;PDK2;ETV5;GPX7;NUDT2;MAPK9;PRKCD;HTRA2;ALDH3B1;ROMO1;TXNRD2;ABL1;MAPK8;PARP1;CYCS;CYBB;SRXN1;GPX1
prerank,cellular response to ketone (GO:1901655),-0.3269808183016666,-1.0421684714157815,0.3651877133105802,0.7829661925939359,1.0,6/35,6.78%,ROCK2;ADCY5;ADCY1;GNAI1;ADCY2;SRC
prerank,positive regulation of wound healing (GO:0090303),-0.3162929846702988,-1.0420799935020293,0.3359073359073359,0.7817981146922248,1.0,10/36,12.82%,PLPP3;VTN;THBS1;RREB1;FOXC2;ANXA1;ST3GAL4;SERPINE1;ADRA2A;HBEGF
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.36293574939064444,1.0417409470274512,0.3962962962962963,0.7945032211899022,1.0,19/72,20.99%,LIFR;IFNGR1;CASP8;SPATA2;SPPL2A;TRAF1;IRAK2;MADD;STAT1;JAK2;PTPN1;CBFB;RACK1;PYCARD;PTPN2;AGPAT1;CD24;SIGIRR;SPPL2B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3325878767566162,1.041648792821387,0.4004424778761062,0.7941836480267248,1.0,14/142,7.28%,EDN1;TRPV4;ITPR3;CCR1;ATP2B4;ATP2B2;CAV1;CACNA1A;CAV2;F2RL1;SLC8A1;IAPP;HCRTR1;CMKLR1
prerank,inflammatory response (GO:0006954),0.3252945734785741,1.0415319597496555,0.4070891514500537,0.7938895050541304,1.0,19/195,11.05%,AFAP1L2;F11R;NOD1;ADGRE5;CCR1;LGALS9;HDAC9;FCGR2B;LY75;IL1A;PXK;MFHAS1;HNRNPA0;CMKLR1;HMGB1;CCL4;GPR68;RAC1;CYBA
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3177229080037465,1.0413272290320381,0.3953252032520325,0.7938518883525538,1.0,65/366,17.07%,SOX17;SOX13;NANOS3;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;APP;SOX18;BTG1;ING2;WWTR1;NLK;MEF2C;PPIE;ORC3;RYBP;GTF2IRD1;CEBPA;TOM1L1;WWC2;SNAI2;SERTAD3;TCF7L1;TCF3;MLF1;HP1BP3;PLAG1;CCDC88A;CYFIP1;NUP35;ASCC1;TRAPPC2;OBI1;TESMIN;SAP30L;GRM5;ORC5;HINFP;SOX6;HIF1A;RHOH;ELAVL2;METTL18;ATXN1;EIF2A;KAT7;ACVR2B;YBX1;TRRAP;TCOF1;ESR1;NFIL3;ESRRG;DAXX;SOX7;SOX12
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3503958491650284,1.040431071926299,0.4034229828850856,0.7954774124429296,1.0,29/87,21.23%,FAM107A;KLF4;PSMD13;PSMD4;RBL1;APC;ZFP36L2;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;E2F7;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;CDKN2D;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;ZFP36L1;USP47
prerank,smooth muscle contraction (GO:0006939),0.4651136479335436,1.040345108993675,0.41833333333333333,0.7951316797102779,1.0,5/14,10.82%,MYLK;PIK3C2A;SLC8A1;ROCK1;TPCN2
prerank,coenzyme A biosynthetic process (GO:0015937),0.4892853812986287,1.0401635820481787,0.43456375838926176,0.7938744636904853,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4892853812986287,1.0401635820481787,0.43456375838926176,0.7938744636904853,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4892853812986287,1.0401635820481787,0.43456375838926176,0.7938744636904853,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.48814090245403835,1.0398337430178548,0.42694805194805197,0.794111011678078,1.0,2/12,2.05%,PLCB1;DUSP1
prerank,regulation of myoblast differentiation (GO:0045661),0.3991696421757903,1.0398206485277277,0.4115983026874116,0.7935659930402676,1.0,5/32,6.06%,PLCB1;NOTCH1;BTG1;MEF2C;EID2B
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.45720921095264977,1.0395634463252101,0.41965678627145087,0.7936433713771656,1.0,5/18,11.99%,RPS6KA5;PRKD1;CD200;CRTC1;PRKD2
prerank,regulation of cilium movement (GO:0003352),0.5043194443327681,1.0391642650757411,0.43611584327086883,0.7940603846866527,1.0,2/10,8.62%,CFAP206;CFAP43
prerank,response to muscle stretch (GO:0035994),-0.4019915209645069,-1.0390774805011167,0.41964285714285715,0.7888039714486106,1.0,2/15,0.82%,DMD;GSN
prerank,positive regulation of T cell migration (GO:2000406),0.44070824202487163,1.0389986058172545,0.40963855421686746,0.7938946913288668,1.0,5/20,9.42%,OXSR1;APP;ADAM17;STK39;ADAM10
prerank,cytoskeleton organization (GO:0007010),0.3380322870840427,1.0389870805332473,0.4043778801843318,0.7933477516542878,1.0,17/114,6.86%,FGD5;RND1;RHOB;MAST4;NEDD9;DIAPH1;SIPA1L3;PACSIN2;SH3KBP1;ARAP3;DST;FMNL3;FGD6;PACSIN1;LRCH3;MAST1;KLHL20
prerank,RNA methylation (GO:0001510),0.3702050590870538,1.0385372401566668,0.41842105263157897,0.7938892102635262,1.0,18/60,21.08%,TRDMT1;TRMT61A;MRM2;TRMT5;METTL2A;METTL2B;METTL5;ALKBH8;TRMT61B;VIRMA;FBLL1;METTL14;TFB2M;RBM15;NSUN5;FTSJ3;NSUN4;NSUN6
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.340422265237464,1.0384810294849558,0.41965317919075146,0.7934491971712991,1.0,44/110,25.82%,RPS21;RPL27;RPL7;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;HELZ2;RPL30;RPS5;RPL27A;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CTIF;SMG7;RPL18;RPL39;RPS19;SMG9;RPL31;RPS8;SMG8;EIF4G1;RPL3;PPP2R2A;PPP2R1A;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,mitotic cytokinetic process (GO:1902410),0.43265422068607357,1.0384776125767907,0.41602465331278893,0.7928928540269378,1.0,12/20,27.34%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;CNTROB;VPS4B;MITD1;CHMP4A;CHMP4B
prerank,cellular response to hormone stimulus (GO:0032870),0.36024065478296674,1.0384585081013127,0.3868974042027194,0.7923648925131004,1.0,12/69,10.55%,LMO2;ATP1A1;ATP1A3;CAV1;PELP1;INPP5K;MEF2C;BRD8;TRIM24;NCOA4;ARID5A;SFR1
prerank,protein localization to cell surface (GO:0034394),0.42123428738793356,1.0383600449413704,0.4154727793696275,0.792056762922377,1.0,7/26,14.25%,FBLN5;EMP2;ANGPT1;PTPRU;SMURF1;MESD;CTNNB1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.3356923280441545,-1.0382909401655112,0.3665594855305466,0.7895426899211129,1.0,8/27,17.37%,NAPEPLD;NAAA;SLC27A1;CHKB;ETNK2;PLA2G15;SELENOI;PLA2G6
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3645982678420852,-1.0381510655534099,0.40173410404624277,0.7884640042764083,1.0,7/19,20.56%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2649527499071739,-1.038081616437806,0.34415584415584416,0.7872393512917084,1.0,16/96,8.12%,EPHA7;NUPR1;BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;BACE1;NTRK2;NGF;EGLN3;FOXO3;SIX1;PRKCI
prerank,regulation of double-strand break repair (GO:2000779),-0.3132123635021295,-1.037451052660124,0.3905109489051095,0.7874904550785187,1.0,17/39,30.63%,TRIP12;SLF1;FMN2;ACTR2;RTEL1;DEK;TWIST1;PML;TIMELESS;SLF2;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6;MGMT;OTUB2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.36346568915780036,-1.0372513498938838,0.4161676646706587,0.786580738441063,1.0,10/21,22.61%,SULF1;SULF2;XYLT1;B3GAT3;HS2ST1;NDST3;GPC1;SGSH;HS3ST4;EXT2
prerank,regulation of interferon-beta production (GO:0032648),0.37824099080965456,1.0372295858621436,0.40735694822888285,0.7941637250080518,1.0,9/46,13.70%,IFIH1;TLR3;TIRAP;OAS2;POLR3B;CACTIN;DHX9;IRF5;RIOK3
prerank,meiosis I (GO:0007127),0.4193462199300204,1.036989218260689,0.4119448698315467,0.7941966612627183,1.0,6/23,18.63%,DDX4;ING2;PTTG1;SYCP3;SGO1;TDRD9
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.45276486639257785,-1.0369126400990198,0.4146919431279621,0.7861247215384435,1.0,4/10,18.94%,SET;KLF15;TAF7;NOC2L
prerank,hexose metabolic process (GO:0019318),-0.3051696101865538,-1.0366650878844705,0.38596491228070173,0.7854053003909235,1.0,13/39,22.90%,APOD;GALK2;CHST15;IRS2;ADPGK;PGM1;GALK1;AKR1A1;PMM1;GDPGP1;SLC35A2;FUCA2;PPARD
prerank,response to UV (GO:0009411),-0.2603773108566783,-1.0363791843611005,0.3630573248407643,0.7847925346853087,1.0,22/95,15.27%,EGFR;PTPRK;CREBBP;DDB2;CAT;SCARA3;BRSK1;DCUN1D3;TAF1;USP1;ERCC5;MAP2K7;CDC25A;ATR;REV1;BCL3;MFAP4;UVSSA;MSH6;RHNO1;ERCC2;EIF2AK4
prerank,mRNA splice site selection (GO:0006376),-0.33371547417533604,-1.0361637677429647,0.40540540540540543,0.7839672559560246,1.0,5/30,10.79%,CELF2;SRSF5;SRSF1;PUF60;SRSF6
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4555762129680488,1.0361385718850424,0.4129746835443038,0.7957199963530754,1.0,1/16,0.24%,SOX13
prerank,regulation of RNA metabolic process (GO:0051252),-0.2805675108127855,-1.0359000816389017,0.38317757009345793,0.7832928497733694,1.0,18/59,16.15%,MITF;SON;SNRNP70;NOVA1;AFF2;HNRNPH1;AHNAK2;BRDT;AHNAK;CLK1;FUS;CLK4;YTHDF2;RBM20;HNRNPLL;HNRNPL;PCBP4;CLK2
prerank,regulation of transmembrane transport (GO:0034762),0.40369810702114955,1.0357165390520577,0.4322033898305085,0.7961626408228821,1.0,5/31,11.20%,SLC2A1;OCLN;CTTNBP2NL;NEDD4L;ACTB
prerank,negative regulation of T cell activation (GO:0050868),0.40130424534766396,1.035546844932482,0.4230769230769231,0.7960198791031278,1.0,6/35,14.84%,CEACAM1;FCGR2B;ARG1;DUSP3;LAPTM5;HAVCR2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4839364368012648,1.035472810210947,0.44201680672268906,0.7956353423463647,1.0,5/12,20.67%,WRNIP1;KAT7;METTL4;WDR18;BLM
prerank,carboxylic acid metabolic process (GO:0019752),0.3985100636450689,1.0349835071880629,0.4120956399437412,0.796249614998279,1.0,9/33,16.28%,SLC2A1;GLYAT;LIPT2;GLUD1;SIRT4;LIPT1;ST3GAL1;PTGIS;PON3
prerank,positive regulation of protein import (GO:1904591),-0.3383080566651185,-1.034953260258608,0.3835125448028674,0.7844136664751453,1.0,10/30,18.45%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,UV protection (GO:0009650),-0.448656640214773,-1.0347584903857476,0.4364508393285372,0.7835696688226157,1.0,5/10,15.10%,CAT;SCARA3;ERCC5;MFAP4;ERCC2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3870033653643441,1.0346887212696607,0.41970310391363025,0.7963811884901966,1.0,11/47,14.51%,EFNA5;NEDD9;CRK;ACTN4;APOA1;LIMS2;PTK2;RAC1;DOCK1;ITGB1BP1;SPRY4
prerank,positive regulation of intracellular transport (GO:0032388),0.39328239965410816,1.0346827516320172,0.4276315789473684,0.7958292717487916,1.0,10/38,16.40%,PLK3;EHD1;PGAP1;PRR5L;PCM1;RIPOR1;NUMA1;ICE1;PDCD10;TENM1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4876621914590229,1.0343526344895058,0.45230263157894735,0.796050990876025,1.0,2/11,5.32%,TGFB2;MEF2C
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.37296385270949156,1.033936683929358,0.4280104712041885,0.7964710497439283,1.0,9/54,13.96%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.42819391308694366,1.033684520391384,0.430635838150289,0.7965107483523096,1.0,6/23,9.29%,PDGFB;INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.26960626613968186,-1.0333008286931415,0.3872832369942196,0.7861342815789736,1.0,28/80,21.59%,PLPP3;KIF3C;ERGIC2;STX18;COPZ2;COPA;SURF4;PITPNB;ARFGAP1;ERGIC3;COPG1;ARCN1;COPB2;ARF5;TMED3;BICD2;COG3;ATP9A;KIF3A;NAPA;ZW10;RER1;LMAN2;PICK1;KDELR1;KIF11;RACGAP1;RINT1
prerank,protein localization to lysosome (GO:0061462),0.41338783748405433,1.0331829060878885,0.43759177679882527,0.7971936650277353,1.0,15/28,26.54%,SH3BP4;NCOA4;RNF128;RTN4;LAPTM5;VPS4A;NAGPA;AP3M1;ZFYVE16;SORL1;ATP13A2;SCARB2;LMBRD1;GLMP;LAMTOR4
prerank,regulation of neuron projection arborization (GO:0150011),-0.4014856307441137,-1.0329185720030933,0.4257142857142857,0.7857715555495074,1.0,6/15,17.16%,WNT5A;GRIP1;DLG4;MFSD2A;MYO9A;NTNG1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.40196505083447986,1.0328259096836758,0.42777777777777776,0.7974863324899713,1.0,6/34,9.31%,GATA2;FOXO1;TRIO;WWTR1;GATA3;ZFP36L2
prerank,regulation of protein localization to nucleus (GO:1900180),0.37577397474431196,1.0325678523057802,0.399452804377565,0.7975474783447419,1.0,18/43,26.17%,CARD10;WWTR1;SUMO3;MFHAS1;CTNNA1;NVL;LIMK2;DTX3L;PIN1;KAT7;SIN3A;GSK3B;YAP1;GLUL;ATP13A2;TPR;TGFB1;PARP9
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.47180647785407664,1.0325461795780992,0.4402730375426621,0.7970326114018259,1.0,5/13,13.22%,ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,gastrulation (GO:0007369),-0.3915351012717959,-1.0324978394174147,0.39344262295081966,0.7855011355314863,1.0,3/15,6.51%,GPC3;NPHP3;MEGF8
prerank,positive regulation of proteolysis (GO:0045862),-0.28733798961254653,-1.0322653373600348,0.40969162995594716,0.7847536891840079,1.0,15/55,17.47%,OGT;CCBE1;APOE;CYFIP2;ADAM9;IST1;ATP5IF1;GPLD1;NDUFA13;ADRA2A;PACSIN3;CTSC;RCN3;STUB1;FBXW11
prerank,acyl-CoA metabolic process (GO:0006637),0.4090855820155286,1.0315259923229239,0.4186991869918699,0.7988850543210273,1.0,5/35,12.43%,ACSM3;GLYAT;ACOT13;ACACB;HMGCS1
prerank,cell-cell junction maintenance (GO:0045217),0.49658737275600195,1.0310980869624808,0.44153577661431065,0.799359766946894,1.0,2/11,9.21%,F2RL1;TJP1
prerank,spindle assembly (GO:0051225),0.3596950850190237,1.03093781513673,0.42625,0.7991961204211314,1.0,13/67,11.08%,RAB11A;CSNK1D;KIF2A;CLASP1;MAPRE3;KPNB1;STARD9;NEK7;HAUS3;STAG1;CLASP2;TNKS;NUMA1
prerank,lipid droplet formation (GO:0140042),-0.4294372185138824,-1.0308749346280452,0.4081145584725537,0.7872765611977771,1.0,5/10,28.25%,BSCL2;SQLE;PLA2G4C;FITM2;AUP1
prerank,response to amino acid (GO:0043200),0.39874265164288736,1.0307066284891375,0.4138418079096045,0.7991914781997856,1.0,16/31,28.69%,SPAAR;SH3BP4;RRAGD;TMBIM6;GLRA2;RRAGA;RRAGC;LAMTOR3;MEAK7;NSMF;RPTOR;GLRB;LAMTOR4;CAPN2;SLC38A9;LAMTOR1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.32647475251004077,-1.0306049286775243,0.4119601328903654,0.7866175164553016,1.0,12/32,19.41%,DDX5;SNW1;FHIT;RRP8;BCL3;MYBBP1A;BOK;PDK2;DDIT4;AEN;JMY;PML
prerank,regulation of stem cell population maintenance (GO:2000036),-0.38166539897678514,-1.0305828648882402,0.4103896103896104,0.7853078034657448,1.0,4/18,13.29%,PTN;REST;TAF6L;HMGA2
prerank,regulation of protein modification process (GO:0031399),0.3731839679481615,1.029434362585252,0.4174496644295302,0.8017075646561338,1.0,14/50,17.92%,CCDC88C;PPP1R16B;WARS1;HSPB1;NDUFS4;PTK2;CCDC88A;GRM5;PIN1;PHIP;ASPSCR1;KDM4D;ATG14;PPP1R16A
prerank,zinc ion transmembrane transport (GO:0071577),-0.3613136869792934,-1.029174803612801,0.3904494382022472,0.7879001893583918,1.0,5/22,8.22%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,synaptic vesicle endocytosis (GO:0048488),0.4060945460896103,1.0290557328725005,0.41778975741239893,0.8019975504524778,1.0,11/33,18.29%,ITSN2;DNM3;SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,regulation of bone mineralization (GO:0030500),0.36054742607836215,1.0286842518276755,0.42327365728900257,0.8023442234154179,1.0,9/55,6.78%,SGMS2;S1PR1;BMPR2;CCR1;SLC8A1;ANO6;ACVR1;MEF2C;P2RX7
prerank,amino sugar metabolic process (GO:0006040),-0.44530063909334394,-1.0279499735842368,0.4669811320754717,0.7899263568102023,1.0,4/10,14.58%,ST6GAL1;EXTL2;GFPT1;GFPT2
prerank,positive regulation of DNA replication (GO:0045740),-0.38845984306332304,-1.0271850944847152,0.4178272980501393,0.7907113444271849,1.0,2/16,0.88%,EGFR;GLI2
prerank,regulation of mRNA catabolic process (GO:0061013),0.33425445877133836,1.0270178377914918,0.4296875,0.8056943496132823,1.0,41/121,21.60%,VIM;PSMD13;PUM2;APEX1;PSMD4;ZC3H12A;ELAVL1;HSPB1;PRR5L;EXOSC3;UBA52;RPS27A;ZFP36L2;PSMA5;XPO1;PSMB10;CNOT1;GTPBP1;EXOSC8;PSMB8;PSMD14;XRN1;PSMA7;PSMC3;FXR1;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6;ZC3HAV1;PSMB2;ZFP36L1;MAPKAPK2;UBB
prerank,regulation of protein sumoylation (GO:0033233),-0.3773096221807006,-1.0268629443594341,0.4076086956521739,0.7902648864771489,1.0,6/17,22.91%,ZMIZ1;GNL3L;PIAS3;HDAC4;GNL3;PIAS4
prerank,protein oxidation (GO:0018158),-0.44032342902556465,-1.0266681273063136,0.463768115942029,0.7894664138381807,1.0,5/11,16.39%,LOXL1;LOXL3;SUMF1;PRDX3;CHCHD4
prerank,regulation of macrophage activation (GO:0043030),0.4115940010340072,1.0266424915882073,0.4277699859747546,0.8060350888675066,1.0,7/30,8.02%,GPR137B;FCGR2B;KARS1;MFHAS1;ZC3H12A;CEBPA;CD200
prerank,regulation of dendritic spine development (GO:0060998),0.4349457719351751,1.0266102739246956,0.42543171114599687,0.8055577611839947,1.0,5/19,10.91%,TANC2;MEF2C;SHANK3;PPFIA2;GRIN3A
prerank,regulation of cell cycle phase transition (GO:1901987),0.34760271791726144,1.026455707617183,0.41735052754982416,0.8053565253906819,1.0,27/91,19.11%,ATP2B4;PSMD13;UBE2D1;PSMD4;PSMA5;FBXW7;PSMB10;PSMB8;PSMD14;NEK11;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;PSMB9;ANAPC7;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,N-glycan processing (GO:0006491),0.4459382168694343,1.0261762600718132,0.4403225806451613,0.8054265339333584,1.0,3/18,8.17%,ST8SIA6;PRKCSH;GNPTAB
prerank,sterol metabolic process (GO:0016125),-0.28742143304267376,-1.0254589117661492,0.3979591836734694,0.791325205503544,1.0,6/60,2.95%,PRKAG2;CYP27A1;CYP26B1;APOE;LIPA;ABCA1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.41916885130704795,1.0254329162928053,0.41274658573596357,0.8065973018368003,1.0,3/22,4.59%,APOA1;KLF4;GCNT2
prerank,transepithelial transport (GO:0070633),-0.3954733126651554,-1.0254219738997032,0.448,0.7900611759179995,1.0,3/15,1.69%,SLC1A3;CXADR;SLC12A2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2582855895846429,-1.024986641487877,0.4110429447852761,0.7899260316755159,1.0,17/91,8.33%,BMP6;SLC39A14;SCARA5;SLC30A10;SLC39A8;ACO1;SLC39A13;MT1A;MT1H;MT1E;MT1F;MT1M;MT1X;MT1G;MT1B;ARF1;ATP6AP1
prerank,cytosolic transport (GO:0016482),0.3373700719683159,1.0249706507586427,0.4294049008168028,0.8071322299112513,1.0,25/108,20.36%,MYO1D;RAB6B;EMP2;DOP1B;VTI1B;SPAG9;KLHL20;LMTK2;HOOK1;TBC1D5;PIK3C3;HEATR5A;LAPTM5;VPS35;TBC1D10A;KIF16B;GOSR1;DENND5A;MON2;VTI1A;PHETA1;HOOK2;SORT1;CCDC91;EPS15
prerank,relaxation of cardiac muscle (GO:0055119),-0.40094728331063134,-1.0248241136386287,0.431266846361186,0.7890330276500873,1.0,2/13,0.82%,ATP1A2;GSN
prerank,phosphate ion homeostasis (GO:0055062),-0.43403481485762974,-1.0240573296962894,0.4375,0.7897821989468902,1.0,2/10,6.74%,ENPP1;SFRP4
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.47928608268567036,1.0233452202568507,0.44073455759599334,0.809824618503849,1.0,3/12,9.97%,ATP2B4;HOMER2;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.47928608268567036,1.0233452202568507,0.44073455759599334,0.809824618503849,1.0,3/12,9.97%,ATP2B4;HOMER2;PRNP
prerank,photoreceptor cell development (GO:0042461),-0.4061002806418633,-1.0232598577084329,0.43478260869565216,0.7906158966295086,1.0,7/14,32.14%,VEGFA;MFSD2A;TOPORS;ARL3;TULP1;AHI1;CDHR1
prerank,focal adhesion assembly (GO:0048041),-0.35187740014318974,-1.0228419602271432,0.42857142857142855,0.7905282920688597,1.0,4/21,6.78%,SORBS1;PTPRK;ACTN2;SRC
prerank,negative regulation of programmed cell death (GO:0043069),0.30992609822575184,1.0228245763141404,0.43193449334698053,0.8105276785578036,1.0,62/355,14.80%,MECOM;TEK;GATA6;SMAD6;FLT4;FAS;TNFAIP8;PLK3;CCND2;EGR3;FOXO1;CBL;PPT1;ANGPT1;CASP2;LEF1;MAP4K4;AMIGO2;RHBDD1;TAF9B;UFM1;ARHGDIA;SETX;KLHL20;FANK1;HSPB1;HSP90B1;HSPA1B;AATF;DCPS;BCL2L1;UBA52;PRKAA1;PROC;PIM3;RPS27A;TJP1;PTK2;ADAM10;BABAM2;SIAH2;RPS6KA1;RNF144B;HNRNPK;NFKBIA;LAPTM5;NPM1;TMBIM6;CD38;TMEM14A;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;NOL3;LTK;CFL1;BNIP3;CTNNB1;PSMC5;TM7SF3
prerank,myeloid leukocyte differentiation (GO:0002573),0.35747785953427347,1.0220192848902228,0.4320203303684879,0.8119450488360137,1.0,11/65,10.12%,CASP8;F2RL1;LGALS9;LEF1;PIR;SNX10;MYH9;OSCAR;CEBPA;FOXP1;TYROBP
prerank,stem cell development (GO:0048864),0.4569106428514464,1.021904706580473,0.45425361155698235,0.811654140230214,1.0,6/16,21.33%,SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,positive regulation of chromatin organization (GO:1905269),0.4853175935279046,1.02175992546842,0.4496753246753247,0.8114180931906934,1.0,7/12,25.76%,TAL1;DAXX;SIN3A;TERF2IP;H3-3A;TERF2;TINF2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.2949145339700717,-1.0213430289552878,0.40725806451612906,0.7932293873267584,1.0,15/46,22.80%,ZIC1;TCF7L2;CDH1;CAMK1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD;EFCAB7;KHDRBS1;NCBP2
prerank,nuclear transport (GO:0051169),0.4620606347344447,1.0210139189505965,0.43681747269890797,0.8125859403433399,1.0,6/16,23.15%,XPO1;NPM1;RSRC1;NUP205;BANF1;NXT2
prerank,cellular response to reactive oxygen species (GO:0034614),-0.277215505066073,-1.020940005380883,0.4074074074074074,0.7929562190237854,1.0,20/59,22.61%,EGFR;PDGFRA;PTPRK;TPM1;ANXA1;PRDX3;HDAC6;CHUK;FER;MPV17;FXN;PDK2;MAPK9;PRKCD;PAX2;TNFAIP3;ROMO1;ABL1;MAPK8;NET1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.35779060241848676,1.0208553699305938,0.4389937106918239,0.812406778676463,1.0,16/57,20.25%,HIP1R;FBXO7;HRK;TNFSF10;BBC3;CIDEB;VPS35;BNIP3;PYCARD;PLAUR;BMF;GSK3A;BID;PPIF;SPIRE1;GSK3B
prerank,transport along microtubule (GO:0010970),0.4747203253870762,1.0199991696007085,0.44243421052631576,0.8138475553091925,1.0,2/13,2.98%,APBA1;APP
prerank,cardiac muscle contraction (GO:0060048),0.39442000457739873,1.0198638032281122,0.43310344827586206,0.8136141664303632,1.0,4/34,4.95%,KCNQ1;MYBPC3;SLC8A1;CAMK2D
prerank,regulation of establishment of planar polarity (GO:0090175),0.34753278107978786,1.0198405856688546,0.45126353790613716,0.813102014094187,1.0,25/88,18.86%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;AP2M1;PSMB10;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of T cell chemotaxis (GO:0010819),0.4925131618610941,1.0198132387065626,0.45454545454545453,0.8126180394137272,1.0,4/11,9.42%,OXSR1;ADAM17;STK39;ADAM10
prerank,polarized epithelial cell differentiation (GO:0030859),0.4579889628436851,1.0196947728626682,0.4336734693877551,0.8123550220086575,1.0,2/13,4.47%,MSN;SYNE4
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.41757781882350775,-1.0196311240580176,0.44529262086513993,0.7953144609086772,1.0,6/13,16.12%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.34309299980665,1.0196064236751203,0.4501758499413834,0.811998126748172,1.0,24/94,19.51%,ATP2A3;DAB2IP;ARL6IP5;PPP1R13B;PPM1F;STK24;CASP2;TNFRSF1B;CUL3;BBC3;CIDEB;BCL2L1;CUL2;BAG6;BRCA1;ATM;BNIP3;PYCARD;TRIB3;SELENOK;CD24;DNAJC10;ERN1;MCL1
prerank,lipid catabolic process (GO:0016042),0.44556865389199696,1.019358463418247,0.45045045045045046,0.812032490623312,1.0,2/18,3.24%,PNLIP;PPT1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3917545558632321,1.019140019452655,0.4277699859747546,0.811979718257889,1.0,5/35,8.22%,NOTCH1;CAV1;NLK;ADIPOR1;JAK2
prerank,positive regulation of calcium ion import (GO:0090280),0.48204024073452867,1.0188547409437192,0.44839255499153974,0.8121207273705638,1.0,1/12,0.88%,PDGFB
prerank,carboxylic acid transport (GO:0046942),-0.2885950175824158,-1.0187416119174304,0.3983050847457627,0.7964103697928802,1.0,8/55,4.67%,SLC6A13;SLC16A12;SLC13A3;SLC1A5;SLC6A12;SLC16A6;SLC16A9;SLC17A5
prerank,myeloid cell development (GO:0061515),0.42793125909606033,1.018482461693598,0.43862275449101795,0.812434075483542,1.0,4/18,9.10%,APP;ALAS1;THPO;FOXP1
prerank,digestive tract morphogenesis (GO:0048546),0.45763903363016517,1.0180041276102418,0.4594155844155844,0.8130056129136954,1.0,2/14,5.57%,SOX17;BBS7
prerank,regulation of interleukin-4 production (GO:0032673),0.43025980193967905,1.017959086617651,0.4444444444444444,0.8125523923808343,1.0,5/21,16.90%,LGALS9;LEF1;GATA3;HAVCR2;RARA
prerank,regulation of sensory perception of pain (GO:0051930),0.4862436045617971,1.0179381948841741,0.4639344262295082,0.8120473040126138,1.0,2/11,4.17%,TMEM100;SCN11A
prerank,transcription preinitiation complex assembly (GO:0070897),-0.41746968973504395,-1.0178886599188668,0.43596059113300495,0.7973562198017734,1.0,8/12,30.04%,TAF1;DR1;GTF2B;TAF7;GTF2A2;BDP1;TBP;POLR1E
prerank,negative regulation of cyclase activity (GO:0031280),-0.4124723762690245,-1.0174918732148845,0.4583333333333333,0.7971169181909815,1.0,6/14,16.12%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3108368239594108,1.0174124232330612,0.4428424304840371,0.8127263370209957,1.0,84/314,20.43%,RNF103;FBXL2;ZNRF1;PSMD13;FBXL14;FBXL5;RNF185;CUL3;UBE2D1;PSMD4;KLHL20;FBXL18;PTTG1;HSP90B1;ARRB1;WWP1;UBE4A;UBA52;FEM1C;NFE2L2;TMUB2;RPS27A;PPP2R5C;FBXL16;PSMA5;FBXW7;RBX1;PSMB10;SIAH2;CUL2;TRIM25;NEDD4L;BAG6;PSMB8;PSMD14;FBXO4;SMURF1;KCTD10;RMND5B;YOD1;UBE2J2;PSMA7;RNF103-CHMP3;PSMC3;FOXRED2;SGTB;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;NHLRC1;UBE2D3;PSMB9;UBQLN2;SPOPL;FBXL13;ANAPC7;PSMC6;AMN1;SEL1L;ERLIN2;PSMA4;FBXO6;GSK3A;PSMD5;PSMD9;FEM1A;FBXL6;PSMB6;DNAJC10;FBXL15;ANAPC4;FBXO45;ZFAND2A;MAEA;RNF5;KCTD2;RNF34;PSMB2
prerank,actin crosslink formation (GO:0051764),-0.41491884198128987,-1.0173677712088145,0.44080604534005036,0.7961020256675243,1.0,4/12,19.65%,DPYSL3;FLNA;BAIAP2;GAS2L1
prerank,regulation of proteolysis (GO:0030162),0.36879665609686846,1.0171577425872562,0.4419525065963061,0.8127998497449661,1.0,3/48,2.42%,LTBP4;CAV1;CASP8
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3719864220800062,1.0169028255009813,0.43905635648754915,0.8128341474577924,1.0,5/44,8.42%,FCHSD2;EVL;CDC42EP1;WHAMM;NCKAP1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4085159618096011,1.0165763618731927,0.4534711964549483,0.8130289335693393,1.0,7/26,13.57%,GCH1;NOS1AP;ATP7A;NUS1;CDH3;PIK3CB;HIF1A
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4794740945695306,1.0164897527446566,0.440625,0.8126773086096717,1.0,1/12,1.46%,PLK3
prerank,membrane fusion (GO:0061025),0.3942711967837992,1.016484977431474,0.4447592067988669,0.8121358796454806,1.0,11/33,24.61%,DYSF;DNM3;VTI1B;MYOF;NSF;VAPA;GCA;NAPG;USO1;RIMS1;UBXN2A
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.49954614424668775,1.0163245552728593,0.42783505154639173,0.8119455553248033,1.0,2/10,3.82%,F2RL1;TIRAP
prerank,positive regulation of cellular protein localization (GO:1903829),0.349629445271903,1.0161293494153565,0.42927429274292744,0.8118501570376502,1.0,16/69,16.03%,FYN;GPR137B;CARD10;WWTR1;PRKAA1;APC;VPS28;RTN4;TYROBP;CCDC88A;LIMK2;NUMA1;DTX3L;KAT7;ABCA7;NDC80
prerank,regulation of neuron differentiation (GO:0045664),0.34864919135996497,1.0150372321246501,0.4618181818181818,0.8138604367620661,1.0,24/76,21.62%,CASZ1;HEY1;ARHGEF2;MEF2C;ALK;LRRK2;NRCAM;ROCK1;TCF3;ZC4H2;MMD;PCP4;YWHAH;HES3;LTK;SIN3A;HOXD3;SOX11;MMD2;BDNF;CNTN4;CDK5RAP1;NLGN1;ECT2
prerank,nuclear export (GO:0051168),-0.2627631006218851,-1.0148916981026868,0.41975308641975306,0.8014806041370701,1.0,29/80,26.04%,RANBP3L;SRSF5;PHAX;NEMF;NCBP1;SRRM1;SRSF1;CSE1L;NUP155;SRSF6;PKD1;THOC1;RANBP17;NXF1;MAGOH;RANBP3;U2AF2;MAGOHB;UPF3B;SRSF3;SRSF11;NCBP2;SRSF2;POM121;EIF4A3;U2AF1;ZC3H11A;THOC7;NUP188
prerank,negative regulation of apoptotic process (GO:0043066),0.3048153551015651,1.014531666329095,0.4630192502532928,0.8144902500007305,1.0,82/444,15.79%,TEK;GATA6;SMAD6;FLT4;FAS;TBX1;TNFAIP8;NR4A2;MERTK;PLK3;CCND2;NOTCH1;FOXQ1;EGR3;FOXO1;CAV1;CBL;PPT1;KLF4;ANGPT1;CASP2;LEF1;MAP4K4;MEF2C;RHBDD1;TAF9B;ASAH2;TOX3;MAPK1;UFM1;ARHGDIA;SETX;KLHL20;FANK1;ZC3H12A;HSPB1;HSP90B1;HSPA1B;AATF;BCL2L1;UBA52;PRKAA1;PROC;PIM3;RPS27A;SNAI2;TJP1;PTK2;ADAM10;BABAM2;SIAH2;PRKCG;RPS6KA1;RNF144B;HNRNPK;NFKBIA;NPM1;TMBIM6;CD38;TMEM14A;CX3CR1;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;NOL3;LTK;CFL1;APOH;ITGA5;BNIP3;CTNNB1;FZD9;FZD3;FGF20;DFFA;PDCD10;CDKN2D;PAK2;DNAJB6;VDAC1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.4605659089616787,1.0141922754719968,0.48083067092651754,0.8147197850433708,1.0,5/14,15.47%,SLC25A33;MTERF2;FASTKD5;TFB2M;TEFM
prerank,intermediate filament organization (GO:0045109),0.44565793221554945,1.0141629933289928,0.44513137557959814,0.8142284665056937,1.0,4/17,15.90%,VIM;DSP;DNAJB6;KLHL24
prerank,myelination (GO:0042552),0.36945873870810364,1.0141340925490356,0.4521497919556172,0.813750999679341,1.0,15/46,18.78%,MALL;MPZ;ACSBG1;CMTM8;MARVELD1;MAL;EIF2B2;NFASC;B4GALT6;SOX10;ARHGEF10;CXCR4;PLLP;MAL2;SKI
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41245344464789324,1.0140393514013504,0.4581005586592179,0.8128506697585987,1.0,7/29,22.61%,ACSM3;GLYAT;ACOT13;CROT;ACAT1;OXSM;ACLY
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41245344464789324,1.0140393514013504,0.4581005586592179,0.8128506697585987,1.0,7/29,22.61%,ACSM3;GLYAT;ACOT13;CROT;ACAT1;OXSM;ACLY
prerank,negative regulation of neuron differentiation (GO:0045665),0.4197037259199461,1.0138289942975345,0.4177978883861237,0.8127780194829677,1.0,2/22,1.98%,B2M;HEY1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3626917983892059,1.0138203017544223,0.4451530612244898,0.8122447324355592,1.0,9/50,11.98%,SMAD7;CAV1;HSPA1B;ARRB1;VPS28;PRKCG;ADGRB1;NXN;DTX3L
prerank,L-serine metabolic process (GO:0006563),0.4947893790840927,1.0137714106785218,0.4603174603174603,0.8118117226324155,1.0,2/10,11.61%,SERINC3;SERINC5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4685117328157691,1.0136349166638476,0.4300168634064081,0.8115761956532921,1.0,6/12,15.39%,FKBP1A;TMED10;ROCK1;PRNP;RANBP9;ABCA7
prerank,negative regulation of reproductive process (GO:2000242),-0.3760352138115746,-1.0127528693944639,0.4557291666666667,0.8059753164832926,1.0,3/17,3.09%,IGF1;SULF1;GJA1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3558111879735651,1.012525350965974,0.4499396863691194,0.8136475610429071,1.0,19/68,22.61%,ACSM3;GLYAT;SULT6B1;RAB23;LRRK2;ACOT13;GTPBP1;MFN1;BPNT1;RAN;EFL1;NT5C2;CROT;ACAT1;SULT1A1;OXSM;EPHA2;ADSS2;ACLY
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.47995527457250997,1.0125194335971797,0.4451939291736931,0.8131082338638318,1.0,2/11,2.42%,ARHGEF2;CASP8
prerank,positive regulation of exosomal secretion (GO:1903543),-0.38178884876221497,-1.0123295635865892,0.4481865284974093,0.805786120843397,1.0,7/15,26.72%,SDCBP;TSG101;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,regulation of response to oxidative stress (GO:1902882),0.474449062246755,1.011877483494378,0.4612676056338028,0.8140946932956751,1.0,1/11,1.49%,MCTP1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.48797888191793015,1.0115648542881985,0.4677137870855148,0.8142433945111672,1.0,4/10,20.59%,RNF125;RIOK3;SEC14L1;DHX58
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41372618293056,1.0114804985906576,0.4397590361445783,0.8138844619455248,1.0,5/24,11.98%,AIM2;TRIM6;ZC3H12A;STAT1;DTX3L
prerank,negative regulation of neuron projection development (GO:0010977),0.362491536028972,1.0113053928922493,0.42911877394636017,0.8137399975689132,1.0,10/56,12.58%,TRPV4;STMN2;FKBP4;EFNA1;ARHGDIA;PTPRO;RTN4;SPOCK1;DCC;TSKU
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4366529179681073,1.0112275610242174,0.45396825396825397,0.8133626402534073,1.0,4/18,8.22%,CBL;STAT1;CEBPA;JAK2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.39143439191450613,-1.0103686195916766,0.4386422976501306,0.8099382733302705,1.0,4/14,11.20%,AUTS2;SNW1;WDR5;CTR9
prerank,cortical cytoskeleton organization (GO:0030865),0.3725412882399915,1.010090909609448,0.4453551912568306,0.815452525041135,1.0,10/41,14.80%,TRPV4;RND1;RHOB;FMNL3;NCKAP1;ROCK1;RAC1;RND2;RHOH;LCP1
prerank,microtubule polymerization (GO:0046785),0.3986743790274764,1.0100133734743197,0.45677233429394815,0.8150855060285095,1.0,6/28,13.11%,TRPV4;CSNK1D;CLASP1;CLASP2;RANBP9;PIN1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.2956945316364811,-1.0096140092320045,0.4065934065934066,0.8106802155712672,1.0,7/39,10.01%,PLPP3;PDGFRA;MEGF11;UBASH3B;FLNA;MYL9;PPIA
prerank,negative regulation of lyase activity (GO:0051350),-0.38850620433083327,-1.0095896733030127,0.46419098143236076,0.8094202250013802,1.0,6/16,16.12%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,vascular transport (GO:0010232),0.3440528556300699,1.009570896551486,0.452991452991453,0.815586318099998,1.0,8/81,2.99%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.37584836493737966,1.0095334715735864,0.4505208333333333,0.81512164684988,1.0,9/43,13.57%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,positive regulation of catalytic activity (GO:0043085),0.3869271832218579,1.0093454367452233,0.4213406292749658,0.8150153067049362,1.0,15/37,24.22%,NOD2;CAV1;APOA1;ATP7A;SSBP1;APH1A;CHTOP;PSEN2;MAPK14;ABL2;XRCC4;SOD1;NCSTN;WRN;NHEJ1
prerank,microtubule depolymerization (GO:0007019),0.43648795083542613,1.008971914477063,0.4594155844155844,0.8153275189239098,1.0,2/17,6.54%,STMN2;KIF2A
prerank,organic acid transport (GO:0015849),0.33746508683986076,1.0088910039208088,0.44588235294117645,0.8149898792278437,1.0,6/94,2.99%,SLC6A6;ABCC4;CEACAM1;SLC25A32;SLC7A7;SLCO1C1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3905973437240203,1.0084818218067848,0.45786516853932585,0.8153748619686317,1.0,10/38,13.70%,GBP5;PUM2;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;DHX9;CYBA;RIOK3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.31801984537786465,-1.0084722636398797,0.40514469453376206,0.8111201923776524,1.0,6/30,12.71%,DDX5;DAB2;HEYL;KLK2;HDAC1;HDAC6
prerank,transport across blood-brain barrier (GO:0150104),0.34290740594184405,1.0079392788217016,0.4602203182374541,0.8160969308144088,1.0,8/83,2.99%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.332659941919937,-1.0077815006189343,0.4342105263157895,0.8115877941657582,1.0,5/29,10.78%,DDO;ALDH4A1;PRODH;GSTZ1;SARDH
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4210789801718705,1.007766337179892,0.462109955423477,0.815927460740726,1.0,2/22,3.71%,NOTCH1;MGAT5
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.30170529783273925,1.0075723120735924,0.46,0.8158633222076924,1.0,86/807,9.99%,PRDM16;MECOM;SOX13;NOTCH4;KLF8;EDN1;GATA6;PLCB1;PDGFB;LDB2;DACH1;RPS6KA5;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;FOXO1;ELK3;NR1I3;KLF12;HEY1;KLF7;DAB2IP;IRF2;CAV1;LRRFIP1;SAP30;HNF4A;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;MAFK;EFNA1;MEF2C;SMAD2;BTAF1;DAP;TAF9B;COMMD7;PHF6;GATA3;EID2B;BCL6B;RTF1;PDCD4;UBE2D1;ZBTB16;GTF2IRD1;PHC3;STAT1;PURA;TMPRSS6;CEBPA;WWP1;UBA52;ZHX3;WWC2;RPS14;GATAD2A;RPS27A;NR1D1;SNAI2;ERF;KLF11;FOXP1;UXT;MBD1;JUN;TCF3;HMGB1;ARID5A;MAD2L2;ZBTB14
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.43482599198726485,-1.0073642747357276,0.47477064220183485,0.8113816175107867,1.0,6/10,35.82%,TICAM1;MYD88;CD68;TREM2;CD36;TLR6
prerank,superoxide metabolic process (GO:0006801),0.40275944645932177,1.0072098239204628,0.45803698435277385,0.8161518805706084,1.0,4/29,11.05%,NOS3;ATP7A;TAFA4;CYBA
prerank,potassium ion transmembrane transport (GO:0071805),0.3233102508533151,1.0070588466104708,0.474972191323693,0.8159581783648527,1.0,10/135,3.90%,KCNN4;KCNQ1;KCNE3;KCNH8;ATP1A4;ATP1A1;ATP1A3;KCNN3;KCNG3;SLC12A8
prerank,regulation of macroautophagy (GO:0016241),-0.24876455253699203,-1.0070422021665502,0.42953020134228187,0.8109641037141554,1.0,33/105,22.55%,PRKAG2;DCN;PRKAA2;GPSM1;SNX6;VPS26B;SESN1;ATP6V1B2;SNX32;TBK1;ATP6V0B;PRKACA;CASP3;SESN2;PRKAB2;HDAC6;UCHL1;TSC1;WAC;ATP6V1A;LAMTOR2;LARP1;PRKAG3;TSC2;SNX5;CLN3;MAP3K7;MAPK8;LAMTOR5;CDK5;ATP6V1H;ATP6V0D2;PAFAH1B2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4374320683545405,1.0069134510221602,0.4363905325443787,0.8157477082420721,1.0,4/18,8.02%,TGFB2;LGALS9;CD34;CD200
prerank,response to hydroxyurea (GO:0072710),0.4815259895291719,1.0068983881743878,0.46481178396072015,0.81523939136852,1.0,5/11,25.13%,NSMCE3;SPIDR;KAT7;BLM;RTF2
prerank,regulation of telomere maintenance (GO:0032204),-0.3321556683138584,-1.0066083845602278,0.41916167664670656,0.810861489310788,1.0,13/26,31.48%,RAD50;PPP1R10;YLPM1;XRCC5;RTEL1;PML;GNL3;ATRX;HDAC8;HNRNPD;SMG6;SIRT6;UPF1
prerank,histone H3 acetylation (GO:0043966),-0.29718989146973174,-1.006465334909873,0.45588235294117646,0.809936176017341,1.0,14/40,21.87%,LDB1;TADA2A;KAT2B;DR1;WDR5;MEAF6;TAF6L;NAA60;TAF5;TADA3;BRPF3;SUPT7L;MAP3K7;TAF10
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.45425598593992866,1.006436549106116,0.44264943457189015,0.8157921935689068,1.0,5/14,16.19%,NFKBIE;NFKBIB;NFKBIA;KEAP1;TMSB4X
prerank,cellular protein metabolic process (GO:0044267),0.3056736378372868,1.0064298297607126,0.4893184130213632,0.8152600568985018,1.0,101/396,21.23%,GATA6;LMCD1;DENND3;ST3GAL6;FBXL2;DUSP12;MSRB3;MMP1;DAB2IP;GOLM1;APP;CSF2RB;UBA7;APOA1;RPS21;RPL27;MANBA;OMA1;PCSK5;STK38;TMEM132A;RPL7;FURIN;FARSB;CHRM3;WARS1;ADAM17;MRPL18;MRPL41;PRKCSH;IGFBP7;HSP90B1;UBA52;PCMT1;PROC;RPS14;RPS27A;RPL35;APH1A;YES1;CSNK1G3;IGFBP4;ADAM10;RPL21;SIAH2;RPL37;RPS28;RPL34;MRPL36;APLP2;MRPL52;RPS9;FBXW2;LIPT1;CDH2;RPLP2;MRPL23;RPS25;CP;RPL30;RPS5;RPL27A;NAGPA;MRPL24;ST3GAL1;FBXO2;MRPL32;MRPS12;RPL23A;RPS15;MSRA;UBE2D3;RPL19;RPS18;RPL32;PSEN2;CST3;RPL37A;RPL18A;MEN1;CALU;MRPS18B;COPS5;CDKL3;PENK;TIMP1;VGF;DARS1;RNF5;GNMT;MRPL11;CTSH;RSL24D1;RPL18;LCMT1;APH1B;WWP2;PNPLA2;RPL39;RAB12;RPS19
prerank,gonad development (GO:0008406),0.38601082555656335,1.0064041416762262,0.45776566757493187,0.8147795795826333,1.0,6/41,8.81%,GATA6;KITLG;TGFB2;GATA3;COL9A3;NCOA4
prerank,positive regulation of kinase activity (GO:0033674),0.3303684914094608,1.0062090336455858,0.47218934911242605,0.8147050118194276,1.0,12/107,7.56%,TEK;RAPGEF2;FLT1;TIE1;FLT4;MERTK;INSR;IQGAP1;FGFR3;ALK;LMTK2;MAPRE3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.46760718982187566,1.0060288827802353,0.4694589877835951,0.8145898406428911,1.0,5/11,19.66%,UQCC3;UQCRB;UQCRFS1;UQCRC1;UQCRC2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.38696994746808333,-1.005701478225657,0.4401114206128134,0.8106493401611776,1.0,5/15,16.11%,NTRK2;NGF;CASP3;ZFYVE27;DDIT4
prerank,protein K63-linked deubiquitination (GO:0070536),-0.32287950707322416,-1.0056967485388542,0.4413793103448276,0.809334659792744,1.0,11/31,16.72%,USP33;USP20;USP13;USP50;ABRAXAS2;OTUD7B;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.38663299385486893,-1.004921347584605,0.4613333333333333,0.8101286897472905,1.0,5/14,22.29%,FUS;ACTR2;FANCB;TIMELESS;PARP1
prerank,cholesterol efflux (GO:0033344),0.42616748727495724,1.0047717984443354,0.47368421052631576,0.8170299486084888,1.0,7/20,18.32%,APOA1;STX12;ABCG4;TSKU;ABCA7;SCARB1;SOAT1
prerank,positive regulation of transferase activity (GO:0051347),0.31941444239773653,1.0042902282023063,0.45403587443946186,0.8175773089113216,1.0,27/142,14.25%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;HMBOX1;KLF4;FGFR3;MAPK1;ALK;LMTK2;NVL;CD200;NEK7;FBXW7;DKC1;PTGES3;TNKS;POLG2;CCT2;SERINC5;DTX3L;CCT4;PIN1;LTK;CTNNB1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.462218499233356,1.0042028296945913,0.477491961414791,0.8172566668495685,1.0,1/13,1.35%,DOC2B
prerank,regulation of protein secretion (GO:0050708),0.3253435437590494,1.0040506114292953,0.45067264573991034,0.8170765035468638,1.0,11/119,6.22%,CD2AP;UNC13B;ITPR3;SLC2A1;CACNA1A;TGFB2;HNF4A;SYT7;RAPGEF4;TMED10;IL1A
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.39628198801769654,1.0038781588980688,0.44923504867872044,0.8169520225740458,1.0,11/29,22.61%,FASN;PPT1;ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;SLC25A1;ACSL4;ACLY
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3463610452709591,-1.0035236686585014,0.40298507462686567,0.8126075291864261,1.0,6/21,22.24%,SAMD4A;CNOT10;TUT4;ZFP36;PNLDC1;SAMD4B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3066286036795323,1.0024972338306581,0.4831804281345566,0.8196486509833957,1.0,40/327,12.21%,SOX17;SOX13;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;SOX18;BTG1;ACTN4;ING2;WWTR1;NLK;MEF2C;PPIE;RYBP;GTF2IRD1;CEBPA;WWC2;SNAI2;SERTAD3;TCF7L1;TCF3;MLF1;HP1BP3;PLAG1;NUP35;ASCC1;TRAPPC2;TESMIN;SAP30L;HINFP;SOX6
prerank,mitochondrial translational elongation (GO:0070125),0.3405297340368717,1.0020425320438444,0.4712103407755582,0.8201357291288727,1.0,39/88,28.54%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;GFM1;MRPL11;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.37160729503475687,-1.0020250465408178,0.4585492227979275,0.8152831498280719,1.0,8/15,24.80%,GPLD1;SLC27A1;SREBF1;MFSD2A;SIK1;NR1H3;FITM2;C3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4045188554419036,1.0012180267636945,0.45682888540031397,0.8214609068983085,1.0,2/24,3.80%,RAPGEF2;PDE3B
prerank,protein homotrimerization (GO:0070207),-0.3893711155940351,-1.0008202464714302,0.4581151832460733,0.8158927798385266,1.0,4/14,15.74%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,protein trimerization (GO:0070206),-0.3893711155940351,-1.0008202464714302,0.4581151832460733,0.8158927798385266,1.0,4/14,15.74%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4349209929721254,-1.0005909582800723,0.4549763033175355,0.815120298599003,1.0,4/10,25.19%,DICER1;TERT;TSNAX;MRPL44
prerank,regulation of mononuclear cell migration (GO:0071675),0.41026982426959213,1.0004732664829907,0.47147147147147145,0.8226474349974036,1.0,5/23,9.21%,STK10;MSN;MAPK1;CMKLR1;PTK2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4230944331688728,-1.0004391349376327,0.45539906103286387,0.8141890545599848,1.0,3/11,6.17%,BACE2;ITM2A;NECAB1
prerank,motile cilium assembly (GO:0044458),0.46694964102224973,0.9999414242797185,0.48896434634974534,0.823330346390384,1.0,2/12,6.69%,DNAAF3;SPATA6
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.40031570118130055,-0.9998168515095524,0.4831730769230769,0.8145957658892587,1.0,4/13,10.32%,ERRFI1;CBLB;SNX6;TSG101
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3547356821792824,-0.9996347701261643,0.47988505747126436,0.8138197600090085,1.0,10/21,31.38%,AMPD3;NUDT4;XDH;NT5E;PNP;NT5C1A;FITM2;PDE2A;NUDT18;NUDT11
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3898564344141877,0.9994913229999141,0.4646892655367232,0.8238143620647544,1.0,7/33,13.93%,EDN1;PIK3C2A;PLEKHA1;GATA3;HTR2A;PIK3CB;LTK
prerank,protein localization to phagophore assembly site (GO:0034497),0.47025250775389066,0.998761512636732,0.4504950495049505,0.8249633197122436,1.0,1/11,1.80%,TRAPPC8
prerank,early endosome to late endosome transport (GO:0045022),0.4220454016520617,0.9987115148517887,0.449685534591195,0.8245430620039234,1.0,6/20,18.81%,EMP2;LMTK2;HOOK1;PIK3C3;KIF16B;HOOK2
prerank,protein localization to synapse (GO:0035418),-0.41307105214839823,-0.9986193675266081,0.4835443037974684,0.8151512789018068,1.0,2/12,4.01%,DLG4;NLGN2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.39197633318704045,-0.998490197598628,0.4406779661016949,0.8141824261905783,1.0,8/14,34.87%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4336577282012574,0.9972923193706417,0.48177496038034867,0.827360844397251,1.0,2/18,9.31%,CRTAM;ZFP36L2
prerank,myotube cell development (GO:0014904),-0.42092986432124535,-0.9968757285104181,0.46733668341708545,0.8172703084893559,1.0,2/10,7.10%,IGF1;SIX1
prerank,regulation of gene expression (GO:0010468),0.2975259558623254,0.9964682337110189,0.515,0.8287221168870884,1.0,122/903,12.61%,NANOS1;PLCG2;SOX17;SOX13;NOS3;ENG;CLDN5;GATA2;PDGFB;TRIM14;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;CCR1;FOXO4;ESRP2;NOVA2;OCLN;ACVRL1;NOTCH1;ATP2B4;INSR;HEY1;IRF2;IFNGR1;CASP8;TGFB2;TNRC6C;SAP30;LGALS9;DLL4;APP;SOX18;BTG1;AFF1;HEY2;TLR3;NOS1AP;MED26;SLC8A1;KLF4;PPM1F;KRAS;ING2;PUM2;MSN;ANGPT1;WWTR1;LEF1;GCNT2;MBNL1;YBX2;TRIM11;TRIM6;NLK;NKAPL;MEF2C;CD34;PPIE;GATA3;BCL6B;WARS1;IL1A;SMCR8;MAPK1;RYBP;P2RX7;GTF2IRD1;ZC3H12A;HSPA1B;RBL1;CEBPA;PLSCR1;ZC3H7A;CDH3;NFE2L2;PRKAA1;WWC2;CAVIN4;ACTG1;SNAI2;ROCK1;CACTIN;FOXP1;STAP1;NDFIP2;SERTAD3;TCF7L1;TCF3;ADAM10;DHH;EGR1;MLF1;FBXW7;HP1BP3;PLAG1;TCEAL1;TYROBP;HNRNPK;AGO4;TRIM17;NUP35;VSIR;ASCC1;PTBP3;NWD1;TRAPPC2;VPS35;PCBP1;BRCA1;TESMIN;VSTM2A;CLU;SAP30L;HINFP;SOX6;TOB1;PIK3CB;TSKU;TTBK1
prerank,nuclear pore organization (GO:0006999),0.45447550324465186,0.99621508265024,0.454242928452579,0.8287713939180675,1.0,5/14,15.93%,RTN4;NUP54;NUP35;NUP153;NUP205
prerank,nucleotide biosynthetic process (GO:0009165),-0.36977691731410406,-0.9959881994306707,0.45108695652173914,0.8183634867370241,1.0,5/18,13.04%,NMNAT2;ME1;PRPSAP2;MTHFD1;PNP
prerank,mesenchymal cell differentiation (GO:0048762),0.36388726359114604,0.9958077101785975,0.4890710382513661,0.8291566579454424,1.0,8/51,5.32%,NOTCH4;ENG;NOTCH1;TGFB2;HEY2;LEF1;FOXF2;MEF2C
prerank,cellular macromolecule catabolic process (GO:0044265),0.36716731448458534,0.9950148907422016,0.4669211195928753,0.8304604213510589,1.0,15/49,21.06%,DENND3;DAB2IP;MANBA;DFFB;SIAH2;RNASEH2B;XRN2;RNASE6;FBXO2;OGA;FBXO6;NGLY1;NEU4;RNF5;RAB12
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.30917877061127563,-0.9948820541433465,0.4726027397260274,0.8201281472341866,1.0,8/37,8.48%,IGF1;BMPR1A;IGFBP5;GJA1;TPM1;FGF2;MMP2;EFEMP2
prerank,dendritic spine organization (GO:0097061),0.398614443227228,0.99469579611768,0.4623493975903614,0.8306397493487374,1.0,4/26,9.97%,FYN;INSR;SHANK3;PRNP
prerank,negative regulation of immune system process (GO:0002683),-0.36880661713337726,-0.9946785886909593,0.43908629441624364,0.8193244630469757,1.0,4/16,17.03%,COL3A1;IL17D;HOXA7;GPER1
prerank,regulation of anoikis (GO:2000209),0.42329117592769794,0.9945214347900778,0.465818759936407,0.8305115699280151,1.0,5/19,14.00%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,positive regulation of reproductive process (GO:2000243),-0.3141473072192836,-0.9943141073630314,0.4318181818181818,0.8190464869253637,1.0,12/31,23.57%,PDE3A;SYDE1;VEGFA;LHFPL2;ACVR1B;SIRT2;CACNA1H;INHBA;CFAP69;TACR3;INHBB;C1QBP
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.45762237151835666,0.9942762554849682,0.4483306836248013,0.8304912675460916,1.0,5/13,18.13%,NOTCH1;HEY2;NPY5R;GSK3A;SMAD4
prerank,mitochondrial transcription (GO:0006390),0.48653665728695566,0.994113256037822,0.4802065404475043,0.830309201995014,1.0,4/10,15.47%,SLC25A33;MTERF2;TFB2M;TEFM
prerank,transferrin transport (GO:0033572),-0.31141779353527427,-0.9935285709268893,0.4602649006622517,0.8198232539040731,1.0,6/33,8.33%,STEAP3;ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6AP1
prerank,skin development (GO:0043588),0.34534160542574144,0.993155570567713,0.4701397712833545,0.8319960889299416,1.0,7/65,5.79%,JAG1;GATA6;CLIC4;LSR;BCR;ATP7A;COL5A2
prerank,regulation of protein kinase A signaling (GO:0010738),0.41806995746615494,0.9928897553429141,0.4984076433121019,0.8320736656695671,1.0,4/20,7.14%,ADRB2;AKAP5;IAPP;LRRK2
prerank,sodium ion export across plasma membrane (GO:0036376),0.46894687957419995,0.9928802595901592,0.47527910685805425,0.8315439567932623,1.0,3/13,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,thyroid hormone generation (GO:0006590),-0.43206508342681804,-0.9924008116549112,0.47980997624703087,0.8215943475962132,1.0,2/10,6.82%,CPQ;SLC5A5
prerank,pore complex assembly (GO:0046931),0.42258846869798117,0.9922702190578283,0.4813153961136024,0.8323792093003313,1.0,7/19,15.93%,ANO6;P2RX7;ADAM10;RTN4;PDZD11;NUP153;NUP205
prerank,positive regulation of nervous system process (GO:0031646),0.42829719857971443,0.9922690774375497,0.4661764705882353,0.8318366682464157,1.0,3/18,10.75%,UNC13B;TNFRSF1B;TENM4
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3916386363222618,0.9919813157457503,0.4950071326676177,0.8319754107370854,1.0,5/29,8.54%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,tRNA modification (GO:0006400),0.350173074535944,0.9918632832443864,0.4740834386852086,0.831687395635,1.0,11/62,13.52%,ADAT2;TRDMT1;OSGEP;TRMT61A;TRMT5;TRUB1;METTL2A;METTL2B;ALKBH8;TRMT61B;TYW1
prerank,zymogen activation (GO:0031638),0.37659653421583006,0.991785205789374,0.4814305364511692,0.8313212822855541,1.0,8/39,13.99%,CASP8;OMA1;FURIN;PGK1;CIDEB;VSIR;TBC1D10A;APOH
prerank,prostanoid biosynthetic process (GO:0046457),0.43867557466680135,0.9907858842926031,0.47715736040609136,0.8331202929545558,1.0,1/15,0.47%,EDN1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2942159250503587,0.9906462350472997,0.563,0.8329005043958588,1.0,229/1646,14.31%,PRDM16;NOS1;MECOM;EPAS1;SOX17;SOX13;NOTCH4;KLF8;AFAP1L2;ERG;ENG;IRF6;GATA6;GATA2;SMAD6;TAL2;MSX1;PLCB1;PDGFB;DACH1;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;CDK17;TBX1;APBB2;MLF2;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;ACVRL1;NOTCH1;FOXQ1;ATP2B4;ZFP69;EGR3;FOXO1;ELK3;INSR;KLF12;HEY1;TAL1;OLIG2;KLF7;DAB2IP;IRF2;CDK14;ZNF296;ZNF235;LRRFIP1;SAP30;HNF1A;HNF4A;KLF3;ID1;KLF6;ARID3B;HDAC9;ZGLP1;SOX18;BTG1;CRK;HHEX;TEAD4;FLI1;INPP5K;RBBP8;HEY2;HMBOX1;MED26;KLF4;PPM1F;ACVR1;ING2;SIM2;WWTR1;LEF1;MAFK;IRF9;CCNE1;ZBTB46;CAMK2D;PKN1;SP4;MAFF;KARS1;NLK;ELOC;FOXF2;MEF2C;SMAD2;BTAF1;DAP;PPIE;BBS7;ZBTB48;FOSL2;COMMD7;PHF6;GATA3;EID2B;BCL6B;TOX3;RXRG;PDCD4;RAD21;SRCAP;RYBP;ZBTB16;FANK1;GTF2IRD1;MRGBP;PHC3;KDM3A;LCORL;STAT1;ELP4;TOX4;AATF;PURA;MAPRE3;EBF3;ELP2;TMPRSS6;ARRB1;CEBPA;WWP1;DNAJC2;ZHX3;NFE2L2;WWC2;GATAD2A;KMT2E;NR1D1;SNAI2;ERF;KLF11;ZBTB40;FOXP1;UXT;MBD1;KMT2B;JUN;BRF2;SERTAD3;TCF7L1;TCF3;ELOA;EGR1;HMGB1;MLF1;ZNF182;DHX9;HP1BP3;ARID5A;PLAG1;SEC14L2;MAD2L2;ZBTB14;CHD5;ZXDB;RPS6KA1;HNRNPK;SFR1;BRIP1;NUP35;ZBTB34;POLA1;DEAF1;ASCC1;RAI1;SAMD1;NPM1;PHOX2A;HDX;TRAPPC2;DMAP1;E2F7;BRCA1;TIAL1;NR4A1;TESMIN;CD38;SAP30L;ILF2;DTX3L;ARID5B;KLF13;SOX10;HINFP;SOX6;TLX3;MED30;SUV39H2;IRF5;SETD3;ELF2;CBFB;CTBP2;ATP8B1;RPS6KA3;TGIF1;ASCL4;YWHAH;POU3F2;ZNF32;PHIP;RIOX1;TBX20;HIF1A;NFATC1;IKZF5;RHOH;ETV6;MYT1L;HES3;LRP5;USF2;MED27;SMARCC1;ELAVL2;CTNNB1;MED17;MLLT3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.40752219995582456,0.9902890163041549,0.4735202492211838,0.833190094705058,1.0,7/24,15.49%,AQP11;LRRK2;BCL2L1;LPCAT3;TMBIM6;CLU;RACK1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3480791875364978,-0.9902368698161776,0.45482866043613707,0.8260905098494169,1.0,2/22,1.85%,ALDH1A2;RBP1
prerank,maintenance of protein location in nucleus (GO:0051457),0.4182812098884353,0.9900494938079367,0.4664586583463339,0.8332060228172283,1.0,7/20,21.56%,SYNE1;RANGAP1;ARL2BP;TAF8;TAF3;BARD1;SUN1
prerank,long-term synaptic potentiation (GO:0060291),-0.3491299425384536,-0.9896904234404983,0.4657142857142857,0.8261991732510193,1.0,5/21,9.76%,STX4;SLC8A3;TSHZ3;GRIN2D;PRKCZ
prerank,cellular response to alkaloid (GO:0071312),0.43485842531213764,0.989643112497898,0.4694835680751174,0.8335739175814685,1.0,6/17,23.13%,SLC8A1;HTR1B;SPIDR;CASP7;BLM;RYR2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4182892787932435,-0.9895572787247225,0.47783251231527096,0.8252541925343232,1.0,3/10,12.70%,CREBBP;KAT2B;ESCO1
prerank,regulation of protein dephosphorylation (GO:0035304),0.3831325781278196,0.9895418838190463,0.4598639455782313,0.8332636519714268,1.0,19/37,27.96%,PPP1R16B;MFHAS1;HSP90B1;ARPP19;CDCA2;CALM3;PIN1;CNEP1R1;TIPRL;PPP1R16A;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;CALM1;SYMPK;SPPL3;SMPD1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.35792302120540764,-0.9893978481652781,0.47757255936675463,0.8243626439662989,1.0,7/17,20.56%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,retinal metabolic process (GO:0042574),-0.4075433788230234,-0.9892313409851227,0.48148148148148145,0.8234876473928284,1.0,8/12,45.75%,ABCA4;ALDH1A3;DHRS13;BCO2;ALDH8A1;CYP1B1;RDH10;BCO1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.4759610468730219,0.9890243993656068,0.49146757679180886,0.8338653813399369,1.0,2/10,5.58%,APP;SHANK3
prerank,regulation of p38MAPK cascade (GO:1900744),0.38190402877799917,0.9889928946316389,0.47375690607734805,0.8333972125773631,1.0,7/35,10.64%,DUSP1;DAB2IP;LGALS9;MFHAS1;ZC3H12A;GADD45G;MINK1
prerank,regulation of interferon-alpha production (GO:0032647),0.40445597964470387,0.9889240735412489,0.47575757575757577,0.8330122974574077,1.0,6/23,14.84%,IFIH1;TLR3;STAT1;DHX9;IRF5;HAVCR2
prerank,cellular response to virus (GO:0098586),0.3897847726033685,0.9886784735370763,0.48261474269819193,0.8329886359775892,1.0,8/30,17.65%,IFIH1;LGALS9;IRGM;ZC3H12A;HIF1A;RIOK3;MAPK14;CXCL10
prerank,copper ion transport (GO:0006825),0.4759446262840189,0.9885906462862291,0.5134228187919463,0.8326599518175928,1.0,3/11,4.64%,ATOX1;ATP7A;SLC31A1
prerank,regulation of cell death (GO:0010941),0.33176373469648884,0.9881075094539805,0.48484848484848486,0.8331683970202907,1.0,19/94,14.86%,ACER2;PRKD1;SNCG;TMEM109;TNFRSF1B;ZC3H12A;LRRK2;HSPA1B;PDE8A;CIDEB;APC;RRAS2;DCC;VPS35;CLU;BNIP3L;BNIP3;RAD18;SARM1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3364116602749422,0.9880059995369996,0.4907292954264524,0.8328611249826297,1.0,7/75,3.90%,TRPV4;ATP2B4;ATP1A4;ATP1A1;ATP1A3;SLC8A1;SLC12A8
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.35719666375452347,0.9879326083165689,0.4588688946015424,0.8325107578267992,1.0,21/55,21.23%,PSMD13;PSMD4;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;USP47
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3918735297635566,-0.9878213819684293,0.4730077120822622,0.8259188242791228,1.0,2/12,4.04%,DPYSL3;DPYD
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.33288730407842704,-0.9875974201194424,0.45307443365695793,0.8252327759868703,1.0,9/23,16.45%,UACA;BMP7;CCN3;PPM1A;C1QTNF3;DDX3X;PPM1B;CYLD;NLRC3
prerank,ncRNA catabolic process (GO:0034661),0.38781255356614724,0.9868249369648793,0.4802816901408451,0.8345027379967943,1.0,11/28,24.98%,RBM7;TRIR;EXOSC3;EXOSC8;XRN1;EXOSC9;POP1;EXOSC10;DIS3L2;NUDT16;NUDT16L1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.37077136493241286,-0.986406481361949,0.47837150127226463,0.8272176328406957,1.0,6/16,14.90%,DDX5;DDX17;SRSF1;PUF60;SRSF6;SCNM1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3872982268195393,0.9862901176940843,0.49642346208869814,0.8351468802679439,1.0,5/30,8.54%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,pharyngeal system development (GO:0060037),0.44273147691027603,0.9859479333580431,0.47030497592295345,0.8354429107484312,1.0,4/15,6.03%,BMPR2;TBX1;TGFB2;GATA3
prerank,response to interleukin-1 (GO:0070555),0.34197457481226196,0.9853036752735344,0.4773561811505508,0.8364274033038467,1.0,13/73,11.38%,DAB2IP;LGALS9;APP;HYAL2;IRAK2;GBP3;CD47;ZC3H12A;NR1D1;ACOD1;CACTIN;CCL4;GBP2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4028256088236076,0.9850912126604746,0.49025487256371814,0.8363905024447029,1.0,5/25,9.89%,HEY1;HEY2;TRIM6;GATA3;MAD2L2
prerank,sodium ion homeostasis (GO:0055078),0.42336218281974364,0.9850758503438013,0.48833592534992226,0.8358967635752322,1.0,4/21,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,response to progesterone (GO:0032570),0.4258780987222053,0.9849664751229361,0.4937888198757764,0.8355971891317018,1.0,4/18,8.74%,CAV1;TGFB2;UBE3A;ACOD1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3505719115286622,0.9849160739383027,0.5012626262626263,0.835157703994515,1.0,23/62,24.60%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;EAF2;GTF2H3;MLLT3;ELOF1;NELFB;POLR2I;AFF4;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,regulation of neuron projection development (GO:0010975),0.3114643550028718,0.9848774091523732,0.4972436604189636,0.8347030621326845,1.0,32/163,14.06%,TRPV4;STMN2;RAPGEF2;TANC2;RAPGEF1;FKBP4;DAB2IP;PRKD1;SERPINI1;FES;FBXO7;PDLIM5;SHANK3;CAMSAP2;SETX;LRRK2;PTPRO;TENM3;LRRC4C;SCN1B;PPFIA2;CCDC88A;CDH2;SPOCK1;DCC;CSMD3;MARK2;CTNNA2;TSKU;LTK;CFL1;EFHC2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.47009117160266073,0.9847892602788262,0.49,0.8343917426208639,1.0,5/10,22.04%,UBA52;RPS27A;TUT7;UBB;DIS3L2
prerank,tRNA aminoacylation (GO:0043039),0.37309395497393644,0.9844848735367715,0.47928176795580113,0.8345532499752697,1.0,10/37,19.48%,GARS1;VARS1;KARS1;FARSB;WARS1;FARS2;GATB;RARS1;EEF1E1;DARS1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.45574101812489104,0.9844512145444616,0.511437908496732,0.8340933373269013,1.0,4/13,10.53%,ZC3H12A;PRR5L;CNOT1;GTPBP1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.41310614297501436,-0.9833841881518242,0.4867469879518072,0.8338793287984737,1.0,4/12,3.47%,DOCK5;IGFBP5;DOCK7;TPM1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3956559663960213,0.982914345907998,0.461864406779661,0.8370256102207021,1.0,4/25,9.23%,VCAM1;IZUMO1;CD200;DSP
prerank,neurotransmitter transport (GO:0006836),0.34040861765563635,0.9823942406154124,0.5006060606060606,0.837632460864476,1.0,22/73,21.06%,UNC13B;APBA1;SYN3;GLS2;GLS;SLC6A4;PPFIA2;SLC6A2;PDZD11;SLC1A1;GABRA2;SLC1A2;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYNJ1;SYT1;SLC1A6;NRXN1;SLC29A4
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.45619477835049527,0.9823408986768034,0.49760765550239233,0.8372360672297026,1.0,2/12,6.71%,PTPN14;UHMK1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4445971238812246,0.9821685540660859,0.4865293185419968,0.8370912902011398,1.0,4/15,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2970679615628591,-0.9811740174410624,0.4866920152091255,0.8386955770717877,1.0,13/38,25.44%,PRPF8;COIL;GEMIN5;SMN1;PRPF31;PRPF3;SNRPF;SNUPN;SNRPD3;GEMIN7;CD2BP2;WDR77;SNRPD1
prerank,positive regulation of response to external stimulus (GO:0032103),0.31841372447683736,0.9807783542104277,0.5046082949308756,0.839711014078283,1.0,23/128,13.99%,PDGFB;GBP5;F2RL1;APP;TLR3;PPM1F;PUM2;HYAL2;PDCD4;CD47;CEBPA;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;DHX9;NFKBIA;CYBA;DDT;ABCC1;RIOK3;APOH
prerank,RNA splicing (GO:0008380),-0.24073346850921457,-0.9802134558245088,0.49645390070921985,0.8399788111835216,1.0,32/95,25.44%,NOVA1;SNRNP40;SCAF11;NCBP1;PRPF8;SRRM1;FUS;CDK12;PRPF3;TARDBP;SNRPF;WBP4;SNRPA1;SCNM1;MAGOH;PPP2CA;BCAS2;SNRPD3;MAGOHB;MPHOSPH10;LSM6;DHX8;SF3B1;SRPK2;SRSF11;NCBP2;DHX15;TCERG1;SRSF2;U2AF1;WDR83;SNRPD1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.42432369215524046,0.9797628820440406,0.5061919504643962,0.8414935971289612,1.0,2/19,7.30%,EDN1;PPP3CA
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.4649344698384923,0.9794965471593391,0.5008517887563884,0.8415559804719304,1.0,1/11,1.35%,NR4A2
prerank,regulation of type I interferon production (GO:0032479),0.33304196468352654,0.9794772667199134,0.5042321644498187,0.841060759172986,1.0,16/84,14.25%,IFIH1;LRRFIP1;UBA7;TIRAP;DDX41;RNF125;NLRC5;POLR3B;ACOD1;GAPDH;DHX9;TRIM25;POLA1;IRF5;PIN1;CTNNB1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3197403306036162,-0.9793195456354534,0.47692307692307695,0.8411327525185913,1.0,5/29,4.30%,SNTA1;WNK1;KCNIP3;CD63;SLMAP
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.35133182037076477,0.9791145700875692,0.48544973544973546,0.8413560889569696,1.0,25/51,28.72%,HMBOX1;MAPK1;CCT8;NEK7;STN1;TNKS;CCT2;FBXO4;CCT4;XRN1;ATM;CTNNB1;CCT6A;CTC1;MAPKAPK5;EXOSC10;TERF2;TCP1;CCT3;TINF2;MAP3K4;TNKS2;HNRNPC;SMG5;HNRNPA1
prerank,ureteric bud morphogenesis (GO:0060675),-0.374412905266931,-0.978878759454084,0.4920212765957447,0.8409975584758913,1.0,4/16,11.08%,BMP4;FGF2;SIX1;SALL1
prerank,regulation of cell projection organization (GO:0031344),0.4589592779624681,0.9788684257925889,0.5084459459459459,0.841389852799793,1.0,2/13,10.30%,MACF1;ERMN
prerank,protein K48-linked ubiquitination (GO:0070936),0.3518651843041872,0.9787431422831914,0.5178335535006605,0.8411696951046337,1.0,12/54,14.78%,ZNRF1;KLHL3;CUL3;UBE2D1;UBE3A;RNF115;RBX1;NEDD4L;DTX3L;UBE2T;UBE2E1;UBE2D3
prerank,sensory perception of chemical stimulus (GO:0007606),0.43672641896103503,0.9786824720572159,0.4820261437908497,0.8407538541473143,1.0,2/15,14.01%,GNAL;SLC24A4
prerank,negative regulation of binding (GO:0051100),0.3311929329375732,0.9785897954917001,0.5054945054945055,0.8404299796502551,1.0,20/81,15.64%,PDGFB;CAV1;SUMO3;LEF1;BTAF1;LRRK2;JAK2;CTNNBIP1;ROCK1;JUN;NFKBIA;ACTB;TMBIM6;TTBK1;ITGB1BP1;PIN1;HABP4;NES;RACK1;SLPI
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3744308408467242,0.9783648083016453,0.4860724233983287,0.8404052750557225,1.0,4/35,5.27%,FASN;FAR2;PPT1;FAR1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4600764614605011,0.9781778396081245,0.490787269681742,0.8402989983752062,1.0,2/11,5.76%,ING2;TAF9B
prerank,regulation of lipase activity (GO:0060191),0.44819102043853865,0.9781530648408993,0.4889267461669506,0.8398355836896922,1.0,2/13,5.65%,PCSK5;FURIN
prerank,ncRNA transcription (GO:0098781),0.44161015278914073,0.9781354388349025,0.4796747967479675,0.8393326567412335,1.0,6/13,24.72%,CAVIN1;SPIN1;USPL1;ANG;BRF1;SNAPC3
prerank,antibacterial humoral response (GO:0019731),0.435124667213112,0.9778771329719592,0.48330683624801274,0.8394140788845131,1.0,6/16,24.07%,DEFA6;RNASE6;SLPI;ANG;RPL39;RNASE7
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.39418994926585116,-0.9775439063098363,0.4888888888888889,0.8433290339486821,1.0,6/12,26.90%,NINL;BICD2;KIF3A;CCDC68;CCDC120;CEP19
prerank,regulation of cellular response to stress (GO:0080135),0.3183955840248019,0.9771058356849277,0.5143184421534936,0.8406052232182681,1.0,22/115,16.99%,NUAK1;FKBP4;ING2;CAMK2D;MAPK1;CHCHD2;MBTPS2;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NPM1;NUP153;NUP160;ATM;NUP42;DNAJB6;NUP205;ARMT1;DNAJC7
prerank,stress granule assembly (GO:0034063),-0.3448929826155257,-0.9770221850228907,0.4726775956284153,0.8433951694129026,1.0,6/20,13.48%,YTHDF1;ATXN2;UBAP2L;YTHDF2;DDX3X;PRRC2C
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.4684167822914148,0.9769848044419939,0.5098684210526315,0.8403493810034085,1.0,2/10,5.71%,NOTCH1;TNFRSF1B
prerank,import into cell (GO:0098657),0.3678355430675547,0.9767338882290749,0.508519003931848,0.8403712903574149,1.0,2/41,0.35%,SLC6A6;LRRC8C
prerank,water transport (GO:0006833),0.4524105238030963,0.9766131773474209,0.500805152979066,0.8401165666186172,1.0,1/12,2.23%,AQP11
prerank,mRNA modification (GO:0016556),0.3944373872076009,0.976611238448697,0.4808823529411765,0.8395883141396525,1.0,7/22,17.96%,TRMT61A;DKC1;TRUB1;TRMT61B;VIRMA;METTL14;RPUSD2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.2866805458583465,-0.9765664867879869,0.5145228215767634,0.8433320948073889,1.0,10/46,16.30%,ATP1A2;NLGN2;GRM3;CACNG4;TSHZ3;ATAD1;HOMER1;DRD2;CACNG8;UNC13A
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.28156773214269,-0.9764339134270514,0.4899598393574297,0.8423600944284124,1.0,6/49,8.98%,IGF1;IL31RA;KIT;IL6R;GHR;VEGFA
prerank,regulation of dephosphorylation (GO:0035303),0.43158099402133865,0.9762141781142629,0.48848684210526316,0.8399757839279649,1.0,8/15,28.52%,INPP5K;PPP1R16B;PPP1R16A;SMG7;IGBP1;MTMR2;MTMR9;SMG5
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.2632518411385258,-0.9752824846613286,0.4954954954954955,0.8441142454736486,1.0,17/63,15.30%,LEPR;NUPR1;BCL2;KLHL22;GOLGA2;TIMP2;PTPN3;PTPN22;TAB3;GPLD1;DAPL1;MET;FOXK2;KDM4A;SIRT2;MFSD2A;ATRAID
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4541422846330638,0.974724489926895,0.46991869918699186,0.84277990201142,1.0,8/12,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,entry into host (GO:0044409),-0.3840517658499401,-0.9745365953016891,0.4923469387755102,0.8448372150986566,1.0,5/13,10.95%,ITGAV;CDH1;SRC;PPIA;MET
prerank,negative regulation of microtubule polymerization (GO:0031115),0.45219326147558525,0.9744551975253366,0.4865771812080537,0.8428555111365931,1.0,1/12,0.60%,STMN2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3839682814510729,0.97437249764394,0.49277456647398843,0.8424875436944785,1.0,9/29,21.18%,SMAD7;FBXW7;DTX3L;PIN1;BMI1;TRIB3;FEM1A;ARRDC4;DCUN1D2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3812338123401354,0.9743415148461585,0.48106591865357645,0.8420320443299694,1.0,4/34,5.16%,NOD2;F2RL1;TRIM6;GPI
prerank,RNA biosynthetic process (GO:0032774),-0.3024231609075456,-0.9737640977574925,0.4794520547945205,0.8456026771806684,1.0,10/31,15.81%,RSF1;TAF4;SMN1;HELB;SMARCA5;TTF1;GTF2B;TERT;TAF7;TAF5
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2749927635873753,-0.9737058438727678,0.4883720930232558,0.8444560377394961,1.0,6/52,4.18%,CELF2;DDX5;NOVA1;FXR2;RBMX;DDX17
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.44082409968859476,0.9735648158695122,0.5124792013311148,0.8432217016046422,1.0,1/14,1.84%,PAEP
prerank,tRNA methylation (GO:0030488),0.379637014118262,0.9733671123694476,0.4872881355932203,0.8431268409419835,1.0,7/34,11.54%,TRDMT1;TRMT61A;TRMT5;METTL2A;METTL2B;ALKBH8;TRMT61B
prerank,positive regulation of neuron death (GO:1901216),0.35846297380965214,0.9732711937834788,0.5186170212765957,0.842805791219519,1.0,13/46,16.68%,FYN;TGFB2;FCGR2B;ITGAM;GRIN2B;EGR1;PRNP;TYROBP;CLU;CTNNB1;SARM1;EIF2S1;DAXX
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3366996386424419,0.9729260217126757,0.5114213197969543,0.8430310206978052,1.0,11/66,11.55%,PLCB1;CCND2;FAM107A;CCND3;KLF4;ADAM17;RBL1;APC;KMT2E;ADAMTS1;E2F7
prerank,vesicle transport along microtubule (GO:0047496),-0.3374539542435495,-0.9726920014613274,0.47058823529411764,0.8459717521086076,1.0,9/23,23.50%,TRAK1;NDE1;KIF13A;NDEL1;KIF3A;FBXW11;CLN3;KIF5B;KIF1C
prerank,protein-containing complex disassembly (GO:0032984),0.34831076234673525,0.9723975974028407,0.503382949932341,0.8436695951004884,1.0,12/54,14.36%,CAV1;VTI1B;GABARAPL1;TECPR1;VAMP8;APC;VAMP7;LIX1;VPS4A;CHMP3;CTNNB1;MAP1LC3A
prerank,cellular defense response (GO:0006968),-0.2876019929185365,-0.9723253237278241,0.48363636363636364,0.845648678849539,1.0,5/40,8.08%,DCDC2;LBP;LSP1;CCR9;TCIRG1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.414739212363645,0.972324018728605,0.4937694704049844,0.8432937799860505,1.0,3/17,8.29%,PDE3B;ALK;PRKAA1
prerank,receptor signaling pathway via STAT (GO:0097696),0.39616062202973906,0.971539418713787,0.5036927621861153,0.8445408140696389,1.0,6/25,8.46%,IFNAR1;SOCS6;STAT1;THPO;JAK2;NMI
prerank,protein methylation (GO:0006479),-0.2934858463945092,-0.9713481421776297,0.5346938775510204,0.8468512132732072,1.0,10/40,18.20%,NSD3;NSD1;EHMT1;GSPT1;METTL21A;FAM98B;EEF1AKMT1;N6AMT1;EEF1AKMT2;SNRPD3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.32155324209087277,-0.9710945811687434,0.4748427672955975,0.8462363448858624,1.0,4/24,5.15%,SULF1;CCBE1;SULF2;RORA
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4545129597264498,0.9710092713094061,0.4894991922455573,0.8452341097457433,1.0,2/12,4.67%,LY6E;TRIM11
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.301243070713659,0.9709442844543269,0.5311510031678986,0.8448484393576933,1.0,50/248,14.81%,DKK2;SOX17;SOX13;CCDC88C;FZD6;CCNY;GNAQ;TMEM88;DAB2IP;CDK14;CAV1;HHEX;LGR5;PSMD13;WWTR1;CSNK1D;CUL3;PSMD4;SHISA6;LRRK2;PTPRU;PTPRO;CDH3;APC;SNAI2;MCC;CSNK1G3;IGFBP4;AMER3;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;NKD2;TNKS;PSMB8;PSMD14;PSMA7;PSMC3;PIN1;ADGRA2;PSMA8;PSMC1;PSMB5;CTNNB1;MLLT3;PSMC5;FZD9
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3475368820932985,0.970880113792249,0.4974937343358396,0.8444600626933039,1.0,24/61,22.44%,AZIN1;CAV1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NCOR2;NQO1
prerank,regulation of presynapse assembly (GO:1905606),-0.34892592944754874,-0.9708472235757062,0.4919786096256685,0.8443072561389592,1.0,1/18,0.01%,GPC6
prerank,regulation of presynapse organization (GO:0099174),-0.34892592944754874,-0.9708472235757062,0.4919786096256685,0.8443072561389592,1.0,1/18,0.01%,GPC6
prerank,cellular protein localization (GO:0034613),0.2982966394124203,0.9707592740436856,0.5555555555555556,0.8442061286435415,1.0,54/285,14.48%,FBLN5;RABGAP1;OCLN;TRAPPC8;ARHGEF2;RAB6B;HERC2;EMP2;ID1;ESAM;HHEX;HEY2;STX7;TBC1D30;SCG5;EHD1;SGSM1;ANGPT1;TBC1D8;TMED10;PACSIN1;RAB23;CEP68;RAB3GAP2;LRRK2;TBC1D12;PTPRU;TLK1;TBC1D5;STX12;TBC1D1;ARF3;RRAGD;TM9SF1;REEP1;LAPTM5;NPM1;VPS35;TMED9;SMURF1;RAB19;STX19;TM9SF3;YWHAH;USP6NL;TBC1D10A;WDR11;TBC1D4;STXBP3;MESD;TBC1D9;NSF;CTNNB1;TMED4
prerank,membrane raft organization (GO:0031579),0.4319295184425188,0.9707252996306303,0.4952978056426332,0.8437421460622578,1.0,2/15,3.24%,EMP2;PPT1
prerank,mitotic cell cycle phase transition (GO:0044772),0.30203025251229787,0.9706520766363191,0.532620320855615,0.8433889603689543,1.0,45/203,21.20%,PLCB1;CCNY;PLK3;CCND2;CCND3;CDK14;ACVR1;CCNE1;TUBB;CSNK1D;CDC25C;CUL3;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;CLASP2;CUL2;DYNLL1;CEP76;USP29;ARPP19;HINFP;RPS6KB1;TUBA1A;CDC27;NES;CHMP7;CDKN2D;ANAPC7;CACUL1;E2F3;FBXL6;FBXL15;ACTR1A;PPME1;CEP192;MAX;LCMT1;DYNC1I2;MNAT1;BCAT1
prerank,neuron migration (GO:0001764),0.34906777205496253,0.9699529136840856,0.4821192052980132,0.8444108046722942,1.0,9/48,12.15%,RAPGEF2;CEP85L;NR4A2;MEF2C;NRCAM;RAC1;SPOCK1;NAV1;MARK2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.41913789845817917,0.9698983199029654,0.5,0.8440105580225462,1.0,2/17,3.52%,SMAD7;INPP5K
prerank,negative regulation of interleukin-10 production (GO:0032693),0.42032767772855556,0.9695356941513664,0.5032894736842105,0.8443077371067864,1.0,5/16,23.33%,FCGR2B;TYROBP;VSIR;AGER;DLL1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.40530816009692444,0.9694863499393649,0.5212922173274597,0.8438851789077232,1.0,6/23,21.74%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3;ABHD4
prerank,postsynaptic membrane organization (GO:0001941),-0.3595249222687159,-0.9693330799692474,0.5363408521303258,0.8471788654599459,1.0,5/17,8.95%,APOE;DLG4;NLGN2;DNAJA3;LRRC4
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3811555836282585,0.9692248801858988,0.48462664714494874,0.8439559746539503,1.0,5/32,6.44%,ADIPOR2;CEACAM1;APOA1;SIRT4;ADIPOR1
prerank,positive regulation of gene expression (GO:0010628),0.29204352013629864,0.9690673624340528,0.569838056680162,0.8437423422091522,1.0,74/442,13.64%,PLCG2;NOS3;CLDN5;GATA2;PDGFB;CRTAM;OCLN;NOTCH1;HEY1;IFNGR1;TNRC6C;LGALS9;VIM;CADM1;DLL4;APP;HEY2;TLR3;NOS1AP;MED26;KLF4;PPM1F;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;TAF1A;WARS1;IL1A;MAPK1;SETX;P2RX7;ZC3H12A;PLD1;ELAVL1;HSPA1B;TENT4A;PLSCR1;MYO1C;CDH3;NFE2L2;PRKAA1;PASK;ACTG1;GAPDH;ELAVL4;ROCK1;STAP1;POLR1F;EGR1;TYROBP;LURAP1;AGO4;VSIR;METTL5;ACTB;NPM1;EEF2;NWD1;VPS35;BRCA1;VSTM2A;CLU;HINFP;PIK3CB;TTBK1;RPS6KB1;FXR1;METTL14;HABP4;HIF1A;DDX21
prerank,neuropeptide signaling pathway (GO:0007218),0.3474343268945449,0.9689088991208833,0.515748031496063,0.8435587884358252,1.0,14/58,23.17%,RAPGEF2;HCRTR1;GAL;NXPH2;NMU;GLRA2;GPR149;PENK;SORCS1;SORT1;HCRTR2;SORL1;PDYN;NTS
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.30080895073954345,-0.9688688984262045,0.46226415094339623,0.8471583317909706,1.0,5/32,6.78%,AUTS2;PLCE1;RREB1;PIK3R1;SRC
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33105861577541373,0.9679647472559095,0.5153751537515375,0.8451744546674719,1.0,11/75,13.83%,EDN1;RGS3;PLCB1;GIT2;MRAP2;NMT1;ROCK1;GNG4;KCTD8;METAP2;RGS12
prerank,protein localization to Golgi apparatus (GO:0034067),0.3861580510692424,0.9678956096390944,0.5014792899408284,0.8448071551326496,1.0,5/27,9.54%,GBP5;CSNK1D;TMED10;VPS13D;RIPOR1
prerank,glycosphingolipid metabolic process (GO:0006687),0.3590110647990775,0.9674512986497699,0.5066137566137566,0.8452804414795564,1.0,5/42,9.87%,ST6GALNAC3;ESYT2;GLTP;A4GALT;B4GALT6
prerank,regulation of cartilage development (GO:0061035),0.4124981258800879,0.9670009599489156,0.49614791987673346,0.8457335237381467,1.0,4/18,12.21%,BMPR2;MBOAT2;ZBTB16;SOX6
prerank,triglyceride metabolic process (GO:0006641),-0.2766797177502007,-0.9667299429130489,0.515748031496063,0.8514996996263235,1.0,6/48,9.81%,AGMO;LPGAT1;APOE;MOGAT3;GK;DGAT1
prerank,GPI anchor metabolic process (GO:0006505),-0.3176161828192118,-0.9666721260555712,0.5142857142857142,0.8503673750746067,1.0,14/26,26.51%,GPLD1;PIGA;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PGAP4;PIGZ;PGAP3;PIGL;PIGW
prerank,cellular protein catabolic process (GO:0044257),0.34055917149148135,0.9666582155784823,0.504424778761062,0.8459805393458696,1.0,17/59,21.06%,DENND3;DAB2IP;CASP8;AP2B1;AP2M1;SIAH2;RSPRY1;BNIP3L;VLDLR;BNIP3;CTSK;CTSO;MALT1;PISD;RNF5;CTSH;RAB12
prerank,acidic amino acid transport (GO:0015800),0.43190789131105195,0.9660861435838716,0.5031152647975078,0.8467738584129532,1.0,2/17,2.39%,SLC6A6;ARL6IP5
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4485476980718121,0.9654914186440654,0.5117004680187207,0.8476205014803758,1.0,5/13,25.31%,DUSP1;NDC80;LCMT1;GEN1;TPR
prerank,cranial nerve development (GO:0021545),-0.3941687574444417,-0.964735406615514,0.4793187347931874,0.8541798974400997,1.0,7/11,44.25%,SALL1;PAX2;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.44187473874763505,0.9645835626369635,0.5117004680187207,0.8491382495894931,1.0,3/14,17.63%,DAB2IP;PTPN1;COPS5
prerank,regulation of mast cell activation (GO:0033003),0.4638810523627035,0.9645154127357287,0.5296108291032149,0.8487757611659834,1.0,2/10,7.88%,MILR1;PLSCR1
prerank,nucleotide metabolic process (GO:0009117),-0.33662277384337885,-0.9644882752362504,0.5235294117647059,0.8535686908351501,1.0,10/23,19.85%,NMNAT2;FHIT;ME1;ENPP3;AK5;PNP;CMPK2;CTPS2;AK1;NME2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3792243241675941,0.9641765894422173,0.5036603221083455,0.849007513049427,1.0,9/28,19.74%,DAB2IP;CASP8;CRADD;DELE1;CASP8AP2;DAXX;DDX47;BID;SORT1
prerank,regulation of viral genome replication (GO:0045069),0.34179462634969643,0.9639574180764978,0.5018963337547409,0.84897628429677,1.0,17/56,20.97%,ADARB1;IFIH1;TRIM6;PPIE;PLSCR1;OAS2;ADAR;PPIH;SLPI;PKN2;RSAD2;SRPK1;IFITM3;PPID;ZC3HAV1;EIF2AK2;BANF1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3822338705203466,0.9638033052071446,0.48625180897250364,0.8488002935902291,1.0,6/29,20.04%,SYCP2;RAD21;MEI4;BAG6;TERB1;PRDM9
prerank,regulation of lamellipodium assembly (GO:0010591),-0.300368329761909,-0.963296277259347,0.5102040816326531,0.8553992259380507,1.0,7/34,13.50%,AUTS2;PLCE1;SLIT2;PIK3R1;CAPZB;ACTR2;FER
prerank,cellular response to starvation (GO:0009267),0.3069327992985472,0.9628793858334147,0.5447427293064877,0.8503969153803874,1.0,18/147,10.04%,NUAK1;BMPR2;FAS;CASTOR1;FOXO1;PRKD1;STK24;DAP;GABARAPL1;MAPK1;ZC3H12A;SIK2;WDR59;LRRK2;PRKAA1;PIK3C3;RIPOR1;RRAGD
prerank,cellular response to insulin stimulus (GO:0032869),0.3157559679427967,0.9628287148189044,0.5284738041002278,0.8499769215575348,1.0,16/124,8.51%,CEACAM1;FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;HDAC9;INPP5K;PDE3B;BCAR3;PCK2;SLC25A33;SYAP1;APC;NAMPT
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.24860479494958293,-0.9626673817367869,0.503030303030303,0.8558720814132629,1.0,23/80,19.43%,SAMD4A;ROCK2;SLC2A13;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;SIRT3;CASP3;ERBB2;PCIF1;LARP4B;DDX3X;BCL3;EIF3D;CPEB3;RPS4X;EIF3E;PLA2G6;PRKCD;LARP6;UPF3B
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3322966935669988,0.9623068103103559,0.5281173594132029,0.8505905354466722,1.0,15/74,11.14%,SMAD7;DAB2IP;TGFB2;IL17RD;WWTR1;LEF1;GCNT2;EFNA1;SMAD2;GATA3;ADIPOR1;CLASP1;MAD2L2;CLASP2;MCRIP1
prerank,cellular response to radiation (GO:0071478),0.3641314876509043,0.9620988725120903,0.5210084033613446,0.8505546556650417,1.0,12/40,21.62%,RHOB;RRH;NSMCE3;SPIDR;RAD1;RAD9B;KDM4D;MAPK14;EEF1D;HUS1;BLM;ECT2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.34051409683945977,0.9618339733229995,0.5453400503778337,0.8506361854897125,1.0,23/64,24.60%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;EAF2;GTF2H3;MLLT3;ELOF1;NELFB;POLR2I;AFF4;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3198269800623006,-0.961681206243981,0.4984709480122324,0.8572309845801663,1.0,7/25,15.60%,SCAF8;LDB1;CCNK;ELL;THOC1;HMGN1;HTATSF1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3241280639790496,0.9613143897221819,0.527027027027027,0.8512633078035398,1.0,12/83,12.94%,CDK17;PLK3;CDK14;ACVR1;CCNE1;CUL3;KLF11;CUL2;POLA1;USP29;HINFP;RPS6KB1
prerank,regulation of astrocyte differentiation (GO:0048710),0.45413047650926186,0.9612206170276468,0.5049668874172185,0.8509355954663201,1.0,1/12,1.60%,NOTCH1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.39474879195551105,-0.9612131583940532,0.5298507462686567,0.8571229477501644,1.0,3/11,16.15%,C1QTNF3;SIK1;CLK2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.40835257364022365,-0.9611369473498981,0.5361596009975063,0.856041947793441,1.0,2/10,16.86%,RPS6KA6;TFAP4
prerank,androgen metabolic process (GO:0008209),-0.3554282965910647,-0.9609096187167465,0.5168539325842697,0.8553552378853083,1.0,15/18,54.17%,SPP1;SRD5A1;HSD17B10;HSD17B11;SRD5A3;SHH;HSD17B7;SRD5A2;HSD3B2;CYP19A1;MED1;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4541772196202294,0.9606721448296685,0.5016393442622951,0.8516018521279185,1.0,4/12,13.01%,KLF2;CNOT1;CTBP2;CYP26C1
prerank,cellular response to purine-containing compound (GO:0071415),0.4563969530726654,0.960630637385106,0.5166374781085814,0.851181050425929,1.0,4/10,23.13%,SLC8A1;TRPM2;P2RY1;RYR2
prerank,response to nutrient levels (GO:0031667),0.41458366756750337,0.9605308600214499,0.5253968253968254,0.8508846535831088,1.0,7/17,27.00%,FAM107A;PRKAA1;RPS6KB1;EIF4G1;MEAK7;RPTOR;ULK1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.392243126423789,-0.9600323406608843,0.5096153846153846,0.856442130299802,1.0,2/12,6.03%,ANK2;UBASH3B
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.30724398616239723,-0.9597718825669553,0.5228070175438596,0.8558579550561685,1.0,5/30,10.20%,OGT;FHIT;MAP1A;TRIM39;SDCBP
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2390739601096836,-0.9595986132233356,0.5957446808510638,0.8549785038885839,1.0,30/101,19.68%,SAMD4A;OGT;CYFIP2;THBS1;FXR2;NIBAN1;DACT1;PLXNB2;YTHDF1;IST1;ERBB2;PCIF1;LARP4B;DDX3X;BCL3;EIF3D;CPEB3;AGTR1;ATG7;RPS4X;NR1H3;EIF3E;AMER1;STUB1;FBXW11;EZR;LARP6;UPF3B;FGFR4;INHBA
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3335920475577006,-0.9595524567679329,0.49107142857142855,0.8538223732923195,1.0,9/22,23.09%,DMD;AHNAK;CACNB1;CACNB2;DRD2;PDE4B;CACNB3;STAC3;CBARP
prerank,proteasomal protein catabolic process (GO:0010498),0.2989869432342978,0.9589451056398706,0.5605573419078242,0.8538326851982774,1.0,56/201,20.43%,ZNRF1;PSMD13;RHBDD1;RNF185;CUL3;PSMD4;KLHL20;SOCS6;ARRB1;WWP1;FEM1C;NFE2L2;NR1D1;PPP2R5C;PSMA5;FBXW7;RBX1;PSMB10;SIAH2;ENC1;NEDD4L;BAG6;PSMB8;PSMD14;SMURF1;KCTD10;RMND5B;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;CTNNB1;PSMC5;TRIM2;NHLRC1;UBE2D3;PSMB9;SPOPL;PSMC6;RNF139;UBXN6;SEL1L;PSMA4;CCDC47;GSK3A;PSMD5;PSMD9;PSMB6;FBXO45;ZFAND2A;MAEA;RNF5;KCTD2;RNF34;PSMB2
prerank,prostaglandin biosynthetic process (GO:0001516),0.4116686825260556,0.9584500749632017,0.49522292993630573,0.8543799074004289,1.0,1/18,0.47%,EDN1
prerank,negative regulation of phosphatase activity (GO:0010923),0.38848641445832177,0.9581780011990686,0.5092724679029957,0.8544443176170693,1.0,4/25,6.45%,TGFB2;FKBP1A;ZCCHC9;GPATCH2
prerank,intracellular protein transport (GO:0006886),-0.2103155917301385,-0.9580889805669884,0.6666666666666666,0.8564547583776899,1.0,79/304,18.40%,RANBP3L;WLS;APPL2;STX4;SGSM2;GGA2;TRAK1;TBC1D2B;SNX6;VPS26B;UNC93B1;SIL1;COPZ2;TBC1D9B;NUP107;COPA;C2CD5;SURF4;VIPAS39;CLIP3;VPS45;LMAN1;SEC31A;HEATR3;KIF13B;ARF1;CSE1L;GRTP1;PPP1R10;ARCN1;STX3;KIF13A;COPB2;NUP155;ADPRH;RAB22A;COX18;TBC1D16;TNPO3;ARF5;ARL6;EIF2D;RABGAP1L;RANBP6;STX5;ARL4A;SNX1;TMED3;HOMER3;PKD1;VPS33A;STX16;IPO5;TBC1D17;FAM53C;SAR1A;BAG3;HDAC6;NUP93;SNX8;NAPA;TRIM23;HPS4;TNPO2;IFT27;SEC16A;RANBP17;GGA1;STX17;ARL5A;TMED1;RANBP3;TSC2;GABARAP;CD74;PHB2;VPS33B;RAB29;AP1S3
prerank,gliogenesis (GO:0042063),0.4281410240705151,0.9580522396201732,0.5204402515723271,0.8542090577504454,1.0,4/15,14.36%,TGFB2;CDH2;METTL14;CD9
prerank,ribosome assembly (GO:0042255),0.3506537968160723,0.957866506189813,0.5071335927367056,0.8540707704987954,1.0,18/47,25.03%,BOP1;DHX37;RPS14;RPS28;NPM1;RPS5;RPL23A;RPS15;EIF6;EIF2A;EFL1;PWP2;RSL24D1;RPS19;NOP53;RPF2;RPL3;MDN1
prerank,regulation of T cell activation (GO:0050863),0.36025104682070486,0.9576045965350417,0.5082191780821917,0.854143355862031,1.0,5/42,11.23%,CRTAM;TNFRSF1B;CD47;DUSP3;LAPTM5
prerank,potassium ion homeostasis (GO:0055075),0.4011562177148509,0.9575964872243184,0.5306427503736921,0.8536345948091868,1.0,4/23,3.90%,ATP1A4;ATP1A1;ATP1A3;SLC12A8
prerank,neuromuscular junction development (GO:0007528),0.3899407125646037,0.9575083003311166,0.5439642324888226,0.8533057714024029,1.0,5/24,7.14%,UNC13B;AGRN;PPFIBP1;GPHN;LRRK2
prerank,regulation of autophagy (GO:0010506),0.2992313863727538,0.957037415440744,0.5765957446808511,0.8538130117851066,1.0,56/216,20.83%,ACER2;RASIP1;TRIM14;FBXL2;DRAM1;FOXO1;PRKD1;PIK3C2A;ATG101;GPR137B;TRIM6;DAP;SMCR8;SH3BP4;DEPP1;IRGM;ZC3H12A;LRRK2;HSPB1;PRKAA1;GAPDH;ROCK1;HMGB1;FBXW7;RRAGD;EXOC8;TPCN2;TAB2;VPS35;TRIM8;DRAM2;PIK3CB;KEAP1;ATM;BNIP3;RHEB;RUBCN;UBQLN2;VDAC1;RMC1;TRIB3;ATP6V1G1;BMF;GSK3A;EXOC4;ATP6V1C1;CAPN1;RRAGA;ERN1;MCL1;ATP6V0A1;RRAGC;GSK3B;LAMTOR3;ATP6V1D;MID2
prerank,negative regulation of coagulation (GO:0050819),0.4280790786464784,0.957014770678501,0.5280373831775701,0.8533439432550362,1.0,5/14,13.99%,EDN1;CD34;PROC;HS3ST5;APOH
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3189377436114368,-0.9565678162445244,0.5248447204968945,0.8591295601888393,1.0,8/26,12.82%,ERRFI1;CBLB;SHC1;SNX6;TGFA;TSG101;ADRA2A;HBEGF
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4649353877690013,0.9560479730419793,0.5159663865546219,0.854937493826271,1.0,3/10,9.11%,F2RL1;ANO6;STAP1
prerank,mRNA methylation (GO:0080009),0.41935104658666805,0.9559012272541378,0.5167464114832536,0.8547366229195041,1.0,4/15,13.27%,TRMT61A;TRMT61B;VIRMA;METTL14
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.40879151549068177,0.9556753377337336,0.5159817351598174,0.8547060727994957,1.0,10/19,27.97%,CEBPA;BRF2;ICE1;TENM1;ZC3H8;POLR3C;DHX36;RPTOR;PRDX5;ICE2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.29503957852343066,-0.955641837960187,0.51985559566787,0.8603215731776616,1.0,11/35,17.12%,PPARGC1B;DDX5;ZMIZ1;DDX17;SRC;CALCOCO1;PADI2;SAFB;TADA3;GPER1;AR
prerank,regulation of intracellular transport (GO:0032386),0.3644500598274884,0.9554225270527118,0.5283540802213001,0.8547555829241443,1.0,10/38,18.42%,MYBPC3;LRRK2;NEFH;PTPN1;NUMA1;INPP5F;LCP1;MAP2;RNF139;HAP1
prerank,positive regulation of cell growth (GO:0030307),0.3187709686367465,0.9551319208209007,0.5330188679245284,0.8548812868518366,1.0,24/96,18.71%,EDN1;MACF1;ITSN2;TGFB2;NTN1;SHTN1;SEMA7A;BRAT1;TAF9B;ADAM17;SLC25A33;ISLR2;ADAM10;RPS6KA1;NEDD4L;SMURF1;RPS6KA3;RASAL1;EXOSC9;ADNP2;SYT1;SYT2;CDKN2AIP;H3-3A
prerank,fatty acid elongation (GO:0030497),0.4466244962843138,0.9550587425150051,0.4788273615635179,0.8545006444295237,1.0,6/13,19.38%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,cilium organization (GO:0044782),0.2979644836134513,0.9549281649759404,0.5686900958466453,0.8542566898483934,1.0,24/209,10.78%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;TEKT5;TTC29;EHD1;FAM161A;TTBK2;TTC36;FNBP1L;BBS7;SNX10;RAB23;TMEM216;IFT140;CFAP43;PCM1;CFAP52;CDC14A;DYNLL1;EXOC8
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3972664691022533,-0.9538186733899439,0.5104408352668214,0.8638843537454579,1.0,4/10,19.56%,SH3RF1;RUNX1;NCKAP1L;ZBTB7B
prerank,sulfur compound transport (GO:0072348),0.3817348034957664,0.9538001704167326,0.5205882352941177,0.85627667461795,1.0,1/27,0.19%,SLC6A6
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.31226037717360644,-0.9535636383124912,0.5080906148867314,0.8632980765393277,1.0,4/26,5.15%,SULF1;CCBE1;SULF2;RORA
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.43197516606073716,0.9531926093540923,0.521079258010118,0.857121630641249,1.0,1/13,0.28%,KCNQ1
prerank,positive regulation of insulin secretion (GO:0032024),0.3676599213059948,0.9530584067216997,0.5147058823529411,0.8568833242829412,1.0,3/36,5.83%,MYRIP;DOC2B;GLUD1
prerank,transition metal ion transport (GO:0000041),0.36732540465078856,0.9516743806085829,0.5304101838755304,0.8594026744357662,1.0,10/35,17.78%,ATOX1;ATP2C1;ATP7A;SLC31A1;SLC30A1;TRPC7;CP;TRPC5;HEPH;ATP7B
prerank,glycerophospholipid catabolic process (GO:0046475),0.3853378194349458,0.9515030433393676,0.5403458213256485,0.8592429039831402,1.0,5/27,11.65%,GPCPD1;PNPLA6;GDPD1;ENPP6;INPP5F
prerank,fatty acid transport (GO:0015908),-0.3506214158421419,-0.951389526062788,0.5350140056022409,0.8677548929416671,1.0,5/17,15.02%,ACSL1;APOE;SLC27A1;PPARG;MFSD2A
prerank,regulation of muscle cell differentiation (GO:0051147),0.37086844067424546,0.9513130823440528,0.5167883211678832,0.8591388522561735,1.0,11/31,18.66%,HDAC9;MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.2773998282125475,-0.9509237405271154,0.5430711610486891,0.867704647148159,1.0,7/41,14.03%,PRKAG2;OGT;LACC1;NUP107;NUP155;AAAS;NUP93
prerank,regulation of fibroblast proliferation (GO:0048145),-0.276224164191743,-0.9502616250454398,0.5180722891566265,0.8681169372627943,1.0,16/45,21.65%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6;PEX2;SPHK1;CD300A;CDKN1A;NLRC3;CD74;MORC3;NF1;AGT;E2F1;CDK4
prerank,eye photoreceptor cell development (GO:0042462),-0.36256823090193946,-0.9497477730140136,0.5083532219570406,0.8681487039398015,1.0,8/15,41.57%,VEGFA;TOPORS;TULP1;RPGRIP1L;THY1;BBS4;CRB2;NRL
prerank,homocysteine metabolic process (GO:0050667),0.44308160997793394,0.9489544111533136,0.5129533678756477,0.8638311768365006,1.0,1/11,2.88%,TST
prerank,gene expression (GO:0010467),0.28873714705648396,0.9487457279717767,0.6251276813074566,0.8637300113310765,1.0,122/348,26.42%,NR4A2;ADARB1;RBPMS;HHEX;RPS21;RPL27;TSPAN14;DDX39A;RPL7;TSPAN32;FARSB;WARS1;MRPL18;SETX;CPSF1;MRPL41;POLR2G;RPS14;RPS27A;RPL35;ADAR;ELAVL4;MLF1;NUP54;RPL21;DKC1;DUSP11;NFKBIB;POLR2D;RPL37;RPS28;RPL34;HNRNPK;MRPL36;MRPL52;NUP35;RPS9;XRN2;RANBP2;FIP1L1;RPLP2;MRPL23;RPS25;CHTOP;RPL30;SRSF9;RPS5;NUP153;RPL27A;NUP160;MRPL24;MRPL32;MRPS12;TAF1B;RPL23A;THOC3;NUP42;ATXN1;RPS15;PRPF4;RPL19;RPS18;RPL32;POLR2I;DHX38;NUP205;DROSHA;PWP1;RPL37A;RPL18A;POLDIP3;MMS19;MRPS18B;COPS5;DDX39B;HOXD3;GOLPH3;MEF2A;HNRNPUL1;LMF2;PTMA;DARS1;SMG7;RRAGC;SYNCRIP;YTHDC1;CPSF3;MRPL11;RSL24D1;SORL1;RPL18;RPL39;RPS19;NUP50;RPL31;RPS8;POLR2C;PAX8;EIF4G1;POLR2B;POLR2J;MRPL34;EIF4EBP2;RPL3;RAE1;TESC;ALYREF;SEH1L;THOC5;RPL28;TPR;WDR33;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;HNRNPF;SYMPK;MRPS18C;MRPL27
prerank,sodium ion transmembrane transport (GO:0035725),0.3196516201119543,0.9484711119738546,0.5397796817625459,0.8638063234785551,1.0,13/84,9.99%,SLC6A6;ATP1A4;ATP1A1;ATP1A3;SLC8A1;ANO6;SCN11A;SLC6A4;SCN1B;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.40157914613355994,0.9483765457655514,0.5352323838080959,0.8634757358389579,1.0,9/20,22.60%,PLSCR1;PTDSS1;GSS;GAMT;GATM;CHAC2;MTHFS;GGCT;GCLM
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4590643695728821,0.9482527188955607,0.5190713101160862,0.863221202412155,1.0,5/11,16.01%,ZC3H12A;BCL2L1;FZD3;DFFA;PTGIS
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.391163788621693,0.9477633050897578,0.5,0.8637955882953767,1.0,6/24,16.23%,FYN;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.39236594362863003,0.9474296575110955,0.5054773082942097,0.8640055987075268,1.0,7/20,20.25%,FAS;CASP2;BCL2L1;DCC;GSK3A;MCL1;GSK3B
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2974687864257709,0.946861197135709,0.557628979143798,0.8647163405344367,1.0,18/150,7.53%,ENG;SMAD6;CEACAM1;CNKSR3;SMAD7;OCLN;GNAQ;DAB2IP;CAV1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;ZC3H12A;LRRK2;HSPB1;PRR5L
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3258682997439005,-0.9467621767973666,0.5531914893617021,0.8747369323650773,1.0,9/22,22.28%,ANK2;CALM2;ATP1B1;GSTM2;JPH2;SLC9A1;P2RY6;STAC3;GSTO1
prerank,response to glucocorticoid (GO:0051384),-0.30673482025957477,-0.9466033710087458,0.5641025641025641,0.8738381912583002,1.0,8/26,19.02%,SLIT2;ANXA1;ADAM9;REST;UBE2L3;GOT1;HNRNPU;ZFP36
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.438206661995713,0.9465048294826939,0.5130293159609121,0.8649599008937944,1.0,4/13,15.49%,LRRK2;PDE8A;NFE2L2;RACK1
prerank,generation of neurons (GO:0048699),0.2938968528761199,0.9464701742937255,0.575240128068303,0.8645120782417746,1.0,32/190,16.89%,RAPGEF2;CEP85L;NR4A2;NEUROG2;ATP2B2;EML1;HEY1;OLIG2;TGFB2;TAFA1;HEY2;MEF2C;MYEF2;PRUNE1;NGRN;NRCAM;RAC1;SPOCK1;NAV1;MARK2;CX3CR1;PIN1;POU3F2;MYT1L;HES3;CTNNB1;HMGB2;FZD3;ASTN1;SNPH;OPHN1;LRP12
prerank,COPII-coated vesicle budding (GO:0090114),-0.2562717328150134,-0.94635722573717,0.5781990521327014,0.8731881874579167,1.0,35/68,29.48%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;SAR1A;TRAPPC3;VAPB;NAPA;SEC16A;CTSC;F5;SCAP;SEC23B;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8;SEC31B;GORASP1;TRAPPC2L;PPP6R3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4400623577974895,0.9463097591291768,0.5331125827814569,0.8643565085632653,1.0,3/13,3.97%,PLXNA4;SEMA3F;PLXND1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.39514884141592693,-0.9462545889329442,0.5121359223300971,0.8721785272770537,1.0,3/10,8.66%,APOE;ABCA1;PRKACA
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.33945193326889606,0.9462142753670647,0.5598958333333334,0.8640216727279839,1.0,9/55,8.72%,FAS;DAB2IP;CAV1;TNFSF10;HYAL2;BBC3;CRADD;BCL2L1;TPD52L1
prerank,organic anion transport (GO:0015711),0.32495463662036217,0.9459053620775898,0.5432692307692307,0.8641732492644804,1.0,8/76,9.08%,LRRC8C;ABCC4;SLCO1C1;SLC17A9;CYB5R1;SLC16A2;MFSD10;SLC4A9
prerank,peripheral nervous system development (GO:0007422),0.3908139956336729,0.9458793826425035,0.5251479289940828,0.8637122989485,1.0,6/23,14.59%,SERPINI1;NFASC;ASIC2;ADGRB1;SOX10;GFRA3
prerank,neuron apoptotic process (GO:0051402),0.399424665393624,0.9458580776450849,0.5310015898251192,0.8632384539891141,1.0,5/19,14.44%,FAS;APP;GAPDH;BNIP3;TRPC5
prerank,monocarboxylic acid transport (GO:0015718),0.34505663089152355,0.9457931025774399,0.5441558441558442,0.8628757698241638,1.0,6/51,7.46%,ABCC4;CEACAM1;SLCO1C1;ABCB4;SLC16A2;SLC16A4
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3693278673216943,0.9457927125904648,0.5389972144846796,0.862358422545144,1.0,6/33,11.28%,RHOB;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.340815470007736,-0.9457760700983032,0.5469613259668509,0.8721745170790663,1.0,7/19,23.33%,PPARA;IRS2;IRS1;TWIST1;PRKCD;MTLN;ANGPTL3
prerank,fatty acid metabolic process (GO:0006631),0.3125592446089088,0.945360977987978,0.5579793340987371,0.8627729557267978,1.0,10/115,8.59%,ADIPOR2;ACSM3;FASN;AOAH;SLC27A6;ACSL5;ACSBG1;ADIPOR1;ACOX1;ELOVL4
prerank,regulation of aerobic respiration (GO:1903715),0.4239175463730759,0.9451895765629408,0.5457570715474209,0.8626649211938894,1.0,5/15,22.21%,ATP7A;SLC25A33;CBFA2T3;UQCC2;NOP53
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.39994959158071225,0.944919227375139,0.5435435435435435,0.8627276842572508,1.0,8/22,16.29%,HNF1A;MED30;PSMC3;MED17;MED4;PSMC5;PSMC6;ESR1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.383165192758213,0.9448201323753822,0.5383480825958702,0.8624303571834335,1.0,5/26,10.68%,SYNPO;SHANK3;ACTG1;ROCK1;RAC1
prerank,regulation of hippo signaling (GO:0035330),0.4087037902112196,0.9445977684064445,0.5219435736677116,0.8623994309709015,1.0,7/17,19.90%,WWC2;MARK3;NF2;SCHIP1;MAPK14;SOX11;SHANK2
prerank,positive regulation of viral life cycle (GO:1903902),0.3957976392119486,0.9444738684299677,0.5159332321699545,0.8621349040775911,1.0,5/22,15.24%,LGALS9;TRIM11;VPS4A;CHMP3;CHMP2B
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4375803336810914,0.9444246479163538,0.5384615384615384,0.8617077321833442,1.0,2/12,5.76%,ING2;TAF9B
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.36763553782958475,-0.9443706152027895,0.5425531914893617,0.8745926472600943,1.0,5/15,13.54%,APOE;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,blood vessel endothelial cell migration (GO:0043534),0.4030704152179798,0.9440673732529075,0.5383411580594679,0.861976284118696,1.0,5/22,6.05%,EGR3;EMP2;ID1;SOX18;MYH9
prerank,apical protein localization (GO:0045176),0.4612177838993289,0.9439500677006176,0.5435540069686411,0.8617100560113865,1.0,4/10,12.78%,GOPC;MAL;ACTB;ATP8B1
prerank,membrane lipid catabolic process (GO:0046466),0.4598304678535432,0.9434572234237857,0.5289389067524116,0.8622514245653511,1.0,1/10,3.24%,PPT1
prerank,rRNA 3'-end processing (GO:0031125),0.46144219324743874,0.9433655255427206,0.5234899328859061,0.8619325749069703,1.0,5/10,21.35%,RPS21;EXOSC3;EXOSC8;EXOSC9;EXOSC10
prerank,protein localization to cilium (GO:0061512),-0.29445518012373484,-0.9433421792170482,0.5482758620689655,0.8760123917526329,1.0,14/32,20.71%,TULP3;INVS;BBS9;WDR35;ARL6;TCTN2;TTC21B;WDR19;ZNF423;IFT20;RAB29;ARL3;NPHP4;RABEP1
prerank,gluconeogenesis (GO:0006094),-0.288019600374807,-0.9432911827297399,0.5059760956175299,0.8748668929117306,1.0,13/39,21.23%,SLC39A14;SLC25A13;RBP4;ENO2;PGM1;MDH2;SLC25A12;GOT1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,DNA-dependent DNA replication (GO:0006261),0.31026620788358755,0.9432907725700381,0.5967741935483871,0.861577731137148,1.0,33/128,18.86%,PSMD13;WRNIP1;SSBP1;ORC3;PSMD4;PURA;UBA52;RPS27A;PSMA5;PSMB10;POLA1;POLG2;POLB;PSMB8;PSMD14;WDHD1;ORC5;PSMA7;PSMC3;DDX21;PSMA8;PSMC1;PSMB5;PSMC5;RFC2;TEFM;PSMB9;PSMC6;MCMBP;PSMA4;PSMD5;PSMD9;PSMB6
prerank,negative regulation of endopeptidase activity (GO:0010951),0.34753207011200354,0.9429942588580609,0.546284224250326,0.8616868161263547,1.0,7/47,11.08%,RECK;SERPINI1;SPOCK2;TIMP3;SPOCK3;GAPDH;SPOCK1
prerank,DNA double-strand break processing (GO:0000729),0.40556167022486994,0.9427990989766327,0.5521472392638037,0.8615814142199721,1.0,7/18,20.67%,RBBP8;EXD2;BRCA1;SMARCAD1;ATM;BARD1;BLM
prerank,protein depolymerization (GO:0051261),-0.3055299176195876,-0.9427249129506199,0.551622418879056,0.8750623061634796,1.0,6/27,9.46%,MICAL3;GSN;MICAL2;NCKAP5;CKAP5;STMN4
prerank,heterocycle biosynthetic process (GO:0018130),0.43213695011160247,0.9424265872630047,0.5454545454545454,0.8618604186723231,1.0,2/14,3.81%,GCH1;GPHN
prerank,organophosphate ester transport (GO:0015748),-0.3189346495746904,-0.9423074676184322,0.5294117647058824,0.8748707389814928,1.0,10/24,23.13%,OSBPL8;PITPNB;SCP2;TNFAIP8L3;MTTP;PITPNC1;PRELID2;PCTP;PRELID1;PITPNM1
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.29636956932159897,-0.9421523275132211,0.5933333333333334,0.874021256644027,1.0,13/33,23.82%,SCAF8;NUDT21;NCBP1;PABPN1;SNRPF;CSTF2T;PCF11;SNRPD3;LSM11;SLBP;NCBP2;PAPOLA;LSM10
prerank,positive regulation of viral transcription (GO:0050434),0.3812152885615375,0.9421322995177659,0.5412445730824892,0.8619975660375496,1.0,9/25,23.64%,POLR2G;DHX9;POLR2D;NELFB;POLR2I;NELFA;POLR2C;POLR2B;POLR2J
prerank,positive regulation of inflammatory response (GO:0050729),0.3155599885511343,0.9417521454657619,0.558968058968059,0.8623086303451479,1.0,14/86,12.95%,APP;TLR3;KARS1;HYAL2;PDCD4;CD47;VAMP8;CEBPA;NMI;VAMP7;DHX9;NFKBIA;DDT;ABCC1
prerank,positive regulation of embryonic development (GO:0040019),0.3988783681370435,0.9417367995281316,0.5299539170506913,0.8618358251426133,1.0,5/19,18.50%,PLCB1;TENM4;CFL1;RACK1;ZBED3
prerank,snRNA metabolic process (GO:0016073),0.4109087757157603,0.9411820362750638,0.5218068535825545,0.8625257557344737,1.0,4/17,14.07%,RBM7;INTS11;INTS12;INTS5
prerank,prostaglandin metabolic process (GO:0006693),0.37481323691179036,0.9411614694847346,0.49850746268656715,0.862053987005808,1.0,3/26,10.16%,EDN1;ACOX1;PTGES3
prerank,endocytic recycling (GO:0032456),0.34323375447807464,0.94090644456469,0.5284237726098191,0.862119456854198,1.0,6/50,13.84%,EHD4;EHD1;LMTK2;RAB35;VPS35;RAB11FIP4
prerank,protein processing (GO:0016485),-0.23506724134490847,-0.9408549206158219,0.6183206106870229,0.8761184027419485,1.0,21/102,14.38%,AEBP1;OGT;MMP14;CPE;BACE1;ADAMTS3;HM13;ADAM19;F3;CPXM2;TMEM208;PTCH1;YME1L1;MMP16;KLK2;CPXM1;ZMPSTE24;SPCS3;PCSK7;CLN5;FXN
prerank,negative regulation of cell cycle (GO:0045786),0.3254462164601431,0.9406432643684765,0.5594936708860759,0.8621824383440241,1.0,14/73,11.76%,DUSP1;RHOB;BTG2;BTG1;HHEX;PPP1R13B;GMNC;GATA3;PDCD4;CEBPA;APC;ANGEL2;NPPC;NR4A1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.32117315636330895,0.9406354238406921,0.5536374845869297,0.8616840078219716,1.0,14/79,13.57%,MFSD6;AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3492361158836315,0.9397563324447328,0.5444126074498568,0.8630792571569921,1.0,12/44,13.86%,LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;CCDC88A;RAC1;SORBS3;NF2;ITGB1BP1;ARHGEF10
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.36852200672233537,-0.9394598538799109,0.5598958333333334,0.8784604146640191,1.0,3/15,5.02%,LACTB2;DICER1;NYNRIN
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3695981313733151,-0.9390852018152428,0.5618556701030928,0.8781397768855795,1.0,3/13,10.96%,PRPF8;PRPF31;PRPF3
prerank,cation transport (GO:0006812),0.29738947906958757,0.9389437836397404,0.5968819599109132,0.8643242623222643,1.0,21/167,12.72%,SLC6A6;KCNN4;PIEZO1;RHCG;ATP1A4;SLC5A10;SLC8A1;ANO6;SCN11A;MCOLN1;SLC7A1;KCNC1;NDFIP2;SGK1;SLC6A17;NEDD4L;TRPM2;SLC1A1;KCNK9;KCNC4;KCNA1
prerank,regulation of nuclear division (GO:0051783),0.40132523708887036,0.9386340545065458,0.5377503852080123,0.8644591375800843,1.0,3/20,13.11%,CAV2;CDC25C;PIN1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4456514818871799,0.9385155948534674,0.5301204819277109,0.8641966801705812,1.0,2/10,10.88%,PRNP;VSIR
prerank,cellular component disassembly (GO:0022411),-0.25884216104408014,-0.9384530791318453,0.5665236051502146,0.8785359007249718,1.0,13/53,13.94%,GSN;MMP14;TLL1;ADAMTS5;SH3PXD2B;TIMP2;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,positive regulation of macrophage activation (GO:0043032),-0.3406672161671168,-0.9382374262799812,0.5340314136125655,0.8778635285898365,1.0,3/17,3.41%,LBP;WNT5A;THBS1
prerank,receptor catabolic process (GO:0032801),0.3809700943206178,0.9380459238406302,0.527536231884058,0.8647133964671292,1.0,15/24,29.94%,AP2B1;AP2M1;ZNRF3;SMURF1;VLDLR;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;GPRASP1;AP2A1;CLTC;SH3GLB1;AP2S1
prerank,regulation of necroptotic process (GO:0060544),0.38736299580568323,0.9376591300087411,0.5310650887573964,0.8650512552534194,1.0,3/23,2.47%,ARHGEF2;CASP8;SPATA2
prerank,regulation of protein processing (GO:0070613),-0.3258364893908306,-0.9376020498312423,0.5576923076923077,0.8782810879548492,1.0,4/21,5.93%,CCBE1;GAS1;SERPINE2;RUNX1
prerank,nuclear membrane organization (GO:0071763),-0.34120001219023055,-0.9371751929445344,0.5431754874651811,0.8780082167012666,1.0,7/19,17.03%,TOR1AIP1;TOR1B;UBXN2B;TARDBP;AKAP8L;SPAST;GPER1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.29679986084440196,0.9363214955215303,0.5995623632385121,0.8674184427417513,1.0,18/152,12.93%,ADGRL4;S1PR1;ADGRE5;GNAQ;ADRB2;GNAL;LGR5;AKAP5;IAPP;GNAI2;MC4R;HTR1B;ADCY4;ADGRB1;GLP1R;HTR1F;WASF2;GPR26
prerank,ERK1 and ERK2 cascade (GO:0070371),0.39120064209147004,0.9362018027509829,0.5185758513931888,0.8671512607842795,1.0,5/21,9.31%,LGALS9;APOA1;KARS1;MAPK1;ZFP36L2
prerank,fluid transport (GO:0042044),0.4357593825761457,0.9358024822290844,0.5601926163723917,0.8674912757733689,1.0,1/12,2.23%,AQP11
prerank,regulation of mitochondrial fission (GO:0090140),-0.3143850095518228,-0.9357939356544721,0.564179104477612,0.8803633545542553,1.0,4/24,8.53%,DCN;PRKN;DDHD1;MYO19
prerank,L-amino acid transport (GO:0015807),-0.29528610423455093,-0.9355453999743814,0.5777777777777777,0.879740515649593,1.0,3/28,3.00%,SLC1A3;SLC7A2;SLC25A13
prerank,negative regulation of hemostasis (GO:1900047),0.43076946175219444,0.9354430651187537,0.5553772070626003,0.8677476647268781,1.0,3/12,8.44%,EDN1;CD34;PROC
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.39647009390716115,0.934989334936175,0.5476550680786687,0.86822694961536,1.0,7/21,20.25%,FKBP1A;PPP1R16B;MFHAS1;ARPP19;BOD1;TIPRL;GSK3B
prerank,regulation of axon regeneration (GO:0048679),-0.3786781294726904,-0.9347099296316422,0.5356200527704486,0.8806022693092833,1.0,1/12,0.29%,PTN
prerank,chromosome organization (GO:0051276),-0.23466909978985703,-0.9346390846568384,0.6196319018404908,0.8795253693828748,1.0,33/99,24.12%,TCF7L2;LDB1;NUCKS1;TOP2B;MTF2;DDB2;EHMT1;SETD7;DOT1L;CUL4B;CUL4A;NUP155;HDAC1;HMGN1;PADI2;AXIN2;COPS7B;MSH6;HMGA2;SAFB;SUV39H1;LATS1;RFWD3;COPS6;SOX2;GPS1;MTHFR;ABL1;HDAC8;PARP1;HDAC10;TOP2A;BRWD1
prerank,protein-containing complex assembly (GO:0065003),0.28752064727216053,0.9346160510369694,0.6328852119958635,0.8685208770757901,1.0,48/259,16.22%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;AIM2;CASP8;ANO6;CARD10;LEF1;CSNK1D;TRAF1;TMED10;MCFD2;CUL3;CD247;P2RX7;ZC3H12A;LRRK2;IL1RAP;GRIA1;APC;TCF7L1;ADAM10;DHX9;RBX1;AP2M1;PDZD11;RANBP9;TRAPPC2;TRAPPC6B;ITGB1BP1;SEC24B;TAPBP;CAPG;NOL3;NSF;PPIH;CTNNB1;CSNK2B;TRAPPC5;KPNA3;CLDN14;TRRAP;SAMM50;VIL1;FERMT3
prerank,axon development (GO:0061564),0.31322164564688076,0.934403520546961,0.5721153846153846,0.8684648143635781,1.0,17/78,12.57%,KLF7;APP;VASH2;SHTN1;CAMSAP2;ATL1;LMTK2;NRCAM;TAOK2;RTN4;NEFH;ADGRB1;ACTB;DCC;MARK2;CTNNA2;SLITRK2
prerank,extracellular matrix disassembly (GO:0022617),-0.2584863880963126,-0.9342150041115778,0.5545851528384279,0.8793612276363996,1.0,13/53,13.94%,GSN;MMP14;TLL1;ADAMTS5;SH3PXD2B;TIMP2;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3622702001277769,-0.9338894341473241,0.5516304347826086,0.8789217382183189,1.0,3/15,12.70%,TCF7L2;CAMK1;BAG3
prerank,heterochromatin assembly (GO:0031507),-0.3428322689309018,-0.9338369890976023,0.5288461538461539,0.8778011048651838,1.0,5/20,14.40%,HDAC1;RRP8;HMGA2;SUV39H1;SIRT2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.44474822057498103,0.9334641221118803,0.5401709401709401,0.8699708361521863,1.0,3/10,12.21%,ACVRL1;ZBTB16;SOX6
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.4059707542123557,0.9331170840631873,0.5406698564593302,0.8702256094344513,1.0,3/18,9.31%,FAM107A;PCK2;ZFP36L2
prerank,keratan sulfate metabolic process (GO:0042339),-0.2971289668726303,-0.9329823284769636,0.5418060200668896,0.8786649757807818,1.0,8/31,7.47%,OGN;FMOD;B3GNT2;GNS;PRELP;HEXA;ST3GAL4;B4GALT1
prerank,regulation of centrosome cycle (GO:0046605),0.3969239994836092,0.9327909294153165,0.531437125748503,0.8704108743250768,1.0,10/21,27.34%,CHMP1B;NPM1;CHMP3;CHMP2B;MARK4;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,extracellular transport (GO:0006858),0.4365942907220445,0.9324103938752538,0.5272727272727272,0.8707587052267037,1.0,3/12,14.14%,ADCY10;ARRDC1;SPA17
prerank,negative regulation of signal transduction (GO:0009968),0.2864289948124169,0.9324076737125183,0.6253934942287513,0.8702569313683782,1.0,46/249,13.93%,PTPRJ;MMRN2;GATA2;NR4A2;EGFL7;HEY1;DAB2IP;DLL4;HHEX;INPP5K;NTN1;ACVR1;KIF26A;PTPRE;NLK;ASAH2;GATA3;ARRDC1;NFKBIL1;CD47;LRRK2;PTPN12;ARRB1;SNAI2;CTNNBIP1;CACTIN;FBXW7;SIAH2;TAX1BP3;EPN2;CNOT1;NKD2;PTPN1;NXN;HIF1AN;DCC;TMBIM6;HMGXB4;PIK3CB;TSKU;CX3CR1;RPS6KB1;CYP26C1;APLN;NFATC1;GRB14
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.35984406191578167,-0.932230420017174,0.5317460317460317,0.8792654231664347,1.0,2/15,4.31%,IGF1;PRKN
prerank,cellular response to nutrient levels (GO:0031669),0.32839976792206993,0.9322024834512127,0.5701298701298702,0.8701541877826814,1.0,8/62,10.04%,BMPR2;FOXO1;FAM107A;STK24;LRRK2;PRKAA1;RIPOR1;RRAGD
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.42021789469883297,0.9320187940718874,0.5373376623376623,0.8700295412750011,1.0,3/15,9.04%,EDN1;CAMK2D;ROCK1
prerank,"wound healing, spreading of cells (GO:0044319)",0.38817141398428695,0.9318475593893444,0.5325264750378215,0.8698758918103977,1.0,7/24,15.45%,CEACAM1;ACVRL1;ADAM17;MRTFA;ITGA5;LCP1;PDCD10
prerank,regulation of complement activation (GO:0030449),-0.27470520497243844,-0.9316232224795464,0.5576208178438662,0.8794753043332142,1.0,15/40,27.37%,SERPING1;VTN;CD55;CD81;C4B;C1QC;C1QA;CFHR2;PHB2;C1QB;C2;C1QBP;C3;C3AR1;C6
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4340096369904255,0.9315110845946015,0.5401709401709401,0.8701011384716144,1.0,5/12,14.20%,MBTPS2;KPNB1;SEC14L2;LPCAT3;RAN
prerank,negative regulation of biosynthetic process (GO:0009890),0.4128327863604939,0.9310024951483409,0.564945226917058,0.870679660077336,1.0,1/16,0.80%,CEACAM1
prerank,autonomic nervous system development (GO:0048483),0.4079541357728498,0.9309959560041812,0.5387045813586098,0.8701832571215772,1.0,4/17,12.09%,KIF26A;GATA3;PHOX2A;SOX10
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.35042189327020257,-0.9301347389124147,0.5702702702702702,0.8819872721937686,1.0,4/15,8.98%,BMPER;FGF1;FGF2;VEGFA
prerank,tRNA wobble uridine modification (GO:0002098),0.4165368843327435,0.9300668431695618,0.533011272141707,0.8716465377756154,1.0,6/14,20.60%,ELP4;ALKBH8;ELP3;DPH3;TRMU;KTI12
prerank,ERBB signaling pathway (GO:0038127),0.32541977272888634,0.9300367955380832,0.5869297163995068,0.8711958218207985,1.0,14/64,15.85%,PTPRR;RPS6KA5;PIK3C2A;CBL;IQGAP1;ADAM17;MAPK1;PTPN12;PTK2;PLCG1;MATK;SOS1;KIF16B;VIL1
prerank,regulation of actin nucleation (GO:0051125),-0.3733491575910033,-0.9298208080965353,0.5515463917525774,0.8815831740477366,1.0,5/12,21.74%,GSN;ARF1;ARPIN;PICK1;ARFIP1
prerank,kinetochore organization (GO:0051383),-0.37284729247236237,-0.9297470467602912,0.5411140583554377,0.8805226022503551,1.0,9/13,39.75%,CENPC;MIS12;CENPE;CENPH;CENPF;CENPA;DLGAP5;NUF2;CENPW
prerank,negative regulation of leukocyte activation (GO:0002695),0.41940342406922426,0.9295930689657974,0.5451664025356577,0.8716099266541437,1.0,4/15,8.02%,FCGR2B;MILR1;ZC3H12A;CD200
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4443874300183749,0.9295111175374644,0.5395189003436426,0.8712746932825584,1.0,5/11,21.01%,RNF185;BAG6;UGGT1;RNF5;POMT2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.38140630578894946,-0.9291974382182846,0.5323383084577115,0.8807526040520163,1.0,7/12,28.67%,NABP1;ZWILCH;ZW10;CHFR;BUB1B;ZWINT;NABP2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.2932401729753159,-0.9290652138221339,0.5344262295081967,0.8798316608916879,1.0,5/32,7.04%,DAPK1;GRIA3;ACTN2;DLG4;SLC6A9
prerank,regulation of monocyte chemotaxis (GO:0090025),0.38655591035951137,0.9279149089650542,0.5598802395209581,0.874109376845345,1.0,3/24,3.92%,CCR1;DUSP1;ANO6
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2916835049092761,0.9274587093770184,0.6198704103671706,0.8745683990273594,1.0,39/166,17.48%,EDN1;PDGFB;KLF2;INSR;VIM;APOA1;NOS1AP;KLF4;ATP7A;PAOX;BCAR3;ASS1;PLD1;ELAVL1;CDH3;PASK;NR1D1;STN1;EGR1;DHX9;METTL5;NPM1;EEF2;CLU;PRKD2;ARPP19;RPS6KB1;FXR1;METTL14;HIF1A;CNEP1R1;ELOVL5;EIF6;KAT7;POLDIP3;NSUN5;SCARB1;PTPN2;FABP3
prerank,male meiosis I (GO:0007141),0.4038497881842959,0.9266773715305521,0.5773524720893142,0.8757442697090396,1.0,4/16,18.63%,DDX4;ING2;SYCP3;TDRD9
prerank,tRNA transport (GO:0051031),0.3556793951674251,0.9265795977644694,0.5459533607681756,0.8754422824459397,1.0,10/35,15.93%,TOMM20L;NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;YBX1;NUP205
prerank,histone ubiquitination (GO:0016574),-0.3224380958258689,-0.9260163938893803,0.5718654434250765,0.8863723327124308,1.0,6/21,16.43%,UBE2N;PAF1;CTR9;USP22;ATXN7L3;WAC
prerank,response to steroid hormone (GO:0048545),0.36171858022738024,0.925953822279978,0.5836849507735584,0.876295512386235,1.0,6/31,8.68%,ATP1A1;ATP1A3;CAV1;TGFB2;PAQR8;UBE3A
prerank,ESCRT III complex disassembly (GO:1904903),0.438782376150258,0.9251446000126727,0.5482233502538071,0.8769841318521591,1.0,6/10,26.18%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,ESCRT complex disassembly (GO:1904896),0.438782376150258,0.9251446000126727,0.5482233502538071,0.8769841318521591,1.0,6/10,26.18%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3978892932750251,0.9247275722969973,0.5464396284829721,0.8773431734477655,1.0,4/18,14.15%,DAB2IP;MSN;VPS35;NELL1
prerank,phospholipid homeostasis (GO:0055091),0.4394769636603256,0.9246812013130621,0.5618556701030928,0.876932693763553,1.0,2/11,3.48%,HNF4A;APOA1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.412543947764942,0.9242229215226452,0.5432300163132137,0.8773879460707128,1.0,14/14,58.78%,PTGER3;OSMR;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;IL6;ADAM8;CREB3L3;IL6ST;TNF;PARK7
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.35651324919222543,0.9241562043709716,0.562962962962963,0.8770167687141116,1.0,11/31,21.37%,MSN;SYNE4;WDR1;PDZD11;MARK2;ANK1;OPHN1;LRRC7;ERBIN;MTCL1;CRB1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.34524880284142206,0.924029247769642,0.573997233748271,0.8767825135661719,1.0,14/40,19.44%,HRK;TNFSF10;BBC3;CIDEB;BCL2L1;CLU;NOL3;BNIP3;PYCARD;PLAUR;BMF;BID;PLSCR3;PPIF
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3927690136357253,0.9238572846380638,0.5615141955835962,0.8766590712503022,1.0,3/18,9.67%,GPR137B;TLR3;FBXW7
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2755713711851053,-0.9237266392774849,0.6020408163265306,0.890888328466917,1.0,10/36,16.98%,AFDN;VAMP5;GGA2;GCC2;OPTN;KIF13A;GORASP2;GOLGA4;GGA1;NECTIN3
prerank,modification-dependent protein catabolic process (GO:0019941),0.28989508821357646,0.9235497124701647,0.6279569892473118,0.8767896348094126,1.0,52/193,21.13%,CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PTTG1;ARRB1;UBE4A;UBA52;FEM1C;RPS27A;NDFIP2;RNF128;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;NEDD4L;BAG6;PSMD14;DTX3L;SMURF1;KCTD10;KEAP1;UBE2E1;CDC27;UBE3B;UBQLN2;KLHL25;ANAPC7;RNF150;FBXO8;UBQLN4;FBXO10;PSMD9;FEM1A;ANAPC4;RNF166;FBXO45;RNF5;RNF34;RNF11;KCTD21;UBA1
prerank,secretory granule organization (GO:0033363),-0.39222926450631374,-0.9234432557105879,0.5485327313769752,0.8903456607233426,1.0,4/10,19.44%,ABCA1;DTNBP1;VPS33B;BLOC1S2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.43209652540037663,0.9232431249730326,0.5701906412478336,0.8764111029853071,1.0,1/12,0.75%,LMCD1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.43209652540037663,0.9232431249730326,0.5701906412478336,0.8764111029853071,1.0,1/12,0.75%,LMCD1
prerank,endomembrane system organization (GO:0010256),0.28926577518283797,0.9230458009301148,0.5986984815618221,0.8763210118634195,1.0,41/178,20.00%,SYNE1;ALS2CL;DYSF;TRAPPC8;PRKD1;ATL2;CAV2;DOP1B;CSNK1D;TMED10;SNX10;ATL1;CLASP1;LRRK2;SUN3;HOOK1;A4GALT;CLASP2;MYOF;EXOC8;TMED9;REEP3;ATP8B1;VPS4A;USP6NL;TMED4;VAPA;CHMP2B;ANK3;PLEKHM2;SRGN;SPTBN1;GOLPH3L;PHETA1;GOLPH3;TOR1AIP2;HOOK2;MYO18A;ATP8B2;TMED7;DNAJC28
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.29361449581854854,0.9229841815637841,0.6100766703176341,0.8759449164290191,1.0,35/148,20.67%,NUAK1;PLK3;BOP1;PPP1R13B;RBBP8;ING2;TAF9B;PAK1IP1;PRKAA1;PPP2R5C;SGK1;RPL37;CHD5;BRIP1;BRCA1;PIN1;RAD1;ATM;RPS15;CSNK2B;RFC2;TAF11;RAD9B;RICTOR;DAXX;MAPK14;ATRIP;TAF3;MAPKAPK5;BARD1;HUS1;RBBP4;RNF34;SMYD2;BLM
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.34698795637145574,0.9228342868998253,0.55858310626703,0.8757514854891671,1.0,10/42,15.87%,WRNIP1;USP43;POLK;UBA52;RPS27A;TRIM25;POLA1;RFC2;CDKN2D;SPRTN
prerank,negative regulation by host of viral transcription (GO:0043922),0.42795983192006565,0.9226978834952944,0.5592105263157895,0.8755219698937746,1.0,4/12,13.02%,INPP5K;JUN;CCL4;PSMC3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.32716920180100384,0.9221761577825037,0.5662042875157629,0.8760968846386342,1.0,9/63,13.96%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.44996212702839034,0.9221218214119217,0.5522875816993464,0.8757141812944684,1.0,3/10,10.96%,CAMK2D;STK39;NEDD4L
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4370707503483434,0.9218872586555613,0.560702875399361,0.8756832629096416,1.0,2/12,10.63%,DAB2IP;PTPN1
prerank,organelle organization (GO:0006996),0.2772539649584414,0.9217586035126761,0.6957403651115619,0.8754332816722454,1.0,67/388,15.51%,NOS3;FGD5;SYNE1;IRAG2;TRAPPC8;CAV1;PRKD1;ATL2;CAV2;MAST4;NEDD9;DIAPH1;SIPA1L3;DOP1B;PACSIN2;SH3KBP1;ARAP3;STX7;DST;TTC29;ATP7A;RAB34;SSBP1;CSNK1D;FMNL3;FAM161A;FGD6;FNBP1L;TMED10;ATL1;PACSIN1;SIRT4;CHCHD2;SLC25A33;CLASP1;MAST1;ALAS1;KLHL20;LRRK2;MCOLN1;VPS13D;CHMP1B;HPS3;CLASP2;RANBP9;POLG2;NUMA1;SNX11;CHGA;TMED9;ATP8B1;VPS4A;TTC17;CHMP3;CYP26C1;USP6NL;RHOT2;PHIP;CEP55;CFL1;TFB2M;TMED4;VAPA;ANK1;CHMP2B;CHMP7;PTCD2
prerank,mitochondrial translation (GO:0032543),0.3086308021060055,0.9217523943005327,0.6048667439165701,0.874940674730312,1.0,46/104,29.88%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MTIF2;GATB;MRPL54;MRPS18B;MRPS30;GFM1;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40;MRPS18A;MRPS5;FASTKD2;IARS2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3928262047820051,0.9215399453157747,0.549079754601227,0.8748588985116595,1.0,9/18,20.86%,ADAM17;APH1A;ADAM10;ACHE;LDLRAP1;TMCC2;PSEN2;NSG1;APH1B
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.4380307537691288,0.9213939109899836,0.5595854922279793,0.8746780629063066,1.0,3/10,13.91%,TBX1;STAT1;LRP5
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2652173806064185,-0.9208962178313705,0.6286919831223629,0.8956842513862829,1.0,16/48,21.33%,DOCK5;CUX1;RREB1;OBSL1;FLNA;MDK;TRIOBP;S100A10;PTPRD;FBXW8;SS18L2;TESK1;P4HB;CUX2;CIB1;ABL1
prerank,gas transport (GO:0015669),-0.4019048675301175,-0.9208038684154434,0.5831435079726651,0.894684343582843,1.0,7/10,46.11%,CA2;CYGB;MYC;AQP1;MB;NGB;RHAG
prerank,chemical homeostasis (GO:0048878),-0.25119919028718773,-0.9207965647386775,0.6227272727272727,0.8934614954843139,1.0,15/61,16.82%,ZBTB20;SLC4A10;RBP1;WNK1;WNK4;TLCD2;IRS2;NR1D2;SLC4A2;PPARG;DDX3X;TENT4B;SLC4A3;NR1H3;ABHD8
prerank,lipid droplet organization (GO:0034389),-0.31262461715710577,-0.9205600465939314,0.56797583081571,0.892837765797934,1.0,7/22,28.25%,PPIA;BSCL2;SQLE;PLA2G4C;FITM2;RAB3GAP1;AUP1
prerank,canonical Wnt signaling pathway (GO:0060070),0.31983116808906004,0.9203901902662772,0.5842696629213483,0.8762531906168914,1.0,13/68,14.82%,FZD6;NR4A2;CAV1;LEF1;GATA3;LRRK2;CDH3;APC;TCF7L1;LRP5;CTNNB1;FZD9;FZD3
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.38037273495704443,-0.9195630914219739,0.571078431372549,0.8942242080862453,1.0,5/10,20.74%,GALNT1;POGLUT2;POGLUT3;GALNT16;GALNT3
prerank,response to ATP (GO:0033198),-0.33508622609943833,-0.9195544097125855,0.5659340659340659,0.8930110923768176,1.0,4/18,8.20%,TRPC3;ABCC9;P2RX4;TAF1
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2480210996113448,-0.9193899955956298,0.6298076923076923,0.8921834707955448,1.0,11/69,8.12%,BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;NTRK2;NGF;SIX1;PRKCI
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.29128453015626143,0.9192593693745722,0.6357688113413305,0.8780630396485029,1.0,21/158,11.13%,TRIM14;NOD1;NOD2;PRKD1;CASP8;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;JMJD8;GAPDH;NDFIP2;TRIM25;LURAP1;CASP1;TAB2;MAP3K3
prerank,regulation of TORC1 signaling (GO:1903432),0.35525531840652114,0.918577030785568,0.5641748942172073,0.8790079155348277,1.0,5/33,10.04%,SPAAR;CASTOR1;GPR137B;SMCR8;RRAGD
prerank,negative regulation of translation (GO:0017148),0.3076121144105544,0.9182305801784167,0.5954922894424673,0.8792214014493225,1.0,3/87,2.84%,NANOS1;NANOS3;BTG2
prerank,regulation of defense response to virus (GO:0050688),-0.35819620697873183,-0.9181575225309679,0.5443037974683544,0.8939506853166099,1.0,8/14,34.10%,ZMPSTE24;PPM1B;TNFAIP3;ELMOD2;C1QBP;TRAF3IP1;RNF26;IFNLR1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3557211684167526,-0.9181139796461045,0.5611702127659575,0.8928295767077427,1.0,8/14,30.68%,SLC27A1;CHKB;ETNK2;SELENOI;CHKA;LPIN3;LPIN1;ETNK1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3144171080540913,-0.9178837523180213,0.5682451253481894,0.8921759453004883,1.0,4/22,8.48%,AEBP1;APOE;MAP1A;EFEMP2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.38110542587199536,0.9173424238143187,0.5660091047040972,0.8800208027127416,1.0,4/23,7.71%,CASP8;PPP1R13B;BBC3;NMT1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.38110542587199536,0.9173424238143187,0.5660091047040972,0.8800208027127416,1.0,4/23,7.71%,CASP8;PPP1R13B;BBC3;NMT1
prerank,anterior/posterior pattern specification (GO:0009952),0.3360943306653673,0.9172564922315639,0.5719895287958116,0.8797058685441167,1.0,7/53,5.38%,BMPR2;TBX1;HEY1;HHEX;HEY2;PCSK5;SMAD2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.36194164549552044,0.9170159050132147,0.5653450807635829,0.8797135198478192,1.0,3/28,7.47%,FCHSD2;ESAM;WDR1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.35489998658348243,0.9166365224726338,0.5799457994579946,0.8799967829938266,1.0,10/35,18.10%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.323209691904115,0.9163463394349346,0.57875,0.8800924075064882,1.0,22/65,21.23%,PSMD13;PSMD4;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;VPS4A;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;USP47
prerank,regulation of gene silencing by RNA (GO:0060966),0.33247339968383544,0.9159077462440006,0.5766710353866317,0.8800029670693941,1.0,20/50,25.31%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.33247339968383544,0.9159077462440006,0.5766710353866317,0.8800029670693941,1.0,20/50,25.31%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR
prerank,establishment of apical/basal cell polarity (GO:0035089),0.40499621284454923,0.9158444053977187,0.5564516129032258,0.8796318069461605,1.0,2/14,4.47%,MSN;SYNE4
prerank,regulation of B cell apoptotic process (GO:0002902),-0.36876375528109984,-0.9157877481983195,0.551980198019802,0.8963370129309992,1.0,3/12,9.57%,IRS2;BCL6;FNIP1
prerank,regulation of signal transduction (GO:0009966),0.28956324222475677,0.9153227136248084,0.6410537870472008,0.8801712075077917,1.0,35/190,14.23%,RGS3;PLCB1;FYN;MFNG;LIFR;CASTOR1;KAZALD1;PRKD1;APP;CRK;LRIT3;ACVR1;KIF26A;GIT2;WWTR1;TMEM204;TSPAN12;IRAK2;GATA3;SIK2;LRRK2;IGFBP7;PLSCR1;IGFBP4;TCF7L1;PRNP;GNG4;PTPN1;KCTD8;CLU;CBFB;ITGB1BP1;WDR11;RGS12;ITGA3
prerank,positive regulation of myoblast differentiation (GO:0045663),0.3971971710023881,0.9143642644469742,0.55,0.8816670303887605,1.0,3/16,5.32%,PLCB1;BTG1;MEF2C
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32876347867892136,0.9142055656085114,0.5842985842985843,0.8815105506964152,1.0,13/54,20.23%,SMAD7;CAV1;HSPA1B;ARRB1;VPS28;PRKCG;ADGRB1;NXN;CTNNB1;SPOPL;CRY1;COPS9;DNAJA1
prerank,megakaryocyte differentiation (GO:0030219),0.43577447888950693,0.9141550116227678,0.580327868852459,0.8811208939356567,1.0,2/11,7.97%,TAL1;THPO
prerank,receptor internalization (GO:0031623),0.3390201426243636,0.9139170959180134,0.5618421052631579,0.8811305832266899,1.0,7/44,14.36%,CEACAM1;CAV1;DNM3;ARRB1;AP2M1;LDLRAP1;CD9
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.32060031342314116,-0.913506258275578,0.5658682634730539,0.9007639860414722,1.0,10/20,22.91%,GSN;PLA2R1;THBS1;SFRP4;PRKCI;ITGA4;GPER1;CD40;RGCC;PIAS4
prerank,stem cell differentiation (GO:0048863),0.3388444287161685,0.9134195772961733,0.5887207702888583,0.8816624058716812,1.0,4/39,5.32%,ACE;FOXO4;TGFB2;MEF2C
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3596479672298606,0.9132481325594656,0.5674891146589259,0.881494175269468,1.0,14/30,26.49%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;IDI1;MVK;INSIG1;HMGCR;FDFT1;LBR
prerank,regulation of microglial cell activation (GO:1903978),0.40532274200570817,0.913240298163779,0.5534591194968553,0.8810085945139543,1.0,3/15,12.61%,NR1D1;STAP1;TTBK1
prerank,regulation of fat cell differentiation (GO:0045598),0.3132931578856464,0.9131514616648148,0.5811138014527845,0.8807096041350435,1.0,11/74,9.31%,GATA2;FOXO1;TRIO;WWTR1;GATA3;ZBTB16;ZC3H12A;CMKLR1;SYAP1;NR1D1;ZFP36L2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3291314571839183,0.9130340034766578,0.5749674054758801,0.8804512481650599,1.0,12/49,19.51%,SGMS1;CAV1;BBC3;BCL2L1;RTKN2;RACK1;PYCARD;PLAUR;BMF;BID;PPIF;MCL1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.33699325644369893,-0.9129078933857422,0.5970149253731343,0.9010218152748338,1.0,13/16,45.58%,TOP2B;HFM1;TOP2A;EME2;CENPX;FANCM;SLX4;MEIOB;MSH4;MUS81;EME1;SHOC1;CENPS
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.40160559705095084,0.9123501798613843,0.5631067961165048,0.8813737412335508,1.0,3/17,6.31%,PRKG1;MEF2C;PDCD4
prerank,histone H2A acetylation (GO:0043968),0.39778646974427284,0.9122917601554374,0.5815047021943573,0.8810054779235618,1.0,4/16,15.52%,ING3;BRD8;DMAP1;TRRAP
prerank,regulation of protein export from nucleus (GO:0046825),0.37591980566763816,0.9122506984442251,0.5961251862891207,0.8805979795674067,1.0,3/23,7.21%,PTPN14;UHMK1;RANGAP1
prerank,positive regulation of exocytosis (GO:0045921),0.35587433396702256,0.9121594218325421,0.5664233576642336,0.8802903037772404,1.0,8/35,17.97%,CADPS2;CLASP1;CLASP2;CADPS;VPS4A;RAB27B;STXBP5;RAB27A
prerank,negative regulation of organelle assembly (GO:1902116),-0.28366978580566526,-0.9120398770049183,0.5780141843971631,0.9019578093304929,1.0,10/35,12.89%,NUPR1;KAT2B;RBM14;ODF2L;MDM1;FEZ2;CEP97;TMEM39A;CCP110;CDK10
prerank,transition metal ion homeostasis (GO:0055076),0.36229876994262716,0.9119543029078117,0.5737463126843658,0.8802229156095869,1.0,8/28,18.52%,B2M;FBXL5;TMPRSS6;HMOX2;CP;CYBRD1;HEPH;XIAP
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.27230078339570357,-0.9119476510372593,0.6287878787878788,0.900943314129881,1.0,16/40,25.55%,FXR2;UBE2V2;UBE2N;USP1;BCLAF1;HMGA2;WDR76;NEK4;RFWD3;PRKCD;PARG;ABL1;CASP9;FEM1B;RPA2;KMT5A
prerank,stress fiber assembly (GO:0043149),-0.3505128558852444,-0.9117806502039394,0.5532467532467532,0.8989160383207067,1.0,5/15,8.80%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3505128558852444,-0.9117806502039394,0.5532467532467532,0.8989160383207067,1.0,5/15,8.80%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,response to reactive oxygen species (GO:0000302),-0.2626329148465937,-0.9116616523403034,0.6558704453441295,0.8979927494750367,1.0,14/54,15.36%,EGFR;PDGFRA;APOD;PTPRK;APOE;TPM1;CAT;ADAM9;HYAL1;PRDX3;CHUK;FER;MPV17;PDK2
prerank,negative regulation of cell communication (GO:0010648),0.3895679733519247,0.9116136895560042,0.5671406003159558,0.8804137657632194,1.0,6/21,23.11%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,regulation of transposition (GO:0010528),0.4140660706401432,0.9115098014170573,0.5681063122923588,0.8801285035743857,1.0,1/13,3.85%,DDX4
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.41822391089165045,0.9111590987242552,0.5854430379746836,0.8803484168433862,1.0,4/13,17.26%,CASP8;CIDEB;TBC1D10A;GRIN2A
prerank,positive regulation of cell aging (GO:0090343),0.4378105233076195,0.9108417829884708,0.5785714285714286,0.8805503275099579,1.0,1/11,1.74%,B2M
prerank,alpha-amino acid metabolic process (GO:1901605),0.3387255843828755,0.9108046254242241,0.5701058201058201,0.8801189367440478,1.0,6/45,6.07%,HNF4A;GLS2;GLS;ATP7A;GLUD1;ASS1
prerank,glucose metabolic process (GO:0006006),-0.25271592396593245,-0.9107947316816215,0.7077625570776256,0.8989186114017756,1.0,18/58,21.23%,APOD;SLC39A14;SLC25A13;RBP4;IRS2;ENO2;ADPGK;PGM1;MDH2;SLC25A12;GOT1;AKR1A1;PFKFB1;GDPGP1;CRTC2;G6PC3;TPI1;ENO3
prerank,regulation of protein kinase activity (GO:0045859),0.2973225618874621,0.9106236295977286,0.6276595744680851,0.8799940933502911,1.0,14/106,11.10%,RAPGEF2;CEACAM1;GNAQ;IQGAP1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1;MAPRE3;PTK2;TAB2;MMD
prerank,regulation of humoral immune response (GO:0002920),0.3414993177116153,0.9104643635021645,0.5745257452574526,0.8798064976429345,1.0,7/44,13.34%,GATA6;FCGR2B;SUSD4;CR1L;CLU;CFB;CR2
prerank,negative regulation of viral life cycle (GO:1903901),0.40872373582509036,0.9104372373961795,0.5608214849921012,0.8793739686709662,1.0,2/15,4.67%,LY6E;TRIM11
prerank,negative regulation of cation channel activity (GO:2001258),0.3602970173906475,0.9102495345208718,0.5585331452750353,0.8792554663793848,1.0,2/26,2.67%,KCNE3;FKBP1A
prerank,regulation of cytokinesis (GO:0032465),0.308037004428351,0.9102275507207174,0.5705596107055961,0.8787986191126111,1.0,21/78,21.88%,PLK3;RAB11A;CUL3;BCL2L1;PIK3C3;CDC14A;E2F7;CALM3;VPS4A;PRC1;PIN1;RAB11FIP4;PKN2;KLHL9;GIT1;MAP10;RAB11FIP3;GIPC1;SETD2;ECT2;KIF23
prerank,protein sumoylation (GO:0016925),0.3284775902978092,0.910008529793954,0.5784061696658098,0.8787804054998345,1.0,11/49,15.93%,IFIH1;SUMO2;SUMO3;RANGAP1;NUP54;NUP35;RANBP2;NUP153;NUP160;NUP42;NUP205
prerank,peptidyl-amino acid modification (GO:0018193),0.4497959685243601,0.9099850273962754,0.5939716312056738,0.878322057839403,1.0,3/10,12.51%,APOA1;ATP7A;METAP2
prerank,positive regulation of cell communication (GO:0010647),0.3590817268303504,0.9099404127898976,0.5734870317002881,0.8779012637204346,1.0,9/28,18.99%,EDN1;GATA3;GRIK2;RIMS3;NMU;ANK3;SYT1;CDKN2AIP;SOX11
prerank,regulation of extracellular matrix organization (GO:1903053),0.4092017695276261,0.909749491790518,0.5493630573248408,0.8777896154449699,1.0,2/15,1.60%,TIE1;NOTCH1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3820472756744337,0.9095363883685671,0.5701754385964912,0.8777412723876821,1.0,5/21,11.52%,NPR2;ADCY10;NPR1;ADCY4;NPPC
prerank,regulation of T cell proliferation (GO:0042129),0.3166829746175954,0.9093249351595194,0.5813366960907944,0.8776884325668656,1.0,4/61,7.82%,VCAM1;TNFRSF1B;ARG1;SLC7A1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4055537026695219,0.9090794402104522,0.579734219269103,0.8777010353472954,1.0,6/16,17.41%,GCH1;NOS1AP;NUS1;PIK3CB;HIF1A;SCARB1
prerank,protein localization to chromatin (GO:0071168),0.3912817322826409,0.9090607205552416,0.552099533437014,0.8772533553333266,1.0,6/18,19.96%,RAD21;TASOR;SGF29;CHMP7;ESR1;PPHLN1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.2604336255118175,-0.9090503368440017,0.6442687747035574,0.9019184077298299,1.0,13/52,14.99%,ME1;IDH2;ADHFE1;SLC19A1;GCLC;L2HGDH;MTHFD1;MDH2;IDH1;MTHFD2L;ALDH18A1;GOT1;DLST
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2912012894640992,0.9089684668679265,0.6328125,0.8769453155250997,1.0,16/128,10.48%,PLCB1;CCNY;PLK3;CDK14;TUBB;CSNK1D;CDC25C;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;DYNLL1;CEP76
prerank,B cell mediated immunity (GO:0019724),0.44811379668091444,0.9087156056615207,0.5647058823529412,0.8769639887468115,1.0,1/10,4.30%,FCGR2B
prerank,protein prenylation (GO:0018342),0.4367446277543792,0.9082173671871308,0.5850340136054422,0.8775000005095905,1.0,1/10,6.42%,PGGT1B
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.38905498692441587,-0.9079088398476243,0.5608591885441527,0.9034171002446224,1.0,5/10,27.39%,SMARCB1;CAMK1;PIH1D1;SPHK2;CHEK1
prerank,detection of mechanical stimulus (GO:0050982),0.3881788207845832,0.907832997536421,0.5699558173784978,0.8778415119806487,1.0,4/19,14.25%,PIEZO1;PTK2;CDH2;CTNNB1
prerank,cellular response to nitrogen compound (GO:1901699),0.3839107904158093,0.9074835011214402,0.5572289156626506,0.8780511800803112,1.0,6/20,20.67%,ATP2B4;NSMCE3;SPIDR;RIOK3;DAXX;BLM
prerank,phosphatidylserine metabolic process (GO:0006658),0.35259586700112483,0.9074305110182682,0.5873452544704264,0.8776687989340161,1.0,8/32,18.29%,MBOAT2;LPCAT4;PLSCR1;LPCAT3;PTDSS1;SERINC5;PLA2G12A;PLAAT3
prerank,negative regulation of type I interferon production (GO:0032480),0.3457697599178211,0.9074064388298798,0.5876712328767123,0.8772262807609272,1.0,10/40,16.66%,IFIH1;UBA7;RNF125;NLRC5;ACOD1;CACTIN;TRIM25;PIN1;HAVCR2;PYCARD
prerank,cell cycle G2/M phase transition (GO:0044839),0.2911976193780651,0.9073542657856993,0.6374859708193041,0.8768396944225092,1.0,16/129,10.48%,PLCB1;CCNY;PLK3;CDK14;TUBB;CSNK1D;CDC25C;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;DYNLL1;CEP76
prerank,response to ketone (GO:1901654),-0.30956488708492524,-0.9071228416913687,0.6089743589743589,0.9040883761887616,1.0,4/24,7.08%,TGFBR3;SLIT2;THBS1;CATSPER2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.41465859887153,0.9069080208038107,0.5681444991789819,0.877266560813605,1.0,8/14,24.02%,ADAM17;APH1A;ADAM10;ABCA7;PSEN2;DYRK1A;APH1B;NCSTN
prerank,regulation of spindle organization (GO:0090224),-0.33438336810482094,-0.9068913368849667,0.5828877005347594,0.90344277282512,1.0,8/18,29.85%,GNAI1;GPSM2;RNF4;PARP3;BORA;TPX2;FSD1;NUP62
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.34942455838032793,0.9067950875504551,0.5701754385964912,0.876987180596853,1.0,3/31,3.11%,SMAD6;NOTCH1;HDAC7
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.38080833791548824,-0.9065493379168965,0.5810473815461347,0.9030404230970052,1.0,2/10,10.07%,ADGRV1;WHRN
prerank,positive regulation of histone deacetylation (GO:0031065),0.42486479399752497,0.9063399372087257,0.5983333333333334,0.8774614939683001,1.0,3/12,11.99%,PRKD1;ING2;PRKD2
prerank,negative regulation of kinase activity (GO:0033673),0.3147446678877496,0.9058508537041072,0.595360824742268,0.87797479057414,1.0,8/62,7.36%,CEACAM1;GNAQ;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3986175161962978,0.905693160674925,0.559190031152648,0.8778263599772422,1.0,3/17,6.44%,ADIPOR2;CAV1;ADIPOR1
prerank,acetyl-CoA metabolic process (GO:0006084),0.4093595741202019,0.9056242941061773,0.5684380032206119,0.877475121496999,1.0,7/15,23.74%,ACACB;HMGCS1;PPCS;MVD;ACAT1;ACLY;MVK
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.21726182246263331,-0.9054538431376176,0.7422680412371134,0.9045973032460495,1.0,38/132,24.09%,CELF2;SRSF5;SCAF11;DICER1;NUDT21;NCBP1;TRAF7;RPL24;COIL;DENR;SRSF1;EIF2S2;GEMIN5;SMN1;EIF2D;PUF60;SRSF6;DDX1;SNRPF;RRP7A;XRCC5;RPLP0;RAMAC;SNUPN;SNRPD3;MRPS11;XAB2;SF1;RRS1;LUC7L;SF3B1;SRPK2;SF3A2;GEMIN7;CELF1;NAF1;CELF5;WDR77
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3329265189201079,0.9053713591702764,0.5791610284167794,0.877509707266767,1.0,11/42,19.48%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2;TARS3;RARS1;EEF1E1;DARS1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4251286687963796,0.9050606025847437,0.5709728867623605,0.877650697104431,1.0,5/13,16.50%,PTPN1;PPP1R15B;ABCA7;RACK1;NCK1
prerank,protein deneddylation (GO:0000338),0.43899282489556124,0.9049665147552032,0.5642737896494157,0.8773553022477966,1.0,3/10,17.63%,COPS4;COPS8;COPS5
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.36148189761690624,0.9048085547466164,0.5716417910447761,0.8771851239125755,1.0,13/27,24.62%,ZC3H12A;TRIR;RNASE1;NHP2;XRN1;RNASE6;POP1;KHNYN;ERN1;RNASE4;CPSF3;NUDT16;RNASEH1
prerank,proteolysis (GO:0006508),-0.2064750092633849,-0.9047843448519508,0.8043478260869565,0.9049873598686384,1.0,42/252,14.06%,TRABD2B;AEBP1;ADAMTS12;CPQ;OGT;ADGRV1;BACE2;MMP14;HTRA3;ANPEP;CPE;DPP4;BACE1;ADAMTS3;HM13;CLPX;FAP;ADAM19;UFSP2;ADAMTS9;F3;MMP2;ERMP1;ADAM33;PRCP;CPXM2;CASP3;NAALAD2;PTCH1;ATG4D;YME1L1;MMP16;GGT5;CPXM1;ZMPSTE24;ENPEP;MMP19;MDM2;SENP1;RNPEP;SPCS3;PCSK7
prerank,regulation of amyloid-beta formation (GO:1902003),0.3568489495781281,0.9047770844833648,0.5971830985915493,0.8767559361802951,1.0,16/34,21.58%,IFNGR1;EFNA1;TMED10;RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;GSK3A;HAP1;RELA;SORL1;EPHA4
prerank,primary neural tube formation (GO:0014020),-0.287907287807749,-0.9045417270550252,0.6389776357827476,0.9043739264051842,1.0,10/30,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,positive regulation of protein metabolic process (GO:0051247),0.29571529525679174,0.9040439759638275,0.6271186440677966,0.877707910851122,1.0,15/110,12.34%,KLF2;PAEP;FOXO1;DAB2IP;APP;KLF4;WWP1;ASB5;APC;VPS28;NFKBIA;RANBP9;NEDD4L;CLU;SMURF1
prerank,regulation of RNA splicing (GO:0043484),-0.2385988503660208,-0.9037116141237346,0.6825396825396826,0.9051982101838228,1.0,20/69,17.82%,SON;SNRNP70;AFF2;HNRNPH1;AHNAK2;BRDT;AHNAK;PIK3R1;CLK1;FUS;JMJD6;CLK4;RBM39;RBM20;HNRNPLL;HNRNPL;RPS26;CLK2;ZPR1;U2AF2
prerank,renal system development (GO:0072001),0.32836900757467724,0.903274279604891,0.6030534351145038,0.8787677879418173,1.0,7/52,7.31%,SOX17;ACE;TGFB2;PCSK5;HYAL2;GATA3;STAT1
prerank,myeloid dendritic cell activation (GO:0001773),0.4233347242116844,0.9031261370469114,0.5677966101694916,0.8785859784932242,1.0,4/12,22.63%,HMGB1;DOCK2;PYCARD;CAMK4
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.35946213617070594,-0.9030836059112284,0.6109660574412533,0.9055340218686173,1.0,5/13,17.12%,BMP7;BMP4;CALCOCO1;GPER1;AR
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.30666332248703904,0.9028099493814895,0.6212303980699638,0.8787280718444509,1.0,10/86,6.32%,ENG;BMPR2;ACVRL1;NOTCH1;RBPMS;TGFB2;ACVR1;ING2;SMAD2;ADAM17
prerank,positive regulation of dendritic spine development (GO:0060999),-0.31859276803923076,-0.9023956159282105,0.5617647058823529,0.9059492203489884,1.0,5/20,13.86%,APOE;CAMK1;DBN1;LLPH;CPEB3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2774627373041789,-0.901856042661499,0.6564625850340136,0.9059675819871589,1.0,8/33,17.12%,DDX5;UBA5;RUNX1;UFSP2;KLK2;HDAC6;LATS1;AR
prerank,axonal transport (GO:0098930),0.34750807541992373,0.9017811359870054,0.584931506849315,0.8802924999251452,1.0,10/36,22.31%,BLOC1S6;DST;AP3S1;HIF1A;SYBU;KIF1A;AP3M1;HAP1;AP3D1;SOD1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3253314642323848,-0.9015796753644275,0.5631868131868132,0.9053685619737251,1.0,10/18,39.63%,FLNA;ERBB2;MAF1;UBTF;PHF8;DHX33;POLR2L;HEATR1;POLR2K;EIF2AK3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.42390564812797016,0.9012551513476866,0.5879396984924623,0.8808980563209289,1.0,6/13,19.38%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4221238963761227,0.9011855449102487,0.5728643216080402,0.8805452084087289,1.0,4/11,13.91%,TBX1;STAT1;CTNNBIP1;LRP5
prerank,regulation of primary metabolic process (GO:0080090),0.2943154048233425,0.9004606686176047,0.6427771556550952,0.8814578312114953,1.0,46/126,24.17%,AZIN1;FASN;ZFP69;HNF4A;PLPP1;PSMD13;ADIPOR1;PSMD4;NR1D1;PSMA5;PSMB10;ACACB;PSMB8;PSMD14;LACTB;HELZ2;HMGCS1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;ABCA7;PSMB9;PSMC6;PSMA4;MVD;SIN3A;NCOA6;PSMD5;PSMD9;PSMB6;PSMB2;DHCR7;SREBF2;GGPS1;OAZ2;NCOR2;NQO1;EDF1;IDI1;CERS2;MVK;NCOA2;PSMD2
prerank,negative regulation of bone mineralization (GO:0030502),0.40702163329132707,0.9002144583673377,0.5874363327674024,0.8814636788698047,1.0,1/13,1.34%,CCR1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3818956538470432,0.8999779943693931,0.5836012861736335,0.8814689609306775,1.0,7/18,20.25%,UFM1;RAB23;MFHAS1;CTNNA1;CABP1;SIN3A;GSK3B
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.34269806179457585,0.8999354137967662,0.5797101449275363,0.8810713093293341,1.0,10/40,17.71%,FOXF2;UBE3A;PTK2;XPO1;FBXW7;LAPTM5;CLU;SMURF1;RNF139;UBQLN4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.34074156696277785,0.899766310929034,0.6036988110964333,0.8809131498075379,1.0,6/37,6.98%,SMAD7;APP;INPP5K;TRIM6;MAPK1;IRGM
prerank,negative regulation of cilium assembly (GO:1902018),0.41780689160205425,0.8992156218295786,0.5820642978003384,0.8815266395762252,1.0,3/12,10.83%,MAP4;TBC1D30;LIMK2
prerank,mitochondrial translational termination (GO:0070126),0.3062058888660199,0.8990450730200972,0.6400937866354045,0.8813834675847412,1.0,37/88,28.54%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,regulation of smooth muscle contraction (GO:0006940),0.3842405254388536,0.8987713348197791,0.5946348733233979,0.8814640575825293,1.0,5/20,15.88%,CAV1;ADRB2;CHRM3;SETD3;NMU
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3727082314838533,0.8985352682994928,0.5769805680119582,0.8814091324020826,1.0,8/25,21.01%,OMA1;RNF185;CUL3;BAG6;UGGT1;NGLY1;RNF5;POMT2
prerank,membrane depolarization (GO:0051899),0.3498972071665662,0.8985027875624934,0.6005788712011577,0.8809961129726396,1.0,9/32,18.28%,CAV1;CACNA1A;SCN11A;P2RX7;SCN1B;YWHAH;SCN9A;CACNA1E;SCN1A
prerank,histone H3-K36 demethylation (GO:0070544),-0.38417445680842865,-0.8984776964372153,0.5728643216080402,0.9118068172840651,1.0,5/10,20.14%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,regulation of T cell differentiation (GO:0045580),0.3473767155962912,0.8983693410127715,0.6132208157524613,0.8807839586502038,1.0,5/33,13.75%,CRTAM;TNFRSF18;GATA3;CBFB;RHOH
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3966270020648911,-0.8981903862776923,0.5919811320754716,0.9113239734494671,1.0,7/10,34.16%,MTHFD1;MTHFD2L;TYMS;MTHFR;DHFR;SHMT2;SHMT1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.327486000442324,-0.8979072479956357,0.5887323943661972,0.9107600902602847,1.0,7/17,16.38%,PTPN22;ANXA1;SSC5D;OTUD7B;MAPKBP1;BCL3;ANXA4
prerank,receptor recycling (GO:0001881),0.43517272172524624,0.8976570986034289,0.5842293906810035,0.8817237740937411,1.0,5/10,20.71%,LMTK2;PHETA1;NSG1;REP15;SORL1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.38535742027414666,-0.8970687658498436,0.5673076923076923,0.9116313438769951,1.0,3/10,9.96%,PRKAA2;FLCN;KLF15
prerank,regulation of cell cycle process (GO:0010564),0.2975652171280735,0.8970242479955058,0.6385964912280702,0.8824834986611587,1.0,16/104,14.25%,PLK3;RAB11A;CAV2;TTL;CDC25C;BCL2L1;APC;PIK3C3;RPRD1B;NUMA1;CALM3;PRC1;PIN1;BUB1;RAB11FIP4;CTNNB1
prerank,lipid homeostasis (GO:0055088),-0.2546014602865297,-0.8969603201461663,0.6457399103139013,0.9106682806898182,1.0,19/57,23.75%,ZBTB20;RBP1;APOE;ABCA1;PRKAA2;TLCD2;IRS2;NR1D2;PPARG;DDX3X;NR1H3;RCN3;ABHD8;ORMDL2;TLCD1;DGAT2;MLXIPL;ANGPTL3;FITM2
prerank,dendritic cell differentiation (GO:0097028),0.3805132285833479,0.8965396159268098,0.6140888208269525,0.8830117401934916,1.0,2/22,2.67%,F2RL1;LGALS9
prerank,mRNA 3'-end processing (GO:0031124),-0.2355610841801025,-0.8965287370359899,0.6962025316455697,0.9104611256373754,1.0,33/78,26.16%,SRSF5;SCAF8;NUDT21;NCBP1;SRRM1;SRSF1;PAF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;CSTF2T;PCF11;MAGOH;AHCYL1;U2AF2;MAGOHB;PABPC1;LSM11;UPF3B;SRSF3;SLBP;PAPOLB;SRSF11;NCBP2;PAPOLA;SRSF2;EIF4A3;U2AF1;ZC3H11A;THOC7;GRSF1
prerank,protein acylation (GO:0043543),0.3419706002127909,0.8964955988571112,0.6129905277401895,0.8826123054526657,1.0,3/38,2.79%,FOXO1;ZDHHC22;NAT9
prerank,activation of protein kinase activity (GO:0032147),0.2935674009736915,0.8963717757954757,0.6623681125439624,0.8823487709815789,1.0,19/106,13.05%,PDGFB;INSR;TGFB2;ADRB2;EMP2;TLR3;TIRAP;CARD10;ANGPT1;MAP4K4;TOM1L1;JAK2;TAOK2;ADCY4;CCDC88A;MINK1;MARK2;COPS8;ITGB1BP1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3058912727728443,0.8961622955706594,0.6206896551724138,0.882290827959628,1.0,14/84,13.89%,PLK3;FOXO1;DAB2IP;MSN;FURIN;TNFRSF1B;WWP1;ASB5;APC;VPS28;NEDD4L;VPS35;SMURF1;NSF
prerank,substantia nigra development (GO:0021762),-0.27049868897425705,-0.896053555857053,0.6518771331058021,0.910385030035033,1.0,14/37,17.91%,NDRG2;NDUFS3;CALM2;PLP1;MAPKAP1;CKB;PADI2;YWHAQ;SIRT2;MBP;SEC16A;CNP;BASP1;FGF9
prerank,heme catabolic process (GO:0042167),-0.3426137041649021,-0.8959385450537729,0.5963060686015831,0.9082516025644761,1.0,2/14,11.57%,SLCO2B1;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3426137041649021,-0.8959385450537729,0.5963060686015831,0.9082516025644761,1.0,2/14,11.57%,SLCO2B1;BLVRB
prerank,lysosome localization (GO:0032418),0.3422616627037047,0.8956409596168728,0.6062246278755075,0.8828357664064798,1.0,9/37,16.27%,RAB34;MILR1;SPAG9;MYH9;PLEKHM1;KLC2;CHGA;TMEM106B;PLEKHM2
prerank,regulation of organelle organization (GO:0033043),0.30368416586893865,0.8955527831546395,0.6283292978208233,0.8825342972135524,1.0,15/80,15.69%,F11R;DIAPH1;CLIC4;MSN;CAMSAP2;MAPK1;TJP1;PTK2;VPS35;MARK2;TMED9;USP6NL;RHOT2;PDCD10;PAK2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.29683713312085597,-0.895530394845115,0.5838709677419355,0.9079824573747354,1.0,8/25,21.15%,SNRNP40;SCAF11;PRPF8;SRRM1;PRPF3;BCAS2;MPHOSPH10;SF3B1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.42986786942518823,0.89548761907948,0.5903010033444817,0.8821821923478735,1.0,1/11,0.92%,FYN
prerank,cilium movement (GO:0003341),0.3259083946682928,0.895118448073333,0.6063408190224571,0.8824378398291168,1.0,4/47,4.33%,CFAP206;ADCY10;TEKT5;TTC29
prerank,regulation of chromosome segregation (GO:0051983),0.3950864900793215,0.8948803813747779,0.5839874411302983,0.8824303620596725,1.0,4/16,14.43%,PUM2;NUMA1;BUB1;RAD18
prerank,cellular response to decreased oxygen levels (GO:0036294),0.31049901543595654,0.894806602940965,0.6207759699624531,0.8820987996217173,1.0,2/65,0.62%,EPAS1;GATA6
prerank,phosphatidylcholine metabolic process (GO:0046470),0.31123699013469414,0.894806505065709,0.6221959858323495,0.8816183536524245,1.0,14/70,18.29%,APOA1;SLC44A1;MBOAT2;LPCAT4;LCAT;PCYT1A;TMEM86B;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B;PLA2G12A;PLAAT3
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.39360582865633753,0.8944509467364142,0.6144393241167435,0.8818157433903359,1.0,7/18,24.23%,PUM2;RNF125;SEC14L1;DHX58;ANKRD17;NOP53;OASL
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.42153396201070403,0.8941387319710348,0.5778491171749599,0.8819494203191837,1.0,3/11,10.96%,GOPC;TAX1BP3;NEDD4L
prerank,metanephros development (GO:0001656),0.364531987822733,0.8936071656397828,0.6131934032983508,0.8825321630269887,1.0,1/26,0.23%,SOX17
prerank,ether lipid metabolic process (GO:0046485),-0.3379066107970915,-0.8934177596329222,0.6457765667574932,0.9118327162695203,1.0,3/14,7.84%,AGMO;GNPAT;PEDS1
prerank,amino acid transmembrane transport (GO:0003333),0.3280189448461369,0.893188521394024,0.5964240102171137,0.8828655203198664,1.0,5/45,7.82%,SLC6A6;SLC7A7;SFXN1;SLC16A2;SLC7A1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.38095467129435207,0.8930633346295683,0.6265243902439024,0.8826268620153007,1.0,1/22,1.73%,NOD2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2837476618999265,0.8928695245830762,0.6670258620689655,0.8825317118348989,1.0,39/166,19.01%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;TAF9B;TAF1A;RXRG;POLR2G;NR1D1;POLR1F;BRF2;POLR2D;TBPL1;MAML2;CAVIN1;GTF2H3;NR4A1;GTF2A1;TFB2M;MED27;TAF1B;MED17;TAF11;NR2C1;POLR2I;ESR1;ESRRG;RARA;TAF8;E2F3;NCOA6;NR2C2AP;TAF3
prerank,tube closure (GO:0060606),-0.2835453309888494,-0.8927333087211143,0.656957928802589,0.9122256231073157,1.0,10/31,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,tRNA processing (GO:0008033),0.3172602688130535,0.8926867612003034,0.6382165605095541,0.882425101077018,1.0,14/61,21.08%,ADAT2;TRDMT1;TRMT61A;KARS1;TRPT1;CPSF1;FARS2;TRUB1;TRMT10B;ELAC2;POP1;CSTF2;TRMT1;NSUN6
prerank,positive regulation of cholesterol transport (GO:0032376),0.3612629359582604,0.8926221633679249,0.614138438880707,0.8820670913816522,1.0,8/27,16.84%,CAV1;APOA1;PLTP;ABCB4;LPCAT3;NFKBIA;ABCA7;EEPD1
prerank,pseudouridine synthesis (GO:0001522),0.4094059760976706,0.8920813576654346,0.6114649681528662,0.8826638270052265,1.0,4/13,17.96%,DKC1;TRUB1;NHP2;RPUSD2
prerank,negative regulation of cell cycle process (GO:0010948),0.3154917003996174,0.8913763923374022,0.6125786163522012,0.8835518407053424,1.0,10/61,12.82%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;TOM1L1;UXT;E2F7;BRCA1;VPS4A
prerank,cardiac myofibril assembly (GO:0055003),0.3971589731339739,0.8907498934013148,0.5868167202572347,0.884284492835261,1.0,1/15,0.60%,NEBL
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3795615832362438,0.8906221717109355,0.5886736214605067,0.8840465198660026,1.0,4/20,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,long-chain fatty acid import into cell (GO:0044539),0.4443520249405989,0.8901857153272619,0.6031468531468531,0.8844054279934469,1.0,3/10,14.78%,SLC2A1;RPS6KB1;SLC27A2
prerank,tryptophan metabolic process (GO:0006568),0.4291616356046264,0.8898903506438157,0.6209262435677531,0.8845033749149166,1.0,3/11,21.84%,ATP7A;KYAT1;KYNU
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.35030478640111307,0.8897854534041627,0.5883190883190883,0.8842267415948295,1.0,9/30,15.26%,SLC27A6;ACSBG1;ACOX1;ELOVL4;HACD4;ELOVL7;ELOVL5;SLC27A2;TECR
prerank,neuron cell-cell adhesion (GO:0007158),0.4070160736214639,0.8896466202937914,0.6110154905335629,0.8840271245981776,1.0,7/14,25.99%,NCAM2;ASTN1;NRXN3;CNTN4;NRXN1;NLGN1;RET
prerank,inorganic anion transmembrane transport (GO:0098661),0.3092441043967363,0.8896452301097536,0.6551282051282051,0.8835549749228847,1.0,17/63,18.08%,SLC12A8;ANO6;GABRQ;CLCN3;SLC25A30;CLCN1;GABRA4;XPR1;SLC1A1;GABRA2;SLC37A2;GABRE;SLC37A3;GLRA2;SLC25A10;GABRG3;GABRB1
prerank,positive regulation of cellular component organization (GO:0051130),0.29183142459041694,0.8895700382147966,0.6486175115207373,0.8832300355279047,1.0,11/107,6.20%,ATP10A;INSR;TAL1;MMP1;DAB2IP;TGFB2;TIRAP;HRK;SHANK3;ABCB4;WARS1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.31577138533367843,0.8889460777071915,0.6330845771144279,0.8839799440229394,1.0,13/60,14.45%,TNRC6C;HNF1A;HEY2;MED26;LEF1;AGO4;MED30;CBFB;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3119249432817245,-0.8886821463657479,0.6456456456456456,0.9207735750945192,1.0,7/22,13.54%,APOE;TIMP2;PTPN3;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,regulation of secretion by cell (GO:1903530),0.32231493506916925,0.8881120602726237,0.6183206106870229,0.8851774218544811,1.0,11/54,18.42%,MCTP1;SCG5;MEF2C;VAMP8;SNCAIP;NSF;CPLX1;STXBP5L;STXBP5;SYT1;HAP1
prerank,DNA strand elongation (GO:0022616),-0.3245874200310306,-0.8881119668771753,0.6270718232044199,0.9209204489651006,1.0,11/18,40.00%,RAD50;TERT;DCLRE1B;POLD2;GINS1;RFC4;MCM7;POLD3;GINS3;GINS2;MRE11
prerank,pyruvate metabolic process (GO:0006090),0.3251857039435222,0.8880590164097641,0.611764705882353,0.884797482980846,1.0,11/52,16.13%,GPI;PGK1;PCK2;BSG;GAPDH;LDHC;DLD;ME3;LDHAL6B;VDAC1;PFKM
prerank,organelle disassembly (GO:1903008),-0.28336222081293805,-0.8880540948592298,0.631768953068592,0.9198489487042715,1.0,11/33,15.95%,GOLGA2;TEX264;UBA5;DENR;ATG2A;MRRF;EIF2D;ULK2;STX5;KIF9;PLK5
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.3623631685577629,0.8875935007446101,0.6077844311377245,0.8852432811517869,1.0,7/23,17.63%,COPS4;UBA52;RPS27A;RBX1;COPS8;XPC;COPS5
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3518963048221338,0.8874958193087981,0.6164978292329957,0.8849581596508468,1.0,8/31,19.18%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3796334177167283,-0.8874919165085732,0.6099290780141844,0.9200497549709172,1.0,5/10,26.90%,NINL;KIF3A;CCDC68;CCDC120;CEP19
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3128010206412981,0.8874736795680819,0.6191677175283733,0.8845211151274925,1.0,24/62,25.89%,PUM2;ELAVL1;POLR2G;NUP54;DHX9;POLR2D;NUP35;RANBP2;NUP153;FXR1;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR;TGFB1
prerank,phospholipid transport (GO:0015914),0.31606167911470634,0.887346607910568,0.633377135348226,0.8842939480232733,1.0,8/52,12.95%,ATP10A;APOA1;PLTP;ABCB4;PITPNA;ATP11C;ATP8B1;ABCC1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.39053000470762683,0.8869788985228909,0.5876923076923077,0.8845521103078489,1.0,4/17,16.90%,LGALS9;GATA3;HAVCR2;RARA
prerank,sister chromatid segregation (GO:0000819),-0.28301652687154044,-0.8868792312293781,0.6221498371335505,0.9204306153540143,1.0,16/31,32.35%,KLHL22;TOP2B;NCAPG2;MIS12;LATS1;CENPK;ZW10;NUSAP1;TOP2A;ZWINT;SPAG5;KIF18B;KIFC1;NSL1;TUBG2;CDCA8
prerank,synapse organization (GO:0050808),0.2858636687168684,0.8859345719553655,0.6773455377574371,0.8861375443687822,1.0,26/125,13.24%,UNC13B;APBB2;AGRN;APP;PPFIBP1;DNM3;SNCG;GPHN;SPOCK2;PLXND1;SHANK3;LRRK2;NRCAM;FLRT3;LRRC4C;PPFIA2;CYFIP1;KIRREL3;ZC4H2;CDH2;ACHE;GRM5;SLITRK2;CX3CR1;PIN1;PCDHB16
prerank,epithelial structure maintenance (GO:0010669),0.4217786474036462,0.8859243102475051,0.6038394415357766,0.8856773934291382,1.0,1/11,1.73%,NOD2
prerank,positive regulation of growth (GO:0045927),0.3118340089417703,0.8857049596640806,0.6297709923664122,0.8856389181259515,1.0,10/64,10.40%,PLCB1;INSR;TGFB2;PPM1F;BRAT1;TAF9B;ADAM17;SLC25A33;ADAM10;RPS6KA1
prerank,amyloid-beta metabolic process (GO:0050435),0.3937252787815434,0.8856425267033855,0.584518167456556,0.885291565106211,1.0,8/16,24.02%,ACE;APH1A;ABCA7;PSEN2;DYRK1A;APH1B;MME;NCSTN
prerank,regulation of phosphorylation (GO:0042325),0.28917717546980515,0.8856366965772712,0.6791569086651054,0.8848304323647228,1.0,28/120,16.04%,CCDC88C;LDB2;EMP2;APP;JMJD8;HSPB1;NLRC5;NDUFS4;ROCK1;STAP1;PTK2;NUP54;PTGES3;CCDC88A;DYNLL1;NUP35;RANBP2;GRM5;NUP153;PIN1;PHIP;NUP160;HIF1A;NUP42;EIF6;CDKN2D;NUP205;KDM4D
prerank,ribosomal small subunit assembly (GO:0000028),0.38898401097994756,0.8855550526259026,0.6255924170616114,0.8845148515299804,1.0,6/16,21.23%,RPS14;RPS28;RPS5;RPS15;PWP2;RPS19
prerank,response to interferon-alpha (GO:0035455),0.39624704023807034,0.8849209762147581,0.6003134796238244,0.8852861482169126,1.0,4/16,9.00%,IFNAR1;GATA3;KLHL20;ADAR
prerank,response to nitric oxide (GO:0071731),0.40658177394769945,0.8844911268262696,0.6079365079365079,0.8856582722876731,1.0,1/13,1.88%,FOXO1
prerank,vitamin D metabolic process (GO:0042359),-0.348075835022147,-0.8844895042549358,0.6397984886649875,0.9248246974493257,1.0,10/13,49.38%,LGMN;PIAS4;CYP2R1;CUBN;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.41976034395534506,0.8844825995044718,0.6092943201376936,0.8852022687476995,1.0,2/11,11.45%,NOVA2;PCBP1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3661684237391471,0.8844019551789153,0.606015037593985,0.8848887899850988,1.0,8/22,21.70%,MSX1;RPL37;CHD5;ATM;RPS15;EEF1E1;UBB;HEXIM1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4268339152180882,0.884322100219032,0.6044142614601019,0.8845658928588916,1.0,4/10,22.19%,ATP7A;KYAT1;KYNU;QDPR
prerank,positive regulation of response to wounding (GO:1903036),0.3583791378870056,0.8842795477007497,0.6313432835820896,0.8841761881843325,1.0,4/24,9.21%,OCLN;MYLK;ACTG1;PTK2
prerank,positive regulation of phospholipid transport (GO:2001140),0.43016060779481124,0.8838742289348107,0.5962199312714777,0.8845365454257726,1.0,3/10,15.39%,APOA1;ABCB4;ABCA7
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3912101342811255,0.8837822473304516,0.5994108983799705,0.8842327454813335,1.0,4/16,15.59%,BCL2L1;SNAI2;CLU;CDKN2D
prerank,positive regulation of translation (GO:0045727),-0.22334630358827165,-0.8835821800444158,0.71875,0.9258570567450201,1.0,24/94,17.06%,SAMD4A;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;RMND1;TRUB2;YBX3;CDC123;ERBB2;PCIF1;LARP4B;YTHDF2;DDX3X;BCL3;EIF3D;CPEB3;RCC1L;RPS4X;EIF3E;RPUSD4;JMJD4;LARP1
prerank,glycolipid biosynthetic process (GO:0009247),-0.2642461001589291,-0.8833726273824519,0.6423076923076924,0.9251131476372612,1.0,18/38,20.25%,LARGE1;ST3GAL5;ST3GAL4;PIGA;GBGT1;SCCPDH;PIGB;PIGN;ST6GALNAC5;PIGH;PGAP2;DPM2;PIGG;ST8SIA1;ST8SIA3;PIGP;PGAP4;PIGZ
prerank,negative regulation of protein catabolic process (GO:0042177),0.326347168301814,0.8830827347749446,0.6272108843537415,0.8851041757657638,1.0,9/40,14.15%,AZIN1;DAB2IP;TIMP3;ROCK1;MAD2L2;PRKCG;ADGRB1;PIN1;NELL1
prerank,T cell differentiation in thymus (GO:0033077),-0.3452574630788595,-0.8830303102455929,0.6348773841961853,0.92472165933071,1.0,1/14,0.41%,GLI3
prerank,negative regulation of transferase activity (GO:0051348),0.34959788073905845,0.8825044777259294,0.6172661870503597,0.8857304189348316,1.0,7/28,20.25%,SMAD7;INPP5K;DTX3L;ERCC4;MEN1;GSK3A;GSK3B
prerank,negative regulation of B cell activation (GO:0050869),0.3662770084417489,0.8824084343984087,0.6046875,0.8854367307215879,1.0,6/21,19.95%,FCGR2B;TYROBP;LAPTM5;ATM;BANK1;FOXJ1
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.366527859684182,-0.8818592572882862,0.6229508196721312,0.9263347696547158,1.0,4/12,18.63%,ACSL1;SCP2;FADS2;ELOVL1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4110592565400504,0.88172784636543,0.598705501618123,0.8862613248407631,1.0,2/13,7.12%,F2RL1;ITGAM
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.34017379965202516,-0.8815349602248865,0.6412776412776413,0.9258900879404499,1.0,6/14,19.85%,ENPP1;ENPP3;AK5;CMPK2;AK1;NME2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3444307460254297,0.8814987014677893,0.6109589041095891,0.8862180105674323,1.0,6/33,8.75%,DGLUCY;GLS2;GLS;GLUD1;SIRT4;CAD
prerank,positive regulation of macrophage migration (GO:1905523),-0.31190605152887285,-0.8813571473402994,0.6483516483516484,0.9251036908903636,1.0,4/19,12.66%,IL34;THBS1;P2RX4;MDK
prerank,apoptotic DNA fragmentation (GO:0006309),0.3960232457422356,0.881106503784658,0.6056782334384858,0.8864977516518104,1.0,6/16,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3562379016059776,0.8808830458536457,0.6275362318840579,0.8864538188642496,1.0,5/29,10.51%,MCTP1;APP;SHISA8;SHISA6;GRIK2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3803623025504069,-0.880628236130404,0.6297229219143576,0.9256290370778009,1.0,6/10,29.70%,PIH1D1;ZNHIT6;NAF1;ZNHIT3;TAF9;PIH1D2
prerank,GPI anchor biosynthetic process (GO:0006506),-0.2776832148121171,-0.8805673856081144,0.6484641638225256,0.9245554484440257,1.0,14/30,26.77%,PIGA;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PGAP4;PIGZ;PGAP3;PIGL;PIGW;GPAA1
prerank,organelle assembly (GO:0070925),0.26640887417077125,0.8803507407689263,0.7791411042944786,0.8870035527581681,1.0,59/384,15.56%,EXOC6;EHD4;SYNPO;ABCC4;ABLIM1;NOTCH1;RAB11A;ATG101;FLII;STX7;TEKT5;EHD1;DHX37;CSNK1D;FAM161A;TTBK2;CD34;TTC36;FNBP1L;BBS7;SNX10;GABARAPL1;VPS36;RAB23;IRGM;MAPRE3;TMEM216;IFT140;STARD9;STX12;CFAP43;NEK7;HAUS3;PCM1;VPS28;CHMP1B;PIK3C3;CFAP52;CDC14A;DYNLL1;EXOC8;TNKS;NPM1;OCRL;RAB19;VPS4A;TMOD3;CHMP3;WDR11;KIF24;CEP83;MAP1LC3A;EIF2S1;EIF2A;EDC3;CHMP2B;CHMP7;DDX6;UBQLN2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.33830396451034306,-0.8799657954069254,0.6124661246612466,0.9247348666859803,1.0,4/15,21.25%,BMP4;SFRP4;NME2;ETV4
prerank,cell cycle G1/S phase transition (GO:0044843),0.30732383158062704,0.8799574167755905,0.640926640926641,0.8872727408886978,1.0,15/61,21.20%,PLK3;ACVR1;CCNE1;CUL3;MAP3K11;CUL2;USP29;HINFP;RPS6KB1;CDKN2D;CACUL1;E2F3;MAX;MNAT1;BCAT1
prerank,cellular potassium ion homeostasis (GO:0030007),0.4139107769938625,0.8796648082337098,0.6009852216748769,0.8873667597793619,1.0,3/13,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3781568445742738,0.8796085923663574,0.621875,0.88700407087976,1.0,3/20,8.36%,MCUB;SMDT1;MCUR1
prerank,cellular response to hydroxyurea (GO:0072711),0.4350946369565143,0.8794857649650561,0.6235294117647059,0.8867659365188214,1.0,4/10,25.13%,NSMCE3;SPIDR;BLM;RTF2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.35596770727466,-0.8791926380668981,0.6341463414634146,0.925276085652142,1.0,5/12,24.63%,PARP8;PARP3;PARP1;PARP6;PARP2
prerank,glycerol metabolic process (GO:0006071),-0.3757536236981007,-0.8789564408418612,0.6097560975609756,0.9246024620917841,1.0,5/10,23.33%,GK;GOT1;COQ2;TPI1;ANGPTL3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.41825290164848,0.8788842612705583,0.6085526315789473,0.8874650171600297,1.0,3/11,15.49%,FBXO7;HIF1A;RACK1
prerank,protein localization to vacuole (GO:0072665),0.4014141599357442,0.8787827780671533,0.6077441077441077,0.8871876924542061,1.0,3/13,9.49%,SH3BP4;RNF128;RTN4
prerank,cilium assembly (GO:0060271),0.2685115619646166,0.8786450432944867,0.7482014388489209,0.8869777462006859,1.0,34/296,10.78%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;CFAP206;TEKT5;EHD1;DNAAF3;TUBB;CSNK1D;FAM161A;TTBK2;TTC36;FNBP1L;BBS7;SNX10;TUBB4B;RAB23;SPATA6;CLASP1;TMEM216;NEDD1;IFT140;CFAP43;CEP135;HAUS3;PCM1;CFAP52;CDC14A;DYNLL1;CEP76;EXOC8
prerank,spermatid development (GO:0007286),0.3441184196441809,0.878498506208704,0.6364922206506365,0.8868061060987087,1.0,2/32,4.15%,JAM2;ING2
prerank,nervous system development (GO:0007399),0.26364839622285263,0.8783043601715463,0.788675429726997,0.8867011254896352,1.0,68/429,14.81%,JAG1;KALRN;EFNA5;LDB2;RNF103;SLC2A1;MERTK;APBA1;MPZ;GDA;RAPGEF5;NRGN;GJB1;SERPINI1;PPT1;DNM3;EVL;SNTG2;SPOCK2;PLXND1;WWTR1;MBNL1;MEF2C;PCDH1;SHANK3;SH3GL1;CHRM3;ZBTB16;WWP1;NRCAM;FLRT3;NCKAP1;APC;MAL;EIF2B2;NFASC;ASIC2;FAT4;ADGRB1;KIRREL3;ZC4H2;CDH2;SPOCK1;NCAN;BPNT1;NAV1;GSS;ACHE;SOX10;SOX6;RPS6KA3;CYP26C1;POU3F2;PCDHB16;RBM45;SDCBP2;CAPG;ADGRA2;MYT1L;VLDLR;NELL1;NAV3;TRPC5;PCDHB14;ATXN1;GFRA3;CXCR4;FZD9
prerank,cellular response to amino acid starvation (GO:0034198),0.3031219899460415,0.8778621475573223,0.6662484316185696,0.88708493366495,1.0,19/71,20.88%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;LAMTOR3;ATP6V1D;EIF2AK2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2851216904175039,0.8776885874905589,0.6782511210762332,0.8869370728506839,1.0,28/138,17.09%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;TAF9B;RXRG;POLR2G;NR1D1;POLR2D;MAML2;GTF2H3;NR4A1;GTF2A1;MED27;MED17;TAF11;NR2C1;POLR2I;ESR1;ESRRG;RARA;TAF8
prerank,positive regulation of coagulation (GO:0050820),-0.36263301571202455,-0.8776538237203129,0.6228287841191067,0.9252222357471708,1.0,3/10,11.24%,THBS1;ST3GAL4;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.36263301571202455,-0.8776538237203129,0.6228287841191067,0.9252222357471708,1.0,3/10,11.24%,THBS1;ST3GAL4;SERPINE1
prerank,nuclear body organization (GO:0030575),-0.35483136880125354,-0.8772335507325446,0.6345177664974619,0.9250640137634125,1.0,5/12,21.60%,AFF2;USP50;ZPR1;PML;SRPK2
prerank,regulation of cellular protein localization (GO:1903827),-0.261392649342065,-0.8771364462245367,0.6914498141263941,0.9240923031541903,1.0,3/45,2.96%,GPC6;GPC3;PRKAA2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.416804694463889,0.8771314663290791,0.6128472222222222,0.8875505160311067,1.0,3/11,12.50%,KLF2;EPN2;PIK3CB
prerank,protein deubiquitination (GO:0016579),0.2691539541987602,0.8770953217559163,0.727743271221532,0.8871554032172985,1.0,53/242,18.93%,SMAD7;FOXO4;SPATA2;USP38;IFIH1;ADRB2;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;UBA52;APC;RPS27A;RNF128;PSMA5;BABAM2;PSMB10;SIAH2;NFKBIA;USP12;POLB;PSMB8;ACTB;PSMD14;BRCA1;EIF3F;USP29;YOD1;PSMA7;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;MINDY1;PSMB5;USP9Y;PSMC5;PSMB9;TRRAP;PSMC6;ESR1;USP35;PSMA4;COPS5;SMAD4;PSMD5;PSMD9;PSMB6;INO80D
prerank,positive regulation of type I interferon production (GO:0032481),0.3005049029726153,0.8769178974489926,0.6455696202531646,0.8870248494430152,1.0,17/73,20.59%,IFIH1;LRRFIP1;TLR3;DDX41;STAT1;OAS2;POLR3B;GAPDH;DHX9;IRF5;RIOK3;CTNNB1;RELA;G3BP1;SETD2;POLR3C;DHX58
prerank,negative regulation of bone remodeling (GO:0046851),0.4226921221867559,0.8763888992305704,0.6256077795786061,0.8876164349070879,1.0,2/11,6.78%,GPR137B;P2RX7
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.2457964241985196,-0.8760282049898437,0.7258064516129032,0.9254208081553351,1.0,17/55,21.82%,PID1;PDGFRB;THBS1;PRKN;XDH;DHRS4;PDK3;AGTR1;MPV17;SIRT2;TGFBR2;CDKN1A;ACE2;PAX2;AGT;ROMO1;SPHK2
prerank,regulation of lipid metabolic process (GO:0019216),-0.22155056503078724,-0.87590763326274,0.7701149425287356,0.9245189807573161,1.0,14/88,10.78%,PRKAG2;CHD9;TBL1XR1;PPARA;CREBBP;RORA;NFYC;IRS2;OPA3;NR1D2;C1QTNF2;CCDC3;TNFAIP8L3;PPARG
prerank,Golgi inheritance (GO:0048313),0.41105997918582016,0.8758009901644965,0.5963756177924218,0.8883078157748074,1.0,3/11,15.45%,PLK3;VRK1;PDCD10
prerank,aerobic respiration (GO:0009060),-0.3136416733632056,-0.8756961726267167,0.6705539358600583,0.923820300511517,1.0,10/20,25.94%,SIRT3;MDH2;NDUFS7;SDHB;MTFR1L;UQCRH;ATP5F1D;SLC25A14;MTFR2;NDUFS8
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4192821699457159,0.8754155517452754,0.6091205211726385,0.8885948726187036,1.0,2/11,7.74%,ADRB2;ARRB1
prerank,negative regulation of cellular component movement (GO:0051271),0.3911417191440607,0.8753341734778208,0.6205787781350482,0.8882877560764996,1.0,7/15,15.25%,CRK;SPOCK3;GATA3;SPINT2;PIN1;CD9;FRMD5
prerank,membrane protein proteolysis (GO:0033619),0.3323692892695865,0.8750033657236559,0.64,0.8884582630450508,1.0,19/37,25.99%,SPPL2A;RHBDD1;MYH9;ADAM17;MBTPS2;TMPRSS6;APH1A;ADAM10;PSEN2;RELA;CTSH;APH1B;SPPL2B;ERAP1;AFG3L2;NCSTN;PARL;TGFB1;RET
prerank,autophagosome assembly (GO:0000045),0.31314330423013126,0.8741631550351252,0.6309677419354839,0.8895794929220281,1.0,12/52,16.99%,TRAPPC8;ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;SMURF1;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,regulation of cell killing (GO:0031341),0.38493050899602765,0.8738629109441326,0.6012364760432767,0.8896575120353871,1.0,4/16,11.05%,TGFB2;CR1L;RAC1;CYBA
prerank,bone morphogenesis (GO:0060349),0.3918126351180633,0.8735452317132268,0.6238095238095238,0.8898137205371791,1.0,2/14,5.43%,BMPR2;FGFR3
prerank,RNA 3'-end processing (GO:0031123),-0.23274888818150802,-0.8732686316853361,0.6927374301675978,0.9282280033644158,1.0,28/69,25.49%,SRSF5;NUDT21;NCBP1;LIN28B;SRRM1;SRSF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;SUPV3L1;CSTF2T;PCF11;MAGOH;U2AF2;TUT4;MAGOHB;UPF3B;SRSF3;SRSF11;NCBP2;PAPOLA;SRSF2;EIF4A3;U2AF1;ZC3H11A;THOC7
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3213314853375059,-0.872842804746474,0.6256544502617801,0.928010628648032,1.0,7/18,18.62%,APOE;DACT1;ATP5IF1;CD81;CTSC;AMER1;EZR
prerank,cellular response to UV-A (GO:0071492),0.4187198403965411,0.8722412153272832,0.6093489148580968,0.8918169561156014,1.0,4/11,22.89%,MMP1;PPID;TIMP1;MME
prerank,positive regulation of organelle assembly (GO:1902117),0.3216837796407781,0.8721016949205539,0.6223118279569892,0.8916213473964213,1.0,13/44,21.43%,SAXO1;RAB3GAP2;CNOT6L;CNOT1;CCDC88A;NUMA1;CAPG;LCP1;CEP120;CNOT2;G3BP1;MARK4;RALB
prerank,negative regulation of mRNA processing (GO:0050686),-0.3315967929727197,-0.8715529560068492,0.6054794520547945,0.929751653738835,1.0,8/15,34.87%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,regulation of interleukin-17 production (GO:0032660),0.3422263944971986,0.8711988456678079,0.6212765957446809,0.892841649694739,1.0,3/31,10.88%,NOD2;PRNP;VSIR
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.36877396106624016,-0.8711771578502163,0.6295399515738499,0.9294066260900793,1.0,4/11,8.42%,IGF1;IRS1;PIK3R1;GHR
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4206469572246759,0.871078716572201,0.632952691680261,0.8926095780277792,1.0,5/11,22.51%,EXOSC3;DKC1;FBLL1;EXOSC10;FBL
prerank,negative regulation of myotube differentiation (GO:0010832),0.4075485488255312,0.8710476723960993,0.636650868878357,0.8921934699006012,1.0,1/12,1.60%,NOTCH1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.31553588591668236,-0.8709851384669307,0.6171428571428571,0.9286621010967896,1.0,3/18,5.49%,WNK1;PPARA;PTPN22
prerank,histone methylation (GO:0016571),-0.2862623887402257,-0.8706480976615876,0.6896551724137931,0.9283009836787243,1.0,6/26,16.44%,CREBBP;NSD3;NSD1;EHMT1;SUV39H1;N6AMT1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.36656899968655976,-0.8704713837315965,0.6547314578005116,0.9275243217398668,1.0,3/11,6.10%,NBL1;SLIT2;CCN3
prerank,reverse cholesterol transport (GO:0043691),0.4002953297563676,0.8704064534483336,0.6224,0.8929402197464793,1.0,4/13,17.41%,APOA1;LCAT;CLU;SCARB1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.26402468467467805,0.8702009445808603,0.7660878447395302,0.8928341911638544,1.0,88/341,21.13%,ZNRF1;CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PSMD4;KLHL20;PTTG1;ARRB1;WWP1;UBE4A;TOM1L1;FEM1C;NFE2L2;PPP2R5C;NDFIP2;VPS28;RNF128;PSMA5;RNF115;FBXW7;RBX1;PSMB10;ZNRF3;SIAH2;TRIM25;RNF144B;NEDD4L;BAG6;PSMB8;PSMD14;DTX3L;SMURF1;KCTD10;RMND5B;VPS4A;PSMA7;PSMC3;KEAP1;PSMA8;PSMC1;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;PSMB9;UBQLN2;KLHL25;SPOPL;ANAPC7;PSMC6;RNF150;PSMA4;FBXO8;UBQLN4;GSK3A;FBXO10;PSMD5;PSMD9;FEM1A;PSMB6;ANAPC4;RNF166;FBXO45;ZFAND2A;MAEA;MVB12A;RNF5;KCTD2;RNF34;PSMB2;RNF11;WWP2;KCTD21;UBA1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.41898155115274804,0.8701168367099276,0.6333333333333333,0.892533678233127,1.0,2/10,2.96%,NOTCH1;DLL4
prerank,cholesterol biosynthetic process (GO:0006695),0.34108922988237117,0.8699280821207669,0.6248175182481752,0.8924120740253032,1.0,14/31,26.49%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;IDI1;MVK;INSIG1;HMGCR;FDFT1;LBR
prerank,regulation of cholesterol storage (GO:0010885),-0.3303682094619135,-0.8695454099229715,0.6187845303867403,0.928491411530771,1.0,7/15,24.33%,ABCA1;PPARA;PPARG;NR1H3;LPL;PPARD;MSR1
prerank,peptidyl-proline modification (GO:0018208),-0.28934612653829905,-0.8692664021904949,0.7047619047619048,0.9279625452733448,1.0,8/25,11.70%,FKBP5;NKTR;PPIC;FKBP10;PPIA;FKBP7;P3H2;PPIL2
prerank,DNA damage checkpoint signaling (GO:0000077),0.3455188285557947,0.8687950384249103,0.6388059701492538,0.8940830288414057,1.0,10/28,19.45%,BRIP1;HINFP;STK33;RAD1;ATM;MAP3K20;FBXO6;TIPRL;ATRIP;HUS1
prerank,negative regulation of response to wounding (GO:1903035),-0.31537395691790804,-0.868629182098125,0.6647727272727273,0.9282440959407215,1.0,5/19,13.89%,CASK;FGF2;SERPINE1;MDK;PTPRS
prerank,positive regulation of receptor internalization (GO:0002092),0.3664469072908408,0.8686111326551573,0.6333333333333333,0.8939543904600991,1.0,4/22,8.04%,INSR;ANGPT1;ARRB1;TBC1D5
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.37832298871908654,0.8685519344176458,0.6292834890965732,0.8935946580720917,1.0,10/17,20.71%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.33700183458148997,-0.8684667373997337,0.6328767123287671,0.9274240228932958,1.0,3/15,5.29%,SNW1;NUCKS1;SMARCB1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.29238573164795645,0.8683751395546009,0.6573170731707317,0.8934764564099742,1.0,14/88,15.85%,SYNPO;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;SPIDR;CLU;CHGA;VPS4A;ICE1;RACK1;VIL1
prerank,cell projection organization (GO:0030030),0.344772955107285,0.8683246351569788,0.6186943620178041,0.8931088904669292,1.0,8/30,13.75%,PARVB;PACSIN2;NCKAP1;NEFH;CYFIP1;RAC1;CAPG;RHOH
prerank,negative regulation of complement activation (GO:0045916),-0.3723961420652495,-0.8679561075514038,0.6318537859007833,0.9274082077751271,1.0,2/10,4.85%,SERPING1;CD55
prerank,lipid transport (GO:0006869),0.2881716198576168,0.8678470205850735,0.6939010356731876,0.8935441946931763,1.0,10/97,8.63%,ABCC4;CEACAM1;TTPA;SLCO1C1;APOA1;SPNS2;PLTP;GLTP;CERT1;PITPNA
prerank,positive regulation of vasoconstriction (GO:0045907),0.3930998962936036,0.8677850161493528,0.5887230514096186,0.8932076014386899,1.0,1/13,2.28%,CAV1
prerank,positive regulation of cellular component movement (GO:0051272),0.3551489766731946,0.8673786869837377,0.6280864197530864,0.8934904094816831,1.0,5/24,11.30%,ACTN4;SPOCK2;NTN1;ADAM17;CAVIN1
prerank,ovarian follicle development (GO:0001541),-0.34178839731011523,-0.8672451313691001,0.6228710462287105,0.927878480089576,1.0,8/13,34.17%,KIT;CEBPB;VEGFA;INHBA;INHBB;FOXL2;LHCGR;EIF2B5
prerank,positive regulation of synaptic transmission (GO:0050806),-0.23466040399416296,-0.8671377350248523,0.7663043478260869,0.9269735765617176,1.0,19/72,19.58%,ADCY1;STX4;SLC8A3;DLG4;NLGN2;CLSTN2;CACNG4;TSHZ3;GRIN2D;PRKCZ;DTNBP1;ADRA1A;EIF2AK4;CACNG8;GPER1;EPHB2;SLC8A2;KCTD13;LGMN
prerank,response to interleukin-6 (GO:0070741),-0.3773712709900763,-0.8669967429936276,0.6322115384615384,0.9261217184393655,1.0,1/10,0.13%,PID1
prerank,protein modification by small protein removal (GO:0070646),0.26646964016344754,0.8669423845879373,0.7507788161993769,0.8938720890536637,1.0,65/252,21.84%,SMAD7;FOXO4;USP38;IFIH1;ADRB2;COPS4;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;SENP5;UBA52;APC;RPS27A;RNF128;PSMA5;BABAM2;PSMB10;SIAH2;NFKBIA;USP12;POLB;PSMB8;ACTB;PSMD14;BRCA1;EIF3F;USP29;COPS8;YOD1;PSMA7;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;PSMB5;USP9Y;PSMC5;PSMB9;TRRAP;PSMC6;ESR1;USP35;PSMA4;COPS5;SENP7;SMAD4;PSMD5;PSMD9;USPL1;PSMB6;INO80D;BARD1;STAM2;PSMB2;TAB1;SENP6;USP47;UBB;USP14;USP30
prerank,'de novo' posttranslational protein folding (GO:0051084),0.34298884131420226,0.8667779641804325,0.6367521367521367,0.8937182619499217,1.0,7/30,18.60%,HSPA1B;HSPE1;PTGES3;CCT2;UGGT1;DNAJC7;DNAJB5
prerank,mitochondrion localization (GO:0051646),0.3746859013734457,0.8667186467045915,0.6277258566978193,0.8933770080855962,1.0,7/19,18.66%,BRAT1;LRRK2;MFN1;MARK2;HAP1;ZBED3;MEF2A
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3477732655996495,-0.8665486899816137,0.6593137254901961,0.9259288937937926,1.0,5/12,24.04%,PTPN22;RUNX1;CD300A;RC3H1;PTPRC
prerank,L-glutamate transmembrane transport (GO:0015813),-0.36543578143155075,-0.8663580105763954,0.628498727735369,0.9251938342898717,1.0,2/10,3.00%,SLC1A3;SLC25A13
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.31322166109122723,0.8661432203755719,0.6666666666666666,0.8939809273295322,1.0,15/52,18.99%,LSM1;EXOSC3;CNOT6L;DCPS;DCP1B;POLR2D;CNOT1;EXOSC8;EDC3;NT5C3B;DDX6;CNOT2;EXOSC9;TUT7;LSM2
prerank,regulation of mRNA processing (GO:0050684),-0.2786735002146044,-0.8660630451927575,0.697986577181208,0.924676219165368,1.0,16/32,25.89%,SON;NCBP1;JMJD6;PABPN1;RBM39;SAFB;AHCYL1;SRSF3;SF1;SRPK2;SLTM;KHDRBS1;CDK11B;PAPOLA;QKI;LARP7
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3880116803667206,0.8657042353091887,0.5955056179775281,0.8943131334953913,1.0,6/15,28.87%,HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.33884239649985065,-0.8653848499061714,0.6226415094339622,0.9250790100254349,1.0,7/14,25.76%,RMND1;TRUB2;RCC1L;RPUSD4;MPV17L2;C1QBP;FASTKD3
prerank,positive regulation of neuron differentiation (GO:0045666),0.32409917621200673,0.8651307055527928,0.654843110504775,0.8948933186194531,1.0,13/40,21.62%,ARHGEF2;MEF2C;NRCAM;TCF3;ZC4H2;MMD;PCP4;FGF20;SIN3A;HOXD3;SOX11;MMD2;ECT2
prerank,regulation of inclusion body assembly (GO:0090083),0.42672036471312685,0.8649597128216835,0.6495867768595042,0.8947298958438934,1.0,4/11,17.60%,HSPA1B;SNCAIP;DNAJB6;DNAJB8
prerank,defense response to Gram-negative bacterium (GO:0050829),0.32276961942061166,0.8643262647615334,0.6528150134048257,0.8954706123635885,1.0,10/42,16.66%,DEFA6;IRGM;GALP;ADGRB1;CHGA;RPL30;RNASE6;HMGB2;DROSHA;PYCARD
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.23533653234426996,-0.8641825060637219,0.7647058823529411,0.9265802044745935,1.0,18/76,20.86%,LPAR1;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;PTH1R;HOMER1;ADRA2A;AGTR1;DRD2;ADRA1A;LPAR4;TRHR;P2RY6;AGT;OPRK1;HRH1
prerank,acute inflammatory response (GO:0002526),-0.2956631058765061,-0.8638715404113767,0.6568627450980392,0.9261023975882466,1.0,4/23,8.52%,LBP;IL6R;F3;CEBPB
prerank,innate immune response in mucosa (GO:0002227),0.42663540381628745,0.8629210832417752,0.6080843585237259,0.8976372550093584,1.0,1/10,4.04%,DEFA6
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3401624138852053,-0.8628529092358502,0.6540404040404041,0.9271407494019939,1.0,5/13,12.82%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,establishment of protein localization to organelle (GO:0072594),-0.22712042405081145,-0.8619575079566295,0.780373831775701,0.9278952165323403,1.0,21/72,24.39%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;NUP155;TNPO3;RANBP6;HK2;IPO5;FAM53C;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,glycogen biosynthetic process (GO:0005978),0.3973757014022942,0.8618958867250921,0.6217105263157895,0.8986731193105959,1.0,3/12,14.76%,PGM2L1;NR1D1;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.3973757014022942,0.8618958867250921,0.6217105263157895,0.8986731193105959,1.0,3/12,14.76%,PGM2L1;NR1D1;NHLRC1
prerank,regulation of histone deacetylation (GO:0031063),0.3967225441079979,0.8617303159384652,0.6196013289036545,0.8985317669198365,1.0,2/13,4.95%,ING2;CAMK2D
prerank,response to histamine (GO:0034776),0.41367728277142307,0.8615602079096907,0.6122112211221122,0.8983884637277635,1.0,3/10,21.41%,DIAPH1;GABRB1;GABRB3
prerank,cellular response to interleukin-6 (GO:0071354),0.3498548206928996,0.8613297030836377,0.6462686567164179,0.8983322818756779,1.0,9/26,19.14%,ST3GAL6;CBL;STAT1;CEBPA;JAK2;PTGIS;SMAD4;RELA;SELPLG
prerank,response to amino acid starvation (GO:1990928),0.29657642739519685,0.8611329313421501,0.68875,0.898204939474298,1.0,19/72,20.88%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;LAMTOR3;ATP6V1D;EIF2AK2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2520401297917386,-0.8608953321519517,0.6981132075471698,0.9291093131102179,1.0,2/41,0.78%,PRKAG2;OGT
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3402859240611154,0.8608745265552455,0.6361071932299013,0.8982174750415209,1.0,6/29,18.29%,MBOAT2;LPCAT4;TMEM86B;LPCAT3;PLA2G12A;PLAAT3
prerank,keratan sulfate biosynthetic process (GO:0018146),0.34958818711829104,0.8607761627693366,0.6349206349206349,0.8979386166208637,1.0,8/26,15.67%,ST3GAL6;B4GALT4;SLC35D2;B3GNT3;B4GALT6;CHST1;ST3GAL1;ST3GAL2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.34203938982382975,-0.8607499367106429,0.6565656565656566,0.9282557919029522,1.0,6/14,23.05%,NIPBL;AKAP8L;SAP30BP;NNMT;ZBTB7B;APLNR
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.296485622464849,-0.8606899146638944,0.6666666666666666,0.9272421796785504,1.0,1/20,0.35%,IGF1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3509665760673584,0.8599226203623854,0.6470588235294118,0.8990811688923855,1.0,4/26,8.68%,EFNA5;KLF7;PIM3;NR1D1
prerank,regulation of cilium assembly (GO:1902017),0.30057794430467,0.8590456852140792,0.6819923371647509,0.9002523319493,1.0,11/62,13.12%,RABGAP1;SAXO1;TBC1D30;TBC1D8;IFT140;TBC1D5;TBC1D1;CCDC88A;LIMK2;USP6NL;TBC1D10A
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3438687015653751,0.8584919292899322,0.6426512968299711,0.9007834944729074,1.0,3/27,5.59%,F2RL1;GPR157;LPAR6
prerank,regulation of pH (GO:0006885),0.4080200906542812,0.8584473298080101,0.6362126245847176,0.9004020902334107,1.0,3/11,9.59%,ATP1A4;CLCN3;SLC9A7
prerank,ribosomal subunit export from nucleus (GO:0000054),0.39955332486628214,0.8582510870895187,0.6422764227642277,0.9003044052624979,1.0,5/13,14.77%,XPO1;NPM1;RAN;RPS15;EIF6
prerank,mitotic metaphase plate congression (GO:0007080),0.30762841271955654,0.8580365174121165,0.6452476572958501,0.9002422835619143,1.0,11/51,16.03%,RAB11A;CUL3;KPNB1;CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;BOD1;NDC80
prerank,B cell proliferation (GO:0042100),0.3700807363468737,0.8572917695012897,0.6157480314960629,0.9011466139194518,1.0,4/17,15.90%,CTPS1;MEF2C;CR2;CD79A
prerank,signal peptide processing (GO:0006465),0.4005443708549315,0.8572448174178863,0.6285240464344942,0.9007762259931658,1.0,2/11,5.65%,PCSK5;FURIN
prerank,negative regulation of transmembrane transport (GO:0034763),0.41287029350594523,0.8570474114876683,0.6501650165016502,0.9006905258744032,1.0,2/10,5.41%,INPP5K;CTTNBP2NL
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.38088595469847886,0.8567165685353239,0.6157480314960629,0.9003700985860175,1.0,7/15,28.66%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.38088595469847886,0.8567165685353239,0.6157480314960629,0.9003700985860175,1.0,7/15,28.66%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2980655004861461,-0.8560209547807524,0.7065527065527065,0.9361094008244109,1.0,12/21,41.86%,GOLGA2;CDC14B;FZR1;BTRC;BAG2;MAD2L1;GORASP1;PLK1;CDC20;UBE2C;RPL5;RAB1A
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.23655484834063234,-0.855828783923187,0.7181818181818181,0.9330818581634821,1.0,27/61,26.37%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,vesicle coating (GO:0006901),-0.23655484834063234,-0.855828783923187,0.7181818181818181,0.9330818581634821,1.0,27/61,26.37%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,COPII vesicle coating (GO:0048208),-0.23655484834063234,-0.855828783923187,0.7181818181818181,0.9330818581634821,1.0,27/61,26.37%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3825610065055551,0.8558173295662806,0.6302931596091205,0.9015704752996363,1.0,3/16,9.04%,EDN1;CAMK2D;ROCK1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.40481041183004934,0.8555667385275671,0.6363636363636364,0.9015588530649618,1.0,5/10,25.05%,INPP5F;NF2;PTPN2;PARP14;PPP2R1A
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2852154155429666,0.8554660268099781,0.720876585928489,0.901284956986242,1.0,24/100,17.93%,SMAD7;SUMO2;CSNK1D;FOXF2;BBS7;ARIH1;RYBP;LRRK2;HSPA1B;CEBPA;XPO1;RBX1;NKD2;RNF144B;BAG6;CLU;KEAP1;RACK1;EIF3H;CBFA2T3;TRIB3;SOCS5;UBQLN4;GSK3A
prerank,natural killer cell activation (GO:0030101),0.34231721249103675,0.8553118120057386,0.6333830104321908,0.901105300386702,1.0,4/23,16.30%,CASP8;BAG6;KAT7;NFIL3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3840963307936085,0.8552654956659405,0.6209677419354839,0.9007447500071654,1.0,2/13,8.22%,MGAT5;JAK2
prerank,steroid metabolic process (GO:0008202),-0.2309166883158457,-0.8552650383410212,0.7696969696969697,0.9331424419474175,1.0,21/72,29.74%,CYP27A1;CYP26B1;LIPA;SCP2;DHRS4;FDX1;GBA2;AMACR;CYP2A6;LGMN;CYP51A1;PIAS4;STAR;HSD11B1;SRD5A1;HSD17B10;LSS;PRLR;CYP2R1;ARV1;CYP46A1
prerank,muscle cell migration (GO:0014812),-0.36478234906658163,-0.8552424059328457,0.652605459057072,0.9320497912918327,1.0,4/10,16.22%,CCN3;SIX1;DDR1;AAMP
prerank,histone mRNA catabolic process (GO:0071044),0.3826156784459519,0.8540590783962124,0.6409017713365539,0.9024443738905337,1.0,7/15,21.35%,LSM1;MTPAP;XRN1;ATM;TENT2;TUT7;EXOSC10
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3506924842044069,-0.8536783656014065,0.6358974358974359,0.9341700787659571,1.0,10/12,53.71%,CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3069396995103055,0.853490600580774,0.6800518134715026,0.9030087031447386,1.0,17/53,22.21%,ECSCR;DAB2IP;FOXF2;XPO1;FBXW7;PRKCG;PSMD14;PSMC3;PSMC5;PSMC6;OPHN1;UBQLN4;PSME3IP1;TMF1;UBB;USP14;GLMN
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3287918122586538,0.8534085113040435,0.6451127819548872,0.9027010926547321,1.0,5/31,11.55%,FAM107A;KLF4;RBL1;APC;E2F7
prerank,insulin receptor signaling pathway (GO:0008286),0.2968393713320524,0.8533639254289148,0.7070707070707071,0.9023337326715447,1.0,25/69,23.28%,FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;BCAR3;APC;NAMPT;AP3S1;PHIP;GRB14;SOS1;PTPN2;ATP6V1G1;GSK3A;ATP6V1C1;ATP6V0A1;GSK3B;ATP6V1D;PIK3R3;BCAR1;ZNF106;PIK3CA;IGF1R
prerank,histone lysine methylation (GO:0034968),-0.27338563470804067,-0.8532063473692579,0.7119205298013245,0.9340094492362457,1.0,9/33,17.26%,PRDM5;ASH2L;SETD1B;DOT1L;WDR5;DPY30;SUV39H1;N6AMT1;SETDB2
prerank,transcription by RNA polymerase II (GO:0006366),0.2624348044825756,0.8528759444084627,0.804953560371517,0.9027632163721482,1.0,67/305,17.58%,NOTCH4;TSC22D1;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;YBX2;IRF9;PIR;ELOC;TAF9B;TAF1A;INTS11;RTF1;RXRG;TRIM24;EAF1;SETX;CPSF1;ELP4;ELP2;POLR2G;NR1D1;MBD1;ELOA;POLR2D;ELL2;SNRPE;RPRD1B;FIP1L1;DEAF1;TBPL1;MAML2;INTS12;EAF2;GTF2H3;NR4A1;KLF13;CBFB;GTF2A1;DDX21;INTS5;MED27;MED17;MLLT3;MED4;ICE1;ELOF1;TAF11;SNAPC4;NELFB;NR2C1;POLR2I;AFF4;ESR1;ESRRG;NELFA;RARA;TAF8;RPAP1;DRAP1;RPRD2
prerank,B cell activation involved in immune response (GO:0002312),0.40487621172041344,0.8527599440871464,0.6418152350081038,0.9025162035099991,1.0,2/13,7.65%,FCGR2B;EXOSC3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.36008024425968455,-0.8522863688440175,0.648989898989899,0.9348187856004355,1.0,5/10,24.65%,THOC1;WDR76;RFWD3;FEM1B;RPA2
prerank,vitamin transport (GO:0051180),0.3461548093190212,0.8521326616215854,0.6642441860465116,0.9032284707311492,1.0,3/29,3.48%,SLC25A32;TTPA;APOA1
prerank,endosome organization (GO:0007032),0.31887068655329404,0.8521175078772215,0.6620305980528511,0.9027985489608211,1.0,9/41,18.81%,ALS2CL;SNX10;HOOK1;CLCN3;EXOC8;CHMP2B;PHETA1;RAB27A;HOOK2
prerank,lymphocyte chemotaxis (GO:0048247),-0.26262212447499844,-0.8502500529533058,0.7018181818181818,0.9379870433792897,1.0,23/34,51.88%,SLC12A2;CXCL16;CCL25;CKLF;GPR183;CCL19;HSD3B7;PIK3CG;CCL2;CCL14;CX3CL1;GAS6;CCL5;CCL11;CCL7;CCL8;MSMP;ADAM8;CCL1;CCL3;XCL1;CXCL13;CCL13
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.40809686974506215,0.8501106192658535,0.6473594548551959,0.9059513023882688,1.0,1/11,3.68%,NOS1AP
prerank,positive regulation of signaling (GO:0023056),0.3197566072404623,0.8500616175511809,0.6657645466847091,0.9055911534481298,1.0,10/37,18.99%,EDN1;GATA3;GRIK2;INPP5F;RIMS3;NSF;NMU;SYT1;CDKN2AIP;SOX11
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2999882417331597,0.8487912225776281,0.7146596858638743,0.907460253573811,1.0,10/57,11.69%,BOP1;DHX37;RPL7;PAK1IP1;NVL;XPO1;RPS28;MRPL36;NPM1;RPS25
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.2869064717444746,-0.8485655786598257,0.7113095238095238,0.9403239235114246,1.0,4/25,11.07%,B3GALT1;B3GNT2;HS2ST1;NDST3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3589509698742931,0.8479706551511907,0.6484018264840182,0.9085064869627801,1.0,5/22,12.82%,VPS36;TOM1L1;VPS28;RNF115;VPS4A
prerank,response to sterol (GO:0036314),-0.37184016105771533,-0.8474468778268907,0.6796875,0.9415186751155534,1.0,2/11,5.15%,TGFBR1;RORA
prerank,fatty acid catabolic process (GO:0009062),-0.22785235854024477,-0.8471131939863212,0.8085106382978723,0.9410812928831688,1.0,27/67,30.18%,PCCA;ABCD3;SCP2;PEX2;BDH2;ACAT2;EHHADH;ACADM;ECHDC2;PLA2G15;ECI2;HACL1;CPT2;ACAD11;ACADVL;PEX13;NUDT19;FAAH;MTLN;PPARD;PHYH;ECHS1;HSD17B10;LPIN3;PCCB;LPIN1;PECR
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3973543803586392,0.8469716226331087,0.654300168634064,0.9098923509550073,1.0,3/12,6.37%,GLUD1;ASS1;SIRT4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2888702562128482,0.8468883378881864,0.7044334975369458,0.9091163318839774,1.0,20/78,21.88%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;DYNLL2;SEC24A;ACTR1A;CAPZA2;DYNC1I2;DCTN4;KIF23
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2888702562128482,0.8468883378881864,0.7044334975369458,0.9091163318839774,1.0,20/78,21.88%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;DYNLL2;SEC24A;ACTR1A;CAPZA2;DYNC1I2;DCTN4;KIF23
prerank,sensory organ development (GO:0007423),-0.24447403204686124,-0.8467367230253597,0.7355769230769231,0.9407153146158834,1.0,6/51,6.70%,SMOC1;PBX3;RBP4;SH3PXD2B;MEIS1;SHROOM2
prerank,secondary palate development (GO:0062009),0.3791522069904886,0.8466305222820378,0.6198083067092651,0.9090896731164371,1.0,3/14,5.38%,TGFB2;LEF1;SMAD2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.29124407965678917,0.8465313330439604,0.7055214723926381,0.9088274571219663,1.0,13/69,13.93%,EDN1;PLCB1;PLCB4;PIK3C2A;PLEKHA1;GATA3;GPR143;HTR2A;PIK3C3;INPP5F;PIK3CB;RPS6KB1;LTK
prerank,piRNA metabolic process (GO:0034587),0.3599994055633282,0.8452596598512084,0.6456086286594761,0.9106738945336526,1.0,3/19,18.63%,DDX4;EXD1;TDRD9
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3267264618912596,-0.8450892649478634,0.6596858638743456,0.9430094545869567,1.0,2/14,3.41%,IL34;THBS1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.28038602095569276,0.8446222244669105,0.7276995305164319,0.9113412198591625,1.0,22/104,21.43%,CCND2;CCND3;DAB2IP;ADRB2;SLC8A1;CCNE1;SERTAD1;CDC25C;IRGM;SYAP1;ACTB;CALM3;LRP5;PDCD10;CDKN2D;PYCARD;TRIB3;MAP2K1;CAB39;BLM;MNAT1;RALB
prerank,positive regulation of DNA binding (GO:0043388),-0.26975419506479564,-0.8442148284721752,0.6884057971014492,0.9436758961450296,1.0,6/31,14.40%,IGF1;PRKN;NGF;PPARG;TXN;SIRT2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2918254904922364,-0.8441661964693192,0.7119113573407202,0.942645784214258,1.0,10/21,30.02%,COX17;COX16;COX18;COX10;SMIM20;TIMM21;COA6;FASTKD3;COX14;COX19
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3279608492199949,0.8440197482771004,0.6591549295774648,0.9119611325948513,1.0,4/34,4.06%,NEDD9;CRK;APOA1;LIMS2
prerank,regulation of protein transport (GO:0051223),0.3401291421499151,0.8440041130745772,0.6695526695526696,0.9115342407170024,1.0,8/27,20.91%,PPM1F;NDFIP2;PTPN1;LCP1;STXBP5L;STXBP5;DNAJA1;WWP2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3380123255509868,-0.8438973051586655,0.6451612903225806,0.9420136748252158,1.0,3/11,10.85%,KAT2B;RBM14;MDM1
prerank,response to hexose (GO:0009746),-0.28148901303953605,-0.8431169001337491,0.7297297297297297,0.9425740286883815,1.0,4/25,7.53%,TCF7L2;THBS1;IRS2;GPLD1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3474398417944715,-0.842600300656743,0.669047619047619,0.942504527572367,1.0,5/11,12.82%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.36563534323319496,0.8424348761936215,0.6549079754601227,0.9139758744801593,1.0,10/18,27.90%,ZC3H12A;PTBP3;TMBIM6;ESR1;PTBP2;SHQ1;NCOR2;NUDT16;TGFB1;RPS13
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37483997444482686,0.8421475881056293,0.6726998491704375,0.9140504434049231,1.0,2/18,6.02%,RAB11A;CDC25C
prerank,regulation of cellular metabolic process (GO:0031323),-0.2426500110364181,-0.8420654834419211,0.731404958677686,0.942517731017746,1.0,15/45,25.29%,PID1;PPARA;PRKN;ARF1;TBC1D16;PDK3;MPV17;PDK2;STUB1;PANK2;ACACA;MKLN1;SSH1;MBOAT7;PDK4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.30833491637201377,-0.8413208051799224,0.6952908587257618,0.942953543056823,1.0,5/18,13.93%,PTN;IL34;DAAM2;MDK;SLC45A3
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3695130181685454,0.8411055727258068,0.6470588235294118,0.915494490892008,1.0,4/15,11.99%,NOTCH1;PRKD1;HSPB1;PRKD2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2433474106765981,-0.8408512596498877,0.8191489361702128,0.9427794631110532,1.0,8/44,12.90%,SH3RF1;THBS1;NGF;SRC;VEGFA;FNIP1;RAF1;DDX3X
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.31146330028164787,0.840691985732754,0.6890982503364738,0.9157608423111951,1.0,8/42,14.17%,SMARCA2;SRCAP;ACTB;DMAP1;SMARCAD1;ACTR6;VPS72;SMARCC1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3641589902023179,0.8401955957148245,0.673134328358209,0.9161820731948634,1.0,1/17,1.35%,DOC2B
prerank,lymphocyte proliferation (GO:0046651),0.34810550321655365,0.8387201615917415,0.6875,0.9183577802767474,1.0,5/22,15.90%,MSN;CTPS1;MEF2C;CR2;CD79A
prerank,regulation of glycogen metabolic process (GO:0070873),0.3965562530821635,0.8387149512909188,0.6599326599326599,0.9179035942426006,1.0,1/12,3.52%,INPP5K
prerank,potassium ion import across plasma membrane (GO:1990573),0.3148086803500827,0.8385395427363386,0.6934604904632152,0.9177489567375692,1.0,4/41,3.90%,ATP1A4;ATP1A1;ATP1A3;SLC12A8
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.30441338749268404,0.8384663570744253,0.6876640419947506,0.9174386171910008,1.0,11/51,10.64%,DAB2IP;TRIO;ATP7A;SHTN1;MAP4K4;PACSIN1;LRRK2;NCKAP1;SGK1;TAOK2;MINK1
prerank,positive regulation of type 2 immune response (GO:0002830),0.38036309934830437,0.8383022106396321,0.6537216828478964,0.9172547457344117,1.0,3/14,16.90%,NOD2;RSAD2;RARA
prerank,translational termination (GO:0006415),0.28213336033260966,0.8381151621317497,0.7441860465116279,0.9171144513329337,1.0,39/95,28.54%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;ETF1;MRPL19;MRPL15;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;APEH;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3427012365480342,-0.83764391516768,0.6754617414248021,0.9481309650965385,1.0,1/12,0.28%,CACNA1C
prerank,acylglycerol homeostasis (GO:0055090),0.3580161428098563,0.837371265849651,0.6702290076335878,0.9179952848928149,1.0,2/20,3.48%,HNF4A;APOA1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.3435553451882557,-0.8370628898525114,0.6626506024096386,0.9481743887457206,1.0,1/12,1.10%,IL34
prerank,cellular response to ATP (GO:0071318),0.37282327339010723,0.8370117670706235,0.6688,0.9181811477926352,1.0,4/14,17.03%,P2RX7;HSP90B1;P2RY1;CIB2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3511993639626852,0.8366590164456013,0.6501547987616099,0.9183469446839096,1.0,9/20,23.33%,MBTPS2;KPNB1;SEC14L2;LPCAT3;LDLRAP1;RAN;FMO5;SREBF2;TTC39B
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3120356200481532,-0.8363660236186334,0.698005698005698,0.9484395730188118,1.0,2/16,2.91%,LRP1;APOE
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3263482030102841,0.8362821274194044,0.6757925072046109,0.9185726925600706,1.0,10/27,23.94%,FBXO7;FCGR2B;CCDC88A;VPS35;CTNNA2;EFHC2;GSK3A;GSK3B;IL1RAPL1;BRSK2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.41902315767847087,0.8362086529776407,0.6610169491525424,0.9182401150604673,1.0,2/10,11.55%,SSBP1;E2F7
prerank,regulation of DNA replication (GO:0006275),0.30058142787606323,0.8355153137336245,0.6996098829648895,0.919024526948704,1.0,10/49,12.09%,ACVRL1;BCAR3;GMNC;ORC3;STN1;DHX9;CCDC88A;CDAN1;OBI1;ORC5
prerank,neurogenesis (GO:0022008),-0.24199456346568915,-0.835502680022131,0.7711267605633803,0.9489926645715026,1.0,5/43,7.80%,LPAR1;TRAK1;ANXA1;SIX1;BTBD2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3161063742882767,-0.8353039706924158,0.6906666666666667,0.948290204437484,1.0,8/16,25.08%,SIK3;KLHL22;FLCN;PIH1D1;TELO2;GPR137;LAMTOR5;RRAGB
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.38224868462413886,0.8351708001022679,0.6451077943615257,0.9191763423705392,1.0,5/13,15.32%,KPNB1;NUP54;NUP35;RANBP2;KPNA3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3147587917582228,0.8351223204242736,0.6746347941567065,0.918809387781041,1.0,4/37,7.01%,GBP5;NOD2;PDCD4;ZC3H12A
prerank,regulation of receptor recycling (GO:0001919),-0.30688898941864473,-0.835039077231571,0.6860158311345647,0.947694197354097,1.0,3/16,9.52%,ANXA2;OPTN;TBC1D16
prerank,mitotic spindle assembly (GO:0090307),0.31298683167272673,0.8349751216290093,0.7027397260273973,0.9186003409325731,1.0,8/42,13.86%,RAB11A;KIF2A;CLASP1;KPNB1;STAG1;CLASP2;PRC1;ARHGEF10
prerank,myelin assembly (GO:0032288),-0.3475565464716259,-0.8344216890527354,0.6583143507972665,0.9478241356199073,1.0,6/10,31.04%,DICER1;EPB41L3;GPC1;TPPP;NCMAP;CNTNAP1
prerank,regulation of endopeptidase activity (GO:0052548),0.295394057834812,0.8337343949241922,0.6951066499372648,0.9202866273143027,1.0,10/59,11.08%,SERPINI1;SPOCK2;TIMP3;SPOCK3;FURIN;GAPDH;APH1A;VSIR;PSMB8;SPOCK1
prerank,regulation of peptidase activity (GO:0052547),0.3525154103358318,0.8335837705331871,0.686838124054463,0.9201273115279898,1.0,5/19,20.46%,CAV1;FURIN;PSMB8;CST3;CTSH
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.32587466868237613,0.8335332651314225,0.680731364275668,0.9197504667227804,1.0,17/32,27.96%,ITGA1;PPP1R16B;CDCA2;CALM3;PIN1;CNEP1R1;PPP1R15B;DUSP26;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;CALM1;SYMPK;SPPL3;SMPD1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.30595958284243024,-0.8332033310053767,0.7123287671232876,0.9492012251148889,1.0,3/18,6.76%,NLGN2;CACNG4;TSHZ3
prerank,necroptotic process (GO:0070266),0.36167103340925155,0.8328470797686693,0.6524486571879937,0.9205263079587475,1.0,2/16,9.55%,TLR3;MLKL
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.34273994740213065,-0.8323355718846895,0.6810551558752997,0.9498155243727802,1.0,3/12,11.29%,CENPC;RMDN1;MIS12
prerank,mitochondrion disassembly (GO:0061726),-0.2615140707654171,-0.8321475148417945,0.7491408934707904,0.9490830220377253,1.0,13/34,22.26%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;FUNDC2;ULK2;ATG7;WIPI2;MAP1LC3B;GABARAP;WDR45;BECN1
prerank,response to purine-containing compound (GO:0014074),0.359979531405724,0.8320346804948716,0.6597774244833068,0.9215325319698064,1.0,6/17,19.39%,P2RX7;STAT1;NDUFS4;TRPM2;P2RY1;VGF
prerank,negative regulation of transposition (GO:0010529),0.367053020996707,0.8319688094105278,0.6682847896440129,0.9211889903797894,1.0,3/16,18.63%,DDX4;TUT7;TDRD9
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.275979083320137,0.8315656332747933,0.7502876869965478,0.9214529882391408,1.0,10/102,6.64%,CEACAM1;NR4A2;FOXO1;INSR;CAV1;HDAC9;INPP5K;PDE3B;PCK2;SLC25A33
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2664433059565166,0.8314591409629107,0.7370203160270881,0.9212060006605103,1.0,24/125,16.20%,EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;XPO1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;DYNC1LI2;NUP160;BUB1;ITGB3BP;EFHC2;RAN;NDC80;NEK9;SGO1
prerank,mitochondrion organization (GO:0007005),0.26331048429117754,0.8312040414573039,0.802863436123348,0.9211889444105444,1.0,28/165,15.75%,NOS3;CAV2;DNM3;FBXO7;ATP7A;OMA1;SSBP1;CHCHD3;SIRT4;CHCHD2;SLC25A33;ALAS1;AKT3;LRRK2;IMMP2L;BCL2L1;VPS13D;TSPO;MIGA1;MFN1;POLG2;RHOT2;BNIP3L;BNIP3;TFB2M;NUBPL;PTCD2;SAMM50
prerank,chloride transmembrane transport (GO:1902476),0.2991298963444657,0.8306767844978656,0.7104913678618858,0.9216578465295072,1.0,12/48,18.08%,SLC12A8;ANO6;GABRQ;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;GABRB1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.39237321709785017,0.830607716129651,0.6499162479061976,0.9213110546810942,1.0,3/10,15.85%,F2RL1;WDR1;VIL1
prerank,amino acid transport (GO:0006865),0.29964460963193507,0.8303223404438087,0.7029831387808041,0.9213611577297212,1.0,5/49,9.72%,SLC6A6;SLC7A7;SH3BP4;SLC7A1;SLC6A17
prerank,negative regulation of receptor internalization (GO:0002091),-0.3358506378797616,-0.8301286733774844,0.6847290640394089,0.951942838357722,1.0,4/12,14.51%,DLG4;ATXN2;SDCBP;ANKRD13D
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3631869457542907,0.8292565421412099,0.6790123456790124,0.9227628482436734,1.0,10/16,27.32%,MAD2L2;DTX3L;KDM4D;RIF1;SHLD3;SHLD2;WRAP53;SHLD1;PARP9;SMCHD1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.3824284331471838,0.829241126850818,0.6737704918032786,0.9223277093879899,1.0,4/13,17.53%,RHOT2;BNIP3L;BNIP3;BMF
prerank,negative regulation of insulin secretion (GO:0046676),0.35413259243280204,0.8290092852547373,0.6789727126805778,0.9222637411787329,1.0,4/17,11.92%,KLF7;SIRT4;PIM3;CHGA
prerank,genitalia development (GO:0048806),-0.3355840838534141,-0.8284855552152012,0.6731707317073171,0.9541316653350783,1.0,3/12,11.67%,WNT5A;STRA6;PKD1
prerank,neural tube closure (GO:0001843),-0.2557882790405252,-0.8283831346623789,0.7577854671280276,0.9531911193330165,1.0,10/34,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.33020064484255224,0.828194190809784,0.6801152737752162,0.9232454540112212,1.0,9/29,19.36%,SRARP;UFM1;CNOT1;STRN3;BRCA1;CBFB;ESR1;CNOT2;WBP2
prerank,autophagosome maturation (GO:0097352),0.31847890382755645,0.828049152666081,0.6893617021276596,0.9230616682331517,1.0,10/32,18.43%,VTI1B;GABARAPL1;TECPR1;VAMP8;VAMP7;LIX1;CHMP3;MAP1LC3A;ATG14;LAMP2
prerank,organelle transport along microtubule (GO:0072384),-0.2671034091618374,-0.8278759473863763,0.7288135593220338,0.9530237973962343,1.0,9/31,22.04%,TRAK1;COPG1;NDE1;NDEL1;BICD2;ARHGAP21;FBXW11;CLN3;KIF5B
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3473072503560827,0.827872458054979,0.6661742983751846,0.9229183572412104,1.0,5/21,18.29%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3
prerank,negative regulation of cell development (GO:0010721),0.33954145733714397,0.8276913408984894,0.6804915514592934,0.9227857599231969,1.0,4/25,9.67%,NOTCH1;B2M;PCM1;FBXW7
prerank,regulation of ATP metabolic process (GO:1903578),-0.22967263145095396,-0.8276780715440537,0.7909836065573771,0.9522519589904626,1.0,9/54,14.03%,PRKAG2;OGT;NUP107;ATP5IF1;NUP155;COX7A2;AAAS;COX7A2L;NUP93
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.35603861220306576,0.8275203357057831,0.6911076443057722,0.9226487656881559,1.0,10/19,20.71%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,cellular response to glucose starvation (GO:0042149),0.31028199472209117,0.8274971397315128,0.7140939597315437,0.9222383264360298,1.0,5/41,9.53%,NUAK1;ZC3H12A;SIK2;PRKAA1;PIK3C3
prerank,acylglycerol metabolic process (GO:0006639),0.30699907939347937,0.8273644303256583,0.7019774011299436,0.9220233245898432,1.0,12/37,22.82%,CAV1;ABHD6;DGKH;APOH;DGKI;GK5;ABHD2;SEL1L;PLAAT3;DGKA;PNPLA2;MGLL
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.31336777076604627,-0.8270001979113103,0.689156626506024,0.9524445603090346,1.0,4/14,12.31%,PRKN;TXNDC12;CREB3L1;CREB3
prerank,gland development (GO:0048732),0.29548050705117934,0.8268810240710719,0.7011494252873564,0.9224174540354645,1.0,7/59,7.78%,NOTCH4;TBX1;CAV1;LSR;MSN;PRKCSH;CEBPA
prerank,androgen receptor signaling pathway (GO:0030521),-0.34721511089981183,-0.8268186254310115,0.6917293233082706,0.9516865845672176,1.0,3/11,4.18%,DDX5;ZMIZ1;DDX17
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.39508203897177674,0.8259761377351615,0.6711864406779661,0.9235940598619261,1.0,2/11,4.13%,ARL6IP5;STK24
prerank,ncRNA 3'-end processing (GO:0043628),-0.3227797059717987,-0.8258874985536324,0.6955380577427821,0.9524197415306984,1.0,6/14,19.74%,INTS14;SSB;INTS2;PTCD1;TOE1;TRNT1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.35951268624594684,0.825849590620979,0.6421875,0.9233490937695844,1.0,7/17,28.87%,RHBDD1;HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3466032722941231,0.8258132786725622,0.6616541353383458,0.9229398244295742,1.0,8/22,21.58%,IFNGR1;EFNA1;RANBP9;CLU;GSK3A;RELA;AGER;EPHA4
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3772124017954601,0.8256278370325083,0.6693679092382496,0.9228247887165087,1.0,1/13,0.84%,PLCB1
prerank,response to insulin (GO:0032868),0.2828757379531926,0.8252935199521341,0.7385542168674699,0.922980998194693,1.0,9/80,8.36%,CEACAM1;FOXO1;INSR;HDAC9;INPP5K;PDE3B;PCK2;SLC25A33;SYAP1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3643741993214006,0.8246208397241781,0.6688,0.9237055977303326,1.0,4/15,15.24%,WHAMM;ARPC5;ARPC3;ARPC2
prerank,regulation of cell morphogenesis (GO:0022604),0.32298786755041486,0.8245554426793542,0.7144992526158446,0.9233715604150095,1.0,2/30,2.08%,EFNA5;MACF1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.38629762401832646,0.8241592189863969,0.6786885245901639,0.9236123416314399,1.0,6/12,24.49%,PPT1;LRRK2;CCDC115;ATP6AP2;TMEM199;GRN
prerank,cell projection assembly (GO:0030031),0.34721972758172526,0.8235431047655382,0.6729559748427673,0.9242275198892218,1.0,7/22,13.75%,PARVB;NCKAP1;NEFH;CYFIP1;RAC1;CAPG;RHOH
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.39734861898517493,0.8235126581636438,0.688135593220339,0.9238237284977537,1.0,5/10,16.29%,HMGB1;PSMC3;PSMC5;PSMC6;ESR1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.37597577557416234,0.8233164198407558,0.6752,0.9237056559367003,1.0,1/13,0.81%,MSX1
prerank,regulation of lipid kinase activity (GO:0043550),-0.34370744320324326,-0.8231273472526995,0.7017543859649122,0.9566774321561704,1.0,4/11,15.47%,PIK3R1;PIK3R2;WDR81;WDR91
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4024673354277952,0.8226402116588879,0.6672268907563025,0.9239700529663805,1.0,5/10,22.72%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,calcineurin-mediated signaling (GO:0097720),0.4024673354277952,0.8226402116588879,0.6672268907563025,0.9239700529663805,1.0,5/10,22.72%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,positive regulation of translational initiation (GO:0045948),0.353280915140476,0.8224723051508892,0.6534351145038167,0.9238186529732361,1.0,5/18,13.35%,UHMK1;POLR2G;POLR2D;RPS6KB1;HABP4
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2319306539925304,-0.8223569784597736,0.812,0.9570123016020851,1.0,21/47,27.61%,MICOS10;ATP5PD;NDUFA13;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;MICOS13;ATP5MG;MTX3;ATP5F1D;MTX1;MTX2;ROMO1;TIMM29;IMMT;SPG7;APOO;ATP5F1E;OPA1;ATP5MC3
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.33934917145700333,-0.8221887534148106,0.6904176904176904,0.9562242477402646,1.0,3/11,22.84%,PARP8;PARP3;PARP6
prerank,erythrocyte development (GO:0048821),0.3907139740947824,0.8220742913459482,0.6859504132231405,0.9240389367654464,1.0,1/10,6.79%,ALAS1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2926704433368552,0.8220523034819055,0.7227101631116688,0.9236219726208197,1.0,8/59,14.78%,ACSM3;CYP39A1;OSBPL1A;ELOVL4;OSBPL9;GAMT;GATM;SLC27A2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.32370805082271453,-0.8218470180050766,0.7175141242937854,0.9557532697680782,1.0,6/14,20.36%,DPYD;NT5M;NT5E;UPB1;DHODH;NT5C1A
prerank,chromatin remodeling (GO:0006338),-0.20533372959936733,-0.8217866413994527,0.8986486486486487,0.9547360475885278,1.0,20/100,14.57%,CHD4;TADA2A;JARID2;BAZ1B;KAT2B;BRDT;SMARCB1;RSF1;ARID1B;DR1;SMARCD1;SMARCA5;HDAC4;HDAC1;TAF6L;HMGA2;BPTF;KDM4A;MTA2;PIH1D1
prerank,oxoacid metabolic process (GO:0043436),0.3324345642592935,0.8216014005423802,0.7234352256186317,0.9239791458196747,1.0,5/27,11.49%,MINPP1;SULT6B1;LIPT2;LIPT1;BPNT1
prerank,neuron fate commitment (GO:0048663),0.3682240560626014,0.8215804383066531,0.6761904761904762,0.9235631181732159,1.0,3/14,13.79%,DLL4;POU3F2;MYT1L
prerank,regulation of lamellipodium organization (GO:1902743),-0.3266112333392306,-0.821018834987279,0.7117346938775511,0.9550682376898043,1.0,3/14,13.50%,PDPN;CAPZB;FER
prerank,potassium ion transport (GO:0006813),0.2665874951419028,0.820728977317169,0.7672316384180791,0.924586425479852,1.0,6/120,3.68%,KCNN4;KCNQ1;KCNH8;ATP1A4;KCNN3;KCNG3
prerank,thymus development (GO:0048538),0.37411198977699256,0.8203711661074404,0.6714975845410628,0.9247247033757164,1.0,1/13,1.26%,TBX1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3017560630320544,-0.8203643117198403,0.7380281690140845,0.9552003665050729,1.0,4/17,12.16%,EMC2;EMC7;EMC1;GET4
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.26116334955533715,-0.8198076311613771,0.7201365187713311,0.9551702446750615,1.0,9/31,23.33%,GOLGA2;UBE2N;DCUN1D3;UBE2L3;CDC14B;TOPORS;DCUN1D4;FZR1;BTRC
prerank,regulation of T cell migration (GO:2000404),0.3560052108431722,0.8192976222981657,0.6757624398073836,0.9260959975584359,1.0,6/18,20.47%,APP;LRCH1;CD200;PYCARD;CXCL10;CD200R1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3113159013494057,0.8191111443402235,0.6877523553162853,0.9259769512780287,1.0,4/37,7.97%,MSX1;CAV1;BBC3;BCL2L1
prerank,autophagy of mitochondrion (GO:0000422),-0.25058339039916966,-0.8179071837715237,0.8014981273408239,0.9578349813563238,1.0,14/38,22.26%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;FUNDC2;ULK2;ATG7;WIPI2;MAP1LC3B;GABARAP;PHB2;WDR45;BECN1
prerank,modulation by host of symbiont process (GO:0051851),0.3165895830410363,0.8176472302852096,0.7087378640776699,0.9280417426743306,1.0,7/31,15.42%,SAP30;INPP5K;LEF1;JUN;CCL4;CX3CR1;TAF11
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.31802393956016994,-0.8175972965907577,0.7095890410958904,0.9572924852148094,1.0,5/15,11.64%,DAB2;BMP2K;AAK1;SNAP91;DGKD
prerank,steroid biosynthetic process (GO:0006694),-0.22731718943469448,-0.8175349308277367,0.799163179916318,0.9563040923317818,1.0,19/56,31.08%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE;CYP51A1;STAR;SC5D;HSD11B1;SRD5A1;HSD17B10;LSS;PRLR;CYP46A1;PMVK;HSD3B7;EBP
prerank,protein localization to organelle (GO:0033365),0.263605652682755,0.8170578567660541,0.7982261640798226,0.9285881757859267,1.0,25/133,15.39%,MSX1;GBP5;RAB11A;APP;HHEX;PACSIN2;EHD1;CSNK1D;SNX10;CEP68;LRRK2;IFT140;RAB35;RIPOR1;DHX9;PRNP;GET1;GBP2;VPS35;UBE2J2;CNEP1R1;VAPA;TUB;YBX1;ABCA7
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.24889171436239785,-0.8166044906132517,0.7835820895522388,0.956888496616428,1.0,16/39,24.65%,DDB2;FAN1;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.38761213356244195,0.8164742073232593,0.6722408026755853,0.9291380446168506,1.0,3/11,13.08%,PUM2;DHX9;FXR1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.27815999794727836,-0.8163561014459898,0.7349397590361446,0.9562695947861152,1.0,10/24,23.20%,APOE;ATP5IF1;PRKACA;PKD1;CTSC;NUB1;LATS1;RHBDF1;GPX1;PSME1
prerank,fatty acid biosynthetic process (GO:0006633),0.29111856042200973,0.8160535219746743,0.7232142857142857,0.9294477966028533,1.0,11/63,19.38%,ACSM3;ASAH2;ACSBG1;ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;ABHD2;DECR2;HACD2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3503182926851196,-0.8159340766748568,0.7292161520190024,0.9559190399843833,1.0,4/10,16.45%,PTPRS;PPM1B;RELB;NLRC3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3502677984062246,0.8158941503251524,0.6982507288629738,0.929257994322444,1.0,3/21,11.25%,RAB11A;CDC25C;NPM1
prerank,carbohydrate catabolic process (GO:0016052),0.31468730911674964,0.8157830904236691,0.6979310344827586,0.9289895866824683,1.0,8/38,19.35%,MANBA;GPI;PGK1;GAPDH;MAN2C1;PFKM;MAN2B2;NEU4
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3795063947393688,0.8148988959354834,0.6776859504132231,0.9300186244855738,1.0,2/12,2.21%,ATP2B4;DAB2IP
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.24723707984474916,-0.8147378654056727,0.7431506849315068,0.9571031264046422,1.0,12/38,19.47%,PRKN;ATP5IF1;LMAN1;RNF31;UBL5;UBE2L3;SREBF1;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2976439422278858,0.8147374184771371,0.7354085603112841,0.9298535742932214,1.0,13/48,19.73%,NPR2;SLC25A16;ADCY10;NPR1;SLC35B3;ADCY4;NPPC;PAPSS1;PANK3;PPCS;ACAT1;ADSL;GUCY1A1
prerank,cell junction maintenance (GO:0034331),0.3595787407358518,0.8143480742439153,0.66721044045677,0.9300548475935257,1.0,1/14,2.44%,F2RL1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.24823718235642225,-0.8134703188006803,0.7926421404682275,0.9583713910956851,1.0,16/38,27.31%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFAF1;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFB11;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3441048603785587,0.8129221956431457,0.6965620328849028,0.9319928654994902,1.0,7/20,19.44%,FKBP4;FKBP1A;PPIE;PIN1;PPIH;PPID;PPIF
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.35593320510998744,0.8128862350995425,0.689873417721519,0.9316061283551831,1.0,5/16,24.47%,SSBP1;PURA;BLM;WRN;MCMDC2
prerank,embryonic appendage morphogenesis (GO:0035113),0.38430964930479583,0.812772835604992,0.6859504132231405,0.931347243398961,1.0,2/12,4.60%,TGFB2;MBNL1
prerank,rRNA methylation (GO:0031167),0.33360175682310683,0.8125753092256971,0.6757575757575758,0.9312328149230354,1.0,9/22,22.51%,MRM2;METTL5;FBLL1;TFB2M;NSUN5;MRM3;FTSJ3;NSUN4;FBL
prerank,epiboly involved in wound healing (GO:0090505),0.36017210854592185,0.8123548981312176,0.6666666666666666,0.9311609482971253,1.0,4/16,15.45%,CEACAM1;MRTFA;LCP1;PDCD10
prerank,fatty acid oxidation (GO:0019395),0.28826702560305695,0.8123355857762559,0.7239263803680982,0.9307447786277077,1.0,17/57,22.69%,ADIPOR2;ADIPOR1;ACOX1;ACAD10;SLC27A2;ADH5;HADHB;CROT;ECI1;ACAT1;HADHA;HADH;ILVBL;ACAA2;ABCD2;ABCD4;HSD17B4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.28811084578025775,0.812036424843043,0.758800521512386,0.9307679001764955,1.0,9/59,10.93%,DAB2IP;TLR3;IRAK2;NFKBIL1;UBA52;RPS27A;ROCK1;NFKBIA;TAB2
prerank,protein lipidation (GO:0006497),-0.2244884919387089,-0.8115833336565689,0.8899082568807339,0.9608275831716843,1.0,23/59,26.51%,GPLD1;PIGA;ATG5;PIGB;PIGN;ZDHHC17;PIGH;ATG7;PGAP2;DPM2;PIGG;WIPI2;ZDHHC1;PIGP;PGAP4;PIGZ;ZDHHC8;WDR45;ZDHHC16;PORCN;PGAP3;PIGL;PIGW
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3055863818540568,-0.8112397598273331,0.7416879795396419,0.9603199873969192,1.0,3/17,7.03%,PDGFRB;MAGI2;CALM2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2881494869249893,-0.8110888358209316,0.7740112994350282,0.9594648975842417,1.0,3/19,15.68%,APOE;RIC3;CHRNB1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3441869961351347,0.8107069645145507,0.6876832844574781,0.9321082738956976,1.0,5/20,9.29%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,positive regulation of glycolytic process (GO:0045821),0.3441869961351347,0.8107069645145507,0.6876832844574781,0.9321082738956976,1.0,5/20,9.29%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,establishment of protein localization to membrane (GO:0090150),0.28232412098637333,0.8106252474509311,0.7344345616264295,0.9317943818621501,1.0,8/66,11.07%,RAB11A;AQP11;ZDHHC22;NACAD;RAB3GAP2;MYO1C;TAOK2;REEP1
prerank,brain development (GO:0007420),0.25913745597662063,0.810444485865853,0.7842046718576196,0.9316225405681952,1.0,29/136,18.42%,RAPGEF2;SHROOM4;EML1;PPT1;DHX37;AMIGO2;SHANK3;UFM1;MAST1;SLC6A4;NDUFS4;GRIN2B;UBE3A;GRIN2C;SLC6A17;CDH2;BAG6;SOX6;CTNNA2;CX3CR1;ATXN1;CXCR4;NES;MEIS2;ADGRG1;GRIN2A;SYNJ1;NCOA6;HAP1
prerank,proton transmembrane transport (GO:1902600),0.31390896075789537,0.810267565509304,0.7309292649098474,0.9314853013899788,1.0,3/36,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,secondary alcohol metabolic process (GO:1902652),-0.2354026020416384,-0.8097335157427706,0.8116438356164384,0.9608588286480246,1.0,9/42,16.37%,CYP27A1;APOE;ABCA1;IDH2;FDX1;IDH1;GBA2;SQLE;SCAP
prerank,glial cell differentiation (GO:0010001),-0.26590983618381464,-0.8097008384488097,0.7445482866043613,0.9598222887845874,1.0,9/28,21.92%,ADGRG6;SLC8A3;NFIB;GPC1;PICK1;SOX2;PAX2;TPPP;CDK5
prerank,mitotic cytokinesis (GO:0000281),-0.23726294180072005,-0.8090327800729632,0.8046875,0.9599356360033077,1.0,16/47,21.93%,ROCK2;SON;JTB;KLHDC8B;EFHC1;ANLN;SPAST;RTKN;SNX18;STMN1;USP8;ARL3;INCENP;PDCD6IP;RACGAP1;TTC19
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3419406595066876,0.8088456831075898,0.6947852760736196,0.9334270930267227,1.0,4/20,14.77%,TNRC6C;CNOT1;AGO4;EIF6
prerank,negative regulation of immune effector process (GO:0002698),-0.32900178237924793,-0.8082693286569859,0.6973684210526315,0.9602078875151945,1.0,5/13,17.99%,CD55;ENPP3;FER;CD300A;RC3H1
prerank,regulation of centriole replication (GO:0046599),-0.30009940214997377,-0.8081772882505351,0.7331536388140162,0.9592761130802543,1.0,4/17,10.85%,ALMS1;KAT2B;RBM14;MDM1
prerank,protein acetylation (GO:0006473),0.31905229320501655,0.807517495172474,0.7097701149425287,0.9352416818008914,1.0,2/30,2.79%,FOXO1;NAT9
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3209470168342454,0.8075057354686154,0.7036496350364964,0.9348057010144724,1.0,5/29,8.46%,IFNAR1;SOCS6;STAT1;JAK2;NMI
prerank,regulation of vacuole organization (GO:0044088),-0.28341946759008413,-0.8074968376013555,0.7634408602150538,0.9594216762240777,1.0,8/20,27.91%,ANXA2;ENO2;ADPRH;IFT20;IFT88;ENO3;NPRL2;MTM1
prerank,organic substance transport (GO:0071702),0.2652121357840058,0.8069740195524472,0.7957110609480813,0.9352431117176353,1.0,15/121,10.45%,RHCG;ARL6IP5;PPT1;APOA1;SPNS2;PLTP;MYH9;ARRDC1;HSP90B1;SLC6A4;CHMP1B;TAP1;SLC6A2;ABCG4;SLC22A5
prerank,cellular response to lipid (GO:0071396),0.2508171539938252,0.8064043303098305,0.8287234042553191,0.9357375167487667,1.0,27/191,10.37%,TBX1;NOD2;ATP1A1;ATP1A3;DAB2IP;VIM;FES;DEFA6;ADAM15;MSN;MEF2C;TNFRSF1B;ABCB4;IL1A;PDCD4;NFKBIL1;SETX;IRGM;ZC3H12A;NR1D1;ACOD1;NCOA4;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,metal ion homeostasis (GO:0055065),0.30528289405371584,0.8061728091836806,0.7290233837689133,0.9356830543091907,1.0,7/40,17.03%,CAV1;SLC8A1;SLC12A8;TESMIN;KCNA1;ANK3;CIB2
prerank,regulation of synapse assembly (GO:0051963),-0.2330622215965412,-0.8061424744726075,0.8023715415019763,0.9607345210358298,1.0,13/46,20.73%,GPC6;NLGN2;CLSTN2;SLITRK1;MDGA1;SRPX2;EPHB2;EPHB3;PTPRD;GPC4;LHFPL4;CUX2;IL1RAPL2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28553461441857464,0.8060118166598734,0.7626903553299492,0.9354967611935272,1.0,21/58,25.41%,HERC2;HMGB1;BABAM2;POLA1;POLB;PSMD14;BRCA1;ERCC4;ATM;HMGB2;KDM2A;BARD1;NSD2;MDC1;RIF1;CYREN;XRCC4;PAXIP1;NHEJ1;UVRAG;BABAM1
prerank,positive regulation of B cell activation (GO:0050871),0.2884914431698509,0.805901613577883,0.7271540469973891,0.9352224415499176,1.0,7/50,12.62%,NOD2;SH3KBP1;TIRAP;MEF2C;MAD2L2;CD38;BTK
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.33032035184345176,0.8057350997834498,0.7153502235469449,0.9350419383489904,1.0,7/26,23.28%,DUSP1;CUL3;CDC27;ANAPC7;ANAPC4;LCMT1;ANAPC11
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.34445413198002406,-0.8056875396597908,0.6905311778290993,0.9604720927601522,1.0,3/10,12.82%,APOD;RIPOR2;PADI2
prerank,positive regulation of leukocyte migration (GO:0002687),0.3214745310738105,0.805499489004308,0.705710102489019,0.9349844895996895,1.0,3/27,6.32%,F2RL1;TNFRSF18;ADAM17
prerank,protein-DNA complex assembly (GO:0065004),0.2626067251054198,0.8046974989481323,0.7956867196367764,0.9358812837425055,1.0,36/116,21.60%,PSMD13;ORC3;PSMD4;UBA52;RPS27A;PSMA5;RBX1;PSMB10;ASF1A;PSMB8;NPM1;PSMD14;GTF2H3;ORC5;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;ANP32B;HMGB2;PSMC5;XPC;PSMB9;PSMC6;DAXX;PSMA4;PSMD5;PSMD9;H3-3A;NAP1L4;PSMB6;PSMB2;MNAT1;NAP1L3;UBB
prerank,photoperiodism (GO:0009648),-0.26336505574252517,-0.804564168588807,0.7796052631578947,0.9613356539542653,1.0,13/28,36.85%,CLOCK;CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;PPP1CB;TP53
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2622959394269424,-0.8040662535170418,0.7958477508650519,0.9611598626016438,1.0,13/29,24.65%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,regulation of cholesterol transport (GO:0032374),0.3452572588409435,0.8037428234214823,0.7187017001545595,0.9370374099702795,1.0,4/20,8.90%,APOA1;ABCB4;NUS1;TSPO
prerank,cellular glucose homeostasis (GO:0001678),0.3000005169066856,0.8035214318317879,0.7312834224598931,0.936972239052477,1.0,5/41,8.68%,UNC13B;FOXO1;PCK2;PRKAA1;NR1D1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.30657580151853964,-0.8032785180389389,0.7312138728323699,0.9614998352154905,1.0,7/16,18.07%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.3760167296278159,0.8032579554200286,0.6939443535188216,0.9369857987320993,1.0,1/13,0.88%,PDGFB
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.20366314085723253,-0.8032152439510002,0.8954248366013072,0.9605192271309247,1.0,44/95,32.11%,NUCKS1;RAD51B;SMC6;ZFYVE26;NIPBL;FBH1;FAN1;UBE2N;SWI5;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;CDC7;POLN;RFWD3;RPA3;RECQL;RAD54L;FANCB;PALB2;RPA1;PARP1;POLQ;MMS22L;MCM8;RPA2;RAD51;CDC45;RAD51AP2;ZSWIM7;NSMCE2;NABP2;XRCC3;FANCM;AP5S1;MCM7;SLX4;MORF4L1;MCM5;POLL;MCM2
prerank,protein autoubiquitination (GO:0051865),0.2841743610524085,0.8031118461624666,0.7614795918367347,0.9367707811807594,1.0,14/61,15.90%,ASB4;RNF185;CUL3;UBE3A;RNF141;RNF115;TRIM17;OBI1;BRCA1;DTX3L;UBE2T;RAD18;UBE2D3;KLHL24
prerank,mitochondrial protein processing (GO:0034982),0.3948753465977941,0.8030691039748266,0.6971235194585449,0.9363865823962746,1.0,2/11,7.63%,OMA1;IMMP2L
prerank,cell chemotaxis (GO:0060326),0.2841864415531655,0.8029547078871333,0.7528809218950064,0.9361442484995802,1.0,5/60,5.26%,PDGFB;CCR1;EGR3;LEF1;PLEKHG5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.34173882507879716,-0.8028360694553041,0.7128953771289538,0.9601250561141785,1.0,8/11,55.80%,RTP4;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,in utero embryonic development (GO:0001701),0.3222989769331651,0.8020877046191364,0.7272727272727273,0.9371798715607995,1.0,5/25,12.11%,PTPRR;MBNL1;EGFL8;ADAM10;HINFP
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.27066097550634655,-0.8018130024692367,0.7777777777777778,0.9608715671056993,1.0,6/26,14.88%,DAB2;KANK2;HEYL;HDAC1;CLOCK;CRY2
prerank,Golgi organization (GO:0007030),0.26415965489323623,0.8016725971503906,0.7992957746478874,0.9374175244313078,1.0,25/112,20.00%,SYNE1;PLK3;TRAPPC8;PRKD1;ATL2;VTI1B;CSNK1D;TMED10;CLASP1;LRRK2;CLASP2;VRK1;TMED9;ATP8B1;USP6NL;TMED4;PDCD10;PLEKHM2;VTI1A;GOLPH3L;GOLPH3;MYO18A;ATP8B2;TMED7;DNAJC28
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.24116546366186192,-0.8016361296485965,0.8404255319148937,0.9600772843828203,1.0,6/36,10.20%,OGT;FHIT;MAP1A;PSMF1;TRIM39;SDCBP
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.33910299268318994,0.8008799790799963,0.7091757387247278,0.9382917361030538,1.0,12/20,31.26%,PFDN6;PTGES3;CCT2;CLU;PSMG2;HOPX;MKKS;HSP90AA1;HSP90AB1;HSPA1A;TMEM35A;LONP1
prerank,signal release from synapse (GO:0099643),0.2996155052346585,0.8007857918975126,0.7427821522309711,0.9380202214021568,1.0,14/43,26.90%,SYN3;PIP5K1C;PDZD11;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYT1;NRXN1;RIMS1;PTPRN2;SYN2;SNCA
prerank,positive regulation of fat cell differentiation (GO:0045600),0.2980524416878165,0.8006493605537476,0.7348586810228802,0.9377840128114013,1.0,5/47,8.36%,SOX13;ZBTB16;ZC3H12A;CMKLR1;SYAP1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.20977354557625752,-0.80053328956473,0.8716577540106952,0.9610282371051491,1.0,14/73,13.57%,JARID2;BAZ1B;MTF2;KAT2B;MECP2;TAF1D;IGF2;DNMT3A;SMARCA5;RBBP7;HDAC4;HDAC6;MYBBP1A;MPHOSPH8
prerank,central nervous system development (GO:0007417),0.24616235448823034,0.8003742278085909,0.8647242455775234,0.9377839890108143,1.0,65/250,21.97%,SHROOM4;RNF103;SLC2A1;NR4A2;EML1;SERPINI1;PPT1;LSR;SNTG2;DHX37;AMIGO2;SH3GL1;UFM1;MAST1;ZBTB16;ITGAM;WWP1;NRCAM;NDUFS4;GRIN2B;NCKAP1;MAL;UBE3A;GRIN2C;EIF2B2;ASIC2;SLC6A17;CDH2;BAG6;SPOCK1;NCAN;SOX10;SOX6;CX3CR1;RPS6KA3;CYP26C1;CAPG;ADGRA2;ATXN1;CXCR4;NES;GRIK1;MEIS2;ADGRG1;SOX12;GRIN2A;SYNJ1;NPTX1;TBX6;NCOA6;HAP1;SOX11;ELP3;FOXJ1;POU3F3;DCX;CNTN4;EEF1AKMT4-ECE2;CNTN6;CIC;CDK5RAP1;SMG9;BCAN;BTD;ATP6AP2
prerank,regulation of chemotaxis (GO:0050920),0.3209017277571067,0.7999203019178991,0.7327586206896551,0.9380825404678842,1.0,8/30,14.74%,PDGFB;F2RL1;PPM1F;DUSP3;ZSWIM6;ZSWIM4;ADGRA2;CXCR4
prerank,engulfment of apoptotic cell (GO:0043652),0.3597448907190305,0.799655280376875,0.7032786885245902,0.938076055119184,1.0,4/15,13.75%,XKR6;ADGRB1;RAC1;RHOH
prerank,positive regulation of cholesterol efflux (GO:0010875),0.33788660115314373,0.7994848038465255,0.7254290171606864,0.9379175164095196,1.0,6/21,16.84%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.27161680437427627,-0.7992025061255615,0.7631578947368421,0.9622558561932095,1.0,10/22,24.99%,NFU1;NFS1;CIAPIN1;FXN;CIAO3;NDOR1;CIAO1;CIAO2A;NUBP1;LYRM4
prerank,mitotic spindle organization (GO:0007052),0.2530866285764718,0.7991535415073856,0.8168859649122807,0.9380329970256881,1.0,28/153,16.20%,RAB11A;EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;XPO1;STAG1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;PRC1;DYNC1LI2;NUP160;BUB1;ITGB3BP;ARHGEF10;EFHC2;RAN;NDC80;NEK9;SGO1
prerank,ncRNA metabolic process (GO:0034660),0.30385656599895,0.7984586416333164,0.7431318681318682,0.9387293295232817,1.0,7/37,18.63%,DTD2;DDX4;RAN;DROSHA;EXD1;TUT7;TDRD9
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.33526442613982277,0.7979877870867883,0.7088989441930619,0.9390723165067048,1.0,6/21,14.45%,HNF1A;SETX;JUN;MED30;MED17;MED4
prerank,positive regulation of dephosphorylation (GO:0035306),0.3208723075579285,0.7975666752769969,0.7323741007194244,0.9393921861545182,1.0,14/27,27.96%,PPP1R16B;CDCA2;CALM3;PIN1;CNEP1R1;PPP1R7;CDH5;NSMF;TGFB1;CALM1;SYMPK;MTMR9;SPPL3;SMPD1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3619241552583738,0.7973852386841851,0.7090032154340836,0.9392474524206973,1.0,6/15,24.78%,SRP14;RAB3GAP2;SRPRA;ZFAND2A;RYR2;SPCS2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3596274709022027,0.7971781195622243,0.7210084033613445,0.9391629251820227,1.0,1/15,1.56%,GBP5
prerank,response to metal ion (GO:0010038),0.2764134709227096,0.7971546675710196,0.7814814814814814,0.9387560074899741,1.0,12/67,14.97%,ITPR3;CAV1;GPHN;IL1A;PPP3CA;MT2A;PLSCR1;NEDD4L;TESMIN;CALM3;HIF1A;PPP2CB
prerank,positive regulation of telomere capping (GO:1904355),0.34290931348112597,0.7971382939320423,0.7093206951026856,0.9383320553345313,1.0,3/17,10.95%,MAPK1;NEK7;TNKS
prerank,negative regulation of lymphocyte activation (GO:0051250),0.33588710172653924,0.7971312470912816,0.7028301886792453,0.9378978652837718,1.0,6/21,19.95%,FCGR2B;DUSP3;LAPTM5;SOX11;BANK1;FOXJ1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.29987634302738697,0.7971231415554936,0.7489878542510121,0.9374611879514091,1.0,7/39,13.00%,UTRN;CHRM3;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,positive regulation of ATPase activity (GO:0032781),0.29898803421502695,0.7968316786958884,0.7417582417582418,0.9375154441172779,1.0,11/41,19.72%,MYBPC3;SSBP1;PLSCR1;DHX9;DYNLL1;CHTOP;AHSA1;TOR1AIP2;DYNLL2;DNAJC10;DNAL4
prerank,regulation of myelination (GO:0031641),-0.2658470615108729,-0.796359177196754,0.7565982404692082,0.966252621744959,1.0,3/25,4.46%,PTN;DICER1;PARD3
prerank,sympathetic nervous system development (GO:0048485),0.35786932136622435,0.7962201410736544,0.7014218009478673,0.9380879490185573,1.0,5/15,18.99%,SEMA3F;GATA3;CTNNB1;FZD3;SOX11
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2556332017950982,0.7956697572419216,0.8533916849015317,0.9385305164459298,1.0,38/145,21.23%,RAB11A;PSMD13;TUBB;CSNK1D;CDC25C;TUBB4B;PSMD4;CLASP1;NEDD1;CEP135;HAUS3;PCM1;PSMA5;RBX1;PSMB10;DYNLL1;CEP76;PSMB8;PSMD14;PSMA7;PSMC3;TUBA1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;KCNH5;PSMD5;PSMD9;PSMB6;ACTR1A;CEP192;PSMB2;DYNC1I2;USP47
prerank,cardiolipin metabolic process (GO:0032048),0.3717800438057199,0.7954497371965482,0.7333333333333333,0.9384442387715577,1.0,5/13,19.19%,CRLS1;LCLAT1;HADHB;HADHA;PLSCR3
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3725474417062541,0.7954093080616653,0.7019867549668874,0.938072009664141,1.0,4/13,13.18%,NFKBIE;GOPC;NFKBIA;KEAP1
prerank,ganglion development (GO:0061548),-0.3351835742625907,-0.7953189164481435,0.7525510204081632,0.9669945614087961,1.0,2/11,5.38%,NRP2;SEMA3A
prerank,response to organophosphorus (GO:0046683),0.3486075364718645,0.7945848869692216,0.7156862745098039,0.939002824295629,1.0,3/16,8.30%,P2RX7;STAT1;NDUFS4
prerank,regulation of nervous system development (GO:0051960),0.2988390505970763,0.7945563255090545,0.739010989010989,0.9385988785911724,1.0,9/37,14.54%,HEY1;HEY2;TNFRSF1B;PRUNE1;TENM4;CX3CR1;HES3;CTNNB1;HMGB2
prerank,peptidyl-lysine methylation (GO:0018022),-0.2604667566176749,-0.7944016866448007,0.7794117647058824,0.9674428524133318,1.0,16/26,35.03%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SUV39H1;SETD4;N6AMT1;EEF1AKMT2;ANTKMT;KMT5A;TRMT112;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.23584174202439612,-0.7942729160704471,0.8458498023715415,0.9666085957111149,1.0,7/44,16.16%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE
prerank,centromere complex assembly (GO:0034508),-0.2419939184145834,-0.7940773903408784,0.8059701492537313,0.9658660984508776,1.0,18/36,31.93%,RSF1;CENPC;SMARCA5;RBBP7;MIS12;CENPK;CENPQ;MIS18BP1;KNL1;CENPE;CENPX;NASP;HELLS;CENPH;MIS18A;CENPN;CENPF;CENPA
prerank,telomere maintenance via recombination (GO:0000722),-0.3323317833898012,-0.7934877956625188,0.7308641975308642,0.9658305886987004,1.0,2/11,6.61%,SMC6;RAD50
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.3496529983619235,0.7934725218453033,0.7224806201550388,0.9399408631858681,1.0,9/17,22.31%,MBTPS2;KPNB1;PRKAA1;SEC14L2;LPCAT3;RAN;ERLIN2;SREBF2;SOD1
prerank,microtubule nucleation (GO:0007020),-0.2775946009652744,-0.7932995247068774,0.7650429799426934,0.965065769509457,1.0,5/19,9.85%,SLAIN2;GOLGA2;TUBGCP4;NDE1;NDEL1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3483106294626538,0.7926820872583825,0.723916532905297,0.9408343218535561,1.0,2/17,6.77%,LPCAT4;CRLS1
prerank,cell differentiation in hindbrain (GO:0021533),0.37219328784397226,0.7926335880388296,0.6928,0.9404608795334284,1.0,3/11,19.60%,ATP7A;OPHN1;GRID2
prerank,glycine metabolic process (GO:0006544),0.37374625514931137,0.7922922944342764,0.71875,0.9405827177690821,1.0,2/12,14.38%,GLYAT;DLD
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3279170522526065,-0.7916427846629278,0.737417943107221,0.9668402553841154,1.0,4/11,18.62%,DAB2;PRKN;PTPN23;EZR
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3233173247172915,0.791585655764897,0.71875,0.9412587457496194,1.0,7/23,17.42%,CAV1;CBL;HYAL2;GPRC5A;DUSP22;SH3BP5L;SOCS5
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.28762432823955053,-0.7910816660766246,0.7513227513227513,0.9667412437788565,1.0,8/18,30.02%,COX17;COX16;COX18;SMIM20;TIMM21;FASTKD3;COX14;COX19
prerank,histone monoubiquitination (GO:0010390),-0.26958650721861,-0.790872915762192,0.8018575851393189,0.9660156609654296,1.0,7/24,16.43%,DDB2;CUL4B;PAF1;CTR9;ATXN7L3;BCOR;WAC
prerank,regulation of cytoplasmic transport (GO:1903649),0.3758256856950922,0.7908690920869289,0.7265238879736409,0.942015341895547,1.0,4/11,19.49%,MAPK1;LRRK2;CHMP3;MAP2K1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.22402008555066155,-0.7905226579353235,0.8468468468468469,0.9655176043494933,1.0,6/57,8.98%,IGF1;IL31RA;KIT;IL6R;GHR;VEGFA
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.34041606526823587,0.7901468916218579,0.7058823529411765,0.9427294362132672,1.0,7/18,19.75%,CAV1;CAMK2D;STK39;NEDD4L;EPO;PPIF;CAB39
prerank,cellular response to DNA damage stimulus (GO:0006974),0.24038507285869543,0.7898876539301648,0.9095580678314491,0.9427304338371044,1.0,68/336,19.51%,ACER2;PLK3;FOXO1;HERC2;BTG2;UBA7;RBBP8;CASP2;BRAT1;TNFRSF1B;APEX1;SIRT4;SETX;ENDOV;ZC3H12A;AATF;CIDEB;POLK;BCL2L1;APC;FEN1;ZBTB40;FOXP1;TAOK2;NSMCE3;BABAM2;SPIDR;ASF1A;POLA1;POLB;ALKBH8;NPM1;WDHD1;GTF2H3;BRCA1;DTX3L;HINFP;UBE2T;STK33;LIG1;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAD18;XPC;RFC2;TRRAP;RAD9B;TRAIP;SPRTN;CBX1;FBXO6;MAPK14;MEN1;MMS19;UBQLN4;NCOA6;ATRIP;CDKN2AIP;XIAP;CRY1;BID;FBXO45;BARD1;HUS1;MCL1
prerank,actin filament network formation (GO:0051639),0.36812797995683594,0.7895531561658566,0.7119741100323624,0.9428264390651595,1.0,4/11,21.45%,PLS3;LCP1;SPIRE1;CARMIL1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.27441322434771953,-0.788388752241546,0.7770700636942676,0.968060603639196,1.0,10/25,20.17%,SLIT2;ARHGAP24;CAPZB;ODF2L;CEP97;CCP110;CDK10;PFN2;PRKCD;TESK1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.333207510482911,0.7881357922494211,0.7350689127105666,0.9446940490761205,1.0,5/21,12.73%,FCGR2B;FOXP1;STAP1;ELF2;CBFB
prerank,mitochondrion distribution (GO:0048311),-0.32320918919455704,-0.7877634636857065,0.7177615571776156,0.9680508394139969,1.0,4/12,18.00%,TRAK1;CLUH;ATCAY;DNM1L
prerank,negative regulation of DNA replication (GO:0008156),0.36056450163673215,0.7872422925749599,0.7220394736842105,0.945717610280865,1.0,2/13,10.41%,GMNC;CDAN1
prerank,peptidyl-methionine modification (GO:0018206),0.3624233062824487,0.7871559026770367,0.7178217821782178,0.9454095734983922,1.0,4/12,21.28%,APOA1;METAP2;NAA30;NAA25
prerank,monosaccharide transmembrane transport (GO:0015749),0.3470843693518425,0.785720209618959,0.7104851330203443,0.9472570365808373,1.0,2/16,8.42%,SLC5A10;SLC2A9
prerank,nuclear pore complex assembly (GO:0051292),0.3733510501546844,0.7855825359578437,0.7018739352640545,0.9470194132530229,1.0,3/10,15.93%,RTN4;NUP153;NUP205
prerank,regulation of protein kinase C signaling (GO:0090036),0.35914352798498544,0.785488637049279,0.7142857142857143,0.946739907422575,1.0,1/14,1.01%,FLT4
prerank,negative regulation of cellular protein localization (GO:1903828),0.3013482459190989,0.7854491260913279,0.7329545454545454,0.9463549699525304,1.0,7/34,10.96%,GOPC;TTBK2;ANKRD13A;MFHAS1;CTNNA1;TAX1BP3;NEDD4L
prerank,proteoglycan biosynthetic process (GO:0030166),0.3063400533174333,0.7853470830088862,0.7667597765363129,0.9460746063090198,1.0,8/31,19.29%,BMPR2;EXT1;CHST11;B3GAT2;EXTL3;GLCE;CSGALNACT2;CHST9
prerank,mitochondrial membrane organization (GO:0007006),-0.24394457462453736,-0.7853207304492774,0.8133802816901409,0.9711161118604885,1.0,14/32,29.09%,BCL2;MICOS10;SLC25A4;RCC1L;MICOS13;MTX3;MTX1;MTX2;IMMT;SPG7;APOO;OPA1;BAD;TIMM50
prerank,positive regulation of rRNA processing (GO:2000234),-0.34051439831578556,-0.7851977828206796,0.7210401891252955,0.9702708207941214,1.0,5/10,33.90%,BUD23;RIOK2;TRMT112;DIMT1;HEATR1
prerank,purine nucleotide catabolic process (GO:0006195),0.35547532982653207,0.7847508845901398,0.7274247491638796,0.9466239812179439,1.0,1/13,1.85%,GDA
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3649256309960249,0.7844932015712944,0.7201986754966887,0.9466006945460957,1.0,6/12,27.34%,SGTB;SEC62;SEC63;SGTA;CHMP4A;CHMP4B
prerank,positive regulation of catabolic process (GO:0009896),0.2764700835341252,0.7843465342964381,0.7746305418719212,0.9463946015004996,1.0,15/65,20.91%,FOXO1;DAB2IP;WWP1;ASB5;APC;VPS28;VSIR;NEDD4L;SMURF1;NSF;GSK3A;BARD1;GSK3B;SORL1;WWP2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.32910233392488275,0.7843139099932327,0.7417910447761195,0.9460054827840654,1.0,8/22,24.24%,RPS21;EXOSC3;EXOSC8;EXOSC9;FTSJ3;EXOSC10;URB1;UTP20
prerank,synaptic vesicle transport (GO:0048489),-0.33389057001226424,-0.7837475118982703,0.7673130193905817,0.9715937595736658,1.0,5/11,23.84%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.31962097275565127,0.7836358053072251,0.7533834586466165,0.9466506702034283,1.0,5/21,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,actin-myosin filament sliding (GO:0033275),0.292245112737716,0.7833586295747136,0.7567204301075269,0.9462096706019627,1.0,3/38,7.82%,MYBPC3;VIM;MYL6
prerank,muscle filament sliding (GO:0030049),0.292245112737716,0.7833586295747136,0.7567204301075269,0.9462096706019627,1.0,3/38,7.82%,MYBPC3;VIM;MYL6
prerank,striated muscle cell differentiation (GO:0051146),0.3547408620311939,0.7832487363914893,0.7261345852895149,0.9459380474713556,1.0,5/16,19.74%,MEF2C;MYEF2;POPDC3;SKI;SORT1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.32516068018647815,0.7826929001948717,0.7519260400616333,0.9464087865690931,1.0,2/23,8.22%,NOTCH1;JAK2
prerank,microtubule-based transport (GO:0099111),0.37233145249898103,0.7826587581285513,0.7280405405405406,0.9460102883489293,1.0,3/12,21.10%,ADCY10;SPA17;DYNC1I2
prerank,P-body assembly (GO:0033962),-0.32162084997134044,-0.7826425956678769,0.7548543689320388,0.9723495386386113,1.0,2/12,7.56%,LIMD1;ATXN2
prerank,positive regulation of TOR signaling (GO:0032008),0.2938749721530238,0.7826337827777403,0.7556497175141242,0.94560931019074,1.0,22/40,28.69%,GPR137B;SMCR8;WDR59;RRAGD;RHEB;RICTOR;MIOS;GPR137C;GOLPH3;RRAGA;HTR6;RRAGC;LAMTOR3;WDR24;PIK3CA;SEH1L;MLST8;RPTOR;LAMTOR4;CLEC16A;SLC38A9;LAMTOR1
prerank,DNA geometric change (GO:0032392),-0.2654684204043973,-0.7825382464567245,0.8065573770491803,0.9714640564999968,1.0,8/24,21.05%,HNRNPA2B1;ANXA1;RAD50;DDX1;SUPV3L1;RTEL1;RECQL;ZRANB3
prerank,glutathione metabolic process (GO:0006749),-0.23295025159769894,-0.7822063044328509,0.8641509433962264,0.9708940106394005,1.0,9/38,16.48%,GSTT1;GCLC;GSTZ1;GGT5;ETHE1;GSTA3;GSTM1;GSTM2;GGT7
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.26673924582782543,-0.782181696786648,0.7962382445141066,0.9698672338216036,1.0,5/24,15.09%,LPGAT1;PLA2G4A;SLC27A1;PGS1;PLA2G15
prerank,regulation of catabolic process (GO:0009894),-0.29218129648333263,-0.781758271467822,0.7527472527472527,0.9694661729627914,1.0,13/18,36.97%,FAP;ODC1;MDM2;HPGD;SNF8;RARRES2;CENATAC;TMEM9;ZDHHC2;CHMP6;FAF1;FAM83D;HGS
prerank,positive regulation of cellular respiration (GO:1901857),-0.33485736388795256,-0.7816742379081404,0.7511415525114156,0.9685335593685879,1.0,1/11,1.83%,NUPR1
prerank,negative regulation of catabolic process (GO:0009895),0.2831610142115395,0.7815423153595266,0.7693333333333333,0.9469304114129525,1.0,10/47,16.35%,AZIN1;PDE3B;ALK;PRKAA1;MAD2L2;PRKCG;ADGRB1;PIN1;CBFA2T3;CST3
prerank,macroautophagy (GO:0016236),0.25288392266477194,0.7813941582224402,0.8468677494199536,0.946721802995339,1.0,31/118,19.88%,ATG101;VTI1B;KLHL3;GABARAPL1;VPS36;TECPR1;VAMP8;PLEKHM1;TBC1D5;PRKAA1;NBR1;VAMP7;VPS28;PIK3C3;DYNLL1;MFN1;LIX1;YOD1;VPS4A;CHMP3;MAP1LC3A;CSNK2B;CHMP2B;VDAC1;UBXN6;ATG14;LAMP2;DYNLL2;TOMM7;MVB12A;STAM2
prerank,integrated stress response signaling (GO:0140467),0.3600103933633108,0.7813936534935636,0.7352472089314195,0.9462802132850433,1.0,6/14,26.28%,OMA1;NFE2L2;EIF2S1;EIF2AK1;DDIT3;HERPUD1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2661464778396546,0.7809571375210721,0.8166877370417194,0.9465092836268575,1.0,19/75,16.64%,KLF7;APP;SHTN1;MEF2C;ATL1;LMTK2;NRCAM;TAOK2;NEFH;ADGRB1;MINK1;ACTB;DCC;CTNNA2;SLITRK2;MAP2;TMEM106B;ANK3;OPHN1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.2928437232608443,-0.7808062470117246,0.7650429799426934,0.9688747646893697,1.0,7/17,18.07%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.32509185220174985,0.7805878757637612,0.75,0.9457632143710204,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.32509185220174985,0.7805878757637612,0.75,0.9457632143710204,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.32509185220174985,0.7805878757637612,0.75,0.9457632143710204,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.25278916851084093,0.780267208882489,0.8498293515358362,0.9458243756794629,1.0,22/122,13.27%,PDGFB;NOD2;INSR;TGFB2;VIM;KLF4;BCAR3;PLD1;ELAVL1;NLRC5;JAK2;PASK;NAMPT;STN1;DHX9;METTL5;NPM1;EEF2;PRKD2;RPS6KB1;FXR1;METTL14
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2678917963623486,-0.7801379943022361,0.7710843373493976,0.9689098223658362,1.0,6/22,15.32%,RELL1;SASH1;XDH;VEGFA;GADD45B;SPHK1
prerank,phagosome acidification (GO:0090383),-0.25725593312091927,-0.7801341616750216,0.7912772585669782,0.9678516582406381,1.0,8/26,22.20%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V1H;ATP6V0D2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.28237684066897956,0.7800535024572189,0.7704918032786885,0.9457216241193118,1.0,19/54,26.14%,BOP1;RPL7;PAK1IP1;NVL;MRPL1;RRP15;NPM1;NHP2;RPL23A;EIF6;LAS1L;RSL24D1;NOP53;RPF2;RPL3;MRTO4;MDN1;RPL26;NIP7
prerank,regulation of protein catabolic process (GO:0042176),0.26074567343780236,0.7799368394105726,0.7957992998833139,0.9454589758523463,1.0,15/99,13.89%,AZIN1;FOXO1;DAB2IP;FURIN;WWP1;ASB5;APC;VPS28;MAD2L2;PRKCG;ADGRB1;NEDD4L;SMURF1;PIN1;NSF
prerank,DNA conformation change (GO:0071103),0.34320227156875427,0.7799003083602408,0.7428571428571429,0.945075924307334,1.0,3/17,14.54%,HHEX;HMGB1;HMGB2
prerank,negative regulation of innate immune response (GO:0045824),0.30445524606613134,0.7797126053617872,0.7541666666666667,0.9449339407469198,1.0,12/34,24.80%,SUSD4;NLRC5;NMI;ACOD1;CACTIN;FAM3A;PTPN2;DHX58;RPS19;A2M;GRN;TTLL12
prerank,recombinational repair (GO:0000725),-0.20473282017475364,-0.779463540326411,0.9090909090909091,0.9679015148729616,1.0,30/77,27.53%,NUCKS1;RAD51B;SMC6;ZFYVE26;FBH1;FAN1;UBE2N;SWI5;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;RHNO1;POLN;RFWD3;RPA3;RECQL;PALB2;RPA1;PARP1;POLQ;MMS22L;MCM8;RPA2;RAD51;RAD51AP2;ZSWIM7;NSMCE2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3100346080605613,0.7789783141921116,0.7259475218658892,0.9456675101221457,1.0,4/28,5.58%,FAM107A;APP;AKAP5;SHANK3
prerank,neurotransmitter secretion (GO:0007269),0.29080954677047416,0.7785705520595148,0.7891963109354414,0.9458613090139926,1.0,14/44,26.90%,SYN3;PIP5K1C;PDZD11;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYT1;NRXN1;RIMS1;PTPRN2;SYN2;SNCA
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.24593042353047623,0.7785602587167316,0.889247311827957,0.9454306137937084,1.0,44/184,19.11%,PSMD13;TUBB;CSNK1D;CUL3;UBE2D1;TUBB4B;PSMD4;CLASP1;NEDD1;UBA52;RPS27A;CEP135;HAUS3;PCM1;ZFP36L2;PSMA5;PSMB10;CDC14A;DYNLL1;CEP76;PSMB8;PSMD14;NEK11;PSMA7;PSMC3;TUBA1A;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;PSMB9;ANAPC7;PSMC6;PSMA4;KCNH5;PPP1R9B;PSMD5;PSMD9;PSMB6;ACTR1A;ANAPC4
prerank,hippo signaling (GO:0035329),0.3150852150077439,0.7785382126490906,0.741506646971935,0.9450286410070565,1.0,5/26,10.54%,TEAD4;WWTR1;TJP2;TJP1;FAT4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.3334665291653834,-0.7784623092301973,0.7348837209302326,0.9684945250069541,1.0,1/10,2.84%,WNT5A
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3563347313602013,0.7782603417867774,0.7131537242472267,0.9450332706734023,1.0,6/13,30.40%,NAMPT;PTGIS;NAXE;PARP9;NUDT12;PARP16
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2251314974603738,-0.7781351855904272,0.8885017421602788,0.967930164216412,1.0,24/43,38.31%,BRSK1;TRIM39;NABP1;HMGA2;CDC14B;CDKN1A;DONSON;ORC1;TAOK1;CHFR;FZR1;TAOK3;RINT1;CHEK1;NABP2;FOXN3;DTL;UIMC1;CDK5RAP3;HUS1B;PLK1;CDK1;CDC6;TICRR
prerank,modulation by host of viral genome replication (GO:0044827),0.3557455090432568,0.7781095897889226,0.71869918699187,0.9448252084543467,1.0,2/13,7.01%,FBXL2;ZC3H12A
prerank,positive regulation of macroautophagy (GO:0016239),0.2847647319080964,0.77805749372761,0.7696404793608522,0.944472628291433,1.0,12/48,15.79%,ADRB2;SPTLC2;SPTLC1;SMCR8;IRGM;FYCO1;RAB3GAP2;VPS13D;BNIP3L;BNIP3;EPM2A;VDAC1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2800360930190947,0.7777298245831517,0.766887417218543,0.9445364037923241,1.0,12/49,22.21%,SMAD6;IAPP;HMGB1;PMEPA1;AIDA;CLU;RIOK3;PYDC1;GSK3B;SORL1;LCMT1;NOP53
prerank,regulation of acute inflammatory response (GO:0002673),-0.2827146932470589,-0.7776225952983645,0.7535410764872521,0.9676095990396543,1.0,13/18,54.89%,PTGES;KLKB1;IL4;GSTP1;IL6ST;CREB3L3;ADAM8;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B
prerank,positive regulation of intracellular protein transport (GO:0090316),0.24939364939006592,0.7774237814997494,0.859375,0.9445916432822812,1.0,38/144,21.67%,FYN;PLK3;CASP8;PPP1R13B;AKAP5;HYAL2;BBC3;ZC3H12A;ITGAM;PRR5L;NMT1;MYO1C;PCM1;RIPOR1;FBXW7;PRNP;DMAP1;UBE2J2;YWHAH;ITGB1BP1;RAN;ANP32B;ICE1;UBE2D3;PDCD10;ANK3;TENM1;GSK3A;BID;TOMM7;JUP;GSK3B;SORL1;MTCL1;PPP3CC;SREBF2;ECT2;LEPROT
prerank,regulation of activated T cell proliferation (GO:0046006),0.3059759833104701,0.7769501845082677,0.7690058479532164,0.9448755995812185,1.0,8/30,19.95%,CRTAM;LGALS9;HMGB1;PRNP;IL27RA;PYCARD;CD24;AGER
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.33308199665113647,0.7762564666287812,0.7484848484848485,0.9455413369096876,1.0,5/19,14.99%,EXT1;HS3ST5;EXTL3;NDST4;GLCE
prerank,cell proliferation in forebrain (GO:0021846),-0.32734554299693547,-0.7757855425242998,0.7198177676537585,0.9695378451160304,1.0,2/10,8.52%,DOCK7;NUMBL
prerank,negative regulation of TOR signaling (GO:0032007),0.2961925417123441,0.7757516511979015,0.7485795454545454,0.9458857263494148,1.0,10/36,21.45%,SPAAR;CASTOR1;SH3BP4;PRKAA1;ATM;EPM2A;GSK3A;MAPKAPK5;NPRL3;AKT1S1
prerank,superoxide anion generation (GO:0042554),0.3593898814048319,0.7755262329413043,0.7164179104477612,0.9457818275999019,1.0,3/13,14.82%,TAFA4;CYBA;NCF2
prerank,membrane assembly (GO:0071709),-0.24006451877348936,-0.7751119354257493,0.8362369337979094,0.9695192968704095,1.0,11/34,24.97%,ANXA2;STX4;NLGN2;TLCD2;UBXN2B;SPAST;S100A10;PTPRD;TLCD1;STX2;NLGN3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.2868056068296751,-0.7747775862873473,0.7945945945945946,0.9690056828899588,1.0,3/18,9.76%,DLG4;NLGN2;PRKCZ
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.29251762010550314,0.7742228678297413,0.7786774628879892,0.9473877890387549,1.0,7/39,13.00%,UTRN;CAMK2D;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,negative regulation of inclusion body assembly (GO:0090084),0.38483555465685293,0.7740631766706467,0.7591973244147158,0.9471978192485846,1.0,4/10,20.71%,HSPA1B;DNAJB6;DNAJB8;SORL1
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.32631837824588095,-0.7739054366152371,0.7419354838709677,0.9693290157842942,1.0,5/11,23.25%,NCBP1;PAF1;AHCYL1;NCBP2;PAPOLA
prerank,regulation of cell division (GO:0051302),0.264422301825153,0.7738866831937776,0.780940594059406,0.9470404144712404,1.0,16/72,20.67%,PLK3;RAB11A;TAL1;BCL2L1;PIK3C3;CALM3;PRC1;PIN1;RAB11FIP4;MLLT3;RACK1;KLHL9;GIT1;RAB11FIP3;SETD2;BLM
prerank,cellular response to hexose stimulus (GO:0071331),0.31800990457118317,0.7736520092589447,0.7470588235294118,0.9469708942909284,1.0,3/23,8.29%,UNC13B;PCK2;PRKAA1
prerank,nucleotide catabolic process (GO:0009166),0.3345068546165044,0.7735204227390479,0.7380560131795717,0.9467490211671022,1.0,1/16,1.85%,GDA
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.32218232368727495,0.7729952726339873,0.7503607503607503,0.9471222086445615,1.0,4/20,10.96%,GOPC;CAMK2D;STK39;NEDD4L
prerank,positive regulation of viral process (GO:0048524),0.27204883904518407,0.7724943777283816,0.7940813810110974,0.9474411690959184,1.0,14/60,18.64%,ADARB1;PPIE;POLR2G;ADAR;DHX9;POLR2D;VPS4A;PPIH;NELFB;PKN2;POLR2I;NELFA;SRPK1;PPID
prerank,response to UV-A (GO:0070141),-0.3058783945022927,-0.7723261962944679,0.7789757412398922,0.9707120824093619,1.0,2/14,7.62%,EGFR;MMP2
prerank,regulation of isotype switching (GO:0045191),0.3464310165834919,0.772198966688104,0.7355769230769231,0.947452144503726,1.0,7/14,25.96%,SLC15A4;MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.23242916811494024,-0.7714725553912406,0.8536585365853658,0.97100143036151,1.0,3/40,6.52%,PID1;BCL2;ATP5IF1
prerank,immunoglobulin mediated immune response (GO:0016064),0.37997557255092007,0.7709163070155619,0.7327586206896551,0.9489793203940493,1.0,1/10,4.30%,FCGR2B
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.33661003693305647,0.7707539256140054,0.7484276729559748,0.9487982075165383,1.0,7/17,20.37%,NUS1;ALG14;DOLK;MVD;DPAGT1;DOLPP1;ALG1
prerank,protein maturation (GO:0051604),0.2549413134548674,0.7704692534176939,0.8352941176470589,0.9487687896490961,1.0,27/95,21.25%,CPD;TSPAN14;CASP2;LIPT2;PCSK5;FURIN;TSPAN32;ADAM17;APH1A;ADAM10;BOLA2;LIPT1;GLRX3;METAP2;CPM;PSEN2;SRGN;LONP2;XPNPEP3;MMS19;TYSND1;LMF2;ECE2;EEF1AKMT4-ECE2;SORL1;APH1B;CCS
prerank,regulation of monocyte differentiation (GO:0045655),0.3534308309666604,0.7702158998860426,0.7611940298507462,0.948706676412494,1.0,3/14,9.10%,FES;CTNNBIP1;FOXP1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3386673982179654,0.7701936192355414,0.7457627118644068,0.9483091358518145,1.0,5/17,22.31%,HSPB1;NFE2L2;NOL3;NME5;SOD1
prerank,neuromuscular process controlling balance (GO:0050885),0.36117133038931704,0.7700625986177859,0.743006993006993,0.9480679504073465,1.0,3/12,21.03%,PCDH15;NRXN1;MYO7A
prerank,sodium-independent organic anion transport (GO:0043252),0.37239464395285693,0.7700074983274798,0.7217391304347827,0.9477205521624118,1.0,3/10,9.08%,SLCO1C1;SLC16A2;MFSD10
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.32693841217165936,0.7694706561214277,0.7573872472783826,0.948119573403595,1.0,3/21,14.25%,CAV1;APC;CTNNB1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3368116222479956,0.7689505439294675,0.7537764350453172,0.9485061017645885,1.0,7/18,25.39%,FCGR2B;RNF185;BAG6;NCK1;ERN1;RNFT1;DDIT3
prerank,regulation of defense response (GO:0031347),0.26279357758427935,0.768922819197652,0.8275862068965517,0.9481193560693688,1.0,10/76,10.37%,NOD2;CASP8;SPATA2;TIRAP;FCGR2B;SEMA7A;BCL6B;JAK2;FOXP1;CASP1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.26398890130722125,0.768865470403803,0.8054862842892768,0.9477716403126139,1.0,14/72,15.83%,ESRP2;CBL;FGFR3;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;POLR2D;TIAL1;FGF20;KIF16B;POLR2I
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3662670265520057,0.7687196271871886,0.7524916943521595,0.9475593105129715,1.0,11/11,63.40%,MALT1;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;PRKCQ;NFKBID
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.20788322314034438,-0.7683532370966609,0.9010989010989011,0.9746969163198881,1.0,23/68,23.82%,SCAF8;NUDT21;NCBP1;TAF1D;SMN1;PABPN1;SNRPF;TTF1;ERCC2;CSTF2T;PCF11;GTF2H5;UBTF;GTF2H1;SNRPD3;LSM11;SLBP;GTF2H4;POLR1A;POLR1H;NCBP2;PAPOLA;LSM10
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.2997108522262359,0.7680576176442944,0.7581329561527581,0.9481390487759864,1.0,4/32,10.49%,CAV1;P2RX7;CASQ1;PLCG1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2915379755354951,0.7676798895069945,0.7741046831955923,0.9482757356083946,1.0,3/37,7.48%,EDN1;ANKRD13A;AATF
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.28165357883705366,-0.7668809646761995,0.8212435233160622,0.9759473604332394,1.0,9/18,25.05%,EHMT1;SETD7;SETD1A;SETD1B;SUV39H1;SETD4;EEF1AKMT2;KMT2D;SETMAR
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2660852174161488,-0.76677018106996,0.8155844155844156,0.9750541583486348,1.0,3/18,12.53%,BCL2;SLC25A4;THEM4
prerank,protein alkylation (GO:0008213),-0.26698421744203255,-0.7664976282335534,0.7689969604863222,0.9744059590393579,1.0,6/22,18.20%,GSPT1;METTL21A;FAM98B;EEF1AKMT1;EEF1AKMT2;SNRPD3
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.37047577693343814,0.765205029737971,0.752542372881356,0.9516252580748774,1.0,2/10,7.72%,ATP5MC1;ATP5F1A
prerank,regulation of mRNA stability (GO:0043488),0.24475053002807026,0.7649278758975544,0.8656387665198237,0.9516105267666554,1.0,36/145,18.86%,VIM;PSMD13;PUM2;APEX1;PSMD4;ELAVL1;HSPB1;EXOSC3;UBA52;RPS27A;ROCK1;ZFP36L2;PSMA5;XPO1;PSMB10;EXOSC8;PSMB8;NPM1;PSMD14;XRN1;PSMA7;PSMC3;FXR1;METTL14;PSMA8;PSMC1;PSMB5;PSMC5;YBX1;PSMB9;PSMC6;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.27295622319331453,0.7649222303115815,0.8133159268929504,0.9511817778809872,1.0,13/57,18.45%,APP;SHISA8;MEF2C;SHISA6;GRIA1;GRIN2B;MINK1;LYNX1;NPTX2;GRIN2A;NPTX1;LRRC7;CAPN1
prerank,positive regulation of protein maturation (GO:1903319),0.36608011361634374,0.7648385365167841,0.7627416520210897,0.950887188418085,1.0,2/11,10.31%,RHBDD1;NKD2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3109649883468584,0.764735548262239,0.7609682299546142,0.9506095817017736,1.0,6/24,15.24%,OCLN;NCKAP1;CYFIP1;RAC1;WASF2;ARPC2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.30385656942066563,-0.7645771196663591,0.7760814249363868,0.9762956515329657,1.0,1/13,1.89%,AXL
prerank,regulation of immune effector process (GO:0002697),-0.22809537367178412,-0.7644581727302012,0.9003690036900369,0.9754236993901577,1.0,15/41,27.37%,SERPING1;VTN;CD55;CD81;C4B;C1QC;C1QA;CFHR2;PHB2;C1QB;C2;C1QBP;C3;C3AR1;C6
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.27133180360501247,0.7641729327990624,0.8135376756066411,0.9510143734030341,1.0,8/63,6.59%,FAS;CAV1;CASP8;ACVR1;TNFSF10;HYAL2;TRAF1;MADD
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.3120398276557656,-0.7641590796949801,0.7801047120418848,0.9748219097298327,1.0,7/12,40.84%,CDC7;CDC45;MCM7;MCM5;MCM2;GINS2;MUS81
prerank,positive regulation of cell division (GO:0051781),-0.22780067540730375,-0.7639590514313457,0.8896551724137931,0.974068718378666,1.0,7/38,15.69%,FGFR2;FGF1;SVIL;SPAST;DRD2;SIRT2;CDC14B
prerank,toxin transport (GO:1901998),-0.3329576998677519,-0.7624723002749592,0.7896039603960396,0.9752512904098577,1.0,4/10,18.82%,ANTXR2;ANTXR1;RAB29;SLC22A2
prerank,establishment of vesicle localization (GO:0051650),0.32983311858082975,0.7622405982158253,0.753731343283582,0.9534749615698824,1.0,4/18,17.97%,RAB11A;LIMK2;SYNJ1;RAB27A
prerank,negative regulation of cell aging (GO:0090344),0.3298081598259964,0.7618773245822978,0.7520128824476651,0.9535799668228547,1.0,4/16,15.27%,AKT3;RBL1;MAP3K3;YBX1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.29946388718865863,0.76175866602366,0.7862266857962698,0.9533187836762299,1.0,7/29,17.69%,RAB6B;VTI1B;COG5;NSF;COG6;GOSR1;VTI1A
prerank,"transcription, DNA-templated (GO:0006351)",0.23673890498207473,0.760996086245904,0.8842105263157894,0.9540421319912646,1.0,49/207,19.85%,TSC22D1;NR4A2;YBX2;IRF9;PIR;ELOC;TAF9B;TAF1A;RTF1;TRIM24;EAF1;SLC25A33;SETX;POLR2G;MBD1;BRF2;ELOA;MLF1;NFKBIB;POLR2D;DEAF1;TBPL1;EAF2;GTF2H3;KLF13;CBFB;GTF2A1;DDX21;TFB2M;TAF1B;MLLT3;MED4;TAF11;TEFM;NELFB;POLR2I;AFF4;PWP1;NELFA;MMS19;RPAP1;DRAP1;HOXD3;NCOA6;MEF2A;PTMA;TAF3;PKNOX1;RRAGC
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.23797566622080302,-0.760491670711426,0.8339350180505415,0.9771268285054211,1.0,6/31,18.02%,STX4;RBP4;KMT5C;KMT5B;EPHB2;PHB2
prerank,histone H3-K9 demethylation (GO:0033169),-0.32245981077897434,-0.7604189815798353,0.7642679900744417,0.9761830736030878,1.0,4/11,20.14%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,cellular response to ionizing radiation (GO:0071479),0.2713371361781276,0.7601515785321311,0.8213820078226858,0.9548796407000478,1.0,15/47,24.11%,RHOB;TMEM109;SPIDR;RAD1;ATM;MAP3K20;RAD9B;KDM4D;MAPK14;EEF1D;HUS1;BLM;ECT2;WRN;YAP1
prerank,ERBB2 signaling pathway (GO:0038128),-0.24875429120479955,-0.7593034949094061,0.8405797101449275,0.9767524500845078,1.0,9/31,17.09%,EGFR;SHC1;PIK3R1;SRC;PRKCA;ERBB2;HBEGF;GAB1;STUB1
prerank,regulation of response to stress (GO:0080134),0.37572181772533264,0.759267657072122,0.731418918918919,0.9557733068454085,1.0,10/10,62.45%,EIF4G1;ADCY8;MLC1;OPRM1;STOX1;IL10;SLC38A2;CRHBP;DYRK3;CORO2B
prerank,peptidyl-arginine modification (GO:0018195),-0.29586698092984814,-0.7586629955887755,0.7690217391304348,0.9765963406617482,1.0,3/15,12.82%,ART3;NDUFAF5;PADI2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3495979451455685,0.758518902537987,0.7736486486486487,0.956492697081939,1.0,2/13,9.53%,IRAK2;PIK3C3
prerank,negative regulation of signaling (GO:0023057),0.3120617641717634,0.7581452549239869,0.7621212121212121,0.9566168463505705,1.0,6/25,23.11%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.30767138701940916,-0.7574872432759842,0.7737226277372263,0.9772548828098899,1.0,4/12,20.24%,DGAT1;MTTP;MFSD2A;P4HB
prerank,mRNA transport (GO:0051028),-0.18775213426934412,-0.7574515484121733,0.9558823529411765,0.9762593467686086,1.0,35/101,26.04%,SRSF5;HNRNPA2B1;NUP107;NCBP1;UPF2;SRRM1;SRSF1;NUP155;SRSF6;THOC1;AGFG1;AAAS;NUP93;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;UPF3B;MCM3AP;SRSF3;KIF5C;SLBP;SEC13;SRSF11;NCBP2;DDX25;SRSF2;POM121;EIF4A3;DDX19B;U2AF1;ZC3H11A;THOC7;NUP188
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2636481384370275,0.7572136330214976,0.8454773869346733,0.9575921482817019,1.0,14/66,15.09%,CARD10;WWTR1;HYAL2;ZC3H12A;CCT8;DKC1;LIMK2;CCT2;DMAP1;DTX3L;CCT4;RAN;CCT6A;KAT7
prerank,mitotic recombination (GO:0006312),0.3448695751180487,0.7571192615488789,0.7654320987654321,0.9572916307636529,1.0,1/15,1.69%,RAD54B
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.27403499825951283,-0.7568049687365377,0.8101983002832861,0.976243297220937,1.0,2/17,6.88%,LPGAT1;PLA2G4A
prerank,positive regulation of T cell proliferation (GO:0042102),-0.21481115231058806,-0.756653802632604,0.9572649572649573,0.9754135079261776,1.0,7/55,13.16%,IGF1;IGFBP2;ANXA1;IGF2;NCKAP1L;PNP;CD80
prerank,regulation of neutrophil migration (GO:1902622),0.36946712889571365,0.756574114477191,0.7544715447154472,0.957705669975009,1.0,2/10,13.75%,RAC1;RHOH
prerank,regulation of receptor internalization (GO:0002090),0.2936826134356653,0.7563807865489354,0.7762237762237763,0.957547519730693,1.0,5/35,8.04%,INSR;ANGPT1;ANKRD13A;ARRB1;TBC1D5
prerank,glial cell development (GO:0021782),0.30850950942025934,0.7562367862268268,0.7751479289940828,0.9573180114753131,1.0,5/25,18.99%,APP;EIF2B2;SOX10;NSUN5;SOX11
prerank,negative regulation of cell division (GO:0051782),0.36255122263906675,0.7561937477797287,0.7491638795986622,0.9569476175420493,1.0,3/11,20.67%,E2F7;VPS4A;BLM
prerank,neuronal action potential (GO:0019228),-0.26431578795788724,-0.756069560806215,0.8258426966292135,0.975212379223783,1.0,6/22,17.40%,SCN7A;SCN2A;CACNA1G;KCNMB2;GPER1;CACNA1H
prerank,regulation of RNA export from nucleus (GO:0046831),0.3574298124991857,0.7551478385540182,0.7901861252115059,0.958065750740695,1.0,5/11,25.31%,DHX9;NUP153;SETD2;IWS1;TPR
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.2916872613397393,-0.7548097015996172,0.7803030303030303,0.9758709461549107,1.0,4/14,15.04%,CD55;PTPN22;CD81;TGFBR2
prerank,covalent chromatin modification (GO:0016569),-0.2915701128607674,-0.7545973334924593,0.7958115183246073,0.9751375166352705,1.0,4/14,27.79%,HDAC1;HLCS;PARP2;HELLS
prerank,nucleic acid metabolic process (GO:0090304),0.2627068671649247,0.753844625859079,0.8201970443349754,0.9595306774378084,1.0,16/69,17.71%,LSM1;EXD2;HNRNPA0;POLR2G;FEN1;DUSP11;POLR2D;HNRNPK;XRN2;PCBP1;METTL14;HNRNPH2;RAN;POLR2I;MMS19;DXO
prerank,cellular polysaccharide catabolic process (GO:0044247),0.33365022999025085,0.753649915472521,0.7783094098883573,0.9593766625764643,1.0,2/16,4.25%,AOAH;PGM2L1
prerank,anterior/posterior axis specification (GO:0009948),0.33254397125348845,0.753565370583743,0.7664,0.9590768863236675,1.0,6/15,25.39%,TBXT;TASOR;SKI;TBX3;RIPPLY2;DDIT3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2307044686005073,-0.753448569129547,0.8503649635036497,0.975763008955891,1.0,15/37,24.65%,DDB2;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,snRNA 3'-end processing (GO:0034472),0.319347015603137,0.7526636578802209,0.7609682299546142,0.9599716642763934,1.0,6/19,17.49%,EXOSC3;EXOSC8;INTS12;INTS5;INTS6L;EXOSC9
prerank,carboxylic acid catabolic process (GO:0046395),-0.30961226668606767,-0.7525350663596492,0.8015463917525774,0.9760310529918204,1.0,7/12,39.88%,RENBP;NAGK;AMDHD2;NPL;GNPDA1;IL4I1;ACOT8
prerank,synapse assembly (GO:0007416),0.2635739582523101,0.7524769221261384,0.8197747183979975,0.9598011047628625,1.0,22/67,21.52%,DNM3;SPOCK2;PLXND1;SHANK3;NRCAM;FLRT3;CBLN4;KIRREL3;CDH2;GABRA2;ACHE;PCDHB16;LGI2;PCDHB14;PCDHB9;DSCAM;GRID2;SHANK2;BDNF;NRXN1;GABRB3;NLGN1
prerank,regulation of cellular component size (GO:0032535),0.2988241950577649,0.7520035502320715,0.7782738095238095,0.9600866531469461,1.0,13/30,27.18%,MSN;RAP1GAP2;AP2M1;HP1BP3;RAC1;PEX11A;PEX11G;PPP1R15A;ATP13A2;RDX;RPTOR;LAMTOR4;RIN3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3086746995731809,0.7518268772248979,0.7727975270479135,0.9599138988891874,1.0,5/25,17.03%,CAV1;SLC8A1;KCNA1;ANK3;CIB2
prerank,negative regulation of cellular senescence (GO:2000773),0.3420335885000603,0.7517421178184941,0.745819397993311,0.9595961891901033,1.0,4/13,15.27%,AKT3;RBL1;MAP3K3;YBX1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2943242300997247,-0.7514147939171848,0.8163265306122449,0.9766144078650302,1.0,5/16,17.73%,AMPD3;LHPP;ATIC;NUDT2;IMPDH2
prerank,diacylglycerol metabolic process (GO:0046339),-0.2565437005462109,-0.751063217726679,0.8760563380281691,0.9760425975035175,1.0,5/23,15.09%,PLCE1;DGAT1;DGKD;PGS1;PLA2G15
prerank,positive regulation of secretion (GO:0051047),0.3602674062582386,0.7510328004640772,0.7523961661341853,0.9601917314029887,1.0,1/11,6.82%,NPR1
prerank,myelin maintenance (GO:0043217),-0.317564170213287,-0.750961651788228,0.7963917525773195,0.9751690249582422,1.0,2/10,9.11%,EPB41L3;DEGS1
prerank,regulation of protein localization to centrosome (GO:1904779),0.35938249230653513,0.7507679895245833,0.7478991596638656,0.9601613917176419,1.0,5/10,27.59%,APC;GSK3B;MARK4;CEP72;BICD1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2878124941605874,0.7505640016671594,0.7986013986013986,0.9600072596197146,1.0,8/33,14.81%,OMA1;IAPP;BCL2L1;CLU;TMEM14A;NOL3;BNIP3;FZD9
prerank,skeletal muscle organ development (GO:0060538),0.3053485130994521,0.7505093842278222,0.773121387283237,0.9596570780452116,1.0,5/26,15.28%,CAV1;MEF2C;MYL6;FXR1;POPDC3
prerank,protein deacylation (GO:0035601),0.3080831803356554,0.7502481645474949,0.7703488372093024,0.9596215226957746,1.0,2/23,3.24%,HDAC7;PPT1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.2108164315975396,-0.7497541754710624,0.8875968992248062,0.9758798401471122,1.0,10/50,14.57%,SH3RF1;THBS1;NGF;SRC;VEGFA;FNIP1;RAF1;BCL2L12;DDX3X;PIH1D1
prerank,response to unfolded protein (GO:0006986),0.27630757830210323,0.7496853648629392,0.8278580814717477,0.9600123705610053,1.0,12/48,20.23%,DAB2IP;RHBDD1;HSPB1;HSPA1B;HSPE1;PTPN1;TMBIM6;TM7SF3;DAXX;DNAJB5;ERN1;DNAJA1
prerank,cellular response to gamma radiation (GO:0071480),0.32352269435952297,0.749602986786019,0.7837837837837838,0.9597098102896107,1.0,6/17,25.80%,TMEM109;ATM;MAP3K20;WRN;YAP1;RPL26
prerank,regulation of macromolecule metabolic process (GO:0060255),0.23534658785517593,0.7489557273057813,0.9059459459459459,0.9602279246477936,1.0,31/170,16.78%,TRIM14;NOVA2;APP;AFF1;SLC8A1;YBX2;TRIM11;TRIM6;NKAPL;ZC3H12A;CAVIN4;CACTIN;FOXP1;DHH;HNRNPK;TRIM17;PCBP1;HINFP;TOB1;TSKU;PIN1;TAPBP;UNCX;HIF1A;NELL1;ATXN7L3B;YBX1;KIF16B;AFF4;ZNF711;BMI1
prerank,regulation of myoblast fusion (GO:1901739),0.3541035953793136,0.7489303491722704,0.7487684729064039,0.9598326974850657,1.0,3/11,16.98%,EHD1;ADGRB1;MAPK14
prerank,erythrocyte differentiation (GO:0030218),0.2704504368966924,0.7482675137439825,0.8154050464807437,0.9603489182810842,1.0,6/44,8.61%,TAL1;ALAS1;MFHAS1;JAK2;RPS14;KMT2E
prerank,homologous chromosome segregation (GO:0045143),0.31553245691264104,0.7475090422187805,0.764612954186414,0.9609784523153578,1.0,5/20,20.04%,PTTG1;MEI4;SGO1;TERB1;PRDM9
prerank,iron ion homeostasis (GO:0055072),0.2617435770332737,0.7471351862350262,0.8433121019108281,0.9610899395380356,1.0,20/58,24.88%,B2M;FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;GLRX3;CP;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;TMEM199;FTH1;IREB2;FTL;ATP13A2
prerank,axoneme assembly (GO:0035082),0.2930710747961704,0.7471296823581391,0.7831491712707183,0.9606667309645245,1.0,3/30,7.77%,CFAP206;DNAAF3;TTC12
prerank,histone exchange (GO:0043486),0.2849636750137293,0.7469250402794865,0.8091286307053942,0.960531386939923,1.0,8/37,13.98%,CENPU;SRCAP;NPM1;DMAP1;ACTR6;CENPI;ITGB3BP;VPS72
prerank,mitochondrial gene expression (GO:0140053),0.27976749885112273,0.7468918382028569,0.791268758526603,0.9601503166120661,1.0,10/42,17.63%,SLC25A33;MRPL47;MRPL23;FASTKD5;MRPS34;MRPS12;TFB2M;TEFM;GATB;MRPS18B
prerank,regulation of endocytic recycling (GO:2001135),0.35402777333781776,0.7467989480948068,0.7718120805369127,0.9598621391588632,1.0,4/11,21.72%,EHD1;INPP5F;SORL1;ARHGAP1
prerank,cellular respiration (GO:0045333),0.2790333462400218,0.746665181371305,0.8016194331983806,0.9596343741021663,1.0,10/41,16.38%,ETFDH;ETFA;ETFB;NDUFS4;UQCRB;UQCRFS1;UQCRC1;COX15;ME3;SDHC
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3257736388345527,0.7465246369275181,0.770096463022508,0.9594031694664138,1.0,2/17,3.51%,BTG1;TMEM100
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.2615301528637797,-0.7458349057663146,0.8455056179775281,0.9792300681373286,1.0,8/20,22.28%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,glutathione derivative metabolic process (GO:1901685),-0.2615301528637797,-0.7458349057663146,0.8455056179775281,0.9792300681373286,1.0,8/20,22.28%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,magnesium ion transport (GO:0015693),-0.3079963778659311,-0.745763252721607,0.7922077922077922,0.9782806324911869,1.0,5/12,18.09%,SLC41A1;TUSC3;NIPA1;MAGT1;NIPAL4
prerank,positive regulation of chromosome organization (GO:2001252),-0.28584626744098335,-0.7449142823814531,0.7759562841530054,0.9783976565455116,1.0,6/15,20.27%,RAD50;PPP1R10;RTEL1;PML;GNL3;ATRX
prerank,regulation of cholesterol efflux (GO:0010874),0.2964947477884527,0.7447352140328152,0.7922636103151862,0.9615620427619319,1.0,7/30,17.06%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1;NAXE
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.35273963402667396,0.7445521582777346,0.7744107744107744,0.9613934394001445,1.0,5/12,25.89%,ZC3H12A;ELAVL1;ESR1;NCOR2;TGFB1
prerank,quinone biosynthetic process (GO:1901663),0.33411930850555904,0.7440689515046589,0.7558139534883721,0.9616312057320124,1.0,5/14,18.47%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,protein targeting to membrane (GO:0006612),-0.18878602601697994,-0.7435604636872495,0.9827586206896551,0.9791277101432713,1.0,17/83,15.22%,ABCD3;PARD3;SIL1;ATG3;RAB3IP;SSR1;PRKCI;ATAD1;TRAM1;PEX2;PXMP4;SDCBP;ARL6;SSR2;PXMP2;RABGEF1;GDAP1
prerank,regulation of immunoglobulin production (GO:0002637),0.305528423002568,0.7433584353006308,0.7846820809248555,0.9622320548722265,1.0,2/23,5.16%,FCGR2B;GPI
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.26372447293484824,0.7431999377531457,0.83729662077597,0.9620138391587056,1.0,17/62,20.23%,ARHGEF2;LRRK2;HSPB1;BCL2L1;NFE2L2;SNAI2;TMBIM6;CLU;RTKN2;NOL3;ARMC10;CDKN2D;PLAUR;EPO;PPIF;MCL1;DNAJA1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.26293074516199916,0.7430492684905567,0.8314745972738538,0.9617894588681889,1.0,13/59,14.45%,TNRC6C;MED26;LEF1;SETX;JUN;AGO4;MED30;CBFB;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3460138939114291,0.7423258646546306,0.8051948051948052,0.9623903388484503,1.0,1/13,3.80%,STX7
prerank,regulation of fibroblast migration (GO:0010762),0.3132158382677598,0.7418240924685473,0.7739403453689168,0.9626470981527077,1.0,5/20,13.05%,HYAL2;PRR5L;PTK2;RAC1;ITGB1BP1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.29115859444124903,-0.7417830045264315,0.8264058679706602,0.9804476005962031,1.0,3/13,11.82%,NUPR1;FEZ2;TMEM39A
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.29489915024240176,0.7416572388391106,0.8076379066478077,0.9624458729571691,1.0,10/30,25.98%,BCL2L1;SNAI2;CLU;CDKN2D;DDX39B;DYRK1A;YJU2;TMEM161A;THOC5;PSMD10
prerank,protein localization to condensed chromosome (GO:1903083),0.34713901745184106,0.7416495889840852,0.7647058823529411,0.9620262554414227,1.0,2/12,8.02%,IK;MTBP
prerank,regulation of exit from mitosis (GO:0007096),0.28396085402731885,0.7415325115838418,0.8094575799721836,0.961762029946081,1.0,11/38,23.28%,UBE2D1;UBA52;RPS27A;CDC14A;UBE2E1;CDC27;ANAPC7;PPP1R9B;ANAPC4;UBB;ANAPC11
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.2977043480930551,-0.7413657253642421,0.8065326633165829,0.9799924824816002,1.0,2/13,2.84%,AXL;WNT5A
prerank,lytic vacuole organization (GO:0080171),0.2963404311600557,0.7399239615525358,0.8020527859237536,0.963589385173418,1.0,9/32,21.03%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,peptidyl-asparagine modification (GO:0018196),0.2923727904183826,0.7398967381317691,0.8,0.9631920093702362,1.0,13/31,24.19%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;HIF1AN;UGGT1;DDOST;DAD1;MGAT2;FUT8;NUDT14;DPM3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.27236988675317503,-0.7393035390400797,0.8031496062992126,0.9816734964684906,1.0,5/16,15.80%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,nuclear membrane disassembly (GO:0051081),-0.2906764048739693,-0.7390164073816065,0.8113695090439277,0.9810121225450215,1.0,4/14,15.84%,PRKCB;PRKCA;AKAP8L;NEK6
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.26490249781631753,-0.7387917241554959,0.8338278931750742,0.9802492738544604,1.0,5/19,15.35%,GNL3L;SRC;TENT4B;TEN1;HNRNPU
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.32081666226336025,0.7387646007324865,0.7830045523520486,0.9643679820326516,1.0,5/20,17.28%,CEACAM1;FBXW7;BRCA1;ERLIN2;TRIB3
prerank,catecholamine metabolic process (GO:0006584),0.3352852608062985,0.7387372983510941,0.7777777777777778,0.9639774003066943,1.0,2/14,11.63%,ATP7A;SNCAIP
prerank,cristae formation (GO:0042407),0.294816110175873,0.7387353938820442,0.7833333333333333,0.9635509861569223,1.0,6/27,15.75%,CHCHD3;UQCC3;ATP5MC1;ATP5F1A;ATP5ME;SAMM50
prerank,aggrephagy (GO:0035973),0.2955698064436758,0.738651139920195,0.8132183908045977,0.9632442944715262,1.0,8/27,21.60%,VIM;UBA52;RPS27A;DYNLL1;DYNC1LI2;DYNLL2;DYNC1I2;UBB
prerank,positive regulation of peptidase activity (GO:0010952),0.3109600396075458,0.7385452338626539,0.7946708463949843,0.962959564877344,1.0,8/20,27.71%,APH1A;VSIR;CTSH;APH1B;NCSTN;GRN;TANK;DDRGK1
prerank,purine nucleotide metabolic process (GO:0006163),0.2934121792128654,0.7384877706036108,0.8064024390243902,0.9626046308640823,1.0,2/24,3.76%,GDA;GART
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.2772345331079821,0.7384849271139221,0.820979020979021,0.9621818433807681,1.0,8/41,16.90%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR;HAVCR2;RARA
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2884949921685091,-0.7383185540867191,0.8282051282051283,0.9798073415424742,1.0,6/13,30.36%,BCAP31;UBE2G2;ERLEC1;SVIP;EDEM2;DERL2
prerank,mitotic sister chromatid segregation (GO:0000070),0.2443655387157665,0.7379076425645197,0.8761792452830188,0.9625874778948463,1.0,19/98,16.20%,RAB11A;CUL3;RAD21;KPNB1;TENT4A;DSN1;CHMP1B;VPS4A;PRC1;CHMP3;NCAPG;CEP55;RAN;CSNK2B;CHMP2B;CHMP7;BOD1;NDC80;SGO1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.32063623665160035,0.7379057414585605,0.7866868381240545,0.9621632696434482,1.0,7/18,22.41%,ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;ACSL4
prerank,negative regulation of DNA recombination (GO:0045910),0.277435486126101,0.7377542334455248,0.8326745718050066,0.9619472802880363,1.0,18/43,25.96%,POLR2G;PARPBP;MAD2L2;POLR2D;POLR2I;DAXX;UBQLN4;TERF2IP;BLM;RIF1;SHLD3;POLR2C;SHLD2;TERF2;POLR2B;POLR2J;TINF2;SHLD1
prerank,oligodendrocyte development (GO:0014003),0.33268265335544445,0.7376707173904594,0.7715654952076677,0.9616314384298691,1.0,4/15,17.24%,EIF2B2;B4GALT6;SOX10;NSUN5
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2538659464175479,-0.7375235738436245,0.8546511627906976,0.9798382782943746,1.0,5/21,14.80%,PRKN;TXNDC12;CREB3L1;CREB3;BOK
prerank,regulation of neuroblast proliferation (GO:1902692),0.3277080126650636,0.7371697985430307,0.7800632911392406,0.9619181287036903,1.0,5/15,14.82%,TAFA1;LRRK2;CX3CR1;CTNNB1;FZD3
prerank,activin receptor signaling pathway (GO:0032924),0.3269856094891378,0.7365250352763746,0.7720706260032103,0.9623842144379742,1.0,4/15,15.16%,ACVR1;SMAD2;ACVR2A;ACVR2B
prerank,regulation of store-operated calcium entry (GO:2001256),0.359307063474358,0.7362108818190245,0.7760942760942761,0.9624020864771505,1.0,2/10,7.79%,HOMER2;CASQ1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.25641842932947007,0.7359200315605853,0.8487084870848709,0.9624086963953796,1.0,14/72,15.83%,COPS4;PPIE;POLK;UBA52;POLR2G;RPS27A;RBX1;POLR2D;GTF2H3;COPS8;LIG1;ERCC4;RFC2;POLR2I
prerank,chloride transport (GO:0006821),0.24861602015813664,0.7339191596636966,0.8567870485678705,0.9647993541086222,1.0,16/74,18.08%,CLIC4;SLC12A8;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;CLIC5;GABRB1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.32901103804397147,0.7335125499226652,0.7875399361022364,0.9649190574619464,1.0,3/16,14.04%,INSR;ETF1;BNIP3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.25444497743346783,-0.7334349514925835,0.8619718309859155,0.9840418993372443,1.0,1/20,0.19%,NR2F2
prerank,protein autoprocessing (GO:0016540),0.32195341405490036,0.7332626470420908,0.7779527559055118,0.9648113324812864,1.0,3/17,15.87%,OMA1;CASP1;SPRTN
prerank,rRNA transcription (GO:0009303),0.31418870586929265,0.7331174844498145,0.8045602605863192,0.9645793146304191,1.0,6/17,21.04%,CAVIN1;TAF1B;TCOF1;SPIN1;ANG;BRF1
prerank,T cell activation involved in immune response (GO:0002286),0.3409393394798804,0.7330918712301042,0.7623762376237624,0.9641904023190465,1.0,1/12,2.44%,F2RL1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2509588671060559,0.7328837793953592,0.8669108669108669,0.9640400711859083,1.0,18/80,18.77%,NOD1;ARL6IP5;KLF4;PPM1F;TNFSF10;GRAMD4;DELE1;HMGB1;SIAH2;CASP1;RPS6KA1;RPS6KA3;CDKN2D;DNAJB6;PYCARD;SOX7;XIAP;MALT1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.29551275571432,-0.7326706960970968,0.8045685279187818,0.983999080528342,1.0,1/12,1.76%,BMP7
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.24582669502827054,0.7325722706508574,0.8778173190984578,0.9640531122001876,1.0,22/87,23.04%,OMA1;TMEM126B;SCO1;UQCC3;SLC25A33;IMMP2L;NDUFS4;NDUFA12;NDUFB5;NDUFB7;UQCRFS1;TIMMDC1;ACAD9;NUBPL;SAMM50;PET100;NDUFB4;UQCC2;NDUFA9;NDUFV1;BCS1L;NDUFC1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3100079246189406,0.7325127592962719,0.8030534351145038,0.9637021533578742,1.0,10/19,29.78%,HSPA1B;CHMP1B;CHMP3;CHMP2B;CHMP1A;TPR;VPS4B;CHMP4B;EML3;HSPA1A
prerank,neuron differentiation (GO:0030182),0.23096388100285792,0.7324670601028839,0.9041394335511983,0.9633358221873465,1.0,23/165,16.64%,NR4A2;NEUROG2;ATP2B2;OLIG2;TGFB2;PPT1;MEF2C;MYEF2;ALK;NGRN;TENM3;TENM4;SPOCK1;PHOX2A;PIN1;POU3F2;MYT1L;CTNNB1;FZD3;TENM2;TENM1;SNPH;OPHN1
prerank,protein import into mitochondrial matrix (GO:0030150),0.3153361405480515,0.7324164354328911,0.7777777777777778,0.962985041784427,1.0,3/18,15.95%,TOMM20L;DNLZ;PAM16
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2909950523036372,0.7322605311074155,0.8226527570789866,0.9627836443912915,1.0,7/29,17.51%,PUM2;SMAD2;ZC3H7A;ADAR;AGO4;DROSHA;TUT7
prerank,sensory perception of taste (GO:0050909),0.35601305548581463,0.7318574802556636,0.7749140893470791,0.9629126581312151,1.0,10/10,64.42%,ASIC2;PKD1L3;PKD2L1;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;CD36
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2720289627152789,0.7318416623363891,0.8390646492434664,0.9625169060994226,1.0,6/43,10.88%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR
prerank,cellular response to misfolded protein (GO:0071218),0.31470810715894987,0.7316570641549253,0.7835703001579779,0.9623302875507193,1.0,6/20,21.01%,RNF185;CUL3;BAG6;UGGT1;RNF5;POMT2
prerank,positive regulation of myelination (GO:0031643),-0.3073096761867149,-0.731503412337772,0.8086734693877551,0.984488021025928,1.0,2/11,4.46%,DICER1;PARD3
prerank,regulation of phosphatase activity (GO:0010921),0.30142765223293877,0.7314772110213625,0.7916063675832128,0.962162155423141,1.0,3/24,7.44%,ZCCHC9;GPATCH2;HSP90B1
prerank,negative regulation of neuron death (GO:1901215),0.24440495597117465,0.7309489592886818,0.8642857142857143,0.9624676553982383,1.0,33/93,27.52%,FOXQ1;PPT1;FBXO7;MEF2C;CD34;TNFRSF1B;TOX3;LRRK2;CD200;PRKCG;VPS35;CHGA;FZD9;FGF20;KDM2B;UNC5B;NENF;BDNF;GSK3B;CD200R1;SORL1;SOD1;EIF4G1;GRN;ATP13A2;CSF1;CLCF1;GDNF;SNCA;CHMP4A;CHMP4B;TRAF2;RASA1
prerank,ubiquinone biosynthetic process (GO:0006744),0.322649193643482,0.7308548994566185,0.7761437908496732,0.962155842090887,1.0,6/15,22.39%,COQ3;PDSS2;PDSS1;COQ5;COQ7;NDUFA9
prerank,regulation of biosynthetic process (GO:0009889),0.3448642174780201,0.7307366178894451,0.8021015761821366,0.9619032133388248,1.0,1/11,6.64%,SLC25A33
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3493195163679117,0.7306459699529826,0.7750865051903114,0.9615999519528954,1.0,2/10,8.73%,PLPP1;DGKH
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.33928161074935687,0.7304811960160023,0.7798319327731092,0.9614115528599265,1.0,3/13,10.51%,SHISA8;SHISA6;GRIK2
prerank,positive regulation of transporter activity (GO:0032411),0.32617542325625903,0.730347531776936,0.7977707006369427,0.9611783033194564,1.0,2/13,9.30%,STK39;SGK1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.28058246285897204,-0.7302470092347856,0.845945945945946,0.985032065342598,1.0,9/16,38.31%,TIPIN;ORC1;TIMELESS;RAD9A;CDC45;DNA2;HUS1B;CDC6;TICRR
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.25129423384437843,-0.7301266647146251,0.8287461773700305,0.9841594654685125,1.0,12/23,37.34%,HSPA4;NDUFA13;COX18;TOMM22;ROMO1;TIMM29;BAD;BAX;TIMM10;TIMM9;PMAIP1;TIMM13
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.2804761678836643,0.7300340502429327,0.8017241379310345,0.9611751399682563,1.0,4/31,13.96%,FCGR2B;ARG1;TYROBP;ATM
prerank,programmed necrotic cell death (GO:0097300),0.3117579703525819,0.7300323986787982,0.797191887675507,0.9607556135005896,1.0,2/18,9.55%,TLR3;MLKL
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3232162916640606,0.729961885102595,0.7747603833865815,0.960432600052074,1.0,2/15,9.31%,FAM107A;ZFP36L2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.32822553689109313,0.7296255001138545,0.7561779242174629,0.9604684758784413,1.0,3/15,17.43%,NLRC5;CACTIN;PTPN2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3138365922545189,0.729556805164158,0.8145800316957211,0.9601556553191477,1.0,7/19,21.37%,CLIC4;MARK2;LRRC7;ERBIN;FOXJ1;MTCL1;CRB1
prerank,negative regulation of histone acetylation (GO:0035067),-0.3039129667856682,-0.729488239124099,0.8166666666666667,0.9839426959464124,1.0,3/11,18.94%,SET;TAF7;NOC2L
prerank,regulation of stem cell proliferation (GO:0072091),0.3096985660949507,0.7294033049364399,0.7967479674796748,0.9599457954397995,1.0,1/17,1.04%,ACE
prerank,positive regulation of vacuole organization (GO:0044090),-0.3186837824316281,-0.7288929402424453,0.7915632754342432,0.9836614396208332,1.0,2/10,7.77%,ANXA2;PIP4K2A
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2943577581038254,-0.7280365289341896,0.821078431372549,0.9837320498747408,1.0,4/13,15.74%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,mRNA destabilization (GO:0061157),-0.2216646589370594,-0.7280338129771623,0.8865248226950354,0.9827168465208969,1.0,11/38,19.02%,ROCK2;YTHDF1;FTO;PUM1;TARDBP;YTHDF2;CPEB3;GIGYF2;RC3H1;TUT4;ZFP36
prerank,motor neuron axon guidance (GO:0008045),0.33326228244175726,0.7279324337448039,0.7750865051903114,0.9615276831494943,1.0,6/15,21.58%,NTN1;TMEFF1;RAC1;RHOH;SLIT1;EPHA4
prerank,postreplication repair (GO:0006301),0.2697387478663539,0.7274831007097825,0.8236877523553163,0.9617211314085479,1.0,9/45,15.87%,USP43;POLK;UBA52;RPS27A;TRIM25;BRCA1;RAD18;RFC2;SPRTN
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3123273914135074,-0.7265268044242061,0.8052256532066508,0.9824755500326366,1.0,10/10,68.79%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3123273914135074,-0.7265268044242061,0.8052256532066508,0.9824755500326366,1.0,10/10,68.79%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,RNA metabolic process (GO:0016070),0.23510963579416735,0.725127853221744,0.9087875417130145,0.9644347004936499,1.0,31/127,19.86%,ADARB1;RBPMS;LSM1;SETX;HNRNPA0;ZC3H12A;POLR2G;ADAR;ELAVL4;DHX9;DKC1;DUSP11;POLR2D;HNRNPK;AGO4;RNASE1;RNASEH2B;XRN2;PCBP1;METTL14;RNASE6;HNRNPH2;ATXN1;PRPF4;POLR2I;DROSHA;TENT2;DDX39B;HNRNPUL1;RNASE4;SYNCRIP
prerank,response to UV-B (GO:0010224),-0.2957142894538466,-0.7250271560833288,0.8025641025641026,0.9832497510543379,1.0,4/12,16.10%,HYAL1;CRIP1;MFAP4;CDKN1A
prerank,response to gamma radiation (GO:0010332),0.28892988098984185,0.7248765277557285,0.8279411764705882,0.9643471438320695,1.0,8/24,25.80%,TMEM109;PRKAA1;ATM;MAP3K20;MEN1;WRN;YAP1;RPL26
prerank,UV-damage excision repair (GO:0070914),-0.2931248457619285,-0.7248350334597772,0.8132387706855791,0.9824506921784942,1.0,2/12,7.99%,DDB2;CUL4B
prerank,regulation of translational initiation (GO:0006446),0.25670925741821454,0.7247825419051352,0.8594327990135635,0.9640560699165656,1.0,15/63,16.50%,UHMK1;HSPB1;POLR2G;EIF3B;EIF2B2;POLR2D;EIF1;NPM1;RPS6KB1;HABP4;PPP1R15B;MTIF2;EIF3H;KLHL25;NCK1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.24203494976805126,-0.7247650258156487,0.8712574850299402,0.9815263208096602,1.0,5/24,13.57%,JARID2;MTF2;DNMT3A;RBBP7;MPHOSPH8
prerank,cellular response to glucose stimulus (GO:0071333),0.28367004930891815,0.7247259591978846,0.8110014104372355,0.9637062826903093,1.0,3/30,8.29%,UNC13B;PCK2;PRKAA1
prerank,aminoglycan metabolic process (GO:0006022),-0.31110863672533273,-0.7246334685739854,0.8301886792452831,0.9806821191961023,1.0,4/10,23.67%,XYLT1;B3GAT3;B3GAT1;CLN6
prerank,regulation of programmed necrotic cell death (GO:0062098),0.30693452251123887,0.7244787906480419,0.7972350230414746,0.9636258063991462,1.0,2/20,2.47%,CASP8;SPATA2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.31664110003174745,-0.7241866542830815,0.8154613466334164,0.9801959719062013,1.0,2/10,6.40%,DCN;XDH
prerank,visual system development (GO:0150063),0.2708319641056999,0.7239072431893575,0.8282290279627164,0.9639742036718155,1.0,4/37,7.12%,TGFB2;SIPA1L3;ADAMTS18;ITGAM
prerank,negative regulation of protein transport (GO:0051224),-0.24100185952913694,-0.7238318954002216,0.8720238095238095,0.9796149084393202,1.0,8/25,21.98%,APOE;PKDCC;SNX12;DRD2;SERGEF;RHBDF1;CYP51A1;ERP29
prerank,maturation of SSU-rRNA (GO:0030490),0.2719034906431982,0.7235834892014117,0.8310249307479224,0.9639835661371643,1.0,10/34,21.86%,DHX37;RPS14;WDR46;RPS28;RIOK3;NOB1;DCAF13;PWP2;RPS19;RPS8
prerank,synaptic vesicle cycle (GO:0099504),0.28798187391061664,0.7235024181465292,0.8159771754636234,0.9636645169862691,1.0,8/30,26.90%,SYT7;PIP5K1C;SLC32A1;CPLX1;NLGN1;RIMS1;PLD2;SNCA
prerank,protein monoubiquitination (GO:0006513),0.2799043905956199,0.7229714269127212,0.8401639344262295,0.963925731498471,1.0,9/36,14.78%,CUL3;RBX1;TRIM25;OBI1;DTX3L;UBE2T;UBE2E1;RAD18;UBE2D3
prerank,positive regulation of cell killing (GO:0031343),-0.28659999743198783,-0.7224989518585305,0.8556962025316456,0.9801759028511629,1.0,5/13,27.35%,WNT5A;FZD7;MAPK8;SYK;NOXO1
prerank,histone deubiquitination (GO:0016578),-0.2575597129007063,-0.7222795307066548,0.861671469740634,0.9794164571754614,1.0,3/18,13.64%,USP3;USP22;ATXN7L3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.30730941861812006,0.722159366904822,0.800302571860817,0.9645758601363341,1.0,6/20,18.51%,NOTCH1;NFE2L2;CHD6;HIF1A;SMAD4;RELA
prerank,regulation of centrosome duplication (GO:0010824),0.2898788116739289,0.7218513268579411,0.7942446043165468,0.9645730098685962,1.0,11/29,27.34%,CHMP1B;CEP76;NPM1;CHMP3;CHMP2B;CEP120;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.2580273282368662,-0.7217078854591356,0.8369905956112853,0.9791327071616114,1.0,4/20,13.07%,IL1R1;CD55;PRKCZ;CD81
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2805622927249167,0.7208353921774152,0.8278443113772455,0.9654719198046554,1.0,6/30,17.43%,CAV1;HYAL2;INPP5F;NF2;SH3BP5L;PTPN2
prerank,organelle fission (GO:0048285),-0.2440682139654181,-0.7206870949343923,0.8776758409785933,0.9793507709485627,1.0,10/24,29.49%,PRKN;SEC16B;TMCC1;GDAP1;MTFR1L;DNM1L;PEX11B;MTFR2;OPA1;MTFP1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2527028810954911,0.7197502050245949,0.8592964824120602,0.9665100438738756,1.0,4/63,7.82%,VCAM1;TIRAP;MEF2C;SLC7A1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2619970832820724,0.7193857781188884,0.8526727509778357,0.9661205529834808,1.0,12/51,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,mitotic nuclear membrane organization (GO:0101024),0.2619970832820724,0.7193857781188884,0.8526727509778357,0.9661205529834808,1.0,12/51,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.2952712146135408,0.7191971923758316,0.8320950965824666,0.9659481141171159,1.0,5/25,18.60%,HSPA1B;HSPE1;PTGES3;DNAJC7;DNAJB5
prerank,peroxisome organization (GO:0007031),-0.24265138086689503,-0.7191661054563769,0.8987341772151899,0.9801379774689402,1.0,8/25,24.75%,ABCD3;PEX2;SEC16B;DNM1L;PEX7;PEX11B;PEX3;PEX16
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3093531616058639,0.719145287544882,0.8088467614533965,0.9655985985944558,1.0,6/17,21.53%,BBC3;BCL2L1;CLU;FZD9;BID;GGCT
prerank,protein transport (GO:0015031),0.21815889615650758,0.71903311765519,0.9671457905544147,0.9653335546571175,1.0,79/332,22.04%,RABGAP1;ARHGEF2;MACF1;RAB6B;ARL6IP5;HERC2;PPT1;STX7;TBC1D30;SCG5;EHD1;SGSM1;RAB34;TBC1D8;TMED10;MYH9;ARRDC1;RAB23;RAB3GAP2;LMTK2;HSP90B1;MCOLN1;TBC1D12;TLK1;TBC1D5;STX12;TBC1D1;CHMP1B;ARF3;LAPTM5;NPM1;VPS35;CLU;TMED9;RAB19;STX19;CHMP3;YWHAH;USP6NL;TBC1D10A;WDR11;TBC1D4;STXBP3;TBC1D9;NSF;VLDLR;TMED4;RUNDC1;TANGO6;CHMP2B;ARL5B;ANK3;ARFIP2;SEL1L;RUFY1;ATP6V1G1;SPTBN1;GOLPH3L;ARL4C;ATP6V1C1;TBC1D8B;GOLPH3;LAMP2;RAB5C;TVP23A;TMED7;ATP6V0A1;REP15;RAB31;LRP1B;ARRDC4;ATP6V1D;SCAMP1;RAB12;AP3D1;MYO6;ARHGAP1;CHMP1A;TBC1D14
prerank,regulation of chromosome organization (GO:0033044),-0.24766064463878906,-0.7189358534864095,0.8602150537634409,0.9794288322920249,1.0,11/22,37.72%,YLPM1;XRCC5;HDAC8;SETMAR;RMI2;LIG4;HNRNPD;SMG6;UPF1;MYC;PIF1
prerank,triglyceride homeostasis (GO:0070328),0.2909601517786709,0.718918470518486,0.8234442836468886,0.9650797527721461,1.0,2/26,3.48%,HNF4A;APOA1
prerank,establishment of spindle orientation (GO:0051294),-0.22778429059604288,-0.7180959184460962,0.8909090909090909,0.979367115317151,1.0,5/28,9.85%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,organonitrogen compound catabolic process (GO:1901565),0.2542630370021197,0.7179757931265811,0.8625954198473282,0.9658797804881823,1.0,4/57,6.50%,ACE;TST;PPT1;TRIM24
prerank,mitochondrial genome maintenance (GO:0000002),0.33403467651960056,0.7178937753042586,0.7884615384615384,0.9655744704879871,1.0,2/11,6.91%,SLC25A33;AKT3
prerank,lipid phosphorylation (GO:0046834),0.3451219277926725,0.7177677101214531,0.7745454545454545,0.9653195744971338,1.0,4/10,25.02%,DGKH;DGKI;DGKA;DGKB
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.2939175256572433,0.7174024535189989,0.8153409090909091,0.9653656649834432,1.0,6/24,14.25%,TGFB2;ITGAM;FBXW7;PRNP;TYROBP;CTNNB1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3202565701886792,0.7170375063495062,0.8289269051321928,0.9653853440263391,1.0,4/15,16.98%,EHD1;TYROBP;ADGRB1;MAPK14
prerank,histone H4 acetylation (GO:0043967),0.26483829211631765,0.7169708238343165,0.8425925925925926,0.9650561739788357,1.0,9/47,15.52%,ING3;LEF1;BRD8;JADE2;CHD5;DMAP1;KANSL1;KAT7;TRRAP
prerank,mitochondrial fusion (GO:0008053),0.3164901779685903,0.7166132180552727,0.8189233278955954,0.9650948531455993,1.0,8/18,27.67%,CHCHD3;MIGA1;MFN1;USP30;AFG3L2;STOML2;FIS1;MIEF1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3434132137937992,0.7165641563531547,0.7950413223140496,0.9643362633363033,1.0,2/11,12.45%,FKBP1A;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3434132137937992,0.7165641563531547,0.7950413223140496,0.9643362633363033,1.0,2/11,12.45%,FKBP1A;CALM3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.280840052063417,0.7164296060111403,0.8293413173652695,0.9640782877597872,1.0,10/29,25.50%,RPS21;DHX37;RPS14;WDR46;DCAF13;PWP2;RPS19;RPS8;UTP20;RPS16
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.20001514220086844,-0.7162432705713385,0.9414414414414415,0.980353941386366,1.0,23/56,28.68%,ROCK2;SON;IST1;JTB;EFHC1;ANLN;SPAST;RTKN;SNX18;STMN1;USP8;DCTN3;ARL3;INCENP;PDCD6IP;RACGAP1;TTC19;NUSAP1;CKAP2;RHOA;SNX33;CIT;ALKBH4
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2607103619995536,0.7161660203509848,0.8670212765957447,0.9639915056706592,1.0,12/49,18.71%,TNRC6C;MEF2C;THPO;KMT2E;KMT2B;AGO4;CBFB;HMGB2;EIF6;RBM15;SIN3A;H3-3A
prerank,response to light stimulus (GO:0009416),-0.19723630145292875,-0.7160197379795797,0.9451476793248945,0.9795810914665627,1.0,12/55,15.10%,DDB2;BRSK1;USP1;ERCC5;MAP2K7;CLOCK;REV1;UVSSA;MSH6;DRD2;CRY2;ERCC2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2929318038749846,-0.7155993042689375,0.8575498575498576,0.9790574336101326,1.0,4/14,17.73%,ADK;LHPP;ATIC;IMPDH2
prerank,ribosomal large subunit assembly (GO:0000027),0.29771315217494876,0.7149695177371654,0.8163265306122449,0.9651124691920838,1.0,14/24,32.17%,BOP1;DDX28;RPL23A;RSL24D1;NOP53;RPF2;RPL3;MDN1;RPL11;FASTKD2;NOP2;RPL10;NLE1;RPL6
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2867460959434726,0.7148367856997021,0.8328445747800587,0.9648654428264666,1.0,6/27,15.52%,BRD8;MRGBP;BAG6;SGF29;KAT7;TRRAP
prerank,positive regulation of DNA recombination (GO:0045911),-0.23415197080968905,-0.7147845168732696,0.902027027027027,0.9789689648997176,1.0,8/27,22.29%,KMT5C;FUS;KMT5B;ACTR2;ERCC2;FANCB;TIMELESS;PARP1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3215917577519604,0.714005930487759,0.7892234548335975,0.9654973319756285,1.0,3/14,8.68%,TNFRSF1B;CD200;NR1D1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.25979935028160456,0.7123896403514279,0.8651535380507344,0.967184239781473,1.0,15/52,22.72%,CASP8;PPP1R13B;BBC3;NMT1;FBXW7;UBE2J2;YWHAH;UBE2D3;GSK3A;BID;TOMM7;PPP3CC;SREBF2;LEPROT;PPP3R1
prerank,tRNA export from nucleus (GO:0006409),0.278529195695661,0.712245242624858,0.8321678321678322,0.9665130403312342,1.0,8/32,15.93%,NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;NUP205
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.278529195695661,0.712245242624858,0.8321678321678322,0.9665130403312342,1.0,8/32,15.93%,NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;NUP205
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3484315970199459,0.712082939321679,0.808695652173913,0.9663030932090868,1.0,4/10,23.10%,APEX1;TERF2IP;RIF1;TERF2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.31196642077453196,0.7118717556967513,0.7993827160493827,0.9661732752354308,1.0,6/18,21.58%,IFNGR1;EFNA1;CLU;GSK3A;RELA;EPHA4
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.30655781544079125,0.7117394881418959,0.8115015974440895,0.9659230429602896,1.0,5/19,18.49%,APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2894890638769779,0.7114944876491375,0.8251057827926658,0.9658109601468239,1.0,4/26,9.05%,NFKBIL1;NMI;ACOD1;CACTIN
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.29075136950346026,-0.7114766987017631,0.8382352941176471,0.9816420310864371,1.0,1/12,1.83%,NUPR1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23641088409561437,0.7110255731269884,0.9014084507042254,0.9660043928051704,1.0,16/94,14.33%,RAB11A;TUBB;CSNK1D;TTBK2;TUBB4B;CLASP1;TMEM216;NEDD1;CEP135;HAUS3;PCM1;DYNLL1;CEP76;KIF24;TUBA1A;CEP83
prerank,ion homeostasis (GO:0050801),0.2845000290333538,0.7108386676745085,0.8376436781609196,0.9658238996620488,1.0,5/30,10.96%,RHCG;KLHL3;CAMK2D;SLC4A9;NEDD4L
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2828768390052138,0.7107754030878151,0.8326180257510729,0.965494906669985,1.0,3/29,5.33%,CAV1;TNFSF10;HYAL2
prerank,nucleotide-excision repair (GO:0006289),0.23605819487415503,0.7107239494752782,0.8950471698113207,0.9651439728966398,1.0,27/101,23.64%,COPS4;PPIE;POLK;UBA52;POLR2G;RPS27A;RBX1;POLR2D;BRIP1;POLA1;POLB;GTF2H3;COPS8;LIG1;ERCC4;XPC;RFC2;POLR2I;MMS19;COPS5;HUS1;MNAT1;UBB;POLR2C;POLR2B;CETN2;POLR2J
prerank,axonemal dynein complex assembly (GO:0070286),-0.23135911296254766,-0.7106628908340827,0.8843537414965986,0.9815501546031922,1.0,20/27,43.46%,DNAI4;DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;DRC1;CCDC39;ODAD3;CCDC65;DNAAF2;ODAD4;CFAP100;DNAH17;CCDC40;DNAAF4;CCDC63;DNAH8;DNAH1;SPAG1
prerank,protein localization to kinetochore (GO:0034501),0.3255016749456565,0.7099712697681406,0.8116666666666666,0.9657119447495826,1.0,2/14,8.02%,IK;MTBP
prerank,positive regulation of protein localization to membrane (GO:1905477),0.23640077020858394,0.7090911585295817,0.9061757719714965,0.9664030763799352,1.0,22/98,18.54%,FYN;ATP2B4;CASP8;PPP1R13B;DPP10;AKAP5;STAC;BBC3;ITGAM;NMT1;MYO1C;PRNP;NKD2;YWHAH;ITGB1BP1;ITGA3;CNPY4;ZDHHC5;ANK3;SPTBN1;NECAB2;BID
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3408896874427143,0.7084382219311293,0.8056478405315615,0.9668207508873056,1.0,2/10,9.67%,ADAM17;FBXW7
prerank,sensory perception of pain (GO:0019233),0.3048695959275231,0.7083325725073661,0.8230994152046783,0.9665316210502225,1.0,4/21,13.50%,NIPSNAP1;P2RX7;ALOXE3;SCN9A
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2787765929564232,0.7077882247849488,0.8531073446327684,0.9668040883527688,1.0,2/31,3.81%,GCH1;GPHN
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2962442555954062,0.7077436430097503,0.8293051359516617,0.9664374143018236,1.0,3/21,12.42%,PGM2L1;GPI;TALDO1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3115431028446104,0.7075794564251263,0.8275316455696202,0.9662400533742607,1.0,2/15,5.76%,ING2;TAF9B
prerank,glycine transport (GO:0015816),-0.30124263916044836,-0.7065063497935017,0.8317073170731707,0.9851929542201298,1.0,2/10,10.92%,SLC6A9;SLC38A5
prerank,establishment of mitotic spindle localization (GO:0040001),-0.22505026385721577,-0.7058632451317948,0.8936170212765957,0.9849350545283195,1.0,5/28,9.85%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.23283990199877871,-0.7057596723578519,0.9081967213114754,0.9840375422875957,1.0,12/27,36.85%,CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;PPP1CB;TP53
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3082454687981339,0.7053517368113793,0.802653399668325,0.9685967404095028,1.0,4/15,16.19%,PRKD1;HSPB1;PRKD2;TMSB4X
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2743609454315761,0.7053193087012668,0.8400556328233658,0.9682258634474439,1.0,13/33,26.87%,ZBTB48;STN1;DKC1;PTGES3;NHP2;CTC1;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1
prerank,eosinophil migration (GO:0072677),0.3198769462581616,0.7040326121609009,0.8248772504091653,0.9689709255201241,1.0,14/14,68.04%,CCL4;LGALS3;SCG2;CCL24;CCL26;CCL13;CCL3;CCL1;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.3198769462581616,0.7040326121609009,0.8248772504091653,0.9689709255201241,1.0,14/14,68.04%,CCL4;LGALS3;SCG2;CCL24;CCL26;CCL13;CCL3;CCL1;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2
prerank,sterol biosynthetic process (GO:0016126),-0.21769691168687916,-0.7028308790263877,0.9166666666666666,0.9861176903448632,1.0,1/33,0.11%,PRKAG2
prerank,camera-type eye morphogenesis (GO:0048593),-0.29687709003365675,-0.7027518653683591,0.8349056603773585,0.9852023466697529,1.0,3/10,11.27%,SHROOM2;VEGFA;TBX2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.28978057616472536,0.7022350178066247,0.8320950965824666,0.9707605807720842,1.0,3/23,13.49%,PLK3;VPS4A;BUB1
prerank,protein insertion into ER membrane (GO:0045048),0.26473684430522143,0.7020471258977068,0.8492597577388964,0.9705666461909936,1.0,12/37,23.42%,APP;PRNP;GET1;BAG6;UBE2J2;VAPA;CCDC47;EMC3;CYB5A;EMC10;EMD;SGTA
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.29411683790067183,0.7019756224760387,0.8340807174887892,0.9702334037358654,1.0,6/24,15.37%,POLK;UBA52;RPS27A;POLB;LIG1;RFC2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.236400590671748,-0.7018190383915006,0.9121813031161473,0.9852121998334105,1.0,1/22,0.19%,NR2F2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3319119281275096,0.7010651250151732,0.8095238095238095,0.9709070833615158,1.0,1/11,2.42%,CASP8
prerank,protein K11-linked ubiquitination (GO:0070979),-0.22823233560806017,-0.7009468855029727,0.9318885448916409,0.9851842444984396,1.0,4/27,12.45%,UBE2E2;PRKN;RNF4;UBE2L3
prerank,serine family amino acid biosynthetic process (GO:0009070),0.33045860815015793,0.7007808634479571,0.8151815181518152,0.9708232599808803,1.0,2/12,11.61%,SERINC3;SERINC5
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2544049804490706,0.7005475475585183,0.8679738562091504,0.9706867316705602,1.0,4/46,8.90%,FBXO7;TOMM20L;DNLZ;TSPO
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.2733234386665787,-0.699731643510347,0.8597883597883598,0.9854535122795802,1.0,6/13,30.30%,DDO;GOT1;QPRT;ASPA;GOT2;ACSF3
prerank,protein targeting to mitochondrion (GO:0006626),0.25298603451169305,0.6997084863795332,0.8881664499349805,0.9712330935868333,1.0,8/52,15.95%,FBXO7;TOMM20L;IMMP2L;DNLZ;TSPO;AGK;SAMM50;PAM16
prerank,body fluid secretion (GO:0007589),-0.26444143261420106,-0.6988159075315638,0.868632707774799,0.9854418103920674,1.0,4/15,19.56%,SLC22A4;VEGFA;SLC22A2;ZBTB7B
prerank,inorganic ion transmembrane transport (GO:0098660),-0.2871455333354173,-0.6983414162397571,0.837708830548926,0.9849374540347249,1.0,3/12,20.02%,ABCC9;CACNA1H;KCNJ8
prerank,bile acid biosynthetic process (GO:0006699),0.2848648715121861,0.6978905494313443,0.8527696793002916,0.9730233655635243,1.0,4/24,14.78%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,regulation of B cell proliferation (GO:0030888),0.2587243237009579,0.6961877880717601,0.8787061994609164,0.9746920058907412,1.0,6/44,13.96%,TIRAP;FCGR2B;MEF2C;TYROBP;CD38;ATM
prerank,positive regulation of synapse assembly (GO:0051965),0.2814178209304598,0.6961469376703999,0.8535127055306427,0.9743243157518072,1.0,9/27,22.78%,AGRN;IL1RAP;SLITRK2;LRRC4B;GRID2;BDNF;NRXN1;NLGN1;IL1RAPL1
prerank,sarcomere organization (GO:0045214),0.27912230954600153,0.696081776921517,0.8457223001402524,0.9739845655015469,1.0,3/27,7.79%,CSRP2;WDR1;CASQ1
prerank,pentose-phosphate shunt (GO:0006098),-0.2890513326225122,-0.6957557716074455,0.8438287153652393,0.9865292723009561,1.0,5/11,27.74%,RPIA;H6PD;PGD;PGLS;SHPK
prerank,mitotic DNA replication (GO:1902969),0.3306456662466432,0.6955763430262172,0.8327586206896552,0.9741732476809778,1.0,2/10,13.14%,POLA1;LIG1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.30039783123707087,-0.6952002835963579,0.8106796116504854,0.9861038941118782,1.0,3/10,20.27%,JARID2;DNMT3B;ATRX
prerank,histone H2A monoubiquitination (GO:0035518),-0.2526840102648266,-0.6949577309635049,0.8731988472622478,0.9853846415780496,1.0,3/17,7.99%,DDB2;PCGF3;CUL4B
prerank,protein heterooligomerization (GO:0051291),0.29752015048653213,0.6948563166928821,0.8413461538461539,0.9745838922963141,1.0,5/17,20.81%,FARSB;GRIN2B;KCNC2;MAT2A;TMEM120B
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.33299198553915677,0.6944321649462665,0.8330550918196995,0.9746398047439193,1.0,3/11,22.21%,IPPK;PWP1;NOP53
prerank,aromatic amino acid family catabolic process (GO:0009074),0.30710401454787545,0.694396278453705,0.8349358974358975,0.9742699008485619,1.0,4/15,22.19%,HGD;KYAT1;KYNU;QDPR
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22334500216137784,0.6943168379306215,0.9312288613303269,0.9739623400042562,1.0,9/110,6.98%,FBLIM1;TAL1;MMP1;DAB2IP;TIRAP;HRK;IAPP;WARS1;IRGM
prerank,response to glucose (GO:0009749),0.258932810192722,0.6941123254534172,0.8841544607190412,0.9737954074144455,1.0,5/46,9.40%,UNC13B;HNF4A;PCK2;PRKAA1;EIF2B2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2419328302669906,0.693556786638907,0.8925518925518926,0.9740581474998985,1.0,16/72,15.37%,EXD2;ZC3H12A;POLK;UBA52;DCP1B;MEI4;RPS27A;FEN1;RBX1;RNASE1;XRN2;GTF2H3;RNASE6;ERCC4;EDC3;RFC2
prerank,snRNA transcription (GO:0009301),0.24162452370090107,0.6931058291545091,0.9063291139240506,0.9741812769765068,1.0,23/70,23.64%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;TAF11;SNAPC4;POLR2I;TAF8;RPRD2;USPL1;ZC3H8;SNAPC1;POU2F2;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J
prerank,negative regulation of proteolysis (GO:0045861),0.266052261093713,0.6929667588082243,0.869684499314129,0.9739254482029452,1.0,6/34,11.00%,TIMP3;EFNA1;LRRK2;ROCK1;PRNP;BAG6
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2534817960285203,0.6928251803607982,0.8820375335120644,0.9736788628864788,1.0,6/48,9.11%,F2RL1;APOA1;ARG1;NLRC5;CACTIN;STAP1
prerank,intracellular sterol transport (GO:0032366),-0.2759338386570767,-0.6924558863309086,0.8520408163265306,0.9868933209188913,1.0,1/13,2.95%,ABCA1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3062418382060196,0.6922986755059581,0.8322784810126582,0.9738548451031445,1.0,3/16,13.96%,DCPS;CACTIN;SART1
prerank,transcription by RNA polymerase III (GO:0006383),-0.2273875476366182,-0.6922295887157286,0.9051987767584098,0.9861276140178914,1.0,11/27,31.28%,GTF3C3;ELL;CRCP;GTF3C2;GTF3A;TBP;GTF3C1;POLR3K;GTF3C4;POLR2L;SNAPC2
prerank,fatty acid beta-oxidation (GO:0006635),0.2516539672298068,0.6921067306104298,0.8894668400520156,0.9736548823381369,1.0,18/51,22.69%,ETFDH;ETFA;ETFB;ACOX1;ACAD10;SLC27A2;HADHB;ACOX3;CROT;ECI1;ACAT1;DECR2;HADHA;HADH;ACAA2;ABCD2;ABCD4;HSD17B4
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2949563693427008,-0.6919058222977528,0.8527315914489311,0.9854556156439742,1.0,4/10,18.12%,EHMT1;SETD7;SETD4;EEF1AKMT2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.3004627795544196,-0.6917096915760949,0.8707317073170732,0.9846554437501955,1.0,1/10,2.70%,KIT
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.25200572912111086,-0.6915885925393205,0.8699186991869918,0.9838022325172793,1.0,6/18,18.62%,DAB2;SRC;MAP2K2;SNX12;PTPN23;EZR
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.2756935826516666,0.6911401984153163,0.8426470588235294,0.9743587642055789,1.0,3/26,7.14%,APP;SHANK3;LRRK2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.33444864835266536,0.6906889878806867,0.8177257525083612,0.9744793086023896,1.0,3/10,17.96%,DKC1;NHP2;RPUSD2
prerank,sensory perception (GO:0007600),0.25642806603469304,0.6898748805831827,0.8741721854304636,0.9750359796394752,1.0,7/45,13.50%,GNAL;NIPSNAP1;P2RX7;PCDH15;TMEM150C;ALOXE3;SCN9A
prerank,positive regulation of bone resorption (GO:0045780),0.3197495643479694,0.689372012333667,0.8419243986254296,0.9752110167662227,1.0,2/11,7.52%,MC4R;PLEKHM1
prerank,negative regulation of hippo signaling (GO:0035331),0.31666156907462556,0.6893183776127375,0.8169717138103162,0.974870759703907,1.0,4/12,19.90%,WWC2;MARK3;MAPK14;SHANK2
prerank,mRNA catabolic process (GO:0006402),0.25694909915576986,0.6891985232586229,0.8596730245231607,0.9745989044546256,1.0,18/44,25.69%,HSPA1B;ZFP36L2;AGO4;XRN2;XRN1;EXOSC9;TUT7;DXO;NBDY;LSM2;ERN1;EXOSC10;DIS3L2;NUDT16;MRTO4;RNH1;NUDT16L1;LSM5
prerank,intracellular pH reduction (GO:0051452),-0.21560783690183344,-0.6891517176962443,0.9348534201954397,0.9851020313651025,1.0,16/33,34.15%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V1H;ATP6V0D2;ATP6V0C;GPR89B;GPR89A;DMXL1;ATP6V0E2;SLC11A1;TMEM9;RAB20
prerank,mitochondrial transport (GO:0006839),0.24630313245101246,0.6891331069794341,0.9078282828282829,0.974271182759107,1.0,22/53,30.64%,SLC25A16;FBXO7;BCL2L1;TSPO;TMEM14A;BNIP3;TOMM7;PPIF;BCS1L;TIMM17A;MAIP1;PITRM1;HSP90AA1;FIS1;TIMM22;FLVCR1;TOMM70;SLC25A5;MFF;TOMM34;TIMM8B;STARD3
prerank,macromolecule catabolic process (GO:0009057),0.2796382754779923,0.6889874709364505,0.8571428571428571,0.9740126506681461,1.0,9/26,25.93%,PPT1;TRIM24;SMURF1;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;CLN8
prerank,canonical glycolysis (GO:0061621),0.28465847543339334,0.68873369728329,0.8508124076809453,0.9734816993456794,1.0,3/24,8.83%,GPI;PGK1;GAPDH
prerank,glucose catabolic process to pyruvate (GO:0061718),0.28465847543339334,0.68873369728329,0.8508124076809453,0.9734816993456794,1.0,3/24,8.83%,GPI;PGK1;GAPDH
prerank,retrograde axonal transport (GO:0008090),0.30662070611077635,0.6881630955345646,0.823170731707317,0.9737107389527688,1.0,5/16,24.68%,DST;KIF1A;HAP1;SOD1;KIF5A
prerank,positive regulation of blood coagulation (GO:0030194),0.3067578314101894,0.6862769884028638,0.8613707165109035,0.975423637381326,1.0,2/17,4.92%,ANO6;ENPP4
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.34031296269060596,0.6855986628759789,0.8256227758007118,0.9757751078334299,1.0,1/10,2.67%,LGALS9
prerank,purine-containing compound catabolic process (GO:0072523),0.3122546972816145,0.6853333167303023,0.8439597315436241,0.9756724329737871,1.0,1/13,1.85%,GDA
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2776925715227424,0.6848506306778337,0.8600883652430045,0.9758160919643105,1.0,7/27,20.39%,MSX1;SNAI2;ATM;EEF1E1;DYRK1A;YJU2;SMYD2
prerank,regulation of synapse organization (GO:0050807),0.2753466151584003,0.6845486530001303,0.8722466960352423,0.9757480402034957,1.0,7/26,22.78%,PDLIM5;MEF2C;CTNNA2;SLITRK2;ABHD17B;EPHA4;IL1RAPL1
prerank,positive regulation of protein acetylation (GO:1901985),0.3162445917945341,0.6845126999736847,0.8344155844155844,0.975373454352396,1.0,4/12,18.35%,FAM161A;PRKAA1;DIP2B;TERF2IP
prerank,iron-sulfur cluster assembly (GO:0016226),0.2818111306617915,0.6845018538256968,0.8718330849478391,0.9749765927255929,1.0,8/24,19.32%,BOLA2;ISCA2;GLRX5;GLRX3;HSCB;NUBPL;MMS19;IBA57
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2855532492051728,0.6842147002639669,0.8459214501510574,0.9748744686171702,1.0,3/23,12.22%,ASAH2;ACSBG1;ALOXE3
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.29880343698224765,0.6839240548090898,0.8250401284109149,0.9747988345709163,1.0,1/18,2.21%,DAB2IP
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2701646975327697,0.6835443459236504,0.862937062937063,0.9748207488179623,1.0,12/30,24.19%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;UGGT1;DDOST;DAD1;MGAT2;FUT8;NUDT14;DPM3
prerank,chromosome condensation (GO:0030261),-0.20916965061319076,-0.6832559312096388,0.9543859649122807,0.9894953508536446,1.0,15/36,29.10%,SET;NCAPG2;AKAP8L;GPER1;NCAPH2;INCENP;NCAPD2;PHF8;H1-0;NUSAP1;TOP2A;KMT5A;ACIN1;NCAPH;TTN
prerank,regulation of mitochondrion organization (GO:0010821),0.25537110011419967,0.6821116194582723,0.8929539295392954,0.9759975046381987,1.0,17/47,24.90%,OMA1;IAPP;LRRK2;FBXW7;VPS35;INF2;RHOT2;VDAC1;GSK3A;GOLPH3;PISD;PLSCR3;GSK3B;SREBF2;PARL;ATP13A2;CSNK2A2
prerank,protein kinase B signaling (GO:0043491),0.2830577110071397,0.6815027547191256,0.8688760806916427,0.9762821843239384,1.0,2/23,6.67%,PLK3;SETX
prerank,ribosomal small subunit biogenesis (GO:0042274),0.25296748604878244,0.6813506118716193,0.8843537414965986,0.9760368724126148,1.0,10/39,21.23%,RPS14;RPS28;NPM1;RPS25;RPS5;RIOK3;RPS15;NOB1;PWP2;RPS19
prerank,regulation of dendrite morphogenesis (GO:0048814),0.268241441398052,0.6813255381150579,0.8771929824561403,0.9756544958202861,1.0,5/32,14.86%,RAPGEF2;LZTS1;NEDD4L;YWHAH;SARM1
prerank,telomere organization (GO:0032200),0.2529615525731087,0.6813224652139197,0.8874172185430463,0.9752490749548185,1.0,16/43,26.09%,APEX1;STN1;PTGES3;ERCC4;RAD51D;ATM;CTC1;TERF2IP;H3-3A;HUS1;BLM;RIF1;TERF2;WRN;TINF2;PCNA
prerank,selective autophagy (GO:0061912),0.24431843603861844,0.6810264992720226,0.900126422250316,0.9751637392178825,1.0,14/56,21.84%,VIM;KLHL3;UFM1;UBA52;RPS27A;NBR1;DYNLL1;DYNC1LI2;ATM;ATG14;DYNLL2;DYNC1I2;UBB;USP30
prerank,regulation of TOR signaling (GO:0032006),0.23579698564247586,0.6807403371748452,0.9072681704260651,0.9750835682822209,1.0,27/67,26.69%,SMCR8;SH3BP4;WDR59;PRKAA1;RRAGD;RHEB;EPM2A;RICTOR;MIOS;GSK3A;GOLPH3;RRAGA;MAPKAPK5;HTR6;RRAGC;NPRL3;LAMTOR3;AKT1S1;WDR24;PIK3CA;ITFG2;SEH1L;MLST8;RPTOR;TBC1D7;LAMTOR4;PDCD6
prerank,protein targeting (GO:0006605),0.22074790101746586,0.6806876889135897,0.9431171786120591,0.9747302317553419,1.0,21/118,21.52%,AQP11;ZDHHC22;NACAD;FBXO7;SRP14;RASSF9;MYO1C;TSPO;TAOK2;SRPRA;ZDHHC14;LONP2;ZDHHC23;HAP1;LAMP2;TOMM7;ZFAND2A;GIPC1;PEX1;SORL1;NLGN1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.24829616403231372,0.6786786172646957,0.9021739130434783,0.9764730777253372,1.0,5/46,8.73%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2909802986810236,0.6786073618060591,0.8547400611620795,0.9761398041212259,1.0,4/18,13.65%,HSPB1;NFE2L2;HIF1A;NOL3
prerank,cellular response to leucine starvation (GO:1990253),-0.29795623731278054,-0.6785273146168735,0.8708860759493671,0.9928145697333005,1.0,3/10,15.27%,SESN1;SESN2;EIF2AK4
prerank,RNA stabilization (GO:0043489),-0.21413054433249687,-0.677771885396753,0.9383561643835616,0.992493142507262,1.0,11/33,23.54%,PHAX;TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;E2F1;NAF1
prerank,steroid hormone biosynthetic process (GO:0120178),-0.21896236420981913,-0.6776875435525549,0.9324324324324325,0.9915801408396733,1.0,9/29,28.28%,FDX1;AKR1B1;HSD17B8;STAR;SRD5A1;HSD17B11;HSD17B2;TSPOAP1;SRD5A3
prerank,peptidyl-lysine modification (GO:0018205),0.2264347390532732,0.6773464608400523,0.9257075471698113,0.9770856646270242,1.0,16/99,14.41%,IFIH1;HDAC9;ATP7A;SUMO2;SUMO3;LIPT2;SIRT4;RANGAP1;SENP5;NUP54;NUP35;RANBP2;LIPT1;NUP153;NUP160;NUP42
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2563546890820905,-0.6771900064725502,0.9134078212290503,0.9910719309155889,1.0,5/17,17.89%,PRKN;MDM2;SNAI1;TWIST1;CD74
prerank,DNA dealkylation (GO:0035510),0.33075902573458094,0.6763378560009644,0.8243243243243243,0.9773707961613239,1.0,2/10,11.36%,ASCC1;ASCC3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.33075902573458094,0.6763378560009644,0.8243243243243243,0.9773707961613239,1.0,2/10,11.36%,ASCC1;ASCC3
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.29110227545102774,0.6760379142115628,0.8534743202416919,0.9772802049866673,1.0,4/19,13.08%,SULT6B1;SLC35B3;BPNT1;PAPSS1
prerank,glutathione biosynthetic process (GO:0006750),0.3214679313393501,0.6755425875468696,0.8430717863105175,0.9774012074751731,1.0,6/11,29.63%,GSS;CHAC2;GGCT;GCLM;OPLAH;CNDP2
prerank,positive regulation of nervous system development (GO:0051962),0.254907927283621,0.6755318541401427,0.9107391910739191,0.977007065632461,1.0,14/42,22.89%,RASSF10;IL1RAP;NUMB;SLITRK2;CX3CR1;LRRC4B;SPEN;SOX11;GRID2;BDNF;NRXN1;NLGN1;IL1RAPL1;MME
prerank,nuclear membrane reassembly (GO:0031468),0.24302616822956882,0.6753844571571669,0.8988326848249028,0.9767633048871021,1.0,12/54,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,mucosal immune response (GO:0002385),0.30657414207088574,0.675335471560016,0.8409475465313029,0.976405247459415,1.0,1/15,4.04%,DEFA6
prerank,establishment of skin barrier (GO:0061436),0.29615519018551034,0.675111817725686,0.8474295190713101,0.9758458019767788,1.0,2/15,12.22%,LSR;ALOXE3
prerank,regulation of water loss via skin (GO:0033561),0.29615519018551034,0.675111817725686,0.8474295190713101,0.9758458019767788,1.0,2/15,12.22%,LSR;ALOXE3
prerank,osteoclast differentiation (GO:0030316),0.28284639832607417,0.6747974954612098,0.8678678678678678,0.9757721438439481,1.0,7/22,22.01%,SNX10;OSCAR;FOXP1;TYROBP;MAPK14;TNFRSF11A;EPHA2
prerank,double-strand break repair (GO:0006302),0.2137694116204336,0.6743836047257655,0.9639344262295082,0.975803998314631,1.0,26/158,14.54%,RAD54B;HERC2;RBBP8;RAD21;SETX;EXD2;TENT4A;FEN1;HMGB1;BABAM2;SPIDR;MAD2L2;SFR1;BRIP1;POLA1;POLB;PSMD14;BRCA1;SMARCAD1;DTX3L;AP5Z1;EYA3;ERCC4;RAD51D;ATM;HMGB2
prerank,chromatin remodeling at centromere (GO:0031055),-0.2132861394436339,-0.6742557387012943,0.9407665505226481,0.9926347974895499,1.0,15/31,31.93%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;HELLS;CENPH;MIS18A;CENPN;CENPA
prerank,regulation of cholesterol esterification (GO:0010872),0.3240571045330275,0.6739383133461787,0.8452380952380952,0.9758746163008625,1.0,1/10,3.48%,APOA1
prerank,positive regulation of phosphatase activity (GO:0010922),0.2868323296315331,0.673921775920009,0.8730650154798761,0.9754916898794964,1.0,4/21,14.73%,ITGA1;MEF2C;CALM3;PPP1R15B
prerank,cellular response to interleukin-2 (GO:0071352),-0.2784165625096875,-0.6732161807377388,0.8564231738035264,0.9915955547014473,1.0,7/11,43.16%,SHC1;SYK;JAK3;IL2RA;PTK2B;STAT5B;IL2RB
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2784165625096875,-0.6732161807377388,0.8564231738035264,0.9915955547014473,1.0,7/11,43.16%,SHC1;SYK;JAK3;IL2RA;PTK2B;STAT5B;IL2RB
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.2958103617359925,0.672819236598647,0.8741935483870967,0.9762077801646863,1.0,3/15,18.07%,HOMER2;GRM5;GRM7
prerank,RNA catabolic process (GO:0006401),0.24922018583173192,0.6714295942056566,0.887012987012987,0.9773098509478141,1.0,17/46,25.69%,HSPA1B;FEN1;ZFP36L2;AGO4;RNASEH2B;XRN2;RNASE6;DXO;LSM2;ERN1;DIS3L2;NUDT16;RNASEH2A;RNASEH1;RNH1;NUDT16L1;LSM5
prerank,actin nucleation (GO:0045010),0.2795359578943003,0.6713955912974945,0.8683812405446294,0.9769415382907397,1.0,8/21,27.86%,WHAMM;ARPC5;ARPC3;ARPC2;SPIRE1;ARPC1B;WASHC1;ARPC1A
prerank,positive regulation of B cell proliferation (GO:0030890),-0.22045270796082864,-0.6713084112116302,0.9475409836065574,0.9922413565377003,1.0,11/29,27.28%,BCL2;IRS2;NCKAP1L;CD81;EPHB2;CD74;CD40;GPR183;PTPRC;CD320;NFATC2
prerank,protein heterotetramerization (GO:0051290),0.30660421963799694,0.6706543996112724,0.8404802744425386,0.9773342583010127,1.0,2/13,8.37%,FARSB;GRIN2B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.244085514174392,0.6701490160960836,0.9043824701195219,0.977449068779341,1.0,10/48,15.35%,SERTAD2;SERTAD1;TAF1A;MYO1C;POLR1F;ASF1A;ACTB;DDX21;TAF1B;ELOF1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2327908076631637,0.6700134191463802,0.9380421313506815,0.9771782703357449,1.0,15/71,18.77%,CASP8;OMA1;RHBDD1;SOCS6;UBA52;RPS27A;NR1D1;BAG6;RSPRY1;VPS4A;PSMA8;CTSK;CTSO;NGLY1;MALT1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.28960630909984314,0.6699374684163679,0.8623298033282905,0.9768476027577522,1.0,1/18,1.60%,NOTCH1
prerank,histone H4 deacetylation (GO:0070933),0.32444131361719114,0.6696577308814619,0.8484848484848485,0.9767343797324344,1.0,2/10,11.79%,HDAC9;SMARCAD1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24549891273595748,0.6690629753396472,0.9102902374670184,0.9769668164273031,1.0,10/48,16.66%,TMEM109;CASP2;TNFRSF1B;CIDEB;BCL2L1;BAG6;BRCA1;ATM;PHLDA3;PYCARD
prerank,regulation of leukocyte migration (GO:0002685),0.29815370707277733,0.6682776130238335,0.856682769726248,0.9773745005546091,1.0,3/16,13.75%,TNFRSF18;RAC1;RHOH
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2366903160252758,-0.6678486137059558,0.9217391304347826,0.9940927236440683,1.0,8/21,29.59%,CYP26B1;PLA2G15;AGXT;NUDT19;FAAH;PPARD;LPIN3;LPIN1
prerank,DNA alkylation (GO:0006305),0.2864195387408879,0.6677947384498927,0.8505564387917329,0.9770834110857138,1.0,4/19,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,DNA methylation or demethylation (GO:0044728),0.2864195387408879,0.6677947384498927,0.8505564387917329,0.9770834110857138,1.0,4/19,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,negative regulation of JUN kinase activity (GO:0043508),0.32259826991615614,0.667752253832231,0.8324607329842932,0.9767209052054856,1.0,2/10,10.36%,PDCD4;AIDA
prerank,melanosome organization (GO:0032438),-0.22299090315587575,-0.6675064730611717,0.9253731343283582,0.9934211927530553,1.0,9/26,22.25%,SHROOM2;AP1M1;KIF13A;DTNBP1;HPS4;RAB29;BLOC1S2;RAB32;TRAPPC6A
prerank,response to ionizing radiation (GO:0010212),0.22849840469663069,0.6673631646768289,0.9441687344913151,0.9767043893489826,1.0,25/70,26.40%,RHOB;BRAT1;PRKAA1;BABAM2;SPIDR;BRCA1;EYA3;RAD1;ATM;RAD9B;KDM4D;MAPK14;MEN1;EEF1D;HUS1;BLM;ECT2;XRCC4;PAXIP1;NHEJ1;XRRA1;BABAM1;COP1;MTA1;RNF8
prerank,error-prone translesion synthesis (GO:0042276),0.27793221660050627,0.667022488097789,0.8699551569506726,0.9766598244382602,1.0,5/21,15.37%,POLK;UBA52;RPS27A;MAD2L2;RFC2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.20659018601963064,-0.6669394008312624,0.9438943894389439,0.992938318082362,1.0,10/32,21.59%,BRSK1;TRIM39;HMGA2;CDC14B;CDKN1A;DONSON;TAOK1;FZR1;TAOK3;RINT1
prerank,nucleocytoplasmic transport (GO:0006913),0.25324702390646936,0.6664929264242125,0.9010840108401084,0.9767781602032558,1.0,11/40,23.15%,BACH2;XPO1;SNRPE;NPM1;RSRC1;ATXN1;NUP205;MALT1;GEMIN8;LSG1;NXT2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.32559116691140366,0.6659745985635667,0.8544839255499154,0.9768913763641672,1.0,3/10,14.82%,CX3CR1;CTNNB1;FZD3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.26256096847597615,-0.6652375553230844,0.8819095477386935,0.9934158067397701,1.0,4/14,15.74%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.232864740361677,0.6651178140869325,0.9329113924050633,0.9773362333925081,1.0,22/69,23.64%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;TAF11;SNAPC4;POLR2I;TAF8;RPRD2;ZC3H8;SNAPC1;POU2F2;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J
prerank,peptide catabolic process (GO:0043171),0.2721157848645595,0.664731704157881,0.8765243902439024,0.9773023536405864,1.0,1/23,1.04%,ACE
prerank,negative regulation by host of viral process (GO:0044793),0.3229015070918844,0.6644442933795708,0.8578767123287672,0.9772041323312948,1.0,3/10,14.85%,ZC3H12A;PSMC3;VAPA
prerank,regulation of DNA recombination (GO:0000018),-0.20954008612612515,-0.6644205232651679,0.9522184300341296,0.993152018316434,1.0,12/32,29.64%,RAD50;KPNA1;THOC1;MSH6;RTEL1;ZRANB3;H1-0;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6
prerank,regulation of telomere capping (GO:1904353),0.27277505641119004,0.6642365339298862,0.8810975609756098,0.9770044637116071,1.0,4/23,13.96%,MAPK1;NEK7;TNKS;ATM
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2824800584218121,0.6636740234694669,0.8731117824773413,0.9767951496239646,1.0,3/22,18.22%,ZDHHC22;ZDHHC14;ZDHHC23
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2824800584218121,0.6636740234694669,0.8731117824773413,0.9767951496239646,1.0,3/22,18.22%,ZDHHC22;ZDHHC14;ZDHHC23
prerank,histone H3 deacetylation (GO:0070932),0.29681386335002413,0.6632854723864025,0.8751879699248121,0.9767649003797638,1.0,2/15,11.79%,HDAC9;SMARCAD1
prerank,negative regulation of synaptic transmission (GO:0050805),0.27480869404945957,0.6632844552662781,0.8828967642526965,0.9763638522760446,1.0,6/23,23.23%,LRRK2;SLC30A1;ACHE;SLC24A2;SHANK2;MTMR2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.18031082699839862,-0.6632170979186351,0.9765258215962441,0.993130253866433,1.0,30/57,38.31%,TIPIN;BRSK1;TRIM39;ATF2;HMGA2;CDC14B;CDKN1A;WAC;DONSON;RFWD3;TAOK1;FZR1;TAOK3;RINT1;FANCD2;RPA2;EME2;RAD9A;CHEK1;FBXO31;FOXN3;DTL;UIMC1;CDK5RAP3;HUS1B;PLK1;TP53;PRKDC;CDK1;TICRR
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.2824504142606076,-0.6619859589735733,0.8814814814814815,0.9931990093123768,1.0,10/10,71.78%,PDE6A;PDE6G;PDE6B;RHO;GNAT1;CNGB1;GRK1;CNGA1;GNB1;SAG
prerank,synaptic vesicle localization (GO:0097479),-0.2673518885423196,-0.66178833347941,0.9126760563380282,0.9923929264845487,1.0,5/13,23.84%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,autophagosome organization (GO:1905037),0.2384220516050717,0.6617879248845366,0.9111111111111111,0.9774779246001776,1.0,10/50,16.99%,ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25870244968303413,0.6614584557035467,0.9129172714078374,0.9774149232320862,1.0,8/30,20.46%,MACF1;RAB34;NSF;ANK3;SPTBN1;GOLPH3L;GOLPH3;RAB31
prerank,cellular lipid catabolic process (GO:0044242),0.2699560753091898,0.6612737893928172,0.8742937853107344,0.9772028269048745,1.0,2/27,8.17%,AOAH;ACOX1
prerank,DNA duplex unwinding (GO:0032508),0.23881870131166785,0.6612444919640859,0.9286624203821656,0.9768330739198238,1.0,8/50,11.55%,SSBP1;PURA;UBA52;RPS27A;DHX9;RBX1;ASCC3;GTF2H3
prerank,skeletal muscle contraction (GO:0003009),-0.23638799655188056,-0.6611969018828595,0.9193083573487032,0.9918865956288022,1.0,8/19,35.65%,RCSD1;STAC3;TNNT3;TNNI1;STAC2;TNNI3;TNNC1;CCDC78
prerank,cellular amide metabolic process (GO:0043603),0.22169976318344642,0.6611452592101069,0.9457900807381776,0.9765356388114591,1.0,7/102,5.93%,ACSM3;SLC25A32;CPD;PLPP1;GLYAT;DNPEP;ASAH2
prerank,transcription by RNA polymerase I (GO:0006360),-0.20204850928163326,-0.6611207177453416,0.9719298245614035,0.9909865662733205,1.0,13/34,26.28%,RRN3;TAF1D;TAF1;TTF1;ERCC2;GTF2H5;UBTF;GTF2H1;GTF2H4;POLR1A;POLR1H;POLR2H;TBP
prerank,positive regulation of double-strand break repair (GO:2000781),-0.19800954126458412,-0.6606520514257356,0.9573643410852714,0.9904084203089893,1.0,11/39,22.29%,KMT5C;SLF1;FMN2;FUS;KMT5B;ACTR2;FANCB;TIMELESS;PARP3;SLF2;PARP1
prerank,regulation of Golgi organization (GO:1903358),0.28664708926915894,0.6603812860742109,0.8710691823899371,0.9768675884039235,1.0,7/17,24.46%,CAMSAP2;MAPK1;USP6NL;PDCD10;MAP2K1;PDE4DIP;MYO5A
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.2748065352055262,-0.6602532147223472,0.8934010152284264,0.989791067339744,1.0,2/11,7.95%,EFNB2;FZD7
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3103537476105768,0.6599833335901736,0.8654781199351702,0.9768652758176164,1.0,4/12,21.72%,CAD;UMPS;UPP2;TK1
prerank,hyaluronan catabolic process (GO:0030214),0.28905670894908064,0.6596160099672657,0.8740399385560675,0.9768326148293834,1.0,2/18,5.33%,CEMIP2;HYAL2
prerank,Golgi localization (GO:0051645),-0.2736633803902178,-0.6595757028149655,0.8506024096385543,0.9893445068528612,1.0,3/11,15.52%,COPG1;ARCN1;ARHGAP21
prerank,positive regulation of cation channel activity (GO:2001259),0.25011478555920974,0.659571665631462,0.9118825100133512,0.9764812251802497,1.0,9/40,18.42%,ADRB2;STAC;SHANK3;GAL;CASQ1;CALM3;TMSB4X;ANK3;HAP1
prerank,ncRNA export from nucleus (GO:0097064),0.2524032368215575,0.659211255612048,0.9019337016574586,0.9764267310274497,1.0,9/36,15.93%,NUP54;NUP35;RANBP2;NPM1;NUP153;NUP160;RAN;NUP42;NUP205
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.2640629062744766,0.6581251626559315,0.8947368421052632,0.9770470580853418,1.0,4/29,10.63%,TRIM6;NLRC5;CACTIN;PTPN1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.30162545236224364,0.6578492087921576,0.8573717948717948,0.9769093616213635,1.0,3/14,10.63%,JAK2;PTK2;PTPN1
prerank,regulation of rRNA processing (GO:2000232),-0.23988117959030253,-0.6578177781666784,0.8798955613577023,0.9897777913557406,1.0,6/16,29.34%,KAT2B;BUD23;YTHDF2;RIOK2;TRMT112;DIMT1
prerank,negative regulation of macroautophagy (GO:0016242),0.26370891357230425,0.6575714631573524,0.8914956011730205,0.9767780013607357,1.0,11/26,27.63%,SMCR8;LRRK2;LZTS1;RUBCN;UBQLN4;FEZ1;PIK3CA;CHMP4A;CHMP4B;SCFD1;CLEC16A
prerank,negative regulation of ATPase activity (GO:0032780),0.28958460050626705,0.6571652972821432,0.8733974358974359,0.9767757320008886,1.0,3/16,19.44%,PXK;PAM16;PPIF
prerank,cellular iron ion homeostasis (GO:0006879),0.23210091214435866,0.6567363920426076,0.941101152368758,0.9767759519069348,1.0,19/55,24.88%,FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;GLRX3;CP;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;TMEM199;FTH1;IREB2;FTL;ATP13A2
prerank,positive regulation of behavior (GO:0048520),0.3238908459629042,0.6561323570190373,0.8561278863232682,0.9769427601758687,1.0,1/10,5.32%,MEF2C
prerank,negative regulation of cellular component organization (GO:0051129),0.2256130914025494,0.6556567296372168,0.9441069258809235,0.9769768786054118,1.0,19/74,23.23%,MCTP1;PRKD1;APOA1;IAPP;HSPA1B;AIDA;CLU;RIOK3;RUBCN;ABCA7;DNAJB6;DNAJB8;GSK3B;SORL1;LCMT1;CARMIL1;NOP53;TERF2;MTMR2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2949529283285547,0.6555598614278785,0.8691437802907916,0.9766648140211222,1.0,2/14,6.82%,TRPT1;CPSF1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.26595354841734964,0.6554465101074014,0.8623853211009175,0.9763712152388468,1.0,4/22,10.38%,INPP5K;ROCK1;STAP1;DYNLL1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20288639879078504,-0.6549949052431437,0.9736842105263158,0.9910575048837194,1.0,14/32,30.05%,RRN3;TAF1D;TAF1;ERCC2;GTF2H5;UBTF;GTF2H1;GTF2H4;POLR1A;POLR1H;POLR2H;TBP;POLR1E;POLR2L
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.28565887948956575,-0.6548307390692714,0.8813559322033898,0.9902373072840738,1.0,3/10,19.48%,MFSD2A;PHB2;MTMR4
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.27850289232003195,0.6544745056235861,0.8666666666666667,0.9768862717824748,1.0,6/18,24.44%,LRRK2;RIMS3;GSK3B;NLGN1;RAP1B;RIMS1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3167878560028371,0.6541545361244856,0.8425460636515912,0.9767929826704856,1.0,3/10,16.50%,JUN;HIF1AN;NCK1
prerank,phosphatidic acid metabolic process (GO:0046473),0.23751034770219953,0.6539518580018922,0.9297297297297298,0.9765728598805573,1.0,5/48,8.73%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,lipoprotein catabolic process (GO:0042159),0.3084859455433068,0.6536735698068369,0.8836065573770492,0.97642440310161,1.0,4/11,23.73%,PPT1;ABHD17B;LYPLA1;LYPLAL1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2103739965480238,-0.6532770964103891,0.9305555555555556,0.9904603323963627,1.0,10/30,25.10%,TRIP12;FBH1;HELB;HMGA2;TWIST1;KLHL15;FANCB;CGAS;POLQ;RMI2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.20302828038937834,0.6532528249959921,0.9852476290832455,0.9764131997910802,1.0,62/241,23.91%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;PRPF38A;POLR2D;HNRNPK;SNRPE;FIP1L1;PCBP1;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;HNRNPH2;SART1;PPIH;ELAVL2;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;ZMAT5;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;CWC25;PQBP1;PRCC;SF3B3;POLR2C;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1
prerank,regulation of axon guidance (GO:1902667),-0.2776101824070817,-0.65267559809362,0.8758782201405152,0.9899667928698768,1.0,2/10,8.98%,YTHDF1;VEGFA
prerank,t-circle formation (GO:0090656),-0.28437716901318644,-0.6523599067721941,0.8728179551122195,0.9873250082569552,1.0,6/10,38.41%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.28437716901318644,-0.6523599067721941,0.8728179551122195,0.9873250082569552,1.0,6/10,38.41%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.28437716901318644,-0.6523599067721941,0.8728179551122195,0.9873250082569552,1.0,6/10,38.41%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,inhibitory synapse assembly (GO:1904862),0.3111652434130181,0.6523376570092202,0.8728813559322034,0.9768739297572917,1.0,3/11,13.77%,CBLN4;GABRA2;LGI2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.24367870362572974,-0.651951885596715,0.9157894736842105,0.9866738277200324,1.0,11/16,47.41%,ST3GAL4;MDK;RHOA;ITGB2;NFAT5;SELP;ALOX5;FUT4;TNF;SELE;IL6
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.26607635530965285,-0.6513900338586038,0.8908629441624365,0.9861287608443045,1.0,2/11,9.67%,CEBPB;CREB3L1
prerank,RNA interference (GO:0016246),-0.24629390753169778,-0.6508353807707074,0.9297752808988764,0.9856125530713981,1.0,6/17,25.19%,DICER1;TERT;AGO3;TSNAX;CELF1;MRPL44
prerank,mRNA polyadenylation (GO:0006378),0.2674473683605074,0.6494724188241748,0.9093655589123867,0.9787678753538319,1.0,4/26,10.93%,APP;CPSF1;MTPAP;FIP1L1
prerank,RNA polyadenylation (GO:0043631),0.2674473683605074,0.6494724188241748,0.9093655589123867,0.9787678753538319,1.0,4/26,10.93%,APP;CPSF1;MTPAP;FIP1L1
prerank,histone lysine demethylation (GO:0070076),-0.21987771413511217,-0.6484759300831737,0.9512987012987013,0.9863847644067185,1.0,7/25,20.14%,KDM7A;JMJD1C;KDM4A;KDM6B;RIOX2;KDM8;PHF8
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.2615277454793551,-0.6472212909711617,0.908235294117647,0.98634676592104,1.0,4/11,17.97%,RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.25092751325931684,-0.6469201360889294,0.9175257731958762,0.985606269216984,1.0,2/16,5.01%,MAU2;NIPBL
prerank,placenta development (GO:0001890),0.30746864708928273,0.6468696794583854,0.8745928338762216,0.9807458777139001,1.0,4/12,22.31%,PTK2;E2F7;ANG;SOD1
prerank,apoptotic nuclear changes (GO:0030262),0.2672711805666927,0.6466164539168522,0.8988269794721407,0.980571355086444,1.0,6/24,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.2661344653867416,-0.6459464612845147,0.924812030075188,0.9853335819696981,1.0,5/12,28.18%,FDX1;AKR1B1;CACNA1H;STAR;TSPOAP1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.2643319389405,-0.6451174598332768,0.9020618556701031,0.984955308613694,1.0,4/13,17.89%,MDM2;SNAI1;TWIST1;CD74
prerank,pre-miRNA processing (GO:0031054),0.28989428713191673,0.6447898440354851,0.8874388254486134,0.9818028678303052,1.0,4/14,17.51%,ADAR;AGO4;DROSHA;TUT7
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.26808861117231675,0.6447391163558779,0.8859649122807017,0.9814517746873475,1.0,6/23,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,regulation of oxidative phosphorylation (GO:0002082),0.2820188573400552,0.6443719100074907,0.896551724137931,0.9813632253878509,1.0,2/16,6.64%,ATP7A;SLC25A33
prerank,microtubule bundle formation (GO:0001578),0.24379322259454114,0.6434755422580811,0.9423076923076923,0.9817480218849589,1.0,9/42,21.11%,CFAP206;CLIP1;CLASP1;NUMA1;NAV1;FOXJ1;DCX;MTCL1;MARK4
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.27147895472245154,0.6425841215891508,0.8881789137380192,0.982143613572925,1.0,4/20,16.55%,PUM2;ZC3H7A;AGO4;DROSHA
prerank,negative regulation of interleukin-6 production (GO:0032715),0.26025212390991953,0.6425092357808043,0.8985294117647059,0.9817987083243213,1.0,3/27,8.02%,ZC3H12A;ARRB1;CD200
prerank,primary miRNA processing (GO:0031053),-0.2789629197869145,-0.6424627729827929,0.8990384615384616,0.9858000495879231,1.0,2/10,6.30%,HNRNPA2B1;SMAD3
prerank,carnitine metabolic process (GO:0009437),-0.2617501728529801,-0.6424325867963205,0.9230769230769231,0.9848787156044511,1.0,5/12,21.86%,CPT1C;ACADM;TMLHE;CPT2;BBOX1
prerank,protein ADP-ribosylation (GO:0006471),-0.20629286188958723,-0.6419469582142007,0.9390243902439024,0.9842921886254761,1.0,10/28,29.64%,PARP8;SIRT3;ART3;SIRT2;PARP3;PARP1;PARP6;PARP2;HPF1;SIRT6
prerank,ubiquinone metabolic process (GO:0006743),0.283586528650571,0.6418958543744436,0.8903436988543372,0.981948155597364,1.0,5/15,18.47%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,protein export from nucleus (GO:0006611),0.2562035258756654,0.6418359673180585,0.9117221418234442,0.9815974456151592,1.0,6/27,14.41%,DUSP16;XPO6;XPO1;SMURF1;RAN;NUP42
prerank,glycolytic process (GO:0006096),0.2631634068007498,0.6411555517196164,0.9192364170337739,0.9817994242375143,1.0,3/28,8.83%,GPI;PGK1;GAPDH
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.308736967904868,0.6405796278840212,0.8743545611015491,0.9819142041819368,1.0,2/10,15.62%,PDE3B;PDE4D
prerank,PERK-mediated unfolded protein response (GO:0036499),0.31026024940582597,0.6402752825097795,0.8797364085667215,0.9817806127965018,1.0,4/10,26.28%,NFE2L2;EIF2S1;DDIT3;HERPUD1
prerank,bile acid metabolic process (GO:0008206),0.25621505157392055,0.6401971567805734,0.9247467438494935,0.981458021760464,1.0,4/27,14.78%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,global genome nucleotide-excision repair (GO:0070911),0.25734910953866963,0.6395508857688685,0.9198813056379822,0.9816199558164932,1.0,6/26,15.10%,UBA52;RPS27A;RBX1;GTF2H3;ERCC4;XPC
prerank,positive regulation of viral genome replication (GO:0045070),0.2525798272878087,0.6392557415450588,0.9083215796897038,0.9814628720678572,1.0,7/29,18.64%,ADARB1;PPIE;ADAR;PPIH;PKN2;SRPK1;PPID
prerank,apoptotic mitochondrial changes (GO:0008637),-0.20624414899137639,-0.6390738855917694,0.9735099337748344,0.9853033552044014,1.0,7/32,14.80%,BCL2;IFIT2;ATG3;AIFM2;HK2;THEM4;BOK
prerank,cytoplasmic translational initiation (GO:0002183),-0.2361173556597181,-0.6389523531560972,0.9103641456582633,0.9844521554934698,1.0,4/17,13.70%,DENR;EIF2S2;EIF2D;EIF3D
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.25008941355773906,-0.638557282736562,0.9081081081081082,0.9837456887992924,1.0,3/14,13.16%,ANXA1;PRKCZ;CD80
prerank,estrogen metabolic process (GO:0008210),-0.23959383226968722,-0.6379746504348214,0.9185393258426966,0.9832238710070554,1.0,9/15,45.96%,HSD17B8;HSD17B10;HSD17B11;HSD17B2;HSD17B14;HSD17B1;CYP1B1;HSD17B7;CYP1A1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.285072082461116,0.6377956990217438,0.8907014681892332,0.9823322512039772,1.0,4/15,19.18%,TRPT1;CPSF1;CSTF2;ERN1
prerank,epithelial cell development (GO:0002064),0.27131886224307555,0.6363303655520938,0.9034267912772586,0.9831370389167182,1.0,1/20,3.32%,SIPA1L3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.2968905106279808,0.63630518398412,0.8657937806873978,0.9827650158440893,1.0,3/13,18.45%,SULT6B1;BPNT1;SULT1A1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3086212077196605,0.6357130264758942,0.8724489795918368,0.9828483447266171,1.0,3/10,20.02%,JAK2;PTPN1;STAT5A
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.27318214923928497,0.6356813761268122,0.8927444794952681,0.9824787831858265,1.0,8/19,26.91%,FBXO7;FBXW7;VDAC1;GSK3A;SREBF2;ATP13A2;CSNK2A2;HAX1
prerank,heme biosynthetic process (GO:0006783),0.26674365572515824,0.6352255663685252,0.891044776119403,0.9824738400877595,1.0,5/22,17.29%,ALAS1;TSPO;COX15;NFE2L1;CPOX
prerank,icosanoid biosynthetic process (GO:0046456),-0.27784228450514914,-0.6351215170086019,0.9036144578313253,0.9841690349633354,1.0,5/10,36.57%,PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,positive regulation of isotype switching (GO:0045830),0.28179782421263005,0.6350962697585127,0.8961038961038961,0.9821917854605235,1.0,8/15,25.96%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;CLCF1;TGFB1;SHLD1
prerank,lipid biosynthetic process (GO:0008610),0.21733510164523723,0.635016313021912,0.958128078817734,0.9818629734845243,1.0,18/77,25.93%,ACSM3;ACSL5;PRKAA1;ELOVL4;ACSS2;PDSS2;PDSS1;MVD;DOLPP1;AGPAT5;OXSM;GGPS1;AGPS;ACLY;MVK;HMGCR;FDFT1;CLN8
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2717987942892482,-0.6346399367683654,0.8975,0.983560898004454,1.0,6/11,37.34%,NDUFA13;ROMO1;TIMM29;TIMM10;TIMM9;TIMM13
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2432162607452594,-0.633733405857485,0.9116161616161617,0.9832198683988236,1.0,1/14,3.41%,THBS1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2412784130785092,0.633711286503284,0.9415121255349501,0.9825803282722027,1.0,10/36,19.45%,BRIP1;HINFP;RAD1;ATM;MAP3K20;RAD9B;FBXO6;TIPRL;ATRIP;HUS1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.25798747386344284,0.6328413577278633,0.9081632653061225,0.9828754025877338,1.0,3/25,8.83%,GPI;PGK1;GAPDH
prerank,positive regulation of lipid storage (GO:0010884),0.26398541785024515,0.6314548523023619,0.9093655589123867,0.9836134009841666,1.0,5/21,21.40%,EHD1;ZC3H12A;VSTM2A;SCARB1;SREBF2
prerank,carbohydrate derivative transport (GO:1901264),0.27268520221552683,0.6310163385633107,0.9141965678627145,0.9835990398925725,1.0,6/18,22.67%,PLTP;SLC15A4;VLDLR;SCARB1;SLC25A19;SLC10A7
prerank,snRNA processing (GO:0016180),0.27661717510365885,0.6305270797616945,0.9157566302652106,0.983625056567659,1.0,4/16,16.28%,INTS11;INTS12;INTS5;INTS6L
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.29558726775939176,0.6304514865876305,0.9007874015748032,0.983294015843291,1.0,1/12,3.76%,GART
prerank,DNA metabolic process (GO:0006259),0.19306404084941886,0.6302500849505677,0.993717277486911,0.9830748718776485,1.0,68/270,24.65%,BTG2;RBBP8;APEX1;RAD21;ORC3;EXD2;ENDOV;PURA;POLK;UBA52;RPS27A;DFFB;FEN1;STN1;HMGB1;NSMCE3;ASF1A;PTGES3;POLA1;POLB;NPM1;WDHD1;GTF2H3;BRCA1;SMARCAD1;ORC5;HINFP;UBE2T;LIG1;DDX21;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAN;RAD18;HMGB2;XPC;RFC2;TRRAP;RAD9B;FBXO6;MEN1;MMS19;ATRIP;CTC1;TERF2IP;BARD1;HUS1;UHRF2;BLM;MNAT1;RIF1;UBB;GEN1;NOP53;MUTYH;TOP3B;TERF2;ORC4;CNBP;RNASEH2A;PRIM2;WRN;PRIMPOL;RNASEH1;UVRAG
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.1978548325841238,0.6297862626622968,0.9835886214442013,0.9830412019979236,1.0,37/173,20.03%,TRAPPC8;ATL2;VTI1B;GOPC;COG5;TMED10;MCFD2;CUL3;PGAP1;WHAMM;GRIA1;ERGIC1;PROC;VAMP7;DYNLL1;TRAPPC2;TRAPPC6B;TMED9;TEX261;DYNC1LI2;SEC24B;SPTAN1;NSF;TMED4;VAPA;ANK1;TRAPPC5;COG6;ANK3;GOSR1;VTI1A;SPTBN1;DYNLL2;SEC24A;ACTR1A;TMED7;CAPZA2
prerank,hyaluronan metabolic process (GO:0030212),0.25825473668779897,0.6295177889308756,0.9152298850574713,0.9828459462053991,1.0,2/23,5.33%,CEMIP2;HYAL2
prerank,translesion synthesis (GO:0019985),0.23260093262560735,0.6293274830577381,0.9365721997300944,0.9825975401817214,1.0,8/42,15.87%,USP43;POLK;UBA52;RPS27A;MAD2L2;TRIM25;RFC2;SPRTN
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3062763593485981,0.6280623760028489,0.9003496503496503,0.9832088153243271,1.0,4/10,25.94%,CALM3;GNB5;CRHR1;CALM1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.2592707697977408,0.6279648003204746,0.9289940828402367,0.9828868690575763,1.0,3/23,9.59%,SLC12A8;CLCN3;SLC9A7
prerank,regulation of B cell differentiation (GO:0045577),-0.23416606574318619,-0.6272049835739323,0.9159159159159159,0.986378393005454,1.0,4/17,21.63%,MMP14;NCKAP1L;INHBA;SYK
prerank,regulation of mRNA metabolic process (GO:1903311),0.30297888794231465,0.6269722367205558,0.8711864406779661,0.9832658717224412,1.0,5/11,21.40%,DHX9;PTCD2;SRPK1;SAFB2;IWS1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.25857059010687783,0.6268993211302488,0.8913362701908958,0.9829238468466341,1.0,6/22,20.25%,FKBP1A;MGAT5;ROCK1;BOD1;TIPRL;GSK3B
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23196916349828728,0.6268580125378832,0.9398907103825137,0.9825552925685445,1.0,9/45,15.41%,BTG2;BTG1;TOM1L1;ZFP36L2;ANGEL2;BUB1;CTNNB1;FZD3;BTG3
prerank,neuromuscular process (GO:0050905),0.2734612519024901,0.6261850040313051,0.895330112721417,0.98269040569333,1.0,2/16,12.72%,GCH1;KCNA1
prerank,7-methylguanosine RNA capping (GO:0009452),-0.1974885674265651,-0.6245305161059873,0.9719298245614035,0.9861513590922244,1.0,13/31,30.05%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H;CMTR2;POLR2L
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.1974885674265651,-0.6245305161059873,0.9719298245614035,0.9861513590922244,1.0,13/31,30.05%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H;CMTR2;POLR2L
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.27725459957485676,0.624442821857822,0.9078947368421053,0.9836580781006742,1.0,3/17,15.47%,IK;MTBP;BOD1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2031768631461261,-0.6244272559944682,0.9694915254237289,0.9843515073876401,1.0,14/29,31.93%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2031768631461261,-0.6244272559944682,0.9694915254237289,0.9843515073876401,1.0,14/29,31.93%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,lipoxygenase pathway (GO:0019372),0.2853513285991677,0.6239696407648557,0.8799313893653516,0.9836190366222958,1.0,3/14,16.28%,ALOXE3;PON2;PON3
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.1930452853598967,0.6236387926684699,0.997907949790795,0.9834859598373767,1.0,67/264,23.91%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;DCPS;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;CELF4;PRPF38A;POLR2D;HNRNPK;SNRPE;FIP1L1;PCBP1;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;CLNS1A;HNRNPH2;SART1;PPIH;ELAVL2;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;SRPK1;ZMAT5;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;GEMIN8;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;CWC25;PQBP1;PRCC;SF3B3;POLR2C;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.25712128823816804,0.6236225990371188,0.9164222873900293,0.9831081898730459,1.0,4/22,17.07%,TNFRSF18;VSIR;CBFB;SOX12
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2543547505378498,0.623469829454468,0.9093525179856116,0.9828368669810068,1.0,11/25,29.80%,EFNA1;PRKCG;OPHN1;PSME3IP1;EPHA4;SGTA;CSNK2A2;RPL11;F8A1;HSP90AB1;RPS7
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.1931642055988415,-0.623108859746158,0.9657794676806084,0.984217952404547,1.0,18/38,31.93%,RSF1;CENPC;HAT1;SMARCA5;RBBP7;CABIN1;CENPK;ATRX;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;HIRA;CENPA
prerank,histone mRNA metabolic process (GO:0008334),0.25244621936382505,0.6215517387070464,0.9112081513828238,0.9838997439151479,1.0,9/27,21.35%,LSM1;MTPAP;SNRPE;XRN1;ATM;TENT2;TUT7;CPSF3;EXOSC10
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.21272574425059632,-0.6213491867635287,0.954954954954955,0.9843424999243776,1.0,6/22,20.14%,SMARCB1;ERBB2;PIH1D1;UBTF;NCL;PHF8
prerank,telomere maintenance (GO:0000723),0.22674706577306303,0.6213070256282898,0.9513157894736842,0.9836886387464371,1.0,16/50,26.09%,ZBTB48;APEX1;STN1;PTGES3;ERCC4;RAD51D;ATM;CTC1;TERF2IP;HUS1;BLM;RIF1;TERF2;WRN;TINF2;PCNA
prerank,mitotic chromosome condensation (GO:0007076),-0.20358257823844722,-0.6211274098285643,0.9843260188087775,0.9835352473619798,1.0,14/26,37.54%,SET;NCAPG2;AKAP8L;NCAPH2;NCAPD2;PHF8;NUSAP1;KMT5A;NCAPH;TTN;PHF13;SMC2;PLK1;CDK1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2199811641277925,-0.6205013796319089,0.9404761904761905,0.9829714712184213,1.0,6/20,29.74%,FDX1;AKR1B1;STAR;HSD17B10;TSPOAP1;CYP46A1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.2856267198894442,0.620261488409718,0.905982905982906,0.9840818454632333,1.0,1/13,3.44%,UBA7
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.1828075380440477,-0.620229387103875,0.970954356846473,0.9822331090892094,1.0,14/42,25.13%,FBH1;FUS;HELB;ACTR2;RTEL1;KLHL15;FANCB;TIMELESS;CGAS;PARP1;POLQ;RPA2;RMI2;RAD51
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.27154201124123534,0.6194593347918018,0.9154704944178629,0.9842959544059345,1.0,4/19,16.66%,TMEM109;BAG6;PHLDA3;PYCARD
prerank,DNA biosynthetic process (GO:0071897),0.27326599131113277,0.6192668868908369,0.9059967585089141,0.9840566407204248,1.0,3/16,15.59%,WRNIP1;POLA1;CDKN2D
prerank,nuclear envelope organization (GO:0006998),0.26546875954977034,0.6176596549767563,0.925531914893617,0.9848408691911295,1.0,9/20,24.78%,TMEM43;SUN3;REEP3;VPS4A;SUN1;NEMP1;LEMD3;EMD;CTDNEP1
prerank,mRNA stabilization (GO:0048255),0.2310247691154188,0.617200169646722,0.9286694101508917,0.9847764638806499,1.0,8/40,16.98%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;DHX9;ANGEL2;YBX1;MAPK14
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.24319220460947955,0.616235955466998,0.9322766570605188,0.9850989939273,1.0,12/28,27.32%,MAD2L2;DTX3L;KDM4D;RIF1;CYREN;SHLD3;SHLD2;NUDT16L1;WRAP53;SHLD1;PARP9;SMCHD1
prerank,DNA repair (GO:0006281),0.18667156930845172,0.6155886120831888,0.9969262295081968,0.9851802674557749,1.0,45/284,15.87%,HERC2;BTG2;RBBP8;WRNIP1;APEX1;RAD21;SETX;EXD2;ENDOV;TENT4A;POLK;UBA52;RPS27A;FEN1;NSMCE3;BABAM2;MAD2L2;ASF1A;BRIP1;POLA1;POLB;ASCC1;NPM1;ASCC3;WDHD1;GTF2H3;BRCA1;DTX3L;HINFP;EYA3;UBE2T;LIG1;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAD18;XPC;RFC2;TRRAP;RAD9B;CDKN2D;TRAIP;SPRTN
prerank,cellular response to oxygen levels (GO:0071453),-0.26195562615036816,-0.6150628103353996,0.9097387173396675,0.9842088067241027,1.0,4/10,27.31%,ATP6AP1;ATP6V1A;PICK1;NDUFS2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.19446114679596815,-0.6150468324948309,0.9692832764505119,0.9832953544075884,1.0,16/32,38.88%,CEMIP;CALM2;GSTM2;JPH2;GPER1;P2RY6;GSTO1;APLNR;NPSR1;THY1;F2R;PKD2;CAPN3;TRDN;HTT;CX3CL1
prerank,receptor metabolic process (GO:0043112),0.2224244330978962,0.6148694833856254,0.9574742268041238,0.9853094957646278,1.0,13/53,20.46%,CAV1;DNM3;LMTK2;AP2M1;SMURF1;LDLRAP1;CD9;KIF16B;PHETA1;NSG1;MVB12A;REP15;RAB31
prerank,lysosome organization (GO:0007040),0.238649602663904,0.6145617181885266,0.9398280802292264,0.9851381151069354,1.0,9/36,21.03%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,negative regulation of RNA splicing (GO:0033119),-0.22154957312607926,-0.6135958623359679,0.9251497005988024,0.9831266439113776,1.0,5/19,17.82%,RBMX;SRSF6;PCBP4;RPS26;U2AF2
prerank,mRNA processing (GO:0006397),0.18826112443329404,0.613470362660702,0.9979338842975206,0.9854999060863116,1.0,76/287,24.60%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;PRPF38A;POLR2D;HNRNPK;SNRPE;RPRD1B;FIP1L1;PCBP1;GTF2H3;CHTOP;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;HNRNPH2;SART1;PPIH;ELAVL2;THOC3;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;POLDIP3;ZMAT5;RPRD2;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;ERN1;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;MNAT1;CWC25;RPRD1A;PQBP1;PRCC;SF3B3;POLR2C;TBRG4;KIN;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1;PRPF6;ALYREF;CCNH
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.28951105074777506,0.6123425585745416,0.8924914675767918,0.9859222693002968,1.0,5/12,26.40%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,C-terminal protein amino acid modification (GO:0018410),0.290072098608501,0.6122910106457328,0.8944,0.985567134522013,1.0,4/11,22.32%,TTL;LCMT1;AGBL4;FOLH1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3030517655918509,0.6120882686766843,0.8803418803418803,0.9853125598283778,1.0,2/10,12.45%,NOS1AP;CALM3
prerank,long-chain fatty acid metabolic process (GO:0001676),0.21547279048268655,0.6110264757076482,0.9654320987654321,0.9856499562871365,1.0,9/64,14.78%,ACSL5;ASAH2;ACSBG1;ACOX1;ALOXE3;ACAD9;CPT1A;ELOVL5;SLC27A2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.279965614483161,0.6107388439838448,0.9166666666666666,0.9854518872604259,1.0,1/13,3.66%,RPS21
prerank,mismatch repair (GO:0006298),-0.20361684423745213,-0.6104245116761798,0.9655172413793104,0.9839378134163403,1.0,17/27,38.87%,MLH3;MLH1;MSH6;PMS1;RPA3;ABL1;RPA1;POLD2;RPA2;EXO1;POLD3;PMS2;TDG;MSH4;ERCC1;POLD1;MCM9
prerank,protein kinase A signaling (GO:0010737),0.2882412066513378,0.6102042351029445,0.887459807073955,0.9854337787410398,1.0,6/12,29.64%,GAL;LCP1;RDX;PRKACB;MYOM1;RAB13
prerank,regulation of lipid storage (GO:0010883),0.25120299227548004,0.609353695320373,0.9207772795216741,0.9856609567811002,1.0,4/22,11.81%,ZC3H12A;FBXW7;NFKBIA;VSTM2A
prerank,negative regulation of telomere maintenance (GO:0032205),0.2688852360424692,0.6087331358431344,0.9026402640264026,0.9856672973125727,1.0,5/15,23.10%,TNKS;ERCC4;ATM;TERF2IP;TERF2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.20322103459581228,0.6077411968287698,0.9811542991755006,0.9859689317402592,1.0,11/82,11.25%,TUBB;CSNK1D;TUBB4B;CLASP1;NEDD1;CEP135;HAUS3;PCM1;DYNLL1;CEP76;NPM1
prerank,regulation of chromatin organization (GO:1902275),-0.23528649735481516,-0.6076856894231405,0.9313984168865436,0.9844654089394966,1.0,6/14,29.51%,SETD1A;IGF2;HNRNPU;PARG;ALKBH4;HPF1
prerank,regulation of spindle assembly (GO:0090169),0.2456771240430858,0.6064022008483342,0.9384164222873901,0.9865028586116269,1.0,13/25,30.80%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;SENP6;CHMP1A;TPR;VPS4B;CHMP4B;EML3;HSPA1A;DYNC1H1
prerank,non-motile cilium assembly (GO:1905515),0.2411257410303645,0.6042285727697406,0.9383070301291249,0.9875702907471138,1.0,3/30,9.16%,CSNK1D;TMEM216;PCM1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2589443814998908,0.6035753088454933,0.9222042139384117,0.9876216134072776,1.0,4/17,18.99%,CCNE1;THPO;KAT7;SOX11
prerank,histone acetylation (GO:0016573),0.20977586686626357,0.6021709025659459,0.9701492537313433,0.9881779207195771,1.0,11/69,15.52%,ING3;LEF1;BRD8;MRGBP;JADE2;CHD5;BRD1;DMAP1;SGF29;KAT7;TRRAP
prerank,regulation of autophagosome assembly (GO:2000785),0.23122611834208717,0.6015136909231537,0.9402560455192034,0.9882301656700611,1.0,15/33,29.83%,SMCR8;RAB3GAP2;LRRK2;TBC1D12;UBQLN2;NPRL3;RALB;TBC1D14;FEZ1;CHMP4A;CHMP4B;SCFD1;PIP4K2B;PIKFYVE;SH3GLB1
prerank,mitotic nuclear division (GO:0140014),0.20807307505070632,0.6008591513915242,0.9760705289672544,0.9882803652769208,1.0,12/71,16.20%,RAB11A;KIF2A;CLASP1;KPNB1;DSN1;STAG1;CLASP2;ARHGEF10;RAN;CHMP7;NDC80;SGO1
prerank,protein palmitoylation (GO:0018345),0.2394271182892848,0.6005721263134289,0.9527896995708155,0.988074906119039,1.0,6/30,21.35%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;SELENOK;ZDHHC13
prerank,regulation of macrophage differentiation (GO:0045649),0.2687794335244681,0.6005685406647028,0.912828947368421,0.9876877826549897,1.0,1/15,2.42%,CASP8
prerank,mitochondrial fission (GO:0000266),0.26518204044962207,0.6000380544174871,0.9282218597063622,0.9876536648944415,1.0,1/16,3.29%,DNM3
prerank,NAD biosynthetic process (GO:0009435),-0.21365882206915704,-0.6000142297525825,0.9532163742690059,0.9873364341639363,1.0,1/20,1.34%,NMNAT2
prerank,organic cation transport (GO:0015695),0.25101353549090555,0.5987832594340357,0.9063492063492063,0.9880901892222841,1.0,6/20,22.37%,SLC44A1;SLC22A5;SEC14L1;SLC29A4;SLC25A19;SLC25A42
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.24717045974862917,-0.5986034353369862,0.9493670886075949,0.9871403035708717,1.0,3/12,15.84%,PRKCB;PRKCA;NEK6
prerank,chromatin assembly or disassembly (GO:0006333),0.28316469616105483,0.5976547829203437,0.9146757679180887,0.9884467644011885,1.0,4/11,23.76%,CDAN1;SUV39H2;RBBP4;HIRIP3
prerank,platelet aggregation (GO:0070527),0.2305209412336643,0.5972300823238579,0.9554937413073713,0.9883488089694749,1.0,8/33,19.18%,MYH9;HSPB1;ACTG1;ACTB;PIK3CB;STXBP3;FERMT3;VCL
prerank,C4-dicarboxylate transport (GO:0015740),0.2716358318284292,0.5966961426795934,0.9216,0.9882901022915683,1.0,5/14,19.24%,SLC25A30;SLC1A1;SLC1A2;SLC25A10;SLC1A6
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.24792239037180755,0.5960059639903809,0.9309815950920245,0.9883109528402586,1.0,5/22,15.10%,UBA52;RPS27A;RBX1;GTF2H3;XPC
prerank,intracellular protein transmembrane transport (GO:0065002),-0.1758590285582505,-0.5957821845782145,0.9879518072289156,0.9876158198994445,1.0,15/42,29.68%,C2CD5;PEX2;TIMM17B;CHCHD4;TIMM21;PEX7;GRPEL2;SEC61A2;ROMO1;DNAJC15;ZFAND2B;PEX16;SEC61G;TIMM50;PEX12
prerank,anterograde axonal transport (GO:0008089),0.22765280013485237,0.5944579140287226,0.9433701657458563,0.9888601872583388,1.0,14/37,28.93%,BLOC1S6;HSPB1;AP3S1;KIF1A;AP3M1;RAB27B;HAP1;AP3D1;SOD1;KIF5A;AP3B1;BLOC1S5;AP3M2;RAB21
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.2456264968407694,0.5943853743682685,0.9258160237388724,0.9885154939932719,1.0,6/24,21.42%,ALAS1;TSPO;COX15;NFE2L1;CPOX;RSAD1
prerank,regulation of protein acetylation (GO:1901983),0.27794428423091333,0.5930812714960084,0.8951747088186356,0.9889101705953809,1.0,3/12,20.25%,FAM161A;TERF2IP;GSK3B
prerank,positive regulation of telomere maintenance (GO:0032206),-0.1896130226253353,-0.5929426593093131,0.9786476868327402,0.9879854095244184,1.0,13/31,31.43%,HNRNPA2B1;RAD50;PPP1R10;MAP2K7;RTEL1;PML;GNL3;ATRX;NAF1;HNRNPD;NABP2;SIRT6;SLX4
prerank,chromatin assembly (GO:0031497),0.22411203645594752,0.5926767440149462,0.9521203830369357,0.988755616749348,1.0,11/38,21.46%,ASF1A;CDAN1;NPM1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;RBBP4;PRDM9;NAP1L3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.278617249231468,0.5920325127747658,0.9196581196581196,0.9887670717617247,1.0,5/13,26.40%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.23096010708569123,-0.5916528744193167,0.9319371727748691,0.987649295597276,1.0,6/14,30.10%,ATR;TERT;XRCC5;ATRX;NABP2;PINX1
prerank,mRNA export from nucleus (GO:0006406),0.194817459105488,0.5916409829365212,0.9896788990825688,0.9886166816418651,1.0,23/102,21.40%,HHEX;DDX39A;CPSF1;NUP54;POLR2D;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3;NUP50;IWS1
prerank,macrophage chemotaxis (GO:0048246),0.28706611665344955,0.5911534655048245,0.9080068143100511,0.988517810265727,1.0,1/10,7.50%,TAFA4
prerank,aerobic electron transport chain (GO:0019646),0.20458702945566662,0.5904071715506211,0.9769230769230769,0.9885974541284861,1.0,19/68,24.05%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;COX6A1;NDUFB4;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1;NDUFA11
prerank,cholesterol metabolic process (GO:0008203),0.20660695128852286,0.5895485434365673,0.9808917197452229,0.9887084887212315,1.0,21/68,26.49%,APOA1;LCAT;OSBPL1A;PLPP6;HMGCS1;TSKU;LDLRAP1;MVD;SOAT1;ACAA2;DHCR7;GGPS1;ACLY;OSBPL5;IDI1;MVK;INSIG1;HMGCR;FDFT1;CLN8;LBR
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.23809995456956914,0.5886452993727136,0.9512937595129376,0.9888556529444278,1.0,4/25,15.56%,APP;ANKRD13A;RAC1;UBQLN2
prerank,nucleosome assembly (GO:0006334),0.23072828168770124,0.5883985212433667,0.9449152542372882,0.988606065396747,1.0,10/31,21.46%,ASF1A;NPM1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;RBBP4;IPO4;NAP1L3
prerank,intracellular cholesterol transport (GO:0032367),-0.22518436898165634,-0.5881832178535686,0.9513513513513514,0.9882914900776941,1.0,1/15,2.95%,ABCA1
prerank,striated muscle cell development (GO:0055002),0.267243280170084,0.5876149360181212,0.9281150159744409,0.9886827661251798,1.0,4/14,23.89%,FLII;TMOD3;TMOD1;KLHL41
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.24038743864885603,0.5847503048063403,0.9609022556390977,0.9899750175021885,1.0,10/25,27.63%,EAF1;EAF2;EAPP;NELFB;NELFA;HEXIM1;WDR43;ZMYND11;RNF8;CDC73
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.25086515651455144,0.5836795373602646,0.9315525876460768,0.990201325219742,1.0,8/16,28.52%,TNKS;ERCC4;ATM;TERF2;DHX36;TINF2;TNKS2;SMG5
prerank,base-excision repair (GO:0006284),-0.16857673621949643,-0.5821865238783751,1.0,0.9900014894295696,1.0,24/48,38.64%,RFC1;XRCC1;ERCC5;LIG3;HMGA2;RPA3;PARG;RPA1;PARP1;POLQ;NEIL1;POLD2;RPA2;POLE;RFC4;APEX2;POLL;POLD3;RFC5;TDG;DNA2;NEIL2;XPA;POLD1
prerank,organelle fusion (GO:0048284),0.24199128733445446,0.5818520325371147,0.9465648854961832,0.9908409483349458,1.0,4/22,13.01%,CHCHD3;MIGA1;MFN1;CYP26C1
prerank,RNA export from nucleus (GO:0006405),0.19224258792989268,0.580912436466777,0.991869918699187,0.9909678743271373,1.0,21/100,20.19%,HHEX;DDX39A;CPSF1;NUP54;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;RAN;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3
prerank,protein insertion into membrane (GO:0051205),0.22809476990857702,0.5795106179296666,0.9631728045325779,0.9913356171417483,1.0,10/32,23.42%,APP;PRNP;GET1;REEP1;UBE2J2;VAPA;CCDC47;CYB5A;EMD;SGTA
prerank,regulation of microtubule-based movement (GO:0060632),0.27644951155291597,0.5782125396074866,0.9197207678883071,0.9916542732630592,1.0,4/11,22.00%,NEFH;MAP2;HAP1;IGBP1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.23351518977669158,-0.5777623385248674,0.9544303797468354,0.9908952426186893,1.0,2/12,9.63%,GCLC;BDH2
prerank,protein import into peroxisome matrix (GO:0016558),-0.235695224169961,-0.5776597363305435,0.958656330749354,0.9900295337889201,1.0,5/12,29.68%,PEX2;PEX7;PEX13;PEX16;PEX12
prerank,cellular response to pH (GO:0071467),0.2540525313600063,0.5760728169083903,0.940251572327044,0.9923890958245695,1.0,2/17,10.66%,MCOLN1;GPR68
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.19920024149399795,0.5747790746551344,0.9858429858429858,0.9926825127424207,1.0,19/69,24.05%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;COX6A1;NDUFB4;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1;NDUFA11
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2586290840042261,0.5740702114784021,0.9381107491856677,0.9926563016856735,1.0,6/16,27.34%,VPS36;VPS28;CHMP7;LEPROT;CHMP4A;CHMP4B
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.27196393788614964,0.5740055399434045,0.9285714285714286,0.9922989532722004,1.0,6/12,27.60%,BRCA1;RBM15;YTHDC1;LRIF1;SMCHD1;CDYL
prerank,phospholipid metabolic process (GO:0006644),0.19687360589312144,0.5739584937403971,0.9775280898876404,0.9919402998414438,1.0,4/71,5.21%,PLPP1;ACP6;LPCAT4;LCAT
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.28300516934097936,0.5730345636462134,0.9162303664921466,0.9920359234585017,1.0,2/10,14.25%,APOA1;ELOVL5
prerank,regulation of protein localization to cell surface (GO:2000008),0.2218691905063135,0.5710042887875121,0.9774647887323944,0.9926952858658756,1.0,9/33,21.67%,GOPC;TAX1BP3;TYROBP;NEDD4L;CTNNB1;ABCA7;BDNF;KCNAB2;LEPROT
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2393338001952321,0.5691310379595526,0.9464544138929089,0.9932774065168745,1.0,5/20,19.77%,CAMK2D;RAP1GDS1;CCDC47;SELENOK;PACS2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.19813579620000987,-0.5677610084532877,0.967741935483871,0.992971531816793,1.0,10/18,35.13%,NPHP3;OFD1;RFX3;CABYR;CFAP53;ROPN1L;SPAG17;CCDC39;DNAAF2;ODAD4
prerank,protein localization to chromosome (GO:0034502),0.22030840097747548,0.567024386909492,0.9582132564841499,0.9939179808100002,1.0,12/34,28.20%,RAD21;TNKS;CHMP7;BOD1;ESR1;TERF2IP;XRCC4;TERF2;CTCF;TINF2;WAPL;TNKS2
prerank,sulfur amino acid metabolic process (GO:0000096),0.2282518730058187,0.5665081910441837,0.9534534534534534,0.9937700348435043,1.0,3/24,14.70%,TST;SMS;MSRA
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2488277937520384,0.5656646034713041,0.9267175572519084,0.99381735502077,1.0,8/16,27.32%,PARPBP;MAD2L2;UBQLN4;RIF1;SHLD3;SHLD2;SHLD1;SMCHD1
prerank,error-free translesion synthesis (GO:0070987),-0.1973037490394383,-0.5656562660797061,0.9845201238390093,0.9928039398565546,1.0,8/22,27.36%,RCHY1;RFC1;POLDIP2;REV1;RPA3;RPA1;RPA2;RFC4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.200489402441151,-0.5649263529766025,0.9706744868035191,0.9921563131121588,1.0,11/20,39.62%,GRK3;MET;STMN1;PLEK;RPGRIP1L;GRK2;ADA;RGS2;YWHAB;CCL5;MGRN1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.18778455430696767,0.564909752469149,0.991822429906542,0.9938046152863275,1.0,20/96,20.19%,HHEX;DDX39A;CPSF1;NUP54;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3
prerank,negative regulation of cholesterol transport (GO:0032375),-0.24927652068676776,-0.5648689863714379,0.9420289855072463,0.9912677036220482,1.0,4/10,41.66%,NFKB1;APOC1;SHH;ABCA2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.25472041492529324,0.564167284108119,0.955810147299509,0.9937674118838714,1.0,6/14,25.96%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,neuron projection fasciculation (GO:0106030),0.2676632871339838,0.5630468481492886,0.9366197183098591,0.9938987237800576,1.0,4/10,21.58%,NRCAM;RTN4;CNTN4;EPHA4
prerank,regulation of mitochondrial translation (GO:0070129),0.23260380469039005,0.5630069709150404,0.9641791044776119,0.9935266430887795,1.0,2/21,7.26%,MTG2;NGRN
prerank,long-term memory (GO:0007616),-0.20459139044486188,-0.5613286680311417,0.9707602339181286,0.9915869401188082,1.0,3/19,15.27%,APOE;CPEB3;EIF2AK4
prerank,purine nucleotide biosynthetic process (GO:0006164),0.263525022630137,0.5600820209753579,0.9387040280210157,0.9945147062222235,1.0,1/12,3.76%,GART
prerank,acylglycerol catabolic process (GO:0046464),0.21554995849715233,0.5594914842164265,0.9617563739376771,0.9944020075548057,1.0,5/30,22.82%,ABHD6;ABHD2;FABP3;PNPLA2;MGLL
prerank,hydrogen peroxide metabolic process (GO:0042743),0.24044518630199915,0.5574645092560857,0.953968253968254,0.9949311718159926,1.0,5/19,23.71%,ACOX1;CYBA;MAOB;SOD1;NOX1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2636253483995354,0.5569078866646443,0.9410801963993454,0.994791225695564,1.0,4/11,20.99%,ASF1A;H3-3A;RBBP4;IPO4
prerank,nucleosome organization (GO:0034728),0.1994846291081595,0.5564490691383183,0.9836477987421384,0.9946139901295502,1.0,15/55,21.46%,SRCAP;ASF1A;NPM1;DMAP1;ACTR6;VPS72;SMARCC1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;PRDM9;SETD2;NAP1L3
prerank,histone H2B ubiquitination (GO:0033523),0.2678257737331309,0.5564137711497232,0.9276094276094277,0.9942452523099341,1.0,6/10,27.63%,DTX3L;UBE2E1;RNF20;RNF40;RNF8;CDC73
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.20440126970688532,-0.5561709459827532,0.9828571428571429,0.9924485951438903,1.0,4/20,17.73%,AMPD3;LHPP;ATIC;IMPDH2
prerank,DNA catabolic process (GO:0006308),0.27018354378079384,0.5555189929038012,0.9424342105263158,0.9942540308009833,1.0,2/11,10.88%,DFFB;XRN2
prerank,maturation of 5.8S rRNA (GO:0000460),0.24758776216651363,0.5552775235280861,0.9633587786259542,0.9939694710029107,1.0,7/17,22.64%,RRP15;EIF6;LAS1L;FTSJ3;C1D;EXOSC10;URB1
prerank,phagosome maturation (GO:0090382),0.2144085210702687,0.5544790546238929,0.9582753824756607,0.9939178192706939,1.0,8/35,20.77%,RAB34;RAB39A;MCOLN1;ATP6V1G1;ATP6V1C1;ATP6V0A1;RAB31;ATP6V1D
prerank,axonal transport of mitochondrion (GO:0019896),0.26444808692785354,0.5543657257654668,0.9316987740805605,0.9935774250841859,1.0,3/11,18.42%,HIF1A;SYBU;HAP1
prerank,positive regulation of cytokinesis (GO:0032467),0.21301726662473675,0.5541701803816165,0.9646892655367232,0.9932604665657163,1.0,7/32,21.88%,CUL3;CDC14A;PKN2;MAP10;GIPC1;ECT2;KIF23
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.23586795837133512,0.5526657867540419,0.9346092503987241,0.993513411964555,1.0,1/18,3.31%,HHEX
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.26587280717175776,0.5525888547710578,0.943801652892562,0.9931606183491365,1.0,4/10,27.70%,APC;ECT2;KNSTRN;RCC2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.24869224718909624,0.5521269499496396,0.9433070866141732,0.9929752146310906,1.0,1/15,2.87%,SYN3
prerank,DNA packaging (GO:0006323),-0.21081025980331575,-0.5514979770488081,0.9518413597733711,0.9930440720863963,1.0,5/16,25.78%,HAT1;NOC2L;H1-0;NAA10;CHAF1A
prerank,tryptophan catabolic process (GO:0006569),0.2607494821417361,0.5504375238045565,0.9483333333333334,0.9932989547769839,1.0,11/11,73.94%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;AFMID;KMO
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.17744831406812533,-0.5502847945404477,0.9938080495356038,0.992487019695604,1.0,8/30,19.47%,RNF31;UBL5;UBE2L3;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,insulin secretion (GO:0030073),0.23079686219551215,0.5482407641495601,0.9418238993710691,0.9937945287696848,1.0,6/19,29.09%,GAL;SNX19;RAB11FIP2;PTPRN2;SELENOT;MAFA
prerank,glycoprotein catabolic process (GO:0006516),0.23647111388073377,0.5468168336946276,0.966412213740458,0.9940075957158929,1.0,6/17,19.35%,MANBA;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2370542127838243,0.5464612628470453,0.95,0.9937622230440604,1.0,1/19,2.70%,SLC25A32
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21805680559657795,0.5439282306207026,0.9732394366197183,0.9943862519518984,1.0,5/30,14.18%,TAF1A;POLR1F;CAVIN1;GTF2H3;TAF1B
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.22129755009832594,0.5434300041840673,0.9588839941262849,0.9941953251687808,1.0,11/24,28.72%,STN1;TNKS;XRN1;ERCC4;CTC1;EXOSC10;TERF2;TINF2;TNKS2;HNRNPC;HNRNPA1
prerank,vacuolar acidification (GO:0007035),-0.19006223204847902,-0.5417475097226008,0.9827089337175793,0.9940917173485019,1.0,11/21,33.67%,ATP6V0A4;TCIRG1;CLN5;CLN3;ATP6V1H;ATP6V0D2;CLN6;DMXL1;ATP6V0E2;SLC11A1;TMEM9
prerank,branched-chain amino acid catabolic process (GO:0009083),0.22591032266378952,0.5392866285421565,0.9791356184798807,0.9949953790394693,1.0,5/20,21.20%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.22591032266378952,0.5392866285421565,0.9791356184798807,0.9949953790394693,1.0,5/20,21.20%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,indolalkylamine catabolic process (GO:0046218),0.26073311574190317,0.539258664975818,0.9528619528619529,0.9946249996611908,1.0,10/10,73.94%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,cellular response to arsenic-containing substance (GO:0071243),0.23698681280580083,0.5374363489711327,0.9585326953748007,0.9948946176559413,1.0,6/15,28.72%,ZC3H12A;DAXX;PPIF;DHX36;ZFAND1;HNRNPA1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.23884345890684744,0.5348221604910562,0.9568690095846646,0.9954523151037334,1.0,4/16,17.93%,MRAP2;CHGA;NECAB2;GSK3A
prerank,folic acid metabolic process (GO:0046655),0.23221953574988266,0.5344732308362969,0.960127591706539,0.9951911320574143,1.0,1/18,2.70%,SLC25A32
prerank,negative regulation of secretion (GO:0051048),0.2568011221841792,0.5310562231098777,0.949740034662045,0.9959415009614084,1.0,1/10,7.40%,VAMP8
prerank,isotype switching (GO:0045190),0.2613311485286461,0.5297477864130995,0.9546191247974068,0.9960131561307023,1.0,1/10,7.65%,EXOSC3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.18280354439613072,0.5294447386754458,0.9913258983890955,0.9957278766732304,1.0,6/68,10.72%,SLC2A1;SLC25A32;THTPA;RFK;MMAA;PDZD11
prerank,DNA recombination (GO:0006310),0.20363761736325847,0.5287920422205135,0.976063829787234,0.9955527632609757,1.0,3/37,9.50%,RAD54B;RAD21;HMGB1
prerank,DNA replication (GO:0006260),0.1759139366770309,0.5254123263036218,0.9963985594237695,0.9962765080217881,1.0,26/105,24.06%,RBBP8;WRNIP1;ORC3;FEN1;BRIP1;POLA1;POLG2;POLB;WDHD1;BRCA1;ORC5;RAD1;ATM;KAT7;RFC2;RAD9B;MCMBP;ATRIP;BARD1;HUS1;BLM;RMI1;ORC4;KIN;RNASEH2A;WRN
prerank,DNA methylation (GO:0006306),0.217771029277536,0.5250195990555983,0.9674418604651163,0.9960117143286545,1.0,4/23,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,regulation of adaptive immune response (GO:0002819),0.22641635414743805,0.5248392711491126,0.968944099378882,0.9956828673056075,1.0,1/18,4.30%,FCGR2B
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.23095458934513383,0.5245796130190923,0.9772357723577236,0.9953830795968497,1.0,2/18,11.00%,CMKLR1;BAG6
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.22647563033673176,0.5190419470621145,0.9669291338582677,0.9966922057992155,1.0,2/16,9.31%,ZC3H12A;ZFP36L2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.23443275320899634,0.5162610559691464,0.9638752052545156,0.997127444252131,1.0,5/14,22.69%,ACOX1;ACOX3;CROT;DECR2;HSD17B4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.20569911069531893,0.5159188001763764,0.9812138728323699,0.9968511666935952,1.0,2/27,7.42%,CTPS1;CMPK1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.19000401353458746,-0.5141356766776719,0.9917355371900827,1.0,1.0,3/17,12.93%,AFG1L;COX10;COX7A2L
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.18300867001782273,0.5139222040104116,0.9948783610755442,0.996646988671943,1.0,14/56,24.05%,TMEM126B;NDUFS4;NDUFA12;NDUFB5;NDUFB7;TIMMDC1;ACAD9;NUBPL;NDUFB4;NDUFA9;NDUFV1;BCS1L;NDUFC1;NDUFA11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.18300867001782273,0.5139222040104116,0.9948783610755442,0.996646988671943,1.0,14/56,24.05%,TMEM126B;NDUFS4;NDUFA12;NDUFB5;NDUFB7;TIMMDC1;ACAD9;NUBPL;NDUFB4;NDUFA9;NDUFV1;BCS1L;NDUFC1;NDUFA11
prerank,telomere maintenance via telomerase (GO:0007004),0.20402138237696604,0.5096969894692371,0.9870503597122302,0.9974594819911536,1.0,12/28,29.41%,DKC1;PTGES3;NHP2;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1;NOP10;HSP90AB1
prerank,DNA modification (GO:0006304),0.21105527638190932,0.5084012832121845,0.9744360902255639,0.9974436221730039,1.0,22/22,78.92%,EXOSC3;TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1;SMUG1;NEIL3;MPG;MBD4;UNG;NEIL2;TDG;EXOSC4;EXOSC5;PARP2;NEIL1;PARP1;PARP3
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.22900516135187537,0.5064945499421182,0.9677938808373591,0.9975702047330836,1.0,3/15,15.98%,PTTG1;CDC27;ANAPC7
prerank,regulation of phosphate metabolic process (GO:0019220),-0.18968981539620747,-0.5060883453156192,0.9923469387755102,1.0,1.0,16/16,81.06%,SIRT2;SRPX2;TIGAR;PSEN1;SMG6;MCM7;GNB3;IL4;RAD17;IKBKB;SMG5;PGAM1;IGBP1;SMG7;BARD1;CD24
prerank,cellular response to UV (GO:0034644),0.17408583487499302,0.5058442272028809,1.0,0.9973355137541244,1.0,21/76,26.25%,MMP1;HYAL2;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;XPC;BMF;PPID;TIMP1;COPS9;USP47;MME;TMEM161A;DHX36;CARD16;RPL26;PCNA;RUVBL2
prerank,Golgi to lysosome transport (GO:0090160),0.23830412333849416,0.5029833146792652,0.9629005059021922,0.9976757168814434,1.0,3/11,19.92%,LAPTM5;SORT1;CCDC91
prerank,protein localization to mitochondrion (GO:0070585),-0.20856933441498116,-0.5019722049332881,0.9696202531645569,1.0,1.0,2/11,11.10%,COX18;HK2
prerank,cilium-dependent cell motility (GO:0060285),-0.17540595773493567,-0.5019326036899454,0.9787878787878788,0.9998833601727144,1.0,11/22,36.51%,CFAP44;EFHC1;RFX3;GAS8;RSPH9;DRC1;CCDC39;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.1866157797106472,-0.5017646968601946,0.9918256130790191,0.9989931625024228,1.0,10/18,37.65%,LIG3;POLD2;GINS1;POLE;RFC4;MCM7;POLE3;POLD3;GINS3;GINS2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.23621894058895804,0.5011197644341563,0.9811965811965812,0.9977764809279841,1.0,1/11,8.22%,JAK2
prerank,steroid catabolic process (GO:0006706),-0.21069650339028984,-0.4998901227558011,0.9928057553956835,0.9984421726953313,1.0,3/10,26.88%,SPP1;HSD11B1;HSD17B11
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.2090164732989424,-0.4963843780117029,0.9797979797979798,0.9981907160334582,1.0,7/11,42.17%,SIRT2;STMN1;MST1R;HPN;PAK1;HGF;NRP1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.23649833556039707,0.4950493031242766,0.971900826446281,0.9988525069975578,1.0,1/11,9.89%,MAD2L2
prerank,DNA replication initiation (GO:0006270),0.18510611906436952,0.49129603332009425,0.9918144611186903,0.9993230541340126,1.0,4/37,12.09%,ORC3;PURA;POLA1;ORC5
prerank,macrophage migration (GO:1905517),-0.19675628922160546,-0.48934433777354297,0.9840848806366048,0.9984262541747899,1.0,7/13,39.29%,P2RX4;EDNRB;CKLF;CCR2;CCL2;CXCL17;CCL5
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.2069203335015301,-0.4889932323607816,0.9855769230769231,0.9975731458524434,1.0,4/10,30.36%,UBE2G2;ERLEC1;SVIP;DERL2
prerank,cellular response to light stimulus (GO:0071482),0.17261773625561383,0.48823423838808805,0.9963592233009708,0.9996081582711676,1.0,18/66,28.23%,RRH;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;BMF;COPS9;USP47;TMEM161A;DHX36;RPL26;PCNA;RUVBL2;SMPD1;ZBTB1;SAG
prerank,lysine catabolic process (GO:0006554),0.22466839288941617,0.48236609762597193,0.9795221843003413,1.0,1.0,4/12,22.87%,DLD;AASS;PHYKPL;PIPOX
prerank,lysine metabolic process (GO:0006553),0.22466839288941617,0.48236609762597193,0.9795221843003413,1.0,1.0,4/12,22.87%,DLD;AASS;PHYKPL;PIPOX
prerank,tRNA 5'-end processing (GO:0099116),-0.18703311546850854,-0.48186859606833504,0.9821882951653944,0.9977570025630182,1.0,8/15,41.19%,SSB;RPP14;POP4;HSD17B10;RPP25L;POP7;RPP40;POP5
prerank,"base-excision repair, gap-filling (GO:0006287)",0.18373683646512234,0.48111803968525324,0.991701244813278,0.9999299820559118,1.0,5/35,15.37%,APEX1;FEN1;POLB;LIG1;RFC2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.19041576807839183,-0.48049147465709513,0.9877750611246944,0.9970736382571083,1.0,4/13,29.93%,MDK;RHOA;ITGB2;NFAT5
prerank,regulation of lymphocyte proliferation (GO:0050670),0.21142096221651765,0.48033571474455355,0.9824,0.9997137542826607,1.0,1/16,5.71%,TNFRSF1B
prerank,detection of calcium ion (GO:0005513),0.22486907954803392,0.4783597396969393,0.9731543624161074,0.9996905385456216,1.0,5/13,25.94%,CALM3;SYT1;KCNIP2;RYR2;CALM1
prerank,glycerolipid metabolic process (GO:0046486),-0.1997991337643588,-0.47347976804891306,0.9808153477218226,0.9971743356798222,1.0,11/11,80.04%,PLA2G15;GAL3ST1;PDXP;PNPLA3;DGKZ;PGP;DGKQ;PIP5K1A;DGKG;DGKB;DGKA
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.21774154775194826,0.4722805381373153,0.9878048780487805,1.0,1.0,5/12,30.05%,STK33;HUS1;CHEK2;NAE1;TOPBP1
prerank,nucleoside salvage (GO:0043174),0.2303540045192067,0.4709471258750165,0.9862068965517241,1.0,1.0,10/10,76.98%,UPP2;TK1;UCK2;HPRT1;UCKL1;UPP1;TK2;DCK;UCK1;CDA
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.22644877626273435,0.46846511371049654,0.9834162520729685,1.0,1.0,3/10,26.67%,NUMA1;PRKCH;NCOA3
prerank,leukotriene metabolic process (GO:0006691),-0.16894590651664332,-0.4684569040493186,1.0,0.9968851083605217,1.0,9/19,36.57%,PLA2G4A;GGT5;ALOX12;PTGR1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,serine family amino acid metabolic process (GO:0009069),0.20453332396169122,0.46571618539042403,0.988673139158576,1.0,1.0,3/16,19.72%,GLYAT;SEPSECS;CDO1
prerank,cellular response to interleukin-7 (GO:0098761),0.2010162421524405,0.4574289388553756,0.9906687402799378,1.0,1.0,1/17,3.95%,CISH
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.2010162421524405,0.4574289388553756,0.9906687402799378,1.0,1.0,1/17,3.95%,CISH
prerank,histone H2A ubiquitination (GO:0033522),0.1949911285324874,0.45669646272831216,0.9878419452887538,1.0,1.0,3/17,16.94%,RYBP;DTX3L;KDM2B
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.20330701032432957,0.4558519844234843,0.9906687402799378,1.0,1.0,4/15,20.01%,NEK11;RAD9B;HUS1;MDC1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.2134817292722775,0.4550818354096715,0.9837925445705025,1.0,1.0,4/12,25.89%,ZC3H12A;ESR1;NCOR2;TGFB1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.20615276672880184,0.45369959956305145,0.9852459016393442,0.9998778466277873,1.0,4/13,20.37%,ALG14;ALG11;DPAGT1;ALG1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.21783434785841438,0.4532379287920386,0.9830508474576272,0.9995725664030448,1.0,3/11,22.32%,THTPA;NT5C3A;SLC25A19
prerank,"base-excision repair, AP site formation (GO:0006285)",0.19563819412200878,0.4504837171832071,0.9860248447204969,0.9995422003097253,1.0,8/17,32.42%,TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1
prerank,sensory perception of smell (GO:0007608),0.21546758725283566,0.45038261568334054,0.979557069846678,0.999172287339815,1.0,3/11,29.46%,SLC24A4;MKKS;ADCY3
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.18758608656354908,0.4492663698982876,0.9880952380952381,0.9989441205022549,1.0,7/23,26.28%,HSP90B1;TMED9;SEL1L;TECPR2;TMEM129;SELENOS;HERPUD1
prerank,tRNA 5'-leader removal (GO:0001682),-0.17929401071146608,-0.4455381746351736,0.995,0.9983473435251462,1.0,9/13,47.19%,SSB;RPP14;POP4;RPP25L;POP7;RPP40;POP5;PRORP;RPP25
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.17509942706199788,0.443175261210113,0.9957264957264957,0.999350176301984,1.0,9/31,28.30%,TOMM20L;DNLZ;PAM16;PEX1;TIMM17A;PEX26;PEX6;PEX10;TOMM70
prerank,triglyceride catabolic process (GO:0019433),0.1879042893927024,0.442013334961888,0.9921630094043887,0.9991040608782199,1.0,19/19,81.23%,FABP3;PNPLA2;PNPLA5;PNLIPRP2;PNPLA1;LIPI;FABP2;FABP6;APOC3;FABP5;CPS1;LIPG;PNPLA3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.17450365255744058,0.4410565542417178,0.9914772727272727,0.9988427724198743,1.0,12/29,29.41%,DKC1;PTGES3;NHP2;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1;NOP10;HSP90AB1
prerank,icosanoid metabolic process (GO:0006690),0.16601239713318336,0.440614437209545,0.9985734664764622,0.9985141263622224,1.0,12/40,27.51%,ALOXE3;ABCC1;ABCC10;PON2;PTGIS;PON3;MAPKAPK2;MGLL;TBXAS1;LTA4H;EPHX1;DPEP2
prerank,fibrinolysis (GO:0042730),-0.17314332349802247,-0.43489632211330764,0.9946091644204852,0.998304988029277,1.0,13/13,82.71%,SERPINE1;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;SERPINF2;FGG;PLAT;PLAUR
prerank,protein neddylation (GO:0045116),0.20102240895825224,0.43380941622068453,0.9983388704318937,0.998850666186652,1.0,5/13,32.12%,RBX1;DCUN1D2;RNF7;NAE1;UBE2M
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.1770957994084027,0.43248151128026197,0.9956958393113343,0.9986143167147238,1.0,2/23,12.51%,NMT1;METAP2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.17276906028597905,0.4276558360737384,0.997037037037037,0.9987097882045988,1.0,4/27,18.51%,CD47;PYCARD;ETS1;RELA
prerank,cobalamin metabolic process (GO:0009235),0.18525905968396766,0.42753859493316315,0.9919484702093397,0.9983437463876421,1.0,2/17,12.95%,MMAA;ABCC1
prerank,regulation of mitotic spindle organization (GO:0060236),0.15727042890404327,0.4110151132089067,0.9971305595408895,0.9993437756747625,1.0,14/35,29.78%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;CHMP1A;RAE1;TPR;VPS4B;CHMP4B;EML3;DCTN1;CLTC;HSPA1A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.161529286207546,-0.4091501799251932,1.0,0.9987981336133029,1.0,13/13,83.87%,NT5M;NEIL1;TDG;NEIL2;DCTPP1;UNG;DUT;MBD4;SMUG1;NTHL1;OGG1;NT5C;UPP2
prerank,telomere capping (GO:0016233),0.18455520007420206,0.40820092646875505,0.9938080495356038,0.9991631271737467,1.0,5/16,25.76%,STN1;CTC1;TERF2IP;TERF2;TINF2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.1903216378306488,0.40619537903520736,0.9948630136986302,0.9989163865639461,1.0,6/12,31.49%,B4GALT6;HSP90AA1;MYCBP2;HSP90AB1;SPTBN4;B4GALT5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.1939585458536171,0.4056684605321335,0.9966159052453468,0.9985718662743733,1.0,2/10,17.53%,NPTX2;NPTX1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.18998502966993275,0.4017456969995622,0.9966996699669967,0.9984314965951225,1.0,4/11,27.40%,ANK3;PLAUR;RDX;JAK1
prerank,tetrapyrrole metabolic process (GO:0033013),0.17189737010016756,0.40025871536541113,0.9968102073365231,0.9981512778216579,1.0,2/18,12.95%,MMAA;ABCC1
prerank,serine family amino acid catabolic process (GO:0009071),0.18183530002510664,0.3747733504361378,1.0,0.9989277990179327,1.0,10/10,81.83%,DLD;CBS;THNSL2;SDS;AMT;DAO;SHMT1;GLDC;SHMT2;GCSH
